Document_and_Entity_Informatio
Document and Entity Information (USD $) | 12 Months Ended | ||
Dec. 31, 2014 | Feb. 12, 2015 | Jun. 30, 2014 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | FALSE | ||
Document Period End Date | 31-Dec-14 | ||
Document Fiscal Year Focus | 2014 | ||
Document Fiscal Period Focus | FY | ||
Trading Symbol | GNW | ||
Entity Registrant Name | GENWORTH FINANCIAL INC | ||
Entity Central Index Key | 1276520 | ||
Current Fiscal Year End Date | -19 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Common Stock, Shares Outstanding | 496,996,382 | ||
Entity Public Float | $8,600,000,000 |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | ||||
In Millions, unless otherwise specified | ||||||||
Assets | ||||||||
Fixed maturity securities available-for-sale, at fair value | $62,447 | $58,629 | ||||||
Equity securities available-for-sale, at fair value | 282 | 341 | ||||||
Commercial mortgage loans | 6,100 | 5,899 | ||||||
Restricted commercial mortgage loans related to securitization entities | 201 | 233 | ||||||
Policy loans | 1,501 | 1,434 | ||||||
Other invested assets | 2,296 | 1,686 | ||||||
Restricted other invested assets related to securitization entities, at fair value | 411 | 391 | ||||||
Total investments | 73,238 | 68,613 | ||||||
Cash and cash equivalents | 4,918 | 4,214 | 3,632 | |||||
Accrued investment income | 685 | 678 | ||||||
Deferred acquisition costs | 5,042 | 5,278 | 5,036 | |||||
Intangible assets | 272 | 399 | ||||||
Goodwill | 16 | 867 | 868 | |||||
Reinsurance recoverable | 17,346 | 17,219 | ||||||
Other assets | 633 | 639 | ||||||
Separate account assets | 9,208 | 10,138 | ||||||
Total assets | 111,358 | 108,045 | ||||||
Liabilities and stockholders' equity | ||||||||
Future policy benefits | 35,915 | 33,705 | ||||||
Policyholder account balances | 26,043 | 25,528 | ||||||
Liability for policy and contract claims | 8,043 | 7,204 | ||||||
Unearned premiums | 3,986 | 4,107 | ||||||
Other liabilities ($45 and $50 of other liabilities are related to securitization entities) | 3,604 | 4,096 | ||||||
Borrowings related to securitization entities ($85 and $75 are carried at fair value) | 219 | 242 | ||||||
Non-recourse funding obligations | 1,996 | 2,038 | ||||||
Long-term borrowings | 4,639 | 5,161 | ||||||
Deferred tax liability | 908 | 206 | ||||||
Separate account liabilities | 9,208 | 10,138 | ||||||
Total liabilities | 94,561 | 92,425 | ||||||
Commitments and contingencies | ||||||||
Stockholders' equity: | ||||||||
Class A common stock, $0.001 par value; 1.5 billion shares authorized; 585 million and 583 million shares issued as of December 31, 2014 and 2013, respectively; 497 million and 495 million shares outstanding as of December 31, 2014 and 2013, respectively | 1 | 1 | ||||||
Additional paid-in capital | 11,997 | 12,127 | ||||||
Net unrealized investment gains (losses): | ||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 2,431 | 914 | ||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 22 | 12 | ||||||
Net unrealized investment gains (losses) | 2,453 | [1] | 926 | [1] | 2,638 | [1] | 1,485 | [1] |
Derivatives qualifying as hedges | 2,070 | [2] | 1,319 | [2] | 1,909 | [2] | 2,009 | [2] |
Foreign currency translation and other adjustments | -77 | 297 | 655 | 553 | ||||
Total accumulated other comprehensive income (loss) | 4,446 | 2,542 | 5,202 | 4,047 | ||||
Retained earnings | 1,179 | 2,423 | ||||||
Treasury stock, at cost (88 million shares as of December 31, 2014 and 2013) | -2,700 | -2,700 | ||||||
Total Genworth Financial, Inc.'s stockholders' equity | 14,923 | 14,393 | ||||||
Noncontrolling interests | 1,874 | 1,227 | ||||||
Total stockholders' equity | 16,797 | 15,620 | 17,781 | 16,132 | ||||
Total liabilities and stockholders' equity | $111,358 | $108,045 | ||||||
[1] | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. | |||||||
[2] | See note 5 for additional information. |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parenthetical) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, except Share data, unless otherwise specified | ||||
Other liabilities, securitization entities | $45 | $50 | ||
Borrowings related to securitization entities, fair value | $85 | [1] | $75 | [1] |
Class A Common Stock, par value | $0.00 | $0.00 | ||
Class A Common Stock, shares authorized | 1,500,000,000 | 1,500,000,000 | ||
Class A Common Stock, shares issued | 585,000,000 | 583,000,000 | ||
Class A Common Stock, shares outstanding | 497,000,000 | 495,000,000 | ||
Treasury stock, shares | 88,000,000 | 88,000,000 | ||
[1] | See note 18 for additional information related to consolidated securitization entities. |
Consolidated_Statements_of_Inc
Consolidated Statements of Income (USD $) | 12 Months Ended | |||||
In Millions, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Revenues: | ||||||
Premiums | $5,431 | $5,148 | $5,041 | |||
Net investment income | 3,242 | 3,271 | 3,343 | |||
Net investment gains (losses) | -20 | -37 | 27 | |||
Insurance and investment product fees and other | 912 | 1,021 | 1,229 | |||
Total revenues | 9,565 | 9,403 | 9,640 | |||
Benefits and expenses: | ||||||
Benefits and other changes in policy reserves | 6,620 | 4,895 | 5,378 | |||
Interest credited | 737 | 738 | 775 | |||
Acquisition and operating expenses, net of deferrals | 1,585 | 1,659 | 1,594 | |||
Amortization of deferred acquisition costs and intangibles | 571 | 569 | 722 | |||
Goodwill impairment | 849 | 0 | 89 | |||
Interest expense | 479 | 492 | 476 | |||
Total benefits and expenses | 10,841 | 8,353 | 9,034 | |||
Income (loss) from continuing operations before income taxes | -1,276 | 1,050 | 606 | |||
Provision (benefit) for income taxes | -228 | 324 | 138 | |||
Income (loss) from continuing operations | -1,048 | 726 | 468 | |||
Income (loss) from discontinued operations, net of taxes | 0 | -12 | 57 | |||
Net income (loss) | -1,048 | 714 | 525 | |||
Less: net income attributable to noncontrolling interests | 196 | 154 | 200 | |||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -1,244 | 560 | 325 | |||
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per common share: | ||||||
Basic | ($2.51) | $1.16 | $0.55 | |||
Diluted | ($2.51) | $1.15 | $0.54 | |||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders per common share: | ||||||
Basic | ($2.51) | $1.13 | $0.66 | |||
Diluted | ($2.51) | $1.12 | $0.66 | |||
Weighted-average common shares outstanding: | ||||||
Basic | 496.4 | 493.6 | 491.6 | |||
Diluted | 496.4 | [1] | 498.7 | [1] | 494.4 | [1] |
Supplemental disclosures: | ||||||
Total other-than-temporary impairments | -9 | -16 | -62 | |||
Portion of other-than-temporary impairments included in other comprehensive income (loss) | 0 | -9 | -44 | |||
Net other-than-temporary impairments | -9 | -25 | -106 | |||
Other investment gains (losses) | -11 | -12 | 133 | |||
Net investment gains (losses) | ($20) | ($37) | $27 | |||
[1] | Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the year ended December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the year ended December 31, 2014, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.6 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the year ended December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million. |
Consolidated_Statements_of_Com
Consolidated Statements of Comprehensive Income (USD $) | 3 Months Ended | 12 Months Ended | ||||||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||||||
Net income (loss) | ($708) | [1] | ($787) | [1] | $228 | [1] | $219 | [1] | $245 | $148 | $180 | $141 | ($1,048) | $714 | $525 | |||
Other comprehensive income (loss), net of taxes: | ||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,573 | -1,817 | 1,078 | |||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 10 | 66 | 78 | |||||||||||||||
Derivatives qualifying as hedges | 751 | [2] | -590 | [2] | -100 | [2] | ||||||||||||
Foreign currency translation and other adjustments | -537 | -442 | 126 | |||||||||||||||
Total other comprehensive income (loss) | 1,797 | -2,783 | 1,182 | |||||||||||||||
Total comprehensive income (loss) | 749 | -2,069 | 1,707 | |||||||||||||||
Less: comprehensive income attributable to noncontrolling interests | 32 | 31 | 227 | |||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders | $717 | ($2,100) | $1,480 | |||||||||||||||
[1] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. | |||||||||||||||||
[2] | See note 5 for additional information. |
Consolidated_Statements_of_Cha
Consolidated Statements of Changes in Stockholders' Equity (USD $) | Total | Common stock | Additional paid-in capital | Accumulated other comprehensive income (loss) | Retained earnings | Treasury stock, at cost | Total Genworth Financial, Inc.'s stockholders' equity | Noncontrolling interests | |
In Millions, unless otherwise specified | |||||||||
Balances at Dec. 31, 2011 | $16,132 | $1 | $12,136 | $4,047 | $1,538 | ($2,700) | $15,022 | $1,110 | |
Comprehensive income (loss): | |||||||||
Net income (loss) | 525 | 0 | 0 | 0 | 325 | 0 | 325 | 200 | |
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,078 | 0 | 0 | 1,075 | 0 | 0 | 1,075 | 3 | |
Net unrealized gains (losses) on other-than-temporarily impaired securities | 78 | 0 | 0 | 78 | 0 | 0 | 78 | 0 | |
Derivatives qualifying as hedges | -100 | [1] | 0 | 0 | -100 | 0 | 0 | -100 | 0 |
Foreign currency translation and other adjustments | 126 | 0 | 0 | 102 | 0 | 0 | 102 | 24 | |
Total comprehensive income (loss) | 1,707 | 1,480 | 227 | ||||||
Dividends to noncontrolling interests | -50 | 0 | 0 | 0 | 0 | 0 | 0 | -50 | |
Stock-based compensation expense and exercises and other | -8 | 0 | -9 | 0 | 0 | 0 | -9 | 1 | |
Balances at Dec. 31, 2012 | 17,781 | 1 | 12,127 | 5,202 | 1,863 | -2,700 | 16,493 | 1,288 | |
Repurchase of subsidiary shares | -43 | 0 | 0 | 0 | 0 | 0 | 0 | -43 | |
Comprehensive income (loss): | |||||||||
Net income (loss) | 714 | 0 | 0 | 0 | 560 | 0 | 560 | 154 | |
Net unrealized gains (losses) on securities not other-than-temporarily impaired | -1,817 | 0 | 0 | -1,778 | 0 | 0 | -1,778 | -39 | |
Net unrealized gains (losses) on other-than-temporarily impaired securities | 66 | 0 | 0 | 66 | 0 | 0 | 66 | 0 | |
Derivatives qualifying as hedges | -590 | [1] | 0 | 0 | -590 | 0 | 0 | -590 | 0 |
Foreign currency translation and other adjustments | -442 | 0 | 0 | -358 | 0 | 0 | -358 | -84 | |
Total comprehensive income (loss) | -2,069 | -2,100 | 31 | ||||||
Dividends to noncontrolling interests | -52 | 0 | 0 | 0 | 0 | 0 | 0 | -52 | |
Stock-based compensation expense and exercises and other | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | |
Balances at Dec. 31, 2013 | 15,620 | 1 | 12,127 | 2,542 | 2,423 | -2,700 | 14,393 | 1,227 | |
Initial sale of subsidiary shares to noncontrolling interests | 511 | 0 | -145 | -57 | 0 | 0 | -202 | 713 | |
Repurchase of subsidiary shares | -28 | 0 | 0 | 0 | 0 | 0 | 0 | -28 | |
Comprehensive income (loss): | |||||||||
Net income (loss) | -1,048 | 0 | 0 | 0 | -1,244 | 0 | -1,244 | 196 | |
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,573 | 0 | 0 | 1,539 | 0 | 0 | 1,539 | 34 | |
Net unrealized gains (losses) on other-than-temporarily impaired securities | 10 | 0 | 0 | 10 | 0 | 0 | 10 | 0 | |
Derivatives qualifying as hedges | 751 | [1] | 0 | 0 | 751 | 0 | 0 | 751 | 0 |
Foreign currency translation and other adjustments | -537 | 0 | 0 | -339 | 0 | 0 | -339 | -198 | |
Total comprehensive income (loss) | 749 | 717 | 32 | ||||||
Dividends to noncontrolling interests | -75 | 0 | 0 | 0 | 0 | 0 | 0 | -75 | |
Stock-based compensation expense and exercises and other | 20 | 0 | 15 | 0 | 0 | 0 | 15 | 5 | |
Balances at Dec. 31, 2014 | $16,797 | $1 | $11,997 | $4,446 | $1,179 | ($2,700) | $14,923 | $1,874 | |
[1] | See note 5 for additional information. |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Cash flows from operating activities: | |||
Net income (loss) | ($1,048) | $714 | $525 |
Less (income) loss from discontinued operations, net of taxes | 0 | 12 | -57 |
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||
Amortization of fixed maturity discounts and premiums and limited partnerships | -97 | -97 | -88 |
Net investment (gains) losses | 20 | 37 | -27 |
Charges assessed to policyholders | -777 | -812 | -801 |
Acquisition costs deferred | -473 | -457 | -611 |
Amortization of deferred acquisition costs and intangibles | 571 | 569 | 722 |
Goodwill impairment | 849 | 0 | 89 |
Deferred income taxes | -487 | -79 | 82 |
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | 206 | -59 | 191 |
Stock-based compensation expense | 30 | 41 | 26 |
Change in certain assets and liabilities: | |||
Accrued investment income and other assets | -129 | -43 | -68 |
Insurance reserves | 3,212 | 2,256 | 2,330 |
Current tax liabilities | -180 | 288 | -234 |
Other liabilities, policy and contract claims and other policy-related balances | 741 | -1,039 | -1,166 |
Cash from operating activities-discontinued operations | 0 | 68 | 49 |
Net cash from operating activities | 2,438 | 1,399 | 962 |
Cash flows from investing activities: | |||
Fixed maturity securities | 5,364 | 5,040 | 5,176 |
Commercial mortgage loans | 765 | 896 | 891 |
Restricted commercial mortgage loans related to securitization entities | 32 | 60 | 67 |
Proceeds from sales of investments: | |||
Fixed maturity and equity securities | 2,490 | 4,436 | 5,735 |
Purchases and originations of investments: | |||
Fixed maturity and equity securities | -9,492 | -10,805 | -12,322 |
Commercial mortgage loans | -967 | -873 | -692 |
Other invested assets, net | -40 | 89 | 416 |
Policy loans, net | 12 | 242 | -29 |
Proceeds from sale of a subsidiary, net of cash transferred | 0 | 365 | 77 |
Cash from investing activities-discontinued operations | 0 | -30 | -41 |
Net cash from investing activities | -1,836 | -580 | -722 |
Cash flows from financing activities: | |||
Deposits to universal life and investment contracts | 2,993 | 2,999 | 2,810 |
Withdrawals from universal life and investment contracts | -2,588 | -3,269 | -2,781 |
Redemption and repurchase of non-recourse funding obligations | -42 | -28 | -1,056 |
Proceeds from the issuance of long-term debt | 144 | 793 | 361 |
Repayment and repurchase of long-term debt | -621 | -365 | -322 |
Repayment of borrowings related to securitization entities | -32 | -108 | -72 |
Repurchase of subsidiary shares | -28 | -43 | 0 |
Dividends paid to noncontrolling interests | -75 | -52 | -50 |
Proceeds from the sale of subsidiary shares to noncontrolling interests | 517 | 0 | 0 |
Other, net | -63 | -73 | 54 |
Cash from financing activities-discontinued operations | 0 | -3 | -45 |
Net cash from financing activities | 205 | -149 | -1,101 |
Effect of exchange rate changes on cash and cash equivalents | -103 | -109 | 26 |
Net change in cash and cash equivalents | 704 | 561 | -835 |
Cash and cash equivalents at beginning of period | 4,214 | 3,653 | 4,488 |
Cash and cash equivalents at end of period | 4,918 | 4,214 | 3,653 |
Less cash and cash equivalents of discontinued operations at end of period | 0 | 0 | 21 |
Cash and cash equivalents at end of year | $4,918 | $4,214 | $3,632 |
Nature_of_Business_and_Formati
Nature of Business and Formation of Genworth | 12 Months Ended | |||
Dec. 31, 2014 | ||||
Nature of Business and Formation of Genworth | (1) Nature of Business and Formation of Genworth | |||
Genworth Holdings, Inc. (“Genworth Holdings”) (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an initial public offering (“IPO”) of Genworth common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, under the name Sub XLVI, Inc., and was renamed Genworth Financial, Inc. (“Genworth Financial”) upon the completion of the reorganization. | ||||
References to “Genworth,” the “Company,” “we” or “our” in the accompanying consolidated financial statements and these notes thereto have the following meanings, unless the context otherwise requires: | ||||
• | For periods prior to April 1, 2013: Genworth Holdings and its subsidiaries | |||
• | For periods from and after April 1, 2013: Genworth Financial and its subsidiaries | |||
The accompanying financial statements include on a consolidated basis the accounts of Genworth and our affiliate companies in which we hold a majority voting interest or where we are the primary beneficiary of a variable interest entity (“VIE”). All intercompany accounts and transactions have been eliminated in consolidation. | ||||
We have the following operating segments: | ||||
• | U.S. Life Insurance. We offer and manage a variety of insurance and fixed annuity products in the United States. Our primary products include long-term care insurance, life insurance and fixed annuities. | |||
• | International Mortgage Insurance. We are a leading provider of mortgage insurance products and related services in Canada and Australia and also participate in select European and other countries. Our products predominantly insure prime-based, individually underwritten residential mortgage loans, also known as flow mortgage insurance. We also selectively provide mortgage insurance on a structured, or bulk, basis that aids in the sale of mortgages to the capital markets and helps lenders manage capital and risk. Additionally, we offer services, analytical tools and technology that enable lenders to operate efficiently and manage risk. | |||
• | U.S. Mortgage Insurance. In the United States, we offer mortgage insurance products predominantly insuring prime-based, individually underwritten residential mortgage loans, also known as flow mortgage insurance. We selectively provide mortgage insurance on a bulk basis with essentially all of our bulk writings being prime-based. Additionally, we offer services, analytical tools and technology that enable lenders to operate efficiently and manage risk. | |||
• | International Protection. We provide payment protection coverages (referred to as lifestyle protection) in multiple European countries and have operations in select other countries. Our lifestyle protection insurance products primarily help consumers meet specified payment obligations should they become unable to pay due to accident, illness, involuntary unemployment, disability or death. | |||
• | Runoff. The Runoff segment includes the results of non-strategic products which are no longer actively sold. Our non-strategic products primarily include our variable annuity, variable life insurance, institutional, corporate-owned life insurance and other accident and health insurance products. Institutional products consist of: funding agreements, funding agreements backing notes (“FABNs”) and guaranteed investment contracts (“GICs”). We no longer offer retail and group variable annuities but continue to service our existing blocks of business. | |||
We also have Corporate and Other activities which include debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are managed outside of our operating segments, including discontinued operations. See note 25 for additional information related to discontinued operations. |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 12 Months Ended | |||
Dec. 31, 2014 | ||||
Summary of Significant Accounting Policies | (2) Summary of Significant Accounting Policies | |||
Our consolidated financial statements have been prepared on the basis of U.S. generally accepted accounting principles (“U.S. GAAP”). Preparing financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation. | ||||
a) Premiums | ||||
For traditional long-duration insurance contracts, we report premiums as earned when due. For short-duration insurance contracts, we report premiums as revenue over the terms of the related insurance policies on a pro-rata basis or in proportion to expected claims. | ||||
For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums. In addition, we have a practice of refunding the post-delinquent premiums in our U.S. mortgage insurance business to the insured party if the delinquent loan goes to claim. We record a liability for premiums received on the delinquent loans where our practice is to refund post-delinquent premiums. | ||||
Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabilities for policyholder account balances. | ||||
b) Net Investment Income and Net Investment Gains and Losses | ||||
Investment income is recognized when earned. Income or losses upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income, except for hybrid securities where the income or loss upon call is recognized in net investment gains and losses. Investment gains and losses are calculated on the basis of specific identification. | ||||
Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency) which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage-backed and asset-backed securities, future cash flows are estimated and interest income is recognized going forward using the new internal rate of return. | ||||
c) Insurance and Investment Product Fees and Other | ||||
Insurance and investment product fees and other consist primarily of insurance charges assessed on universal and term universal life insurance contracts and fees assessed against customer account values. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders and variable life insurance policyholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered. | ||||
d) Investment Securities | ||||
At the time of purchase, we designate our investment securities as either available-for-sale or trading and report them in our consolidated balance sheets at fair value. Our portfolio of fixed maturity securities comprises primarily investment grade securities. Changes in the fair value of available-for-sale investments, net of the effect on deferred acquisition costs (“DAC”), present value of future profits (“PVFP”), benefit reserves and deferred income taxes, are reflected as unrealized investment gains or losses in a separate component of accumulated other comprehensive income (loss). Realized and unrealized gains and losses related to trading securities are reflected in net investment gains (losses). Trading securities are included in other invested assets in our consolidated balance sheets and primarily represent fixed maturity securities where we utilized the fair value option. | ||||
Other-Than-Temporary Impairments On Available-For-Sale Securities | ||||
As of each balance sheet date, we evaluate securities in an unrealized loss position for other-than-temporary impairments. For debt securities, we consider all available information relevant to the collectability of the security, including information about past events, current conditions, and reasonable and supportable forecasts, when developing the estimate of cash flows expected to be collected. More specifically for mortgage-backed and asset-backed securities, we also utilize performance indicators of the underlying assets including default or delinquency rates, loan to collateral value ratios, third-party credit enhancements, current levels of subordination, vintage and other relevant characteristics of the security or underlying assets to develop our estimate of cash flows. Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the underlying collateral. Where possible, this data is benchmarked against third-party sources. | ||||
We recognize other-than-temporary impairments on debt securities in an unrealized loss position when one of the following circumstances exists: | ||||
• | we do not expect full recovery of our amortized cost based on the estimate of cash flows expected to be collected, | |||
• | we intend to sell a security or | |||
• | it is more likely than not that we will be required to sell a security prior to recovery. | |||
For other-than-temporary impairments recognized during the period, we present the total other-than-temporary impairments, the portion of other-than-temporary impairments included in other comprehensive income (loss) (“OCI”) and the net other-than-temporary impairments as supplemental disclosure presented on the face of our consolidated statements of income. | ||||
Total other-than-temporary impairments are calculated as the difference between the amortized cost and fair value that emerged in the current period. For other-than-temporarily impaired securities where we do not intend to sell the security and it is not more likely than not that we will be required to sell the security prior to recovery, total other-than-temporary impairments are adjusted by the portion of other-than-temporary impairments recognized in OCI (“non-credit”). Net other-than-temporary impairments recorded in net income (loss) represent the credit loss on the other-than-temporarily impaired securities with the offset recognized as an adjustment to the amortized cost to determine the new amortized cost basis of the securities. | ||||
For securities that were deemed to be other-than-temporarily impaired and a non-credit loss was recorded in OCI, the amount recorded as an unrealized gain (loss) represents the difference between the current fair value and the new amortized cost for each period presented. The unrealized gain (loss) on an other-than-temporarily impaired security is recorded as a separate component in OCI until the security is sold or until we record an other-than-temporary impairment where we intend to sell the security or will be required to sell the security prior to recovery. | ||||
To estimate the amount of other-than-temporary impairment attributed to credit losses on debt securities where we do not intend to sell the security and it is not more likely than not that we will be required to sell the security prior to recovery, we determine our best estimate of the present value of the cash flows expected to be collected from a security using the effective yield on the security prior to recording any other-than-temporary impairment. If the present value of the discounted cash flows is lower than the amortized cost of the security, the difference between the present value and amortized cost represents the credit loss associated with the security with the remaining difference between fair value and amortized cost recorded as a non-credit other-than-temporary impairment in OCI. | ||||
The evaluation of other-than-temporary impairments is subject to risks and uncertainties and is intended to determine the appropriate amount and timing for recognizing an impairment charge. The assessment of whether such impairment has occurred is based on management’s best estimate of the cash flows expected to be collected at the individual security level. We regularly monitor our investment portfolio to ensure that securities that may be other-than-temporarily impaired are identified in a timely manner and that any impairment charge is recognized in the proper period. | ||||
While the other-than-temporary impairment model for debt securities generally includes fixed maturity securities, there are certain hybrid securities that are classified as fixed maturity securities where the application of a debt impairment model depends on whether there has been any evidence of deterioration in credit of the issuer, such as a downgrade to below investment grade. Under certain circumstances, evidence of deterioration in credit of the issuer may result in the application of the equity securities impairment model. | ||||
For equity securities, we recognize an impairment charge in the period in which we determine that the security will not recover to book value within a reasonable period. We determine what constitutes a reasonable period on a security-by-security basis based upon consideration of all the evidence available to us, including the magnitude of an unrealized loss and its duration. In any event, this period does not exceed 18 months for common equity securities. We measure other-than-temporary impairments based upon the difference between the amortized cost of a security and its fair value. | ||||
e) Fair Value Measurements | ||||
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity, equity and trading securities, derivatives, embedded derivatives, securities held as collateral, separate account assets and certain other financial instruments, which are carried at fair value. | ||||
Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: | ||||
• | Level 1—Quoted prices for identical instruments in active markets. | |||
• | Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. | |||
• | Level 3—Instruments whose significant value drivers are unobservable. | |||
Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded derivatives and actively traded mutual fund investments. | ||||
Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable, information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity and equity securities; government or agency securities; certain mortgage-backed and asset-backed securities; securities held as collateral; and certain non-exchange-traded derivatives such as interest rate or cross currency swaps. | ||||
Level 3 comprises financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In limited instances, this category may also utilize non-binding broker quotes. This category primarily consists of certain less liquid fixed maturity, equity and trading securities and certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data. | ||||
As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 17 for additional information related to fair value measurements. | ||||
f) Commercial Mortgage Loans | ||||
The carrying value of commercial mortgage loans is stated at original cost, net of principal payments, amortization and allowance for loan losses. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. | ||||
“Impaired” loans are defined by U.S. GAAP as loans for which it is probable that the lender will be unable to collect all amounts due according to original contractual terms of the loan agreement. In determining whether it is probable that we will be unable to collect all amounts due, we consider current payment status, debt service coverage ratios, occupancy levels and current loan-to-value. Impaired loans are carried on a non-accrual status. Loans are placed on non-accrual status when, in management’s opinion, the collection of principal or interest is unlikely, or when the collection of principal or interest is 90 days or more past due. Income on impaired loans is not recognized until the loan is sold or the cash received exceeds the carrying amount recorded. | ||||
We evaluate the impairment of commercial mortgage loans first on an individual loan basis. If an individual loan is not deemed impaired, then we evaluate the remaining loans collectively to determine whether an impairment should be recorded. | ||||
For individually impaired loans, we record an impairment charge when it is probable that a loss has been incurred. The impairment is recorded as an increase in the allowance for loan losses. All losses of principal are charged to the allowance for loan losses in the period in which the loan is deemed to be uncollectible. | ||||
For loans that are not individually impaired where we evaluate the loans collectively, the allowance for loan losses is maintained at a level that we determine is adequate to absorb estimated probable incurred losses in the loan portfolio. Our process to determine the adequacy of the allowance utilizes an analytical model based on historical loss experience adjusted for current events, trends and economic conditions that would result in a loss in the loan portfolio over the next 12 months. Key inputs into our evaluation include debt service coverage ratios, loan-to-value, property-type, occupancy levels, geographic region, and probability weighting of the scenarios generated by the model. The actual amounts realized could differ in the near term from the amounts assumed in arriving at the allowance for loan losses reported in the consolidated financial statements. Additions and reductions to the allowance through periodic provisions or benefits are recorded in net investment gains (losses). | ||||
For commercial mortgage loans classified as held-for-sale, each loan is carried at the lower of cost or market and is included in commercial mortgage loans in our consolidated balance sheets. See note 4 for additional disclosures related to commercial mortgage loans. | ||||
g) Securities Lending Activity | ||||
In the United States and Canada, we engage in certain securities lending transactions for the purpose of enhancing the yield on our investment securities portfolio. We maintain effective control over all loaned securities and, therefore, continue to report such securities as fixed maturity securities on the consolidated balance sheets. We are currently indemnified against counterparty credit risk by the intermediary. | ||||
Under the securities lending program in the United States, the borrower is required to provide collateral, which can consist of cash or government securities, on a daily basis in amounts equal to or exceeding 102% of the applicable securities loaned. Currently, we only accept cash collateral from borrowers under the program. Cash collateral received by us on securities lending transactions is reflected in other invested assets with an offsetting liability recognized in other liabilities for the obligation to return the collateral. Any cash collateral received is reinvested by our custodian based upon the investment guidelines provided within our agreement. In the United States, the reinvested cash collateral is primarily invested in a money market fund approved by the National Association of Insurance Commissioners (“NAIC”), U.S. and foreign government securities, U.S. government agency securities, asset-backed securities and corporate debt securities. As of December 31, 2014 and 2013, the fair value of securities loaned under our securities lending program in the United States was $288 million and $191 million, respectively. As of December 31, 2014 and 2013, the fair value of collateral held under our securities lending program in the United States was $289 million and $187 million, respectively, and the offsetting obligation to return collateral of $299 million and $199 million, respectively, was included in other liabilities in the consolidated balance sheets. We did not have any non-cash collateral provided by the borrower in our securities lending program in the United States as of December 31, 2014 and 2013. | ||||
Under our securities lending program in Canada, the borrower is required to provide collateral consisting of government securities on a daily basis in amounts equal to or exceeding 105% of the fair value of the applicable securities loaned. Securities received from counterparties as collateral are not recorded on our consolidated balance sheet given that the risk and rewards of ownership is not transferred from the counterparties to us in the course of such transactions. Additionally, there was no cash collateral as cash collateral is not permitted as an acceptable form of collateral under the program. In Canada, the lending institution must be included on the approved Securities Lending Borrowers List with the Canadian regulator and the intermediary must be rated at least “AA-” by Standard & Poor’s Financial Services LLC. As of December 31, 2014 and 2013, the fair value of securities loaned under our securities lending program in Canada was $371 million and $229 million, respectively. | ||||
h) Repurchase Agreements | ||||
We have a repurchase program in which we sell an investment security at a specified price and agree to repurchase that security at another specified price at a later date. Repurchase agreements are treated as collateralized financing transactions and are carried at the amounts at which the securities will be subsequently reacquired, including accrued interest, as specified in the respective agreement. The market value of securities to be repurchased is monitored and collateral levels are adjusted where appropriate to protect the counterparty against credit exposure. Cash received is invested in fixed maturity securities. As of December 31, 2014 and 2013, the fair value of securities pledged under the repurchase program was $592 million and $890 million, respectively, and the repurchase obligation of $553 million and $919 million, respectively, was included in other liabilities in the consolidated balance sheets. | ||||
i) Cash and Cash Equivalents | ||||
Certificates of deposit, money market funds and other time deposits with original maturities of 90 days or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than 90 days but less than one year at the time of acquisition are considered short-term investments. | ||||
j) Deferred Acquisition Costs | ||||
Acquisition costs include costs that are directly related to the successful acquisition of new or renewal insurance contracts. Acquisition costs are deferred and amortized to the extent they are recoverable from future profits. | ||||
Long-Duration Contracts. Acquisition costs include commissions in excess of ultimate renewal commissions and for contracts issued, certain other costs such as underwriting, medical inspection and issuance expenses. DAC for traditional long-duration insurance contracts, including term life and long-term care insurance, is amortized as a level percentage of premiums based on assumptions, including, investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured life expectancy or longevity, insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses, established when the contract is issued. Amortization is adjusted each period to reflect actual lapse or termination rates. | ||||
Amortization for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for changes in underlying assumptions relating to future gross profits. Estimates of gross profits for DAC amortization are based on assumptions including interest rates, policyholder persistency or lapses, insured life expectancy or longevity and expenses. | ||||
Short-Duration Contracts. Acquisition costs primarily consist of commissions and premium taxes and are amortized ratably over the terms of the underlying policies. | ||||
We regularly review our assumptions and test DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to income is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserve plus anticipated future premiums and interest income for a line of business are less than the current estimate of future benefits and expenses (including any unamortized DAC), a charge to income is recorded for additional DAC amortization or for increased benefit reserves. See note 6 for additional information related to DAC including loss recognition and recoverability. | ||||
k) Intangible Assets | ||||
Present Value of Future Profits. In conjunction with the acquisition of a block of insurance policies or investment contracts, a portion of the purchase price is assigned to the right to receive future gross profits arising from existing insurance and investment contracts. This intangible asset, called PVFP, represents the actuarially estimated present value of future cash flows from the acquired policies. PVFP is amortized, net of accreted interest, in a manner similar to the amortization of DAC. | ||||
We regularly review our PVFP assumptions and periodically test PVFP for recoverability similar to our treatment of DAC. See note 7 for additional information related to PVFP including loss recognition and recoverability. | ||||
Deferred Sales Inducements to Contractholders. We defer sales inducements to contractholders for features on variable annuities that entitle the contractholder to an incremental amount to be credited to the account value upon making a deposit, and for fixed annuities with crediting rates higher than the contract’s expected ongoing crediting rates for periods after the inducement. Deferred sales inducements to contractholders are reported as a separate intangible asset and amortized in benefits and other changes in policy reserves using the same methodology and assumptions used to amortize DAC. | ||||
Other Intangible Assets. We amortize the costs of other intangibles over their estimated useful lives unless such lives are deemed indefinite. Amortizable intangible assets are tested for impairment based on undiscounted cash flows, which requires the use of estimates and judgment, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested at least annually for impairment using a qualitative or quantitative assessment and are written down to fair value as required. | ||||
l) Goodwill | ||||
Goodwill is not amortized but is tested for impairment annually or between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying value. We are permitted to utilize a qualitative impairment assessment if the fair value of the reporting unit is not more likely than not lower than its carrying value. If a qualitative impairment assessment is not performed, we are required to determine the fair value of the reporting unit. The determination of fair value requires the use of estimates and judgment, at the “reporting unit” level. A reporting unit is the operating segment, or a business, one level below that operating segment (the “component” level) if discrete financial information is prepared and regularly reviewed by management at the component level. If the reporting unit’s fair value is below its carrying value, we must determine the amount of implied goodwill that would be established if the reporting unit was hypothetically purchased on the impairment assessment date. We recognize an impairment charge for any amount by which the carrying amount of a reporting unit’s goodwill exceeds the amount of implied goodwill. | ||||
The determination of fair value for our reporting units is primarily based on an income approach whereby we use discounted cash flows for each reporting unit. When available and as appropriate, we use market approaches or other valuation techniques to corroborate discounted cash flow results. The discounted cash flow model used for each reporting unit is based on either operating income or statutory distributable income, depending on the reporting unit being valued. | ||||
The cash flows used to determine fair value are dependent on a number of significant management assumptions based on our historical experience, our expectations of future performance and expected economic environment. Our estimates are subject to change given the inherent uncertainty in predicting future performance and cash flows, which are impacted by such things as policyholder behavior, competitor pricing, new product introductions and specific industry and market conditions. Additionally, the discount rate used in our discounted cash flow approach is based on management’s judgment of the appropriate rate for each reporting unit based on the relative risk associated with the projected cash flows. | ||||
See note 8 for additional information related to goodwill and impairments recorded. | ||||
m) Reinsurance | ||||
Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to and assumed from other companies. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance is accounted for over the terms of the related treaties using assumptions consistent with those used to account for the underlying reinsured policies. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting. | ||||
n) Derivatives | ||||
Derivative instruments are used to manage risk through one of four principal risk management strategies including: (i) liabilities; (ii) invested assets; (iii) portfolios of assets or liabilities; and (iv) forecasted transactions. | ||||
On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (fair value, cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in income. | ||||
We formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. In this documentation, we specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item, and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure hedge ineffectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument. | ||||
We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated as a hedge instrument; or (iv) it is no longer probable that the forecasted transaction will occur. | ||||
For all qualifying and highly effective cash flow hedges, the effective portion of changes in fair value of the derivative instrument is reported as a component of OCI. The ineffective portion of changes in fair value of the derivative instrument is reported as a component of income. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried in the consolidated balance sheets at its fair value, and gains and losses that were accumulated in OCI are recognized immediately in income. When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in OCI and is recognized when the transaction affects income; however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued on a cash flow hedge, amounts previously deferred in OCI are reclassified into income when income is impacted by the variability of the cash flow of the hedged item. | ||||
For all qualifying and highly effective fair value hedges, the changes in fair value of the derivative instrument are reported in income. In addition, changes in fair value attributable to the hedged portion of the underlying instrument are reported in income. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair value hedge, the derivative continues to be carried in the consolidated balance sheets at its fair value, but the hedged asset or liability will no longer be adjusted for changes in fair value. In all other situations in which hedge accounting is discontinued, the derivative is carried at its fair value in the consolidated balance sheets, with changes in its fair value recognized in current period income. | ||||
We may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, we assess whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determine whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. | ||||
If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded in the consolidated balance sheets at fair value and are classified consistent with their host contract. Changes in their fair value are recognized in current period income. If we are unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried in the consolidated balance sheets at fair value, with changes in fair value recognized in current period income. | ||||
Changes in the fair value of non-qualifying derivatives, including embedded derivatives, changes in fair value of certain derivatives and related hedged items in fair value hedge relationships and hedge ineffectiveness on cash flow hedges are reported in net investment gains (losses). | ||||
The majority of our derivative arrangements require the posting of collateral upon meeting certain net exposure thresholds. The amounts recognized for derivative counterparty collateral received by us was recorded in cash and cash equivalents with a corresponding amount recorded in other liabilities to represent our obligation to return the collateral retained by us. We also receive non-cash collateral that is not recognized in our balance sheet unless we exercise our right to sell or re-pledge the underlying asset. As of December 31, 2014 and 2013, the fair value of non-cash collateral received was $287 million and $70 million, respectively, and the underlying assets were not sold or re-pledged. Additionally, we have pledged $49 million and $394 million of fixed maturity securities as of December 31, 2014 and 2013, respectively. We have not pledged any cash as collateral to derivative counterparties. Fixed maturity securities that we pledge as collateral remain on our balance sheet within fixed maturity securities available-for-sale. Any cash collateral pledged to a derivative counterparty is derecognized with a receivable recorded in other assets for the right to receive our cash collateral back from the counterparty. | ||||
o) Separate Accounts and Related Insurance Obligations | ||||
Separate account assets represent funds for which the investment income and investment gains and losses accrue directly to the contractholders and are reflected in our consolidated balance sheets at fair value, reported as summary total separate account assets with an equivalent summary total reported for liabilities. Amounts assessed against the contractholders for mortality, administrative and other services are included in revenues. Changes in liabilities for minimum guarantees are included in benefits and other changes in policy reserves. Net investment income, net investment gains (losses) and the related liability changes associated with the separate account are offset within the same line item in the consolidated statements of income. There were no gains or losses on transfers of assets from the general account to the separate account. | ||||
We offer certain minimum guarantees associated with our variable annuity contracts. Our variable annuity contracts usually contain a basic guaranteed minimum death benefit (“GMDB”) which provides a minimum benefit to be paid upon the annuitant’s death equal to the larger of account value and the return of net deposits. Some variable annuity contracts permit contractholders to purchase through riders, at an additional charge, enhanced death benefits such as the highest contract anniversary value (“ratchets”), accumulated net deposits at a stated rate (“rollups”), or combinations thereof. | ||||
Additionally, some of our variable annuity contracts provide the contractholder with living benefits such as a guaranteed minimum withdrawal benefit (“GMWB”) or certain types of guaranteed annuitization benefits. The GMWB allows contractholders to withdraw a pre-defined percentage of account value or benefit base each year, either for a specified period of time or for life. The guaranteed annuitization benefit generally provides for a guaranteed minimum level of income upon annuitization accompanied by the potential for upside market participation. | ||||
Most of our reserves for additional insurance and annuitization benefits are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future experience. The projections utilize stochastic scenarios of separate account returns incorporating reversion to the mean, as well as assumptions for mortality and lapses. Some of our minimum guarantees, mainly GMWBs, are accounted for as embedded derivatives; see notes 5 and 17 for additional information on these embedded derivatives and related fair value measurement disclosures. | ||||
p) Insurance Reserves | ||||
Future Policy Benefits | ||||
The liability for future policy benefits is equal to the present value of expected benefits and expenses less the present value of expected future net premiums based on assumptions, including, investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured life expectancy or longevity, insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses, all of which are locked-in at the time the policies are issued or acquired. Claim termination rates refer to the expected rates at which claims end. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. | ||||
The liability for future policy benefits is evaluated at least annually to determine if a premium deficiency exists. Loss recognition testing is generally performed at the line of business level, with acquired blocks and certain reinsured blocks tested separately. If the liability for future policy benefits plus the current present value of expected future premiums are less than the current present value of expected future benefits and expenses (including any unamortized DAC), a charge to income is recorded for accelerated DAC amortization and, if necessary, a premium deficiency reserve is established. If a charge is recorded, DAC amortization and the liability for future policy benefits are measured using updated assumptions, which become the new locked-in assumptions utilized going forward unless another premium deficiency charge is recorded. Our estimates of future premiums used in loss recognition testing for our long-term care insurance business include assumptions for significant premium rate increases that have been filed and approved or are anticipated to be approved. Beginning in the fourth quarter of 2014, estimates of future premiums also include significant anticipated (but not yet filed) future rate increases or benefit reductions. These anticipated future increases are based on our best estimate of the rate increases we expect to obtain, considering, among other factors, our historical experience from prior rate increase approvals and based on our best estimate of expected claim costs. | ||||
We are also required to accrue additional future policy benefit reserves when the overall reserve is adequate, but profits are projected in earlier years followed by losses projected in later years. When this pattern of profits followed by losses exists, we increase reserves in the profitable years by the amounts necessary to offset losses in later years. | ||||
For long-term care insurance products, benefit reductions are treated as partial lapse of coverage with the balance of our future policy benefits and deferred acquisition costs both reduced in proportion to the reduced coverage. For level premium term life insurance products, we floor the liability for future policy benefits on each policy at zero. | ||||
Estimates and actuarial assumptions used for establishing the liability for future policy benefits and in loss recognition testing involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for future policy benefits and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The risk that our claims experience may differ significantly from our pricing and valuation assumptions is particularly significant for our long-term care insurance products. Long-term care insurance policies provide for long-duration coverage and, therefore, our actual claims experience will emerge over many years after pricing and locked-in valuation assumptions have been established. | ||||
Policyholder Account Balances | ||||
The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future experience. | ||||
Investment-type contracts are broadly defined to include contracts without significant mortality or morbidity risk. Payments received from sales of investment contracts are recognized by providing a liability equal to the current account value of the policyholders’ contracts. Interest rates credited to investment contracts are guaranteed for the initial policy term with renewal rates determined as necessary by management. | ||||
q) Liability for Policy and Contract Claims | ||||
The liability for policy and contract claims, or claim reserves, represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (a) claims that have been reported to the insurer; (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims. | ||||
Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss). Estimates and actuarial assumptions used for establishing the liability for policy and contract claims involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for policy and contract claims and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. | ||||
The liability for policy and contract claims for our long-term care insurance products represents the present value of the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. Key assumptions include investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured life expectancy or longevity, insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses. Claim termination rates refer to the expected rates at which claims end. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. Both claim termination rates and benefit utilization rates are influenced by, among other things, gender, age at claim, diagnosis, type of care needed, benefit period, and daily benefit amount. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. | ||||
The liabilities for our mortgage insurance policies represent our best estimates of the liabilities at the time based on known facts, trends and other external factors, including economic conditions, housing prices and employment rates. For our mortgage insurance policies, reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers, using assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, we begin to provide for the ultimate claim payment relating to a potential claim on a defaulted loan when the status of that loan first goes delinquent. Over time, as the status of the underlying delinquent loans move toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase. | ||||
Management considers the liability for policy and contract claims provided to be satisfactory to cover the losses that have occurred. Management monitors actual experience, and where circumstances warrant, will revise its assumptions. The methods of determining such estimates and establishing the reserves are reviewed periodically and any adjustments are reflected in operations in the period in which they become known. Future developments may result in losses and loss expenses greater or less than the liability for policy and contract claims provided. | ||||
r) Unearned Premiums | ||||
For single premium insurance contracts, we recognize premiums over the policy life in accordance with the expected pattern of risk emergence. We recognize a portion of the revenue in premiums earned in the current period, while the remaining portion is deferred as unearned premiums and earned over time in accordance with the expected pattern of risk emergence. If single premium policies are cancelled and the premium is non-refundable, then the remaining unearned premium related to each cancelled policy is recognized to earned premiums upon notification of the cancellation. Expected pattern of risk emergence on which we base premium recognition is inherently judgmental and is based on actuarial analysis of historical experience. We periodically review our premium earnings recognition models with any adjustments to the estimates reflected in current period income. For the years ended December 31, 2014, 2013 and 2012, we updated our premium recognition factors for our international mortgage insurance business. These updates included the consideration of recent and projected loss experience, policy cancellation experience and refinement of actuarial methods. In 2014, 2013 and 2012, adjustments associated with this update resulted in an increase in earned premiums of $6 million, $12 million and $36 million, respectively. | ||||
s) Stock-Based Compensation | ||||
We determine a grant date fair value and recognize the related compensation expense, adjusted for expected forfeitures, through the income statement over the respective vesting period of the awards. | ||||
t) Employee Benefit Plans | ||||
We provide employees with a defined contribution pension plan and recognize expense throughout the year based on the employee’s age, service and eligible pay. We make an annual contribution to the plan. We also provide employees with defined contribution savings plans. We recognize expense for our contributions to the savings plans at the time employees make contributions to the plans. | ||||
Some employees participate in defined benefit pension and postretirement benefit plans. We recognize expense for these plans based upon actuarial valuations performed by external experts. We estimate aggregate benefits by using assumptions for employee turnover, future compensation increases, rates of return on pension plan assets and future health care costs. We recognize an expense for differences between actual experience and estimates over the average future service period of participants. We recognize the overfunded or underfunded status of a defined benefit plan as an asset or liability in our consolidated balance sheets and recognize changes in that funded status in the year in which the changes occur through OCI. | ||||
u) Income Taxes | ||||
We determine deferred tax assets and/or liabilities by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled if there is no change in law. The effect on deferred taxes of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances on deferred tax assets are estimated based on our assessment of the realizability of such amounts. | ||||
We do not record U.S. deferred taxes on foreign income that we do not expect to remit or repatriate to U.S. corporations within our consolidated group. Under U.S. GAAP, we are generally required to record U.S. deferred taxes on the anticipated repatriation of foreign income as the income is recognized for financial reporting purposes. An exception under certain accounting guidance permits us not to record a U.S. deferred tax liability for foreign income that we expect to reinvest in our foreign operations and for which remittance will be postponed indefinitely. If it becomes apparent that we cannot positively assert that some or all undistributed income will be invested in the foreseeable future, the related deferred taxes are recorded in that period. In determining indefinite reinvestment, we regularly evaluate the capital needs of our domestic and foreign operations considering all available information, including operating and capital plans, regulatory capital requirements, parent company financing and cash flow needs, as well as the applicable tax laws to which our domestic and foreign subsidiaries are subject. Our estimates are based on our historical experience and our expectation of future performance. Our judgments and assumptions are subject to change given the inherent uncertainty in predicting future capital needs, which are impacted by such things as regulatory requirements, policyholder behavior, competitor pricing, new product introductions, and specific industry and market conditions. | ||||
Effective with the period beginning January 1, 2011, our companies elected to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). The election was made with the filing of the first life/non-life consolidated return, which was filed in September 2012. All companies domesticated in the United States and our Bermuda and Guernsey subsidiaries which have elected to be taxed as U.S. domestic companies were included in the life/non-life consolidated return as allowed by the tax law and regulations. The tax sharing agreement previously applicable only to the U.S. life insurance entities was terminated with the filing of the life/non-life consolidated return and those entities adopted the tax sharing agreement previously applicable to only the non-life entities (hereinafter the “life/non-life tax sharing agreement”). The two agreements were identical in all material respects. The life/non-life tax sharing agreement was provided to the appropriate state insurance regulators for approval. Intercompany balances relating to the impacts of the life/non-life tax sharing agreement were settled with the insurance companies after approval was received from the insurance regulators. Intercompany balances under all agreements are settled at least annually. For years before 2011, our U.S. non-life insurance entities were included in the consolidated federal income tax return of Genworth and subject to a tax sharing arrangement that allocated tax on a separate company basis but provided benefit for current utilization of losses and credits. Also, our U.S. life insurance entities filed a consolidated life insurance federal income tax return, and were subject to a separate tax sharing agreement, as approved by state insurance regulators, which allocated taxes on a separate company basis but provided benefit for current utilization of losses and credits. | ||||
Our subsidiaries based in Bermuda and Guernsey are treated as U.S. insurance companies under provisions of the U.S. Internal Revenue Code, are included in the life/non-life consolidated return, and have adopted the life-non/life tax sharing agreement. Jurisdictions outside the United States in which our various subsidiaries incur significant taxes include Australia, Canada and the United Kingdom. | ||||
v) Foreign Currency Translation | ||||
The determination of the functional currency is made based on the appropriate economic and management indicators. The assets and liabilities of foreign operations are translated into U.S. dollars at the exchange rates in effect at the balance sheet date. Translation adjustments are included as a separate component of accumulated other comprehensive income (loss). Revenues and expenses of the foreign operations are translated into U.S. dollars at the average rates of exchange during the period of the transaction. Gains and losses from foreign currency transactions are reported in income and have not been material in any years presented in our consolidated statements of income. | ||||
w) Variable Interest Entities | ||||
We are involved in certain entities that are considered VIEs as defined under U.S. GAAP, and, accordingly, we evaluate the VIE to determine whether we are the primary beneficiary and are required to consolidate the assets and liabilities of the entity. The primary beneficiary of a VIE is the enterprise that has the power to direct the activities of a VIE that most significantly impacts the VIE’s economic performance and has the obligation to absorb losses or receive benefits that could potentially be significant to the VIE. The determination of the primary beneficiary for a VIE can be complex and requires management judgment regarding the expected results of the entity and how those results are absorbed by beneficial interest holders, as well as which party has the power to direct activities that most significantly impact the performance of the VIEs. | ||||
Our primary involvement related to VIEs includes securitization transactions, certain investments and certain mortgage insurance policies. | ||||
We have retained interests in VIEs where we are the servicer and transferor of certain assets that were sold to a newly created VIE. Additionally, for certain securitization transactions, we were the transferor of certain assets that were sold to a newly created VIE but did not retain any beneficial interest in the VIE other than acting as the servicer of the underlying assets. | ||||
We hold investments in certain structures that are considered VIEs. Our investments represent beneficial interests that are primarily in the form of structured securities or alternative investments. Our involvement in these structures typically represent a passive investment in the returns generated by the VIE and typically do not result in having significant influence over the economic performance of the VIE. | ||||
We also provide mortgage insurance on certain residential mortgage loans originated and securitized by third parties using VIEs to issue mortgage-backed securities. While we provide mortgage insurance on the underlying loans, we do not typically have any ongoing involvement with the VIE other than our mortgage insurance coverage and do not act in a servicing capacity for the underlying loans held by the VIE. | ||||
See note 18 for additional information related to these consolidated entities. | ||||
x) Accounting Changes | ||||
Investment Companies | ||||
On January 1, 2014, we adopted new accounting guidance on the scope, measurement and disclosure requirements for investment companies. The new guidance clarified the characteristics of an investment company, provided comprehensive guidance for assessing whether an entity is an investment company, required investment companies to measure noncontrolling ownership interest in other investment companies at fair value rather than using the equity method of accounting and required additional disclosures. The adoption of this accounting guidance did not have any impact on our consolidated financial statements. | ||||
Benchmarking Interest Rates Used When Applying Hedge Accounting | ||||
In July 2013, we adopted new accounting guidance to provide additional flexibility in the benchmark interest rates used when applying hedge accounting. The new guidance permits the use of the Federal Funds Effective Swap Rate as a benchmark interest rate for hedge accounting purposes and removes certain restrictions on being able to apply hedge accounting for similar hedges using different benchmark interest rates. The adoption of this accounting guidance did not have a material impact on our consolidated financial statements. | ||||
Offsetting Assets And Liabilities | ||||
On January 1, 2013, we adopted new accounting guidance for disclosures about offsetting assets and liabilities. This guidance requires an entity to disclose information about offsetting and related arrangements to enable users to understand the effect of those arrangements on its financial position. The adoption of this accounting guidance impacted our disclosures only and did not impact our consolidated results. | ||||
Reclassification Of Items Out Of Accumulated Other Comprehensive Income | ||||
On January 1, 2013, we adopted new accounting guidance related to the presentation of the reclassification of items out of accumulated other comprehensive income into net income. The adoption of this accounting guidance impacted our disclosures only and did not impact our consolidated results. | ||||
Testing Indefinite-Lived Intangible Assets For Impairment | ||||
On October 1, 2012, we adopted new accounting guidance on testing indefinite-lived intangible assets for impairment. The new guidance permits the use of a qualitative assessment prior to, and potentially instead of, the quantitative impairment test for indefinite-lived intangible assets. The adoption of this accounting guidance did not have an impact on our consolidated financial statements. | ||||
Fair Value Measurements | ||||
On January 1, 2012, we adopted new accounting guidance related to fair value measurements. This new accounting guidance clarified existing fair value measurement requirements and changed certain fair value measurement principles and disclosure requirements. The adoption of this accounting guidance impacted our disclosures only and did not impact our consolidated results. | ||||
Repurchase Agreements and Other Agreements | ||||
On January 1, 2012, we adopted new accounting guidance related to repurchase agreements and other agreements that both entitle and obligate a transferor to repurchase or redeem financial assets before their maturity. The new guidance removed the requirement to consider a transferor’s ability to fulfill its contractual rights from the criteria used to determine effective control and was effective for us prospectively. The adoption of this accounting guidance did not have a material impact on our consolidated financial statements. | ||||
y) Accounting Pronouncements Not Yet Adopted | ||||
In August 2014, the Financial Accounting Standards Board (the “FASB”) issued new accounting guidance related to measuring the financial assets and financial liabilities of a consolidated collateralized financing entity. The guidance is intended to address the accounting for the measurement difference between the fair value of financial assets and the fair value of financial liabilities of a collateralized financing entity. The new guidance provides an alternative whereby a reporting entity could measure the financial assets and financial liabilities of the collateralized financing entity in its consolidated financial statements using the more observable of the fair values. This guidance is effective for us on January 1, 2016, with early adoption permitted as of the beginning of an annual reporting period. We plan to early adopt this new guidance during the first quarter of 2015 and do not expect any impact on our consolidated financial statements. | ||||
In June 2014, the FASB issued new accounting guidance related to the accounting for repurchase-to-maturity transactions and repurchase financings, and added disclosure requirements for all repurchase agreements, securities lending transactions and repurchase-to-maturity transactions. The new guidance changes the accounting for repurchase-to-maturity transactions and repurchase financing such that they will be consistent with secured borrowing accounting. In addition, the guidance requires new disclosures for all repurchase agreements and securities lending transactions. We do not have repurchase-to-maturity transactions, but have repurchase agreements and securities lending transactions that will be subject to additional disclosures. These new requirements will be effective for us on January 1, 2015 and early adoption is not permitted. This new guidance will only impact our disclosures. | ||||
In May 2014, the FASB issued new accounting guidance related to revenue from contracts with customers. The key principle of the new guidance is that entities should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for such goods or services. The guidance also includes disclosure requirements that provide information about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance is effective for us on January 1, 2017 and early adoption is not permitted. Although insurance contracts are specifically excluded from this new guidance, we have minor services that may be subject to the new revenue recognition guidance. In addition, there is uncertainty whether mortgage insurance and investment contracts are subject to this new guidance, which could result in a significant change in revenue recognition for these contracts. As such, we are still in the process of evaluating the impact, if any, the guidance may have on our consolidated financial statements. | ||||
In January 2014, the FASB issued new accounting guidance related to the accounting for investments in affordable housing projects that qualify for the low-income housing tax credit. The new guidance permits reporting entities to make an accounting policy election to account for investments in qualified affordable housing projects by amortizing the initial cost of the investment in proportion to the tax benefits received and recognize the net investment performance as a component of income tax expense (called the proportional amortization method) if certain conditions are met. The new guidance requires use of the equity method or cost method for investments in qualified affordable housing projects not accounted for using the proportional amortization method. This new guidance will be effective for us and we will adopt the guidance on January 1, 2015. We do not expect this new guidance to have a material impact on our consolidated financial statements. |
Earnings_Loss_Per_Share
Earnings (Loss) Per Share | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Earnings (Loss) Per Share | (3) Earnings (Loss) Per Share | ||||||||||||
Basic and diluted earnings (loss) per share are calculated by dividing each income (loss) category presented below by the weighted-average basic and diluted common shares outstanding for the periods indicated: | |||||||||||||
(Amounts in millions, except per share amounts) | 2014 | 2013 | 2012 | ||||||||||
Weighted-average common shares used in basic earnings (loss) per common share calculations | 496.4 | 493.6 | 491.6 | ||||||||||
Potentially dilutive securities: | |||||||||||||
Stock options, restricted stock units and stock appreciation rights | — | 5.1 | 2.8 | ||||||||||
Weighted-average common shares used in diluted earnings (loss) per common share calculations (1) | 496.4 | 498.7 | 494.4 | ||||||||||
Income (loss) from continuing operations: | |||||||||||||
Income (loss) from continuing operations | $ | (1,048 | ) | $ | 726 | $ | 468 | ||||||
Less: income from continuing operations attributable to noncontrolling interests | 196 | 154 | 200 | ||||||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | $ | 572 | $ | 268 | ||||||
Basic per common share | $ | (2.51 | ) | $ | 1.16 | $ | 0.55 | ||||||
Diluted per common share | $ | (2.51 | ) | $ | 1.15 | $ | 0.54 | ||||||
Income (loss) from discontinued operations: | |||||||||||||
Income (loss) from discontinued operations, net of taxes | $ | — | $ | (12 | ) | $ | 57 | ||||||
Less: income from discontinued operations, net of taxes, attributable to noncontrolling interests | — | — | — | ||||||||||
Income (loss) from discontinued operations, net of taxes, available to Genworth Financial, Inc.’s common stockholders | $ | — | $ | (12 | ) | $ | 57 | ||||||
Basic per common share | $ | — | $ | (0.02 | ) | $ | 0.12 | ||||||
Diluted per common share | $ | — | $ | (0.02 | ) | $ | 0.12 | ||||||
Net income (loss): | |||||||||||||
Income (loss) from continuing operations | $ | (1,048 | ) | $ | 726 | $ | 468 | ||||||
Income (loss) from discontinued operations, net of taxes | — | (12 | ) | 57 | |||||||||
Net income (loss) | (1,048 | ) | 714 | 525 | |||||||||
Less: net income attributable to noncontrolling interests | 196 | 154 | 200 | ||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | $ | 560 | $ | 325 | ||||||
Basic per common share | $ | (2.51 | ) | $ | 1.13 | $ | 0.66 | ||||||
Diluted per common share | $ | (2.51 | ) | $ | 1.12 | $ | 0.66 | ||||||
(1) | Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the year ended December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the year ended December 31, 2014, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.6 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the year ended December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million. |
Investments
Investments | 12 Months Ended | ||||||||||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||||||||||
Investments | (4) Investments | ||||||||||||||||||||||||||||||||||||
(a) Net Investment Income | |||||||||||||||||||||||||||||||||||||
Sources of net investment income were as follows for the years ended December 31: | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Fixed maturity securities—taxable | $ | 2,631 | $ | 2,642 | $ | 2,666 | |||||||||||||||||||||||||||||||
Fixed maturity securities—non-taxable | 12 | 9 | 11 | ||||||||||||||||||||||||||||||||||
Commercial mortgage loans | 333 | 335 | 340 | ||||||||||||||||||||||||||||||||||
Restricted commercial mortgage loans related to securitization entities (1) | 14 | 23 | 32 | ||||||||||||||||||||||||||||||||||
Equity securities | 14 | 17 | 19 | ||||||||||||||||||||||||||||||||||
Other invested assets (2) | 174 | 185 | 206 | ||||||||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (1) | 5 | 4 | 1 | ||||||||||||||||||||||||||||||||||
Policy loans | 129 | 129 | 123 | ||||||||||||||||||||||||||||||||||
Cash, cash equivalents and short-term investments | 24 | 20 | 35 | ||||||||||||||||||||||||||||||||||
Gross investment income before expenses and fees | 3,336 | 3,364 | 3,433 | ||||||||||||||||||||||||||||||||||
Expenses and fees | (94 | ) | (93 | ) | (90 | ) | |||||||||||||||||||||||||||||||
Net investment income | $ | 3,242 | $ | 3,271 | $ | 3,343 | |||||||||||||||||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||
(2) | Included in other invested assets was $8 million, $13 million and $21 million of net investment income related to trading securities for the years ended December 31, 2014, 2013 and 2012, respectively. | ||||||||||||||||||||||||||||||||||||
(b) Net Investment Gains (Losses) | |||||||||||||||||||||||||||||||||||||
The following table sets forth net investment gains (losses) for the years ended December 31: | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Available-for-sale securities: | |||||||||||||||||||||||||||||||||||||
Realized gains | $ | 74 | $ | 176 | $ | 172 | |||||||||||||||||||||||||||||||
Realized losses | (46 | ) | (184 | ) | (143 | ) | |||||||||||||||||||||||||||||||
Net realized gains (losses) on available-for-sale securities | 28 | (8 | ) | 29 | |||||||||||||||||||||||||||||||||
Impairments: | |||||||||||||||||||||||||||||||||||||
Total other-than-temporary impairments | (9 | ) | (16 | ) | (62 | ) | |||||||||||||||||||||||||||||||
Portion of other-than-temporary impairments included in other comprehensive income (loss) | — | (9 | ) | (44 | ) | ||||||||||||||||||||||||||||||||
Net other-than-temporary impairments | (9 | ) | (25 | ) | (106 | ) | |||||||||||||||||||||||||||||||
Trading securities | 39 | (23 | ) | 21 | |||||||||||||||||||||||||||||||||
Commercial mortgage loans | 11 | 4 | 4 | ||||||||||||||||||||||||||||||||||
Net gains (losses) related to securitization entities (1) | 16 | 69 | 81 | ||||||||||||||||||||||||||||||||||
Derivative instruments (2) | (103 | ) | (49 | ) | 4 | ||||||||||||||||||||||||||||||||
Contingent consideration adjustment | (2 | ) | — | (6 | ) | ||||||||||||||||||||||||||||||||
Other | — | (5 | ) | — | |||||||||||||||||||||||||||||||||
Net investment gains (losses) | $ | (20 | ) | $ | (37 | ) | $ | 27 | |||||||||||||||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||
(2) | See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). | ||||||||||||||||||||||||||||||||||||
We generally intend to hold securities in unrealized loss positions until they recover. However, from time to time, our intent on an individual security may change, based upon market or other unforeseen developments. In such instances, we sell securities in the ordinary course of managing our portfolio to meet diversification, credit quality, yield and liquidity requirements. If a loss is recognized from a sale subsequent to a balance sheet date due to these unexpected developments, the loss is recognized in the period in which we determined that we have the intent to sell the securities or it is more likely than not that we will be required to sell the securities prior to recovery. The aggregate fair value of securities sold at a loss during the years ended December 31, 2014, 2013 and 2012 was $873 million, $1,794 million and $1,491 million, respectively, which was approximately 95%, 91% and 92%, respectively, of book value. | |||||||||||||||||||||||||||||||||||||
The following represents the activity for credit losses recognized in net income (loss) on debt securities where an other-than-temporary impairment was identified and a portion of other-than-temporary impairments was included in OCI as of and for the years ended December 31: | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Beginning balance | $ | 101 | $ | 387 | $ | 646 | |||||||||||||||||||||||||||||||
Additions: | |||||||||||||||||||||||||||||||||||||
Other-than-temporary impairments not previously recognized | 1 | 4 | 16 | ||||||||||||||||||||||||||||||||||
Increases related to other-than-temporary impairments previously recognized | 1 | 11 | 55 | ||||||||||||||||||||||||||||||||||
Reductions: | |||||||||||||||||||||||||||||||||||||
Securities sold, paid down or disposed | (20 | ) | (301 | ) | (330 | ) | |||||||||||||||||||||||||||||||
Ending balance | $ | 83 | $ | 101 | $ | 387 | |||||||||||||||||||||||||||||||
(c) Unrealized Investment Gains and Losses | |||||||||||||||||||||||||||||||||||||
Net unrealized gains and losses on available-for-sale investment securities reflected as a separate component of accumulated other comprehensive income (loss) were as follows as of December 31: | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Net unrealized gains (losses) on investment securities: | |||||||||||||||||||||||||||||||||||||
Fixed maturity securities | $ | 5,560 | $ | 2,346 | $ | 6,086 | |||||||||||||||||||||||||||||||
Equity securities | 32 | 23 | 34 | ||||||||||||||||||||||||||||||||||
Other invested assets | (2 | ) | (4 | ) | (8 | ) | |||||||||||||||||||||||||||||||
Subtotal | 5,590 | 2,365 | 6,112 | ||||||||||||||||||||||||||||||||||
Adjustments to DAC, PVFP, sales inducements and benefit reserves | (1,656 | ) | (869 | ) | (1,925 | ) | |||||||||||||||||||||||||||||||
Income taxes, net | (1,372 | ) | (517 | ) | (1,457 | ) | |||||||||||||||||||||||||||||||
Net unrealized investment gains (losses) | 2,562 | 979 | 2,730 | ||||||||||||||||||||||||||||||||||
Less: net unrealized investment gains (losses) attributable to noncontrolling interests | 109 | 53 | 92 | ||||||||||||||||||||||||||||||||||
Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. | $ | 2,453 | $ | 926 | $ | 2,638 | |||||||||||||||||||||||||||||||
The change in net unrealized gains (losses) on available-for-sale investment securities reported in accumulated other comprehensive income (loss) was as follows as of and for the years ended December 31: | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Beginning balance | $ | 926 | $ | 2,638 | $ | 1,485 | |||||||||||||||||||||||||||||||
Unrealized gains (losses) arising during the period: | |||||||||||||||||||||||||||||||||||||
Unrealized gains (losses) on investment securities | 3,244 | (3,780 | ) | 2,318 | |||||||||||||||||||||||||||||||||
Adjustment to DAC | (172 | ) | 248 | (159 | ) | ||||||||||||||||||||||||||||||||
Adjustment to PVFP | (66 | ) | 95 | (6 | ) | ||||||||||||||||||||||||||||||||
Adjustment to sales inducements | (15 | ) | 40 | (33 | ) | ||||||||||||||||||||||||||||||||
Adjustment to benefit reserves | (534 | ) | 673 | (424 | ) | ||||||||||||||||||||||||||||||||
Provision for income taxes | (862 | ) | 952 | (590 | ) | ||||||||||||||||||||||||||||||||
Change in unrealized gains (losses) on investment securities | 1,595 | (1,772 | ) | 1,106 | |||||||||||||||||||||||||||||||||
Reclassification adjustments to net investment (gains) losses, net of taxes of $7, $(12) and $(27) | (12 | ) | 21 | 50 | |||||||||||||||||||||||||||||||||
Change in net unrealized investment gains (losses) | 1,583 | (1,751 | ) | 1,156 | |||||||||||||||||||||||||||||||||
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests | 56 | (39 | ) | 3 | |||||||||||||||||||||||||||||||||
Ending balance | $ | 2,453 | $ | 926 | $ | 2,638 | |||||||||||||||||||||||||||||||
(d) Fixed Maturity and Equity Securities | |||||||||||||||||||||||||||||||||||||
As of December 31, 2014, the amortized cost or cost, gross unrealized gains (losses) and fair value of our fixed maturity and equity securities classified as available-for-sale were as follows: | |||||||||||||||||||||||||||||||||||||
Gross unrealized gains | Gross unrealized losses | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Amortized | Not other- | Other- | Not other- | Other- | Fair | |||||||||||||||||||||||||||||||
cost or | than- | than- | than- | than- | value | ||||||||||||||||||||||||||||||||
cost | temporarily | temporarily | temporarily | temporarily | |||||||||||||||||||||||||||||||||
impaired | impaired | impaired | impaired | ||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 5,006 | $ | 995 | $ | — | $ | (1 | ) | $ | — | $ | 6,000 | ||||||||||||||||||||||||
Tax-exempt | 347 | 29 | — | (14 | ) | — | 362 | ||||||||||||||||||||||||||||||
Government—non-U.S. | 1,952 | 156 | — | (2 | ) | — | 2,106 | ||||||||||||||||||||||||||||||
U.S. corporate | 24,251 | 3,017 | 20 | (88 | ) | — | 27,200 | ||||||||||||||||||||||||||||||
Corporate—non-U.S. | 14,214 | 1,015 | — | (97 | ) | — | 15,132 | ||||||||||||||||||||||||||||||
Residential mortgage-backed | 4,881 | 362 | 15 | (17 | ) | (1 | ) | 5,240 | |||||||||||||||||||||||||||||
Commercial mortgage-backed | 2,564 | 143 | 4 | (9 | ) | — | 2,702 | ||||||||||||||||||||||||||||||
Other asset-backed | 3,735 | 23 | 1 | (54 | ) | — | 3,705 | ||||||||||||||||||||||||||||||
Total fixed maturity securities | 56,950 | 5,740 | 40 | (282 | ) | (1 | ) | 62,447 | |||||||||||||||||||||||||||||
Equity securities | 253 | 36 | — | (7 | ) | — | 282 | ||||||||||||||||||||||||||||||
Total available-for-sale securities | $ | 57,203 | $ | 5,776 | $ | 40 | $ | (289 | ) | $ | (1 | ) | $ | 62,729 | |||||||||||||||||||||||
As of December 31, 2013, the amortized cost or cost, gross unrealized gains (losses) and fair value of our fixed maturity and equity securities classified as available-for-sale were as follows: | |||||||||||||||||||||||||||||||||||||
Gross unrealized gains | Gross unrealized losses | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Amortized | Not other- | Other- | Not other- | Other- | Fair | |||||||||||||||||||||||||||||||
cost or | than- | than- | than- | than- | value | ||||||||||||||||||||||||||||||||
cost | temporarily | temporarily | temporarily | temporarily | |||||||||||||||||||||||||||||||||
impaired | impaired | impaired | impaired | ||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 4,710 | $ | 331 | $ | — | $ | (231 | ) | $ | — | $ | 4,810 | ||||||||||||||||||||||||
Tax-exempt | 324 | 7 | — | (36 | ) | — | 295 | ||||||||||||||||||||||||||||||
Government—non-U.S. | 2,057 | 104 | — | (15 | ) | — | 2,146 | ||||||||||||||||||||||||||||||
U.S. corporate | 23,614 | 1,761 | 19 | (359 | ) | — | 25,035 | ||||||||||||||||||||||||||||||
Corporate—non-U.S. | 14,489 | 738 | — | (156 | ) | — | 15,071 | ||||||||||||||||||||||||||||||
Residential mortgage-backed | 5,058 | 232 | 9 | (70 | ) | (4 | ) | 5,225 | |||||||||||||||||||||||||||||
Commercial mortgage-backed | 2,886 | 75 | 2 | (62 | ) | (3 | ) | 2,898 | |||||||||||||||||||||||||||||
Other asset-backed | 3,171 | 35 | — | (57 | ) | — | 3,149 | ||||||||||||||||||||||||||||||
Total fixed maturity securities | 56,309 | 3,283 | 30 | (986 | ) | (7 | ) | 58,629 | |||||||||||||||||||||||||||||
Equity securities | 318 | 36 | — | (13 | ) | — | 341 | ||||||||||||||||||||||||||||||
Total available-for-sale securities | $ | 56,627 | $ | 3,319 | $ | 30 | $ | (999 | ) | $ | (7 | ) | $ | 58,970 | |||||||||||||||||||||||
The following table presents the gross unrealized losses and fair values of our investment securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, as of December 31, 2014: | |||||||||||||||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | |||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) | Fair | Gross | Number | Fair | Gross | Number | Fair | Gross | Number | ||||||||||||||||||||||||||||
value | unrealized | of | value | unrealized | of | value | unrealized | of | |||||||||||||||||||||||||||||
losses | securities | losses (1) | securities | losses (1) | securities | ||||||||||||||||||||||||||||||||
Description of Securities | |||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | — | $ | — | — | $ | 75 | $ | (1 | ) | 10 | $ | 75 | $ | (1 | ) | 10 | ||||||||||||||||||||
Tax-exempt | — | — | — | 111 | (14 | ) | 10 | 111 | (14 | ) | 10 | ||||||||||||||||||||||||||
Government—non-U.S. | 67 | (1 | ) | 18 | 22 | (1 | ) | 4 | 89 | (2 | ) | 22 | |||||||||||||||||||||||||
U.S. corporate | 1,656 | (31 | ) | 240 | 1,359 | (57 | ) | 210 | 3,015 | (88 | ) | 450 | |||||||||||||||||||||||||
Corporate—non-U.S. | 1,568 | (69 | ) | 239 | 515 | (28 | ) | 70 | 2,083 | (97 | ) | 309 | |||||||||||||||||||||||||
Residential mortgage-backed | 180 | (1 | ) | 24 | 254 | (17 | ) | 90 | 434 | (18 | ) | 114 | |||||||||||||||||||||||||
Commercial mortgage-backed | 163 | — | 21 | 362 | (9 | ) | 49 | 525 | (9 | ) | 70 | ||||||||||||||||||||||||||
Other asset-backed | 1,551 | (12 | ) | 215 | 487 | (42 | ) | 55 | 2,038 | (54 | ) | 270 | |||||||||||||||||||||||||
Subtotal, fixed maturity securities | 5,185 | (114 | ) | 757 | 3,185 | (169 | ) | 498 | 8,370 | (283 | ) | 1,255 | |||||||||||||||||||||||||
Equity securities | 30 | (3 | ) | 46 | 48 | (4 | ) | 6 | 78 | (7 | ) | 52 | |||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 5,215 | $ | (117 | ) | 803 | $ | 3,233 | $ | (173 | ) | 504 | $ | 8,448 | $ | (290 | ) | 1,307 | |||||||||||||||||||
% Below cost—fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
<20% Below cost | $ | 5,148 | $ | (103 | ) | 753 | $ | 3,054 | $ | (115 | ) | 477 | $ | 8,202 | $ | (218 | ) | 1,230 | |||||||||||||||||||
20%-50% Below cost | 37 | (11 | ) | 4 | 131 | (53 | ) | 15 | 168 | (64 | ) | 19 | |||||||||||||||||||||||||
>50% Below cost | — | — | — | — | (1 | ) | 6 | — | (1 | ) | 6 | ||||||||||||||||||||||||||
Total fixed maturity securities | 5,185 | (114 | ) | 757 | 3,185 | (169 | ) | 498 | 8,370 | (283 | ) | 1,255 | |||||||||||||||||||||||||
% Below cost—equity securities: | |||||||||||||||||||||||||||||||||||||
<20% Below cost | 26 | (2 | ) | 40 | 48 | (4 | ) | 6 | 74 | (6 | ) | 46 | |||||||||||||||||||||||||
20%-50% Below cost | 4 | (1 | ) | 6 | — | — | — | 4 | (1 | ) | 6 | ||||||||||||||||||||||||||
Total equity securities | 30 | (3 | ) | 46 | 48 | (4 | ) | 6 | 78 | (7 | ) | 52 | |||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 5,215 | $ | (117 | ) | 803 | $ | 3,233 | $ | (173 | ) | 504 | $ | 8,448 | $ | (290 | ) | 1,307 | |||||||||||||||||||
Investment grade | $ | 4,623 | $ | (75 | ) | 675 | $ | 2,936 | $ | (146 | ) | 431 | $ | 7,559 | $ | (221 | ) | 1,106 | |||||||||||||||||||
Below investment grade (2) | 592 | (42 | ) | 128 | 297 | (27 | ) | 73 | 889 | (69 | ) | 201 | |||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 5,215 | $ | (117 | ) | 803 | $ | 3,233 | $ | (173 | ) | 504 | $ | 8,448 | $ | (290 | ) | 1,307 | |||||||||||||||||||
(1) | Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities. | ||||||||||||||||||||||||||||||||||||
(2) | Amounts that have been in a continuous unrealized loss position for 12 months or more included $1 million of unrealized losses on other-than-temporarily impaired securities. | ||||||||||||||||||||||||||||||||||||
As indicated in the table above, the majority of the securities in a continuous unrealized loss position for less than 12 months were investment grade and less than 20% below cost. These unrealized losses were primarily attributable to lower credit ratings since acquisition for corporate securities across various industry sectors and an increase in U.S. Treasury yields since these securities were purchased. For securities that have been in a continuous unrealized loss position for less than 12 months, the average fair value percentage below cost was approximately 2% as of December 31, 2014. | |||||||||||||||||||||||||||||||||||||
Fixed Maturity Securities In A Continuous Unrealized Loss Position For 12 Months Or More | |||||||||||||||||||||||||||||||||||||
Of the $115 million of unrealized losses on fixed maturity securities in a continuous unrealized loss for 12 months or more that were less than 20% below cost, the weighted-average rating was “A-” and approximately 86% of the unrealized losses were related to investment grade securities as of December 31, 2014. These unrealized losses were attributable to the lower credit ratings for these securities since acquisition, primarily associated with corporate securities in the finance and insurance and utilities and energy sectors and structured securities, in addition to U.S. government, agencies and government-sponsored enterprises securities resulting from an increase in U.S. Treasury yields since these securities were purchased. The average fair value percentage below cost for these securities was approximately 4% as of December 31, 2014. See below for additional discussion related to fixed maturity securities that have been in a continuous unrealized loss position for 12 months or more with a fair value that was more than 20% below cost. | |||||||||||||||||||||||||||||||||||||
The following tables present the concentration of gross unrealized losses and fair values of fixed maturity securities that were more than 20% below cost and in a continuous unrealized loss position for 12 months or more by asset class as of December 31, 2014: | |||||||||||||||||||||||||||||||||||||
Investment Grade | |||||||||||||||||||||||||||||||||||||
20% to 50% | Greater than 50% | ||||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) | Fair | Gross | % of total | Number of | Fair | Gross | % of total | Number of | |||||||||||||||||||||||||||||
value | unrealized | gross | securities | value | unrealized | gross | securities | ||||||||||||||||||||||||||||||
losses | unrealized | losses | unrealized | ||||||||||||||||||||||||||||||||||
losses | losses | ||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
Tax-exempt | $ | 10 | $ | (3 | ) | 1 | % | 1 | $ | — | $ | — | — | % | — | ||||||||||||||||||||||
U.S. corporate | 25 | (10 | ) | 3 | 1 | — | — | — | — | ||||||||||||||||||||||||||||
Structured securities: | |||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 5 | (4 | ) | 1 | 3 | — | — | — | — | ||||||||||||||||||||||||||||
Other asset-backed | 71 | (26 | ) | 9 | 4 | — | — | — | — | ||||||||||||||||||||||||||||
Total structured securities | 76 | (30 | ) | 10 | 7 | — | — | — | — | ||||||||||||||||||||||||||||
Total | $ | 111 | $ | (43 | ) | 14 | % | 9 | $ | — | $ | — | — | % | — | ||||||||||||||||||||||
Below Investment Grade | |||||||||||||||||||||||||||||||||||||
20% to 50% | Greater than 50% | ||||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) | Fair | Gross | % of total | Number of | Fair | Gross | % of total | Number of | |||||||||||||||||||||||||||||
value | unrealized | gross | securities | value | unrealized | gross | securities | ||||||||||||||||||||||||||||||
losses | unrealized | losses | unrealized | ||||||||||||||||||||||||||||||||||
losses | losses | ||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
U.S. corporate | $ | 8 | $ | (2 | ) | 1 | % | 1 | $ | — | $ | — | — | % | — | ||||||||||||||||||||||
Corporate—non-U.S. | 3 | (2 | ) | 1 | 1 | — | — | — | — | ||||||||||||||||||||||||||||
Structured securities: | |||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | — | — | — | — | — | (1 | ) | — | 6 | ||||||||||||||||||||||||||||
Other asset-backed | 9 | (6 | ) | 2 | 4 | — | — | — | — | ||||||||||||||||||||||||||||
Total structured securities | 9 | (6 | ) | 2 | 4 | — | (1 | ) | — | 6 | |||||||||||||||||||||||||||
Total | $ | 20 | $ | (10 | ) | 4 | % | 6 | $ | — | $ | (1 | ) | — | % | 6 | |||||||||||||||||||||
For all securities in an unrealized loss position, we expect to recover the amortized cost based on our estimate of the amount and timing of cash flows to be collected. We do not intend to sell nor do we expect that we will be required to sell these securities prior to recovering our amortized cost. See below for further discussion of gross unrealized losses by asset class. | |||||||||||||||||||||||||||||||||||||
Structured Securities | |||||||||||||||||||||||||||||||||||||
Of the $37 million of unrealized losses related to structured securities that have been in an unrealized loss position for 12 months or more and were more than 20% below cost, $1 million related to other-than-temporarily impaired securities where the unrealized losses represented the portion of the other-than-temporary impairment recognized in OCI. The extent and duration of the unrealized loss position on our structured securities was primarily due to credit spreads that have widened since acquisition. Additionally, the fair value of certain structured securities has been impacted from high risk premiums being incorporated into the valuation as a result of the amount of potential losses that may be absorbed by the security in the event of additional deterioration in the U.S. economy. | |||||||||||||||||||||||||||||||||||||
While we considered the length of time each security had been in an unrealized loss position, the extent of the unrealized loss position and any significant declines in fair value subsequent to the balance sheet date in our evaluation of impairment for each of these individual securities, the primary factor in our evaluation of impairment is the expected performance for each of these securities. Our evaluation of expected performance is based on the historical performance of the associated securitization trust as well as the historical performance of the underlying collateral. Our examination of the historical performance of the securitization trust included consideration of the following factors for each class of securities issued by the trust: i) the payment history, including failure to make scheduled payments; ii) current payment status; iii) current and historical outstanding balances; iv) current levels of subordination and losses incurred to date; and v) characteristics of the underlying collateral. Our examination of the historical performance of the underlying collateral included: i) historical default rates, delinquency rates, voluntary and involuntary prepayments and severity of losses, including recent trends in this information; ii) current payment status; iii) loan to collateral value ratios, as applicable; iv) vintage; and v) other underlying characteristics such as current financial condition. | |||||||||||||||||||||||||||||||||||||
We used our assessment of the historical performance of both the securitization trust and the underlying collateral for each security, along with third-party sources, when available, to develop our best estimate of cash flows expected to be collected. These estimates reflect projections for future delinquencies, prepayments, defaults and losses for the assets that collateralize the securitization trust and are used to determine the expected cash flows for our security, based on the payment structure of the trust. Our projection of expected cash flows is primarily based on the expected performance of the underlying assets that collateralize the securitization trust and is not directly impacted by the rating of our security. While we consider the rating of the security as an indicator of the financial condition of the issuer, this factor does not have a significant impact on our expected cash flows for each security. In limited circumstances, our expected cash flows include expected payments from reliable financial guarantors where we believe the financial guarantor will have sufficient assets to pay claims under the financial guarantee when the cash flows from the securitization trust are not sufficient to make scheduled payments. We then discount the expected cash flows using the effective yield of each security to determine the present value of expected cash flows. | |||||||||||||||||||||||||||||||||||||
Based on this evaluation, the present value of expected cash flows was greater than or equal to the amortized cost for each security. Accordingly, we determined that the unrealized losses on each of our structured securities represented temporary impairments as of December 31, 2014. | |||||||||||||||||||||||||||||||||||||
Despite the considerable analysis and rigor employed on our structured securities, it is at least reasonably possible that the underlying collateral of these investments will perform worse than current market expectations. Such events may lead to adverse changes in cash flows on our holdings of structured securities and future write-downs within our portfolio of structured securities. | |||||||||||||||||||||||||||||||||||||
The following table presents the gross unrealized losses and fair values of our investment securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, as of December 31, 2013: | |||||||||||||||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | |||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) | Fair | Gross | Number | Fair | Gross | Number | Fair | Gross | Number | ||||||||||||||||||||||||||||
value | unrealized | of | value | unrealized | of | value | unrealized | of | |||||||||||||||||||||||||||||
losses | securities | losses (1) | securities | losses (1) | securities | ||||||||||||||||||||||||||||||||
Description of Securities | |||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 796 | $ | (109 | ) | 32 | $ | 335 | $ | (122 | ) | 13 | $ | 1,131 | $ | (231 | ) | 45 | |||||||||||||||||||
Tax-exempt | 82 | (3 | ) | 26 | 97 | (33 | ) | 9 | 179 | (36 | ) | 35 | |||||||||||||||||||||||||
Government—non-U.S. | 479 | (15 | ) | 60 | — | — | — | 479 | (15 | ) | 60 | ||||||||||||||||||||||||||
U.S. corporate | 4,774 | (260 | ) | 707 | 663 | (99 | ) | 82 | 5,437 | (359 | ) | 789 | |||||||||||||||||||||||||
Corporate—non-U.S. | 3,005 | (127 | ) | 379 | 287 | (29 | ) | 34 | 3,292 | (156 | ) | 413 | |||||||||||||||||||||||||
Residential mortgage-backed | 1,052 | (55 | ) | 139 | 157 | (19 | ) | 92 | 1,209 | (74 | ) | 231 | |||||||||||||||||||||||||
Commercial mortgage-backed | 967 | (42 | ) | 107 | 370 | (23 | ) | 62 | 1,337 | (65 | ) | 169 | |||||||||||||||||||||||||
Other asset-backed | 1,089 | (17 | ) | 133 | 145 | (40 | ) | 17 | 1,234 | (57 | ) | 150 | |||||||||||||||||||||||||
Subtotal, fixed maturity securities | 12,244 | (628 | ) | 1,583 | 2,054 | (365 | ) | 309 | 14,298 | (993 | ) | 1,892 | |||||||||||||||||||||||||
Equity securities | 95 | (13 | ) | 41 | — | — | — | 95 | (13 | ) | 41 | ||||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 12,339 | $ | (641 | ) | 1,624 | $ | 2,054 | $ | (365 | ) | 309 | $ | 14,393 | $ | (1,006 | ) | 1,933 | |||||||||||||||||||
% Below cost—fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
<20% Below cost | $ | 12,009 | $ | (547 | ) | 1,571 | $ | 1,575 | $ | (163 | ) | 238 | $ | 13,584 | $ | (710 | ) | 1,809 | |||||||||||||||||||
20%-50% Below cost | 235 | (81 | ) | 12 | 466 | (187 | ) | 51 | 701 | (268 | ) | 63 | |||||||||||||||||||||||||
>50% Below cost | — | — | — | 13 | (15 | ) | 20 | 13 | (15 | ) | 20 | ||||||||||||||||||||||||||
Total fixed maturity securities | 12,244 | (628 | ) | 1,583 | 2,054 | (365 | ) | 309 | 14,298 | (993 | ) | 1,892 | |||||||||||||||||||||||||
% Below cost—equity securities: | |||||||||||||||||||||||||||||||||||||
<20% Below cost | 87 | (11 | ) | 40 | — | — | — | 87 | (11 | ) | 40 | ||||||||||||||||||||||||||
20%-50% Below cost | 8 | (2 | ) | 1 | — | — | — | 8 | (2 | ) | 1 | ||||||||||||||||||||||||||
Total equity securities | 95 | (13 | ) | 41 | — | — | — | 95 | (13 | ) | 41 | ||||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 12,339 | $ | (641 | ) | 1,624 | $ | 2,054 | $ | (365 | ) | 309 | $ | 14,393 | $ | (1,006 | ) | 1,933 | |||||||||||||||||||
Investment grade | $ | 11,896 | $ | (616 | ) | 1,515 | $ | 1,631 | $ | (315 | ) | 208 | $ | 13,527 | $ | (931 | ) | 1,723 | |||||||||||||||||||
Below investment grade (2) | 443 | (25 | ) | 109 | 423 | (50 | ) | 101 | 866 | (75 | ) | 210 | |||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 12,339 | $ | (641 | ) | 1,624 | $ | 2,054 | $ | (365 | ) | 309 | $ | 14,393 | $ | (1,006 | ) | 1,933 | |||||||||||||||||||
(1) | Amounts included $7 million of unrealized losses on other-than-temporarily impaired securities. | ||||||||||||||||||||||||||||||||||||
(2) | Amounts that have been in a continuous unrealized loss position for 12 months or more included $7 million of unrealized losses on other-than-temporarily impaired securities. | ||||||||||||||||||||||||||||||||||||
The scheduled maturity distribution of fixed maturity securities as of December 31, 2014 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties. | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Amortized | Fair | |||||||||||||||||||||||||||||||||||
cost or | value | ||||||||||||||||||||||||||||||||||||
cost | |||||||||||||||||||||||||||||||||||||
Due one year or less | $ | 2,307 | $ | 2,326 | |||||||||||||||||||||||||||||||||
Due after one year through five years | 10,858 | 11,410 | |||||||||||||||||||||||||||||||||||
Due after five years through ten years | 11,888 | 12,496 | |||||||||||||||||||||||||||||||||||
Due after ten years | 20,717 | 24,568 | |||||||||||||||||||||||||||||||||||
Subtotal | 45,770 | 50,800 | |||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 4,881 | 5,240 | |||||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 2,564 | 2,702 | |||||||||||||||||||||||||||||||||||
Other asset-backed | 3,735 | 3,705 | |||||||||||||||||||||||||||||||||||
Total | $ | 56,950 | $ | 62,447 | |||||||||||||||||||||||||||||||||
As of December 31, 2014, $6,713 million of our investments (excluding mortgage-backed and asset-backed securities) were subject to certain call provisions. | |||||||||||||||||||||||||||||||||||||
As of December 31, 2014, securities issued by utilities and energy, finance and insurance, and consumer—non-cyclical industry groups represented approximately 24%, 19% and 12%, respectively, of our domestic and foreign corporate fixed maturity securities portfolio. No other industry group comprised more than 10% of our investment portfolio. This portfolio is widely diversified among various geographic regions in the United States and internationally, and is not dependent on the economic stability of one particular region. | |||||||||||||||||||||||||||||||||||||
As of December 31, 2014, we did not hold any fixed maturity securities in any single issuer, other than securities issued or guaranteed by the U.S. government, which exceeded 10% of stockholders’ equity. | |||||||||||||||||||||||||||||||||||||
As of December 31, 2014 and 2013, $49 million and $50 million, respectively, of securities were on deposit with various state or foreign government insurance departments in order to comply with relevant insurance regulations. | |||||||||||||||||||||||||||||||||||||
(e) Commercial Mortgage Loans | |||||||||||||||||||||||||||||||||||||
Our mortgage loans are collateralized by commercial properties, including multi-family residential buildings. The carrying value of commercial mortgage loans is stated at original cost net of principal payments, amortization and allowance for loan losses. | |||||||||||||||||||||||||||||||||||||
We diversify our commercial mortgage loans by both property type and geographic region. The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of December 31: | |||||||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Carrying | % of | Carrying | % of | |||||||||||||||||||||||||||||||||
value | total | value | total | ||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | 2,150 | 35 | % | $ | 2,073 | 35 | % | |||||||||||||||||||||||||||||
Office | 1,643 | 27 | 1,558 | 26 | |||||||||||||||||||||||||||||||||
Industrial | 1,597 | 26 | 1,581 | 27 | |||||||||||||||||||||||||||||||||
Apartments | 494 | 8 | 491 | 8 | |||||||||||||||||||||||||||||||||
Mixed use/other | 239 | 4 | 229 | 4 | |||||||||||||||||||||||||||||||||
Subtotal | 6,123 | 100 | % | 5,932 | 100 | % | |||||||||||||||||||||||||||||||
Unamortized balance of loan origination fees and costs | (1 | ) | — | ||||||||||||||||||||||||||||||||||
Allowance for losses | (22 | ) | (33 | ) | |||||||||||||||||||||||||||||||||
Total | $ | 6,100 | $ | 5,899 | |||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Carrying | % of | Carrying | % of | |||||||||||||||||||||||||||||||||
value | total | value | total | ||||||||||||||||||||||||||||||||||
Geographic region: | |||||||||||||||||||||||||||||||||||||
South Atlantic | $ | 1,673 | 27 | % | $ | 1,535 | 26 | % | |||||||||||||||||||||||||||||
Pacific | 1,636 | 27 | 1,590 | 27 | |||||||||||||||||||||||||||||||||
Middle Atlantic | 826 | 14 | 828 | 14 | |||||||||||||||||||||||||||||||||
Mountain | 536 | 9 | 478 | 8 | |||||||||||||||||||||||||||||||||
East North Central | 397 | 7 | 404 | 7 | |||||||||||||||||||||||||||||||||
West North Central | 382 | 6 | 377 | 6 | |||||||||||||||||||||||||||||||||
West South Central | 268 | 4 | 241 | 4 | |||||||||||||||||||||||||||||||||
New England | 264 | 4 | 337 | 6 | |||||||||||||||||||||||||||||||||
East South Central | 141 | 2 | 142 | 2 | |||||||||||||||||||||||||||||||||
Subtotal | 6,123 | 100 | % | 5,932 | 100 | % | |||||||||||||||||||||||||||||||
Unamortized balance of loan origination fees and costs | (1 | ) | — | ||||||||||||||||||||||||||||||||||
Allowance for losses | (22 | ) | (33 | ) | |||||||||||||||||||||||||||||||||
Total | $ | 6,100 | $ | 5,899 | |||||||||||||||||||||||||||||||||
The following tables set forth the aging of past due commercial mortgage loans by property type as of December 31: | |||||||||||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 31 - 60 days | 61 - 90 days | Greater than | Total | Current | Total | |||||||||||||||||||||||||||||||
past due | past due | 90 days past | past due | ||||||||||||||||||||||||||||||||||
due | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | — | $ | — | $ | — | $ | — | $ | 2,150 | $ | 2,150 | |||||||||||||||||||||||||
Office | — | — | 6 | 6 | 1,637 | 1,643 | |||||||||||||||||||||||||||||||
Industrial | — | — | 2 | 2 | 1,595 | 1,597 | |||||||||||||||||||||||||||||||
Apartments | — | — | — | — | 494 | 494 | |||||||||||||||||||||||||||||||
Mixed use/other | — | — | — | — | 239 | 239 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | — | $ | — | $ | 8 | $ | 8 | $ | 6,115 | $ | 6,123 | |||||||||||||||||||||||||
% of total commercial mortgage loans | — | % | — | % | — | % | — | % | 100 | % | 100 | % | |||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 31 - 60 days | 61 - 90 days | Greater than | Total | Current | Total | |||||||||||||||||||||||||||||||
past due | past due | 90 days past | past due | ||||||||||||||||||||||||||||||||||
due | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | — | $ | — | $ | 10 | $ | 10 | $ | 2,063 | $ | 2,073 | |||||||||||||||||||||||||
Office | — | — | 6 | 6 | 1,552 | 1,558 | |||||||||||||||||||||||||||||||
Industrial | 2 | 2 | 16 | 20 | 1,561 | 1,581 | |||||||||||||||||||||||||||||||
Apartments | — | — | — | — | 491 | 491 | |||||||||||||||||||||||||||||||
Mixed use/other | 1 | — | — | 1 | 228 | 229 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | 3 | $ | 2 | $ | 32 | $ | 37 | $ | 5,895 | $ | 5,932 | |||||||||||||||||||||||||
% of total commercial mortgage loans | — | % | — | % | 1 | % | 1 | % | 99 | % | 100 | % | |||||||||||||||||||||||||
As of December 31, 2014 and 2013, we had no commercial mortgage loans that were past due for more than 90 days and still accruing interest. We also did not have any commercial mortgage loans that were past due for less than 90 days on non-accrual status as of December 31, 2014 and 2013. | |||||||||||||||||||||||||||||||||||||
We evaluate the impairment of commercial mortgage loans on an individual loan basis. As of December 31, 2014 and 2013, our commercial mortgage loans greater than 90 days past due included loans with appraised values in excess of the recorded investment and the current recorded investment of these loans was expected to be recoverable. | |||||||||||||||||||||||||||||||||||||
During the years ended December 31, 2014 and 2013, we modified or extended 28 and 33 commercial mortgage loans, respectively, with a total carrying value of $254 million and $165 million, respectively. All of these modifications or extensions were based on current market interest rates, did not result in any forgiveness in the outstanding principal amount owed by the borrower and were not considered troubled debt restructurings. | |||||||||||||||||||||||||||||||||||||
The following table sets forth the allowance for credit losses and recorded investment in commercial mortgage loans as of or for the years ended December 31: | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Allowance for credit losses: | |||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 33 | $ | 42 | $ | 51 | |||||||||||||||||||||||||||||||
Charge-offs | (1 | ) | (2 | ) | (2 | ) | |||||||||||||||||||||||||||||||
Recoveries | — | — | — | ||||||||||||||||||||||||||||||||||
Provision | (10 | ) | (7 | ) | (7 | ) | |||||||||||||||||||||||||||||||
Ending balance | $ | 22 | $ | 33 | $ | 42 | |||||||||||||||||||||||||||||||
Ending allowance for individually impaired loans | $ | — | $ | — | $ | — | |||||||||||||||||||||||||||||||
Ending allowance for loans not individually impaired that were evaluated collectively for impairment | $ | 22 | $ | 33 | $ | 42 | |||||||||||||||||||||||||||||||
Recorded investment: | |||||||||||||||||||||||||||||||||||||
Ending balance | $ | 6,123 | $ | 5,932 | $ | 5,912 | |||||||||||||||||||||||||||||||
Ending balance of individually impaired loans | $ | 15 | $ | 2 | $ | — | |||||||||||||||||||||||||||||||
Ending balance of loans not individually impaired that were evaluated collectively for impairment | $ | 6,108 | $ | 5,930 | $ | 5,912 | |||||||||||||||||||||||||||||||
As of December 31, 2014, we had individually impaired commercial mortgage loans included within the industrial property type with a recorded investment of $15 million, an unpaid principal balance of $16 million, charge-offs of $1 million and an average recorded investment of $15 million. As of December 31, 2013, we had individually impaired commercial mortgage loans included within the retail property type with a recorded investment of $2 million, an unpaid principal balance of $3 million, charge-offs of $1 million and an average recorded investment of $2 million. | |||||||||||||||||||||||||||||||||||||
In evaluating the credit quality of commercial mortgage loans, we assess the performance of the underlying loans using both quantitative and qualitative criteria. Certain risks associated with commercial mortgage loans can be evaluated by reviewing both the loan-to-value and debt service coverage ratio to understand both the probability of the borrower not being able to make the necessary loan payments as well as the ability to sell the underlying property for an amount that would enable us to recover our unpaid principal balance in the event of default by the borrower. The average loan-to-value ratio is based on our most recent estimate of the fair value for the underlying property which is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A lower loan-to-value indicates that our loan value is more likely to be recovered in the event of default by the borrower if the property was sold. The debt service coverage ratio is based on “normalized” annual net operating income of the property compared to the payments required under the terms of the loan. Normalization allows for the removal of annual one-time events such as capital expenditures, prepaid or late real estate tax payments or non-recurring third-party fees (such as legal, consulting or contract fees). This ratio is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A higher debt service coverage ratio indicates the borrower is less likely to default on the loan. The debt service coverage ratio should not be used without considering other factors associated with the borrower, such as the borrower’s liquidity or access to other resources that may result in our expectation that the borrower will continue to make the future scheduled payments. | |||||||||||||||||||||||||||||||||||||
The following tables set forth the loan-to-value of commercial mortgage loans by property type as of December 31: | |||||||||||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 0% - 50% | 51% - 60% | 61% - 75% | 76% - 100% | Greater | Total | |||||||||||||||||||||||||||||||
than 100% (1) | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | 671 | $ | 419 | $ | 967 | $ | 75 | $ | 18 | $ | 2,150 | |||||||||||||||||||||||||
Office | 383 | 278 | 782 | 164 | 36 | 1,643 | |||||||||||||||||||||||||||||||
Industrial | 451 | 285 | 778 | 60 | 23 | 1,597 | |||||||||||||||||||||||||||||||
Apartments | 211 | 76 | 199 | 8 | — | 494 | |||||||||||||||||||||||||||||||
Mixed use/other | 45 | 43 | 145 | 6 | — | 239 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | 1,761 | $ | 1,101 | $ | 2,871 | $ | 313 | $ | 77 | $ | 6,123 | |||||||||||||||||||||||||
% of total | 29 | % | 18 | % | 47 | % | 5 | % | 1 | % | 100 | % | |||||||||||||||||||||||||
Weighted-average debt service coverage ratio | 2.27 | 1.75 | 1.61 | 1.02 | 0.72 | 1.78 | |||||||||||||||||||||||||||||||
(1) | Included $15 million of impaired loans, $6 million of loans past due and not individually impaired and $56 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 120%. | ||||||||||||||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 0% - 50% | 51% - 60% | 61% - 75% | 76% - 100% | Greater | Total | |||||||||||||||||||||||||||||||
than 100% (1) | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | 596 | $ | 336 | $ | 1,024 | $ | 95 | $ | 22 | $ | 2,073 | |||||||||||||||||||||||||
Office | 397 | 191 | 716 | 191 | 63 | 1,558 | |||||||||||||||||||||||||||||||
Industrial | 430 | 237 | 748 | 146 | 20 | 1,581 | |||||||||||||||||||||||||||||||
Apartments | 201 | 86 | 176 | 27 | 1 | 491 | |||||||||||||||||||||||||||||||
Mixed use/other | 71 | 36 | 110 | 12 | — | 229 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | 1,695 | $ | 886 | $ | 2,774 | $ | 471 | $ | 106 | $ | 5,932 | |||||||||||||||||||||||||
% of total | 28 | % | 15 | % | 47 | % | 8 | % | 2 | % | 100 | % | |||||||||||||||||||||||||
Weighted-average debt service coverage ratio | 2.14 | 1.79 | 1.66 | 1.03 | 0.63 | 1.75 | |||||||||||||||||||||||||||||||
(1) | Included $2 million of impaired loans, $5 million of loans past due and not individually impaired and $99 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 119%. | ||||||||||||||||||||||||||||||||||||
The following tables set forth the debt service coverage ratio for fixed rate commercial mortgage loans by property type as of December 31: | |||||||||||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Less than 1.00 | 1.00 - 1.25 | 1.26 - 1.50 | 1.51 - 2.00 | Greater | Total | |||||||||||||||||||||||||||||||
than 2.00 | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | 80 | $ | 253 | $ | 524 | $ | 870 | $ | 423 | $ | 2,150 | |||||||||||||||||||||||||
Office | 119 | 101 | 247 | 780 | 389 | 1,636 | |||||||||||||||||||||||||||||||
Industrial | 158 | 142 | 246 | 706 | 343 | 1,595 | |||||||||||||||||||||||||||||||
Apartments | 1 | 48 | 88 | 186 | 171 | 494 | |||||||||||||||||||||||||||||||
Mixed use/other | 6 | 1 | 61 | 135 | 36 | 239 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | 364 | $ | 545 | $ | 1,166 | $ | 2,677 | $ | 1,362 | $ | 6,114 | |||||||||||||||||||||||||
% of total | 6 | % | 9 | % | 19 | % | 44 | % | 22 | % | 100 | % | |||||||||||||||||||||||||
Weighted-average loan-to-value | 77 | % | 64 | % | 64 | % | 59 | % | 45 | % | 59 | % | |||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Less than 1.00 | 1.00 - 1.25 | 1.26 - 1.50 | 1.51 - 2.00 | Greater | Total | |||||||||||||||||||||||||||||||
than 2.00 | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | 106 | $ | 314 | $ | 374 | $ | 779 | $ | 399 | $ | 1,972 | |||||||||||||||||||||||||
Office | 131 | 181 | 225 | 637 | 376 | 1,550 | |||||||||||||||||||||||||||||||
Industrial | 195 | 100 | 270 | 721 | 295 | 1,581 | |||||||||||||||||||||||||||||||
Apartments | 3 | 31 | 107 | 187 | 163 | 491 | |||||||||||||||||||||||||||||||
Mixed use/other | 16 | 9 | 32 | 106 | 66 | 229 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | 451 | $ | 635 | $ | 1,008 | $ | 2,430 | $ | 1,299 | $ | 5,823 | |||||||||||||||||||||||||
% of total | 8 | % | 11 | % | 17 | % | 42 | % | 22 | % | 100 | % | |||||||||||||||||||||||||
Weighted-average loan-to-value | 80 | % | 68 | % | 63 | % | 60 | % | 43 | % | 59 | % | |||||||||||||||||||||||||
As of December 31, 2014 and 2013, we had floating rate commercial mortgage loans of $9 million and $109 million, respectively. | |||||||||||||||||||||||||||||||||||||
(f) Restricted Commercial Mortgage Loans Related To Securitization Entities | |||||||||||||||||||||||||||||||||||||
We have a consolidated securitization entity that holds commercial mortgage loans that are recorded as restricted commercial mortgage loans related to securitization entities. See note 18 for additional information related to consolidated securitization entities. | |||||||||||||||||||||||||||||||||||||
(g) Restricted Other Invested Assets Related To Securitization Entities | |||||||||||||||||||||||||||||||||||||
We have consolidated securitization entities that hold certain investments that are recorded as restricted other invested assets related to securitization entities. The consolidated securitization entities hold certain investments as trading securities whereby the changes in fair value are recorded in current period income (loss). The trading securities comprise asset-backed securities, including residual interest in certain policy loan securitization entities and highly rated bonds that are primarily backed by credit card receivables. See note 18 for additional information related to consolidated securitization entities. | |||||||||||||||||||||||||||||||||||||
Derivative_Instruments
Derivative Instruments | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||
Derivative Instruments | (5) Derivative Instruments | ||||||||||||||||||||||||
Our business activities routinely deal with fluctuations in interest rates, equity prices, currency exchange rates and other asset and liability prices. We use derivative instruments to mitigate or reduce certain of these risks. We have established policies for managing each of these risks, including prohibitions on derivatives market-making and other speculative derivatives activities. These policies require the use of derivative instruments in concert with other techniques to reduce or mitigate these risks. While we use derivatives to mitigate or reduce risks, certain derivatives do not meet the accounting requirements to be designated as hedging instruments and are denoted as “derivatives not designated as hedges” in the following disclosures. For derivatives that meet the accounting requirements to be designated as hedges, the following disclosures for these derivatives are denoted as “derivatives designated as hedges,” which include both cash flow and fair value hedges. | |||||||||||||||||||||||||
The following table sets forth our positions in derivative instruments as of December 31: | |||||||||||||||||||||||||
Derivative assets | Derivative liabilities | ||||||||||||||||||||||||
Balance sheet | Fair value | Balance sheet | Fair value | ||||||||||||||||||||||
(Amounts in millions) | classification | 2014 | 2013 | classification | 2014 | 2013 | |||||||||||||||||||
Derivatives designated as hedges | |||||||||||||||||||||||||
Cash flow hedges: | |||||||||||||||||||||||||
Interest rate swaps | Other invested assets | $ | 639 | $ | 121 | Other liabilities | $ | 27 | $ | 569 | |||||||||||||||
Inflation indexed swaps | Other invested assets | — | — | Other liabilities | 42 | 60 | |||||||||||||||||||
Foreign currency swaps | Other invested assets | 6 | 4 | Other liabilities | — | 2 | |||||||||||||||||||
Forward bond purchase commitments | Other invested assets | — | — | Other liabilities | — | 13 | |||||||||||||||||||
Total cash flow hedges | 645 | 125 | 69 | 644 | |||||||||||||||||||||
Fair value hedges: | |||||||||||||||||||||||||
Interest rate swaps | Other invested assets | — | 1 | Other liabilities | — | — | |||||||||||||||||||
Total fair value hedges | — | 1 | — | — | |||||||||||||||||||||
Total derivatives designated as hedges | 645 | 126 | 69 | 644 | |||||||||||||||||||||
Derivatives not designated as hedges | |||||||||||||||||||||||||
Interest rate swaps | Other invested assets | 452 | 314 | Other liabilities | 177 | 6 | |||||||||||||||||||
Interest rate swaps related to securitization entities (1) | Restricted other | — | — | Other liabilities | 26 | 16 | |||||||||||||||||||
invested assets | |||||||||||||||||||||||||
Credit default swaps | Other invested assets | 4 | 11 | Other liabilities | — | — | |||||||||||||||||||
Credit default swaps related to securitization entities (1) | Restricted other | — | — | Other liabilities | 17 | 32 | |||||||||||||||||||
invested assets | |||||||||||||||||||||||||
Foreign currency swaps | Other invested assets | — | — | Other liabilities | 7 | — | |||||||||||||||||||
Equity index options | Other invested assets | 17 | 12 | Other liabilities | — | — | |||||||||||||||||||
Financial futures | Other invested assets | — | — | Other liabilities | — | — | |||||||||||||||||||
Equity return swaps | Other invested assets | — | — | Other liabilities | 1 | 1 | |||||||||||||||||||
Other foreign currency contracts | Other invested assets | 14 | 8 | Other liabilities | 13 | 4 | |||||||||||||||||||
GMWB embedded derivatives | Reinsurance | 13 | (1 | ) | Policyholder | 291 | 96 | ||||||||||||||||||
recoverable (2) | account balances (3) | ||||||||||||||||||||||||
Fixed index annuity embedded | Other assets | — | — | Policyholder | 276 | 143 | |||||||||||||||||||
derivatives | account balances (4) | ||||||||||||||||||||||||
Indexed universal life embedded | Reinsurance | — | — | Policyholder | 7 | — | |||||||||||||||||||
derivatives | recoverable | account balances (5) | |||||||||||||||||||||||
Total derivatives not designated as hedges | 500 | 344 | 815 | 298 | |||||||||||||||||||||
Total derivatives | $ | 1,145 | $ | 470 | $ | 884 | $ | 942 | |||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||
(2) | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||
(3) | Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||
(4) | Represents the embedded derivatives associated with our fixed index annuity liabilities. | ||||||||||||||||||||||||
(5) | Represents the embedded derivatives associated with our indexed universal life liabilities. | ||||||||||||||||||||||||
The fair value of derivative positions presented above was not offset by the respective collateral amounts received or provided under these agreements. | |||||||||||||||||||||||||
The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for GMWB, fixed index annuity embedded derivatives and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated: | |||||||||||||||||||||||||
(Notional in millions) | Measurement | December 31, | Additions | Maturities/ | December 31, | ||||||||||||||||||||
2013 | terminations | 2014 | |||||||||||||||||||||||
Derivatives designated as hedges | |||||||||||||||||||||||||
Cash flow hedges: | |||||||||||||||||||||||||
Interest rate swaps | Notional | $ | 13,926 | $ | — | $ | (1,965 | ) | $ | 11,961 | |||||||||||||||
Inflation indexed swaps | Notional | 561 | 15 | (5 | ) | 571 | |||||||||||||||||||
Foreign currency swaps | Notional | 35 | — | — | 35 | ||||||||||||||||||||
Forward bond purchase commitments | Notional | 237 | — | (237 | ) | — | |||||||||||||||||||
Total cash flow hedges | 14,759 | 15 | (2,207 | ) | 12,567 | ||||||||||||||||||||
Fair value hedges: | |||||||||||||||||||||||||
Interest rate swaps | Notional | 6 | — | (6 | ) | — | |||||||||||||||||||
Total fair value hedges | 6 | — | (6 | ) | — | ||||||||||||||||||||
Total derivatives designated as hedges | 14,765 | 15 | (2,213 | ) | 12,567 | ||||||||||||||||||||
Derivatives not designated as hedges | |||||||||||||||||||||||||
Interest rate swaps | Notional | 4,822 | 508 | (256 | ) | 5,074 | |||||||||||||||||||
Interest rate swaps related to securitization entities (1) | Notional | 91 | — | (14 | ) | 77 | |||||||||||||||||||
Credit default swaps | Notional | 639 | 5 | (250 | ) | 394 | |||||||||||||||||||
Credit default swaps related to securitization entities (1) | Notional | 312 | — | — | 312 | ||||||||||||||||||||
Equity index options | Notional | 777 | 1,276 | (1,059 | ) | 994 | |||||||||||||||||||
Financial futures | Notional | 1,260 | 5,723 | (5,652 | ) | 1,331 | |||||||||||||||||||
Equity return swaps | Notional | 110 | 231 | (233 | ) | 108 | |||||||||||||||||||
Foreign currency swaps | Notional | — | 104 | — | 104 | ||||||||||||||||||||
Other foreign currency contracts | Notional | 487 | 788 | (850 | ) | 425 | |||||||||||||||||||
Total derivatives not designated as hedges | 8,498 | 8,635 | (8,314 | ) | 8,819 | ||||||||||||||||||||
Total derivatives | $ | 23,263 | $ | 8,650 | $ | (10,527 | ) | $ | 21,386 | ||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||
(Number of policies) | Measurement | December 31, | Additions | Maturities/ | December 31, | ||||||||||||||||||||
2013 | terminations | 2014 | |||||||||||||||||||||||
Derivatives not designated as hedges | |||||||||||||||||||||||||
GMWB embedded derivatives | Policies | 42,045 | — | (3,030 | ) | 39,015 | |||||||||||||||||||
Fixed index annuity embedded derivatives | Policies | 7,705 | 6,436 | (240 | ) | 13,901 | |||||||||||||||||||
Indexed universal life embedded derivatives | Policies | 29 | 394 | (2 | ) | 421 | |||||||||||||||||||
Cash Flow Hedges | |||||||||||||||||||||||||
Certain derivative instruments are designated as cash flow hedges. The changes in fair value of these instruments are recorded as a component of OCI. We designate and account for the following as cash flow hedges when they have met the effectiveness requirements: (i) various types of interest rate swaps to convert floating rate investments to fixed rate investments; (ii) various types of interest rate swaps to convert floating rate liabilities into fixed rate liabilities; (iii) receive U.S. dollar fixed on foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated investments; (iv) forward starting interest rate swaps to hedge against changes in interest rates associated with future fixed rate bond purchases and/or interest income; (v) forward bond purchase commitments to hedge against the variability in the anticipated cash flows required to purchase future fixed rate bonds; and (vi) other instruments to hedge the cash flows of various forecasted transactions. | |||||||||||||||||||||||||
The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2014: | |||||||||||||||||||||||||
(Amounts in millions) | Gain (loss) | Gain (loss) | Classification of gain | Gain (loss) | Classification of gain | ||||||||||||||||||||
recognized | reclassified into | (loss) reclassified into | recognized in | (loss) recognized in | |||||||||||||||||||||
in OCI | net income (loss) | net income (loss) | net income | net income (loss) | |||||||||||||||||||||
from OCI | (loss) (1) | ||||||||||||||||||||||||
Interest rate swaps hedging | $ | 1,229 | $ | 63 | Net investment | $ | 15 | Net investment | |||||||||||||||||
assets | income | gains (losses) | |||||||||||||||||||||||
Interest rate swaps hedging | — | 2 | Net investment | — | Net investment | ||||||||||||||||||||
assets | gains (losses) | gains (losses) | |||||||||||||||||||||||
Interest rate swaps hedging | (69 | ) | 1 | Interest expense | — | Net investment | |||||||||||||||||||
liabilities | gains (losses) | ||||||||||||||||||||||||
Inflation indexed swaps | 17 | (9 | ) | Net investment | — | Net investment | |||||||||||||||||||
income | gains (losses) | ||||||||||||||||||||||||
Foreign currency swaps | 4 | — | Interest expense | — | Net investment | ||||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Forward bond purchase | 34 | — | Net investment | — | Net investment | ||||||||||||||||||||
commitments | income | gains (losses) | |||||||||||||||||||||||
Total | $ | 1,215 | $ | 57 | $ | 15 | |||||||||||||||||||
(1) | Represents ineffective portion of cash flow hedges as there were no amounts excluded from the measurement of effectiveness. | ||||||||||||||||||||||||
The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2013: | |||||||||||||||||||||||||
(Amounts in millions) | Gain (loss) | Gain (loss) | Classification of gain | Gain (loss) | Classification of gain | ||||||||||||||||||||
recognized | reclassified into | (loss) reclassified into | recognized in | (loss) recognized in net | |||||||||||||||||||||
in OCI | net income (loss) | net income (loss) | net income | income (loss) | |||||||||||||||||||||
from OCI | (loss) (1) | ||||||||||||||||||||||||
Interest rate swaps hedging assets | $ | (892 | ) | $ | 47 | Net investment income | $ | (14 | ) | Net investment | |||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Interest rate swaps hedging assets | — | 1 | Net investment gains (losses) | — | Net investment | ||||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Interest rate swaps hedging liabilities | 42 | 2 | Interest expense | — | Net investment | ||||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Inflation indexed swaps | 45 | (5 | ) | Net investment income | — | Net investment | |||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Foreign currency swaps | (1 | ) | — | Interest expense | — | Net investment | |||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Forward bond purchase commitments | (60 | ) | — | Net investment income | — | Net investment | |||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Total | $ | (866 | ) | $ | 45 | $ | (14 | ) | |||||||||||||||||
(1) | Represents ineffective portion of cash flow hedges, as there were no amounts excluded from the measurement of effectiveness. | ||||||||||||||||||||||||
The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2012: | |||||||||||||||||||||||||
(Amounts in millions) | Gain (loss) | Gain (loss) | Classification of gain | Gain (loss) | Classification of gain | ||||||||||||||||||||
recognized | reclassified into | (loss) reclassified | recognized in | (loss) recognized in | |||||||||||||||||||||
in OCI | net income (loss) | into net income (loss) | net income | net income (loss) | |||||||||||||||||||||
from OCI | (loss) (1) | ||||||||||||||||||||||||
Interest rate swaps hedging assets | $ | (74 | ) | $ | 40 | Net investment income | $ | (12 | ) | Net investment gains (losses) | |||||||||||||||
Interest rate swaps hedging assets | — | 2 | Net investment gains (losses) | — | Net investment gains (losses) | ||||||||||||||||||||
Interest rate swaps hedging liabilities | — | 2 | Interest expense | — | Net investment gains (losses) | ||||||||||||||||||||
Inflation indexed swaps | (58 | ) | (9 | ) | Net investment income | — | Net investment gains (losses) | ||||||||||||||||||
Foreign currency swaps | 3 | — | Interest expense | — | Net investment gains (losses) | ||||||||||||||||||||
Forward bond purchase commitments | 14 | — | Net investment income | — | Net investment gains (losses) | ||||||||||||||||||||
Total | $ | (115 | ) | $ | 35 | $ | (12 | ) | |||||||||||||||||
(1) | Represents ineffective portion of cash flow hedges, as there were no amounts excluded from the measurement of effectiveness. | ||||||||||||||||||||||||
The following table provides a reconciliation of current period changes, net of applicable income taxes, for these designated derivatives presented in the separate component of stockholders’ equity labeled “derivatives qualifying as hedges,” for the years ended December 31: | |||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Derivatives qualifying as effective accounting hedges as of January 1 | $ | 1,319 | $ | 1,909 | $ | 2,009 | |||||||||||||||||||
Current period increases (decreases) in fair value, net of deferred taxes of $(427), $305 and $38 | 788 | (561 | ) | (77 | ) | ||||||||||||||||||||
Reclassification to net (income) loss, net of deferred taxes of $20, $16 and $12 | (37 | ) | (29 | ) | (23 | ) | |||||||||||||||||||
Derivatives qualifying as effective accounting hedges as of December 31 | $ | 2,070 | $ | 1,319 | $ | 1,909 | |||||||||||||||||||
The total of derivatives designated as cash flow hedges of $2,070 million, net of taxes, recorded in stockholders’ equity as of December 31, 2014 is expected to be reclassified to net income (loss) in the future, concurrently with and primarily offsetting changes in interest expense and interest income on floating rate instruments and interest income on future fixed rate bond purchases. Of this amount, $57 million, net of taxes, is expected to be reclassified to net income (loss) in the next 12 months. Actual amounts may vary from this amount as a result of market conditions. All forecasted transactions associated with qualifying cash flow hedges are expected to occur by 2047. There were immaterial amounts reclassified to net income (loss) during the years ended December 31, 2014, 2013 and 2012 in connection with forecasted transactions that were no longer considered probable of occurring. | |||||||||||||||||||||||||
Fair Value Hedges | |||||||||||||||||||||||||
Certain derivative instruments are designated as fair value hedges. The changes in fair value of these instruments are recorded in net income (loss). In addition, changes in the fair value attributable to the hedged portion of the underlying instrument are reported in net income (loss). We designate and account for the following as fair value hedges when they have met the effectiveness requirements: (i) interest rate swaps to convert fixed rate liabilities into floating rate liabilities; (ii) cross currency swaps to convert non-U.S. dollar fixed rate liabilities to floating rate U.S. dollar liabilities; and (iii) other instruments to hedge various fair value exposures of investments. | |||||||||||||||||||||||||
There were no pre-tax income (loss) effects of fair value hedges and related hedged items for the year ended December 31, 2014. | |||||||||||||||||||||||||
The following table provides information about the pre-tax income (loss) effects of fair value hedges and related hedged items for the year ended December 31, 2013: | |||||||||||||||||||||||||
Derivative instrument | Hedged item | ||||||||||||||||||||||||
(Amounts in millions) | Gain (loss) | Classification of | Other | Classification of | Gain (loss) | Classification of | |||||||||||||||||||
recognized | gain (losses) | impacts | other impacts to | recognized | gain (losses) | ||||||||||||||||||||
in net | recognized in net | to net | net income (loss) | in net | recognized in net | ||||||||||||||||||||
income | income (loss) | income | income | income (loss) | |||||||||||||||||||||
(loss) | (loss) | (loss) | |||||||||||||||||||||||
Interest rate swaps hedging liabilities | $ | (11 | ) | Net investment gains (losses) | $ | 13 | Interest credited | $ | 11 | Net investment gains (losses) | |||||||||||||||
Foreign currency swaps | (31 | ) | Net investment gains (losses) | — | Interest credited | 31 | Net investment gains (losses) | ||||||||||||||||||
Total | $ | (42 | ) | $ | 13 | $ | 42 | ||||||||||||||||||
The following table provides information about the pre-tax income (loss) effects of fair value hedges and related hedged items for the year ended December 31, 2012: | |||||||||||||||||||||||||
Derivative instrument | Hedged item | ||||||||||||||||||||||||
(Amounts in millions) | Gain (loss) | Classification of | Other | Classification of | Gain (loss) | Classification of | |||||||||||||||||||
recognized | gain (losses) | impacts | other impacts to | recognized | gain (losses) | ||||||||||||||||||||
in net | recognized in net | to net | net income (loss) | in net | recognized in net | ||||||||||||||||||||
income | income (loss) | income | income | income (loss) | |||||||||||||||||||||
(loss) | (loss) | (loss) | |||||||||||||||||||||||
Interest rate swaps hedging assets | $ | 1 | Net investment gains (losses) | $ | (4 | ) | Net investment income | $ | (1 | ) | Net investment gains (losses) | ||||||||||||||
Interest rate swaps hedging liabilities | (30 | ) | Net investment gains (losses) | 38 | Interest credited | 30 | Net investment gains (losses) | ||||||||||||||||||
Foreign currency swaps | (1 | ) | Net investment gains (losses) | 2 | Interest credited | — | Net investment gains (losses) | ||||||||||||||||||
Total | $ | (30 | ) | $ | 36 | $ | 29 | ||||||||||||||||||
The difference between the gain (loss) recognized for the derivative instrument and the hedged item presented above represents the net ineffectiveness of the fair value hedging relationships. The other impacts presented above represent the net income (loss) effects of the derivative instruments that are presented in the same location as the income (loss) activity from the hedged item. There were no amounts excluded from the measurement of effectiveness. | |||||||||||||||||||||||||
Derivatives Not Designated As Hedges | |||||||||||||||||||||||||
We also enter into certain non-qualifying derivative instruments such as: (i) interest rate swaps and financial futures to mitigate interest rate risk as part of managing regulatory capital positions; (ii) credit default swaps to enhance yield and reproduce characteristics of investments with similar terms and credit risk; (iii) equity index options, equity return swaps, interest rate swaps and financial futures to mitigate the risks associated with liabilities that have guaranteed minimum benefits, fixed index annuities and indexed universal life; (iv) interest rate swaps where the hedging relationship does not qualify for hedge accounting; (v) credit default swaps to mitigate loss exposure to certain credit risk; (vi) foreign currency swaps, options and forward contracts to mitigate currency risk associated with non-functional currency investments held by certain foreign subsidiaries and future dividends or other cash flows from certain foreign subsidiaries to our holding company; and (vii) equity index options to mitigate certain macroeconomic risks associated with certain foreign subsidiaries. Additionally, we provide GMWBs on certain variable annuities that are required to be bifurcated as embedded derivatives. We also offer fixed index annuity and indexed universal life products and have reinsurance agreements with certain features that are required to be bifurcated as embedded derivatives. | |||||||||||||||||||||||||
We also have derivatives related to securitization entities where we were required to consolidate the related securitization entity as a result of our involvement in the structure. The counterparties for these derivatives typically only have recourse to the securitization entity. The interest rate swaps used for these entities are typically used to effectively convert the interest payments on the assets of the securitization entity to the same basis as the interest rate on the borrowings issued by the securitization entity. Credit default swaps are utilized in certain securitization entities to enhance the yield payable on the borrowings issued by the securitization entity and also include a settlement feature that allows the securitization entity to provide the par value of assets in the securitization entity for the amount of any losses incurred under the credit default swap. | |||||||||||||||||||||||||
The following table provides the pre-tax gain (loss) recognized in net income (loss) for the effects of derivatives not designated as hedges for the years ended December 31: | |||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | Classification of gain (loss) recognized | |||||||||||||||||||||
in net income (loss) | |||||||||||||||||||||||||
Interest rate swaps | $ | 1 | $ | (7 | ) | $ | 21 | Net investment gains (losses) | |||||||||||||||||
Interest rate swaps related to securitization entities (1) | (9 | ) | 9 | (4 | ) | Net investment gains (losses) | |||||||||||||||||||
Credit default swaps | 1 | 14 | 57 | Net investment gains (losses) | |||||||||||||||||||||
Credit default swaps related to securitization entities (1) | 19 | 77 | 76 | Net investment gains (losses) | |||||||||||||||||||||
Equity index options | (31 | ) | (43 | ) | (58 | ) | Net investment gains (losses) | ||||||||||||||||||
Financial futures | 90 | (232 | ) | (121 | ) | Net investment gains (losses) | |||||||||||||||||||
Equity return swaps | 5 | (33 | ) | (37 | ) | Net investment gains (losses) | |||||||||||||||||||
Other foreign currency contracts | (4 | ) | 6 | (19 | ) | Net investment gains (losses) | |||||||||||||||||||
Foreign currency swaps | (7 | ) | — | — | Net investment gains (losses) | ||||||||||||||||||||
Reinsurance embedded derivatives | — | — | 3 | Net investment gains (losses) | |||||||||||||||||||||
GMWB embedded derivatives | (147 | ) | 277 | 170 | Net investment gains (losses) | ||||||||||||||||||||
Fixed index annuity embedded derivatives | (27 | ) | (18 | ) | (1 | ) | Net investment gains (losses) | ||||||||||||||||||
Indexed universal life embedded derivatives | (1 | ) | — | — | Net investment gains (losses) | ||||||||||||||||||||
Total derivatives not designated as hedges | $ | (110 | ) | $ | 50 | $ | 87 | ||||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||
Derivative Counterparty Credit Risk | |||||||||||||||||||||||||
Most of our derivative arrangements with counterparties require the posting of collateral upon meeting certain net exposure thresholds. For derivatives related to securitization entities, there are no arrangements that require either party to provide collateral and the recourse of the derivative counterparty is typically limited to the assets held by the securitization entity and there is no recourse to any entity other than the securitization entity. | |||||||||||||||||||||||||
The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of December 31: | |||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||
(Amounts in millions) | Derivatives | Derivatives | Net | Derivatives | Derivatives | Net | |||||||||||||||||||
assets (1) | liabilities (2) | derivatives | assets (1) | liabilities (2) | derivatives | ||||||||||||||||||||
Amounts presented in the balance sheet: | |||||||||||||||||||||||||
Gross amounts recognized | $ | 1,157 | $ | 273 | $ | 884 | $ | 496 | $ | 662 | $ | (166 | ) | ||||||||||||
Gross amounts offset in the balance sheet | — | — | — | — | — | — | |||||||||||||||||||
Net amounts presented in the balance sheet | 1,157 | 273 | 884 | 496 | 662 | (166 | ) | ||||||||||||||||||
Gross amounts not offset in the balance sheet: | |||||||||||||||||||||||||
Financial instruments (3) | (227 | ) | (227 | ) | — | (286 | ) | (286 | ) | — | |||||||||||||||
Collateral received | (884 | ) | — | (884 | ) | (199 | ) | — | (199 | ) | |||||||||||||||
Collateral pledged | — | (49 | ) | 49 | — | (394 | ) | 394 | |||||||||||||||||
Over collateralization | 1 | 5 | (4 | ) | 16 | 23 | (7 | ) | |||||||||||||||||
Net amount | $ | 47 | $ | 2 | $ | 45 | $ | 27 | $ | 5 | $ | 22 | |||||||||||||
(1) | Included $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2014 and 2013. | ||||||||||||||||||||||||
(2) | Included $6 million and $7 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2014 and 2013, respectively. | ||||||||||||||||||||||||
(3) | Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. | ||||||||||||||||||||||||
Except for derivatives related to securitization entities, almost all of our master swap agreements contain credit downgrade provisions that allow either party to assign or terminate derivative transactions if the other party’s long-term unsecured debt rating or financial strength rating is below the limit defined in the applicable agreement. If the downgrade provisions had been triggered as of December 31, 2014 and 2013, we could have been allowed to claim $47 million and $27 million, respectively, or required to disburse up to $2 million and $5 million, respectively. The chart above excludes embedded derivatives and derivatives related to securitization entities as those derivatives are not subject to master netting arrangements. | |||||||||||||||||||||||||
Credit Derivatives | |||||||||||||||||||||||||
We sell protection under single name credit default swaps and credit default swap index tranches in combination with purchasing securities to replicate characteristics of similar investments based on the credit quality and term of the credit default swap. Credit default triggers for both indexed reference entities and single name reference entities follow the Credit Derivatives Physical Settlement Matrix published by the International Swaps and Derivatives Association. Under these terms, credit default triggers are defined as bankruptcy, failure to pay or restructuring, if applicable. Our maximum exposure to credit loss equals the notional value for credit default swaps. In the event of default for credit default swaps, we are typically required to pay the protection holder the full notional value less a recovery rate determined at auction. | |||||||||||||||||||||||||
In addition to the credit derivatives discussed above, we also have credit derivative instruments related to securitization entities that we consolidate. These derivatives represent a customized index of reference entities with specified attachment points for certain derivatives. The credit default triggers are similar to those described above. In the event of default, the securitization entity will provide the counterparty with the par value of assets held in the securitization entity for the amount of incurred loss on the credit default swap. The maximum exposure to loss for the securitization entity is the notional value of the derivatives. Certain losses on these credit default swaps would be absorbed by the third-party noteholders of the securitization entity and the remaining losses on the credit default swaps would be absorbed by our portion of the notes issued by the securitization entity. | |||||||||||||||||||||||||
The following table sets forth our credit default swaps where we sell protection on single name reference entities and the fair values as of the dates indicated: | |||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||
(Amounts in millions) | Notional | Assets | Liabilities | Notional | Assets | Liabilities | |||||||||||||||||||
value | value | ||||||||||||||||||||||||
Investment grade | |||||||||||||||||||||||||
Matures in less than one year | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||
Matures after one year through five years | 39 | 1 | — | 39 | 1 | — | |||||||||||||||||||
Total credit default swaps on single name reference entities | $ | 39 | $ | 1 | $ | — | $ | 39 | $ | 1 | $ | — | |||||||||||||
The following table sets forth our credit default swaps where we sell protection on credit default swap index tranches and the fair values as of December 31: | |||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||
(Amounts in millions) | Notional | Assets | Liabilities | Notional | Assets | Liabilities | |||||||||||||||||||
value | value | ||||||||||||||||||||||||
Original index tranche attachment/detachment point and maturity: | |||||||||||||||||||||||||
7% - 15% matures after one year through five years (1) | $ | 100 | $ | 1 | $ | — | $ | 100 | $ | 3 | $ | — | |||||||||||||
9% - 12% matures in less than one year (2) | 250 | 2 | — | — | — | — | |||||||||||||||||||
9% - 12% matures after one year through five years (2) | — | — | — | 250 | 5 | — | |||||||||||||||||||
10% - 15% matures in less than one year (3) | — | — | — | 250 | 2 | — | |||||||||||||||||||
Total credit default swap index tranches | 350 | 3 | — | 600 | 10 | — | |||||||||||||||||||
Customized credit default swap index tranches related to securitization entities: | |||||||||||||||||||||||||
Portion backing third-party borrowings maturing | 12 | — | — | 12 | — | 1 | |||||||||||||||||||
2017 (4) | |||||||||||||||||||||||||
Portion backing our interest maturing 2017 (5) | 300 | — | 17 | 300 | — | 31 | |||||||||||||||||||
Total customized credit default swap index tranches related to securitization entities | 312 | — | 17 | 312 | — | 32 | |||||||||||||||||||
Total credit default swaps on index tranches | $ | 662 | $ | 3 | $ | 17 | $ | 912 | $ | 10 | $ | 32 | |||||||||||||
(1) | The current attachment/detachment as of December 31, 2014 and 2013 was 7% – 15%. | ||||||||||||||||||||||||
(2) | The current attachment/detachment as of December 31, 2014 and 2013 was 9% – 12%. | ||||||||||||||||||||||||
(3) | The current attachment/detachment as of December 31, 2014 and 2013 was 10% – 15%. | ||||||||||||||||||||||||
(4) | Original notional value was $39 million. | ||||||||||||||||||||||||
(5) | Original notional value was $300 million. |
Deferred_Acquisition_Costs
Deferred Acquisition Costs | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Deferred Acquisition Costs | (6) Deferred Acquisition Costs | ||||||||||||
The following table presents the activity impacting DAC as of and for the years ended December 31: | |||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||
Unamortized balance as of January 1 | $ | 5,454 | $ | 5,460 | $ | 5,458 | |||||||
Impact of foreign currency translation | (44 | ) | (12 | ) | 9 | ||||||||
Costs deferred | 473 | 457 | 611 | ||||||||||
Amortization, net of interest accretion | (493 | ) | (451 | ) | (618 | ) | |||||||
Unamortized balance as of December 31 | 5,390 | 5,454 | 5,460 | ||||||||||
Accumulated effect of net unrealized investment (gains) losses | (348 | ) | (176 | ) | (424 | ) | |||||||
Balance as of December 31 | $ | 5,042 | $ | 5,278 | $ | 5,036 | |||||||
We regularly review DAC to determine if it is recoverable from future income. As of December 31, 2014 and 2013, we believe all of our businesses have sufficient future income and therefore the related DAC is recoverable. As part of a life block transaction in the third quarter of 2012, we recorded $39 million of additional DAC amortization to reflect loss recognition on certain term life insurance policies under a reinsurance treaty. As of December 31, 2012, we believed all of our other businesses had sufficient future income and therefore the related DAC was recoverable. | |||||||||||||
In the first quarter of 2012, we also wrote off $142 million of DAC associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction. The write-off was included in amortization, net of interest accretion. |
Intangible_Assets
Intangible Assets | 12 Months Ended | ||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||
Intangible Assets | (7) Intangible Assets | ||||||||||||||||
The following table presents our intangible assets as of December 31: | |||||||||||||||||
2014 | 2013 | ||||||||||||||||
(Amounts in millions) | Gross | Accumulated | Gross | Accumulated | |||||||||||||
carrying | amortization | carrying | amortization | ||||||||||||||
amount | amount | ||||||||||||||||
PVFP | $ | 1,995 | $ | (1,917 | ) | $ | 2,061 | $ | (1,900 | ) | |||||||
Capitalized software | 736 | (604 | ) | 704 | (545 | ) | |||||||||||
Deferred sales inducements to contractholders | 209 | (153 | ) | 195 | (123 | ) | |||||||||||
Other | 55 | (49 | ) | 54 | (47 | ) | |||||||||||
Total | $ | 2,995 | $ | (2,723 | ) | $ | 3,014 | $ | (2,615 | ) | |||||||
Amortization expense related to PVFP, capitalized software and other intangible assets for the years ended December 31, 2014, 2013 and 2012 was $78 million, $118 million and $104 million, respectively. Amortization expense related to deferred sales inducements of $30 million, $24 million and $29 million, respectively, for the years ended December 31, 2014, 2013 and 2012 was included in benefits and other changes in policy reserves. | |||||||||||||||||
Present Value of Future Profits | |||||||||||||||||
The following table presents the activity in PVFP as of and for the years ended December 31: | |||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||
Unamortized balance as of January 1 | $ | 246 | $ | 297 | $ | 339 | |||||||||||
Interest accreted at 5.89%, 5.52% and 5.66% | 14 | 15 | 18 | ||||||||||||||
Amortization | (31 | ) | (66 | ) | (60 | ) | |||||||||||
Unamortized balance as of December 31 | 229 | 246 | 297 | ||||||||||||||
Accumulated effect of net unrealized investment (gains) losses | (151 | ) | (85 | ) | (180 | ) | |||||||||||
Balance as of December 31 | $ | 78 | $ | 161 | $ | 117 | |||||||||||
We regularly review our assumptions and periodically test PVFP for recoverability in a manner similar to our treatment of DAC. During the fourth quarter of 2014, the loss recognition testing for our acquired block of long-term care insurance business resulted in a premium deficiency. As a result, we wrote off the entire PVFP balance for our long-term care insurance business of $6 million through amortization with a corresponding change to net unrealized investment gains (losses). The results of the test were driven by changes to assumptions and methodologies primarily impacting claim termination rates, most significantly in later-duration claims, and benefit utilization rates. As of December 31, 2014, we believe all of our other businesses have sufficient future income and therefore the related PVFP is recoverable. For the years ended December 31, 2013 and 2012, there were no charges to income as a result of our PVFP recoverability testing. | |||||||||||||||||
The percentage of the December 31, 2014 PVFP balance net of interest accretion, before the effect of unrealized investment gains or losses, estimated to be amortized over each of the next five years is as follows: | |||||||||||||||||
2015 | 9.1 | % | |||||||||||||||
2016 | 11.1 | % | |||||||||||||||
2017 | 9.5 | % | |||||||||||||||
2018 | 7.7 | % | |||||||||||||||
2019 | 6.2 | % | |||||||||||||||
Amortization expense for PVFP in future periods will be affected by acquisitions, dispositions, net investment gains (losses) or other factors affecting the ultimate amount of gross profits realized from certain lines of business. Similarly, future amortization expense for other intangibles will depend on future acquisitions, dispositions and other business transactions. |
Goodwill_And_Dispositions
Goodwill And Dispositions | 12 Months Ended | ||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||
Goodwill And Dispositions | (8) Goodwill And Dispositions | ||||||||||||||||||||||||||||
Goodwill | |||||||||||||||||||||||||||||
The following is a summary of our goodwill balance by segment and Corporate and Other activities as of the dates indicated: | |||||||||||||||||||||||||||||
(Amounts in millions) | U.S. Life | International | U.S. | International | Runoff | Corporate | Total | ||||||||||||||||||||||
Insurance | Mortgage | Mortgage | Protection | and Other | |||||||||||||||||||||||||
Insurance | Insurance | ||||||||||||||||||||||||||||
Balance as of December 31, 2012: | |||||||||||||||||||||||||||||
Gross goodwill | $ | 1,034 | $ | 19 | $ | 22 | $ | 89 | $ | 70 | $ | 29 | $ | 1,263 | |||||||||||||||
Accumulated impairment losses | (185 | ) | — | (22 | ) | (89 | ) | (70 | ) | (29 | ) | (395 | ) | ||||||||||||||||
Goodwill | 849 | 19 | — | — | — | — | 868 | ||||||||||||||||||||||
Foreign exchange translation | — | (1 | ) | — | — | — | — | (1 | ) | ||||||||||||||||||||
Balance as of December 31, 2013: | |||||||||||||||||||||||||||||
Gross goodwill | 1,034 | 18 | 22 | 89 | 70 | — | 1,233 | ||||||||||||||||||||||
Accumulated impairment losses | (185 | ) | — | (22 | ) | (89 | ) | (70 | ) | — | (366 | ) | |||||||||||||||||
Goodwill | 849 | 18 | — | — | — | — | 867 | ||||||||||||||||||||||
Impairment losses | (849 | ) | — | — | — | — | — | (849 | ) | ||||||||||||||||||||
Foreign exchange translation | — | (2 | ) | — | — | — | — | (2 | ) | ||||||||||||||||||||
Balance as of December 31, 2014: | |||||||||||||||||||||||||||||
Gross goodwill | 1,034 | 16 | 22 | 89 | 70 | — | 1,231 | ||||||||||||||||||||||
Accumulated impairment losses | (1,034 | ) | — | (22 | ) | (89 | ) | (70 | ) | — | (1,215 | ) | |||||||||||||||||
Goodwill | $ | — | $ | 16 | $ | — | $ | — | $ | — | $ | — | $ | 16 | |||||||||||||||
Goodwill impairments | |||||||||||||||||||||||||||||
During 2014, we recorded goodwill impairments of $849 million in our U.S. Life Insurance segment, including $354 million for our long-term care insurance reporting unit and $495 million for our life insurance reporting unit. | |||||||||||||||||||||||||||||
For the first half of 2014, overall market sales for the long-term care insurance industry declined approximately 30% as compared to the same period last year. Given these trends, our annual sales projections included in our determination of fair value for our long-term care insurance reporting unit were lower than the prior year’s goodwill testing analysis. Based on the fair value of projected new business for our long-term care insurance reporting unit, we recorded a goodwill impairment of $200 million during the third quarter of 2014, with the remaining goodwill balance of $154 million deemed recoverable as of September 30, 2014 based on our determination of implied goodwill. | |||||||||||||||||||||||||||||
During the third quarter of 2014, in connection with our strategic planning process, we revisited our prior strategy of focusing on term life insurance, given the capital-intensive nature of the product and our revised capital plan. We are in the process of transitioning to higher return permanent products, including universal life insurance, indexed universal life insurance and linked-benefit products. Given this transition, our annual sales projections included in the determination of fair value for our life insurance reporting unit were significantly lower than sales levels expected in prior year’s goodwill testing analysis. Based on the fair value of projected new business for our life insurance reporting unit, we recorded a goodwill impairment of $350 million during the third quarter of 2014, with the remaining goodwill balance of $145 million deemed recoverable as of September 30, 2014 based on our determination of implied goodwill. | |||||||||||||||||||||||||||||
During the fourth quarter of 2014 and in connection with the preparation of the financial statements, due to negative actions taken by rating agencies and suspension of sales by certain distributors, we performed an interim goodwill impairment analysis for our long-term care and life insurance businesses. As a result of current market conditions, decreases in sales projections from negative rating actions and overall uncertainty created as a result of the recent long-term care insurance reserve increases, we recorded a goodwill impairment of $154 million in our long-term care insurance business and $145 million in our life insurance business. The goodwill impairments reduced the goodwill balances of these businesses to zero. The current uncertainty associated with the level and value of new business that a market participant would place on our long-term care and life insurance businesses resulted in concluding the goodwill balances were no longer recoverable. | |||||||||||||||||||||||||||||
There were no goodwill impairment charges recorded in 2013. | |||||||||||||||||||||||||||||
During the third quarter of 2012, as part of our annual goodwill impairment analysis based on data as of July 1, 2012, we recorded a goodwill impairment of $89 million associated with our international protection reporting unit. Considering current market conditions, including the market environment in Europe and lower trading multiples of European financial services companies, and the impact of those conditions on our international protection reporting unit in a market transaction that may require a higher risk premium, we determined the fair value of the reporting unit was below book value and determined the goodwill associated with this reporting unit was not recoverable. Therefore, we recognized a goodwill impairment for all of the goodwill associated with our international protection reporting unit during the third quarter of 2012. | |||||||||||||||||||||||||||||
Deteriorating or adverse market conditions for certain businesses may have a significant impact on the fair value of our reporting units and could result in future impairments of goodwill. | |||||||||||||||||||||||||||||
Dispositions | |||||||||||||||||||||||||||||
Effective April 1, 2013 (immediately prior to the holding company reorganization), Genworth Holdings completed the sale of its reverse mortgage business (which had been part of Corporate and Other activities) for total proceeds of $22 million. The gain on the sale was not significant. |
Reinsurance
Reinsurance | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||
Reinsurance | (9) Reinsurance | ||||||||||||||||||||||||
We reinsure a portion of our policy risks to other insurance companies in order to reduce our ultimate losses, diversify our exposures and provide capital flexibility. We also assume certain policy risks written by other insurance companies. Reinsurance accounting is followed for assumed and ceded transactions when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. | |||||||||||||||||||||||||
Reinsurance does not relieve us from our obligations to policyholders. In the event that the reinsurers are unable to meet their obligations, we remain liable for the reinsured claims. We monitor both the financial condition of individual reinsurers and risk concentrations arising from similar geographic regions, activities and economic characteristics of reinsurers to lessen the risk of default by such reinsurers. Other than the relationship discussed below with Union Fidelity Life Insurance Company (“UFLIC”), we do not have significant concentrations of reinsurance with any one reinsurer that could have a material impact on our financial position. | |||||||||||||||||||||||||
As of December 31, 2014, the maximum amount of individual ordinary life insurance normally retained by us on any one individual life policy was $5 million. | |||||||||||||||||||||||||
We have several significant reinsurance transactions (“Reinsurance Transactions”) with UFLIC. In these transactions, we ceded to UFLIC in-force blocks of structured settlements issued prior to 2004, substantially all of our in-force blocks of variable annuities issued prior to 2004 and a block of long-term care insurance policies that we reinsured in 2000 from MetLife Insurance Company USA. Although we remain directly liable under these contracts and policies as the ceding insurer, the Reinsurance Transactions have the effect of transferring the financial results of the reinsured blocks to UFLIC. As of December 31, 2014 and 2013, we had a reinsurance recoverable of $14,494 million and $14,622 million, respectively, associated with those Reinsurance Transactions. | |||||||||||||||||||||||||
To secure the payment of its obligations to us under the reinsurance agreements governing the Reinsurance Transactions, UFLIC has established trust accounts to maintain an aggregate amount of assets with a statutory book value at least equal to the statutory general account reserves attributable to the reinsured business less an amount required to be held in certain claims-paying accounts. A trustee administers the trust accounts and we are permitted to withdraw from the trust accounts amounts due to us pursuant to the terms of the reinsurance agreements that are not otherwise paid by UFLIC. In addition, pursuant to a Capital Maintenance Agreement, General Electric Capital Corporation, an indirect subsidiary of General Electric Company (“GE”), agreed to maintain sufficient capital in UFLIC to maintain UFLIC’s risk-based capital (“RBC”) at not less than 150% of its company action level, as defined from time to time by the NAIC. | |||||||||||||||||||||||||
Under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets in either separate portfolios or in trust for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. We had pledged fixed maturity securities and commercial mortgage loans of $8,737 million and $544 million, respectively, as of December 31, 2014 and $7,823 million and $603 million, respectively, as of December 31, 2013 in connection with these reinsurance agreements. However, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. | |||||||||||||||||||||||||
Under the terms of certain reinsurance agreements that our international insurance subsidiaries have with external parties, we deposited $33 million of assets in an authorized account for the benefit of the external reinsurers. These pledged assets support the reserves and certain expenses in accordance with the reinsurance agreement. | |||||||||||||||||||||||||
The following table sets forth net domestic life insurance in-force as of December 31: | |||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Direct life insurance in-force | $ | 701,797 | $ | 708,271 | $ | 730,016 | |||||||||||||||||||
Amounts assumed from other companies | 935 | 1,070 | 1,148 | ||||||||||||||||||||||
Amounts ceded to other companies (1) | (393,244 | ) | (313,593 | ) | (331,909 | ) | |||||||||||||||||||
Net life insurance in-force | $ | 309,488 | $ | 395,748 | $ | 399,255 | |||||||||||||||||||
Percentage of amount assumed to net | — | % | — | % | — | % | |||||||||||||||||||
(1) | Includes amounts accounted for under the deposit method. | ||||||||||||||||||||||||
The following table sets forth the effects of reinsurance on premiums written and earned for the years ended December 31: | |||||||||||||||||||||||||
Written | Earned | ||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | 2014 | 2013 | 2012 | |||||||||||||||||||
Direct: | |||||||||||||||||||||||||
Life insurance | $ | 1,241 | $ | 1,199 | $ | 1,284 | $ | 1,257 | $ | 1,214 | $ | 1,304 | |||||||||||||
Accident and health insurance | 3,063 | 2,944 | 2,853 | 3,087 | 2,945 | 2,840 | |||||||||||||||||||
Property and casualty insurance | 108 | 97 | 95 | 97 | 85 | 84 | |||||||||||||||||||
Mortgage insurance | 1,814 | 1,682 | 1,720 | 1,588 | 1,608 | 1,645 | |||||||||||||||||||
Total direct | 6,226 | 5,922 | 5,952 | 6,029 | 5,852 | 5,873 | |||||||||||||||||||
Assumed: | |||||||||||||||||||||||||
Life insurance | 45 | 9 | 9 | 39 | 8 | 7 | |||||||||||||||||||
Accident and health insurance | 568 | 403 | 419 | 559 | 414 | 440 | |||||||||||||||||||
Property and casualty insurance | 2 | — | — | 1 | — | — | |||||||||||||||||||
Mortgage insurance | 20 | 19 | 27 | 31 | 33 | 42 | |||||||||||||||||||
Total assumed | 635 | 431 | 455 | 630 | 455 | 489 | |||||||||||||||||||
Ceded: | |||||||||||||||||||||||||
Life insurance | (351 | ) | (342 | ) | (528 | ) | (351 | ) | (343 | ) | (527 | ) | |||||||||||||
Accident and health insurance | (790 | ) | (735 | ) | (690 | ) | (783 | ) | (725 | ) | (672 | ) | |||||||||||||
Property and casualty insurance | (3 | ) | — | — | (3 | ) | — | — | |||||||||||||||||
Mortgage insurance | (95 | ) | (92 | ) | (132 | ) | (91 | ) | (91 | ) | (122 | ) | |||||||||||||
Total ceded | (1,239 | ) | (1,169 | ) | (1,350 | ) | (1,228 | ) | (1,159 | ) | (1,321 | ) | |||||||||||||
Net premiums | $ | 5,622 | $ | 5,184 | $ | 5,057 | $ | 5,431 | $ | 5,148 | $ | 5,041 | |||||||||||||
Percentage of amount assumed to net | 12 | % | 9 | % | 10 | % | |||||||||||||||||||
Reinsurance recoveries recognized as a reduction of benefits and other changes in policy reserves amounted to $2,872 million, $2,645 million and $2,951 million during 2014, 2013 and 2012, respectively. |
Insurance_Reserves
Insurance Reserves | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Insurance Reserves | (10) Insurance Reserves | ||||||||||||
Future Policy Benefits | |||||||||||||
The following table sets forth our recorded liabilities and the major assumptions underlying our future policy benefits as of December 31: | |||||||||||||
(Amounts in millions) | Mortality/ | Interest rate | 2014 | 2013 | |||||||||
morbidity | assumption | ||||||||||||
assumption | |||||||||||||
Long-term care insurance contracts | (a) | 3.75% - 7.50% | $ | 19,310 | $ | 17,023 | |||||||
Structured settlements with life contingencies | (b) | 1.50% - 8.00% | 9,133 | 9,267 | |||||||||
Annuity contracts with life contingencies | (b) | 1.50% - 8.00% | 4,470 | 4,425 | |||||||||
Traditional life insurance contracts | (c) | 3.00% - 7.50% | 2,733 | 2,736 | |||||||||
Supplementary contracts with life contingencies | (b) | 1.50% - 8.00% | 265 | 249 | |||||||||
Accident and health insurance contracts | (d) | 3.50% - 7.00% | 4 | 5 | |||||||||
Total future policy benefits | $ | 35,915 | $ | 33,705 | |||||||||
(a) | The 1983 Individual Annuitant Mortality Table or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality Table and the 1985 National Nursing Home Study and company experience. | ||||||||||||
(b) | Assumptions for limited-payment contracts come from either the U.S. Population Table, 1983 Group Annuitant Mortality Table, 1983 Individual Annuitant Mortality Table or Annuity 2000 Mortality Table. | ||||||||||||
(c) | Principally modifications based on company experience of the Society of Actuaries 1965-70 or 1975-80 Select and Ultimate Tables, 1941, 1958, 1980 and 2001 Commissioner’s Standard Ordinary Tables, 1980 Commissioner’s Extended Term table and (IA) Standard Table 1996 (modified). | ||||||||||||
(d) | The 1958 and 1980 Commissioner’s Standard Ordinary Tables, or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality. | ||||||||||||
We regularly review our assumptions and perform loss recognition testing at least annually. During the fourth quarter of 2014, loss recognition testing for our acquired block of long-term care insurance business resulted in a premium deficiency. As a result, we wrote off the PVFP balance of $6 million and increased reserves $710 million. The results of the test were driven by changes to assumptions and methodologies primarily impacting claim termination rates, most significantly in later-duration claims, and benefit utilization rates. The liability for future policy benefits for our acquired block of long-term care insurance business represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could possibly be significant and result in further increases in the related future policy benefit reserves for this block of business by an amount that could be material to our results of operations and financial condition and liquidity. | |||||||||||||
Policyholder Account Balances | |||||||||||||
The following table sets forth our recorded liabilities for policyholder account balances as of December 31: | |||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||
Annuity contracts | $ | 14,406 | $ | 13,730 | |||||||||
GICs, funding agreements and FABNs | 493 | 896 | |||||||||||
Structured settlements without life contingencies | 1,828 | 1,956 | |||||||||||
Supplementary contracts without life contingencies | 742 | 714 | |||||||||||
Other | 28 | 34 | |||||||||||
Total investment contracts | 17,497 | 17,330 | |||||||||||
Universal life insurance contracts | 8,546 | 8,198 | |||||||||||
Total policyholder account balances | $ | 26,043 | $ | 25,528 | |||||||||
Certain of our U.S. life insurance companies are members of the Federal Home Loan Bank (the “FHLB”) system in their respective regions. As of December 31, 2014 and 2013, we held $33 million and $70 million, respectively, of FHLB common stock related to those memberships which was included in equity securities. We have outstanding funding agreements with the FHLBs and also have letters of credit which have not been drawn upon. The FHLBs have been granted a lien on certain of our invested assets to collateralize our obligations; however, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by us, the FHLB’s recovery on the collateral is limited to the amount of our funding agreement liabilities to the FHLB. The amount of funding agreements outstanding with the FHLB was $199 million and $493 million, respectively, as of December 31, 2014 and 2013 which was included in policyholder account balances. We had letters of credit related to the FHLB of $583 million as of December 31, 2014 and 2013. These funding agreements and letters of credit were collateralized by fixed maturity securities with a fair value of $854 million and $1,153 million, respectively, as of December 31, 2014 and 2013. | |||||||||||||
Certain Non-Traditional Long-Duration Contracts | |||||||||||||
The following table sets forth information about our variable annuity products with death and living benefit guarantees as of December 31: | |||||||||||||
(Dollar amounts in millions) | 2014 | 2013 | |||||||||||
Account values with death benefit guarantees (net of reinsurance): | |||||||||||||
Standard death benefits (return of net deposits) account value | $ | 2,877 | $ | 3,164 | |||||||||
Net amount at risk | $ | 5 | $ | 6 | |||||||||
Average attained age of contractholders | 72 | 72 | |||||||||||
Enhanced death benefits (ratchet, rollup) account value | $ | 3,443 | $ | 3,853 | |||||||||
Net amount at risk | $ | 119 | $ | 114 | |||||||||
Average attained age of contractholders | 73 | 72 | |||||||||||
Account values with living benefit guarantees: | |||||||||||||
GMWBs | $ | 3,675 | $ | 4,054 | |||||||||
Guaranteed annuitization benefits | $ | 1,362 | $ | 1,508 | |||||||||
Variable annuity contracts may contain more than one death or living benefit; therefore, the amounts listed above are not mutually exclusive. Substantially all of our variable annuity contracts have some form of GMDB. | |||||||||||||
As of December 31, 2014 and 2013, our total liability associated with variable annuity contracts with minimum guarantees was approximately $7,108 million and $7,704 million, respectively. The liability, net of reinsurance, for our variable annuity contracts with GMDB and guaranteed annuitization benefits was $55 million and $39 million as of December 31, 2014 and 2013, respectively. | |||||||||||||
The contracts underlying the lifetime benefits such as GMWB and guaranteed annuitization benefits are considered “in the money” if the contractholder’s benefit base, or the protected value, is greater than the account value. As of December 31, 2014 and 2013, our exposure related to GMWB and guaranteed annuitization benefit contracts that were considered “in the money” was $532 million and $467 million, respectively. For GMWBs and guaranteed annuitization benefits, the only way the contractholder can monetize the excess of the benefit base over the account value of the contract is through lifetime withdrawals or lifetime income payments after annuitization. | |||||||||||||
Account balances of variable annuity contracts with death or living benefit guarantees were invested in separate account investment options as follows as of December 31: | |||||||||||||
(Amounts in millions) | 2014 | 2013 (1) | |||||||||||
Balanced funds | $ | 3,848 | $ | 4,187 | |||||||||
Equity funds | 1,639 | 1,778 | |||||||||||
Bond funds | 707 | 897 | |||||||||||
Money market funds | 96 | 98 | |||||||||||
Total | $ | 6,290 | $ | 6,960 | |||||||||
(1) | The balances as of December 31, 2013 have been represented as a result of classification changes and to exclude fixed account assets from bond funds. |
Liability_for_Policy_and_Contr
Liability for Policy and Contract Claims | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Liability for Policy and Contract Claims | (11) Liability for Policy and Contract Claims | ||||||||||||
The following table sets forth our recorded liability for policy and contract claims by business as of December 31: | |||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||
Long-term care insurance | $ | 6,216 | $ | 4,999 | |||||||||
U.S. mortgage insurance | 1,180 | 1,482 | |||||||||||
International mortgage insurance | 308 | 378 | |||||||||||
Life insurance | 197 | 188 | |||||||||||
Lifestyle protection insurance | 106 | 108 | |||||||||||
Fixed annuities | 21 | 29 | |||||||||||
Runoff | 15 | 20 | |||||||||||
Total liability for policy and contract claims | $ | 8,043 | $ | 7,204 | |||||||||
The liability for policy and contract claims represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could possibly be significant, and result in increases in reserves by an amount that could be material to our results of operations and financial condition and liquidity. | |||||||||||||
Long-term care insurance | |||||||||||||
The following table sets forth changes in the liability for policy and contract claims for our long-term care insurance business for the dates indicated: | |||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||
Beginning balance as of January 1 | $ | 4,999 | $ | 4,655 | $ | 4,130 | |||||||
Less reinsurance recoverables | (1,707 | ) | (1,574 | ) | (1,387 | ) | |||||||
Net balance as of January 1 | 3,292 | 3,081 | 2,743 | ||||||||||
Incurred related to insured events of: | |||||||||||||
Current year | 1,474 | 1,323 | 1,271 | ||||||||||
Prior years | 726 | 3 | 93 | ||||||||||
Total incurred | 2,200 | 1,326 | 1,364 | ||||||||||
Paid related to insured events of: | |||||||||||||
Current year | (134 | ) | (131 | ) | (111 | ) | |||||||
Prior years | (1,263 | ) | (1,160 | ) | (1,068 | ) | |||||||
Total paid | (1,397 | ) | (1,291 | ) | (1,179 | ) | |||||||
Interest on liability for policy and contract claims | 195 | 176 | 153 | ||||||||||
Net balance as of December 31 | 4,290 | 3,292 | 3,081 | ||||||||||
Add reinsurance recoverables | 1,926 | 1,707 | 1,574 | ||||||||||
Ending balance as of December 31 | $ | 6,216 | $ | 4,999 | $ | 4,655 | |||||||
The liability for policy and contract claims of our long-term care insurance business increased in 2014 largely as a result of the completion of a comprehensive review of our long-term care insurance claim reserves conducted during the third quarter of 2014 which resulted in recording higher reserves of $604 million and an increase in reinsurance recoverable of $73 million. This review was commenced as a result of adverse claims experience during the second quarter of 2014 and in connection with our regular review of our claim reserves assumptions during the third quarter of each year. As a result of this review, we made changes to our assumptions and methodologies relating to our long-term care insurance claim reserves primarily impacting claim termination rates, most significantly in later-duration claims, and benefit utilization rates, reflecting that claims are not terminating as quickly and claimants are utilizing more of their available benefits in aggregate than had previously been assumed in our reserve calculations. In conducting the review, we increased the population of claims reviewed, utilizing more of our recent data. | |||||||||||||
During the third quarter of 2014, we also recorded a $61 million unfavorable correction to claim reserves related to a calculation of benefit utilization for policies with a benefit inflation option. This error arose prior to 2011 and was not material to earnings in any interim or annual period. During the fourth quarter of 2014, we recorded an $81 million unfavorable correction to claim reserves primarily related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014 and a $21 million unfavorable adjustment related to a revised interest rate assumption, partially offset by a $49 million favorable refinement of assumptions for claim termination rates. As a result of these items, we also recorded an increase in reinsurance recoverable of $17 million in 2014. The remaining increase was attributable to aging and growth of the in-force block. These impacts related to insured events for prior years. | |||||||||||||
In 2013, the increase in the liability for policy and contract claims of our long-term care insurance business was predominantly related to growth and aging of the in-force block. | |||||||||||||
In 2012, the increase in the liability for policy and contract claims and the increase in prior year claim reserves of our long-term care insurance business was mostly driven by growth and aging of the in-force block, an increase in severity and duration of claims associated with observed loss development and higher average reserve costs on new claims. | |||||||||||||
U.S. mortgage insurance | |||||||||||||
The following table sets forth changes in the liability for policy and contract claims for our U.S. mortgage insurance business for the dates indicated: | |||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||
Beginning balance as of January 1 | $ | 1,482 | $ | 2,009 | $ | 2,488 | |||||||
Less reinsurance recoverables | (44 | ) | (80 | ) | (178 | ) | |||||||
Net balance as of January 1 | 1,438 | 1,929 | 2,310 | ||||||||||
Incurred related to insured events of: | |||||||||||||
Current year | 328 | 476 | 717 | ||||||||||
Prior years | 29 | (63 | ) | 7 | |||||||||
Total incurred | 357 | 413 | 724 | ||||||||||
Paid related to insured events of: | |||||||||||||
Current year | (21 | ) | (45 | ) | (92 | ) | |||||||
Prior years | (618 | ) | (859 | ) | (1,013 | ) | |||||||
Total paid | (639 | ) | (904 | ) | (1,105 | ) | |||||||
Net balance as of December 31 | 1,156 | 1,438 | 1,929 | ||||||||||
Add reinsurance recoverables | 24 | 44 | 80 | ||||||||||
Ending balance as of December 31 | $ | 1,180 | $ | 1,482 | $ | 2,009 | |||||||
The liability for policy and contract claims of our U.S. mortgage insurance business decreased in 2014 predominantly from a decline in new delinquencies, as well as lower reserves on new delinquencies, partially offset by an aggregate increase in our claim reserves in 2014 in connection with the settlement agreement with Bank of America, N.A. and the resolution of a second matter involving a dispute with another servicer over loss mitigation activities. These settlements related to insured events for prior years. | |||||||||||||
In 2013, the liability for policy and contract claims of our U.S. mortgage insurance business decreased due to lower new delinquencies and improvements in net cures and aging on existing delinquencies in 2013. We also decreased prior year claim reserves related to our U.S. mortgage insurance business in 2013 primarily from improvements in net cures. | |||||||||||||
In 2012, the liability for policy and contract claims of our U.S. mortgage insurance business decreased due to lower new delinquencies in 2012, increased loss mitigation efforts and a reserve strengthening in 2011 that did not recur, partially offset by the continued aging of delinquencies. | |||||||||||||
Employee_Benefit_Plans
Employee Benefit Plans | 12 Months Ended |
Dec. 31, 2014 | |
Employee Benefit Plans | (12) Employee Benefit Plans |
(a) Pension and Retiree Health and Life Insurance Benefit Plans | |
Essentially all of our employees are enrolled in a qualified defined contribution pension plan. The plan is 100% funded by Genworth. We make annual contributions to each employee’s pension plan account based on the employee’s age, service and eligible pay. Employees are vested in the plan after three years of service. As of December 31, 2014 and 2013, we recorded a liability related to these benefits of $13 million. | |
In addition, certain employees also participate in non-qualified defined contribution plans and in qualified and non-qualified defined benefit pension plans. The plan assets, projected benefit obligation and accumulated benefit obligation liabilities of these plans were not material to our consolidated financial statements individually or in the aggregate. As of December 31, 2014 and 2013, we recorded a liability related to these plans of $71 million and $38 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. The increase in the liability was largely driven by a decrease in the discount rate assumption in 2014. In 2014, we recognized a decrease of $34 million in OCI related to these plans. In 2013, we recognized an increase of $23 million in OCI related to these plans and also recognized a $4 million gain for the closure of the U.K. pension plan to future service accruals. | |
We provide retiree health benefits to domestic employees hired prior to January 1, 2005 who meet certain service requirements. Under this plan, retirees over 65 years of age receive a subsidy towards the purchase of a Medigap policy, and retirees under 65 years of age receive medical benefits similar to our employees’ medical benefits. In December 2009, we announced that eligibility for retiree medical benefits will be limited to associates who are within 10 years of retirement eligibility as of January 1, 2010. This resulted in a negative plan amendment which will be amortized over the average future service of the participants. We also provide retiree life and long-term care insurance benefits. The plans are funded as claims are incurred. As of December 31, 2014 and 2013, the accumulated postretirement benefit obligation associated with these benefits was $90 million and $79 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2014, we recognized a decrease of $10 million in OCI. In 2013, we recognized an increase of $11 million in OCI and also recognized a $1 million gain related to reduced benefit costs driven by fewer participants due to the sale of our wealth management and reverse mortgage businesses and from an expense reduction plan announced in June 2013. | |
Our cost associated with our pension, retiree health and life insurance benefit plans was $21 million, $22 million and $28 million for the years ended December 31, 2014, 2013 and 2012, respectively. | |
(b) Savings Plans | |
Our domestic employees participate in qualified and non-qualified defined contribution savings plans that allow employees to contribute a portion of their pay to the plan on a pre-tax basis. We match these contributions, which vest immediately, up to 6% of the employee’s pay. Employees hired on or after January 1, 2011 will not vest immediately in Genworth matching contributions but will fully vest in the matching contributions after two complete years of service. One option available to employees in the defined contribution savings plan is the ClearCourse® variable annuity option offered by certain of our life insurance subsidiaries. The amount of deposits recorded by our life insurance subsidiaries in 2014 and 2013 in relation to this plan option was $1 million for each year. Employees also have the option of purchasing a fund which invests primarily in Genworth stock as part of the defined contribution savings plan. Our cost associated with these plans was $16 million, $17 million and $20 million for the years ended December 31, 2014, 2013 and 2012, respectively. | |
(c) Health and Welfare Benefits for Active Employees | |
We provide health and welfare benefits to our employees, including health, life, disability, dental and long-term care insurance. Our long-term care insurance is provided through our group long-term care insurance business. The premiums recorded by these businesses related to these benefits were insignificant during 2014, 2013 and 2012. |
Borrowings_and_Other_Financing
Borrowings and Other Financings | 12 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Borrowings and Other Financings | (13) Borrowings and Other Financings | ||||||||
(a) Short-Term Borrowings | |||||||||
Commercial Paper Facility | |||||||||
In the second quarter of 2013, we terminated our $1.0 billion commercial paper program. There was no amount outstanding under the commercial paper program when terminated and none outstanding since February 2009. | |||||||||
Revolving Credit Facility | |||||||||
In September 2013, Genworth Financial and Genworth Holdings entered into a Credit Agreement (the “Credit Agreement”) which provides Genworth Holdings with a $300 million multi-currency revolving credit facility, with a $100 million sublimit for letters of credit. The credit facility is available on a revolving basis until September 26, 2016, unless the commitments are terminated earlier either at the request of Genworth Holdings or by the lenders as a result of any event of default. On no more than two occasions during the term of the facility, Genworth Holdings may request each lender to extend the maturity date of its commitment for an additional one-year period. Genworth Holdings’ request will be granted if lenders (including any new lenders replacing non-consenting lenders) holding more than 50% of the commitments consent to the requested extension(s). The proceeds of the loans may be used for working capital and general corporate purposes. As of December 31, 2014 and 2013, there was no amount outstanding under the credit facility. The obligations under the Credit Agreement are unsecured and payment of Genworth Holdings’ obligations is fully and unconditionally guaranteed by Genworth Financial. | |||||||||
Any borrowings under the revolving credit facility will bear interest at a rate per annum equal to, at the option of Genworth Holdings, (i) a rate based on the greater of JPMorgan Chase Bank N.A.’s prime rate, the federal funds rate and the one-month adjusted London interbank offered rate from time to time, or (ii) with respect to euro currency borrowings, a rate based on the London interbank offered rate from time to time, plus in each case a margin that fluctuates based upon the ratings assigned from time to time by Moody’s Investors Service, Inc. and Standard & Poor’s Rating Group to Genworth Holdings’ senior unsecured long-term indebtedness for borrowed money that is not guaranteed by any other person other than Genworth Financial or subject to any other credit enhancement. Genworth Holdings will also pay a commitment fee at a rate that varies with Genworth Holdings’ senior unsecured long-term indebtedness ratings and that is calculated on the average daily unused amount of the commitments, payable quarterly in arrears. | |||||||||
The Credit Agreement contains representations, warranties, covenants, terms and conditions customary for transactions of this type. These include negative covenants limiting the ability of Genworth Holdings and its subsidiaries, to: (1) create liens other than permitted liens; (2) in the case of Genworth Holdings and Genworth Life Insurance Company (“GLIC”), merge into or consolidate with any other person or permit any person to merge into or consolidate with them unless Genworth Holdings or GLIC, as applicable, is the surviving person; (3) sell, transfer, lease, or otherwise dispose of all or substantially all of the assets of Genworth Holdings and its subsidiaries, taken as a whole, and the equity interest in or assets of GLIC, subject to certain excluded transactions; (4) enter into certain transactions with affiliates; and (5) enter into certain restrictive agreements. In addition, Genworth Financial agrees not to permit Priority Indebtedness (as defined in the Credit Agreement) to exceed 7.5% of its consolidated total capitalization (as defined in the Credit Agreement) as of the end of any fiscal quarter ending on and after September 30, 2013. | |||||||||
The Credit Agreement also contains financial covenants that require Genworth Financial not to permit (i) its capitalization ratio (as defined in the Credit Agreement) to be greater than 0.35 to 1.00, and (ii) its consolidated net worth (as defined in the Credit Agreement) to be less than the sum of $8.9 billion plus 50% of its consolidated net income (as defined in the Credit Agreement), in each case as of the end of each fiscal quarter ending on and after September 30, 2013. | |||||||||
The Credit Agreement contains certain customary events of default, subject to customary grace periods, including, among others: (1) failure to pay when due principal, interest or any other amounts due and payable under the Credit Agreement; (2) incorrectness in any material respect of representations and warranties when made or deemed made; (3) breach of specified covenants; (4) cross-defaults with other material indebtedness (as defined in the Credit Agreement) exceeding an aggregate principal amount of $100 million; (5) certain ERISA (Employee Retirement Income Security Act of 1974) events, (6) bankruptcy and insolvency events, (7) occurrence of a change in control of either Genworth Financial or Genworth Holdings; (8) inability to pay debts as they become due; (9) certain undischarged judgments; (10) Genworth Financial’s guarantee ceases to be valid, binding and enforceable in accordance with its terms; or (11) issuance by any insurance regulatory official of any material corrective order or initiation by any such official of any material regulatory proceeding to oversee or direct management, if such order of proceeding continues undismissed for a period of 30 days. | |||||||||
(b) Long-Term Borrowings | |||||||||
The following table sets forth total long-term borrowings as of December 31: | |||||||||
(Amounts in millions) | 2014 | 2013 | |||||||
Genworth Holdings | |||||||||
5.75% Senior Notes, due 2014 | $ | — | $ | 485 | |||||
8.625% Senior Notes, due 2016 | 300 | 300 | |||||||
6.52% Senior Notes, due 2018 | 600 | 600 | |||||||
7.70% Senior Notes, due 2020 | 400 | 400 | |||||||
7.20% Senior Notes, due 2021 | 399 | 399 | |||||||
7.625% Senior Notes, due 2021 | 758 | 759 | |||||||
4.90% Senior Notes, due 2023 | 399 | 399 | |||||||
4.80% Senior Notes, due 2024 | 400 | 400 | |||||||
6.50% Senior Notes, due 2034 | 297 | 297 | |||||||
6.15% Fixed-to-Floating Rate Junior Suboridinated Notes, due 2066 | 598 | 598 | |||||||
Canada | |||||||||
4.59% Senior Notes, due 2015 | — | 141 | |||||||
5.68% Senior Notes, due 2020 | 236 | 258 | |||||||
4.24% Senior Notes, due 2024 | 138 | — | |||||||
Australia | |||||||||
Floating Rate Junior Notes, due 2021 | 114 | 125 | |||||||
Total | $ | 4,639 | $ | 5,161 | |||||
Genworth Holdings | |||||||||
Long-Term Senior Notes | |||||||||
As of December 31, 2014, Genworth Holdings had outstanding eight series of fixed rate senior notes with varying interest rates between 4.80% and 8.625% and maturity dates between 2016 and 2034. The senior notes are Genworth Holdings’ direct, unsecured obligations and rank equally in right of payment with all of its existing and future unsecured and unsubordinated obligations. Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior notes and the holders of the senior notes, on an unsecured unsubordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, each outstanding series of senior notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior notes indenture in respect of such senior notes. We have the option to redeem all or a portion of each series of senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread. | |||||||||
We repaid $485 million of our 5.75% senior notes due 2014 issued in June 2004 (the “2014 Notes”) in June 2014 from cash on hand. | |||||||||
In December 2013, Genworth Holdings issued $400 million aggregate principal amount of senior notes, with an interest rate of 4.80% per year payable semi-annually, and maturing in 2024 (“2024 Notes”). The net proceeds of $397 million from the issuance of the 2024 Notes, together with cash on hand at Genworth Financial, were used to contribute $100 million to Genworth Mortgage Insurance Corporation (“GMICO”), our primary U.S. mortgage insurance subsidiary, and an additional $300 million was contributed to a U.S. mortgage holding company to be used to satisfy all or part of the higher capital requirements expected to be imposed by the government-sponsored enterprises (“GSEs”) as part of the anticipated revisions to their asset-and capital-related requirements. In May 2014, our U.S. mortgage holding company contributed the additional $300 million to GMICO. | |||||||||
In August 2013, Genworth Holdings issued $400 million aggregate principal amount of 4.90% senior notes due 2023 (the “2023 Notes”). The net proceeds of $396 million from the issuance of the 2023 Notes, together with cash on hand at Genworth Holdings, were used to redeem all $346 million of the remaining outstanding aggregate principal amount of Genworth Holdings’ 4.95% senior notes due 2015 (the “2015 Notes”) and pay accrued and unpaid interest on such notes and pay a make-whole payment of approximately $30 million pre-tax. | |||||||||
During 2013, Genworth Holdings repurchased $15 million aggregate principal amount of the 2014 Notes, and paid accrued and unpaid interest thereon. In June 2013, Genworth Holdings repurchased $4 million aggregate principal amount of the 2015 Notes, and paid accrued and unpaid interest thereon. | |||||||||
During the fourth quarter of 2012, we completed a tender offer for up to $100 million of 2014 Notes. As a result of this tender offer, we repurchased principal of approximately $100 million of these notes, plus accrued interest on the notes repurchased, for a pre-tax loss of $6 million. | |||||||||
In March 2011, we issued $400 million of 7.625% senior notes due 2021 (the “2021 Notes”) and in March 2012, we issued an additional $350 million aggregate principal amount of the 2021 Notes. The 2021 Notes issued in March 2012 were issued at a public offering price of 103% of principal amount, with a yield to maturity of 7.184%. The net proceeds of $358 million from the issuance of these 2021 Notes were used for general corporate purposes, including increasing liquidity at the Genworth Holdings level. | |||||||||
In June 2012, we repaid $222 million of our 5.65% senior notes due 2012 at their maturity. | |||||||||
Long-Term Junior Subordinated Notes | |||||||||
As of December 31, 2014, Genworth Holdings had outstanding fixed-to-floating rate junior notes having an aggregate principal amount of $598 million, with an annual interest rate equal to 6.15% payable semi-annually, until November 15, 2016, at which point the annual interest rate will be equal to the three-month London Interbank Offered Rate (“LIBOR”) plus 2.0025% payable quarterly, until the notes mature in November 2066 (“2066 Notes”). Subject to certain conditions, Genworth Holdings has the right, on one or more occasions, to defer the payment of interest on the 2066 Notes during any period of up to 10 years without giving rise to an event of default and without permitting acceleration under the terms of the 2066 Notes. Genworth Holdings will not be required to settle deferred interest payments until it has deferred interest for five years or made a payment of current interest. In the event of our bankruptcy, holders will have a limited claim for deferred interest. | |||||||||
Genworth Holdings may redeem the 2066 Notes on November 15, 2036, the “scheduled redemption date,” but only to the extent that it has received net proceeds from the sale of certain qualifying capital securities. Genworth Holdings may redeem the 2066 Notes (i) in whole or in part, at any time on or after November 15, 2016 at their principal amount plus accrued and unpaid interest to the date of redemption or (ii) in whole or in part, prior to November 15, 2016 at their principal amount plus accrued and unpaid interest to the date of redemption or, if greater, a make-whole price. | |||||||||
The 2066 Notes will be subordinated to all existing and future senior, subordinated and junior subordinated debt of Genworth Holdings, except for any future debt that by its terms is not superior in right of payment, and will be effectively subordinated to all liabilities of our subsidiaries. Genworth Financial provides a full and unconditional guarantee to the trustee of the 2066 Notes and the holders of the 2066 Notes, on an unsecured subordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding 2066 Notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the 2066 Notes indenture in respect of the 2066 Notes. | |||||||||
In connection with the issuance of the 2066 Notes, we entered into a Replacement Capital Covenant (the “Replacement Capital Covenant”), whereby we agreed, for the benefit of holders of our 6.5% Senior Notes due 2034, that Genworth Holdings will not repay, redeem or repurchase all or any part of the 2066 Notes on or before November 15, 2046, unless such repayment, redemption or repurchase is made from the proceeds of the issuance of certain replacement capital securities and pursuant to the other terms and conditions set forth in the Replacement Capital Covenant. | |||||||||
Canada | |||||||||
As of December 31, 2014, our indirect majority-owned subsidiary, Genworth MI Canada Inc. (“Genworth Canada”), had outstanding two series of fixed rate senior notes with interest rates of 5.68% and 4.24% and maturity dates of 2020 and 2024, respectively. The senior notes are redeemable at the option of Genworth Canada, in whole or in part, at any time. | |||||||||
In April 2014, Genworth Canada issued CAD$160 million aggregate principal amount of 4.24% senior notes (the “2024 Canada Notes”). The net proceeds of the offering of the 2024 Canada Notes were used to redeem, in full, the CAD$150 million outstanding principal on its existing 4.59% senior notes due 2015. In conjunction with the redemption, Genworth Canada made an early redemption payment to existing noteholders of approximately CAD$7 million and accrued interest of approximately CAD$2 million in the second quarter of 2014. | |||||||||
Australia | |||||||||
As of December 31, 2014, our indirect majority-owned subsidiary, Genworth Financial Mortgage Insurance Pty Limited, had outstanding subordinated floating rate notes due 2021 (the “2021 Australia Notes”) with an interest rate of three-month Bank Bill Swap reference rate plus a margin of 4.75%. Genworth Financial Mortgage Insurance Pty Limited issued AUD$140 million aggregate principal amount of the 2021 Australia Notes in June 2011. The net proceeds of the offering were used for general corporate purposes. | |||||||||
(c) Non-Recourse Funding Obligations | |||||||||
The following table sets forth the non-recourse funding obligations (surplus notes) of our wholly-owned, special purpose consolidated captive insurance subsidiaries as of December 31: | |||||||||
(Amounts in millions) | |||||||||
Issuance | 2014 | 2013 | |||||||
River Lake Insurance Company (a), due 2033 | $ | 570 | $ | 570 | |||||
River Lake Insurance Company (b), due 2033 | 435 | 461 | |||||||
River Lake Insurance Company II (a), due 2035 | 192 | 192 | |||||||
River Lake Insurance Company II (b), due 2035 | 484 | 500 | |||||||
Rivermont Life Insurance Company I (a), due 2050 | 315 | 315 | |||||||
Total | $ | 1,996 | $ | 2,038 | |||||
(a) | Accrual of interest based on one-month LIBOR that resets every 28 days plus a fixed margin. | ||||||||
(b) | Accrual of interest based on one-month LIBOR that resets on a specified date each month plus a contractual margin. | ||||||||
These surplus notes bear a floating rate of interest and have been deposited into a series of trusts that have issued money market or term securities. Both principal and interest payments on the money market and term securities are guaranteed by a third-party insurance company. The holders of the money market or term securities cannot require repayment from us or any of our subsidiaries, other than the River Lake and Rivermont Insurance Companies, as applicable, the direct issuers of the notes. We have provided a limited guarantee to Rivermont Life Insurance Company (“Rivermont I”), where under adverse interest rate, mortality or lapse scenarios (or combination thereof), we may be required to provide additional funds to Rivermont I. Genworth Life and Annuity Insurance Company, our wholly-owned subsidiary, has agreed to indemnify the issuers and the third-party insurer for certain limited costs related to the issuance of these obligations. | |||||||||
Any payment of principal, including by redemption, or interest on the notes may only be made with the prior approval of the Director of Insurance of the State of South Carolina in accordance with the terms of its licensing orders and in accordance with applicable law. The holders of the notes have no rights to accelerate payment of principal of the notes under any circumstances, including without limitation, for non-payment or breach of any covenant. Each issuer reserves the right to repay the notes that it has issued at any time, subject to prior regulatory approval. | |||||||||
During 2014 and 2013, River Lake Insurance Company, our indirect wholly-owned subsidiary, repaid $26 million and $28 million, respectively, of its total outstanding floating rate subordinated notes due in 2033. | |||||||||
During 2014, River Lake Insurance Company II (“River Lake II”), our indirect wholly-owned subsidiary, repaid $16 million of its total outstanding floating rate subordinated notes due in 2035. | |||||||||
In December 2012, we acquired $20 million of non-recourse funding obligations issued by River Lake II, resulting in a U.S. GAAP pre-tax gain of $4 million. We accounted for these transactions as redemptions of our non-recourse funding obligations. | |||||||||
On March 26, 2012, River Lake Insurance Company IV Limited (“River Lake IV”) repaid $3 million of its total outstanding $8 million Class B Floating Rate Subordinated Notes due May 25, 2028 following an early redemption event, in accordance with the priority of payments. During the three months ended September 30, 2012, as part of a life block transaction, we acquired $270 million of non-recourse funding obligations issued by River Lake IV, which were accounted for as redemptions of our non-recourse funding obligations and resulted in a U.S. GAAP after-tax gain of approximately $21 million. The life block transaction also resulted in higher after-tax DAC amortization of $25 million reflecting loss recognition associated with a third-party reinsurance treaty plus additional expenses. The combined transactions resulted in a U.S. GAAP after-tax loss of $6 million in the three months ended September 30, 2012 which was included in our U.S. Life Insurance segment. In December 2012, we repaid the remaining outstanding non-recourse funding obligations issued by River Lake IV of $235 million. | |||||||||
In January 2012, as part of a life block transaction, we acquired $475 million of our non-recourse funding obligations issued by River Lake Insurance Company III (“River Lake III”), our indirect wholly-owned subsidiary, which were accounted for as redemptions of our non-recourse funding obligations and resulted in a U.S. GAAP after-tax gain of approximately $52 million. In connection with the life block transaction, we ceded certain term life insurance policies to a third-party reinsurer resulting in a U.S. GAAP after-tax loss, net of DAC amortization, of $93 million. The combined transactions resulted in a U.S. GAAP after-tax loss of approximately $41 million in the three months ended March 31, 2012 which was included in our U.S. Life Insurance segment. In February and March 2012, we repaid the remaining outstanding non-recourse funding obligations issued by River Lake III of $176 million. | |||||||||
The weighted-average interest rates on the non-recourse funding obligations as of December 31, 2014 and 2013 were 1.51% and 1.50%, respectively. | |||||||||
(d) Liquidity | |||||||||
Principal amounts under our long-term borrowings (including senior notes) and non-recourse funding obligations by maturity were as follows as of December 31, 2014: | |||||||||
(Amounts in millions) | Amount | ||||||||
2015 | $ | — | |||||||
2016 | 300 | ||||||||
2017 | — | ||||||||
2018 | 600 | ||||||||
2019 and thereafter (1) | 5,735 | ||||||||
Total | $ | 6,635 | |||||||
(1) | Repayment of $2.0 billion of our non-recourse funding obligations requires regulatory approval. | ||||||||
Our liquidity requirements are principally met through cash flows from operations. |
Income_Taxes
Income Taxes | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||
Income Taxes | (14) Income Taxes | ||||||||||||||||||||||||
Income (loss) from continuing operations before income taxes included the following components for the years ended December 31: | |||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Domestic | $ | (2,008 | ) | $ | 294 | $ | (73 | ) | |||||||||||||||||
Foreign | 732 | 756 | 679 | ||||||||||||||||||||||
Income (loss) from continuing operations before income taxes | $ | (1,276 | ) | $ | 1,050 | $ | 606 | ||||||||||||||||||
The total provision (benefit) for income taxes was as follows for the years ended December 31: | |||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Current federal income taxes | $ | (3 | ) | $ | (18 | ) | $ | (68 | ) | ||||||||||||||||
Deferred federal income taxes | (443 | ) | 160 | 36 | |||||||||||||||||||||
Total federal income taxes | (446 | ) | 142 | (32 | ) | ||||||||||||||||||||
Current state income taxes | 4 | (1 | ) | (16 | ) | ||||||||||||||||||||
Deferred state income taxes | (4 | ) | (9 | ) | (9 | ) | |||||||||||||||||||
Total state income taxes | — | (10 | ) | (25 | ) | ||||||||||||||||||||
Current foreign income taxes | 258 | 422 | 138 | ||||||||||||||||||||||
Deferred foreign income taxes | (40 | ) | (230 | ) | 57 | ||||||||||||||||||||
Total foreign income taxes | 218 | 192 | 195 | ||||||||||||||||||||||
Total provision (benefit) for income taxes | $ | (228 | ) | $ | 324 | $ | 138 | ||||||||||||||||||
Our current income tax receivable was $30 million as of December 31, 2014 and our current income tax payable was $132 million as of December 31, 2013. | |||||||||||||||||||||||||
The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the years ended December 31: | |||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Pre-tax income (loss) | $ | (1,276 | ) | $ | 1,050 | $ | 606 | ||||||||||||||||||
Statutory U.S. federal income tax rate | (447 | ) | 35 | % | 368 | 35 | % | 212 | 35 | % | |||||||||||||||
Increase (reduction) in rate resulting from: | |||||||||||||||||||||||||
State income tax, net of federal income tax effect | — | — | (2 | ) | (0.2 | ) | (16 | ) | (2.7 | ) | |||||||||||||||
Benefit on tax favored investments | (18 | ) | 1.4 | (18 | ) | (1.7 | ) | (9 | ) | (1.4 | ) | ||||||||||||||
Effect of foreign operations | (69 | ) | 5.4 | (75 | ) | (7.1 | ) | (66 | ) | (10.9 | ) | ||||||||||||||
Change in indefinite reinvestment assertion | 66 | (5.2 | ) | — | — | — | — | ||||||||||||||||||
Interest on uncertain tax positions | (2 | ) | 0.1 | (1 | ) | (0.1 | ) | (3 | ) | (0.6 | ) | ||||||||||||||
Non-deductible expenses | 4 | (0.3 | ) | 2 | 0.2 | 3 | 0.5 | ||||||||||||||||||
Non-deductible goodwill | 245 | (19.2 | ) | — | — | 19 | 3.1 | ||||||||||||||||||
Valuation allowance | (6 | ) | 0.5 | 16 | 1.5 | — | — | ||||||||||||||||||
Stock-based compensation | 4 | (0.3 | ) | 25 | 2.4 | — | — | ||||||||||||||||||
Other, net | (5 | ) | 0.5 | 9 | 0.9 | (2 | ) | (0.2 | ) | ||||||||||||||||
Effective rate | $ | (228 | ) | 17.9 | % | $ | 324 | 30.9 | % | $ | 138 | 22.8 | % | ||||||||||||
For the year ended December 31, 2014, the decrease in the effective tax rate was primarily attributable to non-deductible goodwill impairments in 2014 and a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business, partially offset by a net $108 million benefit in the fourth quarter of 2014 in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. | |||||||||||||||||||||||||
For the year ended December 31, 2013, the increase in the effective tax rate was primarily attributable to additional tax expense of $25 million, including $13 million from a correction of prior years, related to non-deductible stock compensation expense resulting from cancellations recorded in 2013. The increase in the effective tax rate was also attributable to a valuation allowance on a deferred tax asset on a specific separate tax return net operating loss that is no longer expected to be realized, state income taxes and the proportion of lower taxed foreign income to pre-tax earnings in 2013 compared to 2012, partially offset by a non-deductible goodwill impairment in 2012. | |||||||||||||||||||||||||
The components of the net deferred income tax liability were as follows as of December 31: | |||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||
Foreign tax credit carryforwards | $ | 666 | $ | 432 | |||||||||||||||||||||
Accrued commission and general expenses | 219 | 339 | |||||||||||||||||||||||
State income taxes | 275 | 278 | |||||||||||||||||||||||
Net operating loss carryforwards | 1,803 | 1,762 | |||||||||||||||||||||||
Net unrealized losses on derivatives | — | 160 | |||||||||||||||||||||||
Other | 37 | 41 | |||||||||||||||||||||||
Gross deferred income tax assets | 3,000 | 3,012 | |||||||||||||||||||||||
Valuation allowance | (301 | ) | (312 | ) | |||||||||||||||||||||
Total deferred income tax assets | 2,699 | 2,700 | |||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||
Investments | $ | 100 | $ | 140 | |||||||||||||||||||||
Net unrealized gains on investment securities | 1,283 | 454 | |||||||||||||||||||||||
Net unrealized gains on derivatives | 222 | — | |||||||||||||||||||||||
Insurance reserves | 544 | 1,034 | |||||||||||||||||||||||
DAC | 1,095 | 1,130 | |||||||||||||||||||||||
PVFP and other intangibles | 5 | 53 | |||||||||||||||||||||||
Investment in foreign subsidiaries | 310 | 13 | |||||||||||||||||||||||
Other | 48 | 82 | |||||||||||||||||||||||
Total deferred income tax liabilities | 3,607 | 2,906 | |||||||||||||||||||||||
Net deferred income tax liability | $ | 908 | $ | 206 | |||||||||||||||||||||
The above valuation allowances of $301 million and $312 million, respectively, related to state deferred tax assets, foreign net operating losses and a specific federal separate tax return net operating loss deferred tax asset as of December 31, 2014 and 2013, respectively. The state deferred tax assets related primarily to the future deductions associated with the Section 338 elections and non-insurance net operating loss (“NOL”) carryforwards. The net decrease in the valuation allowance during 2014 related to changes in judgments regarding the future realization of deferred tax assets. Based on our analysis, we believe it is more likely than not that the results of future operations and the implementations of tax planning strategies will generate sufficient taxable income to enable us to realize the deferred tax assets for which we have not established valuation allowances. | |||||||||||||||||||||||||
NOL carryforwards amounted to $5,191 million as of December 31, 2014, and, if unused, will expire beginning in 2021. Of this amount, $24 million will result in a benefit recorded in APIC when realized. Foreign tax credit carryforwards amounted to $666 million as of December 31, 2014, and, if unused will begin to expire in 2015. | |||||||||||||||||||||||||
As a consequence of our separation from GE, and our joint election with GE to treat that separation as an asset sale under Section 338 of the Internal Revenue Code, we became entitled to additional tax deductions in post IPO periods. As of December 31, 2014 and 2013, we have recorded in our consolidated balance sheets our estimates of the remaining deferred tax benefits associated with these deductions of $599 million. We are obligated, pursuant to our Tax Matters Agreement with GE, to make fixed payments to GE, over the next 9 years, on an after-tax basis and subject to a cumulative maximum of $640 million, which is 80% of the projected tax savings associated with the Section 338 deductions. We recorded net interest expense of $13 million, $15 million and $17 million for the years ended December 31, 2014, 2013 and 2012, respectively, reflecting accretion of our liability at the Tax Matters Agreement rate of 5.72%. As of December 31, 2014 and 2013, we have recorded the estimated present value of our remaining obligation to GE of $216 million and $245 million, respectively, as a liability in our consolidated balance sheets. Both our IPO-related deferred tax assets and our obligation to GE are estimates that are subject to change. | |||||||||||||||||||||||||
In 2014, we increased our deferred tax liability by $6 million, with an offset to additional paid-in capital related to an unsupported tax balance that arose prior to our IPO. In 2013, we increased our deferred tax liability by $17 million, with an offset to additional paid-in capital related to an unsupported tax balance that arose prior to our IPO. In 2012, we decreased our deferred tax liability by $36 million with an offset to additional paid-in capital related to an unsupported tax balance that arose prior to our IPO. | |||||||||||||||||||||||||
U.S. deferred income taxes are not provided on unremitted foreign income that is considered permanently reinvested, which as of December 31, 2014, amounted to approximately $1,642 million related to our Canadian mortgage insurance business. It is not practicable to determine the income tax liability that might be incurred if all such income was remitted to the United States due to the inherent complexities associated with any hypothetical calculation. We will record deferred taxes in the period in which we are no longer able to assert unremitted earnings of foreign operations are permanently reinvested. Our Canadian mortgage insurance business held cash and short-term investments of $124 million related to the unremitted earnings of foreign operations considered to be permanently reinvested as of December 31, 2014. | |||||||||||||||||||||||||
A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: | |||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Balance as of January 1 | $ | 41 | $ | 55 | $ | 226 | |||||||||||||||||||
Tax positions related to the current period: | |||||||||||||||||||||||||
Gross additions | 7 | 3 | 14 | ||||||||||||||||||||||
Gross reductions | (3 | ) | — | — | |||||||||||||||||||||
Tax positions related to the prior years: | |||||||||||||||||||||||||
Gross additions | 17 | 4 | — | ||||||||||||||||||||||
Gross reductions | (13 | ) | (21 | ) | (131 | ) | |||||||||||||||||||
Settlements | — | — | (54 | ) | |||||||||||||||||||||
Balance as of December 31 | $ | 49 | $ | 41 | $ | 55 | |||||||||||||||||||
The total amount of unrecognized tax benefits was $49 million as of December 31, 2014, of which $44 million, if recognized, would affect the effective rate on continuing operations. These unrecognized tax benefits included the impact of foreign currency translation from our international operations. | |||||||||||||||||||||||||
We recognize accrued interest and penalties related to unrecognized tax benefits as components of income tax expense. We recorded $3 million, $1 million and $5 million, respectively, of benefits related to interest and penalties during 2014, 2013 and 2012. We had no interest and penalties accrued as of December 31, 2014. We had approximately $3 million of interest and penalties accrued as of December 31, 2013. | |||||||||||||||||||||||||
For tax years prior to 2011, we filed U.S. separate non-life consolidated, life consolidated Federal income tax returns, several separate non-life and life returns and various state and local tax returns. For tax years beginning in 2011 and thereafter, we have elected to file a life/non-life consolidated return for U.S. federal income tax purposes. With possible exceptions, we are no longer subject to U.S. Federal tax examinations for years through 2009. Any exposure with respect to these pre-2010 years has been sufficiently recorded in the financial statements. Potential state and local examinations for those years are generally restricted to results that are based on closed U.S. Federal examinations. For our life and non-life consolidated company federal income tax returns, all tax years prior to 2010 have been examined or reviewed. Several of our companies were included in a consolidated return with our former parent, GE, for pre-2005 tax years before our IPO. The Internal Revenue Service completed its examination of these GE consolidated returns in 2010, and the appropriate adjustments under the Tax Matters Agreement and other tax sharing arrangements with GE were settled and finalized during the year ended December 31, 2012. We are also responsible for any tax liability of any separate U.S. Federal and state pre-disposition period returns of former life insurance and non-insurance subsidiaries sold in the years 2011 to 2013. With respect to our foreign affiliates, there are various examinations ongoing by foreign jurisdictions with any material exposure liability related thereto being duly recorded in the financial statements. | |||||||||||||||||||||||||
We believe it is reasonably possible that in 2015 as a result of our open audits and appeals, up to approximately $14 million of unrecognized tax benefits will be recognized. These tax benefits are related to certain insurance tax attributes in the United States and in foreign jurisdictions. |
Supplemental_Cash_Flow_Informa
Supplemental Cash Flow Information | 12 Months Ended |
Dec. 31, 2014 | |
Supplemental Cash Flow Information | (15) Supplemental Cash Flow Information |
Net cash paid for taxes was $439 million, $146 million and $287 million and cash paid for interest was $437 million, $453 million and $465 million for the years ended December 31, 2014, 2013 and 2012, respectively. |
StockBased_Compensation
Stock-Based Compensation | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||
Stock-Based Compensation | (16) Stock-Based Compensation | ||||||||||||||||||||||||
Prior to May 2012, we granted share-based awards to employees and directors, including stock options, stock appreciation rights (“SARs”), restricted stock units (“RSUs”) and deferred stock units (“DSUs”) under the 2004 Genworth Financial, Inc. Omnibus Incentive Plan (the “2004 Omnibus Incentive Plan”). In May 2012, the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (the “2012 Omnibus Incentive Plan,” together with the 2004 Omnibus Incentive Plan, the “Omnibus Incentive Plans”) was approved by stockholders. Under the 2012 Omnibus Incentive Plan, we are authorized to grant 16 million equity awards, plus a number of additional shares not to exceed 25 million underlying awards outstanding under the prior Plan. From and after May 2012, no further awards have been or will be granted under the 2004 Omnibus Incentive Plan and the 2004 Omnibus Incentive Plan will remain in effect only as long as awards granted thereunder remain outstanding. | |||||||||||||||||||||||||
We recorded stock-based compensation expense under the Omnibus Incentive Plans of $22 million, $30 million and $23 million, respectively, for the years ended December 31, 2014, 2013 and 2012. For awards issued prior to January 1, 2006, stock-based compensation expense was recognized on a graded vesting attribution method over the awards’ respective vesting schedule. For awards issued after January 1, 2006, stock-based compensation expense was recognized evenly on a straight-line attribution method over the awards’ respective vesting period. | |||||||||||||||||||||||||
For purposes of determining the fair value of stock-based payment awards on the date of grant, we typically use the Black-Scholes Model. The Black-Scholes Model requires the input of certain assumptions that involve judgment. Management periodically evaluates the assumptions and methodologies used to calculate fair value of share-based compensation. Circumstances may change and additional data may become available over time, which could result in changes to these assumptions and methodologies. | |||||||||||||||||||||||||
The following table contains the stock option and SAR weighted-average grant date fair value information and related valuation assumptions for the years ended December 31: | |||||||||||||||||||||||||
Stock Options and SARs | |||||||||||||||||||||||||
2014 | 2013 | 2012 | |||||||||||||||||||||||
Black-Scholes | Black-Scholes | Monte-Carlo | Black-Scholes | ||||||||||||||||||||||
Model | Model | Simulation (1) | Model | ||||||||||||||||||||||
Awards granted (in thousands) | 2,960 | 3,404 | 1,200 | 5,085 | |||||||||||||||||||||
Maximum share value at exercise of SARs | $ | 75 | $ | 75 | $ | 75 | $ | 75 | |||||||||||||||||
Fair value per options and SARs | $ | 3.05 | $ | 2.53 | $ | 5.88 | $ | 2.34 | |||||||||||||||||
Valuation assumptions: | |||||||||||||||||||||||||
Expected term (years) | 6 | 5.9 | NA | 6 | |||||||||||||||||||||
Expected volatility | 100.2 | % | 100.7 | % | 102.5 | % | 100.7 | % | |||||||||||||||||
Expected dividend yield | 0.5 | % | 0.5 | % | 0.5 | % | 0.5 | % | |||||||||||||||||
Risk-free interest rate | 1.9 | % | 1.1 | % | 1.1 | % | 1.1 | % | |||||||||||||||||
(1) | For purposes of determining the fair value of 1.2 million shares of performance-accelerated SARs that were issued in January 2013, we used a Monte-Carlo Simulation technique. Monte-Carlo Simulation is a method used to simulate future stock price movements in order to determine the fair value due to unique vesting and exercising provisions. The performance-accelerated SARs have a derived service period of one year on average and have a grant price of $7.90. The performance-accelerated SARs vest on the third anniversary of the grant date but are subject to earlier vesting on or after the one year anniversary of the grant date based on the closing price of our Class A Common Stock exceeding certain specified amounts ($12.00, $16.00 and $20.00, respectively) for 45 consecutive trading days. Based on the closing price of our Class A Common Stock, the first tranche at $12.00 vested in January 2014 and the second tranche at $16.00 vested in June 2014. | ||||||||||||||||||||||||
During 2014 and 2013, we granted SARs with exercise prices ranging from $14.30 to $17.89 and $7.90 to $9.06, respectively. These SARs have a feature that places a cap on the amount of gain that can be recognized upon exercise of the SARs. Specifically, if the price of our Class A Common Stock reaches $75.00, any vested portion of the SAR will be automatically exercised. We did not grant stock options during 2014, 2013 or 2012. The SAR grant price equaled the closing market prices of our Class A Common Stock on the date of the grant and the awards have an exercise term of 10 years. The SARs granted in 2014, 2013 and 2012 have average vesting periods of four years in annual increments commencing on the first anniversary of the grant date. Additionally, during 2014 and 2013, we issued RSUs with average restriction periods of four years and a fair value of $9.19 to $17.89 and $7.90 to $15.40, respectively, which were measured at the market price of a share of our Class A Common Stock on the grant date. In 2014, we granted 343,000 performance stock units (“PSUs”) with fair values ranging from $15.23 to $17.89. During 2014, 39,000 PSUs were forfeited due to an executive employee leaving the company prior to the achievement of certain performance goals. The PSUs may be earned over a three year period based upon the achievement of certain performance goals related to our 2016 annual operating return on equity and book value per share. The PSUs will be payable in Genworth Class A Common Stock in March 2017 provided we have attained or exceeded threshold levels related to the performance goals. The two performance goals operate independently and each determine 50% of the potential number of shares to be paid out. If the respective threshold levels have not been achieved by December 31, 2016, no payout will occur and all related expenses recorded to date will be reversed. The PSUs were granted at market price as of the grant date. | |||||||||||||||||||||||||
The following table summarizes stock option activity as of December 31, 2014 and 2013: | |||||||||||||||||||||||||
(Shares in thousands) | Shares subject | Weighted-average | |||||||||||||||||||||||
to option | exercise price | ||||||||||||||||||||||||
Balance as of January 1, 2013 | 6,109 | $ | 11.77 | ||||||||||||||||||||||
Granted | — | $ | — | ||||||||||||||||||||||
Exercised | (1,440 | ) | $ | 6.2 | |||||||||||||||||||||
Forfeited | (359 | ) | $ | 17.26 | |||||||||||||||||||||
Expired | — | $ | — | ||||||||||||||||||||||
Balance as of January 1, 2014 | 4,310 | $ | 13.17 | ||||||||||||||||||||||
Granted | — | $ | — | ||||||||||||||||||||||
Exercised | (921 | ) | $ | 8.1 | |||||||||||||||||||||
Forfeited | (885 | ) | $ | 19.32 | |||||||||||||||||||||
Expired | — | $ | — | ||||||||||||||||||||||
Balance as of December 31, 2014 | 2,504 | $ | 12.86 | ||||||||||||||||||||||
Exercisable as of December 31, 2014 | 2,501 | $ | 12.86 | ||||||||||||||||||||||
The following table summarizes information about stock options outstanding as of December 31, 2014: | |||||||||||||||||||||||||
Outstanding | Exercisable | ||||||||||||||||||||||||
Exercise price range | Shares in | Average | Average | Shares in | Average | Average | |||||||||||||||||||
thousands | life (1) | exercise | thousands | life (1) | exercise | ||||||||||||||||||||
price | price | ||||||||||||||||||||||||
$2.00 - $2.46 (2) | 394 | 4.07 | $ | 2.44 | 394 | 4.07 | $ | 2.44 | |||||||||||||||||
$7.36 - $7.80 | 547 | 2.42 | $ | 7.8 | 547 | 2.42 | $ | 7.8 | |||||||||||||||||
$9.10 - $14.18 | 1,228 | 4.87 | $ | 14.15 | 1,225 | 4.86 | $ | 14.15 | |||||||||||||||||
$14.92 - $22.80 | 123 | 3.26 | $ | 21.96 | 123 | 3.26 | $ | 21.96 | |||||||||||||||||
$30.52 - $34.13 | 212 | 1.4 | $ | 32.56 | 212 | 1.4 | $ | 32.55 | |||||||||||||||||
2,504 | $ | 12.86 | 2,501 | $ | 12.86 | ||||||||||||||||||||
(1) | Average contractual life remaining in years. | ||||||||||||||||||||||||
(2) | These shares have an aggregate intrinsic value of $2 million each for total options outstanding and exercisable options. | ||||||||||||||||||||||||
The following table summarizes the status of our other equity-based awards as of December 31, 2014 and 2013: | |||||||||||||||||||||||||
RSUs | DSUs | SARs | |||||||||||||||||||||||
(Awards in thousands) | Number of | Weighted- | Number of | Weighted- | Number of | Weighted- | |||||||||||||||||||
awards | average grant | awards | average | awards | average grant | ||||||||||||||||||||
date fair value | fair value | date fair value | |||||||||||||||||||||||
Balance as of January 1, 2013 | 2,280 | $ | 12.97 | 690 | $ | 8.74 | 10,359 | $ | 4.44 | ||||||||||||||||
Granted | 2,018 | $ | 9.27 | 98 | $ | 12.17 | 4,604 | $ | 3.4 | ||||||||||||||||
Exercised | (985 | ) | $ | 14.75 | (209 | ) | $ | 4.73 | (1,618 | ) | $ | 5.97 | |||||||||||||
Terminated | (426 | ) | $ | 10.01 | — | $ | — | (980 | ) | $ | 2.91 | ||||||||||||||
Balance as of January 1, 2014 | 2,887 | $ | 10.21 | 579 | $ | 9.43 | 12,365 | $ | 4 | ||||||||||||||||
Granted | 1,226 | $ | 15 | 113 | $ | 12.98 | 2,960 | $ | 3.05 | ||||||||||||||||
Exercised | (938 | ) | $ | 10.06 | (58 | ) | $ | 6.65 | (1,353 | ) | $ | 3.88 | |||||||||||||
Terminated | (262 | ) | $ | 12.16 | — | $ | — | (1,905 | ) | $ | 5.23 | ||||||||||||||
Balance as of December 31, 2014 | 2,913 | $ | 12.09 | 634 | $ | 9.96 | 12,067 | $ | 3.62 | ||||||||||||||||
As of December 31, 2014 and 2013, total unrecognized stock-based compensation expense related to non-vested awards not yet recognized was $35 million and $30 million, respectively. This expense is expected to be recognized over a weighted-average period of two years. | |||||||||||||||||||||||||
There was $20 million and $19 million in cash received from stock options exercised in 2014 and 2013, respectively. New shares were issued to settle all exercised awards. The actual tax benefit realized for the tax deductions from the exercise of share-based awards was $11 million and $10 million as of December 31, 2014 and 2013, respectively. | |||||||||||||||||||||||||
In connection with the IPO of Genworth Canada in July 2009, our indirect subsidiary, Genworth Canada, granted stock options and other equity-based awards to its Canadian employees. The following table summarizes the status of Genworth Canada’s stock option activity and other equity-based awards as of December 31, 2014 and 2013: | |||||||||||||||||||||||||
Stock options | RSUs & PSUs | DSUs | Executive deferred | ||||||||||||||||||||||
stock units (“EDSUs”) | |||||||||||||||||||||||||
(Shares and Awards in thousands) | Shares subject | Number of | Number of | Number of | |||||||||||||||||||||
to option | awards | awards | awards | ||||||||||||||||||||||
Balance as of January 1, 2013 | 1,027 | 143 | 34 | — | |||||||||||||||||||||
Granted | 100 | 106 | 11 | 20 | |||||||||||||||||||||
Exercised | (91 | ) | (66 | ) | — | — | |||||||||||||||||||
Terminated | (49 | ) | (6 | ) | — | — | |||||||||||||||||||
Balance as of January 1, 2014 | 987 | 177 | 45 | 20 | |||||||||||||||||||||
Granted | 114 | 93 | 9 | 1 | |||||||||||||||||||||
Exercised | (93 | ) | (67 | ) | — | — | |||||||||||||||||||
Terminated | (6 | ) | — | — | — | ||||||||||||||||||||
Balance as of December 31, 2014 | 1,002 | 203 | 54 | 21 | |||||||||||||||||||||
As of December 31, 2014 and 2013, all of the stock options, RSUs, PSUs and DSUs, were vested. As of December 31, 2014 and 2013, all of the EDSUs outstanding were unvested. The EDSUs were introduced in 2013 as part of a share-based compensation plan intended for executive level employees entitling them to receive an amount equal to the fair value of Genworth Canada stock. For the years ended December 31, 2014, 2013 and 2012, we recorded stock-based compensation expense of $6 million, $11 million and $3 million, respectively. For the years ended December 31, 2014, 2013 and 2012, we estimated total unrecognized expense of $3 million, $3 million and $1 million, respectively, related to these awards. | |||||||||||||||||||||||||
In connection with the IPO of Genworth Mortgage Insurance Australia Limited (“Genworth Australia”) in May 2014, our indirect subsidiary, Genworth Australia, granted stock options and other equity-based awards to its Australian employees. As of December 31, 2014, Genworth Australia had outstanding 2,803,025 of restricted share rights, of which 99,250 shares were vested and 2,703,775 shares were unvested. During 2014, 4,901 shares were exercised. For the year ended December 31, 2014, we recorded stock-based compensation expense of $2 million and we estimated total unrecognized expense of $5 million related to these awards. |
Fair_Value_of_Financial_Instru
Fair Value of Financial Instruments | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments | (17) Fair Value of Financial Instruments | ||||||||||||||||||||||||||||||||||||||||||||
Assets and liabilities that are reflected in the accompanying consolidated financial statements at fair value are not included in the following disclosure of fair value. Such items include cash and cash equivalents, investment securities, separate accounts, securities held as collateral and derivative instruments. Other financial assets and liabilities—those not carried at fair value—are discussed below. Apart from certain of our borrowings and certain marketable securities, few of the instruments discussed below are actively traded and their fair values must often be determined using models. The fair value estimates are made at a specific point in time, based upon available market information and judgments about the financial instruments, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such estimates do not reflect any premium or discount that could result from offering for sale at one time our entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value estimates cannot be substantiated by comparison to independent markets. | |||||||||||||||||||||||||||||||||||||||||||||
The basis on which we estimate fair value is as follows: | |||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage loans. Based on recent transactions and/or discounted future cash flows, using current market rates. Given the limited availability of data related to transactions for similar instruments, we typically classify these loans as Level 3. | |||||||||||||||||||||||||||||||||||||||||||||
Restricted commercial mortgage loans. Based on recent transactions and/or discounted future cash flows, using current market rates. Given the limited availability of data related to transactions for similar instruments, we typically classify these loans as Level 3. | |||||||||||||||||||||||||||||||||||||||||||||
Other invested assets. Primarily represents short-term investments and limited partnerships accounted for under the cost method. The fair value of short-term investments typically does not include significant unobservable inputs and approximate our amortized cost basis. As a result, short-term investments are classified as Level 2. Limited partnerships are valued based on comparable market transactions, discounted future cash flows, quoted market prices and/or estimates using the most recent data available for the underlying instrument. Cost method limited partnerships typically include significant unobservable inputs as a result of being relatively illiquid with limited market activity for similar instruments and are classified as Level 3. | |||||||||||||||||||||||||||||||||||||||||||||
Long-term borrowings. We utilize available market data when determining fair value of long-term borrowings issued in the United States and Canada, which includes data on recent trades for the same or similar financial instruments. Accordingly, these instruments are classified as Level 2 measurements. In cases where market data is not available such as our long-term borrowings in Australia, we use broker quotes for which we consider the valuation methodology utilized by the third party, but the valuation typically includes significant unobservable inputs. Accordingly, we classify these borrowings where fair value is based on our consideration of broker quotes as Level 3 measurements. | |||||||||||||||||||||||||||||||||||||||||||||
Non-recourse funding obligations. We use an internal model to determine fair value using the current floating rate coupon and expected life/final maturity of the instrument discounted using the floating rate index and current market spread assumption, which is estimated based on recent transactions for these instruments or similar instruments as well as other market information or broker provided data. Given these instruments are private and very little market activity exists, our current market spread assumption is considered to have significant unobservable inputs in calculating fair value and, therefore, results in the fair value of these instruments being classified as Level 3. | |||||||||||||||||||||||||||||||||||||||||||||
Borrowings related to securitization entities. Based on market quotes or comparable market transactions. Some of these borrowings are publicly traded debt securities and are classified as Level 2. Certain borrowings are not publicly traded and are classified as Level 3. | |||||||||||||||||||||||||||||||||||||||||||||
Investment contracts. Based on expected future cash flows, discounted at current market rates for annuity contracts or institutional products. Given the significant unobservable inputs associated with policyholder behavior and current market rate assumptions used to discount the expected future cash flows, we classify these instruments as Level 3 except for certain funding agreement-backed notes that are traded in the marketplace as a security and are classified as Level 2. | |||||||||||||||||||||||||||||||||||||||||||||
The following represents our estimated fair value of financial assets and liabilities that are not required to be carried at fair value as of December 31: | |||||||||||||||||||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||||||||||||||||||
Notional | Carrying | Fair value | |||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | amount | amount | Total | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage loans | $ | (1) | $ | 6,100 | $ | 6,573 | $ | — | $ | — | $ | 6,573 | |||||||||||||||||||||||||||||||||
Restricted commercial mortgage loans (2) | (1) | 201 | 228 | — | — | 228 | |||||||||||||||||||||||||||||||||||||||
Other invested assets | (1) | 374 | 385 | — | 300 | 85 | |||||||||||||||||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Long-term borrowings (3) | (1) | 4,639 | 4,300 | — | 4,181 | 119 | |||||||||||||||||||||||||||||||||||||||
Non-recourse funding obligations (3) | (1) | 1,996 | 1,438 | — | — | 1,438 | |||||||||||||||||||||||||||||||||||||||
Borrowings related to securitization entities (2) | (1) | 134 | 146 | — | 146 | — | |||||||||||||||||||||||||||||||||||||||
Investment contracts | (1) | 17,497 | 18,023 | — | 7 | 18,016 | |||||||||||||||||||||||||||||||||||||||
Other firm commitments: | |||||||||||||||||||||||||||||||||||||||||||||
Commitments to fund limited partnerships | 53 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Ordinary course of business lending commitments | 155 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||||||||||
Notional | Carrying | Fair value | |||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | amount | amount | Total | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage loans | $ | (1) | $ | 5,899 | $ | 6,137 | $ | — | $ | — | $ | 6,137 | |||||||||||||||||||||||||||||||||
Restricted commercial mortgage loans (2) | (1) | 233 | 258 | — | — | 258 | |||||||||||||||||||||||||||||||||||||||
Other invested assets | (1) | 307 | 311 | — | 221 | 90 | |||||||||||||||||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Long-term borrowings (3) | (1) | 5,161 | 5,590 | — | 5,460 | 130 | |||||||||||||||||||||||||||||||||||||||
Non-recourse funding obligations (3) | (1) | 2,038 | 1,459 | — | — | 1,459 | |||||||||||||||||||||||||||||||||||||||
Borrowings related to securitization entities (2) | (1) | 167 | 182 | — | 182 | — | |||||||||||||||||||||||||||||||||||||||
Investment contracts | (1) | 17,330 | 17,827 | — | 86 | 17,741 | |||||||||||||||||||||||||||||||||||||||
Other firm commitments: | |||||||||||||||||||||||||||||||||||||||||||||
Commitments to fund limited partnerships | 65 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Ordinary course of business lending commitments | 138 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
(1) | These financial instruments do not have notional amounts. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(3) | See note 13 for additional information related to borrowings. | ||||||||||||||||||||||||||||||||||||||||||||
Recurring Fair Value Measurements | |||||||||||||||||||||||||||||||||||||||||||||
We have fixed maturity, equity and trading securities, derivatives, embedded derivatives, securities held as collateral, separate account assets and certain other financial instruments, which are carried at fair value. Below is a description of the valuation techniques and inputs used to determine fair value by class of instrument. | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity, equity and trading securities | |||||||||||||||||||||||||||||||||||||||||||||
The valuations of fixed maturity, equity and trading securities are determined using a market approach, income approach or a combination of the market and income approach depending on the type of instrument and availability of information. For all exchange-traded equity securities, the valuations are classified as Level 1. | |||||||||||||||||||||||||||||||||||||||||||||
We utilize certain third-party data providers when determining fair value. We consider information obtained from third-party pricing services (“pricing services”) as well as third-party broker provided prices, or broker quotes, in our determination of fair value. Additionally, we utilize internal models to determine the valuation of securities using an income approach where the inputs are based on third-party provided market inputs. While we consider the valuations provided by pricing services and broker quotes to be of high quality, management determines the fair value of our investment securities after considering all relevant and available information. We also use various methods to obtain an understanding of the valuation methodologies and procedures used by third-party data providers to ensure sufficient understanding to evaluate the valuation data received, including an understanding of the assumptions and inputs utilized to determine the appropriate fair value. For pricing services, we analyze the prices provided by our primary pricing services to other readily available pricing services and perform a detailed review of the assumptions and inputs from each pricing service to determine the appropriate fair value when pricing differences exceed certain thresholds. We also evaluate changes in fair value that are greater than 10% each month to further aid in our review of the accuracy of fair value measurements and our understanding of changes in fair value, with more detailed reviews performed by the asset managers responsible for the related asset class associated with the security being reviewed. A pricing committee provides additional oversight and guidance in the evaluation and review of the pricing methodologies used to value our investment portfolio. | |||||||||||||||||||||||||||||||||||||||||||||
In general, we first obtain valuations from pricing services. If a price is not supplied by a pricing service, we will typically seek a broker quote for public or private fixed maturity securities. In certain instances, we utilize price caps for broker quoted securities where the estimated market yield results in a valuation that may exceed the amount that we believe would be received in a market transaction. For certain private fixed maturity securities where we do not obtain valuations from pricing services, we utilize an internal model to determine fair value since transactions for identical securities are not readily observable and these securities are not typically valued by pricing services. For all securities, excluding certain private fixed maturity securities, if neither a pricing service nor broker quotes valuation is available, we determine fair value using internal models. | |||||||||||||||||||||||||||||||||||||||||||||
For pricing services, we obtain an understanding of the pricing methodologies and procedures for each type of instrument. Additionally, on a monthly basis we review a sample of securities, examining the pricing service’s assumptions to determine if we agree with the service’s derived price. In general, a pricing service does not provide a price for a security if sufficient information is not readily available to determine fair value or if such security is not in the specific sector or class covered by a particular pricing service. Given our understanding of the pricing methodologies and procedures of pricing services, the securities valued by pricing services are typically classified as Level 2 unless we determine the valuation process for a security or group of securities utilizes significant unobservable inputs, which would result in the valuation being classified as Level 3. | |||||||||||||||||||||||||||||||||||||||||||||
For private fixed maturity securities, we utilize an internal model to determine fair value and utilize public bond spreads by sector, rating and maturity to develop the market rate that would be utilized for a similar public bond. We then add an additional premium, which represents an unobservable input, to the public bond spread to adjust for the liquidity and other features of our private placements. We utilize the estimated market yield to discount the expected cash flows of the security to determine fair value. In certain instances, we utilize price caps for securities where the estimated market yield results in a valuation that may exceed the amount that would be received in a market transaction. When a security does not have an external rating, we assign the security an internal rating to determine the appropriate public bond spread that should be utilized in the valuation. To evaluate the reasonableness of the internal model, we review a sample of private fixed maturity securities each month. In that review we compare the modeled prices to the prices of similar public securities in conjunction with analysis on current market indicators. While we generally consider the public bond spreads by sector and maturity to be observable inputs, we evaluate the similarities of our private placement with the public bonds, any price caps utilized, liquidity premiums applied, and whether external ratings are available for our private placements to determine whether the spreads utilized would be considered observable inputs. During the second quarter of 2012, we began classifying private securities without an external rating and public bond spread as Level 3. In general, increases (decreases) in credit spreads will decrease (increase) the fair value for our fixed maturity securities. | |||||||||||||||||||||||||||||||||||||||||||||
For broker quotes, we consider the valuation methodology utilized by the third party and analyze a sample each month to assess reasonableness given then current market conditions. As the valuation typically includes significant unobservable inputs, we classify the securities where fair value is based on our consideration of broker quotes as Level 3 measurements. | |||||||||||||||||||||||||||||||||||||||||||||
For remaining securities priced using internal models, we maximize the use of observable inputs but typically utilize significant unobservable inputs to determine fair value. Accordingly, the valuations are typically classified as Level 3. | |||||||||||||||||||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities | |||||||||||||||||||||||||||||||||||||||||||||
We have trading securities related to securitization entities that are classified as restricted other invested assets and are carried at fair value. The trading securities represent asset-backed securities. The valuation for trading securities is determined using a market approach and/or an income approach depending on the availability of information. For certain highly rated asset-backed securities, there is observable market information for transactions of the same or similar instruments, which is provided to us by a third-party pricing service and is classified as Level 2. For certain securities that are not actively traded, we determine fair value after considering third-party broker provided prices or discounted expected cash flows using current yields for similar securities and classify these valuations as Level 3. | |||||||||||||||||||||||||||||||||||||||||||||
Securities lending and derivative counterparty collateral | |||||||||||||||||||||||||||||||||||||||||||||
The fair value of securities held as collateral is primarily based on Level 2 inputs from market information for the collateral that is held on our behalf by the custodian. We determine fair value after considering prices obtained by third-party pricing services. | |||||||||||||||||||||||||||||||||||||||||||||
Contingent consideration | |||||||||||||||||||||||||||||||||||||||||||||
We have certain contingent purchase price payments and receivables related to acquisitions and sales that are recorded at fair value each period. Fair value is determined using an income approach whereby we project the expected performance of the business and compare our projections of the relevant performance metric to the thresholds established in the purchase or sale agreement to determine our expected payments or receipts. We then discount these expected amounts to calculate the fair value as of the valuation date. We evaluate the underlying projections used in determining fair value each period and update these underlying projections when there have been significant changes in our expectations of the future business performance. The inputs used to determine the discount rate and expected payments or receipts are primarily based on significant unobservable inputs and result in the fair value of the contingent consideration being classified as Level 3. An increase in the discount rate or a decrease in expected payments or receipts will result in a decrease in the fair value of contingent consideration. | |||||||||||||||||||||||||||||||||||||||||||||
Separate account assets | |||||||||||||||||||||||||||||||||||||||||||||
The fair value of separate account assets is based on the quoted prices of the underlying fund investments and, therefore, represents Level 1 pricing. | |||||||||||||||||||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||||||||||||||||||
We consider counterparty collateral arrangements and rights of set-off when evaluating our net credit risk exposure to our derivative counterparties. Accordingly, we are permitted to include consideration of these arrangements when determining whether any incremental adjustment should be made for both the counterparty’s and our non-performance risk in measuring fair value for our derivative instruments. As a result of these counterparty arrangements, we determined that any adjustment for credit risk would not be material and we do not record any incremental adjustment for our non-performance risk or the non-performance risk of the derivative counterparty for our derivative assets or liabilities. We determine fair value for our derivatives using an income approach with internal models based on relevant market inputs for each derivative instrument. We also compare the fair value determined using our internal model to the valuations provided by our derivative counterparties with any significant differences or changes in valuation being evaluated further by our derivatives professionals that are familiar with the instrument and market inputs used in the valuation. | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps. The valuation of interest rate swaps is determined using an income approach. The primary input into the valuation represents the forward interest rate swap curve, which is generally considered an observable input, and results in the derivative being classified as Level 2. For certain interest rate swaps, the inputs into the valuation also include the total returns of certain bonds that would primarily be considered an observable input and result in the derivative being classified as Level 2. For certain other swaps, there are features that provide an option to the counterparty to terminate the swap at specified dates. The interest rate volatility input used to value these options would be considered a significant unobservable input and results in the fair value measurement of the derivative being classified as Level 3. These options to terminate the swap by the counterparty are based on forward interest rate swap curves and volatility. As interest rate volatility increases, our valuation of the derivative changes unfavorably. | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps related to securitization entities. The valuation of interest rate swaps related to securitization entities is determined using an income approach. The primary input into the valuation represents the forward interest rate swap curve, which is generally considered an observable input, and results in the derivative being classified as Level 2. | |||||||||||||||||||||||||||||||||||||||||||||
Inflation indexed swaps. The valuation of inflation indexed swaps is determined using an income approach. The primary inputs into the valuation represent the forward interest rate swap curve, the current consumer price index and the forward consumer price index curve, which are generally considered observable inputs, and results in the derivative being classified as Level 2. | |||||||||||||||||||||||||||||||||||||||||||||
Foreign currency swaps. The valuation of foreign currency swaps is determined using an income approach. The primary inputs into the valuation represent the forward interest rate swap curve and foreign currency exchange rates, both of which are considered an observable input, and results in the derivative being classified as Level 2. | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps. We have both single name credit default swaps and index tranche credit default swaps. For single name credit default swaps, we utilize an income approach to determine fair value based on using current market information for the credit spreads of the reference entity, which is considered observable inputs based on the reference entities of our derivatives and results in these derivatives being classified as Level 2. For index tranche credit default swaps, we utilize an income approach that utilizes current market information related to credit spreads and expected defaults and losses associated with the reference entities that comprise the respective index associated with each derivative. There are significant unobservable inputs associated with the timing and amount of losses from the reference entities as well as the timing or amount of losses, if any, that will be absorbed by our tranche. Accordingly, the index tranche credit default swaps are classified as Level 3. As credit spreads widen for the underlying issuers comprising the index, the change in our valuation of these credit default swaps will be unfavorable. | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities. Credit default swaps related to securitization entities represent customized index tranche credit default swaps and are valued using a similar methodology as described above for index tranche credit default swaps. We determine fair value of these credit default swaps after considering both the valuation methodology described above as well as the valuation provided by the derivative counterparty. In addition to the valuation methodology and inputs described for index tranche credit default swaps, these customized credit default swaps contain a feature that permits the securitization entity to provide the par value of underlying assets in the securitization entity to settle any losses under the credit default swap. The valuation of this settlement feature is dependent upon the valuation of the underlying assets and the timing and amount of any expected loss on the credit default swap, which is considered a significant unobservable input. Accordingly, these customized index tranche credit default swaps related to securitization entities are classified as Level 3. As credit spreads widen for the underlying issuers comprising the customized index, the change in our valuation of these credit default swaps will be unfavorable. | |||||||||||||||||||||||||||||||||||||||||||||
Equity index options. We have equity index options associated with various equity indices. The valuation of equity index options is determined using an income approach. The primary inputs into the valuation represent forward interest rate volatility and time value component associated with the optionality in the derivative, which are considered significant unobservable inputs in most instances. The equity index volatility surface is determined based on market information that is not readily observable and is developed based upon inputs received from several third-party sources. Accordingly, these options are classified as Level 3. As equity index volatility increases, our valuation of these options changes favorably. | |||||||||||||||||||||||||||||||||||||||||||||
Financial futures. The fair value of financial futures is based on the closing exchange prices. Accordingly, these financial futures are classified as Level 1. The period end valuation is zero as a result of settling the margins on these contracts on a daily basis. | |||||||||||||||||||||||||||||||||||||||||||||
Equity return swaps. The valuation of equity return swaps is determined using an income approach. The primary inputs into the valuation represent the forward interest rate swap curve and underlying equity index values, which are generally considered observable inputs, and results in the derivative being classified as Level 2. | |||||||||||||||||||||||||||||||||||||||||||||
Forward bond purchase commitments. The valuation of forward bond purchase commitments is determined using an income approach. The primary input into the valuation represents the current bond prices and interest rates, which are generally considered an observable input, and results in the derivative being classified as Level 2. | |||||||||||||||||||||||||||||||||||||||||||||
Other foreign currency contracts. We have certain foreign currency options classified as other foreign currency contracts. The valuation of foreign currency options is determined using an income approach. The primary inputs into the valuation represent the forward interest rate swap curve, foreign currency exchange rates, forward interest rate, foreign currency exchange rate volatility, foreign equity index volatility and time value component associated with the optionality in the derivative. As a result of the significant unobservable inputs associated with the forward interest rate, foreign currency exchange rate volatility and foreign equity index volatility inputs, the derivative is classified as Level 3. As foreign currency exchange rate volatility and foreign equity index volatility increases, the change in our valuation of these options will be favorable for purchase options and unfavorable for options sold. We also have foreign currency forward contracts where the valuation is determined using an income approach. The primary inputs into the valuation represent the forward foreign currency exchange rates, which are generally considered observable inputs and results in the derivative being classified as Level 2. | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives | |||||||||||||||||||||||||||||||||||||||||||||
We are required to bifurcate an embedded derivative for certain features associated with annuity products and related reinsurance agreements where we provide a GMWB to the policyholder and are required to record the GMWB embedded derivative at fair value. The valuation of our GMWB embedded derivative is based on an income approach that incorporates inputs such as forward interest rates, equity index volatility, equity index and fund correlation, and policyholder assumptions such as utilization, lapse and mortality. In addition to these inputs, we also consider risk and expense margins when determining the projected cash flows that would be determined by another market participant. While the risk and expense margins are considered in determining fair value, these inputs do not have a significant impact on the valuation. We determine fair value using an internal model based on the various inputs noted above. The resulting fair value measurement from the model is reviewed by the product actuarial, risk and finance professionals each reporting period with changes in fair value also being compared to changes in derivatives and other instruments used to mitigate changes in fair value from certain market risks, such as equity index volatility and interest rates. | |||||||||||||||||||||||||||||||||||||||||||||
For GMWB liabilities, non-performance risk is integrated into the discount rate. Our discount rate used to determine fair value of our GMWB liabilities includes market credit spreads above U.S. Treasury rates to reflect an adjustment for the non-performance risk of the GMWB liabilities. As of December 31, 2014 and 2013, the impact of non-performance risk resulted in a lower fair value of our GMWB liabilities of $74 million and $46 million, respectively. | |||||||||||||||||||||||||||||||||||||||||||||
To determine the appropriate discount rate to reflect the non-performance risk of the GMWB liabilities, we evaluate the non-performance risk in our liabilities based on a hypothetical exit market transaction as there is no exit market for these types of liabilities. A hypothetical exit market can be viewed as a hypothetical transfer of the liability to another similarly rated insurance company which would closely resemble a reinsurance transaction. Another hypothetical exit market transaction can be viewed as a hypothetical transaction from the perspective of the GMWB policyholder. In determining the appropriate discount rate to incorporate non-performance risk of the GMWB liabilities, we also considered the impacts of state guarantees embedded in the related insurance product as a form of inseparable third-party guarantee. We believe that a hypothetical exit market participant would use a similar discount rate as described above to value the liabilities. | |||||||||||||||||||||||||||||||||||||||||||||
For equity index volatility, we determine the projected equity market volatility using both historical volatility and projected equity market volatility with more significance being placed on projected near-term volatility and recent historical data. Given the different attributes and market characteristics of GMWB liabilities compared to equity index options in the derivative market, the equity index volatility assumption for GMWB liabilities may be different from the volatility assumption for equity index options, especially for the longer dated points on the curve. | |||||||||||||||||||||||||||||||||||||||||||||
Equity index and fund correlations are determined based on historical price observations for the fund and equity index. | |||||||||||||||||||||||||||||||||||||||||||||
For policyholder assumptions, we use our expected lapse, mortality and utilization assumptions and update these assumptions for our actual experience, as necessary. For our lapse assumption, we adjust our base lapse assumption by policy based on a combination of the policyholder’s current account value and GMWB benefit. | |||||||||||||||||||||||||||||||||||||||||||||
We classify the GMWB valuation as Level 3 based on having significant unobservable inputs, with equity index volatility and non-performance risk being considered the more significant unobservable inputs. As equity index volatility increases, the fair value of the GMWB liabilities will increase. Any increase in non-performance risk would increase the discount rate and would decrease the fair value of the GMWB liability. Additionally, we consider lapse and utilization assumptions to be significant unobservable inputs. An increase in our lapse assumption would decrease the fair value of the GMWB liability, whereas an increase in our utilization rate would increase the fair value. | |||||||||||||||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives | |||||||||||||||||||||||||||||||||||||||||||||
We offer fixed indexed annuity products where interest is credited to the policyholder’s account balance based on equity index changes. This feature is required to be bifurcated as an embedded derivative and recorded at fair value. Fair value is determined using an income approach where the present value of the excess cash flows above the guaranteed cash flows is used to determine the value attributed to the equity index feature. The inputs used in determining the fair value include policyholder behavior (lapses and withdrawals), near-term equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. As a result of our assumptions for policyholder behavior and expected future interest credited being considered significant unobservable inputs, we classify these instruments as Level 3. As lapses and withdrawals increase, the value of our embedded derivative liability will decrease. As expected future interest credited decreases, the value of our embedded derivative liability will decrease. | |||||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives | |||||||||||||||||||||||||||||||||||||||||||||
We offer indexed universal life products where interest is credited to the policyholder’s account balance based on equity index changes. This feature is required to be bifurcated as an embedded derivative and recorded at fair value. Fair value is determined using an income approach where the present value of the excess cash flows above the guaranteed cash flows is used to determine the value attributed to the equity index feature. The inputs used in determining the fair value include policyholder behavior (lapses and withdrawals), near-term equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. As a result of our assumptions for policyholder behavior and expected future interest credited being considered significant unobservable inputs, we classify these instruments as Level 3. As lapses and withdrawals increase, the value of our embedded derivative liability will decrease. As expected future interest credited decreases, the value of our embedded derivative liability will decrease. | |||||||||||||||||||||||||||||||||||||||||||||
Borrowings related to securitization entities | |||||||||||||||||||||||||||||||||||||||||||||
We record certain borrowings related to securitization entities at fair value. The fair value of these borrowings is determined using either a market approach or income approach, depending on the instrument and availability of market information. Given the unique characteristics of the securitization entities that issued these borrowings as well as the lack of comparable instruments, we determine fair value considering the valuation of the underlying assets held by the securitization entities and any derivatives, as well as any unique characteristics of the borrowings that may impact the valuation. After considering all relevant inputs, we determine fair value of the borrowings using the net valuation of the underlying assets and derivatives that are backing the borrowings. Accordingly, these instruments are classified as Level 3. Increases in the valuation of the underlying assets or decreases in the derivative liabilities will result in an increase in the fair value of these borrowings. | |||||||||||||||||||||||||||||||||||||||||||||
The following tables set forth our assets and liabilities by class of instrument that are measured at fair value on a recurring basis as of December 31: | |||||||||||||||||||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Total | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||||||||||||||
Investments: | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 6,000 | $ | — | $ | 5,996 | $ | 4 | |||||||||||||||||||||||||||||||||||||
Tax-exempt | 362 | — | 362 | — | |||||||||||||||||||||||||||||||||||||||||
Government—non-U.S. | 2,106 | — | 2,099 | 7 | |||||||||||||||||||||||||||||||||||||||||
U.S. corporate | 27,200 | — | 24,752 | 2,448 | |||||||||||||||||||||||||||||||||||||||||
Corporate—non-U.S. | 15,132 | — | 13,327 | 1,805 | |||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 5,240 | — | 5,165 | 75 | |||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 2,702 | — | 2,697 | 5 | |||||||||||||||||||||||||||||||||||||||||
Other asset-backed | 3,705 | — | 2,285 | 1,420 | |||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities | 62,447 | — | 56,683 | 5,764 | |||||||||||||||||||||||||||||||||||||||||
Equity securities | 282 | 244 | 4 | 34 | |||||||||||||||||||||||||||||||||||||||||
Other invested assets: | |||||||||||||||||||||||||||||||||||||||||||||
Trading securities | 241 | — | 241 | — | |||||||||||||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 1,091 | — | 1,091 | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency swaps | 6 | — | 6 | — | |||||||||||||||||||||||||||||||||||||||||
Credit default swaps | 4 | — | 1 | 3 | |||||||||||||||||||||||||||||||||||||||||
Equity index options | 17 | — | — | 17 | |||||||||||||||||||||||||||||||||||||||||
Other foreign currency contracts | 14 | — | 14 | — | |||||||||||||||||||||||||||||||||||||||||
Total derivative assets | 1,132 | — | 1,112 | 20 | |||||||||||||||||||||||||||||||||||||||||
Securities lending collateral | 289 | — | 289 | — | |||||||||||||||||||||||||||||||||||||||||
Total other invested assets | 1,662 | — | 1,642 | 20 | |||||||||||||||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (1) | 411 | — | 181 | 230 | |||||||||||||||||||||||||||||||||||||||||
Reinsurance recoverable (2) | 13 | — | — | 13 | |||||||||||||||||||||||||||||||||||||||||
Separate account assets | 9,208 | 9,208 | — | — | |||||||||||||||||||||||||||||||||||||||||
Total assets | $ | 74,023 | $ | 9,452 | $ | 58,510 | $ | 6,061 | |||||||||||||||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (3) | $ | 291 | $ | — | $ | — | $ | 291 | |||||||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives | 276 | — | — | 276 | |||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives | 7 | — | — | 7 | |||||||||||||||||||||||||||||||||||||||||
Total policyholder account balances | 574 | — | — | 574 | |||||||||||||||||||||||||||||||||||||||||
Derivative liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 204 | — | 204 | — | |||||||||||||||||||||||||||||||||||||||||
Interest rate swaps related to securitization entities (1) | 26 | — | 26 | — | |||||||||||||||||||||||||||||||||||||||||
Inflation indexed swaps | 42 | — | 42 | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency swaps | 7 | — | 7 | — | |||||||||||||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities (1) | 17 | — | — | 17 | |||||||||||||||||||||||||||||||||||||||||
Equity return swaps | 1 | — | 1 | — | |||||||||||||||||||||||||||||||||||||||||
Other foreign currency contracts | 13 | — | 13 | — | |||||||||||||||||||||||||||||||||||||||||
Total derivative liabilities | 310 | — | 293 | 17 | |||||||||||||||||||||||||||||||||||||||||
Borrowings related to securitization entities (1) | 85 | — | — | 85 | |||||||||||||||||||||||||||||||||||||||||
Total liabilities | $ | 969 | $ | — | $ | 293 | $ | 676 | |||||||||||||||||||||||||||||||||||||
-1 | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
-2 | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||||||||||||||||||||||
-3 | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Total | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||||||||||||||
Investments: | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 4,810 | $ | — | $ | 4,805 | $ | 5 | |||||||||||||||||||||||||||||||||||||
Tax-exempt | 295 | — | 295 | — | |||||||||||||||||||||||||||||||||||||||||
Government—non-U.S. | 2,146 | — | 2,123 | 23 | |||||||||||||||||||||||||||||||||||||||||
U.S. corporate | 25,035 | — | 22,635 | 2,400 | |||||||||||||||||||||||||||||||||||||||||
Corporate—non-U.S. | 15,071 | — | 13,252 | 1,819 | |||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 5,225 | — | 5,120 | 105 | |||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 2,898 | — | 2,892 | 6 | |||||||||||||||||||||||||||||||||||||||||
Other asset-backed | 3,149 | — | 1,983 | 1,166 | |||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities | 58,629 | — | 53,105 | 5,524 | |||||||||||||||||||||||||||||||||||||||||
Equity securities | 341 | 256 | 7 | 78 | |||||||||||||||||||||||||||||||||||||||||
Other invested assets: | |||||||||||||||||||||||||||||||||||||||||||||
Trading securities | 239 | — | 205 | 34 | |||||||||||||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 436 | — | 436 | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency swaps | 4 | — | 4 | — | |||||||||||||||||||||||||||||||||||||||||
Credit default swaps | 11 | — | 1 | 10 | |||||||||||||||||||||||||||||||||||||||||
Equity index options | 12 | — | — | 12 | |||||||||||||||||||||||||||||||||||||||||
Other foreign currency contracts | 8 | — | 5 | 3 | |||||||||||||||||||||||||||||||||||||||||
Total derivative assets | 471 | — | 446 | 25 | |||||||||||||||||||||||||||||||||||||||||
Securities lending collateral | 187 | — | 187 | — | |||||||||||||||||||||||||||||||||||||||||
Derivatives counterparty collateral | 70 | — | 70 | — | |||||||||||||||||||||||||||||||||||||||||
Total other invested assets | 967 | — | 908 | 59 | |||||||||||||||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (1) | 391 | — | 180 | 211 | |||||||||||||||||||||||||||||||||||||||||
Reinsurance recoverable (2) | (1 | ) | — | — | (1 | ) | |||||||||||||||||||||||||||||||||||||||
Separate account assets | 10,138 | 10,138 | — | — | |||||||||||||||||||||||||||||||||||||||||
Total assets | $ | 70,465 | $ | 10,394 | $ | 54,200 | $ | 5,871 | |||||||||||||||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (3) | $ | 96 | $ | — | $ | — | $ | 96 | |||||||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives | 143 | — | — | 143 | |||||||||||||||||||||||||||||||||||||||||
Total policyholder account balances | 239 | — | — | 239 | |||||||||||||||||||||||||||||||||||||||||
Derivative liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 575 | — | 575 | — | |||||||||||||||||||||||||||||||||||||||||
Interest rate swaps related to securitization entities (1) | 16 | — | 16 | — | |||||||||||||||||||||||||||||||||||||||||
Inflation indexed swaps | 60 | — | 60 | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency swaps | 2 | — | 2 | — | |||||||||||||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities (1) | 32 | — | — | 32 | |||||||||||||||||||||||||||||||||||||||||
Equity return swaps | 1 | — | 1 | — | |||||||||||||||||||||||||||||||||||||||||
Forward bond purchase commitments | 13 | — | 13 | — | |||||||||||||||||||||||||||||||||||||||||
Other foreign currency contracts | 4 | — | 3 | 1 | |||||||||||||||||||||||||||||||||||||||||
Total derivative liabilities | 703 | — | 670 | 33 | |||||||||||||||||||||||||||||||||||||||||
Borrowings related to securitization entities (1) | 75 | — | — | 75 | |||||||||||||||||||||||||||||||||||||||||
Total liabilities | $ | 1,017 | $ | — | $ | 670 | $ | 347 | |||||||||||||||||||||||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||||||||||||||||||||||
(3) | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||||||||||||||||||||||
We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers between levels at the beginning fair value for the reporting period in which the changes occur. Given the types of assets classified as Level 1, which primarily represents mutual fund investments, we typically do not have any transfers between Level 1 and Level 2 measurement categories and did not have any such transfers during any period presented. | |||||||||||||||||||||||||||||||||||||||||||||
Our assessment of whether or not there were significant unobservable inputs related to fixed maturity securities was based on our observations obtained through the course of managing our investment portfolio, including interaction with other market participants, observations related to the availability and consistency of pricing and/or rating, and understanding of general market activity such as new issuance and the level of secondary market trading for a class of securities. Additionally, we considered data obtained from third-party pricing sources to determine whether our estimated values incorporate significant unobservable inputs that would result in the valuation being classified as Level 3. | |||||||||||||||||||||||||||||||||||||||||||||
The following tables present additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of or for the dates indicated: | |||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Total realized and | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total gains | |||||||||||||||||||||||||||||||||||
balance | unrealized gains | into | out of | balance | (losses) | ||||||||||||||||||||||||||||||||||||||||
as of | (losses) | Level 3 | Level 3 | as of | included in | ||||||||||||||||||||||||||||||||||||||||
January 1, | December 31, | net income | |||||||||||||||||||||||||||||||||||||||||||
2014 | 2014 | (loss) | |||||||||||||||||||||||||||||||||||||||||||
attributable | |||||||||||||||||||||||||||||||||||||||||||||
to assets | |||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
income | |||||||||||||||||||||||||||||||||||||||||||||
(loss) | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 5 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | (1 | ) | $ | — | $ | — | $ | 4 | $ | — | ||||||||||||||||||||||
Government—non-U.S. | 23 | — | — | 3 | — | — | (2 | ) | — | (17 | ) | 7 | — | ||||||||||||||||||||||||||||||||
U.S. corporate (1) | 2,400 | 27 | 57 | 211 | (60 | ) | — | (253 | ) | 272 | (206 | ) | 2,448 | 12 | |||||||||||||||||||||||||||||||
Corporate—non-U.S. | 1,819 | 4 | 9 | 282 | (123 | ) | — | (222 | ) | 97 | (61 | ) | 1,805 | 2 | |||||||||||||||||||||||||||||||
Residential mortgage-backed | 105 | — | (3 | ) | 16 | (23 | ) | — | (13 | ) | 24 | (31 | ) | 75 | — | ||||||||||||||||||||||||||||||
Commercial mortgage-backed | 6 | — | 2 | — | — | — | (2 | ) | 7 | (8 | ) | 5 | — | ||||||||||||||||||||||||||||||||
Other asset-backed (1) | 1,166 | 5 | (3 | ) | 298 | (15 | ) | — | (181 | ) | 244 | (94 | ) | 1,420 | 1 | ||||||||||||||||||||||||||||||
Total fixed maturity securities | 5,524 | 36 | 62 | 810 | (221 | ) | — | (674 | ) | 644 | (417 | ) | 5,764 | 15 | |||||||||||||||||||||||||||||||
Equity securities | 78 | — | — | 1 | (38 | ) | — | — | — | (7 | ) | 34 | — | ||||||||||||||||||||||||||||||||
Other invested assets: | |||||||||||||||||||||||||||||||||||||||||||||
Trading securities | 34 | — | — | — | — | — | (3 | ) | — | (31 | ) | — | — | ||||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps | 10 | — | — | — | — | — | (7 | ) | — | — | 3 | — | |||||||||||||||||||||||||||||||||
Equity index options | 12 | (31 | ) | — | 36 | — | — | — | — | — | 17 | (28 | ) | ||||||||||||||||||||||||||||||||
Other foreign currency contracts | 3 | (2 | ) | — | — | (1 | ) | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Total derivative assets | 25 | (33 | ) | — | 36 | (1 | ) | — | (7 | ) | — | — | 20 | (28 | ) | ||||||||||||||||||||||||||||||
Total other invested assets | 59 | (33 | ) | — | 36 | (1 | ) | — | (10 | ) | — | (31 | ) | 20 | (28 | ) | |||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (2) | 211 | 19 | — | — | — | — | — | — | — | 230 | 18 | ||||||||||||||||||||||||||||||||||
Reinsurance recoverable (3) | (1 | ) | 11 | — | — | — | 3 | — | — | — | 13 | 11 | |||||||||||||||||||||||||||||||||
Total Level 3 assets | $ | 5,871 | $ | 33 | $ | 62 | $ | 847 | $ | (260 | ) | $ | 3 | $ | (684 | ) | $ | 644 | $ | (455 | ) | $ | 6,061 | $ | 16 | ||||||||||||||||||||
(1) | The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(3) | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Total realized and | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total gains | |||||||||||||||||||||||||||||||||||
balance | unrealized gains | into | out of | balance | (losses) | ||||||||||||||||||||||||||||||||||||||||
as of | (losses) | Level 3 | Level 3 | as of | included in | ||||||||||||||||||||||||||||||||||||||||
January 1, | December 31, | net income | |||||||||||||||||||||||||||||||||||||||||||
2013 | 2013 | (loss) | |||||||||||||||||||||||||||||||||||||||||||
attributable | |||||||||||||||||||||||||||||||||||||||||||||
to assets | |||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
income | |||||||||||||||||||||||||||||||||||||||||||||
(loss) | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 9 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | (4 | ) | $ | — | $ | — | $ | 5 | $ | — | ||||||||||||||||||||||
Government—non-U.S. | 9 | — | 1 | — | — | — | (3 | ) | 16 | — | 23 | — | |||||||||||||||||||||||||||||||||
U.S. corporate (1) | 2,683 | 18 | (15 | ) | 178 | (151 | ) | — | (349 | ) | 195 | (159 | ) | 2,400 | 13 | ||||||||||||||||||||||||||||||
Corporate—non-U.S. (1) | 1,983 | 4 | (24 | ) | 120 | (33 | ) | — | (220 | ) | 76 | (87 | ) | 1,819 | 2 | ||||||||||||||||||||||||||||||
Residential mortgage-backed | 157 | (9 | ) | 7 | — | (8 | ) | — | (29 | ) | 14 | (27 | ) | 105 | — | ||||||||||||||||||||||||||||||
Commercial mortgage-backed | 35 | (5 | ) | (1 | ) | — | — | — | (32 | ) | 11 | (2 | ) | 6 | (4 | ) | |||||||||||||||||||||||||||||
Other asset-backed (1) | 864 | 4 | 10 | 200 | (49 | ) | — | (89 | ) | 246 | (20 | ) | 1,166 | 4 | |||||||||||||||||||||||||||||||
Total fixed maturity securities | 5,740 | 12 | (22 | ) | 498 | (241 | ) | — | (726 | ) | 558 | (295 | ) | 5,524 | 15 | ||||||||||||||||||||||||||||||
Equity securities | 99 | 2 | — | 1 | (24 | ) | — | — | — | — | 78 | — | |||||||||||||||||||||||||||||||||
Other invested assets: | |||||||||||||||||||||||||||||||||||||||||||||
Trading securities | 76 | 7 | — | — | (40 | ) | — | (9 | ) | — | — | 34 | 2 | ||||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 2 | (1 | ) | — | — | — | — | (1 | ) | — | — | — | (1 | ) | |||||||||||||||||||||||||||||||
Credit default swaps | 7 | 12 | — | — | — | — | (9 | ) | — | — | 10 | 6 | |||||||||||||||||||||||||||||||||
Equity index options | 25 | (43 | ) | — | 39 | — | — | (9 | ) | — | — | 12 | (40 | ) | |||||||||||||||||||||||||||||||
Other foreign currency contracts | — | (1 | ) | — | 4 | — | — | — | — | — | 3 | (1 | ) | ||||||||||||||||||||||||||||||||
Total derivative assets | 34 | (33 | ) | — | 43 | — | — | (19 | ) | — | — | 25 | (36 | ) | |||||||||||||||||||||||||||||||
Total other invested assets | 110 | (26 | ) | — | 43 | (40 | ) | — | (28 | ) | — | — | 59 | (34 | ) | ||||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (2) | 194 | (1 | ) | — | 19 | — | — | (20 | ) | 19 | — | 211 | (1 | ) | |||||||||||||||||||||||||||||||
Other assets (3) | 9 | — | — | — | — | — | (9 | ) | — | — | — | — | |||||||||||||||||||||||||||||||||
Reinsurance recoverable (4) | 10 | (14 | ) | — | — | — | 3 | — | — | — | (1 | ) | (14 | ) | |||||||||||||||||||||||||||||||
Total Level 3 assets | $ | 6,162 | $ | (27 | ) | $ | (22 | ) | $ | 561 | $ | (305 | ) | $ | 3 | $ | (783 | ) | $ | 577 | $ | (295 | ) | $ | 5,871 | $ | (34 | ) | |||||||||||||||||
(1) | The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(3) | Represents contingent receivables associated with recent business dispositions. | ||||||||||||||||||||||||||||||||||||||||||||
(4) | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Total realized and | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total gains | |||||||||||||||||||||||||||||||||||
balance | unrealized gains | into | out of | balance | (losses) | ||||||||||||||||||||||||||||||||||||||||
as of | (losses) | Level 3 | Level 3 | as of | included in | ||||||||||||||||||||||||||||||||||||||||
January 1, | December 31, | net income | |||||||||||||||||||||||||||||||||||||||||||
2012 | 2012 | (loss) | |||||||||||||||||||||||||||||||||||||||||||
attributable | |||||||||||||||||||||||||||||||||||||||||||||
to assets | |||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
income | |||||||||||||||||||||||||||||||||||||||||||||
(loss) | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 13 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 9 | $ | (13 | ) | $ | 9 | $ | — | ||||||||||||||||||||||
Government—non-U.S. | 10 | — | — | — | — | — | (1 | ) | — | — | 9 | — | |||||||||||||||||||||||||||||||||
U.S. corporate (1) | 2,511 | 12 | 118 | 147 | (122 | ) | — | (214 | ) | 726 | (495 | ) | 2,683 | 14 | |||||||||||||||||||||||||||||||
Corporate—non-U.S. (1) | 1,284 | 3 | 92 | 269 | (29 | ) | — | (186 | ) | 711 | (161 | ) | 1,983 | 2 | |||||||||||||||||||||||||||||||
Residential mortgage-backed (1) | 95 | (7 | ) | 14 | 20 | (17 | ) | — | (31 | ) | 86 | (3 | ) | 157 | (7 | ) | |||||||||||||||||||||||||||||
Commercial mortgage-backed | 39 | (2 | ) | 5 | — | (1 | ) | — | (2 | ) | 3 | (7 | ) | 35 | (1 | ) | |||||||||||||||||||||||||||||
Other asset-backed (1) | 271 | (2 | ) | 45 | 350 | (46 | ) | — | (94 | ) | 369 | (29 | ) | 864 | 2 | ||||||||||||||||||||||||||||||
Total fixed maturity securities | 4,223 | 4 | 274 | 786 | (215 | ) | — | (528 | ) | 1,904 | (708 | ) | 5,740 | 10 | |||||||||||||||||||||||||||||||
Equity securities | 98 | 1 | (2 | ) | 10 | (8 | ) | — | — | — | — | 99 | — | ||||||||||||||||||||||||||||||||
Other invested assets: | |||||||||||||||||||||||||||||||||||||||||||||
Trading securities | 264 | 13 | — | 24 | (72 | ) | — | (125 | ) | 4 | (32 | ) | 76 | 15 | |||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 5 | — | — | — | — | — | (3 | ) | — | — | 2 | — | |||||||||||||||||||||||||||||||||
Credit default swaps | — | 12 | — | — | — | — | (5 | ) | — | — | 7 | 12 | |||||||||||||||||||||||||||||||||
Equity index options | 39 | (59 | ) | — | 55 | — | — | (10 | ) | — | — | 25 | (42 | ) | |||||||||||||||||||||||||||||||
Other foreign currency contracts | 9 | (11 | ) | — | 3 | — | — | (1 | ) | — | — | — | (11 | ) | |||||||||||||||||||||||||||||||
Total derivative assets | 53 | (58 | ) | — | 58 | — | — | (19 | ) | — | — | 34 | (41 | ) | |||||||||||||||||||||||||||||||
Total other invested assets | 317 | (45 | ) | — | 82 | (72 | ) | — | (144 | ) | 4 | (32 | ) | 110 | (26 | ) | |||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (2) | 176 | 18 | — | 100 | (100 | ) | — | — | — | — | 194 | 13 | |||||||||||||||||||||||||||||||||
Other assets (3) | — | (7 | ) | — | — | — | 16 | — | — | — | 9 | (7 | ) | ||||||||||||||||||||||||||||||||
Reinsurance recoverable (4) | 16 | (9 | ) | — | — | — | 3 | — | — | — | 10 | (9 | ) | ||||||||||||||||||||||||||||||||
Total Level 3 assets | $ | 4,830 | $ | (38 | ) | $ | 272 | $ | 978 | $ | (395 | ) | $ | 19 | $ | (672 | ) | $ | 1,908 | $ | (740 | ) | $ | 6,162 | $ | (19 | ) | ||||||||||||||||||
(1) | The transfers into and out of Level 3 were primarily related to private fixed rate U.S. corporate and private fixed rate corporate—non-U.S. securities and resulted from a change in the observability of the additional premium to the public bond spread to adjust for the liquidity and other features of our private placements and resulted in unobservable inputs having a significant impact on certain valuations for transfers in or no longer having significant impact on certain valuations for transfers out. During the second quarter of 2012, we began classifying private securities without an external rating as Level 3, which resulted in a significant number of securities being transferred into Level 3. The transfers into Level 3 for structured securities primarily related to securities that were recently purchased and initially classified as Level 2 based on market data that existed at the time of purchase and subsequent valuation included significant unobservable inputs. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(3) | Represents contingent receivables associated with recent business dispositions. | ||||||||||||||||||||||||||||||||||||||||||||
(4) | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||||||||||||||||||||||
The following table presents the gains and losses included in net income (loss) from assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: | |||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||||||||||
Total realized and unrealized gains (losses) included in net income (loss): | |||||||||||||||||||||||||||||||||||||||||||||
Net investment income | $ | 43 | $ | 35 | $ | 32 | |||||||||||||||||||||||||||||||||||||||
Net investment gains (losses) | (10 | ) | (62 | ) | (70 | ) | |||||||||||||||||||||||||||||||||||||||
Total | $ | 33 | $ | (27 | ) | $ | (38 | ) | |||||||||||||||||||||||||||||||||||||
Total gains (losses) included in net income (loss) attributable to assets still held: | |||||||||||||||||||||||||||||||||||||||||||||
Net investment income | $ | 19 | $ | 33 | $ | 25 | |||||||||||||||||||||||||||||||||||||||
Net investment gains (losses) | (3 | ) | (67 | ) | (44 | ) | |||||||||||||||||||||||||||||||||||||||
Total | $ | 16 | $ | (34 | ) | $ | (19 | ) | |||||||||||||||||||||||||||||||||||||
The amount presented for unrealized gains (losses) included in net income (loss) for available-for-sale securities represents impairments and accretion on certain fixed maturity securities. | |||||||||||||||||||||||||||||||||||||||||||||
The following tables present additional information about liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of or for the dates indicated: | |||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Total realized and | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total (gains) | |||||||||||||||||||||||||||||||||||
balance | unrealized (gains) | into | out of | balance | losses | ||||||||||||||||||||||||||||||||||||||||
as of | losses | Level 3 | Level 3 | as of | included in | ||||||||||||||||||||||||||||||||||||||||
January 1, | December 31, | net (income) | |||||||||||||||||||||||||||||||||||||||||||
2014 | 2014 | loss | |||||||||||||||||||||||||||||||||||||||||||
attributable | |||||||||||||||||||||||||||||||||||||||||||||
to liabilities | |||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
(income) | |||||||||||||||||||||||||||||||||||||||||||||
loss | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) | $ | 96 | $ | 158 | $ | — | $ | — | $ | — | $ | 37 | $ | — | $ | — | $ | — | $ | 291 | $ | 160 | |||||||||||||||||||||||
Fixed index annuity embedded derivatives | 143 | 27 | — | — | — | 108 | (2 | ) | — | — | 276 | 27 | |||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives | — | 1 | — | — | — | 6 | — | — | — | 7 | 1 | ||||||||||||||||||||||||||||||||||
Total policyholder account balances | 239 | 186 | — | — | — | 151 | (2 | ) | — | — | 574 | 188 | |||||||||||||||||||||||||||||||||
Derivative liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities (2) | 32 | (19 | ) | — | 4 | — | — | — | — | — | 17 | (19 | ) | ||||||||||||||||||||||||||||||||
Other foreign currency contracts | 1 | 1 | — | — | (2 | ) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Total derivative liabilities | 33 | (18 | ) | — | 4 | (2 | ) | — | — | — | — | 17 | (19 | ) | |||||||||||||||||||||||||||||||
Borrowings related to securitization entities (2) | 75 | 9 | — | — | — | 1 | — | — | — | 85 | 9 | ||||||||||||||||||||||||||||||||||
Total Level 3 liabilities | $ | 347 | $ | 177 | $ | — | $ | 4 | $ | (2 | ) | $ | 152 | $ | (2 | ) | $ | — | $ | — | $ | 676 | $ | 178 | |||||||||||||||||||||
(1) | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total | ||||||||||||||||||||||||||||||||||||
balance | Total realized and | into | out of | balance | (gains) | ||||||||||||||||||||||||||||||||||||||||
as of | unrealized (gains) | Level 3 | Level 3 | as of | losses | ||||||||||||||||||||||||||||||||||||||||
January 1, | losses | December 31, | included in | ||||||||||||||||||||||||||||||||||||||||||
2013 | 2013 | net | |||||||||||||||||||||||||||||||||||||||||||
(income) | |||||||||||||||||||||||||||||||||||||||||||||
loss | |||||||||||||||||||||||||||||||||||||||||||||
attributable | |||||||||||||||||||||||||||||||||||||||||||||
to liabilities | |||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
(income) | |||||||||||||||||||||||||||||||||||||||||||||
loss | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) | $ | 350 | $ | (291 | ) | $ | — | $ | — | $ | — | $ | 37 | $ | — | $ | — | $ | — | $ | 96 | $ | (289 | ) | |||||||||||||||||||||
Fixed index annuity embedded derivatives | 27 | 18 | — | — | — | 98 | — | — | — | 143 | 18 | ||||||||||||||||||||||||||||||||||
Total policyholder account balances | 377 | (273 | ) | — | — | — | 135 | — | — | — | 239 | (271 | ) | ||||||||||||||||||||||||||||||||
Derivative liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps | 1 | (1 | ) | — | — | — | — | — | — | — | — | (1 | ) | ||||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities (2) | 104 | (77 | ) | — | 5 | — | — | — | — | — | 32 | (77 | ) | ||||||||||||||||||||||||||||||||
Equity index options | — | 1 | — | — | — | — | (1 | ) | — | — | — | 1 | |||||||||||||||||||||||||||||||||
Other foreign currency contracts | — | (2 | ) | — | 3 | — | — | — | — | — | 1 | (2 | ) | ||||||||||||||||||||||||||||||||
Total derivative liabilities | 105 | (79 | ) | — | 8 | — | — | (1 | ) | — | — | 33 | (79 | ) | |||||||||||||||||||||||||||||||
Borrowings related to securitization entities (2) | 62 | 13 | — | — | — | — | — | — | — | 75 | 13 | ||||||||||||||||||||||||||||||||||
Total Level 3 liabilities | $ | 544 | $ | (339 | ) | $ | — | $ | 8 | $ | — | $ | 135 | $ | (1 | ) | $ | — | $ | — | $ | 347 | $ | (337 | ) | ||||||||||||||||||||
(1) | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total | ||||||||||||||||||||||||||||||||||||
balance | into | out of | balance as of | (gains) | |||||||||||||||||||||||||||||||||||||||||
as of | Level 3 | Level 3 | December 31, | losses | |||||||||||||||||||||||||||||||||||||||||
January 1, | 2012 | included in | |||||||||||||||||||||||||||||||||||||||||||
2012 | net | ||||||||||||||||||||||||||||||||||||||||||||
(income) | |||||||||||||||||||||||||||||||||||||||||||||
Total realized | loss | ||||||||||||||||||||||||||||||||||||||||||||
and unrealized | attributable | ||||||||||||||||||||||||||||||||||||||||||||
(gains) losses | to liabilities | ||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
(income) | |||||||||||||||||||||||||||||||||||||||||||||
loss | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) | $ | 492 | $ | (179 | ) | $ | — | $ | — | $ | — | $ | 37 | $ | — | $ | — | $ | — | $ | 350 | $ | (175 | ) | |||||||||||||||||||||
Fixed index annuity embedded derivatives | 4 | 1 | — | — | — | 22 | — | — | — | 27 | 1 | ||||||||||||||||||||||||||||||||||
Total policyholder account balances | 496 | (178 | ) | — | — | — | 59 | — | — | — | 377 | (174 | ) | ||||||||||||||||||||||||||||||||
Derivative liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps | 57 | (43 | ) | — | 2 | — | — | (15 | ) | — | — | 1 | (40 | ) | |||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities (2) | 177 | (76 | ) | — | 3 | — | — | — | — | — | 104 | (76 | ) | ||||||||||||||||||||||||||||||||
Total derivative liabilities | 234 | (119 | ) | — | 5 | — | — | (15 | ) | — | — | 105 | (116 | ) | |||||||||||||||||||||||||||||||
Borrowings related to securitization entities (2) | 48 | 14 | — | — | — | — | — | — | — | 62 | 14 | ||||||||||||||||||||||||||||||||||
Total Level 3 liabilities | $ | 778 | $ | (283 | ) | $ | — | $ | 5 | $ | — | $ | 59 | $ | (15 | ) | $ | — | $ | — | $ | 544 | $ | (276 | ) | ||||||||||||||||||||
(1) | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
The following table presents the gains and losses included in net (income) loss from liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: | |||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||||||||||
Total realized and unrealized (gains) losses included in net (income) loss: | |||||||||||||||||||||||||||||||||||||||||||||
Net investment income | $ | — | $ | — | $ | — | |||||||||||||||||||||||||||||||||||||||
Net investment (gains) losses | 177 | (339 | ) | (283 | ) | ||||||||||||||||||||||||||||||||||||||||
Total | $ | 177 | $ | (339 | ) | $ | (283 | ) | |||||||||||||||||||||||||||||||||||||
Total (gains) losses included in net (income) loss attributable to liabilities still held: | |||||||||||||||||||||||||||||||||||||||||||||
Net investment income | $ | — | $ | — | $ | — | |||||||||||||||||||||||||||||||||||||||
Net investment (gains) losses | 178 | (337 | ) | (276 | ) | ||||||||||||||||||||||||||||||||||||||||
Total | $ | 178 | $ | (337 | ) | $ | (276 | ) | |||||||||||||||||||||||||||||||||||||
Purchases, sales, issuances and settlements represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases, sales and settlements of fixed maturity, equity and trading securities and purchases, issuances and settlements of derivative instruments. | |||||||||||||||||||||||||||||||||||||||||||||
Issuances presented for GMWB embedded derivative liabilities are characterized as the change in fair value associated with the product fees recognized that are attributed to the embedded derivative to equal the expected future benefit costs upon issuance. Issuances for fixed index annuity and indexed universal life embedded derivative liabilities represent the amount of the premium received that is attributed to the value of the embedded derivative. Settlements of embedded derivatives are characterized as the change in fair value upon exercising the embedded derivative instrument, effectively representing a settlement of the embedded derivative instrument. We have shown these changes in fair value separately based on the classification of this activity as effectively issuing and settling the embedded derivative instrument with all remaining changes in the fair value of these embedded derivative instruments being shown separately in the category labeled “included in net (income) loss” in the tables presented above. | |||||||||||||||||||||||||||||||||||||||||||||
Certain classes of instruments classified as Level 3 are excluded below as a result of not being material or due to limitations in being able to obtain the underlying inputs used by certain third-party sources, such as broker quotes, used as an input in determining fair value. The following table presents a summary of the significant unobservable inputs used for certain fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2014: | |||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Valuation technique | Fair value | Unobservable input | Range | |||||||||||||||||||||||||||||||||||||||||
(weighted-average) | |||||||||||||||||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. corporate | Internal models | $ | 2,234 | Credit spreads | 76bps -463bps (197bps) | ||||||||||||||||||||||||||||||||||||||||
Corporate—non-U.S. | Internal models | 1,588 | Credit spreads | 81bps - 808bps (178bps) | |||||||||||||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps (1) | Discounted cash flows | 3 | Credit spreads | —bps - 25bps (7bps) | |||||||||||||||||||||||||||||||||||||||||
Equity index options | Discounted cash flows | 17 | Equity index volatility | 14% - 23% (20%) | |||||||||||||||||||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
Withdrawal utilization rate | — % - 98% | ||||||||||||||||||||||||||||||||||||||||||||
Lapse rate | — % - 15% | ||||||||||||||||||||||||||||||||||||||||||||
Non-performance risk (credit spreads) | 40bps - 85bps (70bps) | ||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (2) | Stochastic cash flow model | 291 | Equity index volatility | 17% - 24% (21%) | |||||||||||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives | Option budget method | 276 | Expected future | — % - 3% (2%) | |||||||||||||||||||||||||||||||||||||||||
interest credited | |||||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives | Option budget method | 7 | Expected future | 3% - 9% (6%) | |||||||||||||||||||||||||||||||||||||||||
interest credited | |||||||||||||||||||||||||||||||||||||||||||||
(1) | Unobservable input valuation based on the current market credit default swap premium. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Variable_Interest_and_Securiti
Variable Interest and Securitization Entities | 12 Months Ended | ||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||
Variable Interest and Securitization Entities | (18) Variable Interest and Securitization Entities | ||||||||||||||||
VIEs are generally entities that have either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support or whose equity investors lack the characteristics of a controlling financial interest. We evaluate VIEs to determine whether we are the primary beneficiary and are required to consolidate the assets and liabilities of the entity. The determination of the primary beneficiary for a VIE can be complex and requires management judgment regarding the expected results of the entity and who directs the activities of the entity that most significantly impact the economic results of the VIE. | |||||||||||||||||
(a) Asset Securitizations | |||||||||||||||||
We have used former affiliates and third-party entities to facilitate asset securitizations. Disclosure requirements related to off-balance sheet arrangements encompass a broader array of arrangements than those at risk for consolidation. These arrangements include transactions with term securitization entities, as well as transactions with conduits that are sponsored by third parties. | |||||||||||||||||
The following table summarizes the total securitized assets as of December 31: | |||||||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||||||
Receivables secured by: | |||||||||||||||||
Other assets | $ | 142 | $ | 147 | |||||||||||||
Total securitized assets not required to be consolidated | 142 | 147 | |||||||||||||||
Total securitized assets required to be consolidated | 300 | 314 | |||||||||||||||
Total securitized assets | $ | 442 | $ | 461 | |||||||||||||
We do not have any additional exposure or guarantees associated with these securitization entities. | |||||||||||||||||
There has been no new asset securitization activity in 2014 or 2013. | |||||||||||||||||
(b) Securitization and Variable Interest Entities Required To Be Consolidated | |||||||||||||||||
For VIEs related to asset securitization transactions, we consolidate two securitization entities as a result of our involvement in the entities’ design or having certain decision making ability regarding the assets held by the securitization entity. These securitization entities were designed to have significant limitations on the types of assets owned and the types and extent of permitted activities and decision making rights. The two securitization entities that are consolidated comprise one securitization entity backed by commercial mortgage loans and one backed by residual interests in certain policy loan securitization entities. | |||||||||||||||||
For the commercial mortgage loan securitization entity, our primary economic interest represents the excess interest of the commercial mortgage loans and the subordinated notes of the securitization entity. | |||||||||||||||||
Our primary economic interest in the policy loan securitization entity represents the excess interest received from the residual interest in certain policy loan securitization entities and the floating rate obligation issued by the securitization entity, where our economic interest is not expected to be material in any future years. Upon consolidation, we elected fair value option for the assets and liabilities for the securitization entity. | |||||||||||||||||
For VIEs related to certain investments, we were required to consolidate three securitization entities as a result of having certain decision making rights related to instruments held by the entities. Upon consolidation, we elected fair value option for the assets and liabilities for the securitization entity. | |||||||||||||||||
The following table shows the assets and liabilities that were recorded for the consolidated securitization entities as of December 31: | |||||||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||||||
Assets | |||||||||||||||||
Investments: | |||||||||||||||||
Restricted commercial mortgage loans | $ | 201 | $ | 233 | |||||||||||||
Restricted other invested assets: | |||||||||||||||||
Trading securities | 411 | 391 | |||||||||||||||
Total restricted other invested assets | 411 | 391 | |||||||||||||||
Total investments | 612 | 624 | |||||||||||||||
Cash and cash equivalents | 1 | 1 | |||||||||||||||
Accrued investment income | 1 | 1 | |||||||||||||||
Total assets | $ | 614 | $ | 626 | |||||||||||||
Liabilities | |||||||||||||||||
Other liabilities: | |||||||||||||||||
Derivative liabilities | $ | 43 | $ | 48 | |||||||||||||
Other liabilities | 2 | 2 | |||||||||||||||
Total other liabilities | 45 | 50 | |||||||||||||||
Borrowings related to securitization entities | 219 | 242 | |||||||||||||||
Total liabilities | $ | 264 | $ | 292 | |||||||||||||
The assets and other instruments held by the securitization entities are restricted and can only be used to fulfill the obligations of the securitization entity. Additionally, the obligations of the securitization entities do not have any recourse to the general credit of any other consolidated subsidiaries. | |||||||||||||||||
The following table shows the activity presented in our consolidated statement of income related to the consolidated securitization entities for the years ended December 31: | |||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||
Revenues: | |||||||||||||||||
Net investment income: | |||||||||||||||||
Restricted commercial mortgage loans | $ | 14 | $ | 23 | $ | 29 | |||||||||||
Restricted other invested assets | 5 | 4 | 4 | ||||||||||||||
Total net investment income | 19 | 27 | 33 | ||||||||||||||
Net investment gains (losses): | |||||||||||||||||
Trading securities | 15 | (4 | ) | 23 | |||||||||||||
Derivatives | 10 | 86 | 72 | ||||||||||||||
Borrowings related to securitization entities recorded at fair value | (9 | ) | (13 | ) | (14 | ) | |||||||||||
Total net investment gains (losses) | 16 | 69 | 81 | ||||||||||||||
Other income | — | — | 1 | ||||||||||||||
Total revenues | 35 | 96 | 115 | ||||||||||||||
Expenses: | |||||||||||||||||
Interest expense | 10 | 16 | 21 | ||||||||||||||
Acquisition and operating expenses | — | — | 1 | ||||||||||||||
Total expenses | 10 | 16 | 22 | ||||||||||||||
Income before income taxes | 25 | 80 | 93 | ||||||||||||||
Provision for income taxes | 9 | 27 | 33 | ||||||||||||||
Net income | $ | 16 | $ | 53 | $ | 60 | |||||||||||
(c) Borrowings Related To Consolidated Securitization Entities | |||||||||||||||||
Borrowings related to securitization entities were as follows as of December 31: | |||||||||||||||||
2014 | 2013 | ||||||||||||||||
(Amounts in millions) | Principal | Carrying | Principal | Carrying | |||||||||||||
amount | value | amount | value | ||||||||||||||
GFCM LLC, due 2035, 5.2541% | $ | 21 | $ | 21 | $ | 54 | $ | 54 | |||||||||
GFCM LLC, due 2035, 5.7426% | 113 | 113 | 113 | 113 | |||||||||||||
Marvel Finance 2007-4 LLC, due 2017 (1), (2) | 12 | 12 | 12 | 12 | |||||||||||||
Genworth Special Purpose Five, LLC, due 2040 (1), (2) | NA | (3) | 73 | NA | (3) | 63 | |||||||||||
Total | $ | 146 | $ | 219 | $ | 179 | $ | 242 | |||||||||
(1) | Accrual of interest based on three-month LIBOR that resets every three months plus a fixed margin. | ||||||||||||||||
(2) | Carrying value represents fair value as a result of electing fair value option for these liabilities. | ||||||||||||||||
(3) | Principal amount not applicable. Notional balance was $115 million as of December 31, 2014 and 2013. | ||||||||||||||||
These borrowings are required to be paid down as principal is collected on the restricted investments held by the securitization entities and accordingly the repayment of these borrowings follows the maturity or prepayment, as permitted, of the restricted investments. |
Insurance_Subsidiary_Financial
Insurance Subsidiary Financial Information and Regulatory Matters | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Insurance Subsidiary Financial Information and Regulatory Matters | (19) Insurance Subsidiary Financial Information and Regulatory Matters | ||||||||||||
Dividends | |||||||||||||
Our insurance company subsidiaries are restricted by state and foreign laws and regulations as to the amount of dividends they may pay to their parent without regulatory approval in any year, the purpose of which is to protect affected insurance policyholders or contractholders, not stockholders. Any dividends in excess of limits are deemed “extraordinary” and require approval. Based on estimated statutory results as of December 31, 2014, in accordance with applicable dividend restrictions, our subsidiaries could pay dividends of approximately $0.5 billion to us in 2015 without obtaining regulatory approval, and the remaining net assets are considered restricted. While the $0.5 billion is unrestricted, we do not expect our insurance subsidiaries to pay dividends to us in 2015 at this level as they retain capital for growth and to meet capital requirements and desired thresholds. As of December 31, 2014, Genworth Financial’s and Genworth Holdings’ subsidiaries had restricted net assets of $14.4 billion and $14.5 billion, respectively. There are no regulatory restrictions on the ability of Genworth Financial to pay dividends. Our Board of Directors has suspended the payment of dividends on our common stock indefinitely. The declaration and payment of future dividends to holders of our common stock will be at the discretion of our Board of Directors and will be dependent on many factors including the receipt of dividends from our operating subsidiaries, our financial condition and operating results, the capital requirements of our subsidiaries, legal requirements, regulatory constraints, our credit and financial strength ratings and such other factors as the Board of Directors deems relevant. | |||||||||||||
Our domestic insurance subsidiaries paid dividends of $108 million (none of which were deemed “extraordinary”), $418 million (none of which were deemed “extraordinary”) and $374 million ($175 million of which were deemed “extraordinary”) during 2014, 2013 and 2012, respectively. Our international insurance subsidiaries paid dividends of $630 million, $317 million and $240 million during 2014, 2013 and 2012, respectively. | |||||||||||||
U.S. domiciled insurance subsidiaries—statutory financial information | |||||||||||||
Our U.S. domiciled insurance subsidiaries file financial statements with state insurance regulatory authorities and the NAIC that are prepared on an accounting basis prescribed or permitted by such authorities. Statutory accounting practices differ from U.S. GAAP in several respects, causing differences in reported net income (loss) and stockholders’ equity. | |||||||||||||
Permitted statutory accounting practices encompass all accounting practices not so prescribed but that have been specifically allowed by state insurance authorities. Our U.S. domiciled insurance subsidiaries have no material permitted accounting practices, except for River Lake Insurance Company VI (“River Lake VI”), River Lake Insurance Company VII (“River Lake VII”), River Lake Insurance Company VIII (“River Lake VIII”), River Lake Insurance Company IX (“River Lake IX”), River Lake Insurance Company X ((“River Lake X”), together with River Lake VI, River Lake VII, River Lake VIII and River Lake IX, the “SPFCs”) and Genworth Life Insurance Company of New York (“GLICNY”). The permitted practices of the SPFCs were an essential element of their design and were expressly included in their plans of operation and in the licensing orders issued by their domiciliary state regulators and without those permitted practices, these entities could be subject to regulatory action. Accordingly, we believe that the permitted practices will remain in effect for so long as we maintain the SPFCs. The permitted practices were as follows: | |||||||||||||
• | River Lake IX and River Lake X were granted a permitted accounting practice from the state of Vermont to carry its excess of loss reinsurance agreement with Brookfield Life and Annuity Insurance Company, and Hannover Life Reassurance Company Of America, respectively, as an admitted asset. | ||||||||||||
• | River Lake VII and River Lake VIII were granted a permitted accounting practice from the state of Vermont to carry their reserves on a basis similar to U.S. GAAP. | ||||||||||||
• | River Lake VI was granted a permitted accounting practice from the State of Delaware to carry its excess of loss reinsurance agreement with The Canada Life Assurance Company as an admitted asset. | ||||||||||||
• | GLICNY received a permitted practice from New York to exempt certain of its investments from a NAIC structured security valuation and ratings process. | ||||||||||||
The impact of these permitted practices on our combined U.S. domiciled life insurance subsidiaries’ statutory capital and surplus was $365 million and $450 million as of December 31, 2014 and 2013, respectively. If they had not used a permitted practice, no regulatory event would have been triggered. | |||||||||||||
The tables below include the combined statutory net income (loss) and statutory capital and surplus for our U.S. domiciled insurance subsidiaries: | |||||||||||||
Years ended December 31, | |||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||
Combined statutory net income (loss): | |||||||||||||
Life insurance subsidiaries, excluding captive life reinsurance subsidiaries | $ | (179 | ) | $ | 359 | $ | 378 | ||||||
Mortgage insurance subsidiaries | 198 | 85 | (137 | ) | |||||||||
Combined statutory net income (loss), excluding captive reinsurance subsidiaries | 19 | 444 | 241 | ||||||||||
Captive life insurance subsidiaries | (281 | ) | (102 | ) | (478 | ) | |||||||
Combined statutory net income (loss) | $ | (262 | ) | $ | 342 | $ | (237 | ) | |||||
As of December 31, | |||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||
Combined statutory capital and surplus: | |||||||||||||
Life insurance subsidiaries, excluding captive life reinsurance subsidiaries | $ | 2,560 | $ | 2,777 | |||||||||
Mortgage insurance subsidiaries | 1,792 | 1,226 | |||||||||||
Combined statutory capital and surplus | $ | 4,352 | $ | 4,003 | |||||||||
The statutory net income (loss) from our captive life reinsurance subsidiaries relates to the reinsurance of term and universal life insurance statutory reserves assumed from our U.S. domiciled life insurance companies. These reserves are, in turn, funded through the issuance of surplus notes (non-recourse funding obligations) to third parties or secured by a third-party letter of credit or excess of loss reinsurance treaties with third parties. Accordingly, the life insurance subsidiaries’ combined statutory net income (loss) and distributable income (loss) are not affected by the statutory net income (loss) of the captives, except to the extent dividends are received from the captives. The combined statutory capital and surplus of our life insurance subsidiaries does not include the capital and surplus of our captive life reinsurance subsidiaries of $1,057 million and $1,101 million as of December 31, 2014 and 2013, respectively. Capital and surplus of our captive life reinsurance subsidiaries, excluding River Lake VI, River Lake VII, River Lake VIII, River Lake IX and River Lake X, include surplus notes (non-recourse funding obligations) as further described in note 13. | |||||||||||||
The NAIC has adopted RBC requirements to evaluate the adequacy of statutory capital and surplus in relation to risks associated with: (i) asset risk; (ii) insurance risk; (iii) interest rate and equity market risk; and (iv) business risk. The RBC formula is designated as an early warning tool for the states to identify possible undercapitalized companies for the purpose of initiating regulatory action. In the course of operations, we periodically monitor the RBC level of each of our life insurance subsidiaries. As of December 31, 2014 and 2013, each of our life insurance subsidiaries exceeded the minimum required RBC levels. The consolidated RBC ratio of our U.S. domiciled life insurance subsidiaries was approximately 435% and 485% of the company action level as of December 31, 2014 and 2013, respectively. | |||||||||||||
In 2012, the NAIC adopted revised statutory reserving requirements for new and in-force secondary guarantee universal life business subject to Actuarial Guideline 38 (more commonly known as “AG 38”) provisions, effective December 31, 2012. These requirements reflected an agreement reached and developed by a NAIC Joint Working Group which included regulators from several states, including New York. The financial impact related to the revised statutory reserving requirements on our in-force reserves subject to the new guidance was not significant as of December 31, 2012. On September 11, 2013, the New York Department of Financial Services (the “NYDFS”) announced that it no longer supported the agreement reached by the NAIC Working Group and that it would require New York licensed companies to use an alternative interpretation of AG 38 for universal life insurance products with secondary guarantees. In December 2014, we finalized our discussions with the NYDFS about its alternative interpretation and recorded $70 million and $80 million of additional statutory reserves as of December 31, 2014 and 2013, respectively. | |||||||||||||
In addition, as a result of our annual statutory cash flow testing of our long-term care insurance business in 2014, our New York insurance subsidiary recorded $39 million of additional statutory reserves in the fourth quarter of 2014 and will record an aggregate of $156 million of additional statutory reserves over the next four years. | |||||||||||||
For regulatory purposes, our U.S. mortgage insurance subsidiaries are required to maintain a statutory contingency reserve. Annual additions to the statutory contingency reserve must equal the greater of: (i) 50% of earned premiums or (ii) the required level of policyholders position, as defined by state insurance laws. These contingency reserves generally are held until the earlier of: (i) the time that loss ratios exceed 35% or (ii) 10 years. The statutory contingency reserves for our U.S. mortgage insurance subsidiaries were approximately $193 million and $59 million, respectively, as of December 31, 2014 and 2013 and, were included in the table above containing combined statutory capital and surplus balances. | |||||||||||||
Mortgage insurers are not subject to the NAIC’s RBC requirements but certain states and other regulators impose another form of capital requirement on mortgage insurers requiring maintenance of a risk-to-capital ratio not to exceed 25:1. Fifteen other states maintain similar risk-to-capital requirements. | |||||||||||||
As of December 31, 2014, GMICO’s risk-to-capital ratio under the current regulatory framework as established under North Carolina law and enforced by the North Carolina Department of Insurance (“NCDOI”), GMICO’s domestic insurance regulator, was approximately 14.3:1, compared with a risk-to-capital ratio of approximately 19.3:1 as of December 31, 2013. In December 2013, Genworth Holdings issued $400 million senior notes in anticipation of increased capital requirements expected to be imposed by the GSEs in connection with the revised private mortgage insurance eligibility requirements (“PMIERs”). Following the issuance of the senior notes in December 2013, Genworth Financial contributed $100 million of the proceeds to GMICO, our primary U.S. mortgage insurance subsidiary, and contributed $300 million to Genworth Mortgage Holdings, LLC, a U.S. mortgage insurance holding company. In May 2014, Genworth Mortgage Holdings, LLC contributed the $300 million to GMICO. | |||||||||||||
The NCDOI’s current regulatory framework by which GMICO’s risk-to-capital ratio is calculated differs from the capital requirement methodology that is in the revised draft PMIERs. GMICO’s ongoing risk-to-capital ratio will depend principally on the magnitude of future losses incurred by GMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, as well as the amount of policy lapses and the amount of additional capital that is generated within the business or capital support (if any) that we provide. Our estimate of the amount and timing of future losses and these foregoing factors are inherently uncertain, require significant judgment and may change significantly over time. | |||||||||||||
On July 10, 2014, the Federal Housing Finance Agency (the “FHFA”) released publicly a draft of the revised PMIERs. These requirements, as drafted, contemplate an effective date for compliance 180 days after the final publication date and final publication currently is anticipated to be towards the end of the first quarter or beginning of the second quarter of 2015. In addition, the requirements permit a transition period, subject to GSE approval, of two years from the publication date to meet the required capital levels. We provided comments on September 8, 2014 pursuant to the public request for input and we will continue to work with the FHFA and GSEs in an effort to have appropriate refinements made before the new requirements are finalized. | |||||||||||||
The amount of additional capital that we believe will be required to meet the Net Asset Requirements, as defined in the revised draft PMIERs, and operate our business is dependent upon, among other things, (i) the extent the final PMIERs as ultimately adopted differ materially from the current draft, including with respect to the amount and timing of additional capital requirements and the amount of capital credit provided to various types of assets; (ii) the way the requirements are applied and interpreted by the GSEs and FHFA as and after they are implemented; (iii) the future performance of the U.S. housing market; (iv) our generating and having expected U.S. mortgage insurance business earnings, available assets and risk-based required assets (including as they relate to the value of the shares of our Canadian mortgage insurance subsidiary that are owned by our U.S. mortgage insurance business as a result of share price and foreign exchange movements or otherwise), reducing risk in-force and reducing delinquencies as anticipated, and writing anticipated amounts and types of new U.S. mortgage insurance business; and (v) our projected overall financial performance, capital and liquidity levels being as anticipated. | |||||||||||||
We currently believe we have a variety of sources we could utilize to satisfy these capital requirements and currently intend to utilize primarily reinsurance (or similar) transactions, together with cash available at the holding company, to satisfy them. Our use of reinsurance or similar transactions depends upon, among other things, the availability of the markets for these transactions, the costs and other terms of reinsurance or the other transactions, the GSEs’ approach to, and the capital treatment for, these reinsurance or the other transactions, the performance of the U.S. mortgage insurance business, and the absence of unforeseen developments. Another potential capital source includes, but is not limited to, the issuance of securities by Genworth Financial or Genworth Holdings. | |||||||||||||
We currently intend that our U.S. mortgage insurance business will meet the additional capital requirements contained in the revised draft PMIERs by the anticipated effective date. We will seek to utilize the transition period provided for in the draft guidelines if we do not comply by the anticipated effective date (subject to GSE approval). | |||||||||||||
On January 31, 2013, our European mortgage insurance subsidiaries received a $21 million cash capital contribution. We then subsequently contributed the shares of our European mortgage insurance subsidiaries with an estimated value of $230 million to our U.S. mortgage insurance subsidiaries to increase the statutory capital in those companies. | |||||||||||||
International insurance subsidiaries—statutory financial information | |||||||||||||
Our international insurance subsidiaries also prepare financial statements in accordance with local regulatory requirements. As of December 31, 2014 and 2013, combined local statutory capital and surplus for our international insurance subsidiaries was $6,968 million and $8,248 million, respectively. Combined local statutory net income (loss) for our international insurance subsidiaries was $(65) million, $605 million and $1,190 million for the years ended December 31, 2014, 2013 and 2012, respectively. The regulatory authorities in these international jurisdictions generally establish supervisory solvency requirements. Our international insurance subsidiaries had combined surplus levels that exceeded local solvency requirements by $2,506 million and $3,435 million as of December 31, 2014 and 2013, respectively. | |||||||||||||
Our international insurance subsidiaries do not have any material accounting practices that differ from local regulatory requirements other than one of our insurance subsidiaries domiciled in Bermuda, which was granted approval from the Bermuda Monetary Authority to record a parental guarantee as statutory capital related to an internal reinsurance agreement. The amount recorded as statutory capital is equal to the excess of NAIC statutory reserves less the economic reserves up to the amount of the guarantee resulting in an increase in statutory capital of $205 million and $359 million as of December 31, 2014 and 2013, respectively. | |||||||||||||
Certain of our insurance subsidiaries have securities on deposit with various state or foreign government insurance departments in order to comply with relevant insurance regulations. See note 4(d) for additional information related to these deposits. Additionally, under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets in either separate portfolios or in trust for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. See note 9 for additional information related to these pledged assets under reinsurance agreements. Certain of our U.S. life insurance subsidiaries are also members of regional FHLBs and the FHLBs have been granted a lien on certain of our invested assets to collateralize our obligations. See note 10 for additional information related to these pledged assets with the FHLBs. | |||||||||||||
Guarantees of obligations | |||||||||||||
In addition to the guarantees discussed in notes 18 and 22, we have provided guarantees to third parties for the performance of certain obligations of our subsidiaries. We estimate that our potential obligations under such guarantees, other than the Rivermont I guarantee, were $28 million and $30 million as of December 31, 2014 and 2013, respectively. We provide a limited guarantee to Rivermont I, an indirect subsidiary, which is accounted for as a derivative carried at fair value and is eliminated in consolidation. As of December 31, 2014, the fair value of this derivative was $5 million. As of December 31, 2013, the fair value of this derivative was zero. We also provide an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our mortgage insurance subsidiary located in the United Kingdom. However, based on risk in-force as of December 31, 2014, we believe our U.K. mortgage insurance subsidiary has sufficient reserves and capital to cover its policyholder obligations. | |||||||||||||
Fifty percent of our in-force long-term care insurance business (excluding policies assumed from a non-affiliate third-party reinsurer) of GLIC, a Delaware insurance company and our indirect wholly-owned subsidiary, is reinsured to Brookfield Life and Annuity Insurance Company Limited (“BLAIC”), a Bermuda insurance company and our indirect wholly-owned subsidiary. Brookfield Life Assurance Company Limited (“Brookfield”), a Bermuda insurance company and our indirect wholly-owned subsidiary, has guaranteed BLAIC’s performance of its obligations under that reinsurance agreement. As of December 31, 2014, Brookfield directly or indirectly owns 66.2% of our Australian mortgage insurance subsidiaries, 40.6% of our Canadian mortgage insurance subsidiary and 100% of our lifestyle protection insurance business. As a result of Brookfield’s guarantee, adverse developments in our reinsured long-term care insurance business (including the recent increases in our reserves of that business) have adversely impacted BLAIC’s financial condition, which could, in turn, adversely impact Brookfield’s willingness or ability to pay dividends to Genworth Holdings. |
Segment_Information
Segment Information | 12 Months Ended | ||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||
Segment Information | (20) Segment Information | ||||||||||||||||||||||||||||
(a) Operating Segment Information | |||||||||||||||||||||||||||||
We operate through three divisions: U.S. Life Insurance, Global Mortgage Insurance and Corporate and Other. Under these divisions, there are five operating business segments. The U.S. Life Insurance Division includes the U.S. Life Insurance segment. The Global Mortgage Insurance Division includes the International Mortgage Insurance and U.S. Mortgage Insurance segments. The Corporate and Other Division includes the International Protection and Runoff segments and Corporate and Other activities. Our operating business segments are as follows: (1) U.S. Life Insurance, which includes our long-term care insurance, life insurance and fixed annuities businesses; (2) International Mortgage Insurance, which includes mortgage insurance-related products and services; (3) U.S. Mortgage Insurance, which includes mortgage insurance-related products and services; (4) International Protection, which includes our lifestyle protection insurance business; and (5) Runoff, which includes the results of non-strategic products which are no longer actively sold. Our non-strategic products primarily include our variable annuity, variable life insurance, institutional, corporate-owned life insurance and other accident and health insurance products. Institutional products consist of: funding agreements, FABNs and GICs. | |||||||||||||||||||||||||||||
We also have Corporate and Other activities which include debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are managed outside of our operating segments, including discontinued operations. | |||||||||||||||||||||||||||||
We use the same accounting policies and procedures to measure segment income (loss) and assets as our consolidated net income (loss) and assets. Our chief operating decision maker evaluates segment performance and allocates resources on the basis of “net operating income (loss).” We define net operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income attributable to noncontrolling interests, net investment gains (losses), goodwill impairments, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, gains (losses) on insurance block transactions and infrequent or unusual non-operating items. Gains (losses) on insurance block transactions are defined as gains (losses) on the early extinguishment of non-recourse funding obligations, early termination fees for other financing restructuring and/or resulting gains (losses) on reinsurance restructuring for certain blocks of business. We exclude net investment gains (losses) and infrequent or unusual non-operating items because we do not consider them to be related to the operating performance of our segments and Corporate and Other activities. A component of our net investment gains (losses) is the result of impairments, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. Goodwill impairments and gains (losses) on the sale of businesses, the early extinguishment of debt and insurance block transactions are also excluded from net operating income (loss) because in our opinion, they are not indicative of overall operating trends. Other non-operating items are also excluded from net operating income (loss) if, in our opinion, they are not indicative of overall operating trends. | |||||||||||||||||||||||||||||
In the fourth quarter of 2014, we recorded goodwill impairments of $129 million, net of taxes, in our long-term care insurance business and $145 million, net of taxes, in our life insurance business. In the third quarter of 2014, we recorded goodwill impairments of $167 million, net of taxes, in our long-term care insurance business and $350 million, net of taxes, in our life insurance business. We recorded a goodwill impairment of $86 million, net of taxes, related to our lifestyle protection insurance business in the third quarter of 2012. | |||||||||||||||||||||||||||||
The following transactions were excluded from net operating income (loss) for the periods presented as they related to the gain or loss on the early extinguishment of debt. In the second quarter of 2014, we paid an early redemption payment of approximately $2 million, net of taxes and portion attributable to noncontrolling interests, related to the early redemption of Genworth Canada’s notes that were scheduled to mature in 2015. In the third quarter of 2013, we paid a make-whole expense of approximately $20 million, net of taxes, related to the early redemption of Genworth Holdings’ 2015 Notes. In the fourth quarter of 2012, we repurchased principal of approximately $100 million of Genworth Holdings’ notes that were scheduled to mature in June 2014 for a loss of $4 million, net of taxes. In the fourth quarter of 2012, we also repurchased $20 million of non-recourse funding obligations resulting in a gain of approximately $3 million, net of taxes. | |||||||||||||||||||||||||||||
In the third quarter of 2012, we completed a life block transaction resulting in a loss of $6 million, net of taxes. In January 2012, we also completed a life block transaction resulting in a loss of approximately $41 million, net of taxes. | |||||||||||||||||||||||||||||
There were no infrequent or unusual items excluded from net operating income (loss) during the periods presented other than the following items. There was $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. Although no decisions have been made, we recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefit in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. Also, in the second quarter of 2013, we recorded a $13 million, net of taxes, expense related to restructuring costs. | |||||||||||||||||||||||||||||
While some of these items may be significant components of net income (loss) available to Genworth Financial, Inc.’s common stockholders in accordance with U.S. GAAP, we believe that net operating income (loss), and measures that are derived from or incorporate net operating income (loss), are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses net operating income (loss) as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from net operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Net operating income (loss) is not a substitute for net income (loss) available to Genworth Financial, Inc.’s common stockholders determined in accordance with U.S. GAAP. In addition, our definition of net operating income (loss) may differ from the definitions used by other companies. | |||||||||||||||||||||||||||||
Adjustments to reconcile net income attributable to Genworth Financial, Inc.’s common stockholders and net operating income assume a 35% tax rate and are net of the portion attributable to noncontrolling interests. Net investment gains (losses) are also adjusted for DAC and other intangible amortization and certain benefit reserves. | |||||||||||||||||||||||||||||
The following is a summary of our segments and Corporate and Other activities as of or for the years ended December 31: | |||||||||||||||||||||||||||||
2014 | U.S. Life | International | U.S. | International | Runoff | Corporate | Total | ||||||||||||||||||||||
Insurance | Mortgage | Mortgage | Protection | and Other | |||||||||||||||||||||||||
Insurance | Insurance | ||||||||||||||||||||||||||||
(Amounts in millions) | |||||||||||||||||||||||||||||
Premiums | $ | 3,169 | $ | 950 | $ | 578 | $ | 731 | $ | 3 | $ | — | $ | 5,431 | |||||||||||||||
Net investment income | 2,665 | 303 | 59 | 101 | 129 | (15 | ) | 3,242 | |||||||||||||||||||||
Net investment gains (losses) | 41 | 1 | — | — | (66 | ) | 4 | (20 | ) | ||||||||||||||||||||
Insurance and investment product fees and other | 712 | (14 | ) | 2 | 5 | 209 | (2 | ) | 912 | ||||||||||||||||||||
Total revenues | 6,587 | 1,240 | 639 | 837 | 275 | (13 | ) | 9,565 | |||||||||||||||||||||
Benefits and other changes in policy reserves | 5,820 | 204 | 357 | 202 | 37 | — | 6,620 | ||||||||||||||||||||||
Interest credited | 618 | — | — | — | 119 | — | 737 | ||||||||||||||||||||||
Acquisition and operating expenses, net of deferrals | 658 | 223 | 140 | 462 | 84 | 18 | 1,585 | ||||||||||||||||||||||
Amortization of deferred acquisition costs and intangibles | 345 | 59 | 7 | 118 | 39 | 3 | 571 | ||||||||||||||||||||||
Goodwill impairment | 849 | — | — | — | — | — | 849 | ||||||||||||||||||||||
Interest expense | 87 | 31 | — | 46 | 1 | 314 | 479 | ||||||||||||||||||||||
Total benefits and expenses | 8,377 | 517 | 504 | 828 | 280 | 335 | 10,841 | ||||||||||||||||||||||
Income (loss) from continuing operations before income taxes | (1,790 | ) | 723 | 135 | 9 | (5 | ) | (348 | ) | (1,276 | ) | ||||||||||||||||||
Provision (benefit) for income taxes | (385 | ) | 358 | 44 | (107 | ) | (19 | ) | (119 | ) | (228 | ) | |||||||||||||||||
Income (loss) from continuing operations | (1,405 | ) | 365 | 91 | 116 | 14 | (229 | ) | (1,048 | ) | |||||||||||||||||||
Income (loss) from discontinued operations, net of taxes | — | — | — | — | — | — | — | ||||||||||||||||||||||
Net income (loss) | (1,405 | ) | 365 | 91 | 116 | 14 | (229 | ) | (1,048 | ) | |||||||||||||||||||
Less: net income attributable to noncontrolling interests | — | 196 | — | — | — | — | 196 | ||||||||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (1,405 | ) | $ | 169 | $ | 91 | $ | 116 | $ | 14 | $ | (229 | ) | $ | (1,244 | ) | ||||||||||||
Total assets | $ | 82,906 | $ | 8,815 | $ | 2,324 | $ | 1,833 | $ | 12,971 | $ | 2,509 | $ | 111,358 | |||||||||||||||
International | U.S. | ||||||||||||||||||||||||||||
2013 | U.S. Life | Mortgage | Mortgage | International | Runoff | Corporate | Total | ||||||||||||||||||||||
Insurance | Insurance | Insurance | Protection | and Other | |||||||||||||||||||||||||
(Amounts in millions) | |||||||||||||||||||||||||||||
Premiums | $ | 2,957 | $ | 996 | $ | 554 | $ | 636 | $ | 5 | $ | — | $ | 5,148 | |||||||||||||||
Net investment income | 2,621 | 333 | 60 | 119 | 139 | (1 | ) | 3,271 | |||||||||||||||||||||
Net investment gains (losses) | (3 | ) | 32 | — | 27 | (58 | ) | (35 | ) | (37 | ) | ||||||||||||||||||
Insurance and investment product fees and other | 755 | — | 2 | 4 | 216 | 44 | 1,021 | ||||||||||||||||||||||
Total revenues | 6,330 | 1,361 | 616 | 786 | 302 | 8 | 9,403 | ||||||||||||||||||||||
Benefits and other changes in policy reserves | 3,975 | 317 | 412 | 159 | 32 | — | 4,895 | ||||||||||||||||||||||
Interest credited | 619 | — | — | — | 119 | — | 738 | ||||||||||||||||||||||
Acquisition and operating expenses, net of deferrals | 658 | 241 | 144 | 433 | 81 | 102 | 1,659 | ||||||||||||||||||||||
Amortization of deferred acquisition costs and intangibles | 384 | 60 | 6 | 106 | 6 | 7 | 569 | ||||||||||||||||||||||
Interest expense | 97 | 33 | — | 42 | 2 | 318 | 492 | ||||||||||||||||||||||
Total benefits and expenses | 5,733 | 651 | 562 | 740 | 240 | 427 | 8,353 | ||||||||||||||||||||||
Income (loss) from continuing operations before income taxes | 597 | 710 | 54 | 46 | 62 | (419 | ) | 1,050 | |||||||||||||||||||||
Provision (benefit) for income taxes | 213 | 184 | 17 | 7 | 13 | (110 | ) | 324 | |||||||||||||||||||||
Income (loss) from continuing operations | 384 | 526 | 37 | 39 | 49 | (309 | ) | 726 | |||||||||||||||||||||
Loss from discontinued operations, net of taxes | — | — | — | — | — | (12 | ) | (12 | ) | ||||||||||||||||||||
Net income (loss) | 384 | 526 | 37 | 39 | 49 | (321 | ) | 714 | |||||||||||||||||||||
Less: net income attributable to noncontrolling interests | — | 154 | — | — | — | — | 154 | ||||||||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | 384 | $ | 372 | $ | 37 | $ | 39 | $ | 49 | $ | (321 | ) | $ | 560 | ||||||||||||||
Total assets | $ | 77,261 | $ | 9,194 | $ | 2,361 | $ | 2,061 | $ | 14,062 | $ | 3,106 | $ | 108,045 | |||||||||||||||
International | U.S. | ||||||||||||||||||||||||||||
2012 | U.S. Life | Mortgage | Mortgage | International | Runoff | Corporate | Total | ||||||||||||||||||||||
Insurance | Insurance | Insurance | Protection | and Other | |||||||||||||||||||||||||
(Amounts in millions) | |||||||||||||||||||||||||||||
Premiums | $ | 2,789 | $ | 1,016 | $ | 549 | $ | 682 | $ | 5 | $ | — | $ | 5,041 | |||||||||||||||
Net investment income | 2,594 | 375 | 68 | 131 | 145 | 30 | 3,343 | ||||||||||||||||||||||
Net investment gains (losses) | (8 | ) | 16 | 36 | 6 | 24 | (47 | ) | 27 | ||||||||||||||||||||
Insurance and investment product fees and other | 875 | 1 | 23 | 3 | 207 | 120 | 1,229 | ||||||||||||||||||||||
Total revenues | 6,250 | 1,408 | 676 | 822 | 381 | 103 | 9,640 | ||||||||||||||||||||||
Benefits and other changes in policy reserves | 3,950 | 516 | 725 | 150 | 37 | — | 5,378 | ||||||||||||||||||||||
Interest credited | 643 | — | — | — | 132 | — | 775 | ||||||||||||||||||||||
Acquisition and operating expenses, net of deferrals | 677 | 55 | 143 | 483 | 79 | 157 | 1,594 | ||||||||||||||||||||||
Amortization of deferred acquisition costs and intangibles | 477 | 64 | 5 | 113 | 51 | 12 | 722 | ||||||||||||||||||||||
Goodwill impairment | — | — | — | 89 | — | — | 89 | ||||||||||||||||||||||
Interest expense | 86 | 36 | — | 45 | 1 | 308 | 476 | ||||||||||||||||||||||
Total benefits and expenses | 5,833 | 671 | 873 | 880 | 300 | 477 | 9,034 | ||||||||||||||||||||||
Income (loss) from continuing operations before income taxes | 417 | 737 | (197 | ) | (58 | ) | 81 | (374 | ) | 606 | |||||||||||||||||||
Provision (benefit) for income taxes | 143 | 188 | (83 | ) | 1 | 23 | (134 | ) | 138 | ||||||||||||||||||||
Income (loss) from continuing operations | 274 | 549 | (114 | ) | (59 | ) | 58 | (240 | ) | 468 | |||||||||||||||||||
Income from discontinued operations, net of taxes | — | — | — | — | — | 57 | 57 | ||||||||||||||||||||||
Net income (loss) | 274 | 549 | (114 | ) | (59 | ) | 58 | (183 | ) | 525 | |||||||||||||||||||
Less: net income attributable to noncontrolling interests | — | 200 | — | — | — | — | 200 | ||||||||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | 274 | $ | 349 | $ | (114 | ) | $ | (59 | ) | $ | 58 | $ | (183 | ) | $ | 325 | ||||||||||||
(b) Revenues of Major Product Groups | |||||||||||||||||||||||||||||
The following is a summary of revenues of major product groups for our segments and Corporate and Other activities for the years ended December 31: | |||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||||||
U.S. Life Insurance segment: | |||||||||||||||||||||||||||||
Long-term care insurance | $ | 3,523 | $ | 3,316 | $ | 3,207 | |||||||||||||||||||||||
Life insurance | 1,981 | 1,982 | 1,926 | ||||||||||||||||||||||||||
Fixed annuities | 1,083 | 1,032 | 1,117 | ||||||||||||||||||||||||||
U.S. Life Insurance segment’s revenues | 6,587 | 6,330 | 6,250 | ||||||||||||||||||||||||||
International Mortgage Insurance segment: | |||||||||||||||||||||||||||||
Canada | 669 | 760 | 786 | ||||||||||||||||||||||||||
Australia | 537 | 555 | 567 | ||||||||||||||||||||||||||
Other Countries | 34 | 46 | 55 | ||||||||||||||||||||||||||
International Mortgage Insurance segment’s revenues | 1,240 | 1,361 | 1,408 | ||||||||||||||||||||||||||
U.S. Mortgage Insurance segment’s revenues | 639 | 616 | 676 | ||||||||||||||||||||||||||
International Protection segment’s revenues | 837 | 786 | 822 | ||||||||||||||||||||||||||
Runoff segment’s revenues | 275 | 302 | 381 | ||||||||||||||||||||||||||
Corporate and Other’s revenues | (13 | ) | 8 | 103 | |||||||||||||||||||||||||
Total revenues | $ | 9,565 | $ | 9,403 | $ | 9,640 | |||||||||||||||||||||||
(c) Net Operating Income (Loss) | |||||||||||||||||||||||||||||
The following is a summary of net operating income (loss) for our segments and Corporate and Other activities for the years ended December 31: | |||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||
U.S. Life Insurance segment: | |||||||||||||||||||||||||||||
Long-term care insurance | $ | (815 | ) | $ | 129 | $ | 101 | ||||||||||||||||||||||
Life insurance | 74 | 173 | 151 | ||||||||||||||||||||||||||
Fixed annuities | 100 | 92 | 82 | ||||||||||||||||||||||||||
U.S. Life Insurance segment’s net operating income (loss) | (641 | ) | 394 | 334 | |||||||||||||||||||||||||
International Mortgage Insurance segment: | |||||||||||||||||||||||||||||
Canada | 170 | 170 | 234 | ||||||||||||||||||||||||||
Australia | 200 | 228 | 142 | ||||||||||||||||||||||||||
Other Countries | (25 | ) | (37 | ) | (34 | ) | |||||||||||||||||||||||
International Mortgage Insurance segment’s net operating income | 345 | 361 | 342 | ||||||||||||||||||||||||||
U.S. Mortgage Insurance segment’s net operating income (loss) | 91 | 37 | (138 | ) | |||||||||||||||||||||||||
International Protection segment’s net operating income | 8 | 24 | 24 | ||||||||||||||||||||||||||
Runoff segment’s net operating income | 48 | 66 | 46 | ||||||||||||||||||||||||||
Corporate and Other’s net operating loss | (232 | ) | (266 | ) | (205 | ) | |||||||||||||||||||||||
Net operating income (loss) | (381 | ) | 616 | 403 | |||||||||||||||||||||||||
Net investment gains (losses), net | (4 | ) | (11 | ) | (1 | ) | |||||||||||||||||||||||
Goodwill impairment, net | (791 | ) | — | (86 | ) | ||||||||||||||||||||||||
Gains (losses) on early extinguishment of debt, net | (2 | ) | (20 | ) | (1 | ) | |||||||||||||||||||||||
Gains (losses) from life block transactions, net | — | — | (47 | ) | |||||||||||||||||||||||||
Tax impact from potential business portfolio changes | (66 | ) | — | — | |||||||||||||||||||||||||
Expenses related to restructuring, net | — | (13 | ) | — | |||||||||||||||||||||||||
Income (loss) from discontinued operations, net of taxes | — | (12 | ) | 57 | |||||||||||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | (1,244 | ) | 560 | 325 | |||||||||||||||||||||||||
Add: net income attributable to noncontrolling interests | 196 | 154 | 200 | ||||||||||||||||||||||||||
Net income (loss) | $ | (1,048 | ) | $ | 714 | $ | 525 | ||||||||||||||||||||||
(d) Geographic Segment Information | |||||||||||||||||||||||||||||
We conduct our operations in the following geographic regions: (1) United States (2) Canada (3) Australia and (4) Other Countries. | |||||||||||||||||||||||||||||
The following is a summary of geographic region activity as of or for the years ended December 31: | |||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||
(Amounts in millions) | United States | Canada | Australia | Other | Total | ||||||||||||||||||||||||
Countries | |||||||||||||||||||||||||||||
Total revenues | $ | 7,488 | $ | 669 | $ | 537 | $ | 871 | $ | 9,565 | |||||||||||||||||||
Income (loss) from continuing operations | $ | (1,529 | ) | $ | 307 | $ | 83 | $ | 91 | $ | (1,048 | ) | |||||||||||||||||
Net income (loss) | $ | (1,529 | ) | $ | 307 | $ | 83 | $ | 91 | $ | (1,048 | ) | |||||||||||||||||
Total assets | $ | 100,710 | $ | 4,922 | $ | 3,495 | $ | 2,231 | $ | 111,358 | |||||||||||||||||||
2013 | |||||||||||||||||||||||||||||
(Amounts in millions) | United States | Canada | Australia | Other | Total | ||||||||||||||||||||||||
Countries | |||||||||||||||||||||||||||||
Total revenues | $ | 7,256 | $ | 760 | $ | 555 | $ | 832 | $ | 9,403 | |||||||||||||||||||
Income from continuing operations | $ | 161 | $ | 336 | $ | 227 | $ | 2 | $ | 726 | |||||||||||||||||||
Net income | $ | 149 | $ | 336 | $ | 227 | $ | 2 | $ | 714 | |||||||||||||||||||
Total assets | $ | 96,790 | $ | 5,313 | $ | 3,419 | $ | 2,523 | $ | 108,045 | |||||||||||||||||||
2012 | |||||||||||||||||||||||||||||
(Amounts in millions) | United States | Canada | Australia | Other | Total | ||||||||||||||||||||||||
Countries | |||||||||||||||||||||||||||||
Total revenues | $ | 7,410 | $ | 786 | $ | 567 | $ | 877 | $ | 9,640 | |||||||||||||||||||
Income (loss) from continuing operations | $ | (22 | ) | $ | 439 | $ | 140 | $ | (89 | ) | $ | 468 | |||||||||||||||||
Net income (loss) | $ | 35 | $ | 439 | $ | 140 | $ | (89 | ) | $ | 525 | ||||||||||||||||||
Quarterly_Results_of_Operation
Quarterly Results of Operations (unaudited) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||
Quarterly Results of Operations (unaudited) | (21) Quarterly Results of Operations (unaudited) | ||||||||||||||||
Our unaudited quarterly results of operations for the year ended December 31, 2014 are summarized in the table below. | |||||||||||||||||
Three months ended | |||||||||||||||||
(Amounts in millions, except per share amounts) | March 31, | June 30, | September 30, | December 31, | |||||||||||||
2014 | 2014 | 2014 | 2014 | ||||||||||||||
Total revenues | $ | 2,322 | $ | 2,415 | $ | 2,404 | $ | 2,424 | |||||||||
Total benefits and expenses (1) | $ | 2,016 | $ | 2,102 | $ | 3,376 | $ | 3,347 | |||||||||
Income (loss) from continuing operations (2) | $ | 219 | $ | 228 | $ | (787 | ) | $ | (708 | ) | |||||||
Net income (loss) (2) | $ | 219 | $ | 228 | $ | (787 | ) | $ | (708 | ) | |||||||
Net income attributable to noncontrolling interests | $ | 35 | $ | 52 | $ | 57 | $ | 52 | |||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders (2) | $ | 184 | $ | 176 | $ | (844 | ) | $ | (760 | ) | |||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per common share: | |||||||||||||||||
Basic | $ | 0.37 | $ | 0.35 | $ | (1.70 | ) | $ | (1.53 | ) | |||||||
Diluted | $ | 0.37 | $ | 0.35 | $ | (1.70 | ) | $ | (1.53 | ) | |||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders per common share: | |||||||||||||||||
Basic | $ | 0.37 | $ | 0.35 | $ | (1.70 | ) | $ | (1.53 | ) | |||||||
Diluted | $ | 0.37 | $ | 0.35 | $ | (1.70 | ) | $ | (1.53 | ) | |||||||
Weighted-average common shares outstanding: | |||||||||||||||||
Basic | 495.8 | 496.6 | 496.6 | 496.7 | |||||||||||||
Diluted (3) | 502.7 | 503.6 | 496.6 | 496.7 | |||||||||||||
(1) | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates. | ||||||||||||||||
(2) | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. | ||||||||||||||||
(3) | Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2014 and December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2014 and December 31, 2014, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.4 million and 3.2 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2014 and December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million and 499.9 million, respectively. | ||||||||||||||||
Our unaudited quarterly results of operations for the year ended December 31, 2013 are summarized in the table below. | |||||||||||||||||
Three months ended | |||||||||||||||||
(Amounts in millions, except per share amounts) | March 31, | June 30, | September 30, | December 31, | |||||||||||||
2013 | 2013 | 2013 | 2013 | ||||||||||||||
Total revenues | $ | 2,303 | $ | 2,371 | $ | 2,317 | $ | 2,412 | |||||||||
Total benefits and expenses | $ | 2,066 | $ | 2,124 | $ | 2,066 | $ | 2,097 | |||||||||
Income from continuing operations | $ | 161 | $ | 174 | $ | 146 | $ | 245 | |||||||||
Income (loss) from discontinued operations, net of taxes | $ | (20 | ) | $ | 6 | $ | 2 | $ | — | ||||||||
Net income | $ | 141 | $ | 180 | $ | 148 | $ | 245 | |||||||||
Net income attributable to noncontrolling interests | $ | 38 | $ | 39 | $ | 40 | $ | 37 | |||||||||
Net income available to Genworth Financial, Inc.’s common stockholders | $ | 103 | $ | 141 | $ | 108 | $ | 208 | |||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per common share: | |||||||||||||||||
Basic | $ | 0.25 | $ | 0.27 | $ | 0.21 | $ | 0.42 | |||||||||
Diluted | $ | 0.25 | $ | 0.27 | $ | 0.21 | $ | 0.42 | |||||||||
Net income available to Genworth Financial, Inc.’s common stockholders per common share: | |||||||||||||||||
Basic | $ | 0.21 | $ | 0.29 | $ | 0.22 | $ | 0.42 | |||||||||
Diluted | $ | 0.21 | $ | 0.28 | $ | 0.22 | $ | 0.41 | |||||||||
Weighted-average common shares outstanding: | |||||||||||||||||
Basic | 492.5 | 493.4 | 494 | 494.7 | |||||||||||||
Diluted | 496.8 | 497.5 | 499.3 | 501.2 |
Commitments_and_Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2014 | |
Commitments and Contingencies | (22) Commitments and Contingencies |
(a) Litigation and Regulatory Matters | |
We face the risk of litigation and regulatory investigations and actions in the ordinary course of operating our businesses, including the risk of class action lawsuits. Our pending legal and regulatory actions include proceedings specific to us and others generally applicable to business practices in the industries in which we operate. In our insurance operations, we are, have been, or may become subject to class actions and individual suits alleging, among other things, issues relating to sales or underwriting practices, increases to in-force long-term care insurance premiums, payment of contingent or other sales commissions, claims payments and procedures, product design, product disclosure, administration, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, recommending unsuitable products to customers, our pricing structures and business practices in our mortgage insurance businesses, such as captive reinsurance arrangements with lenders and contract underwriting services, violations of the Real Estate Settlement and Procedures Act of 1974 (“RESPA”) or related state anti-inducement laws, and mortgage insurance policy rescissions and curtailments, and breaching fiduciary or other duties to customers, including but not limited to breach of customer information. Plaintiffs in class action and other lawsuits against us may seek very large or indeterminate amounts which may remain unknown for substantial periods of time. In our investment-related operations, we are subject to litigation involving commercial disputes with counterparties. We are also subject to litigation arising out of our general business activities such as our contractual and employment relationships. In addition, we are also subject to various regulatory inquiries, such as information requests, subpoenas, books and record examinations and market conduct and financial examinations from state, federal and international regulators and other authorities. A substantial legal liability or a significant regulatory action against us could have an adverse effect on our business, financial condition and results of operations. Moreover, even if we ultimately prevail in the litigation, regulatory action or investigation, we could suffer significant reputational harm, which could have an adverse effect on our business, financial condition or results of operations. | |
In August 2014, Genworth Financial, Inc., its current chief executive officer and its current chief financial officer were named in a putative class action lawsuit captioned Manuel Esguerra v. Genworth Financial, Inc., et al, in the United States District Court for the Southern District of New York. Plaintiff alleged securities law violations involving certain disclosures in 2013 and 2014 concerning Genworth’s long-term care insurance reserves. The lawsuit sought unspecified compensatory damages, costs and expenses, including counsel fees and expert fees. In October 2014, a putative class action lawsuit captioned City of Pontiac General Employees’ Retirement System v. Genworth Financial, Inc., et al, was filed in the United States District Court for the Eastern District of Virginia. This lawsuit names the same defendants, alleges the same securities law violations, seeks the same damages and covers the same class as the Esguerra lawsuit. Following the filing of the City of Pontiac lawsuit, the Esguerra lawsuit was voluntarily dismissed without prejudice allowing the City of Pontiac lawsuit to proceed. In the City of Pontiac lawsuit, the United States District Court for the Eastern District of Virginia appointed Her Majesty the Queen in Right of Alberta and Fresno County Employees’ Retirement Association as lead plaintiffs and designated the caption of the action as In re Genworth Financial, Inc. Securities Litigation. On December 22, 2014, the lead plaintiffs filed an amended complaint. On February 5, 2015, we filed a motion to dismiss plaintiffs’ amended complaint. We intend to vigorously defend this action. | |
In April 2014, Genworth Financial, Inc., its former chief executive officer and its current chief financial officer were named in a putative class action lawsuit captioned City of Hialeah Employees’ Retirement System v. Genworth Financial, Inc., et al, in the United States District Court for the Southern District of New York. Plaintiff alleges securities law violations involving certain disclosures in 2012 concerning Genworth’s Australian mortgage insurance business, including our plans for an initial public offering of the business. The lawsuit seeks unspecified damages, costs and attorneys’ fees and such equitable/injunctive relief as the court may deem proper. The United States District Court for the Southern District of New York appointed City of Hialeah Employees’ Retirement System and New Bedford Contributory Retirement System as lead plaintiffs and designated the caption of the action as In re Genworth Financial, Inc. Securities Litigation. On October 3, 2014, the lead plaintiffs filed an amended complaint. On December 2, 2014, we filed a motion to dismiss plaintiffs’ amended complaint. On February 2, 2015, the plaintiffs filed a memorandum of law in opposition to our motion to dismiss. We intend to vigorously defend this action. | |
In early 2006 as part of an industry-wide review, one of our U.S. mortgage insurance subsidiaries received an administrative subpoena from the Minnesota Department of Commerce, which has jurisdiction over insurance matters, with respect to our reinsurance arrangements, including captive reinsurance transactions with lender-affiliated reinsurers. Since 2006, the Minnesota Department of Commerce has periodically requested additional information. We are engaged in discussions with the Minnesota Department of Commerce to resolve the review and we will continue to cooperate as appropriate with respect to any follow-up requests or inquiries. Inquiries from other regulatory bodies with respect to the same subject matter have been resolved or dormant for a number of years. | |
Beginning in December 2011 and continuing through January 2013, one of our U.S. mortgage insurance subsidiaries was named along with several other mortgage insurance participants and mortgage lenders as a defendant in twelve putative class action lawsuits alleging that certain “captive reinsurance arrangements” were in violation of RESPA. Those cases are captioned as follows: Samp, et al. v. JPMorgan Chase Bank, N.A., et al., United States District Court for the Central District of California; White, et al., v. The PNC Financial Services Group, Inc., et al., United States District Court for the Eastern District of Pennsylvania; Menichino, et al. v. Citibank NA, et al., United States District Court for the Western District of Pennsylvania; McCarn, et al. v. HSBC USA, Inc., et al., United States District Court for the Eastern District of California; Manners, et al., v. Fifth Third Bank, et al., United States District Court for the Western District of Pennsylvania; Riddle, et al. v. Bank of America Corporation, et al., United States District Court for the Eastern District of Pennsylvania; Rulison et al. v. ABN AMRO Mortgage Group, Inc. et al., United States District Court for the Southern District of New York; Barlee, et al. v. First Horizon National Corporation, et al., United States District Court for the Eastern District of Pennsylvania; Cunningham, et al. v. M&T Bank Corp., et al., United States District Court for the Middle District of Pennsylvania; Orange, et al. v. Wachovia Bank, N.A., et al., United States District Court for the Central District of California; Hill et al. v. Flagstar Bank, FSB, et al., United States District Court for the Eastern District of Pennsylvania; and Moriba Ba, et al. v. HSBC USA, Inc., et al., United States District Court for the Eastern District of Pennsylvania. Plaintiffs allege that “captive reinsurance arrangements” with providers of private mortgage insurance whereby a mortgage lender through captive reinsurance arrangements received a portion of the borrowers’ private mortgage insurance premiums were in violation of RESPA and unjustly enriched the defendants for which plaintiffs seek declaratory relief and unspecified monetary damages, including restitution. The McCarn case was dismissed by the court with prejudice as to our subsidiary and certain other defendants on November 9, 2012. On July 3, 2012, the Rulison case was voluntarily dismissed by the plaintiffs. The Barlee case was dismissed by the court with prejudice as to our subsidiary and certain other defendants on February 27, 2013. The Manners case was dismissed by voluntary stipulation in March 2013. In early May 2013, the Samp and Orange cases were dismissed with prejudice as to our subsidiary. Plaintiffs appealed both of those dismissals, but have since withdrawn those appeals. The White case was dismissed by the court without prejudice on June 20, 2013, and on July 5, 2013 plaintiffs filed a second amended complaint again naming our U.S. mortgage insurance subsidiary as a defendant. The Menichino case was dismissed by the court without prejudice as to our subsidiary and certain other defendants on July 19, 2013. Plaintiffs filed a second amended complaint again naming our U.S. mortgage insurance subsidiary as a defendant and we moved to dismiss the second amended complaint. In the Riddle, Hill, Ba and Cunningham cases, the defendants’ motions to dismiss were denied, but the court in the Riddle, Hill and Cunningham cases limited discovery to issues surrounding whether the case should be dismissed on statute of limitations grounds. In the Hill case, on December 17, 2013, we moved for summary judgment dismissing the complaint. The court granted our motion, and in July 2014, the Hill plaintiffs filed a notice of appeal with the Third Circuit Court of Appeals. In the Riddle case, in late November 2013, the United States District Court for the Eastern District of Pennsylvania granted our motion for summary judgment dismissing the case. Plaintiffs appealed the dismissal. In October 2014, the Third Circuit Court of Appeals upheld the dismissal of the Riddle action. On January 30, 2015, our U.S. mortgage insurance subsidiary and all named plantiffs in the cases still pending as of such date entered into a settlement agreement that we expect will result in the dismissal of all actions as to our subsidiary. This settlement will not have any impact on our financial position or results of operations. | |
In December 2009, one of our former non-insurance subsidiaries, one of the former subsidiary’s officers and Genworth Financial, Inc. (now known as Genworth Holdings, Inc.) were named in a putative class action lawsuit captioned Michael J. Goodman and Linda Brown v. Genworth Financial Wealth Management, Inc. et al., in the United States District Court for the Eastern District of New York. Plaintiffs allege securities law and other violations involving the selection of mutual funds by our former subsidiary on behalf of certain of its Private Client Group clients. The lawsuit seeks unspecified monetary damages and other relief. In response to our motion to dismiss the complaint in its entirety, the court granted the motion to dismiss the state law fiduciary duty claim and denied the motion to dismiss the remaining federal claims. The District Court denied plaintiffs’ motion to certify a class on April 15, 2014. On April 29, 2014, plaintiffs filed a motion with the Second Circuit Court of Appeals for permission to appeal the District Court’s denial of their motion to certify a class, which we opposed. On July 9, 2014, the Second Circuit Court of Appeals denied plaintiffs’ motion. We will continue to vigorously defend this action. | |
In April 2012, two of our U.S. mortgage insurance subsidiaries were named as respondents in two arbitrations, one brought by Bank of America, N.A. and one brought by Countrywide Home Loans, Inc. and Bank of America, N.A. as claimants. Claimants alleged breach of contract and breach of the covenant of good faith and fair dealing and sought a declaratory judgment relating to our denial, curtailment and rescission of mortgage insurance coverage. In June 2012, our U.S. mortgage insurance subsidiaries responded to the arbitration demands and asserted numerous counterclaims against the claimants. On December 31, 2013, the parties reached an agreement to resolve that portion of both arbitrations involving rescission practices, which settlement took effect in the second quarter of 2014. As a result, the arbitration demands and counterclaims related to that portion of both arbitrations involving rescission practices were dismissed in the third quarter of 2014. In October 2014, the parties executed a definitive settlement agreement to settle all remaining claims in the arbitrations. Implementation of the settlement to resolve the remaining claims was subject to the consent of the GSEs. The settlement provides that our U.S. mortgage insurance subsidiaries will remit a portion of the previously curtailed claim amounts to Bank of America, N.A. and will agree to certain limits on future curtailment activity for loans that are part of the settlement. The consents of the GSEs were obtained in January 2015, and therefore, the parties will move to dismiss all remaining matters in the arbitration. | |
In addition to the negotiated settlement with Bank of America, N.A. discussed above, we have resolved a matter involving a second servicer’s dispute with us on loss mitigation. This second dispute did not involve any formal legal proceeding, as is the case with other discussions we have had from time to time with other lenders and servicers over disputed loss mitigation activities. During the third quarter of 2014, we recorded an aggregate increase in our claim reserves for our U.S. mortgage insurance business of $53 million principally to provide for the anticipated financial impact in connection with the settlement of the Bank of America, N.A. arbitration, as well as the second dispute, both of which were settled for amounts which in the aggregate were included within the claim reserve mentioned above. | |
At this time, we cannot determine or predict the ultimate outcome of any of the pending legal and regulatory matters specifically identified above or the likelihood of potential future legal and regulatory matters against us. Except as disclosed above, we also are not able to provide an estimate or range of reasonably possible losses related to these matters. Therefore, we cannot ensure that the current investigations and proceedings will not have a material adverse effect on our business, financial condition or results of operations. In addition, it is possible that related investigations and proceedings may be commenced in the future, and we could become subject to additional unrelated investigations and lawsuits. Increased regulatory scrutiny and any resulting investigations or proceedings could result in new legal precedents and industry-wide regulations or practices that could adversely affect our business, financial condition and results of operations. | |
(b) Commitments | |
As of December 31, 2014, we were committed to fund $53 million in limited partnership investments, $128 million in U.S. commercial mortgage loan investments and $27 million in private placement investments. | |
In connection with the issuance of non-recourse funding obligations by Rivermont I, Genworth entered into a liquidity commitment agreement with the third-party trusts in which the floating rate notes have been deposited. The liquidity agreement may require that Genworth issue to the trusts either a loan or a letter of credit (“LOC”), at maturity of the notes (2050), in the amount equal to the then market value of the assets supporting the notes held in the trust. Any loan or LOC issued is an obligation of the trust and shall accrue interest at LIBOR plus a margin. In consideration for entering into this agreement, Genworth received, from Rivermont I, a one-time commitment fee of approximately $2 million. The maximum potential amount of future obligation under this agreement is approximately $95 million. |
Changes_In_Accumulated_Other_C
Changes In Accumulated Other Comprehensive Income (Loss) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||
Changes In Accumulated Other Comprehensive Income (Loss) | (23) Changes In Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||
The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated: | |||||||||||||||||
(Amounts in millions) | Net | Derivatives | Foreign | Total | |||||||||||||
unrealized | qualifying as | currency | |||||||||||||||
investment | hedges (2) | translation | |||||||||||||||
gains | and other | ||||||||||||||||
(losses) (1) | adjustments | ||||||||||||||||
Balances as of January 1, 2014 | $ | 926 | $ | 1,319 | $ | 297 | $ | 2,542 | |||||||||
OCI before reclassifications | 1,595 | 788 | (537 | ) | 1,846 | ||||||||||||
Amounts reclassified from (to) OCI | (12 | ) | (37 | ) | — | (49 | ) | ||||||||||
Current period OCI | 1,583 | 751 | (537 | ) | 1,797 | ||||||||||||
Balances as of December 31, 2014 before noncontrolling interests | 2,509 | 2,070 | (240 | ) | 4,339 | ||||||||||||
Less: change in OCI attributable to noncontrolling interests | 56 | — | (163 | ) | (107 | ) | |||||||||||
Balances as of December 31, 2014 | $ | 2,453 | $ | 2,070 | $ | (77 | ) | $ | 4,446 | ||||||||
(1) | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. | ||||||||||||||||
(2) | See note 5 for additional information. | ||||||||||||||||
(Amounts in millions) | Net | Derivatives | Foreign | Total | |||||||||||||
unrealized | qualifying as | currency | |||||||||||||||
investment | hedges (2) | translation | |||||||||||||||
gains | and other | ||||||||||||||||
(losses) (1) | adjustments | ||||||||||||||||
Balances as of January 1, 2013 | $ | 2,638 | $ | 1,909 | $ | 655 | $ | 5,202 | |||||||||
OCI before reclassifications | (1,772 | ) | (561 | ) | (442 | ) | (2,775 | ) | |||||||||
Amounts reclassified from (to) OCI | 21 | (29 | ) | — | (8 | ) | |||||||||||
Current period OCI | (1,751 | ) | (590 | ) | (442 | ) | (2,783 | ) | |||||||||
Balances as of December 31, 2013 before noncontrolling interests | 887 | 1,319 | 213 | 2,419 | |||||||||||||
Less: change in OCI attributable to noncontrolling interests | (39 | ) | — | (84 | ) | (123 | ) | ||||||||||
Balances as of December 31, 2013 | $ | 926 | $ | 1,319 | $ | 297 | $ | 2,542 | |||||||||
(1) | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. | ||||||||||||||||
(2) | See note 5 for additional information. | ||||||||||||||||
(Amounts in millions) | Net | Derivatives | Foreign | Total | |||||||||||||
unrealized | qualifying as | currency | |||||||||||||||
investment | hedges (2) | translation | |||||||||||||||
gains | and other | ||||||||||||||||
(losses) (1) | adjustments | ||||||||||||||||
Balances as of January 1, 2012 | $ | 1,485 | $ | 2,009 | $ | 553 | $ | 4,047 | |||||||||
OCI before reclassifications | 1,106 | (77 | ) | 126 | 1,155 | ||||||||||||
Amounts reclassified from (to) OCI | 50 | (23 | ) | — | 27 | ||||||||||||
Current period OCI | 1,156 | (100 | ) | 126 | 1,182 | ||||||||||||
Balances as of December 31, 2012 before noncontrolling interests | 2,641 | 1,909 | 679 | 5,229 | |||||||||||||
Less: change in OCI attributable to noncontrolling interests | 3 | — | 24 | 27 | |||||||||||||
Balances as of December 31, 2012 | $ | 2,638 | $ | 1,909 | $ | 655 | $ | 5,202 | |||||||||
(1) | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. | ||||||||||||||||
(2) | See note 5 for additional information. | ||||||||||||||||
The foreign currency translation and other adjustments balance included $37 million, $6 million and $26 million, respectively, net of taxes of $14 million, $1 million and $15 million, respectively, related to a net unrecognized postretirement benefit obligation as of December 31, 2014, 2013 and 2012. Amount also included taxes of $(10) million, $39 million and $58 million, respectively, related to foreign currency translation adjustments as of December 31, 2014, 2013 and 2012. | |||||||||||||||||
The following table shows reclassifications out of accumulated other comprehensive income (loss), net of taxes, for the periods presented: | |||||||||||||||||
Amount reclassified from accumulated | Affected line item in the | ||||||||||||||||
other comprehensive income (loss) | consolidated statements | ||||||||||||||||
Years ended December 31, | of income | ||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||
Net unrealized investment (gains) losses: | |||||||||||||||||
Unrealized (gains) losses on investments (1) | $ | (19 | ) | $ | 33 | $ | 77 | Net investment (gains) losses | |||||||||
Provision for income taxes | 7 | (12 | ) | (27 | ) | Provision for income taxes | |||||||||||
Total | $ | (12 | ) | $ | 21 | $ | 50 | ||||||||||
Derivatives qualifying as hedges: | |||||||||||||||||
Interest rate swaps hedging assets | $ | (63 | ) | $ | (47 | ) | $ | (40 | ) | Net investment income | |||||||
Interest rate swaps hedging assets | (2 | ) | (1 | ) | (2 | ) | Net investment (gains) losses | ||||||||||
Interest rate swaps hedging liabilities | (1 | ) | (2 | ) | (2 | ) | Interest expense | ||||||||||
Inflation indexed swaps | 9 | 5 | 9 | Net investment income | |||||||||||||
Provision for income taxes | 20 | 16 | 12 | Provision for income taxes | |||||||||||||
Total | $ | (37 | ) | $ | (29 | ) | $ | (23 | ) | ||||||||
(1) | Amounts exclude adjustments to DAC, PVFP, sales inducements and benefit reserves. | ||||||||||||||||
Noncontrolling_Interests
Noncontrolling Interests | 12 Months Ended | ||||
Dec. 31, 2014 | |||||
Noncontrolling Interests | (24) Noncontrolling Interests | ||||
Canada | |||||
In July 2009, Genworth Canada, our indirect subsidiary, completed the IPO of its common shares and Brookfield Life Assurance Company Limited (“Brookfield”), our indirect wholly-owned subsidiary, beneficially owned 57.5% of the common shares of Genworth Canada. | |||||
We currently hold approximately 57.3% of the outstanding common shares of Genworth Canada on a consolidated basis. In addition, Brookfield has the right, exercisable at its discretion, to purchase for cash these common shares of Genworth Canada from our U.S. mortgage insurance companies at the then-current market price. Brookfield also has a right of first refusal with respect to the transfer of these common shares of Genworth Canada by our U.S. mortgage insurance companies. | |||||
During 2014, Genworth Canada repurchased 1.9 million shares for CAD$75 million through a Normal Course Issuer Bid (“NCIB”) authorized by its board for up to 4.7 million shares. We participated in the NCIB in order to maintain our overall ownership percentage at its current level and received $38 million in cash. | |||||
During 2013, Genworth Canada repurchased 3.9 million shares for CAD$105 million through a NCIB authorized by its board for up to 4.9 million shares. We participated in the NCIB in order to maintain our overall ownership percentage at its then-current level and received $58 million in cash. | |||||
In 2014, 2013 and 2012, dividends of $69 million, $52 million and $50 million, respectively, were paid to the noncontrolling interests of Genworth Canada. | |||||
Australia | |||||
On May 15, 2014, Genworth Australia, a holding company for Genworth’s Australian mortgage insurance business, priced its initial public offering of 220,000,000 of its ordinary shares at an initial public offering price of AUD$2.65 per ordinary share. The offering closed on May 21, 2014. Following completion of the offering, Genworth Financial beneficially owns 66.2% of the ordinary shares of Genworth Australia. | |||||
The net proceeds of the offering were used by Genworth Australia to repay a portion of certain intercompany funding arrangements with our subsidiaries and those funds were then distributed to Genworth Holdings. The gross proceeds of the offering (before payment of fees and expenses) were approximately $541 million. Fees and expenses in connection with the offering were approximately $27 million, including approximately $3 million paid in 2013. | |||||
Consistent with applicable accounting guidance, changes in noncontrolling interests that do not result in a change of control are accounted for as equity transactions. When there are changes in noncontrolling interests of a subsidiary that do not result in a change of control, any difference between carrying value and fair value related to the change in ownership is recorded as an adjustment to stockholders’ equity. A summary of the changes in ownership interests and the effect on stockholders’ equity as a result of the initial public offering of Genworth Australia was as follows for the year ended December 31: | |||||
(Amounts in millions) | 2014 | ||||
Net loss available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | ||
Transfers to the noncontrolling interests: | |||||
Decrease in Genworth Financial, Inc.’s additional paid-in capital for initial sale of Genworth Australia shares to noncontrolling interests | (145 | ) | |||
Net transfers to noncontrolling interests | (145 | ) | |||
Change from net loss available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests | $ | (1,389 | ) | ||
In 2014, dividends of $6 million were paid to the noncontrolling interests of Genworth Australia. |
Discontinued_Operations
Discontinued Operations | 12 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Discontinued Operations | (25) Discontinued Operations | ||||||||
On March 27, 2013, we announced that we had agreed to sell our wealth management business to AqGen Liberty Acquisition, Inc., a subsidiary of AqGen Liberty Holdings LLC, a partnership of Aquiline Capital Partners and Genstar Capital. Historically, this business had been reported as a separate segment. As a result of the sale agreement, this business was accounted for as discontinued operations and its financial position, results of operations and cash flows were separately reported for all periods presented. Also included in discontinued operations was our tax and advisor unit, Genworth Financial Investment Services (“GFIS”), which was part of our wealth management business until the closing of its sale on April 2, 2012 as discussed below. | |||||||||
Summary operating results of discontinued operations were as follows for the years ended December 31: | |||||||||
(Amounts in millions) | 2013 | 2012 | |||||||
Revenues | $ | 211 | $ | 387 | |||||
Income (loss) before income taxes | $ | (5 | ) | $ | 110 | ||||
Provision for income taxes | 7 | 53 | |||||||
Income (loss) from discontinued operations, net of taxes | $ | (12 | ) | $ | 57 | ||||
On December 31, 2010, we acquired the operating assets of Altegris Capital, LLC. (“Altegris”) as part of our wealth management business which provided a platform of alternative investments, including hedge funds and managed futures products. Under the terms of the agreement, we paid approximately $40 million at closing and we could have been obligated to pay additional performance-based payments of up to $88 million during the five-year period following closing. In 2012, we made a payment of $18 million related to the contingent consideration as a result of Altegris achieving certain performance targets. | |||||||||
On August 29, 2008, we acquired Quantuvis Consulting, Inc. (“Quantuvis”), an investment advisor consulting business, as part of our wealth management business for $3 million plus potential contingent consideration of up to $3 million. Quantuvis was included in the sale of our wealth management business in 2013 as discussed below. | |||||||||
On August 30, 2013, we completed the sale of our wealth management business for approximately $412 million with net proceeds of approximately $360 million. During the three months ended March 31, 2013, in connection with the agreement to sell the wealth management business, we recognized a goodwill impairment of $13 million as a result of the carrying value for the business exceeding fair value. Additionally, we agreed to settle our contingent consideration liability related to our purchase of Altegris for approximately $40 million, which resulted in a loss of approximately $5 million from the change in fair value of this liability. In accordance with the accounting guidance for groups of assets that are held-for-sale, we recorded an additional loss of approximately $9 million to record the carrying value of the business at its fair value less costs to sell. During the three months ended September 30, 2013, we recognized an additional after-tax loss on the sale of $2 million at closing, which was based on carrying value and working capital at close, as well as expenses associated with the sale. | |||||||||
On April 2, 2012, we completed the sale of our tax and accounting financial advisor unit, GFIS, for approximately $79 million, plus contingent consideration, to Cetera Financial Group. The contingent consideration was recorded at fair value upon disposition and provides the opportunity for us to receive additional future payments of up to approximately $25 million based on achieving certain revenue goals. The fair value of this contingent consideration receivable was recorded in Corporate and Other activities and remains a component of continuing operations. We recognized an after-tax gain of $13 million related to the sale, which was included in income from discontinued operations, net of taxes. |
Condensed_Consolidating_Financ
Condensed Consolidating Financial Information | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||
Condensed Consolidating Financial Information | (26) Condensed Consolidating Financial Information | ||||||||||||||||||||
Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior notes and the holders of the senior notes, on an unsecured unsubordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, each outstanding series of senior notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior notes indenture in respect of such senior notes. Genworth Financial also provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding subordinated notes and the holders of the subordinated notes, on an unsecured subordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the subordinated notes indenture in respect of the subordinated notes. | |||||||||||||||||||||
The following condensed consolidating financial information of Genworth Financial and its direct and indirect subsidiaries have been prepared pursuant to rules regarding the preparation of consolidating financial information of Regulation S-X. The condensed consolidating financial information has been prepared as if the guarantee had been in place during the periods presented herein. | |||||||||||||||||||||
The condensed consolidating financial information presents the condensed consolidating balance sheet information as of December 31, 2014 and 2013 and the condensed consolidating income statement information, condensed consolidating comprehensive income statement information and condensed consolidating cash flow statement information for the years ended December 31, 2014, 2013 and 2012. | |||||||||||||||||||||
The condensed consolidating financial information reflects Genworth Financial (“Parent Guarantor”), Genworth Holdings (“Issuer”) and each of Genworth Financial’s other direct and indirect subsidiaries (the “All Other Subsidiaries”) on a combined basis, none of which guarantee the senior notes or subordinated notes, as well as the eliminations necessary to present Genworth Financial’s financial information on a consolidated basis and total consolidated amounts. | |||||||||||||||||||||
The accompanying condensed consolidating financial information is presented based on the equity method of accounting for all periods presented. Under this method, investments in subsidiaries are recorded at cost and adjusted for the subsidiaries’ cumulative results of operations, capital contributions and distributions, and other changes in equity. Elimination entries include consolidating and eliminating entries for investments in subsidiaries and intercompany activity. | |||||||||||||||||||||
The following table presents the condensed consolidating balance sheet information as of December 31, 2014: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Assets | |||||||||||||||||||||
Investments: | |||||||||||||||||||||
Fixed maturity securities available-for-sale, at fair value | $ | — | $ | 150 | $ | 62,497 | $ | (200 | ) | $ | 62,447 | ||||||||||
Equity securities available-for-sale, at fair value | — | — | 282 | — | 282 | ||||||||||||||||
Commercial mortgage loans | — | — | 6,100 | — | 6,100 | ||||||||||||||||
Restricted commercial mortgage loans related to securitization entities | — | — | 201 | — | 201 | ||||||||||||||||
Policy loans | — | — | 1,501 | — | 1,501 | ||||||||||||||||
Other invested assets | — | 14 | 2,287 | (5 | ) | 2,296 | |||||||||||||||
Restricted other invested assets related to securitization entities, at fair value | — | — | 411 | — | 411 | ||||||||||||||||
Investments in subsidiaries | 14,895 | 15,003 | — | (29,898 | ) | — | |||||||||||||||
Total investments | 14,895 | 15,167 | 73,279 | (30,103 | ) | 73,238 | |||||||||||||||
Cash and cash equivalents | — | 953 | 3,965 | — | 4,918 | ||||||||||||||||
Accrued investment income | — | — | 689 | (4 | ) | 685 | |||||||||||||||
Deferred acquisition costs | — | — | 5,042 | — | 5,042 | ||||||||||||||||
Intangible assets | — | — | 272 | — | 272 | ||||||||||||||||
Goodwill | — | — | 16 | — | 16 | ||||||||||||||||
Reinsurance recoverable | — | — | 17,346 | — | 17,346 | ||||||||||||||||
Other assets | 2 | 207 | 425 | (1 | ) | 633 | |||||||||||||||
Intercompany notes receivable | 9 | 267 | 395 | (671 | ) | — | |||||||||||||||
Separate account assets | — | — | 9,208 | — | 9,208 | ||||||||||||||||
Total assets | $ | 14,906 | $ | 16,594 | $ | 110,637 | $ | (30,779 | ) | $ | 111,358 | ||||||||||
Liabilities and stockholders’ equity | |||||||||||||||||||||
Liabilities: | |||||||||||||||||||||
Future policy benefits | $ | — | $ | — | $ | 35,915 | $ | — | $ | 35,915 | |||||||||||
Policyholder account balances | — | — | 26,043 | — | 26,043 | ||||||||||||||||
Liability for policy and contract claims | — | — | 8,043 | — | 8,043 | ||||||||||||||||
Unearned premiums | — | — | 3,986 | — | 3,986 | ||||||||||||||||
Other liabilities | 3 | 251 | 3,361 | (11 | ) | 3,604 | |||||||||||||||
Intercompany notes payable | — | 604 | 267 | (871 | ) | — | |||||||||||||||
Borrowings related to securitization entities | — | — | 219 | — | 219 | ||||||||||||||||
Non-recourse funding obligations | — | — | 1,996 | — | 1,996 | ||||||||||||||||
Long-term borrowings | — | 4,151 | 488 | — | 4,639 | ||||||||||||||||
Deferred tax liability | (20 | ) | (970 | ) | 1,898 | — | 908 | ||||||||||||||
Separate account liabilities | — | — | 9,208 | — | 9,208 | ||||||||||||||||
Total liabilities | (17 | ) | 4,036 | 91,424 | (882 | ) | 94,561 | ||||||||||||||
Stockholders’ equity: | |||||||||||||||||||||
Common stock | 1 | — | — | — | 1 | ||||||||||||||||
Additional paid-in capital | 11,997 | 9,162 | 17,080 | (26,242 | ) | 11,997 | |||||||||||||||
Accumulated other comprehensive income (loss) | 4,446 | 4,449 | 4,459 | (8,908 | ) | 4,446 | |||||||||||||||
Retained earnings | 1,179 | (1,053 | ) | (4,205 | ) | 5,258 | 1,179 | ||||||||||||||
Treasury stock, at cost | (2,700 | ) | — | — | — | (2,700 | ) | ||||||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity | 14,923 | 12,558 | 17,334 | (29,892 | ) | 14,923 | |||||||||||||||
Noncontrolling interests | — | — | 1,879 | (5 | ) | 1,874 | |||||||||||||||
Total stockholders’ equity | 14,923 | 12,558 | 19,213 | (29,897 | ) | 16,797 | |||||||||||||||
Total liabilities and stockholders’ equity | $ | 14,906 | $ | 16,594 | $ | 110,637 | $ | (30,779 | ) | $ | 111,358 | ||||||||||
The following table presents the condensed consolidating balance sheet information as of December 31, 2013: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Assets | |||||||||||||||||||||
Investments: | |||||||||||||||||||||
Fixed maturity securities available-for-sale, at fair value | $ | — | $ | 150 | $ | 58,679 | $ | (200 | ) | $ | 58,629 | ||||||||||
Equity securities available-for-sale, at fair value | — | — | 341 | — | 341 | ||||||||||||||||
Commercial mortgage loans | — | — | 5,899 | — | 5,899 | ||||||||||||||||
Restricted commercial mortgage loans related to securitization entities | — | — | 233 | — | 233 | ||||||||||||||||
Policy loans | — | — | 1,434 | — | 1,434 | ||||||||||||||||
Other invested assets | — | 91 | 1,595 | — | 1,686 | ||||||||||||||||
Restricted other invested assets related to securitization entities, at fair value | — | — | 391 | — | 391 | ||||||||||||||||
Investments in subsidiaries | 14,358 | 14,929 | — | (29,287 | ) | — | |||||||||||||||
Total investments | 14,358 | 15,170 | 68,572 | (29,487 | ) | 68,613 | |||||||||||||||
Cash and cash equivalents | — | 1,219 | 2,995 | — | 4,214 | ||||||||||||||||
Accrued investment income | — | — | 682 | (4 | ) | 678 | |||||||||||||||
Deferred acquisition costs | — | — | 5,278 | — | 5,278 | ||||||||||||||||
Intangible assets | — | — | 399 | — | 399 | ||||||||||||||||
Goodwill | — | — | 867 | — | 867 | ||||||||||||||||
Reinsurance recoverable | — | — | 17,219 | — | 17,219 | ||||||||||||||||
Other assets | (2 | ) | 276 | 367 | (2 | ) | 639 | ||||||||||||||
Intercompany notes receivable | 8 | 248 | 393 | (649 | ) | — | |||||||||||||||
Separate account assets | — | — | 10,138 | — | 10,138 | ||||||||||||||||
Total assets | $ | 14,364 | $ | 16,913 | $ | 106,910 | $ | (30,142 | ) | $ | 108,045 | ||||||||||
Liabilities and stockholders’ equity | |||||||||||||||||||||
Liabilities: | |||||||||||||||||||||
Future policy benefits | $ | — | $ | — | $ | 33,705 | $ | — | $ | 33,705 | |||||||||||
Policyholder account balances | — | — | 25,528 | — | 25,528 | ||||||||||||||||
Liability for policy and contract claims | — | — | 7,204 | — | 7,204 | ||||||||||||||||
Unearned premiums | — | — | 4,107 | — | 4,107 | ||||||||||||||||
Other liabilities | (3 | ) | 365 | 3,739 | (5 | ) | 4,096 | ||||||||||||||
Intercompany notes payable | — | 601 | 248 | (849 | ) | — | |||||||||||||||
Borrowings related to securitization entities | — | — | 242 | — | 242 | ||||||||||||||||
Non-recourse funding obligations | — | — | 2,038 | — | 2,038 | ||||||||||||||||
Long-term borrowings | — | 4,636 | 525 | — | 5,161 | ||||||||||||||||
Deferred tax liability | (26 | ) | (796 | ) | 1,028 | — | 206 | ||||||||||||||
Separate account liabilities | — | — | 10,138 | — | 10,138 | ||||||||||||||||
Total liabilities | (29 | ) | 4,806 | 88,502 | (854 | ) | 92,425 | ||||||||||||||
Stockholders’ equity: | |||||||||||||||||||||
Common stock | 1 | — | — | — | 1 | ||||||||||||||||
Additional paid-in capital | 12,127 | 9,297 | 17,215 | (26,512 | ) | 12,127 | |||||||||||||||
Accumulated other comprehensive income (loss) | 2,542 | 2,507 | 2,512 | (5,019 | ) | 2,542 | |||||||||||||||
Retained earnings | 2,423 | 303 | (2,551 | ) | 2,248 | 2,423 | |||||||||||||||
Treasury stock, at cost | (2,700 | ) | — | — | — | (2,700 | ) | ||||||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity | 14,393 | 12,107 | 17,176 | (29,283 | ) | 14,393 | |||||||||||||||
Noncontrolling interests | — | — | 1,232 | (5 | ) | 1,227 | |||||||||||||||
Total stockholders’ equity | 14,393 | 12,107 | 18,408 | (29,288 | ) | 15,620 | |||||||||||||||
Total liabilities and stockholders’ equity | $ | 14,364 | $ | 16,913 | $ | 106,910 | $ | (30,142 | ) | $ | 108,045 | ||||||||||
The following table presents the condensed consolidating income statement information for the year ended December 31, 2014: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||
Premiums | $ | — | $ | — | $ | 5,431 | $ | — | $ | 5,431 | |||||||||||
Net investment income | (2 | ) | — | 3,259 | (15 | ) | 3,242 | ||||||||||||||
Net investment gains (losses) | — | 4 | (24 | ) | — | (20 | ) | ||||||||||||||
Insurance and investment product fees and other | — | (4 | ) | 917 | (1 | ) | 912 | ||||||||||||||
Total revenues | (2 | ) | — | 9,583 | (16 | ) | 9,565 | ||||||||||||||
Benefits and expenses: | |||||||||||||||||||||
Benefits and other changes in policy reserves | — | — | 6,620 | — | 6,620 | ||||||||||||||||
Interest credited | — | — | 737 | — | 737 | ||||||||||||||||
Acquisition and operating expenses, net of deferrals | 21 | — | 1,564 | — | 1,585 | ||||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 571 | — | 571 | ||||||||||||||||
Goodwill impairment | — | — | 849 | — | 849 | ||||||||||||||||
Interest expense | — | 321 | 174 | (16 | ) | 479 | |||||||||||||||
Total benefits and expenses | 21 | 321 | 10,515 | (16 | ) | 10,841 | |||||||||||||||
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries | (23 | ) | (321 | ) | (932 | ) | — | (1,276 | ) | ||||||||||||
Provision (benefit) for income taxes | (8 | ) | (112 | ) | (104 | ) | (4 | ) | (228 | ) | |||||||||||
Equity in income (loss) of subsidiaries | (1,229 | ) | (1,147 | ) | — | 2,376 | — | ||||||||||||||
Income (loss) from continuing operations | (1,244 | ) | (1,356 | ) | (828 | ) | 2,380 | (1,048 | ) | ||||||||||||
Income from discontinued operations, net of taxes | — | — | — | — | — | ||||||||||||||||
Net income (loss) | (1,244 | ) | (1,356 | ) | (828 | ) | 2,380 | (1,048 | ) | ||||||||||||
Less: net income attributable to noncontrolling interests | — | — | 196 | — | 196 | ||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | $ | (1,356 | ) | $ | (1,024 | ) | $ | 2,380 | $ | (1,244 | ) | |||||||
The following table presents the condensed consolidating income statement information for the year ended December 31, 2013: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||
Premiums | $ | — | $ | — | $ | 5,148 | $ | — | $ | 5,148 | |||||||||||
Net investment income | (1 | ) | 1 | 3,286 | (15 | ) | 3,271 | ||||||||||||||
Net investment gains (losses) | — | 6 | (43 | ) | — | (37 | ) | ||||||||||||||
Insurance and investment product fees and other | — | — | 1,025 | (4 | ) | 1,021 | |||||||||||||||
Total revenues | (1 | ) | 7 | 9,416 | (19 | ) | 9,403 | ||||||||||||||
Benefits and expenses: | |||||||||||||||||||||
Benefits and other changes in policy reserves | — | — | 4,895 | — | 4,895 | ||||||||||||||||
Interest credited | — | — | 738 | — | 738 | ||||||||||||||||
Acquisition and operating expenses, net of deferrals | 33 | 32 | 1,594 | — | 1,659 | ||||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 569 | — | 569 | ||||||||||||||||
Interest expense | — | 322 | 189 | (19 | ) | 492 | |||||||||||||||
Total benefits and expenses | 33 | 354 | 7,985 | (19 | ) | 8,353 | |||||||||||||||
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries | (34 | ) | (347 | ) | 1,431 | — | 1,050 | ||||||||||||||
Provision (benefit) for income taxes | 13 | (120 | ) | 431 | — | 324 | |||||||||||||||
Equity in income of subsidiaries | 607 | 796 | — | (1,403 | ) | — | |||||||||||||||
Income from continuing operations | 560 | 569 | 1,000 | (1,403 | ) | 726 | |||||||||||||||
Income (loss) from discontinued operations, net of taxes | — | (29 | ) | 17 | — | (12 | ) | ||||||||||||||
Net income | 560 | 540 | 1,017 | (1,403 | ) | 714 | |||||||||||||||
Less: net income attributable to noncontrolling interests | — | — | 154 | — | 154 | ||||||||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders | $ | 560 | $ | 540 | $ | 863 | $ | (1,403 | ) | $ | 560 | ||||||||||
The following table presents the condensed consolidating income statement information for the year ended December 31, 2012: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||
Premiums | $ | — | $ | — | $ | 5,041 | $ | — | $ | 5,041 | |||||||||||
Net investment income | — | 1 | 3,357 | (15 | ) | 3,343 | |||||||||||||||
Net investment gains (losses) | — | (29 | ) | 56 | — | 27 | |||||||||||||||
Insurance and investment product fees and other | — | (1 | ) | 1,234 | (4 | ) | 1,229 | ||||||||||||||
Total revenues | — | (29 | ) | 9,688 | (19 | ) | 9,640 | ||||||||||||||
Benefits and expenses: | |||||||||||||||||||||
Benefits and other changes in policy reserves | — | — | 5,378 | — | 5,378 | ||||||||||||||||
Interest credited | — | — | 775 | — | 775 | ||||||||||||||||
Acquisition and operating expenses, net of deferrals | 7 | 8 | 1,579 | — | 1,594 | ||||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 722 | — | 722 | ||||||||||||||||
Goodwill impairment | — | — | 89 | — | 89 | ||||||||||||||||
Interest expense | — | 315 | 179 | (18 | ) | 476 | |||||||||||||||
Total benefits and expenses | 7 | 323 | 8,722 | (18 | ) | 9,034 | |||||||||||||||
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries | (7 | ) | (352 | ) | 966 | (1 | ) | 606 | |||||||||||||
Provision (benefit) for income taxes | (3 | ) | (110 | ) | 251 | — | 138 | ||||||||||||||
Equity in income (loss) of subsidiaries | 329 | 636 | (38 | ) | (927 | ) | — | ||||||||||||||
Income from continuing operations | 325 | 394 | 677 | (928 | ) | 468 | |||||||||||||||
Income from discontinued operations, net of taxes | — | — | 57 | — | 57 | ||||||||||||||||
Net income | 325 | 394 | 734 | (928 | ) | 525 | |||||||||||||||
Less: net income attributable to noncontrolling interests | — | — | 200 | — | 200 | ||||||||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders | $ | 325 | $ | 394 | $ | 534 | $ | (928 | ) | $ | 325 | ||||||||||
The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2014: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Net income (loss) | $ | (1,244 | ) | $ | (1,356 | ) | $ | (828 | ) | $ | 2,380 | $ | (1,048 | ) | |||||||
Other comprehensive income (loss), net of taxes: | |||||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,539 | 1,510 | 1,573 | (3,049 | ) | 1,573 | |||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 10 | 11 | 10 | (21 | ) | 10 | |||||||||||||||
Derivatives qualifying as hedges | 751 | 751 | 794 | (1,545 | ) | 751 | |||||||||||||||
Foreign currency translation and other adjustments | (339 | ) | (273 | ) | (537 | ) | 612 | (537 | ) | ||||||||||||
Total other comprehensive income (loss) | 1,961 | 1,999 | 1,840 | (4,003 | ) | 1,797 | |||||||||||||||
Total comprehensive income (loss) | 717 | 643 | 1,012 | (1,623 | ) | 749 | |||||||||||||||
Less: comprehensive income attributable to noncontrolling interests | — | — | 32 | — | 32 | ||||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | 717 | $ | 643 | $ | 980 | $ | (1,623 | ) | $ | 717 | ||||||||||
The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2013: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Net income | $ | 560 | $ | 540 | $ | 1,017 | $ | (1,403 | ) | $ | 714 | ||||||||||
Other comprehensive income (loss), net of taxes: | |||||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | (1,778 | ) | (1,733 | ) | (1,817 | ) | 3,511 | (1,817 | ) | ||||||||||||
Net unrealized gains (losses) on other-than- temporarily impaired securities | 66 | 65 | 66 | (131 | ) | 66 | |||||||||||||||
Derivatives qualifying as hedges | (590 | ) | (590 | ) | (615 | ) | 1,205 | (590 | ) | ||||||||||||
Foreign currency translation and other adjustments | (358 | ) | (335 | ) | (442 | ) | 693 | (442 | ) | ||||||||||||
Total other comprehensive income (loss) | (2,660 | ) | (2,593 | ) | (2,808 | ) | 5,278 | (2,783 | ) | ||||||||||||
Total comprehensive income (loss) | (2,100 | ) | (2,053 | ) | (1,791 | ) | 3,875 | (2,069 | ) | ||||||||||||
Less: comprehensive income attributable to noncontrolling interests | — | — | 31 | — | 31 | ||||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (2,100 | ) | $ | (2,053 | ) | $ | (1,822 | ) | $ | 3,875 | $ | (2,100 | ) | |||||||
The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2012: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Net income | $ | 325 | $ | 394 | $ | 734 | $ | (928 | ) | $ | 525 | ||||||||||
Other comprehensive income (loss), net of taxes: | |||||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,075 | 1,046 | 1,078 | (2,121 | ) | 1,078 | |||||||||||||||
Net unrealized gains (losses) on other-than- temporarily impaired securities | 78 | 78 | 78 | (156 | ) | 78 | |||||||||||||||
Derivatives qualifying as hedges | (100 | ) | (100 | ) | (98 | ) | 198 | (100 | ) | ||||||||||||
Foreign currency translation and other adjustments | 102 | 81 | 126 | (183 | ) | 126 | |||||||||||||||
Total other comprehensive income (loss) | 1,155 | 1,105 | 1,184 | (2,262 | ) | 1,182 | |||||||||||||||
Total comprehensive income (loss) | 1,480 | 1,499 | 1,918 | (3,190 | ) | 1,707 | |||||||||||||||
Less: comprehensive income attributable to noncontrolling interests | — | — | 227 | — | 227 | ||||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | 1,480 | $ | 1,499 | $ | 1,691 | $ | (3,190 | ) | $ | 1,480 | ||||||||||
The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2014: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||
Net income (loss) | $ | (1,244 | ) | $ | (1,356 | ) | $ | (828 | ) | $ | 2,380 | $ | (1,048 | ) | |||||||
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||||||||||||||||||||
Equity in (income) loss from subsidiaries | 1,229 | 1,147 | — | (2,376 | ) | — | |||||||||||||||
Dividends from subsidiaries | — | 630 | (630 | ) | — | — | |||||||||||||||
Amortization of fixed maturity discounts and premiums and limited partnerships | — | — | (97 | ) | — | (97 | ) | ||||||||||||||
Net investment losses (gains) | — | (4 | ) | 24 | — | 20 | |||||||||||||||
Charges assessed to policyholders | — | — | (777 | ) | — | (777 | ) | ||||||||||||||
Acquisition costs deferred | — | — | (473 | ) | — | (473 | ) | ||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 571 | — | 571 | ||||||||||||||||
Goodwill impairment | — | — | 849 | — | 849 | ||||||||||||||||
Deferred income taxes | 4 | (146 | ) | (341 | ) | (4 | ) | (487 | ) | ||||||||||||
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | — | 1 | 205 | — | 206 | ||||||||||||||||
Stock-based compensation expense | 21 | — | 9 | — | 30 | ||||||||||||||||
Change in certain assets and liabilities: | |||||||||||||||||||||
Accrued investment income and other assets | (4 | ) | (9 | ) | (117 | ) | 1 | (129 | ) | ||||||||||||
Insurance reserves | — | — | 3,212 | — | 3,212 | ||||||||||||||||
Current tax liabilities | (2 | ) | (77 | ) | (101 | ) | — | (180 | ) | ||||||||||||
Other liabilities, policy and contract claims and other policy-related balances | 11 | 91 | 645 | (6 | ) | 741 | |||||||||||||||
Net cash from operating activities | 15 | 277 | 2,151 | (5 | ) | 2,438 | |||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||
Proceeds from maturities and repayments of investments: | |||||||||||||||||||||
Fixed maturity securities | — | 150 | 5,214 | — | 5,364 | ||||||||||||||||
Commercial mortgage loans | — | — | 765 | — | 765 | ||||||||||||||||
Restricted commercial mortgage loans related to securitization entities | — | — | 32 | — | 32 | ||||||||||||||||
Proceeds from sales of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | — | 2,490 | — | 2,490 | ||||||||||||||||
Purchases and originations of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | (150 | ) | (9,342 | ) | — | (9,492 | ) | |||||||||||||
Commercial mortgage loans | — | — | (967 | ) | — | (967 | ) | ||||||||||||||
Other invested assets, net | — | — | (45 | ) | 5 | (40 | ) | ||||||||||||||
Policy loans, net | — | — | 12 | — | 12 | ||||||||||||||||
Intercompany notes receivable | (1 | ) | (19 | ) | (2 | ) | 22 | — | |||||||||||||
Capital contributions to subsidiaries | (12 | ) | — | 12 | — | — | |||||||||||||||
Net cash from investing activities | (13 | ) | (19 | ) | (1,831 | ) | 27 | (1,836 | ) | ||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||
Deposits to universal life and investment contracts | — | — | 2,993 | — | 2,993 | ||||||||||||||||
Withdrawals from universal life and investment contracts | — | — | (2,588 | ) | — | (2,588 | ) | ||||||||||||||
Redemption and repurchase of non-recourse funding obligations | — | — | (42 | ) | — | (42 | ) | ||||||||||||||
Proceeds from the issuance of long-term debt | — | — | 144 | — | 144 | ||||||||||||||||
Repayment and repurchase of long-term debt | — | (485 | ) | (136 | ) | — | (621 | ) | |||||||||||||
Repayment of borrowings related to securitization entities | — | — | (32 | ) | — | (32 | ) | ||||||||||||||
Proceeds from intercompany notes payable | — | 3 | 19 | (22 | ) | — | |||||||||||||||
Repurchase of subsidiary shares | — | — | (28 | ) | — | (28 | ) | ||||||||||||||
Dividends paid to noncontrolling interests | — | — | (75 | ) | — | (75 | ) | ||||||||||||||
Dividends paid to parent | — | — | — | — | — | ||||||||||||||||
Proceeds from the sale of subsidiary shares to noncontrolling interests | — | — | 517 | — | 517 | ||||||||||||||||
Other, net | (2 | ) | (42 | ) | (19 | ) | — | (63 | ) | ||||||||||||
Net cash from financing activities | (2 | ) | (524 | ) | 753 | (22 | ) | 205 | |||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | (103 | ) | — | (103 | ) | ||||||||||||||
Net change in cash and cash equivalents | — | (266 | ) | 970 | — | 704 | |||||||||||||||
Cash and cash equivalents at beginning of period | — | 1,219 | 2,995 | — | 4,214 | ||||||||||||||||
Cash and cash equivalents at end of period | $ | — | $ | 953 | $ | 3,965 | $ | — | $ | 4,918 | |||||||||||
The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2013: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||
Net income | $ | 560 | $ | 540 | $ | 1,017 | $ | (1,403 | ) | $ | 714 | ||||||||||
Less (income) loss from discontinued operations, net of taxes | — | 29 | (17 | ) | — | 12 | |||||||||||||||
Adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||
Equity in earnings from subsidiaries | (607 | ) | (796 | ) | — | 1,403 | — | ||||||||||||||
Dividends from subsidiaries | 535 | 376 | (497 | ) | (414 | ) | — | ||||||||||||||
Amortization of fixed maturity discounts and premiums and limited partnerships | — | — | (97 | ) | — | (97 | ) | ||||||||||||||
Net investment losses (gains) | — | (6 | ) | 43 | — | 37 | |||||||||||||||
Charges assessed to policyholders | — | — | (812 | ) | — | (812 | ) | ||||||||||||||
Acquisition costs deferred | — | — | (457 | ) | — | (457 | ) | ||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 569 | — | 569 | ||||||||||||||||
Deferred income taxes | 24 | (138 | ) | 35 | — | (79 | ) | ||||||||||||||
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | — | 1 | (60 | ) | — | (59 | ) | ||||||||||||||
Stock-based compensation expense | 26 | — | 15 | — | 41 | ||||||||||||||||
Change in certain assets and liabilities: | |||||||||||||||||||||
Accrued investment income and other assets | 2 | 67 | (112 | ) | — | (43 | ) | ||||||||||||||
Insurance reserves | — | — | 2,256 | — | 2,256 | ||||||||||||||||
Current tax liabilities | 3 | 45 | 240 | — | 288 | ||||||||||||||||
Other liabilities, policy and contract claims and other policy-related balances | (4 | ) | (11 | ) | (1,024 | ) | — | (1,039 | ) | ||||||||||||
Cash from operating activities—discontinued operations | — | — | 68 | — | 68 | ||||||||||||||||
Net cash from operating activities | 539 | 107 | 1,167 | (414 | ) | 1,399 | |||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||
Proceeds from maturities and repayments of investments: | |||||||||||||||||||||
Fixed maturity securities | — | — | 5,040 | — | 5,040 | ||||||||||||||||
Commercial mortgage loans | — | — | 896 | — | 896 | ||||||||||||||||
Restricted commercial mortgage loans related to securitization entities | — | — | 60 | — | 60 | ||||||||||||||||
Proceeds from sales of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | 150 | 4,286 | — | 4,436 | ||||||||||||||||
Purchases and originations of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | (150 | ) | (10,655 | ) | — | (10,805 | ) | |||||||||||||
Commercial mortgage loans | — | — | (873 | ) | — | (873 | ) | ||||||||||||||
Other invested assets, net | — | — | 89 | — | 89 | ||||||||||||||||
Policy loans, net | — | — | 242 | — | 242 | ||||||||||||||||
Intercompany notes receivable | (8 | ) | (3 | ) | 95 | (84 | ) | — | |||||||||||||
Capital contributions to subsidiaries | (531 | ) | (1 | ) | 532 | — | — | ||||||||||||||
Proceeds from sale of a subsidiary, net of cash transferred | — | 425 | (60 | ) | — | 365 | |||||||||||||||
Cash from investing activities—discontinued operations | — | (30 | ) | — | — | (30 | ) | ||||||||||||||
Net cash from investing activities | (539 | ) | 391 | (348 | ) | (84 | ) | (580 | ) | ||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||
Deposits to universal life and investment contracts | — | — | 2,999 | — | 2,999 | ||||||||||||||||
Withdrawals from universal life and investment contracts | — | — | (3,269 | ) | — | (3,269 | ) | ||||||||||||||
Redemption and repurchase of non-recourse funding obligations | — | — | (28 | ) | — | (28 | ) | ||||||||||||||
Proceeds from the issuance of long-term debt | — | 793 | — | — | 793 | ||||||||||||||||
Repayment and repurchase of long-term debt | — | (365 | ) | — | — | (365 | ) | ||||||||||||||
Repayment of borrowings related to securitization entities | — | — | (108 | ) | — | (108 | ) | ||||||||||||||
Proceeds from intercompany notes payable | — | (87 | ) | 3 | 84 | — | |||||||||||||||
Repurchase of subsidiary shares | — | — | (43 | ) | — | (43 | ) | ||||||||||||||
Dividends paid to noncontrolling interests | — | — | (52 | ) | — | (52 | ) | ||||||||||||||
Dividends paid to parent | — | (414 | ) | — | 414 | — | |||||||||||||||
Other, net | — | (49 | ) | (24 | ) | — | (73 | ) | |||||||||||||
Cash from financing activities—discontinued operations | — | — | (3 | ) | — | (3 | ) | ||||||||||||||
Net cash from financing activities | — | (122 | ) | (525 | ) | 498 | (149 | ) | |||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | (109 | ) | — | (109 | ) | ||||||||||||||
Net change in cash and cash equivalents | — | 376 | 185 | — | 561 | ||||||||||||||||
Cash and cash equivalents at beginning of period | — | 843 | 2,810 | — | 3,653 | ||||||||||||||||
Cash and cash equivalents at end of period | — | 1,219 | 2,995 | — | 4,214 | ||||||||||||||||
Less cash and cash equivalents of discontinued operations at end of period | — | — | — | — | — | ||||||||||||||||
Cash and cash equivalents of continuing operations at end of period | $ | — | $ | 1,219 | $ | 2,995 | $ | — | $ | 4,214 | |||||||||||
The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2012: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||
Net income | $ | 325 | $ | 394 | $ | 734 | $ | (928 | ) | $ | 525 | ||||||||||
Less income from discontinued operations, net of taxes | — | — | (57 | ) | — | (57 | ) | ||||||||||||||
Adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||
Equity in (income) loss from subsidiaries | (329 | ) | (636 | ) | 38 | 927 | — | ||||||||||||||
Dividends from subsidiaries | — | 545 | (545 | ) | — | — | |||||||||||||||
Amortization of fixed maturity discounts and premiums and limited partnerships | — | — | (88 | ) | — | (88 | ) | ||||||||||||||
Net investment losses (gains) | — | 29 | (56 | ) | — | (27 | ) | ||||||||||||||
Charges assessed to policyholders | — | — | (801 | ) | — | (801 | ) | ||||||||||||||
Acquisition costs deferred | — | — | (611 | ) | — | (611 | ) | ||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 722 | — | 722 | ||||||||||||||||
Goodwill impairment | — | — | 89 | — | 89 | ||||||||||||||||
Deferred income taxes | (3 | ) | (274 | ) | 359 | — | 82 | ||||||||||||||
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | — | (27 | ) | 218 | — | 191 | |||||||||||||||
Stock-based compensation expense | 7 | 16 | 3 | — | 26 | ||||||||||||||||
Change in certain assets and liabilities: | |||||||||||||||||||||
Accrued investment income and other assets | — | 53 | (122 | ) | 1 | (68 | ) | ||||||||||||||
Insurance reserves | — | — | 2,330 | — | 2,330 | ||||||||||||||||
Current tax liabilities | — | (43 | ) | (191 | ) | — | (234 | ) | |||||||||||||
Other liabilities, policy and contract claims and other policy-related balances | — | 10 | (1,181 | ) | 5 | (1,166 | ) | ||||||||||||||
Cash from operating activities—discontinued operations | — | — | 49 | — | 49 | ||||||||||||||||
Net cash from operating activities | — | 67 | 890 | 5 | 962 | ||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||
Proceeds from maturities and repayments of investments: | |||||||||||||||||||||
Fixed maturity securities | — | — | 5,176 | — | 5,176 | ||||||||||||||||
Commercial mortgage loans | — | — | 891 | — | 891 | ||||||||||||||||
Restricted commercial mortgage loans related to securitization entities | — | — | 67 | — | 67 | ||||||||||||||||
Proceeds from sales of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | 10 | 5,725 | — | 5,735 | ||||||||||||||||
Purchases and originations of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | (150 | ) | (12,172 | ) | — | (12,322 | ) | |||||||||||||
Commercial mortgage loans | — | — | (692 | ) | — | (692 | ) | ||||||||||||||
Other invested assets, net | — | 30 | 391 | (5 | ) | 416 | |||||||||||||||
Policy loans, net | — | — | (29 | ) | — | (29 | ) | ||||||||||||||
Intercompany notes receivable | — | (31 | ) | (58 | ) | 89 | — | ||||||||||||||
Capital contributions to subsidiaries | — | (20 | ) | 20 | — | — | |||||||||||||||
Proceeds from sale of a subsidiary, net of cash transferred | — | — | 77 | — | 77 | ||||||||||||||||
Cash from investing activities—discontinued operations | — | (18 | ) | (23 | ) | — | (41 | ) | |||||||||||||
Net cash from investing activities | — | (179 | ) | (627 | ) | 84 | (722 | ) | |||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||
Deposits to universal life and investment contracts | — | — | 2,810 | — | 2,810 | ||||||||||||||||
Withdrawals from universal life and investment contracts | — | — | (2,781 | ) | — | (2,781 | ) | ||||||||||||||
Redemption and repurchase of non-recourse funding obligations | — | — | (1,056 | ) | — | (1,056 | ) | ||||||||||||||
Proceeds from the issuance of long-term debt | — | 361 | — | — | 361 | ||||||||||||||||
Repayment and repurchase of long-term debt | — | (322 | ) | — | — | (322 | ) | ||||||||||||||
Repayment of borrowings related to securitization entities | — | — | (72 | ) | — | (72 | ) | ||||||||||||||
Proceeds from intercompany notes payable | — | 58 | 31 | (89 | ) | — | |||||||||||||||
Dividends paid to noncontrolling interests | — | — | (50 | ) | — | (50 | ) | ||||||||||||||
Other, net | — | (49 | ) | 103 | — | 54 | |||||||||||||||
Cash from financing activities—discontinued operations | — | — | (45 | ) | — | (45 | ) | ||||||||||||||
Net cash from financing activities | — | 48 | (1,060 | ) | (89 | ) | (1,101 | ) | |||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | 26 | — | 26 | ||||||||||||||||
Net change in cash and cash equivalents | — | (64 | ) | (771 | ) | — | (835 | ) | |||||||||||||
Cash and cash equivalents at beginning of period | — | 907 | 3,581 | — | 4,488 | ||||||||||||||||
Cash and cash equivalents at end of period | — | 843 | 2,810 | — | 3,653 | ||||||||||||||||
Less cash and cash equivalents of discontinued operations at end of period | — | — | 21 | — | 21 | ||||||||||||||||
Cash and cash equivalents of continuing operations at end of period | $ | — | $ | 843 | $ | 2,789 | $ | — | $ | 3,632 | |||||||||||
For information on significant restrictions on dividends by, or loans or advances from, subsidiaries of Genworth Financial and Genworth Holdings, and the restricted net assets of those subsidiaries, see note 19. |
Schedule_I_Genworth_Financial_
Schedule I Genworth Financial, Inc. Summary of investments-other than investments in related parties | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Schedule I Genworth Financial, Inc. Summary of investments-other than investments in related parties | Schedule I | ||||||||||||
Genworth Financial, Inc. | |||||||||||||
Summary of Investments—Other Than Investments in Related Parties | |||||||||||||
(Amounts in millions) | |||||||||||||
As of December 31, 2014, the amortized cost or cost, fair value and carrying value of our invested assets were as follows: | |||||||||||||
Type of investment | Amortized cost | Fair | Carrying | ||||||||||
or cost | value | value | |||||||||||
Fixed maturity securities: | |||||||||||||
Bonds: | |||||||||||||
U.S. government, agencies and authorities | $ | 5,006 | $ | 6,000 | $ | 6,000 | |||||||
Tax-exempt | 347 | 362 | 362 | ||||||||||
Government—non-U.S. | 1,952 | 2,106 | 2,106 | ||||||||||
Public utilities | 3,551 | 4,167 | 4,167 | ||||||||||
All other corporate bonds | 46,094 | 49,812 | 49,812 | ||||||||||
Total fixed maturity securities | 56,950 | 62,447 | 62,447 | ||||||||||
Equity securities | 253 | 282 | 282 | ||||||||||
Commercial mortgage loans | 6,100 | xxxxx | 6,100 | ||||||||||
Restricted commercial mortgage loans related to securitization entities | 201 | xxxxx | 201 | ||||||||||
Policy loans | 1,501 | xxxxx | 1,501 | ||||||||||
Other invested assets (1) | 1,132 | xxxxx | 2,296 | ||||||||||
Restricted other invested assets related to securitization entities | 411 | xxxxx | 411 | ||||||||||
Total investments | $ | 66,548 | xxxxx | $ | 73,238 | ||||||||
(1) | The amount shown in the consolidated balance sheet for other invested assets differs from amortized cost or cost presented, as other invested assets include certain assets with a carrying amount that differs from amortized cost or cost. | ||||||||||||
See Accompanying Report of Independent Registered Public Accounting Firm |
Schedule_II_Genworth_Financial
Schedule II Genworth Financial, Inc. (Parent Company Only) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Schedule II Genworth Financial, Inc. (Parent Company Only) | Schedule II | ||||||||||||
Genworth Financial, Inc. | |||||||||||||
(Parent Company Only) | |||||||||||||
Balance Sheets | |||||||||||||
(Amounts in millions) | |||||||||||||
December 31, | |||||||||||||
2014 | 2013 | ||||||||||||
Assets | |||||||||||||
Investments in subsidiaries | $ | 14,895 | $ | 14,358 | |||||||||
Deferred tax asset | 20 | 26 | |||||||||||
Other assets | 2 | 7 | |||||||||||
Intercompany notes receivable | 9 | 8 | |||||||||||
Total assets | $ | 14,926 | $ | 14,399 | |||||||||
Liabilities and stockholders’ equity | |||||||||||||
Liabilities: | |||||||||||||
Other liabilities | $ | 3 | $ | 6 | |||||||||
Total liabilities | 3 | 6 | |||||||||||
Commitments and contingencies | |||||||||||||
Stockholders’ equity: | |||||||||||||
Common stock | 1 | 1 | |||||||||||
Additional paid-in capital | 11,997 | 12,127 | |||||||||||
Accumulated other comprehensive income (loss): | |||||||||||||
Net unrealized investment gains (losses): | |||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 2,431 | 914 | |||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 22 | 12 | |||||||||||
Net unrealized investment gains (losses) | 2,453 | 926 | |||||||||||
Derivatives qualifying as hedges | 2,070 | 1,319 | |||||||||||
Foreign currency translation and other adjustments | (77 | ) | 297 | ||||||||||
Total accumulated other comprehensive income (loss) | 4,446 | 2,542 | |||||||||||
Retained earnings | 1,179 | 2,423 | |||||||||||
Treasury stock, at cost | (2,700 | ) | (2,700 | ) | |||||||||
Total Genworth Financial, Inc.’s stockholders’ equity | 14,923 | 14,393 | |||||||||||
Total liabilities and stockholders’ equity | $ | 14,926 | $ | 14,399 | |||||||||
See Notes to Schedule II | |||||||||||||
See Accompanying Report of Independent Registered Public Accounting Firm | |||||||||||||
Schedule II | |||||||||||||
Genworth Financial, Inc. | |||||||||||||
(Parent Company Only) | |||||||||||||
Statements of Income | |||||||||||||
(Amounts in millions) | |||||||||||||
Years ended December 31, | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Revenues: | |||||||||||||
Net investment income | $ | (2 | ) | $ | (1 | ) | $ | — | |||||
Total revenues | (2 | ) | (1 | ) | — | ||||||||
Benefits and expenses: | |||||||||||||
Acquisition and operating expenses, net of deferrals | 21 | 33 | 7 | ||||||||||
Total benefits and expenses | 21 | 33 | 7 | ||||||||||
Loss before income taxes and equity in income (loss) of subsidiaries | (23 | ) | (34 | ) | (7 | ) | |||||||
Provision (benefit) from income taxes | (8 | ) | 13 | (3 | ) | ||||||||
Equity in income (loss) of subsidiaries | (1,229 | ) | 607 | 329 | |||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | $ | 560 | $ | 325 | ||||||
See Notes to Schedule II | |||||||||||||
See Accompanying Report of Independent Registered Public Accounting Firm | |||||||||||||
Schedule II | |||||||||||||
Genworth Financial, Inc. | |||||||||||||
(Parent Company Only) | |||||||||||||
Statements of Comprehensive Income | |||||||||||||
(Amounts in millions) | |||||||||||||
Years ended December 31, | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | $ | 560 | $ | 325 | ||||||
Other comprehensive income (loss), net of taxes: | |||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,539 | (1,778 | ) | 1,075 | |||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 10 | 66 | 78 | ||||||||||
Derivatives qualifying as hedges | 751 | (590 | ) | (100 | ) | ||||||||
Foreign currency translation and other adjustments | (339 | ) | (358 | ) | 102 | ||||||||
Total other comprehensive income (loss) | 1,961 | (2,660 | ) | 1,155 | |||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | 717 | $ | (2,100 | ) | $ | 1,480 | ||||||
See Notes to Schedule II | |||||||||||||
See Accompanying Report of Independent Registered Public Accounting Firm | |||||||||||||
Schedule II | |||||||||||||
Genworth Financial, Inc. | |||||||||||||
(Parent Company Only) | |||||||||||||
Statements of Cash Flows | |||||||||||||
(Amounts in millions) | |||||||||||||
Years ended December 31, | |||||||||||||
2014 | 2013 | 2012 | |||||||||||
Cash flows from operating activities: | |||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | $ | 560 | $ | 325 | ||||||
Adjustments to reconcile net income (loss) available to Genworth Financial, Inc.’s common stockholders to net cash from operating activities: | |||||||||||||
Equity in (income) loss from subsidiaries | 1,229 | (607 | ) | (329 | ) | ||||||||
Dividends from subsidiaries | — | 535 | — | ||||||||||
Deferred income taxes | 4 | 24 | (3 | ) | |||||||||
Stock-based compensation expense | 21 | 26 | 7 | ||||||||||
Change in certain assets and liabilities: | |||||||||||||
Accrued investment income and other assets | (4 | ) | 2 | — | |||||||||
Current tax liabilities | (2 | ) | 3 | — | |||||||||
Other liabilities and other policy-related balances | 11 | (4 | ) | — | |||||||||
Net cash from operating activities | 15 | 539 | — | ||||||||||
Cash flows from investing activities: | |||||||||||||
Intercompany notes receivable | (1 | ) | (8 | ) | — | ||||||||
Capital contribution paid to subsidiaries | (12 | ) | (531 | ) | — | ||||||||
Net cash from investing activities | (13 | ) | (539 | ) | — | ||||||||
Cash flows from financing activities: | |||||||||||||
Other, net | (2 | ) | — | — | |||||||||
Net cash from financing activities | (2 | ) | — | — | |||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | |||||||||||
Cash and cash equivalents at beginning of year | — | — | — | ||||||||||
Cash and cash equivalents at end of year | $ | — | $ | — | $ | — | |||||||
See Notes to Schedule II | |||||||||||||
See Accompanying Report of Independent Registered Public Accounting Firm | |||||||||||||
Schedule II | |||||||||||||
Genworth Financial, Inc. | |||||||||||||
(Parent Company Only) | |||||||||||||
Notes to Schedule II | |||||||||||||
Years Ended December 31, 2014, 2013 and 2012 | |||||||||||||
(1) Organization and Purpose | |||||||||||||
Genworth Holdings, Inc. (“Genworth Holdings”) (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an initial public offering (“IPO”) of Genworth common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, under the name Sub XLVI, Inc., and was renamed Genworth Financial, Inc. (“Genworth Financial”) upon the completion of the reorganization. | |||||||||||||
To implement the reorganization, Genworth Holdings formed Genworth Financial and Genworth Financial, in turn, formed Sub XLII, Inc. (“Merger Sub”). The holding company structure was implemented pursuant to Section 251(g) of the General Corporation Law of the State of Delaware (“DGCL”) by the merger of Merger Sub with and into Genworth Holdings (the “Merger”). Genworth Holdings survived the Merger as a direct, 100% owned subsidiary of Genworth Financial and each share of Genworth Holdings Class A Common Stock, par value $0.001 per share (“Genworth Holdings Class A Common Stock”), issued and outstanding immediately prior to the Merger and each share of Genworth Holdings Class A Common Stock held in the treasury of Genworth Holdings immediately prior to the Merger converted into one issued and outstanding or treasury, as applicable, share of Genworth Financial Class A Common Stock, par value $0.001 per share, having the same designations, rights, powers and preferences and the qualifications, limitations and restrictions as the Genworth Holdings Class A Common Stock being converted. | |||||||||||||
Immediately after the consummation of the Merger, Genworth Financial had the same authorized, outstanding and treasury capital stock as Genworth Holdings immediately prior to the Merger. Each share of Genworth Financial common stock outstanding immediately prior to the Merger was cancelled. Effective upon the consummation of the Merger, Genworth Financial adopted an amended and restated certificate of incorporation and amended and restated bylaws that were identical to those of Genworth Holdings immediately prior to the consummation of the Merger (other than provisions regarding certain technical matters, as permitted by Section 251(g) of the DGCL). Genworth Financial’s directors and executive officers immediately after the consummation of the Merger were the same as the directors and executive officers of Genworth Holdings immediately prior to the consummation of the Merger. Immediately after the consummation of the Merger, Genworth Financial had, on a consolidated basis, the same assets, businesses and operations as Genworth Holdings had immediately prior to the consummation of the Merger. | |||||||||||||
On April 1, 2013, in connection with the reorganization, immediately following the consummation of the Merger, Genworth Holdings distributed to Genworth Financial (as its sole stockholder), through a dividend (the “Distribution”), the 84.6% membership interest in one of its subsidiaries (Genworth Mortgage Holdings, LLC (“GMHL”)) that it held directly, and 100% of the shares of another of its subsidiaries (Genworth Mortgage Holdings, Inc. (“GMHI”)), that held the remaining 15.4% of outstanding membership interests of GMHL. At the time of the Distribution, GMHL and GMHI together owned (directly or indirectly) 100% of the shares or other equity interests of all of the subsidiaries that conducted Genworth Holdings’ U.S. mortgage insurance business (these subsidiaries also owned the subsidiaries that conducted Genworth Holdings’ European mortgage insurance business). As part of the comprehensive U.S. mortgage insurance capital plan, on April 1, 2013, immediately prior to the Distribution, Genworth Holdings contributed $100 million to the U.S. mortgage insurance subsidiaries. | |||||||||||||
The financial information contained herein has been prepared as if the reorganization occurred on January 1, 2012. | |||||||||||||
Genworth Financial is a holding company whose subsidiaries provide long-term care, life and mortgage insurance, as well as annuities and other investment products. | |||||||||||||
(2) Commitments | |||||||||||||
Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior notes and the holders of the senior notes, on an unsecured unsubordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, each outstanding series of senior notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior notes indenture in respect of such senior notes. Genworth Financial also provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding subordinated notes and the holders of the subordinated notes, on an unsecured subordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the subordinated notes indenture in respect of the subordinated notes. Genworth Financial also provides a full and unconditional guarantee of Genworth Holdings’ obligations associated with Rivermont Insurance Company and the Tax Matters Agreement. | |||||||||||||
The obligations under Genworth Holdings’ credit agreement are unsecured and payment of Genworth Holdings’ obligations is fully and unconditionally guaranteed by Genworth Financial. | |||||||||||||
(3) Income Taxes | |||||||||||||
As of December 31, 2014 and 2013, Genworth Financial had a deferred tax asset of $20 million and $26 million, respectively, primarily comprised of share-based compensation. These amounts are undiscounted pursuant to the applicable rules governing deferred taxes. Genworth Financial’s current income tax receivable was $3 million as of December 31, 2014 and current income tax payable was $6 million as of December 31, 2013. Net cash received for taxes was $23 million and $5 million for the years ended December 31, 2014 and 2013, respectively. |
Schedule_III_Genworth_Financia
Schedule III Genworth Financial, Inc. Supplemental Insurance Information | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||
Schedule III Genworth Financial, Inc. Supplemental Insurance Information | Schedule III | ||||||||||||||||||||||||
Genworth Financial, Inc. | |||||||||||||||||||||||||
Supplemental Insurance Information | |||||||||||||||||||||||||
(Amounts in millions) | |||||||||||||||||||||||||
Segment | Deferred | Future Policy | Policyholder | Liability for Policy | Unearned | ||||||||||||||||||||
Acquisition Costs | Benefits | Account | and Contract Claims | Premiums | |||||||||||||||||||||
Balances | |||||||||||||||||||||||||
31-Dec-14 | |||||||||||||||||||||||||
U.S. Life Insurance | $ | 4,390 | $ | 35,911 | $ | 22,874 | $ | 6,434 | $ | 639 | |||||||||||||||
International Mortgage Insurance | 150 | — | — | 308 | 2,723 | ||||||||||||||||||||
U.S. Mortgage Insurance | 16 | — | — | 1,180 | 178 | ||||||||||||||||||||
International Protection | 193 | — | 11 | 106 | 439 | ||||||||||||||||||||
Runoff | 293 | 4 | 3,158 | 15 | 7 | ||||||||||||||||||||
Corporate and Other | — | — | — | — | — | ||||||||||||||||||||
Total | $ | 5,042 | $ | 35,915 | $ | 26,043 | $ | 8,043 | $ | 3,986 | |||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||
U.S. Life Insurance | $ | 4,537 | $ | 33,700 | $ | 22,210 | $ | 5,216 | $ | 632 | |||||||||||||||
International Mortgage Insurance | 152 | — | — | 378 | 2,815 | ||||||||||||||||||||
U.S. Mortgage Insurance | 12 | — | — | 1,482 | 129 | ||||||||||||||||||||
International Protection | 243 | — | 16 | 108 | 522 | ||||||||||||||||||||
Runoff | 334 | 5 | 3,302 | 20 | 9 | ||||||||||||||||||||
Corporate and Other | — | — | — | — | — | ||||||||||||||||||||
Total | $ | 5,278 | $ | 33,705 | $ | 25,528 | $ | 7,204 | $ | 4,107 | |||||||||||||||
See Accompanying Report of Independent Registered Public Accounting Firm | |||||||||||||||||||||||||
Schedule III—Continued | |||||||||||||||||||||||||
Genworth Financial, Inc. | |||||||||||||||||||||||||
Supplemental Insurance Information | |||||||||||||||||||||||||
(Amounts in millions) | |||||||||||||||||||||||||
Segment | Premium | Net | Interest Credited | Amortization | Other | Premiums | |||||||||||||||||||
Revenue | Investment | and Benefits and | of Deferred | Operating | Written | ||||||||||||||||||||
Income | Other Changes in | Acquisition | Expenses | ||||||||||||||||||||||
Policy Reserves | Costs | ||||||||||||||||||||||||
December 31, 2014 | |||||||||||||||||||||||||
U.S. Life Insurance | $ | 3,169 | $ | 2,665 | $ | 6,438 | $ | 291 | $ | 1,648 | $ | 3,172 | |||||||||||||
International Mortgage Insurance | 950 | 303 | 204 | 50 | 263 | 1,111 | |||||||||||||||||||
U.S. Mortgage Insurance | 578 | 59 | 357 | 5 | 142 | 628 | |||||||||||||||||||
International Protection | 731 | 101 | 202 | 110 | 516 | 709 | |||||||||||||||||||
Runoff | 3 | 129 | 156 | 37 | 87 | 2 | |||||||||||||||||||
Corporate and Other | — | (15 | ) | — | — | 335 | — | ||||||||||||||||||
Total | $ | 5,431 | $ | 3,242 | $ | 7,357 | $ | 493 | $ | 2,991 | $ | 5,622 | |||||||||||||
December 31, 2013 | |||||||||||||||||||||||||
U.S. Life Insurance | $ | 2,957 | $ | 2,621 | $ | 4,594 | $ | 298 | $ | 841 | $ | 2,963 | |||||||||||||
International Mortgage Insurance | 996 | 333 | 317 | 48 | 286 | 1,042 | |||||||||||||||||||
U.S. Mortgage Insurance | 554 | 60 | 412 | 4 | 146 | 567 | |||||||||||||||||||
International Protection | 636 | 119 | 159 | 97 | 484 | 608 | |||||||||||||||||||
Runoff | 5 | 139 | 151 | 4 | 85 | 4 | |||||||||||||||||||
Corporate and Other | — | (1 | ) | — | — | 427 | — | ||||||||||||||||||
Total | $ | 5,148 | $ | 3,271 | $ | 5,633 | $ | 451 | $ | 2,269 | $ | 5,184 | |||||||||||||
December 31, 2012 | |||||||||||||||||||||||||
U.S. Life Insurance | $ | 2,789 | $ | 2,594 | $ | 4,593 | $ | 410 | $ | 830 | $ | 2,818 | |||||||||||||
International Mortgage Insurance | 1,016 | 375 | 516 | 52 | 103 | 1,061 | |||||||||||||||||||
U.S. Mortgage Insurance | 549 | 68 | 725 | 3 | 145 | 554 | |||||||||||||||||||
International Protection | 682 | 131 | 150 | 106 | 624 | 619 | |||||||||||||||||||
Runoff | 5 | 145 | 169 | 47 | 84 | 5 | |||||||||||||||||||
Corporate and Other | — | 30 | — | — | 477 | — | |||||||||||||||||||
Total | $ | 5,041 | $ | 3,343 | $ | 6,153 | $ | 618 | $ | 2,263 | $ | 5,057 | |||||||||||||
See Accompanying Report of Independent Registered Public Accounting Firm |
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Policies) | 12 Months Ended | |||
Dec. 31, 2014 | ||||
Premiums | a) Premiums | |||
For traditional long-duration insurance contracts, we report premiums as earned when due. For short-duration insurance contracts, we report premiums as revenue over the terms of the related insurance policies on a pro-rata basis or in proportion to expected claims. | ||||
For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums. In addition, we have a practice of refunding the post-delinquent premiums in our U.S. mortgage insurance business to the insured party if the delinquent loan goes to claim. We record a liability for premiums received on the delinquent loans where our practice is to refund post-delinquent premiums. | ||||
Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabilities for policyholder account balances. | ||||
Net Investment Income and Net Investment Gains and Losses | b) Net Investment Income and Net Investment Gains and Losses | |||
Investment income is recognized when earned. Income or losses upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income, except for hybrid securities where the income or loss upon call is recognized in net investment gains and losses. Investment gains and losses are calculated on the basis of specific identification. | ||||
Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency) which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage-backed and asset-backed securities, future cash flows are estimated and interest income is recognized going forward using the new internal rate of return. | ||||
Insurance and Investment Product Fees and Other | c) Insurance and Investment Product Fees and Other | |||
Insurance and investment product fees and other consist primarily of insurance charges assessed on universal and term universal life insurance contracts and fees assessed against customer account values. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders and variable life insurance policyholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered. | ||||
Investment Securities | d) Investment Securities | |||
At the time of purchase, we designate our investment securities as either available-for-sale or trading and report them in our consolidated balance sheets at fair value. Our portfolio of fixed maturity securities comprises primarily investment grade securities. Changes in the fair value of available-for-sale investments, net of the effect on deferred acquisition costs (“DAC”), present value of future profits (“PVFP”), benefit reserves and deferred income taxes, are reflected as unrealized investment gains or losses in a separate component of accumulated other comprehensive income (loss). Realized and unrealized gains and losses related to trading securities are reflected in net investment gains (losses). Trading securities are included in other invested assets in our consolidated balance sheets and primarily represent fixed maturity securities where we utilized the fair value option. | ||||
Other-Than-Temporary Impairments On Available-For-Sale Securities | ||||
As of each balance sheet date, we evaluate securities in an unrealized loss position for other-than-temporary impairments. For debt securities, we consider all available information relevant to the collectability of the security, including information about past events, current conditions, and reasonable and supportable forecasts, when developing the estimate of cash flows expected to be collected. More specifically for mortgage-backed and asset-backed securities, we also utilize performance indicators of the underlying assets including default or delinquency rates, loan to collateral value ratios, third-party credit enhancements, current levels of subordination, vintage and other relevant characteristics of the security or underlying assets to develop our estimate of cash flows. Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the underlying collateral. Where possible, this data is benchmarked against third-party sources. | ||||
We recognize other-than-temporary impairments on debt securities in an unrealized loss position when one of the following circumstances exists: | ||||
• | we do not expect full recovery of our amortized cost based on the estimate of cash flows expected to be collected, | |||
• | we intend to sell a security or | |||
• | it is more likely than not that we will be required to sell a security prior to recovery. | |||
For other-than-temporary impairments recognized during the period, we present the total other-than-temporary impairments, the portion of other-than-temporary impairments included in other comprehensive income (loss) (“OCI”) and the net other-than-temporary impairments as supplemental disclosure presented on the face of our consolidated statements of income. | ||||
Total other-than-temporary impairments are calculated as the difference between the amortized cost and fair value that emerged in the current period. For other-than-temporarily impaired securities where we do not intend to sell the security and it is not more likely than not that we will be required to sell the security prior to recovery, total other-than-temporary impairments are adjusted by the portion of other-than-temporary impairments recognized in OCI (“non-credit”). Net other-than-temporary impairments recorded in net income (loss) represent the credit loss on the other-than-temporarily impaired securities with the offset recognized as an adjustment to the amortized cost to determine the new amortized cost basis of the securities. | ||||
For securities that were deemed to be other-than-temporarily impaired and a non-credit loss was recorded in OCI, the amount recorded as an unrealized gain (loss) represents the difference between the current fair value and the new amortized cost for each period presented. The unrealized gain (loss) on an other-than-temporarily impaired security is recorded as a separate component in OCI until the security is sold or until we record an other-than-temporary impairment where we intend to sell the security or will be required to sell the security prior to recovery. | ||||
To estimate the amount of other-than-temporary impairment attributed to credit losses on debt securities where we do not intend to sell the security and it is not more likely than not that we will be required to sell the security prior to recovery, we determine our best estimate of the present value of the cash flows expected to be collected from a security using the effective yield on the security prior to recording any other-than-temporary impairment. If the present value of the discounted cash flows is lower than the amortized cost of the security, the difference between the present value and amortized cost represents the credit loss associated with the security with the remaining difference between fair value and amortized cost recorded as a non-credit other-than-temporary impairment in OCI. | ||||
The evaluation of other-than-temporary impairments is subject to risks and uncertainties and is intended to determine the appropriate amount and timing for recognizing an impairment charge. The assessment of whether such impairment has occurred is based on management’s best estimate of the cash flows expected to be collected at the individual security level. We regularly monitor our investment portfolio to ensure that securities that may be other-than-temporarily impaired are identified in a timely manner and that any impairment charge is recognized in the proper period. | ||||
While the other-than-temporary impairment model for debt securities generally includes fixed maturity securities, there are certain hybrid securities that are classified as fixed maturity securities where the application of a debt impairment model depends on whether there has been any evidence of deterioration in credit of the issuer, such as a downgrade to below investment grade. Under certain circumstances, evidence of deterioration in credit of the issuer may result in the application of the equity securities impairment model. | ||||
For equity securities, we recognize an impairment charge in the period in which we determine that the security will not recover to book value within a reasonable period. We determine what constitutes a reasonable period on a security-by-security basis based upon consideration of all the evidence available to us, including the magnitude of an unrealized loss and its duration. In any event, this period does not exceed 18 months for common equity securities. We measure other-than-temporary impairments based upon the difference between the amortized cost of a security and its fair value. | ||||
Fair Value Measurements | e) Fair Value Measurements | |||
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity, equity and trading securities, derivatives, embedded derivatives, securities held as collateral, separate account assets and certain other financial instruments, which are carried at fair value. | ||||
Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: | ||||
• | Level 1—Quoted prices for identical instruments in active markets. | |||
• | Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. | |||
• | Level 3—Instruments whose significant value drivers are unobservable. | |||
Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded derivatives and actively traded mutual fund investments. | ||||
Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable, information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity and equity securities; government or agency securities; certain mortgage-backed and asset-backed securities; securities held as collateral; and certain non-exchange-traded derivatives such as interest rate or cross currency swaps. | ||||
Level 3 comprises financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In limited instances, this category may also utilize non-binding broker quotes. This category primarily consists of certain less liquid fixed maturity, equity and trading securities and certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data. | ||||
As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 17 for additional information related to fair value measurements. | ||||
Commercial Mortgage Loans | f) Commercial Mortgage Loans | |||
The carrying value of commercial mortgage loans is stated at original cost, net of principal payments, amortization and allowance for loan losses. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. | ||||
“Impaired” loans are defined by U.S. GAAP as loans for which it is probable that the lender will be unable to collect all amounts due according to original contractual terms of the loan agreement. In determining whether it is probable that we will be unable to collect all amounts due, we consider current payment status, debt service coverage ratios, occupancy levels and current loan-to-value. Impaired loans are carried on a non-accrual status. Loans are placed on non-accrual status when, in management’s opinion, the collection of principal or interest is unlikely, or when the collection of principal or interest is 90 days or more past due. Income on impaired loans is not recognized until the loan is sold or the cash received exceeds the carrying amount recorded. | ||||
We evaluate the impairment of commercial mortgage loans first on an individual loan basis. If an individual loan is not deemed impaired, then we evaluate the remaining loans collectively to determine whether an impairment should be recorded. | ||||
For individually impaired loans, we record an impairment charge when it is probable that a loss has been incurred. The impairment is recorded as an increase in the allowance for loan losses. All losses of principal are charged to the allowance for loan losses in the period in which the loan is deemed to be uncollectible. | ||||
For loans that are not individually impaired where we evaluate the loans collectively, the allowance for loan losses is maintained at a level that we determine is adequate to absorb estimated probable incurred losses in the loan portfolio. Our process to determine the adequacy of the allowance utilizes an analytical model based on historical loss experience adjusted for current events, trends and economic conditions that would result in a loss in the loan portfolio over the next 12 months. Key inputs into our evaluation include debt service coverage ratios, loan-to-value, property-type, occupancy levels, geographic region, and probability weighting of the scenarios generated by the model. The actual amounts realized could differ in the near term from the amounts assumed in arriving at the allowance for loan losses reported in the consolidated financial statements. Additions and reductions to the allowance through periodic provisions or benefits are recorded in net investment gains (losses). | ||||
For commercial mortgage loans classified as held-for-sale, each loan is carried at the lower of cost or market and is included in commercial mortgage loans in our consolidated balance sheets. See note 4 for additional disclosures related to commercial mortgage loans. | ||||
Securities Lending Activity | g) Securities Lending Activity | |||
In the United States and Canada, we engage in certain securities lending transactions for the purpose of enhancing the yield on our investment securities portfolio. We maintain effective control over all loaned securities and, therefore, continue to report such securities as fixed maturity securities on the consolidated balance sheets. We are currently indemnified against counterparty credit risk by the intermediary. | ||||
Under the securities lending program in the United States, the borrower is required to provide collateral, which can consist of cash or government securities, on a daily basis in amounts equal to or exceeding 102% of the applicable securities loaned. Currently, we only accept cash collateral from borrowers under the program. Cash collateral received by us on securities lending transactions is reflected in other invested assets with an offsetting liability recognized in other liabilities for the obligation to return the collateral. Any cash collateral received is reinvested by our custodian based upon the investment guidelines provided within our agreement. In the United States, the reinvested cash collateral is primarily invested in a money market fund approved by the National Association of Insurance Commissioners (“NAIC”), U.S. and foreign government securities, U.S. government agency securities, asset-backed securities and corporate debt securities. As of December 31, 2014 and 2013, the fair value of securities loaned under our securities lending program in the United States was $288 million and $191 million, respectively. As of December 31, 2014 and 2013, the fair value of collateral held under our securities lending program in the United States was $289 million and $187 million, respectively, and the offsetting obligation to return collateral of $299 million and $199 million, respectively, was included in other liabilities in the consolidated balance sheets. We did not have any non-cash collateral provided by the borrower in our securities lending program in the United States as of December 31, 2014 and 2013. | ||||
Under our securities lending program in Canada, the borrower is required to provide collateral consisting of government securities on a daily basis in amounts equal to or exceeding 105% of the fair value of the applicable securities loaned. Securities received from counterparties as collateral are not recorded on our consolidated balance sheet given that the risk and rewards of ownership is not transferred from the counterparties to us in the course of such transactions. Additionally, there was no cash collateral as cash collateral is not permitted as an acceptable form of collateral under the program. In Canada, the lending institution must be included on the approved Securities Lending Borrowers List with the Canadian regulator and the intermediary must be rated at least “AA-” by Standard & Poor’s Financial Services LLC. As of December 31, 2014 and 2013, the fair value of securities loaned under our securities lending program in Canada was $371 million and $229 million, respectively. | ||||
Repurchase Agreements | h) Repurchase Agreements | |||
We have a repurchase program in which we sell an investment security at a specified price and agree to repurchase that security at another specified price at a later date. Repurchase agreements are treated as collateralized financing transactions and are carried at the amounts at which the securities will be subsequently reacquired, including accrued interest, as specified in the respective agreement. The market value of securities to be repurchased is monitored and collateral levels are adjusted where appropriate to protect the counterparty against credit exposure. Cash received is invested in fixed maturity securities. As of December 31, 2014 and 2013, the fair value of securities pledged under the repurchase program was $592 million and $890 million, respectively, and the repurchase obligation of $553 million and $919 million, respectively, was included in other liabilities in the consolidated balance sheets. | ||||
Cash and Cash Equivalents | i) Cash and Cash Equivalents | |||
Certificates of deposit, money market funds and other time deposits with original maturities of 90 days or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than 90 days but less than one year at the time of acquisition are considered short-term investments. | ||||
Deferred Acquisition Costs | j) Deferred Acquisition Costs | |||
Acquisition costs include costs that are directly related to the successful acquisition of new or renewal insurance contracts. Acquisition costs are deferred and amortized to the extent they are recoverable from future profits. | ||||
Long-Duration Contracts. Acquisition costs include commissions in excess of ultimate renewal commissions and for contracts issued, certain other costs such as underwriting, medical inspection and issuance expenses. DAC for traditional long-duration insurance contracts, including term life and long-term care insurance, is amortized as a level percentage of premiums based on assumptions, including, investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured life expectancy or longevity, insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses, established when the contract is issued. Amortization is adjusted each period to reflect actual lapse or termination rates. | ||||
Amortization for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for changes in underlying assumptions relating to future gross profits. Estimates of gross profits for DAC amortization are based on assumptions including interest rates, policyholder persistency or lapses, insured life expectancy or longevity and expenses. | ||||
Short-Duration Contracts. Acquisition costs primarily consist of commissions and premium taxes and are amortized ratably over the terms of the underlying policies. | ||||
We regularly review our assumptions and test DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to income is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserve plus anticipated future premiums and interest income for a line of business are less than the current estimate of future benefits and expenses (including any unamortized DAC), a charge to income is recorded for additional DAC amortization or for increased benefit reserves. See note 6 for additional information related to DAC including loss recognition and recoverability. | ||||
Intangible Assets | k) Intangible Assets | |||
Present Value of Future Profits. In conjunction with the acquisition of a block of insurance policies or investment contracts, a portion of the purchase price is assigned to the right to receive future gross profits arising from existing insurance and investment contracts. This intangible asset, called PVFP, represents the actuarially estimated present value of future cash flows from the acquired policies. PVFP is amortized, net of accreted interest, in a manner similar to the amortization of DAC. | ||||
We regularly review our PVFP assumptions and periodically test PVFP for recoverability similar to our treatment of DAC. See note 7 for additional information related to PVFP including loss recognition and recoverability. | ||||
Deferred Sales Inducements to Contractholders. We defer sales inducements to contractholders for features on variable annuities that entitle the contractholder to an incremental amount to be credited to the account value upon making a deposit, and for fixed annuities with crediting rates higher than the contract’s expected ongoing crediting rates for periods after the inducement. Deferred sales inducements to contractholders are reported as a separate intangible asset and amortized in benefits and other changes in policy reserves using the same methodology and assumptions used to amortize DAC. | ||||
Other Intangible Assets. We amortize the costs of other intangibles over their estimated useful lives unless such lives are deemed indefinite. Amortizable intangible assets are tested for impairment based on undiscounted cash flows, which requires the use of estimates and judgment, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested at least annually for impairment using a qualitative or quantitative assessment and are written down to fair value as required. | ||||
Goodwill | l) Goodwill | |||
Goodwill is not amortized but is tested for impairment annually or between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying value. We are permitted to utilize a qualitative impairment assessment if the fair value of the reporting unit is not more likely than not lower than its carrying value. If a qualitative impairment assessment is not performed, we are required to determine the fair value of the reporting unit. The determination of fair value requires the use of estimates and judgment, at the “reporting unit” level. A reporting unit is the operating segment, or a business, one level below that operating segment (the “component” level) if discrete financial information is prepared and regularly reviewed by management at the component level. If the reporting unit’s fair value is below its carrying value, we must determine the amount of implied goodwill that would be established if the reporting unit was hypothetically purchased on the impairment assessment date. We recognize an impairment charge for any amount by which the carrying amount of a reporting unit’s goodwill exceeds the amount of implied goodwill. | ||||
The determination of fair value for our reporting units is primarily based on an income approach whereby we use discounted cash flows for each reporting unit. When available and as appropriate, we use market approaches or other valuation techniques to corroborate discounted cash flow results. The discounted cash flow model used for each reporting unit is based on either operating income or statutory distributable income, depending on the reporting unit being valued. | ||||
The cash flows used to determine fair value are dependent on a number of significant management assumptions based on our historical experience, our expectations of future performance and expected economic environment. Our estimates are subject to change given the inherent uncertainty in predicting future performance and cash flows, which are impacted by such things as policyholder behavior, competitor pricing, new product introductions and specific industry and market conditions. Additionally, the discount rate used in our discounted cash flow approach is based on management’s judgment of the appropriate rate for each reporting unit based on the relative risk associated with the projected cash flows. | ||||
See note 8 for additional information related to goodwill and impairments recorded. | ||||
Reinsurance | m) Reinsurance | |||
Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to and assumed from other companies. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance is accounted for over the terms of the related treaties using assumptions consistent with those used to account for the underlying reinsured policies. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting. | ||||
Derivatives | n) Derivatives | |||
Derivative instruments are used to manage risk through one of four principal risk management strategies including: (i) liabilities; (ii) invested assets; (iii) portfolios of assets or liabilities; and (iv) forecasted transactions. | ||||
On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (fair value, cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in income. | ||||
We formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. In this documentation, we specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item, and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure hedge ineffectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument. | ||||
We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated as a hedge instrument; or (iv) it is no longer probable that the forecasted transaction will occur. | ||||
For all qualifying and highly effective cash flow hedges, the effective portion of changes in fair value of the derivative instrument is reported as a component of OCI. The ineffective portion of changes in fair value of the derivative instrument is reported as a component of income. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried in the consolidated balance sheets at its fair value, and gains and losses that were accumulated in OCI are recognized immediately in income. When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in OCI and is recognized when the transaction affects income; however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued on a cash flow hedge, amounts previously deferred in OCI are reclassified into income when income is impacted by the variability of the cash flow of the hedged item. | ||||
For all qualifying and highly effective fair value hedges, the changes in fair value of the derivative instrument are reported in income. In addition, changes in fair value attributable to the hedged portion of the underlying instrument are reported in income. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair value hedge, the derivative continues to be carried in the consolidated balance sheets at its fair value, but the hedged asset or liability will no longer be adjusted for changes in fair value. In all other situations in which hedge accounting is discontinued, the derivative is carried at its fair value in the consolidated balance sheets, with changes in its fair value recognized in current period income. | ||||
We may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, we assess whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determine whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. | ||||
If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded in the consolidated balance sheets at fair value and are classified consistent with their host contract. Changes in their fair value are recognized in current period income. If we are unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried in the consolidated balance sheets at fair value, with changes in fair value recognized in current period income. | ||||
Changes in the fair value of non-qualifying derivatives, including embedded derivatives, changes in fair value of certain derivatives and related hedged items in fair value hedge relationships and hedge ineffectiveness on cash flow hedges are reported in net investment gains (losses). | ||||
The majority of our derivative arrangements require the posting of collateral upon meeting certain net exposure thresholds. The amounts recognized for derivative counterparty collateral received by us was recorded in cash and cash equivalents with a corresponding amount recorded in other liabilities to represent our obligation to return the collateral retained by us. We also receive non-cash collateral that is not recognized in our balance sheet unless we exercise our right to sell or re-pledge the underlying asset. As of December 31, 2014 and 2013, the fair value of non-cash collateral received was $287 million and $70 million, respectively, and the underlying assets were not sold or re-pledged. Additionally, we have pledged $49 million and $394 million of fixed maturity securities as of December 31, 2014 and 2013, respectively. We have not pledged any cash as collateral to derivative counterparties. Fixed maturity securities that we pledge as collateral remain on our balance sheet within fixed maturity securities available-for-sale. Any cash collateral pledged to a derivative counterparty is derecognized with a receivable recorded in other assets for the right to receive our cash collateral back from the counterparty. | ||||
Separate Accounts and Related Insurance Obligations | o) Separate Accounts and Related Insurance Obligations | |||
Separate account assets represent funds for which the investment income and investment gains and losses accrue directly to the contractholders and are reflected in our consolidated balance sheets at fair value, reported as summary total separate account assets with an equivalent summary total reported for liabilities. Amounts assessed against the contractholders for mortality, administrative and other services are included in revenues. Changes in liabilities for minimum guarantees are included in benefits and other changes in policy reserves. Net investment income, net investment gains (losses) and the related liability changes associated with the separate account are offset within the same line item in the consolidated statements of income. There were no gains or losses on transfers of assets from the general account to the separate account. | ||||
We offer certain minimum guarantees associated with our variable annuity contracts. Our variable annuity contracts usually contain a basic guaranteed minimum death benefit (“GMDB”) which provides a minimum benefit to be paid upon the annuitant’s death equal to the larger of account value and the return of net deposits. Some variable annuity contracts permit contractholders to purchase through riders, at an additional charge, enhanced death benefits such as the highest contract anniversary value (“ratchets”), accumulated net deposits at a stated rate (“rollups”), or combinations thereof. | ||||
Additionally, some of our variable annuity contracts provide the contractholder with living benefits such as a guaranteed minimum withdrawal benefit (“GMWB”) or certain types of guaranteed annuitization benefits. The GMWB allows contractholders to withdraw a pre-defined percentage of account value or benefit base each year, either for a specified period of time or for life. The guaranteed annuitization benefit generally provides for a guaranteed minimum level of income upon annuitization accompanied by the potential for upside market participation. | ||||
Most of our reserves for additional insurance and annuitization benefits are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future experience. The projections utilize stochastic scenarios of separate account returns incorporating reversion to the mean, as well as assumptions for mortality and lapses. Some of our minimum guarantees, mainly GMWBs, are accounted for as embedded derivatives; see notes 5 and 17 for additional information on these embedded derivatives and related fair value measurement disclosures. | ||||
Insurance Reserves | p) Insurance Reserves | |||
Future Policy Benefits | ||||
The liability for future policy benefits is equal to the present value of expected benefits and expenses less the present value of expected future net premiums based on assumptions, including, investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured life expectancy or longevity, insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses, all of which are locked-in at the time the policies are issued or acquired. Claim termination rates refer to the expected rates at which claims end. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. | ||||
The liability for future policy benefits is evaluated at least annually to determine if a premium deficiency exists. Loss recognition testing is generally performed at the line of business level, with acquired blocks and certain reinsured blocks tested separately. If the liability for future policy benefits plus the current present value of expected future premiums are less than the current present value of expected future benefits and expenses (including any unamortized DAC), a charge to income is recorded for accelerated DAC amortization and, if necessary, a premium deficiency reserve is established. If a charge is recorded, DAC amortization and the liability for future policy benefits are measured using updated assumptions, which become the new locked-in assumptions utilized going forward unless another premium deficiency charge is recorded. Our estimates of future premiums used in loss recognition testing for our long-term care insurance business include assumptions for significant premium rate increases that have been filed and approved or are anticipated to be approved. Beginning in the fourth quarter of 2014, estimates of future premiums also include significant anticipated (but not yet filed) future rate increases or benefit reductions. These anticipated future increases are based on our best estimate of the rate increases we expect to obtain, considering, among other factors, our historical experience from prior rate increase approvals and based on our best estimate of expected claim costs. | ||||
We are also required to accrue additional future policy benefit reserves when the overall reserve is adequate, but profits are projected in earlier years followed by losses projected in later years. When this pattern of profits followed by losses exists, we increase reserves in the profitable years by the amounts necessary to offset losses in later years. | ||||
For long-term care insurance products, benefit reductions are treated as partial lapse of coverage with the balance of our future policy benefits and deferred acquisition costs both reduced in proportion to the reduced coverage. For level premium term life insurance products, we floor the liability for future policy benefits on each policy at zero. | ||||
Estimates and actuarial assumptions used for establishing the liability for future policy benefits and in loss recognition testing involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for future policy benefits and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The risk that our claims experience may differ significantly from our pricing and valuation assumptions is particularly significant for our long-term care insurance products. Long-term care insurance policies provide for long-duration coverage and, therefore, our actual claims experience will emerge over many years after pricing and locked-in valuation assumptions have been established. | ||||
Policyholder Account Balances | ||||
The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future experience. | ||||
Investment-type contracts are broadly defined to include contracts without significant mortality or morbidity risk. Payments received from sales of investment contracts are recognized by providing a liability equal to the current account value of the policyholders’ contracts. Interest rates credited to investment contracts are guaranteed for the initial policy term with renewal rates determined as necessary by management. | ||||
Liability for Policy and Contract Claims | q) Liability for Policy and Contract Claims | |||
The liability for policy and contract claims, or claim reserves, represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (a) claims that have been reported to the insurer; (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims. | ||||
Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss). Estimates and actuarial assumptions used for establishing the liability for policy and contract claims involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for policy and contract claims and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. | ||||
The liability for policy and contract claims for our long-term care insurance products represents the present value of the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. Key assumptions include investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured life expectancy or longevity, insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses. Claim termination rates refer to the expected rates at which claims end. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. Both claim termination rates and benefit utilization rates are influenced by, among other things, gender, age at claim, diagnosis, type of care needed, benefit period, and daily benefit amount. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. | ||||
The liabilities for our mortgage insurance policies represent our best estimates of the liabilities at the time based on known facts, trends and other external factors, including economic conditions, housing prices and employment rates. For our mortgage insurance policies, reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers, using assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, we begin to provide for the ultimate claim payment relating to a potential claim on a defaulted loan when the status of that loan first goes delinquent. Over time, as the status of the underlying delinquent loans move toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase. | ||||
Management considers the liability for policy and contract claims provided to be satisfactory to cover the losses that have occurred. Management monitors actual experience, and where circumstances warrant, will revise its assumptions. The methods of determining such estimates and establishing the reserves are reviewed periodically and any adjustments are reflected in operations in the period in which they become known. Future developments may result in losses and loss expenses greater or less than the liability for policy and contract claims provided. | ||||
Unearned Premiums | r) Unearned Premiums | |||
For single premium insurance contracts, we recognize premiums over the policy life in accordance with the expected pattern of risk emergence. We recognize a portion of the revenue in premiums earned in the current period, while the remaining portion is deferred as unearned premiums and earned over time in accordance with the expected pattern of risk emergence. If single premium policies are cancelled and the premium is non-refundable, then the remaining unearned premium related to each cancelled policy is recognized to earned premiums upon notification of the cancellation. Expected pattern of risk emergence on which we base premium recognition is inherently judgmental and is based on actuarial analysis of historical experience. We periodically review our premium earnings recognition models with any adjustments to the estimates reflected in current period income. For the years ended December 31, 2014, 2013 and 2012, we updated our premium recognition factors for our international mortgage insurance business. These updates included the consideration of recent and projected loss experience, policy cancellation experience and refinement of actuarial methods. In 2014, 2013 and 2012, adjustments associated with this update resulted in an increase in earned premiums of $6 million, $12 million and $36 million, respectively. | ||||
Stock-Based Compensation | s) Stock-Based Compensation | |||
We determine a grant date fair value and recognize the related compensation expense, adjusted for expected forfeitures, through the income statement over the respective vesting period of the awards. | ||||
Employee Benefit Plans | t) Employee Benefit Plans | |||
We provide employees with a defined contribution pension plan and recognize expense throughout the year based on the employee’s age, service and eligible pay. We make an annual contribution to the plan. We also provide employees with defined contribution savings plans. We recognize expense for our contributions to the savings plans at the time employees make contributions to the plans. | ||||
Some employees participate in defined benefit pension and postretirement benefit plans. We recognize expense for these plans based upon actuarial valuations performed by external experts. We estimate aggregate benefits by using assumptions for employee turnover, future compensation increases, rates of return on pension plan assets and future health care costs. We recognize an expense for differences between actual experience and estimates over the average future service period of participants. We recognize the overfunded or underfunded status of a defined benefit plan as an asset or liability in our consolidated balance sheets and recognize changes in that funded status in the year in which the changes occur through OCI. | ||||
Income Taxes | u) Income Taxes | |||
We determine deferred tax assets and/or liabilities by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled if there is no change in law. The effect on deferred taxes of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances on deferred tax assets are estimated based on our assessment of the realizability of such amounts. | ||||
We do not record U.S. deferred taxes on foreign income that we do not expect to remit or repatriate to U.S. corporations within our consolidated group. Under U.S. GAAP, we are generally required to record U.S. deferred taxes on the anticipated repatriation of foreign income as the income is recognized for financial reporting purposes. An exception under certain accounting guidance permits us not to record a U.S. deferred tax liability for foreign income that we expect to reinvest in our foreign operations and for which remittance will be postponed indefinitely. If it becomes apparent that we cannot positively assert that some or all undistributed income will be invested in the foreseeable future, the related deferred taxes are recorded in that period. In determining indefinite reinvestment, we regularly evaluate the capital needs of our domestic and foreign operations considering all available information, including operating and capital plans, regulatory capital requirements, parent company financing and cash flow needs, as well as the applicable tax laws to which our domestic and foreign subsidiaries are subject. Our estimates are based on our historical experience and our expectation of future performance. Our judgments and assumptions are subject to change given the inherent uncertainty in predicting future capital needs, which are impacted by such things as regulatory requirements, policyholder behavior, competitor pricing, new product introductions, and specific industry and market conditions. | ||||
Effective with the period beginning January 1, 2011, our companies elected to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). The election was made with the filing of the first life/non-life consolidated return, which was filed in September 2012. All companies domesticated in the United States and our Bermuda and Guernsey subsidiaries which have elected to be taxed as U.S. domestic companies were included in the life/non-life consolidated return as allowed by the tax law and regulations. The tax sharing agreement previously applicable only to the U.S. life insurance entities was terminated with the filing of the life/non-life consolidated return and those entities adopted the tax sharing agreement previously applicable to only the non-life entities (hereinafter the “life/non-life tax sharing agreement”). The two agreements were identical in all material respects. The life/non-life tax sharing agreement was provided to the appropriate state insurance regulators for approval. Intercompany balances relating to the impacts of the life/non-life tax sharing agreement were settled with the insurance companies after approval was received from the insurance regulators. Intercompany balances under all agreements are settled at least annually. For years before 2011, our U.S. non-life insurance entities were included in the consolidated federal income tax return of Genworth and subject to a tax sharing arrangement that allocated tax on a separate company basis but provided benefit for current utilization of losses and credits. Also, our U.S. life insurance entities filed a consolidated life insurance federal income tax return, and were subject to a separate tax sharing agreement, as approved by state insurance regulators, which allocated taxes on a separate company basis but provided benefit for current utilization of losses and credits. | ||||
Our subsidiaries based in Bermuda and Guernsey are treated as U.S. insurance companies under provisions of the U.S. Internal Revenue Code, are included in the life/non-life consolidated return, and have adopted the life-non/life tax sharing agreement. Jurisdictions outside the United States in which our various subsidiaries incur significant taxes include Australia, Canada and the United Kingdom. | ||||
Foreign Currency Translation | v) Foreign Currency Translation | |||
The determination of the functional currency is made based on the appropriate economic and management indicators. The assets and liabilities of foreign operations are translated into U.S. dollars at the exchange rates in effect at the balance sheet date. Translation adjustments are included as a separate component of accumulated other comprehensive income (loss). Revenues and expenses of the foreign operations are translated into U.S. dollars at the average rates of exchange during the period of the transaction. Gains and losses from foreign currency transactions are reported in income and have not been material in any years presented in our consolidated statements of income. | ||||
Variable Interest Entities | w) Variable Interest Entities | |||
We are involved in certain entities that are considered VIEs as defined under U.S. GAAP, and, accordingly, we evaluate the VIE to determine whether we are the primary beneficiary and are required to consolidate the assets and liabilities of the entity. The primary beneficiary of a VIE is the enterprise that has the power to direct the activities of a VIE that most significantly impacts the VIE’s economic performance and has the obligation to absorb losses or receive benefits that could potentially be significant to the VIE. The determination of the primary beneficiary for a VIE can be complex and requires management judgment regarding the expected results of the entity and how those results are absorbed by beneficial interest holders, as well as which party has the power to direct activities that most significantly impact the performance of the VIEs. | ||||
Our primary involvement related to VIEs includes securitization transactions, certain investments and certain mortgage insurance policies. | ||||
We have retained interests in VIEs where we are the servicer and transferor of certain assets that were sold to a newly created VIE. Additionally, for certain securitization transactions, we were the transferor of certain assets that were sold to a newly created VIE but did not retain any beneficial interest in the VIE other than acting as the servicer of the underlying assets. | ||||
We hold investments in certain structures that are considered VIEs. Our investments represent beneficial interests that are primarily in the form of structured securities or alternative investments. Our involvement in these structures typically represent a passive investment in the returns generated by the VIE and typically do not result in having significant influence over the economic performance of the VIE. | ||||
We also provide mortgage insurance on certain residential mortgage loans originated and securitized by third parties using VIEs to issue mortgage-backed securities. While we provide mortgage insurance on the underlying loans, we do not typically have any ongoing involvement with the VIE other than our mortgage insurance coverage and do not act in a servicing capacity for the underlying loans held by the VIE. | ||||
See note 18 for additional information related to these consolidated entities. | ||||
Accounting Changes | x) Accounting Changes | |||
Investment Companies | ||||
On January 1, 2014, we adopted new accounting guidance on the scope, measurement and disclosure requirements for investment companies. The new guidance clarified the characteristics of an investment company, provided comprehensive guidance for assessing whether an entity is an investment company, required investment companies to measure noncontrolling ownership interest in other investment companies at fair value rather than using the equity method of accounting and required additional disclosures. The adoption of this accounting guidance did not have any impact on our consolidated financial statements. | ||||
Benchmarking Interest Rates Used When Applying Hedge Accounting | ||||
In July 2013, we adopted new accounting guidance to provide additional flexibility in the benchmark interest rates used when applying hedge accounting. The new guidance permits the use of the Federal Funds Effective Swap Rate as a benchmark interest rate for hedge accounting purposes and removes certain restrictions on being able to apply hedge accounting for similar hedges using different benchmark interest rates. The adoption of this accounting guidance did not have a material impact on our consolidated financial statements. | ||||
Offsetting Assets And Liabilities | ||||
On January 1, 2013, we adopted new accounting guidance for disclosures about offsetting assets and liabilities. This guidance requires an entity to disclose information about offsetting and related arrangements to enable users to understand the effect of those arrangements on its financial position. The adoption of this accounting guidance impacted our disclosures only and did not impact our consolidated results. | ||||
Reclassification Of Items Out Of Accumulated Other Comprehensive Income | ||||
On January 1, 2013, we adopted new accounting guidance related to the presentation of the reclassification of items out of accumulated other comprehensive income into net income. The adoption of this accounting guidance impacted our disclosures only and did not impact our consolidated results. | ||||
Testing Indefinite-Lived Intangible Assets For Impairment | ||||
On October 1, 2012, we adopted new accounting guidance on testing indefinite-lived intangible assets for impairment. The new guidance permits the use of a qualitative assessment prior to, and potentially instead of, the quantitative impairment test for indefinite-lived intangible assets. The adoption of this accounting guidance did not have an impact on our consolidated financial statements. | ||||
Fair Value Measurements | ||||
On January 1, 2012, we adopted new accounting guidance related to fair value measurements. This new accounting guidance clarified existing fair value measurement requirements and changed certain fair value measurement principles and disclosure requirements. The adoption of this accounting guidance impacted our disclosures only and did not impact our consolidated results. | ||||
Repurchase Agreements and Other Agreements | ||||
On January 1, 2012, we adopted new accounting guidance related to repurchase agreements and other agreements that both entitle and obligate a transferor to repurchase or redeem financial assets before their maturity. The new guidance removed the requirement to consider a transferor’s ability to fulfill its contractual rights from the criteria used to determine effective control and was effective for us prospectively. The adoption of this accounting guidance did not have a material impact on our consolidated financial statements. | ||||
Accounting Pronouncements Not Yet Adopted | y) Accounting Pronouncements Not Yet Adopted | |||
In August 2014, the Financial Accounting Standards Board (the “FASB”) issued new accounting guidance related to measuring the financial assets and financial liabilities of a consolidated collateralized financing entity. The guidance is intended to address the accounting for the measurement difference between the fair value of financial assets and the fair value of financial liabilities of a collateralized financing entity. The new guidance provides an alternative whereby a reporting entity could measure the financial assets and financial liabilities of the collateralized financing entity in its consolidated financial statements using the more observable of the fair values. This guidance is effective for us on January 1, 2016, with early adoption permitted as of the beginning of an annual reporting period. We plan to early adopt this new guidance during the first quarter of 2015 and do not expect any impact on our consolidated financial statements. | ||||
In June 2014, the FASB issued new accounting guidance related to the accounting for repurchase-to-maturity transactions and repurchase financings, and added disclosure requirements for all repurchase agreements, securities lending transactions and repurchase-to-maturity transactions. The new guidance changes the accounting for repurchase-to-maturity transactions and repurchase financing such that they will be consistent with secured borrowing accounting. In addition, the guidance requires new disclosures for all repurchase agreements and securities lending transactions. We do not have repurchase-to-maturity transactions, but have repurchase agreements and securities lending transactions that will be subject to additional disclosures. These new requirements will be effective for us on January 1, 2015 and early adoption is not permitted. This new guidance will only impact our disclosures. | ||||
In May 2014, the FASB issued new accounting guidance related to revenue from contracts with customers. The key principle of the new guidance is that entities should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for such goods or services. The guidance also includes disclosure requirements that provide information about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance is effective for us on January 1, 2017 and early adoption is not permitted. Although insurance contracts are specifically excluded from this new guidance, we have minor services that may be subject to the new revenue recognition guidance. In addition, there is uncertainty whether mortgage insurance and investment contracts are subject to this new guidance, which could result in a significant change in revenue recognition for these contracts. As such, we are still in the process of evaluating the impact, if any, the guidance may have on our consolidated financial statements. | ||||
In January 2014, the FASB issued new accounting guidance related to the accounting for investments in affordable housing projects that qualify for the low-income housing tax credit. The new guidance permits reporting entities to make an accounting policy election to account for investments in qualified affordable housing projects by amortizing the initial cost of the investment in proportion to the tax benefits received and recognize the net investment performance as a component of income tax expense (called the proportional amortization method) if certain conditions are met. The new guidance requires use of the equity method or cost method for investments in qualified affordable housing projects not accounted for using the proportional amortization method. This new guidance will be effective for us and we will adopt the guidance on January 1, 2015. We do not expect this new guidance to have a material impact on our consolidated financial statements. |
Earnings_Loss_Per_Share_Tables
Earnings (Loss) Per Share (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Earnings (Loss) per Share | Basic and diluted earnings (loss) per share are calculated by dividing each income (loss) category presented below by the weighted-average basic and diluted common shares outstanding for the periods indicated: | ||||||||||||
(Amounts in millions, except per share amounts) | 2014 | 2013 | 2012 | ||||||||||
Weighted-average common shares used in basic earnings (loss) per common share calculations | 496.4 | 493.6 | 491.6 | ||||||||||
Potentially dilutive securities: | |||||||||||||
Stock options, restricted stock units and stock appreciation rights | — | 5.1 | 2.8 | ||||||||||
Weighted-average common shares used in diluted earnings (loss) per common share calculations (1) | 496.4 | 498.7 | 494.4 | ||||||||||
Income (loss) from continuing operations: | |||||||||||||
Income (loss) from continuing operations | $ | (1,048 | ) | $ | 726 | $ | 468 | ||||||
Less: income from continuing operations attributable to noncontrolling interests | 196 | 154 | 200 | ||||||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | $ | 572 | $ | 268 | ||||||
Basic per common share | $ | (2.51 | ) | $ | 1.16 | $ | 0.55 | ||||||
Diluted per common share | $ | (2.51 | ) | $ | 1.15 | $ | 0.54 | ||||||
Income (loss) from discontinued operations: | |||||||||||||
Income (loss) from discontinued operations, net of taxes | $ | — | $ | (12 | ) | $ | 57 | ||||||
Less: income from discontinued operations, net of taxes, attributable to noncontrolling interests | — | — | — | ||||||||||
Income (loss) from discontinued operations, net of taxes, available to Genworth Financial, Inc.’s common stockholders | $ | — | $ | (12 | ) | $ | 57 | ||||||
Basic per common share | $ | — | $ | (0.02 | ) | $ | 0.12 | ||||||
Diluted per common share | $ | — | $ | (0.02 | ) | $ | 0.12 | ||||||
Net income (loss): | |||||||||||||
Income (loss) from continuing operations | $ | (1,048 | ) | $ | 726 | $ | 468 | ||||||
Income (loss) from discontinued operations, net of taxes | — | (12 | ) | 57 | |||||||||
Net income (loss) | (1,048 | ) | 714 | 525 | |||||||||
Less: net income attributable to noncontrolling interests | 196 | 154 | 200 | ||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | $ | 560 | $ | 325 | ||||||
Basic per common share | $ | (2.51 | ) | $ | 1.13 | $ | 0.66 | ||||||
Diluted per common share | $ | (2.51 | ) | $ | 1.12 | $ | 0.66 | ||||||
(1) | Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the year ended December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the year ended December 31, 2014, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.6 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the year ended December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million. |
Investments_Tables
Investments (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||||||||||
Net Investment Income | Sources of net investment income were as follows for the years ended December 31: | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Fixed maturity securities—taxable | $ | 2,631 | $ | 2,642 | $ | 2,666 | |||||||||||||||||||||||||||||||
Fixed maturity securities—non-taxable | 12 | 9 | 11 | ||||||||||||||||||||||||||||||||||
Commercial mortgage loans | 333 | 335 | 340 | ||||||||||||||||||||||||||||||||||
Restricted commercial mortgage loans related to securitization entities (1) | 14 | 23 | 32 | ||||||||||||||||||||||||||||||||||
Equity securities | 14 | 17 | 19 | ||||||||||||||||||||||||||||||||||
Other invested assets (2) | 174 | 185 | 206 | ||||||||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (1) | 5 | 4 | 1 | ||||||||||||||||||||||||||||||||||
Policy loans | 129 | 129 | 123 | ||||||||||||||||||||||||||||||||||
Cash, cash equivalents and short-term investments | 24 | 20 | 35 | ||||||||||||||||||||||||||||||||||
Gross investment income before expenses and fees | 3,336 | 3,364 | 3,433 | ||||||||||||||||||||||||||||||||||
Expenses and fees | (94 | ) | (93 | ) | (90 | ) | |||||||||||||||||||||||||||||||
Net investment income | $ | 3,242 | $ | 3,271 | $ | 3,343 | |||||||||||||||||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||
(2) | Included in other invested assets was $8 million, $13 million and $21 million of net investment income related to trading securities for the years ended December 31, 2014, 2013 and 2012, respectively. | ||||||||||||||||||||||||||||||||||||
Net Investment Gains (Losses) | The following table sets forth net investment gains (losses) for the years ended December 31: | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Available-for-sale securities: | |||||||||||||||||||||||||||||||||||||
Realized gains | $ | 74 | $ | 176 | $ | 172 | |||||||||||||||||||||||||||||||
Realized losses | (46 | ) | (184 | ) | (143 | ) | |||||||||||||||||||||||||||||||
Net realized gains (losses) on available-for-sale securities | 28 | (8 | ) | 29 | |||||||||||||||||||||||||||||||||
Impairments: | |||||||||||||||||||||||||||||||||||||
Total other-than-temporary impairments | (9 | ) | (16 | ) | (62 | ) | |||||||||||||||||||||||||||||||
Portion of other-than-temporary impairments included in other comprehensive income (loss) | — | (9 | ) | (44 | ) | ||||||||||||||||||||||||||||||||
Net other-than-temporary impairments | (9 | ) | (25 | ) | (106 | ) | |||||||||||||||||||||||||||||||
Trading securities | 39 | (23 | ) | 21 | |||||||||||||||||||||||||||||||||
Commercial mortgage loans | 11 | 4 | 4 | ||||||||||||||||||||||||||||||||||
Net gains (losses) related to securitization entities (1) | 16 | 69 | 81 | ||||||||||||||||||||||||||||||||||
Derivative instruments (2) | (103 | ) | (49 | ) | 4 | ||||||||||||||||||||||||||||||||
Contingent consideration adjustment | (2 | ) | — | (6 | ) | ||||||||||||||||||||||||||||||||
Other | — | (5 | ) | — | |||||||||||||||||||||||||||||||||
Net investment gains (losses) | $ | (20 | ) | $ | (37 | ) | $ | 27 | |||||||||||||||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||
(2) | See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). | ||||||||||||||||||||||||||||||||||||
Credit Losses Recognized in Net Income (Loss) | The following represents the activity for credit losses recognized in net income (loss) on debt securities where an other-than-temporary impairment was identified and a portion of other-than-temporary impairments was included in OCI as of and for the years ended December 31: | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Beginning balance | $ | 101 | $ | 387 | $ | 646 | |||||||||||||||||||||||||||||||
Additions: | |||||||||||||||||||||||||||||||||||||
Other-than-temporary impairments not previously recognized | 1 | 4 | 16 | ||||||||||||||||||||||||||||||||||
Increases related to other-than-temporary impairments previously recognized | 1 | 11 | 55 | ||||||||||||||||||||||||||||||||||
Reductions: | |||||||||||||||||||||||||||||||||||||
Securities sold, paid down or disposed | (20 | ) | (301 | ) | (330 | ) | |||||||||||||||||||||||||||||||
Ending balance | $ | 83 | $ | 101 | $ | 387 | |||||||||||||||||||||||||||||||
Unrealized Investment Gains and Losses | Net unrealized gains and losses on available-for-sale investment securities reflected as a separate component of accumulated other comprehensive income (loss) were as follows as of December 31: | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Net unrealized gains (losses) on investment securities: | |||||||||||||||||||||||||||||||||||||
Fixed maturity securities | $ | 5,560 | $ | 2,346 | $ | 6,086 | |||||||||||||||||||||||||||||||
Equity securities | 32 | 23 | 34 | ||||||||||||||||||||||||||||||||||
Other invested assets | (2 | ) | (4 | ) | (8 | ) | |||||||||||||||||||||||||||||||
Subtotal | 5,590 | 2,365 | 6,112 | ||||||||||||||||||||||||||||||||||
Adjustments to DAC, PVFP, sales inducements and benefit reserves | (1,656 | ) | (869 | ) | (1,925 | ) | |||||||||||||||||||||||||||||||
Income taxes, net | (1,372 | ) | (517 | ) | (1,457 | ) | |||||||||||||||||||||||||||||||
Net unrealized investment gains (losses) | 2,562 | 979 | 2,730 | ||||||||||||||||||||||||||||||||||
Less: net unrealized investment gains (losses) attributable to noncontrolling interests | 109 | 53 | 92 | ||||||||||||||||||||||||||||||||||
Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. | $ | 2,453 | $ | 926 | $ | 2,638 | |||||||||||||||||||||||||||||||
Change in Net Unrealized Gains (Losses) on Available-for-Sale Investment Securities Reported in Accumulated Other Comprehensive Income (Loss) | The change in net unrealized gains (losses) on available-for-sale investment securities reported in accumulated other comprehensive income (loss) was as follows as of and for the years ended December 31: | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Beginning balance | $ | 926 | $ | 2,638 | $ | 1,485 | |||||||||||||||||||||||||||||||
Unrealized gains (losses) arising during the period: | |||||||||||||||||||||||||||||||||||||
Unrealized gains (losses) on investment securities | 3,244 | (3,780 | ) | 2,318 | |||||||||||||||||||||||||||||||||
Adjustment to DAC | (172 | ) | 248 | (159 | ) | ||||||||||||||||||||||||||||||||
Adjustment to PVFP | (66 | ) | 95 | (6 | ) | ||||||||||||||||||||||||||||||||
Adjustment to sales inducements | (15 | ) | 40 | (33 | ) | ||||||||||||||||||||||||||||||||
Adjustment to benefit reserves | (534 | ) | 673 | (424 | ) | ||||||||||||||||||||||||||||||||
Provision for income taxes | (862 | ) | 952 | (590 | ) | ||||||||||||||||||||||||||||||||
Change in unrealized gains (losses) on investment securities | 1,595 | (1,772 | ) | 1,106 | |||||||||||||||||||||||||||||||||
Reclassification adjustments to net investment (gains) losses, net of taxes of $7, $(12) and $(27) | (12 | ) | 21 | 50 | |||||||||||||||||||||||||||||||||
Change in net unrealized investment gains (losses) | 1,583 | (1,751 | ) | 1,156 | |||||||||||||||||||||||||||||||||
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests | 56 | (39 | ) | 3 | |||||||||||||||||||||||||||||||||
Ending balance | $ | 2,453 | $ | 926 | $ | 2,638 | |||||||||||||||||||||||||||||||
Fixed Maturity and Equity Securities | As of December 31, 2014, the amortized cost or cost, gross unrealized gains (losses) and fair value of our fixed maturity and equity securities classified as available-for-sale were as follows: | ||||||||||||||||||||||||||||||||||||
Gross unrealized gains | Gross unrealized losses | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Amortized | Not other- | Other- | Not other- | Other- | Fair | |||||||||||||||||||||||||||||||
cost or | than- | than- | than- | than- | value | ||||||||||||||||||||||||||||||||
cost | temporarily | temporarily | temporarily | temporarily | |||||||||||||||||||||||||||||||||
impaired | impaired | impaired | impaired | ||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 5,006 | $ | 995 | $ | — | $ | (1 | ) | $ | — | $ | 6,000 | ||||||||||||||||||||||||
Tax-exempt | 347 | 29 | — | (14 | ) | — | 362 | ||||||||||||||||||||||||||||||
Government—non-U.S. | 1,952 | 156 | — | (2 | ) | — | 2,106 | ||||||||||||||||||||||||||||||
U.S. corporate | 24,251 | 3,017 | 20 | (88 | ) | — | 27,200 | ||||||||||||||||||||||||||||||
Corporate—non-U.S. | 14,214 | 1,015 | — | (97 | ) | — | 15,132 | ||||||||||||||||||||||||||||||
Residential mortgage-backed | 4,881 | 362 | 15 | (17 | ) | (1 | ) | 5,240 | |||||||||||||||||||||||||||||
Commercial mortgage-backed | 2,564 | 143 | 4 | (9 | ) | — | 2,702 | ||||||||||||||||||||||||||||||
Other asset-backed | 3,735 | 23 | 1 | (54 | ) | — | 3,705 | ||||||||||||||||||||||||||||||
Total fixed maturity securities | 56,950 | 5,740 | 40 | (282 | ) | (1 | ) | 62,447 | |||||||||||||||||||||||||||||
Equity securities | 253 | 36 | — | (7 | ) | — | 282 | ||||||||||||||||||||||||||||||
Total available-for-sale securities | $ | 57,203 | $ | 5,776 | $ | 40 | $ | (289 | ) | $ | (1 | ) | $ | 62,729 | |||||||||||||||||||||||
As of December 31, 2013, the amortized cost or cost, gross unrealized gains (losses) and fair value of our fixed maturity and equity securities classified as available-for-sale were as follows: | |||||||||||||||||||||||||||||||||||||
Gross unrealized gains | Gross unrealized losses | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Amortized | Not other- | Other- | Not other- | Other- | Fair | |||||||||||||||||||||||||||||||
cost or | than- | than- | than- | than- | value | ||||||||||||||||||||||||||||||||
cost | temporarily | temporarily | temporarily | temporarily | |||||||||||||||||||||||||||||||||
impaired | impaired | impaired | impaired | ||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 4,710 | $ | 331 | $ | — | $ | (231 | ) | $ | — | $ | 4,810 | ||||||||||||||||||||||||
Tax-exempt | 324 | 7 | — | (36 | ) | — | 295 | ||||||||||||||||||||||||||||||
Government—non-U.S. | 2,057 | 104 | — | (15 | ) | — | 2,146 | ||||||||||||||||||||||||||||||
U.S. corporate | 23,614 | 1,761 | 19 | (359 | ) | — | 25,035 | ||||||||||||||||||||||||||||||
Corporate—non-U.S. | 14,489 | 738 | — | (156 | ) | — | 15,071 | ||||||||||||||||||||||||||||||
Residential mortgage-backed | 5,058 | 232 | 9 | (70 | ) | (4 | ) | 5,225 | |||||||||||||||||||||||||||||
Commercial mortgage-backed | 2,886 | 75 | 2 | (62 | ) | (3 | ) | 2,898 | |||||||||||||||||||||||||||||
Other asset-backed | 3,171 | 35 | — | (57 | ) | — | 3,149 | ||||||||||||||||||||||||||||||
Total fixed maturity securities | 56,309 | 3,283 | 30 | (986 | ) | (7 | ) | 58,629 | |||||||||||||||||||||||||||||
Equity securities | 318 | 36 | — | (13 | ) | — | 341 | ||||||||||||||||||||||||||||||
Total available-for-sale securities | $ | 56,627 | $ | 3,319 | $ | 30 | $ | (999 | ) | $ | (7 | ) | $ | 58,970 | |||||||||||||||||||||||
Gross Unrealized Losses and Fair Values of Investment Securities | The following table presents the gross unrealized losses and fair values of our investment securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, as of December 31, 2014: | ||||||||||||||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | |||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) | Fair | Gross | Number | Fair | Gross | Number | Fair | Gross | Number | ||||||||||||||||||||||||||||
value | unrealized | of | value | unrealized | of | value | unrealized | of | |||||||||||||||||||||||||||||
losses | securities | losses (1) | securities | losses (1) | securities | ||||||||||||||||||||||||||||||||
Description of Securities | |||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | — | $ | — | — | $ | 75 | $ | (1 | ) | 10 | $ | 75 | $ | (1 | ) | 10 | ||||||||||||||||||||
Tax-exempt | — | — | — | 111 | (14 | ) | 10 | 111 | (14 | ) | 10 | ||||||||||||||||||||||||||
Government—non-U.S. | 67 | (1 | ) | 18 | 22 | (1 | ) | 4 | 89 | (2 | ) | 22 | |||||||||||||||||||||||||
U.S. corporate | 1,656 | (31 | ) | 240 | 1,359 | (57 | ) | 210 | 3,015 | (88 | ) | 450 | |||||||||||||||||||||||||
Corporate—non-U.S. | 1,568 | (69 | ) | 239 | 515 | (28 | ) | 70 | 2,083 | (97 | ) | 309 | |||||||||||||||||||||||||
Residential mortgage-backed | 180 | (1 | ) | 24 | 254 | (17 | ) | 90 | 434 | (18 | ) | 114 | |||||||||||||||||||||||||
Commercial mortgage-backed | 163 | — | 21 | 362 | (9 | ) | 49 | 525 | (9 | ) | 70 | ||||||||||||||||||||||||||
Other asset-backed | 1,551 | (12 | ) | 215 | 487 | (42 | ) | 55 | 2,038 | (54 | ) | 270 | |||||||||||||||||||||||||
Subtotal, fixed maturity securities | 5,185 | (114 | ) | 757 | 3,185 | (169 | ) | 498 | 8,370 | (283 | ) | 1,255 | |||||||||||||||||||||||||
Equity securities | 30 | (3 | ) | 46 | 48 | (4 | ) | 6 | 78 | (7 | ) | 52 | |||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 5,215 | $ | (117 | ) | 803 | $ | 3,233 | $ | (173 | ) | 504 | $ | 8,448 | $ | (290 | ) | 1,307 | |||||||||||||||||||
% Below cost—fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
<20% Below cost | $ | 5,148 | $ | (103 | ) | 753 | $ | 3,054 | $ | (115 | ) | 477 | $ | 8,202 | $ | (218 | ) | 1,230 | |||||||||||||||||||
20%-50% Below cost | 37 | (11 | ) | 4 | 131 | (53 | ) | 15 | 168 | (64 | ) | 19 | |||||||||||||||||||||||||
>50% Below cost | — | — | — | — | (1 | ) | 6 | — | (1 | ) | 6 | ||||||||||||||||||||||||||
Total fixed maturity securities | 5,185 | (114 | ) | 757 | 3,185 | (169 | ) | 498 | 8,370 | (283 | ) | 1,255 | |||||||||||||||||||||||||
% Below cost—equity securities: | |||||||||||||||||||||||||||||||||||||
<20% Below cost | 26 | (2 | ) | 40 | 48 | (4 | ) | 6 | 74 | (6 | ) | 46 | |||||||||||||||||||||||||
20%-50% Below cost | 4 | (1 | ) | 6 | — | — | — | 4 | (1 | ) | 6 | ||||||||||||||||||||||||||
Total equity securities | 30 | (3 | ) | 46 | 48 | (4 | ) | 6 | 78 | (7 | ) | 52 | |||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 5,215 | $ | (117 | ) | 803 | $ | 3,233 | $ | (173 | ) | 504 | $ | 8,448 | $ | (290 | ) | 1,307 | |||||||||||||||||||
Investment grade | $ | 4,623 | $ | (75 | ) | 675 | $ | 2,936 | $ | (146 | ) | 431 | $ | 7,559 | $ | (221 | ) | 1,106 | |||||||||||||||||||
Below investment grade (2) | 592 | (42 | ) | 128 | 297 | (27 | ) | 73 | 889 | (69 | ) | 201 | |||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 5,215 | $ | (117 | ) | 803 | $ | 3,233 | $ | (173 | ) | 504 | $ | 8,448 | $ | (290 | ) | 1,307 | |||||||||||||||||||
(1) | Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities. | ||||||||||||||||||||||||||||||||||||
(2) | Amounts that have been in a continuous unrealized loss position for 12 months or more included $1 million of unrealized losses on other-than-temporarily impaired securities. | ||||||||||||||||||||||||||||||||||||
The following table presents the gross unrealized losses and fair values of our investment securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, as of December 31, 2013: | |||||||||||||||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | |||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) | Fair | Gross | Number | Fair | Gross | Number | Fair | Gross | Number | ||||||||||||||||||||||||||||
value | unrealized | of | value | unrealized | of | value | unrealized | of | |||||||||||||||||||||||||||||
losses | securities | losses (1) | securities | losses (1) | securities | ||||||||||||||||||||||||||||||||
Description of Securities | |||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 796 | $ | (109 | ) | 32 | $ | 335 | $ | (122 | ) | 13 | $ | 1,131 | $ | (231 | ) | 45 | |||||||||||||||||||
Tax-exempt | 82 | (3 | ) | 26 | 97 | (33 | ) | 9 | 179 | (36 | ) | 35 | |||||||||||||||||||||||||
Government—non-U.S. | 479 | (15 | ) | 60 | — | — | — | 479 | (15 | ) | 60 | ||||||||||||||||||||||||||
U.S. corporate | 4,774 | (260 | ) | 707 | 663 | (99 | ) | 82 | 5,437 | (359 | ) | 789 | |||||||||||||||||||||||||
Corporate—non-U.S. | 3,005 | (127 | ) | 379 | 287 | (29 | ) | 34 | 3,292 | (156 | ) | 413 | |||||||||||||||||||||||||
Residential mortgage-backed | 1,052 | (55 | ) | 139 | 157 | (19 | ) | 92 | 1,209 | (74 | ) | 231 | |||||||||||||||||||||||||
Commercial mortgage-backed | 967 | (42 | ) | 107 | 370 | (23 | ) | 62 | 1,337 | (65 | ) | 169 | |||||||||||||||||||||||||
Other asset-backed | 1,089 | (17 | ) | 133 | 145 | (40 | ) | 17 | 1,234 | (57 | ) | 150 | |||||||||||||||||||||||||
Subtotal, fixed maturity securities | 12,244 | (628 | ) | 1,583 | 2,054 | (365 | ) | 309 | 14,298 | (993 | ) | 1,892 | |||||||||||||||||||||||||
Equity securities | 95 | (13 | ) | 41 | — | — | — | 95 | (13 | ) | 41 | ||||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 12,339 | $ | (641 | ) | 1,624 | $ | 2,054 | $ | (365 | ) | 309 | $ | 14,393 | $ | (1,006 | ) | 1,933 | |||||||||||||||||||
% Below cost—fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
<20% Below cost | $ | 12,009 | $ | (547 | ) | 1,571 | $ | 1,575 | $ | (163 | ) | 238 | $ | 13,584 | $ | (710 | ) | 1,809 | |||||||||||||||||||
20%-50% Below cost | 235 | (81 | ) | 12 | 466 | (187 | ) | 51 | 701 | (268 | ) | 63 | |||||||||||||||||||||||||
>50% Below cost | — | — | — | 13 | (15 | ) | 20 | 13 | (15 | ) | 20 | ||||||||||||||||||||||||||
Total fixed maturity securities | 12,244 | (628 | ) | 1,583 | 2,054 | (365 | ) | 309 | 14,298 | (993 | ) | 1,892 | |||||||||||||||||||||||||
% Below cost—equity securities: | |||||||||||||||||||||||||||||||||||||
<20% Below cost | 87 | (11 | ) | 40 | — | — | — | 87 | (11 | ) | 40 | ||||||||||||||||||||||||||
20%-50% Below cost | 8 | (2 | ) | 1 | — | — | — | 8 | (2 | ) | 1 | ||||||||||||||||||||||||||
Total equity securities | 95 | (13 | ) | 41 | — | — | — | 95 | (13 | ) | 41 | ||||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 12,339 | $ | (641 | ) | 1,624 | $ | 2,054 | $ | (365 | ) | 309 | $ | 14,393 | $ | (1,006 | ) | 1,933 | |||||||||||||||||||
Investment grade | $ | 11,896 | $ | (616 | ) | 1,515 | $ | 1,631 | $ | (315 | ) | 208 | $ | 13,527 | $ | (931 | ) | 1,723 | |||||||||||||||||||
Below investment grade (2) | 443 | (25 | ) | 109 | 423 | (50 | ) | 101 | 866 | (75 | ) | 210 | |||||||||||||||||||||||||
Total for securities in an unrealized loss position | $ | 12,339 | $ | (641 | ) | 1,624 | $ | 2,054 | $ | (365 | ) | 309 | $ | 14,393 | $ | (1,006 | ) | 1,933 | |||||||||||||||||||
(1) | Amounts included $7 million of unrealized losses on other-than-temporarily impaired securities. | ||||||||||||||||||||||||||||||||||||
(2) | Amounts that have been in a continuous unrealized loss position for 12 months or more included $7 million of unrealized losses on other-than-temporarily impaired securities. | ||||||||||||||||||||||||||||||||||||
Fixed Maturity Securities More Than 20% Below Cost and in Continuous Loss Position for 12 Months or More by Asset Class | The following tables present the concentration of gross unrealized losses and fair values of fixed maturity securities that were more than 20% below cost and in a continuous unrealized loss position for 12 months or more by asset class as of December 31, 2014: | ||||||||||||||||||||||||||||||||||||
Investment Grade | |||||||||||||||||||||||||||||||||||||
20% to 50% | Greater than 50% | ||||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) | Fair | Gross | % of total | Number of | Fair | Gross | % of total | Number of | |||||||||||||||||||||||||||||
value | unrealized | gross | securities | value | unrealized | gross | securities | ||||||||||||||||||||||||||||||
losses | unrealized | losses | unrealized | ||||||||||||||||||||||||||||||||||
losses | losses | ||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
Tax-exempt | $ | 10 | $ | (3 | ) | 1 | % | 1 | $ | — | $ | — | — | % | — | ||||||||||||||||||||||
U.S. corporate | 25 | (10 | ) | 3 | 1 | — | — | — | — | ||||||||||||||||||||||||||||
Structured securities: | |||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 5 | (4 | ) | 1 | 3 | — | — | — | — | ||||||||||||||||||||||||||||
Other asset-backed | 71 | (26 | ) | 9 | 4 | — | — | — | — | ||||||||||||||||||||||||||||
Total structured securities | 76 | (30 | ) | 10 | 7 | — | — | — | — | ||||||||||||||||||||||||||||
Total | $ | 111 | $ | (43 | ) | 14 | % | 9 | $ | — | $ | — | — | % | — | ||||||||||||||||||||||
Below Investment Grade | |||||||||||||||||||||||||||||||||||||
20% to 50% | Greater than 50% | ||||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) | Fair | Gross | % of total | Number of | Fair | Gross | % of total | Number of | |||||||||||||||||||||||||||||
value | unrealized | gross | securities | value | unrealized | gross | securities | ||||||||||||||||||||||||||||||
losses | unrealized | losses | unrealized | ||||||||||||||||||||||||||||||||||
losses | losses | ||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||
U.S. corporate | $ | 8 | $ | (2 | ) | 1 | % | 1 | $ | — | $ | — | — | % | — | ||||||||||||||||||||||
Corporate—non-U.S. | 3 | (2 | ) | 1 | 1 | — | — | — | — | ||||||||||||||||||||||||||||
Structured securities: | |||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | — | — | — | — | — | (1 | ) | — | 6 | ||||||||||||||||||||||||||||
Other asset-backed | 9 | (6 | ) | 2 | 4 | — | — | — | — | ||||||||||||||||||||||||||||
Total structured securities | 9 | (6 | ) | 2 | 4 | — | (1 | ) | — | 6 | |||||||||||||||||||||||||||
Total | $ | 20 | $ | (10 | ) | 4 | % | 6 | $ | — | $ | (1 | ) | — | % | 6 | |||||||||||||||||||||
Maturity Distribution of Fixed Maturity Securities | The scheduled maturity distribution of fixed maturity securities as of December 31, 2014 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties. | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Amortized | Fair | |||||||||||||||||||||||||||||||||||
cost or | value | ||||||||||||||||||||||||||||||||||||
cost | |||||||||||||||||||||||||||||||||||||
Due one year or less | $ | 2,307 | $ | 2,326 | |||||||||||||||||||||||||||||||||
Due after one year through five years | 10,858 | 11,410 | |||||||||||||||||||||||||||||||||||
Due after five years through ten years | 11,888 | 12,496 | |||||||||||||||||||||||||||||||||||
Due after ten years | 20,717 | 24,568 | |||||||||||||||||||||||||||||||||||
Subtotal | 45,770 | 50,800 | |||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 4,881 | 5,240 | |||||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 2,564 | 2,702 | |||||||||||||||||||||||||||||||||||
Other asset-backed | 3,735 | 3,705 | |||||||||||||||||||||||||||||||||||
Total | $ | 56,950 | $ | 62,447 | |||||||||||||||||||||||||||||||||
Commercial Mortgage Loans by Property Type | The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of December 31: | ||||||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Carrying | % of | Carrying | % of | |||||||||||||||||||||||||||||||||
value | total | value | total | ||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | 2,150 | 35 | % | $ | 2,073 | 35 | % | |||||||||||||||||||||||||||||
Office | 1,643 | 27 | 1,558 | 26 | |||||||||||||||||||||||||||||||||
Industrial | 1,597 | 26 | 1,581 | 27 | |||||||||||||||||||||||||||||||||
Apartments | 494 | 8 | 491 | 8 | |||||||||||||||||||||||||||||||||
Mixed use/other | 239 | 4 | 229 | 4 | |||||||||||||||||||||||||||||||||
Subtotal | 6,123 | 100 | % | 5,932 | 100 | % | |||||||||||||||||||||||||||||||
Unamortized balance of loan origination fees and costs | (1 | ) | — | ||||||||||||||||||||||||||||||||||
Allowance for losses | (22 | ) | (33 | ) | |||||||||||||||||||||||||||||||||
Total | $ | 6,100 | $ | 5,899 | |||||||||||||||||||||||||||||||||
Commercial Mortgage Loans by Geographic Region | |||||||||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Carrying | % of | Carrying | % of | |||||||||||||||||||||||||||||||||
value | total | value | total | ||||||||||||||||||||||||||||||||||
Geographic region: | |||||||||||||||||||||||||||||||||||||
South Atlantic | $ | 1,673 | 27 | % | $ | 1,535 | 26 | % | |||||||||||||||||||||||||||||
Pacific | 1,636 | 27 | 1,590 | 27 | |||||||||||||||||||||||||||||||||
Middle Atlantic | 826 | 14 | 828 | 14 | |||||||||||||||||||||||||||||||||
Mountain | 536 | 9 | 478 | 8 | |||||||||||||||||||||||||||||||||
East North Central | 397 | 7 | 404 | 7 | |||||||||||||||||||||||||||||||||
West North Central | 382 | 6 | 377 | 6 | |||||||||||||||||||||||||||||||||
West South Central | 268 | 4 | 241 | 4 | |||||||||||||||||||||||||||||||||
New England | 264 | 4 | 337 | 6 | |||||||||||||||||||||||||||||||||
East South Central | 141 | 2 | 142 | 2 | |||||||||||||||||||||||||||||||||
Subtotal | 6,123 | 100 | % | 5,932 | 100 | % | |||||||||||||||||||||||||||||||
Unamortized balance of loan origination fees and costs | (1 | ) | — | ||||||||||||||||||||||||||||||||||
Allowance for losses | (22 | ) | (33 | ) | |||||||||||||||||||||||||||||||||
Total | $ | 6,100 | $ | 5,899 | |||||||||||||||||||||||||||||||||
Aging of Past Due Commercial Mortgage Loans by Property Type | The following tables set forth the aging of past due commercial mortgage loans by property type as of December 31: | ||||||||||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 31 - 60 days | 61 - 90 days | Greater than | Total | Current | Total | |||||||||||||||||||||||||||||||
past due | past due | 90 days past | past due | ||||||||||||||||||||||||||||||||||
due | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | — | $ | — | $ | — | $ | — | $ | 2,150 | $ | 2,150 | |||||||||||||||||||||||||
Office | — | — | 6 | 6 | 1,637 | 1,643 | |||||||||||||||||||||||||||||||
Industrial | — | — | 2 | 2 | 1,595 | 1,597 | |||||||||||||||||||||||||||||||
Apartments | — | — | — | — | 494 | 494 | |||||||||||||||||||||||||||||||
Mixed use/other | — | — | — | — | 239 | 239 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | — | $ | — | $ | 8 | $ | 8 | $ | 6,115 | $ | 6,123 | |||||||||||||||||||||||||
% of total commercial mortgage loans | — | % | — | % | — | % | — | % | 100 | % | 100 | % | |||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 31 - 60 days | 61 - 90 days | Greater than | Total | Current | Total | |||||||||||||||||||||||||||||||
past due | past due | 90 days past | past due | ||||||||||||||||||||||||||||||||||
due | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | — | $ | — | $ | 10 | $ | 10 | $ | 2,063 | $ | 2,073 | |||||||||||||||||||||||||
Office | — | — | 6 | 6 | 1,552 | 1,558 | |||||||||||||||||||||||||||||||
Industrial | 2 | 2 | 16 | 20 | 1,561 | 1,581 | |||||||||||||||||||||||||||||||
Apartments | — | — | — | — | 491 | 491 | |||||||||||||||||||||||||||||||
Mixed use/other | 1 | — | — | 1 | 228 | 229 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | 3 | $ | 2 | $ | 32 | $ | 37 | $ | 5,895 | $ | 5,932 | |||||||||||||||||||||||||
% of total commercial mortgage loans | — | % | — | % | 1 | % | 1 | % | 99 | % | 100 | % | |||||||||||||||||||||||||
Allowance for Credit Losses and Recorded Investment in Commercial Mortgage Loans | The following table sets forth the allowance for credit losses and recorded investment in commercial mortgage loans as of or for the years ended December 31: | ||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||
Allowance for credit losses: | |||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 33 | $ | 42 | $ | 51 | |||||||||||||||||||||||||||||||
Charge-offs | (1 | ) | (2 | ) | (2 | ) | |||||||||||||||||||||||||||||||
Recoveries | — | — | — | ||||||||||||||||||||||||||||||||||
Provision | (10 | ) | (7 | ) | (7 | ) | |||||||||||||||||||||||||||||||
Ending balance | $ | 22 | $ | 33 | $ | 42 | |||||||||||||||||||||||||||||||
Ending allowance for individually impaired loans | $ | — | $ | — | $ | — | |||||||||||||||||||||||||||||||
Ending allowance for loans not individually impaired that were evaluated collectively for impairment | $ | 22 | $ | 33 | $ | 42 | |||||||||||||||||||||||||||||||
Recorded investment: | |||||||||||||||||||||||||||||||||||||
Ending balance | $ | 6,123 | $ | 5,932 | $ | 5,912 | |||||||||||||||||||||||||||||||
Ending balance of individually impaired loans | $ | 15 | $ | 2 | $ | — | |||||||||||||||||||||||||||||||
Ending balance of loans not individually impaired that were evaluated collectively for impairment | $ | 6,108 | $ | 5,930 | $ | 5,912 | |||||||||||||||||||||||||||||||
Average Loan-to-Value of Commercial Mortgage Loans by Property Type | The following tables set forth the loan-to-value of commercial mortgage loans by property type as of December 31: | ||||||||||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 0% - 50% | 51% - 60% | 61% - 75% | 76% - 100% | Greater | Total | |||||||||||||||||||||||||||||||
than 100% (1) | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | 671 | $ | 419 | $ | 967 | $ | 75 | $ | 18 | $ | 2,150 | |||||||||||||||||||||||||
Office | 383 | 278 | 782 | 164 | 36 | 1,643 | |||||||||||||||||||||||||||||||
Industrial | 451 | 285 | 778 | 60 | 23 | 1,597 | |||||||||||||||||||||||||||||||
Apartments | 211 | 76 | 199 | 8 | — | 494 | |||||||||||||||||||||||||||||||
Mixed use/other | 45 | 43 | 145 | 6 | — | 239 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | 1,761 | $ | 1,101 | $ | 2,871 | $ | 313 | $ | 77 | $ | 6,123 | |||||||||||||||||||||||||
% of total | 29 | % | 18 | % | 47 | % | 5 | % | 1 | % | 100 | % | |||||||||||||||||||||||||
Weighted-average debt service coverage ratio | 2.27 | 1.75 | 1.61 | 1.02 | 0.72 | 1.78 | |||||||||||||||||||||||||||||||
(1) | Included $15 million of impaired loans, $6 million of loans past due and not individually impaired and $56 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 120%. | ||||||||||||||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 0% - 50% | 51% - 60% | 61% - 75% | 76% - 100% | Greater | Total | |||||||||||||||||||||||||||||||
than 100% (1) | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | 596 | $ | 336 | $ | 1,024 | $ | 95 | $ | 22 | $ | 2,073 | |||||||||||||||||||||||||
Office | 397 | 191 | 716 | 191 | 63 | 1,558 | |||||||||||||||||||||||||||||||
Industrial | 430 | 237 | 748 | 146 | 20 | 1,581 | |||||||||||||||||||||||||||||||
Apartments | 201 | 86 | 176 | 27 | 1 | 491 | |||||||||||||||||||||||||||||||
Mixed use/other | 71 | 36 | 110 | 12 | — | 229 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | 1,695 | $ | 886 | $ | 2,774 | $ | 471 | $ | 106 | $ | 5,932 | |||||||||||||||||||||||||
% of total | 28 | % | 15 | % | 47 | % | 8 | % | 2 | % | 100 | % | |||||||||||||||||||||||||
Weighted-average debt service coverage ratio | 2.14 | 1.79 | 1.66 | 1.03 | 0.63 | 1.75 | |||||||||||||||||||||||||||||||
(1) | Included $2 million of impaired loans, $5 million of loans past due and not individually impaired and $99 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 119%. | ||||||||||||||||||||||||||||||||||||
Debt Service Coverage Ratio for Fixed Rate Commercial Mortgage Loans by Property Type | The following tables set forth the debt service coverage ratio for fixed rate commercial mortgage loans by property type as of December 31: | ||||||||||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Less than 1.00 | 1.00 - 1.25 | 1.26 - 1.50 | 1.51 - 2.00 | Greater | Total | |||||||||||||||||||||||||||||||
than 2.00 | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | 80 | $ | 253 | $ | 524 | $ | 870 | $ | 423 | $ | 2,150 | |||||||||||||||||||||||||
Office | 119 | 101 | 247 | 780 | 389 | 1,636 | |||||||||||||||||||||||||||||||
Industrial | 158 | 142 | 246 | 706 | 343 | 1,595 | |||||||||||||||||||||||||||||||
Apartments | 1 | 48 | 88 | 186 | 171 | 494 | |||||||||||||||||||||||||||||||
Mixed use/other | 6 | 1 | 61 | 135 | 36 | 239 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | 364 | $ | 545 | $ | 1,166 | $ | 2,677 | $ | 1,362 | $ | 6,114 | |||||||||||||||||||||||||
% of total | 6 | % | 9 | % | 19 | % | 44 | % | 22 | % | 100 | % | |||||||||||||||||||||||||
Weighted-average loan-to-value | 77 | % | 64 | % | 64 | % | 59 | % | 45 | % | 59 | % | |||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Less than 1.00 | 1.00 - 1.25 | 1.26 - 1.50 | 1.51 - 2.00 | Greater | Total | |||||||||||||||||||||||||||||||
than 2.00 | |||||||||||||||||||||||||||||||||||||
Property type: | |||||||||||||||||||||||||||||||||||||
Retail | $ | 106 | $ | 314 | $ | 374 | $ | 779 | $ | 399 | $ | 1,972 | |||||||||||||||||||||||||
Office | 131 | 181 | 225 | 637 | 376 | 1,550 | |||||||||||||||||||||||||||||||
Industrial | 195 | 100 | 270 | 721 | 295 | 1,581 | |||||||||||||||||||||||||||||||
Apartments | 3 | 31 | 107 | 187 | 163 | 491 | |||||||||||||||||||||||||||||||
Mixed use/other | 16 | 9 | 32 | 106 | 66 | 229 | |||||||||||||||||||||||||||||||
Total recorded investment | $ | 451 | $ | 635 | $ | 1,008 | $ | 2,430 | $ | 1,299 | $ | 5,823 | |||||||||||||||||||||||||
% of total | 8 | % | 11 | % | 17 | % | 42 | % | 22 | % | 100 | % | |||||||||||||||||||||||||
Weighted-average loan-to-value | 80 | % | 68 | % | 63 | % | 60 | % | 43 | % | 59 | % | |||||||||||||||||||||||||
Derivative_Instruments_Tables
Derivative Instruments (Tables) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||
Schedule Of Positions in Derivative Instruments | The following table sets forth our positions in derivative instruments as of December 31: | ||||||||||||||||||||||||
Derivative assets | Derivative liabilities | ||||||||||||||||||||||||
Balance sheet | Fair value | Balance sheet | Fair value | ||||||||||||||||||||||
(Amounts in millions) | classification | 2014 | 2013 | classification | 2014 | 2013 | |||||||||||||||||||
Derivatives designated as hedges | |||||||||||||||||||||||||
Cash flow hedges: | |||||||||||||||||||||||||
Interest rate swaps | Other invested assets | $ | 639 | $ | 121 | Other liabilities | $ | 27 | $ | 569 | |||||||||||||||
Inflation indexed swaps | Other invested assets | — | — | Other liabilities | 42 | 60 | |||||||||||||||||||
Foreign currency swaps | Other invested assets | 6 | 4 | Other liabilities | — | 2 | |||||||||||||||||||
Forward bond purchase commitments | Other invested assets | — | — | Other liabilities | — | 13 | |||||||||||||||||||
Total cash flow hedges | 645 | 125 | 69 | 644 | |||||||||||||||||||||
Fair value hedges: | |||||||||||||||||||||||||
Interest rate swaps | Other invested assets | — | 1 | Other liabilities | — | — | |||||||||||||||||||
Total fair value hedges | — | 1 | — | — | |||||||||||||||||||||
Total derivatives designated as hedges | 645 | 126 | 69 | 644 | |||||||||||||||||||||
Derivatives not designated as hedges | |||||||||||||||||||||||||
Interest rate swaps | Other invested assets | 452 | 314 | Other liabilities | 177 | 6 | |||||||||||||||||||
Interest rate swaps related to securitization entities (1) | Restricted other | — | — | Other liabilities | 26 | 16 | |||||||||||||||||||
invested assets | |||||||||||||||||||||||||
Credit default swaps | Other invested assets | 4 | 11 | Other liabilities | — | — | |||||||||||||||||||
Credit default swaps related to securitization entities (1) | Restricted other | — | — | Other liabilities | 17 | 32 | |||||||||||||||||||
invested assets | |||||||||||||||||||||||||
Foreign currency swaps | Other invested assets | — | — | Other liabilities | 7 | — | |||||||||||||||||||
Equity index options | Other invested assets | 17 | 12 | Other liabilities | — | — | |||||||||||||||||||
Financial futures | Other invested assets | — | — | Other liabilities | — | — | |||||||||||||||||||
Equity return swaps | Other invested assets | — | — | Other liabilities | 1 | 1 | |||||||||||||||||||
Other foreign currency contracts | Other invested assets | 14 | 8 | Other liabilities | 13 | 4 | |||||||||||||||||||
GMWB embedded derivatives | Reinsurance | 13 | (1 | ) | Policyholder | 291 | 96 | ||||||||||||||||||
recoverable (2) | account balances (3) | ||||||||||||||||||||||||
Fixed index annuity embedded | Other assets | — | — | Policyholder | 276 | 143 | |||||||||||||||||||
derivatives | account balances (4) | ||||||||||||||||||||||||
Indexed universal life embedded | Reinsurance | — | — | Policyholder | 7 | — | |||||||||||||||||||
derivatives | recoverable | account balances (5) | |||||||||||||||||||||||
Total derivatives not designated as hedges | 500 | 344 | 815 | 298 | |||||||||||||||||||||
Total derivatives | $ | 1,145 | $ | 470 | $ | 884 | $ | 942 | |||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||
(2) | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||
(3) | Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||
(4) | Represents the embedded derivatives associated with our fixed index annuity liabilities. | ||||||||||||||||||||||||
(5) | Represents the embedded derivatives associated with our indexed universal life liabilities. | ||||||||||||||||||||||||
Activity Associated with Derivative Instruments | The following tables represent activity associated with derivative instruments as of the dates indicated: | ||||||||||||||||||||||||
(Notional in millions) | Measurement | December 31, | Additions | Maturities/ | December 31, | ||||||||||||||||||||
2013 | terminations | 2014 | |||||||||||||||||||||||
Derivatives designated as hedges | |||||||||||||||||||||||||
Cash flow hedges: | |||||||||||||||||||||||||
Interest rate swaps | Notional | $ | 13,926 | $ | — | $ | (1,965 | ) | $ | 11,961 | |||||||||||||||
Inflation indexed swaps | Notional | 561 | 15 | (5 | ) | 571 | |||||||||||||||||||
Foreign currency swaps | Notional | 35 | — | — | 35 | ||||||||||||||||||||
Forward bond purchase commitments | Notional | 237 | — | (237 | ) | — | |||||||||||||||||||
Total cash flow hedges | 14,759 | 15 | (2,207 | ) | 12,567 | ||||||||||||||||||||
Fair value hedges: | |||||||||||||||||||||||||
Interest rate swaps | Notional | 6 | — | (6 | ) | — | |||||||||||||||||||
Total fair value hedges | 6 | — | (6 | ) | — | ||||||||||||||||||||
Total derivatives designated as hedges | 14,765 | 15 | (2,213 | ) | 12,567 | ||||||||||||||||||||
Derivatives not designated as hedges | |||||||||||||||||||||||||
Interest rate swaps | Notional | 4,822 | 508 | (256 | ) | 5,074 | |||||||||||||||||||
Interest rate swaps related to securitization entities (1) | Notional | 91 | — | (14 | ) | 77 | |||||||||||||||||||
Credit default swaps | Notional | 639 | 5 | (250 | ) | 394 | |||||||||||||||||||
Credit default swaps related to securitization entities (1) | Notional | 312 | — | — | 312 | ||||||||||||||||||||
Equity index options | Notional | 777 | 1,276 | (1,059 | ) | 994 | |||||||||||||||||||
Financial futures | Notional | 1,260 | 5,723 | (5,652 | ) | 1,331 | |||||||||||||||||||
Equity return swaps | Notional | 110 | 231 | (233 | ) | 108 | |||||||||||||||||||
Foreign currency swaps | Notional | — | 104 | — | 104 | ||||||||||||||||||||
Other foreign currency contracts | Notional | 487 | 788 | (850 | ) | 425 | |||||||||||||||||||
Total derivatives not designated as hedges | 8,498 | 8,635 | (8,314 | ) | 8,819 | ||||||||||||||||||||
Total derivatives | $ | 23,263 | $ | 8,650 | $ | (10,527 | ) | $ | 21,386 | ||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||
(Number of policies) | Measurement | December 31, | Additions | Maturities/ | December 31, | ||||||||||||||||||||
2013 | terminations | 2014 | |||||||||||||||||||||||
Derivatives not designated as hedges | |||||||||||||||||||||||||
GMWB embedded derivatives | Policies | 42,045 | — | (3,030 | ) | 39,015 | |||||||||||||||||||
Fixed index annuity embedded derivatives | Policies | 7,705 | 6,436 | (240 | ) | 13,901 | |||||||||||||||||||
Indexed universal life embedded derivatives | Policies | 29 | 394 | (2 | ) | 421 | |||||||||||||||||||
Schedule of Pre-Tax Income (Loss) Effects of Cash Flow Hedges | The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2014: | ||||||||||||||||||||||||
(Amounts in millions) | Gain (loss) | Gain (loss) | Classification of gain | Gain (loss) | Classification of gain | ||||||||||||||||||||
recognized | reclassified into | (loss) reclassified into | recognized in | (loss) recognized in | |||||||||||||||||||||
in OCI | net income (loss) | net income (loss) | net income | net income (loss) | |||||||||||||||||||||
from OCI | (loss) (1) | ||||||||||||||||||||||||
Interest rate swaps hedging | $ | 1,229 | $ | 63 | Net investment | $ | 15 | Net investment | |||||||||||||||||
assets | income | gains (losses) | |||||||||||||||||||||||
Interest rate swaps hedging | — | 2 | Net investment | — | Net investment | ||||||||||||||||||||
assets | gains (losses) | gains (losses) | |||||||||||||||||||||||
Interest rate swaps hedging | (69 | ) | 1 | Interest expense | — | Net investment | |||||||||||||||||||
liabilities | gains (losses) | ||||||||||||||||||||||||
Inflation indexed swaps | 17 | (9 | ) | Net investment | — | Net investment | |||||||||||||||||||
income | gains (losses) | ||||||||||||||||||||||||
Foreign currency swaps | 4 | — | Interest expense | — | Net investment | ||||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Forward bond purchase | 34 | — | Net investment | — | Net investment | ||||||||||||||||||||
commitments | income | gains (losses) | |||||||||||||||||||||||
Total | $ | 1,215 | $ | 57 | $ | 15 | |||||||||||||||||||
(1) | Represents ineffective portion of cash flow hedges as there were no amounts excluded from the measurement of effectiveness. | ||||||||||||||||||||||||
The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2013: | |||||||||||||||||||||||||
(Amounts in millions) | Gain (loss) | Gain (loss) | Classification of gain | Gain (loss) | Classification of gain | ||||||||||||||||||||
recognized | reclassified into | (loss) reclassified into | recognized in | (loss) recognized in net | |||||||||||||||||||||
in OCI | net income (loss) | net income (loss) | net income | income (loss) | |||||||||||||||||||||
from OCI | (loss) (1) | ||||||||||||||||||||||||
Interest rate swaps hedging assets | $ | (892 | ) | $ | 47 | Net investment income | $ | (14 | ) | Net investment | |||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Interest rate swaps hedging assets | — | 1 | Net investment gains (losses) | — | Net investment | ||||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Interest rate swaps hedging liabilities | 42 | 2 | Interest expense | — | Net investment | ||||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Inflation indexed swaps | 45 | (5 | ) | Net investment income | — | Net investment | |||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Foreign currency swaps | (1 | ) | — | Interest expense | — | Net investment | |||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Forward bond purchase commitments | (60 | ) | — | Net investment income | — | Net investment | |||||||||||||||||||
gains (losses) | |||||||||||||||||||||||||
Total | $ | (866 | ) | $ | 45 | $ | (14 | ) | |||||||||||||||||
(1) | Represents ineffective portion of cash flow hedges, as there were no amounts excluded from the measurement of effectiveness. | ||||||||||||||||||||||||
The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2012: | |||||||||||||||||||||||||
(Amounts in millions) | Gain (loss) | Gain (loss) | Classification of gain | Gain (loss) | Classification of gain | ||||||||||||||||||||
recognized | reclassified into | (loss) reclassified | recognized in | (loss) recognized in | |||||||||||||||||||||
in OCI | net income (loss) | into net income (loss) | net income | net income (loss) | |||||||||||||||||||||
from OCI | (loss) (1) | ||||||||||||||||||||||||
Interest rate swaps hedging assets | $ | (74 | ) | $ | 40 | Net investment income | $ | (12 | ) | Net investment gains (losses) | |||||||||||||||
Interest rate swaps hedging assets | — | 2 | Net investment gains (losses) | — | Net investment gains (losses) | ||||||||||||||||||||
Interest rate swaps hedging liabilities | — | 2 | Interest expense | — | Net investment gains (losses) | ||||||||||||||||||||
Inflation indexed swaps | (58 | ) | (9 | ) | Net investment income | — | Net investment gains (losses) | ||||||||||||||||||
Foreign currency swaps | 3 | — | Interest expense | — | Net investment gains (losses) | ||||||||||||||||||||
Forward bond purchase commitments | 14 | — | Net investment income | — | Net investment gains (losses) | ||||||||||||||||||||
Total | $ | (115 | ) | $ | 35 | $ | (12 | ) | |||||||||||||||||
(1) | Represents ineffective portion of cash flow hedges, as there were no amounts excluded from the measurement of effectiveness. | ||||||||||||||||||||||||
Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedges | The following table provides a reconciliation of current period changes, net of applicable income taxes, for these designated derivatives presented in the separate component of stockholders’ equity labeled “derivatives qualifying as hedges,” for the years ended December 31: | ||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Derivatives qualifying as effective accounting hedges as of January 1 | $ | 1,319 | $ | 1,909 | $ | 2,009 | |||||||||||||||||||
Current period increases (decreases) in fair value, net of deferred taxes of $(427), $305 and $38 | 788 | (561 | ) | (77 | ) | ||||||||||||||||||||
Reclassification to net (income) loss, net of deferred taxes of $20, $16 and $12 | (37 | ) | (29 | ) | (23 | ) | |||||||||||||||||||
Derivatives qualifying as effective accounting hedges as of December 31 | $ | 2,070 | $ | 1,319 | $ | 1,909 | |||||||||||||||||||
Schedule of Pre-Tax Income (Loss) Effects of Fair Value Hedges and Related Hedged Items | The following table provides information about the pre-tax income (loss) effects of fair value hedges and related hedged items for the year ended December 31, 2013: | ||||||||||||||||||||||||
Derivative instrument | Hedged item | ||||||||||||||||||||||||
(Amounts in millions) | Gain (loss) | Classification of | Other | Classification of | Gain (loss) | Classification of | |||||||||||||||||||
recognized | gain (losses) | impacts | other impacts to | recognized | gain (losses) | ||||||||||||||||||||
in net | recognized in net | to net | net income (loss) | in net | recognized in net | ||||||||||||||||||||
income | income (loss) | income | income | income (loss) | |||||||||||||||||||||
(loss) | (loss) | (loss) | |||||||||||||||||||||||
Interest rate swaps hedging liabilities | $ | (11 | ) | Net investment gains (losses) | $ | 13 | Interest credited | $ | 11 | Net investment gains (losses) | |||||||||||||||
Foreign currency swaps | (31 | ) | Net investment gains (losses) | — | Interest credited | 31 | Net investment gains (losses) | ||||||||||||||||||
Total | $ | (42 | ) | $ | 13 | $ | 42 | ||||||||||||||||||
The following table provides information about the pre-tax income (loss) effects of fair value hedges and related hedged items for the year ended December 31, 2012: | |||||||||||||||||||||||||
Derivative instrument | Hedged item | ||||||||||||||||||||||||
(Amounts in millions) | Gain (loss) | Classification of | Other | Classification of | Gain (loss) | Classification of | |||||||||||||||||||
recognized | gain (losses) | impacts | other impacts to | recognized | gain (losses) | ||||||||||||||||||||
in net | recognized in net | to net | net income (loss) | in net | recognized in net | ||||||||||||||||||||
income | income (loss) | income | income | income (loss) | |||||||||||||||||||||
(loss) | (loss) | (loss) | |||||||||||||||||||||||
Interest rate swaps hedging assets | $ | 1 | Net investment gains (losses) | $ | (4 | ) | Net investment income | $ | (1 | ) | Net investment gains (losses) | ||||||||||||||
Interest rate swaps hedging liabilities | (30 | ) | Net investment gains (losses) | 38 | Interest credited | 30 | Net investment gains (losses) | ||||||||||||||||||
Foreign currency swaps | (1 | ) | Net investment gains (losses) | 2 | Interest credited | — | Net investment gains (losses) | ||||||||||||||||||
Total | $ | (30 | ) | $ | 36 | $ | 29 | ||||||||||||||||||
Schedule of Pre-Tax Gain (Loss) Recognized in Net Income (Loss) for Effects of Derivatives Not Designated as Hedges | The following table provides the pre-tax gain (loss) recognized in net income (loss) for the effects of derivatives not designated as hedges for the years ended December 31: | ||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | Classification of gain (loss) recognized | |||||||||||||||||||||
in net income (loss) | |||||||||||||||||||||||||
Interest rate swaps | $ | 1 | $ | (7 | ) | $ | 21 | Net investment gains (losses) | |||||||||||||||||
Interest rate swaps related to securitization entities (1) | (9 | ) | 9 | (4 | ) | Net investment gains (losses) | |||||||||||||||||||
Credit default swaps | 1 | 14 | 57 | Net investment gains (losses) | |||||||||||||||||||||
Credit default swaps related to securitization entities (1) | 19 | 77 | 76 | Net investment gains (losses) | |||||||||||||||||||||
Equity index options | (31 | ) | (43 | ) | (58 | ) | Net investment gains (losses) | ||||||||||||||||||
Financial futures | 90 | (232 | ) | (121 | ) | Net investment gains (losses) | |||||||||||||||||||
Equity return swaps | 5 | (33 | ) | (37 | ) | Net investment gains (losses) | |||||||||||||||||||
Other foreign currency contracts | (4 | ) | 6 | (19 | ) | Net investment gains (losses) | |||||||||||||||||||
Foreign currency swaps | (7 | ) | — | — | Net investment gains (losses) | ||||||||||||||||||||
Reinsurance embedded derivatives | — | — | 3 | Net investment gains (losses) | |||||||||||||||||||||
GMWB embedded derivatives | (147 | ) | 277 | 170 | Net investment gains (losses) | ||||||||||||||||||||
Fixed index annuity embedded derivatives | (27 | ) | (18 | ) | (1 | ) | Net investment gains (losses) | ||||||||||||||||||
Indexed universal life embedded derivatives | (1 | ) | — | — | Net investment gains (losses) | ||||||||||||||||||||
Total derivatives not designated as hedges | $ | (110 | ) | $ | 50 | $ | 87 | ||||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||
Derivative Assets and Liabilities Subject to Master Netting Arrangement | The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of December 31: | ||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||
(Amounts in millions) | Derivatives | Derivatives | Net | Derivatives | Derivatives | Net | |||||||||||||||||||
assets (1) | liabilities (2) | derivatives | assets (1) | liabilities (2) | derivatives | ||||||||||||||||||||
Amounts presented in the balance sheet: | |||||||||||||||||||||||||
Gross amounts recognized | $ | 1,157 | $ | 273 | $ | 884 | $ | 496 | $ | 662 | $ | (166 | ) | ||||||||||||
Gross amounts offset in the balance sheet | — | — | — | — | — | — | |||||||||||||||||||
Net amounts presented in the balance sheet | 1,157 | 273 | 884 | 496 | 662 | (166 | ) | ||||||||||||||||||
Gross amounts not offset in the balance sheet: | |||||||||||||||||||||||||
Financial instruments (3) | (227 | ) | (227 | ) | — | (286 | ) | (286 | ) | — | |||||||||||||||
Collateral received | (884 | ) | — | (884 | ) | (199 | ) | — | (199 | ) | |||||||||||||||
Collateral pledged | — | (49 | ) | 49 | — | (394 | ) | 394 | |||||||||||||||||
Over collateralization | 1 | 5 | (4 | ) | 16 | 23 | (7 | ) | |||||||||||||||||
Net amount | $ | 47 | $ | 2 | $ | 45 | $ | 27 | $ | 5 | $ | 22 | |||||||||||||
(1) | Included $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2014 and 2013. | ||||||||||||||||||||||||
(2) | Included $6 million and $7 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2014 and 2013, respectively. | ||||||||||||||||||||||||
(3) | Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. | ||||||||||||||||||||||||
Schedule of Credit Default Swaps Where We Sell Protection on Single Name Reference Entities and Fair Values | The following table sets forth our credit default swaps where we sell protection on single name reference entities and the fair values as of the dates indicated: | ||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||
(Amounts in millions) | Notional | Assets | Liabilities | Notional | Assets | Liabilities | |||||||||||||||||||
value | value | ||||||||||||||||||||||||
Investment grade | |||||||||||||||||||||||||
Matures in less than one year | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||
Matures after one year through five years | 39 | 1 | — | 39 | 1 | — | |||||||||||||||||||
Total credit default swaps on single name reference entities | $ | 39 | $ | 1 | $ | — | $ | 39 | $ | 1 | $ | — | |||||||||||||
Schedule of Credit Default Swaps Where We Sell Protection on Credit Default Swap Index Tranches and Fair Values | The following table sets forth our credit default swaps where we sell protection on credit default swap index tranches and the fair values as of December 31: | ||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||
(Amounts in millions) | Notional | Assets | Liabilities | Notional | Assets | Liabilities | |||||||||||||||||||
value | value | ||||||||||||||||||||||||
Original index tranche attachment/detachment point and maturity: | |||||||||||||||||||||||||
7% - 15% matures after one year through five years (1) | $ | 100 | $ | 1 | $ | — | $ | 100 | $ | 3 | $ | — | |||||||||||||
9% - 12% matures in less than one year (2) | 250 | 2 | — | — | — | — | |||||||||||||||||||
9% - 12% matures after one year through five years (2) | — | — | — | 250 | 5 | — | |||||||||||||||||||
10% - 15% matures in less than one year (3) | — | — | — | 250 | 2 | — | |||||||||||||||||||
Total credit default swap index tranches | 350 | 3 | — | 600 | 10 | — | |||||||||||||||||||
Customized credit default swap index tranches related to securitization entities: | |||||||||||||||||||||||||
Portion backing third-party borrowings maturing | 12 | — | — | 12 | — | 1 | |||||||||||||||||||
2017 (4) | |||||||||||||||||||||||||
Portion backing our interest maturing 2017 (5) | 300 | — | 17 | 300 | — | 31 | |||||||||||||||||||
Total customized credit default swap index tranches related to securitization entities | 312 | — | 17 | 312 | — | 32 | |||||||||||||||||||
Total credit default swaps on index tranches | $ | 662 | $ | 3 | $ | 17 | $ | 912 | $ | 10 | $ | 32 | |||||||||||||
(1) | The current attachment/detachment as of December 31, 2014 and 2013 was 7% – 15%. | ||||||||||||||||||||||||
(2) | The current attachment/detachment as of December 31, 2014 and 2013 was 9% – 12%. | ||||||||||||||||||||||||
(3) | The current attachment/detachment as of December 31, 2014 and 2013 was 10% – 15%. | ||||||||||||||||||||||||
(4) | Original notional value was $39 million. | ||||||||||||||||||||||||
(5) | Original notional value was $300 million. |
Deferred_Acquisition_Costs_Tab
Deferred Acquisition Costs (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Activity Impacting Deferred Acquisition Costs | The following table presents the activity impacting DAC as of and for the years ended December 31: | ||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||
Unamortized balance as of January 1 | $ | 5,454 | $ | 5,460 | $ | 5,458 | |||||||
Impact of foreign currency translation | (44 | ) | (12 | ) | 9 | ||||||||
Costs deferred | 473 | 457 | 611 | ||||||||||
Amortization, net of interest accretion | (493 | ) | (451 | ) | (618 | ) | |||||||
Unamortized balance as of December 31 | 5,390 | 5,454 | 5,460 | ||||||||||
Accumulated effect of net unrealized investment (gains) losses | (348 | ) | (176 | ) | (424 | ) | |||||||
Balance as of December 31 | $ | 5,042 | $ | 5,278 | $ | 5,036 | |||||||
Intangible_Assets_Tables
Intangible Assets (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||
Intangible Assets | The following table presents our intangible assets as of December 31: | ||||||||||||||||
2014 | 2013 | ||||||||||||||||
(Amounts in millions) | Gross | Accumulated | Gross | Accumulated | |||||||||||||
carrying | amortization | carrying | amortization | ||||||||||||||
amount | amount | ||||||||||||||||
PVFP | $ | 1,995 | $ | (1,917 | ) | $ | 2,061 | $ | (1,900 | ) | |||||||
Capitalized software | 736 | (604 | ) | 704 | (545 | ) | |||||||||||
Deferred sales inducements to contractholders | 209 | (153 | ) | 195 | (123 | ) | |||||||||||
Other | 55 | (49 | ) | 54 | (47 | ) | |||||||||||
Total | $ | 2,995 | $ | (2,723 | ) | $ | 3,014 | $ | (2,615 | ) | |||||||
Activity in Present Value of Future Profits | The following table presents the activity in PVFP as of and for the years ended December 31: | ||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||
Unamortized balance as of January 1 | $ | 246 | $ | 297 | $ | 339 | |||||||||||
Interest accreted at 5.89%, 5.52% and 5.66% | 14 | 15 | 18 | ||||||||||||||
Amortization | (31 | ) | (66 | ) | (60 | ) | |||||||||||
Unamortized balance as of December 31 | 229 | 246 | 297 | ||||||||||||||
Accumulated effect of net unrealized investment (gains) losses | (151 | ) | (85 | ) | (180 | ) | |||||||||||
Balance as of December 31 | $ | 78 | $ | 161 | $ | 117 | |||||||||||
Percentage of Current PVFP Balance Estimated to be Amortized | The percentage of the December 31, 2014 PVFP balance net of interest accretion, before the effect of unrealized investment gains or losses, estimated to be amortized over each of the next five years is as follows: | ||||||||||||||||
2015 | 9.1 | % | |||||||||||||||
2016 | 11.1 | % | |||||||||||||||
2017 | 9.5 | % | |||||||||||||||
2018 | 7.7 | % | |||||||||||||||
2019 | 6.2 | % |
Goodwill_And_Dispositions_Tabl
Goodwill And Dispositions (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||
Summary of Goodwill Balance by Segment and Corporate and Other Activities | The following is a summary of our goodwill balance by segment and Corporate and Other activities as of the dates indicated: | ||||||||||||||||||||||||||||
(Amounts in millions) | U.S. Life | International | U.S. | International | Runoff | Corporate | Total | ||||||||||||||||||||||
Insurance | Mortgage | Mortgage | Protection | and Other | |||||||||||||||||||||||||
Insurance | Insurance | ||||||||||||||||||||||||||||
Balance as of December 31, 2012: | |||||||||||||||||||||||||||||
Gross goodwill | $ | 1,034 | $ | 19 | $ | 22 | $ | 89 | $ | 70 | $ | 29 | $ | 1,263 | |||||||||||||||
Accumulated impairment losses | (185 | ) | — | (22 | ) | (89 | ) | (70 | ) | (29 | ) | (395 | ) | ||||||||||||||||
Goodwill | 849 | 19 | — | — | — | — | 868 | ||||||||||||||||||||||
Foreign exchange translation | — | (1 | ) | — | — | — | — | (1 | ) | ||||||||||||||||||||
Balance as of December 31, 2013: | |||||||||||||||||||||||||||||
Gross goodwill | 1,034 | 18 | 22 | 89 | 70 | — | 1,233 | ||||||||||||||||||||||
Accumulated impairment losses | (185 | ) | — | (22 | ) | (89 | ) | (70 | ) | — | (366 | ) | |||||||||||||||||
Goodwill | 849 | 18 | — | — | — | — | 867 | ||||||||||||||||||||||
Impairment losses | (849 | ) | — | — | — | — | — | (849 | ) | ||||||||||||||||||||
Foreign exchange translation | — | (2 | ) | — | — | — | — | (2 | ) | ||||||||||||||||||||
Balance as of December 31, 2014: | |||||||||||||||||||||||||||||
Gross goodwill | 1,034 | 16 | 22 | 89 | 70 | — | 1,231 | ||||||||||||||||||||||
Accumulated impairment losses | (1,034 | ) | — | (22 | ) | (89 | ) | (70 | ) | — | (1,215 | ) | |||||||||||||||||
Goodwill | $ | — | $ | 16 | $ | — | $ | — | $ | — | $ | — | $ | 16 | |||||||||||||||
Reinsurance_Tables
Reinsurance (Tables) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||
Net Domestic Life Insurance In-Force | The following table sets forth net domestic life insurance in-force as of December 31: | ||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Direct life insurance in-force | $ | 701,797 | $ | 708,271 | $ | 730,016 | |||||||||||||||||||
Amounts assumed from other companies | 935 | 1,070 | 1,148 | ||||||||||||||||||||||
Amounts ceded to other companies (1) | (393,244 | ) | (313,593 | ) | (331,909 | ) | |||||||||||||||||||
Net life insurance in-force | $ | 309,488 | $ | 395,748 | $ | 399,255 | |||||||||||||||||||
Percentage of amount assumed to net | — | % | — | % | — | % | |||||||||||||||||||
(1) | Includes amounts accounted for under the deposit method. | ||||||||||||||||||||||||
Schedule of Effects of Reinsurance on Premiums Written and Earned | The following table sets forth the effects of reinsurance on premiums written and earned for the years ended December 31: | ||||||||||||||||||||||||
Written | Earned | ||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | 2014 | 2013 | 2012 | |||||||||||||||||||
Direct: | |||||||||||||||||||||||||
Life insurance | $ | 1,241 | $ | 1,199 | $ | 1,284 | $ | 1,257 | $ | 1,214 | $ | 1,304 | |||||||||||||
Accident and health insurance | 3,063 | 2,944 | 2,853 | 3,087 | 2,945 | 2,840 | |||||||||||||||||||
Property and casualty insurance | 108 | 97 | 95 | 97 | 85 | 84 | |||||||||||||||||||
Mortgage insurance | 1,814 | 1,682 | 1,720 | 1,588 | 1,608 | 1,645 | |||||||||||||||||||
Total direct | 6,226 | 5,922 | 5,952 | 6,029 | 5,852 | 5,873 | |||||||||||||||||||
Assumed: | |||||||||||||||||||||||||
Life insurance | 45 | 9 | 9 | 39 | 8 | 7 | |||||||||||||||||||
Accident and health insurance | 568 | 403 | 419 | 559 | 414 | 440 | |||||||||||||||||||
Property and casualty insurance | 2 | — | — | 1 | — | — | |||||||||||||||||||
Mortgage insurance | 20 | 19 | 27 | 31 | 33 | 42 | |||||||||||||||||||
Total assumed | 635 | 431 | 455 | 630 | 455 | 489 | |||||||||||||||||||
Ceded: | |||||||||||||||||||||||||
Life insurance | (351 | ) | (342 | ) | (528 | ) | (351 | ) | (343 | ) | (527 | ) | |||||||||||||
Accident and health insurance | (790 | ) | (735 | ) | (690 | ) | (783 | ) | (725 | ) | (672 | ) | |||||||||||||
Property and casualty insurance | (3 | ) | — | — | (3 | ) | — | — | |||||||||||||||||
Mortgage insurance | (95 | ) | (92 | ) | (132 | ) | (91 | ) | (91 | ) | (122 | ) | |||||||||||||
Total ceded | (1,239 | ) | (1,169 | ) | (1,350 | ) | (1,228 | ) | (1,159 | ) | (1,321 | ) | |||||||||||||
Net premiums | $ | 5,622 | $ | 5,184 | $ | 5,057 | $ | 5,431 | $ | 5,148 | $ | 5,041 | |||||||||||||
Percentage of amount assumed to net | 12 | % | 9 | % | 10 | % | |||||||||||||||||||
Insurance_Reserves_Tables
Insurance Reserves (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Recorded Liabilities and Major Assumptions Underlying Future Policy Benefits | The following table sets forth our recorded liabilities and the major assumptions underlying our future policy benefits as of December 31: | ||||||||||||
(Amounts in millions) | Mortality/ | Interest rate | 2014 | 2013 | |||||||||
morbidity | assumption | ||||||||||||
assumption | |||||||||||||
Long-term care insurance contracts | (a) | 3.75% - 7.50% | $ | 19,310 | $ | 17,023 | |||||||
Structured settlements with life contingencies | (b) | 1.50% - 8.00% | 9,133 | 9,267 | |||||||||
Annuity contracts with life contingencies | (b) | 1.50% - 8.00% | 4,470 | 4,425 | |||||||||
Traditional life insurance contracts | (c) | 3.00% - 7.50% | 2,733 | 2,736 | |||||||||
Supplementary contracts with life contingencies | (b) | 1.50% - 8.00% | 265 | 249 | |||||||||
Accident and health insurance contracts | (d) | 3.50% - 7.00% | 4 | 5 | |||||||||
Total future policy benefits | $ | 35,915 | $ | 33,705 | |||||||||
(a) | The 1983 Individual Annuitant Mortality Table or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality Table and the 1985 National Nursing Home Study and company experience. | ||||||||||||
(b) | Assumptions for limited-payment contracts come from either the U.S. Population Table, 1983 Group Annuitant Mortality Table, 1983 Individual Annuitant Mortality Table or Annuity 2000 Mortality Table. | ||||||||||||
(c) | Principally modifications based on company experience of the Society of Actuaries 1965-70 or 1975-80 Select and Ultimate Tables, 1941, 1958, 1980 and 2001 Commissioner’s Standard Ordinary Tables, 1980 Commissioner’s Extended Term table and (IA) Standard Table 1996 (modified). | ||||||||||||
(d) | The 1958 and 1980 Commissioner’s Standard Ordinary Tables, or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality. | ||||||||||||
Recorded Liabilities for Policyholder Account Balances | The following table sets forth our recorded liabilities for policyholder account balances as of December 31: | ||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||
Annuity contracts | $ | 14,406 | $ | 13,730 | |||||||||
GICs, funding agreements and FABNs | 493 | 896 | |||||||||||
Structured settlements without life contingencies | 1,828 | 1,956 | |||||||||||
Supplementary contracts without life contingencies | 742 | 714 | |||||||||||
Other | 28 | 34 | |||||||||||
Total investment contracts | 17,497 | 17,330 | |||||||||||
Universal life insurance contracts | 8,546 | 8,198 | |||||||||||
Total policyholder account balances | $ | 26,043 | $ | 25,528 | |||||||||
Information about Variable Annuity Products with Death and Living Benefit Guarantees | The following table sets forth information about our variable annuity products with death and living benefit guarantees as of December 31: | ||||||||||||
(Dollar amounts in millions) | 2014 | 2013 | |||||||||||
Account values with death benefit guarantees (net of reinsurance): | |||||||||||||
Standard death benefits (return of net deposits) account value | $ | 2,877 | $ | 3,164 | |||||||||
Net amount at risk | $ | 5 | $ | 6 | |||||||||
Average attained age of contractholders | 72 | 72 | |||||||||||
Enhanced death benefits (ratchet, rollup) account value | $ | 3,443 | $ | 3,853 | |||||||||
Net amount at risk | $ | 119 | $ | 114 | |||||||||
Average attained age of contractholders | 73 | 72 | |||||||||||
Account values with living benefit guarantees: | |||||||||||||
GMWBs | $ | 3,675 | $ | 4,054 | |||||||||
Guaranteed annuitization benefits | $ | 1,362 | $ | 1,508 | |||||||||
Account Balances of Variable Annuity Contract with Death or Living Benefit Guarantees Invested in Separate Account Investment Options | Account balances of variable annuity contracts with death or living benefit guarantees were invested in separate account investment options as follows as of December 31: | ||||||||||||
(Amounts in millions) | 2014 | 2013 (1) | |||||||||||
Balanced funds | $ | 3,848 | $ | 4,187 | |||||||||
Equity funds | 1,639 | 1,778 | |||||||||||
Bond funds | 707 | 897 | |||||||||||
Money market funds | 96 | 98 | |||||||||||
Total | $ | 6,290 | $ | 6,960 | |||||||||
(1) | The balances as of December 31, 2013 have been represented as a result of classification changes and to exclude fixed account assets from bond funds. |
Liability_for_Policy_and_Contr1
Liability for Policy and Contract Claims (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Schedule of Liability for Policy and Contract Claims | The following table sets forth our recorded liability for policy and contract claims by business as of December 31: | ||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||
Long-term care insurance | $ | 6,216 | $ | 4,999 | |||||||||
U.S. mortgage insurance | 1,180 | 1,482 | |||||||||||
International mortgage insurance | 308 | 378 | |||||||||||
Life insurance | 197 | 188 | |||||||||||
Lifestyle protection insurance | 106 | 108 | |||||||||||
Fixed annuities | 21 | 29 | |||||||||||
Runoff | 15 | 20 | |||||||||||
Total liability for policy and contract claims | $ | 8,043 | $ | 7,204 | |||||||||
U.S. Mortgage Insurance | |||||||||||||
Changes in Liability for Policy and Contract Claims | The following table sets forth changes in the liability for policy and contract claims for our U.S. mortgage insurance business for the dates indicated: | ||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||
Beginning balance as of January 1 | $ | 1,482 | $ | 2,009 | $ | 2,488 | |||||||
Less reinsurance recoverables | (44 | ) | (80 | ) | (178 | ) | |||||||
Net balance as of January 1 | 1,438 | 1,929 | 2,310 | ||||||||||
Incurred related to insured events of: | |||||||||||||
Current year | 328 | 476 | 717 | ||||||||||
Prior years | 29 | (63 | ) | 7 | |||||||||
Total incurred | 357 | 413 | 724 | ||||||||||
Paid related to insured events of: | |||||||||||||
Current year | (21 | ) | (45 | ) | (92 | ) | |||||||
Prior years | (618 | ) | (859 | ) | (1,013 | ) | |||||||
Total paid | (639 | ) | (904 | ) | (1,105 | ) | |||||||
Net balance as of December 31 | 1,156 | 1,438 | 1,929 | ||||||||||
Add reinsurance recoverables | 24 | 44 | 80 | ||||||||||
Ending balance as of December 31 | $ | 1,180 | $ | 1,482 | $ | 2,009 | |||||||
Long-term Care Insurance | |||||||||||||
Changes in Liability for Policy and Contract Claims | The following table sets forth changes in the liability for policy and contract claims for our long-term care insurance business for the dates indicated: | ||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||
Beginning balance as of January 1 | $ | 4,999 | $ | 4,655 | $ | 4,130 | |||||||
Less reinsurance recoverables | (1,707 | ) | (1,574 | ) | (1,387 | ) | |||||||
Net balance as of January 1 | 3,292 | 3,081 | 2,743 | ||||||||||
Incurred related to insured events of: | |||||||||||||
Current year | 1,474 | 1,323 | 1,271 | ||||||||||
Prior years | 726 | 3 | 93 | ||||||||||
Total incurred | 2,200 | 1,326 | 1,364 | ||||||||||
Paid related to insured events of: | |||||||||||||
Current year | (134 | ) | (131 | ) | (111 | ) | |||||||
Prior years | (1,263 | ) | (1,160 | ) | (1,068 | ) | |||||||
Total paid | (1,397 | ) | (1,291 | ) | (1,179 | ) | |||||||
Interest on liability for policy and contract claims | 195 | 176 | 153 | ||||||||||
Net balance as of December 31 | 4,290 | 3,292 | 3,081 | ||||||||||
Add reinsurance recoverables | 1,926 | 1,707 | 1,574 | ||||||||||
Ending balance as of December 31 | $ | 6,216 | $ | 4,999 | $ | 4,655 | |||||||
Borrowings_and_Other_Financing1
Borrowings and Other Financings (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Schedule of Long Term Borrowings | The following table sets forth total long-term borrowings as of December 31: | ||||||||
(Amounts in millions) | 2014 | 2013 | |||||||
Genworth Holdings | |||||||||
5.75% Senior Notes, due 2014 | $ | — | $ | 485 | |||||
8.625% Senior Notes, due 2016 | 300 | 300 | |||||||
6.52% Senior Notes, due 2018 | 600 | 600 | |||||||
7.70% Senior Notes, due 2020 | 400 | 400 | |||||||
7.20% Senior Notes, due 2021 | 399 | 399 | |||||||
7.625% Senior Notes, due 2021 | 758 | 759 | |||||||
4.90% Senior Notes, due 2023 | 399 | 399 | |||||||
4.80% Senior Notes, due 2024 | 400 | 400 | |||||||
6.50% Senior Notes, due 2034 | 297 | 297 | |||||||
6.15% Fixed-to-Floating Rate Junior Suboridinated Notes, due 2066 | 598 | 598 | |||||||
Canada | |||||||||
4.59% Senior Notes, due 2015 | — | 141 | |||||||
5.68% Senior Notes, due 2020 | 236 | 258 | |||||||
4.24% Senior Notes, due 2024 | 138 | — | |||||||
Australia | |||||||||
Floating Rate Junior Notes, due 2021 | 114 | 125 | |||||||
Total | $ | 4,639 | $ | 5,161 | |||||
Schedule of Non-Recourse Funding Obligations of Special Purpose Consolidated Captive Insurance Subsidiaries | The following table sets forth the non-recourse funding obligations (surplus notes) of our wholly-owned, special purpose consolidated captive insurance subsidiaries as of December 31: | ||||||||
(Amounts in millions) | |||||||||
Issuance | 2014 | 2013 | |||||||
River Lake Insurance Company (a), due 2033 | $ | 570 | $ | 570 | |||||
River Lake Insurance Company (b), due 2033 | 435 | 461 | |||||||
River Lake Insurance Company II (a), due 2035 | 192 | 192 | |||||||
River Lake Insurance Company II (b), due 2035 | 484 | 500 | |||||||
Rivermont Life Insurance Company I (a), due 2050 | 315 | 315 | |||||||
Total | $ | 1,996 | $ | 2,038 | |||||
(a) | Accrual of interest based on one-month LIBOR that resets every 28 days plus a fixed margin. | ||||||||
(b) | Accrual of interest based on one-month LIBOR that resets on a specified date each month plus a contractual margin. | ||||||||
Principal Amounts of Long Term Debt Including Senior Notes and Non-Recourse Funding by Maturity | Principal amounts under our long-term borrowings (including senior notes) and non-recourse funding obligations by maturity were as follows as of December 31, 2014: | ||||||||
(Amounts in millions) | Amount | ||||||||
2015 | $ | — | |||||||
2016 | 300 | ||||||||
2017 | — | ||||||||
2018 | 600 | ||||||||
2019 and thereafter (1) | 5,735 | ||||||||
Total | $ | 6,635 | |||||||
(1) | Repayment of $2.0 billion of our non-recourse funding obligations requires regulatory approval. |
Income_Taxes_Tables
Income Taxes (Tables) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||
Components of Income (Loss) before Income Taxes | Income (loss) from continuing operations before income taxes included the following components for the years ended December 31: | ||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Domestic | $ | (2,008 | ) | $ | 294 | $ | (73 | ) | |||||||||||||||||
Foreign | 732 | 756 | 679 | ||||||||||||||||||||||
Income (loss) from continuing operations before income taxes | $ | (1,276 | ) | $ | 1,050 | $ | 606 | ||||||||||||||||||
Components of Income Tax (Benefit) Expense | The total provision (benefit) for income taxes was as follows for the years ended December 31: | ||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Current federal income taxes | $ | (3 | ) | $ | (18 | ) | $ | (68 | ) | ||||||||||||||||
Deferred federal income taxes | (443 | ) | 160 | 36 | |||||||||||||||||||||
Total federal income taxes | (446 | ) | 142 | (32 | ) | ||||||||||||||||||||
Current state income taxes | 4 | (1 | ) | (16 | ) | ||||||||||||||||||||
Deferred state income taxes | (4 | ) | (9 | ) | (9 | ) | |||||||||||||||||||
Total state income taxes | — | (10 | ) | (25 | ) | ||||||||||||||||||||
Current foreign income taxes | 258 | 422 | 138 | ||||||||||||||||||||||
Deferred foreign income taxes | (40 | ) | (230 | ) | 57 | ||||||||||||||||||||
Total foreign income taxes | 218 | 192 | 195 | ||||||||||||||||||||||
Total provision (benefit) for income taxes | $ | (228 | ) | $ | 324 | $ | 138 | ||||||||||||||||||
Reconciliation of Federal Statutory Tax Rate to Effective Income Tax Rate | The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the years ended December 31: | ||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Pre-tax income (loss) | $ | (1,276 | ) | $ | 1,050 | $ | 606 | ||||||||||||||||||
Statutory U.S. federal income tax rate | (447 | ) | 35 | % | 368 | 35 | % | 212 | 35 | % | |||||||||||||||
Increase (reduction) in rate resulting from: | |||||||||||||||||||||||||
State income tax, net of federal income tax effect | — | — | (2 | ) | (0.2 | ) | (16 | ) | (2.7 | ) | |||||||||||||||
Benefit on tax favored investments | (18 | ) | 1.4 | (18 | ) | (1.7 | ) | (9 | ) | (1.4 | ) | ||||||||||||||
Effect of foreign operations | (69 | ) | 5.4 | (75 | ) | (7.1 | ) | (66 | ) | (10.9 | ) | ||||||||||||||
Change in indefinite reinvestment assertion | 66 | (5.2 | ) | — | — | — | — | ||||||||||||||||||
Interest on uncertain tax positions | (2 | ) | 0.1 | (1 | ) | (0.1 | ) | (3 | ) | (0.6 | ) | ||||||||||||||
Non-deductible expenses | 4 | (0.3 | ) | 2 | 0.2 | 3 | 0.5 | ||||||||||||||||||
Non-deductible goodwill | 245 | (19.2 | ) | — | — | 19 | 3.1 | ||||||||||||||||||
Valuation allowance | (6 | ) | 0.5 | 16 | 1.5 | — | — | ||||||||||||||||||
Stock-based compensation | 4 | (0.3 | ) | 25 | 2.4 | — | — | ||||||||||||||||||
Other, net | (5 | ) | 0.5 | 9 | 0.9 | (2 | ) | (0.2 | ) | ||||||||||||||||
Effective rate | $ | (228 | ) | 17.9 | % | $ | 324 | 30.9 | % | $ | 138 | 22.8 | % | ||||||||||||
Components of Net Deferred Income Tax Liability | The components of the net deferred income tax liability were as follows as of December 31: | ||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||
Foreign tax credit carryforwards | $ | 666 | $ | 432 | |||||||||||||||||||||
Accrued commission and general expenses | 219 | 339 | |||||||||||||||||||||||
State income taxes | 275 | 278 | |||||||||||||||||||||||
Net operating loss carryforwards | 1,803 | 1,762 | |||||||||||||||||||||||
Net unrealized losses on derivatives | — | 160 | |||||||||||||||||||||||
Other | 37 | 41 | |||||||||||||||||||||||
Gross deferred income tax assets | 3,000 | 3,012 | |||||||||||||||||||||||
Valuation allowance | (301 | ) | (312 | ) | |||||||||||||||||||||
Total deferred income tax assets | 2,699 | 2,700 | |||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||
Investments | $ | 100 | $ | 140 | |||||||||||||||||||||
Net unrealized gains on investment securities | 1,283 | 454 | |||||||||||||||||||||||
Net unrealized gains on derivatives | 222 | — | |||||||||||||||||||||||
Insurance reserves | 544 | 1,034 | |||||||||||||||||||||||
DAC | 1,095 | 1,130 | |||||||||||||||||||||||
PVFP and other intangibles | 5 | 53 | |||||||||||||||||||||||
Investment in foreign subsidiaries | 310 | 13 | |||||||||||||||||||||||
Other | 48 | 82 | |||||||||||||||||||||||
Total deferred income tax liabilities | 3,607 | 2,906 | |||||||||||||||||||||||
Net deferred income tax liability | $ | 908 | $ | 206 | |||||||||||||||||||||
Reconciliation of Unrecognized Tax Benefits | A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: | ||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||
Balance as of January 1 | $ | 41 | $ | 55 | $ | 226 | |||||||||||||||||||
Tax positions related to the current period: | |||||||||||||||||||||||||
Gross additions | 7 | 3 | 14 | ||||||||||||||||||||||
Gross reductions | (3 | ) | — | — | |||||||||||||||||||||
Tax positions related to the prior years: | |||||||||||||||||||||||||
Gross additions | 17 | 4 | — | ||||||||||||||||||||||
Gross reductions | (13 | ) | (21 | ) | (131 | ) | |||||||||||||||||||
Settlements | — | — | (54 | ) | |||||||||||||||||||||
Balance as of December 31 | $ | 49 | $ | 41 | $ | 55 | |||||||||||||||||||
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||
Stock Option Weighted-Average Grant-Date Fair Value Information and Related Valuation Assumptions, Excluding Exchanged Grants and Performance-Accelerated Options | The following table contains the stock option and SAR weighted-average grant date fair value information and related valuation assumptions for the years ended December 31: | ||||||||||||||||||||||||
Stock Options and SARs | |||||||||||||||||||||||||
2014 | 2013 | 2012 | |||||||||||||||||||||||
Black-Scholes | Black-Scholes | Monte-Carlo | Black-Scholes | ||||||||||||||||||||||
Model | Model | Simulation (1) | Model | ||||||||||||||||||||||
Awards granted (in thousands) | 2,960 | 3,404 | 1,200 | 5,085 | |||||||||||||||||||||
Maximum share value at exercise of SARs | $ | 75 | $ | 75 | $ | 75 | $ | 75 | |||||||||||||||||
Fair value per options and SARs | $ | 3.05 | $ | 2.53 | $ | 5.88 | $ | 2.34 | |||||||||||||||||
Valuation assumptions: | |||||||||||||||||||||||||
Expected term (years) | 6 | 5.9 | NA | 6 | |||||||||||||||||||||
Expected volatility | 100.2 | % | 100.7 | % | 102.5 | % | 100.7 | % | |||||||||||||||||
Expected dividend yield | 0.5 | % | 0.5 | % | 0.5 | % | 0.5 | % | |||||||||||||||||
Risk-free interest rate | 1.9 | % | 1.1 | % | 1.1 | % | 1.1 | % | |||||||||||||||||
(1) | For purposes of determining the fair value of 1.2 million shares of performance-accelerated SARs that were issued in January 2013, we used a Monte-Carlo Simulation technique. Monte-Carlo Simulation is a method used to simulate future stock price movements in order to determine the fair value due to unique vesting and exercising provisions. The performance-accelerated SARs have a derived service period of one year on average and have a grant price of $7.90. The performance-accelerated SARs vest on the third anniversary of the grant date but are subject to earlier vesting on or after the one year anniversary of the grant date based on the closing price of our Class A Common Stock exceeding certain specified amounts ($12.00, $16.00 and $20.00, respectively) for 45 consecutive trading days. Based on the closing price of our Class A Common Stock, the first tranche at $12.00 vested in January 2014 and the second tranche at $16.00 vested in June 2014. | ||||||||||||||||||||||||
Rollforward of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding | The following table summarizes stock option activity as of December 31, 2014 and 2013: | ||||||||||||||||||||||||
(Shares in thousands) | Shares subject | Weighted-average | |||||||||||||||||||||||
to option | exercise price | ||||||||||||||||||||||||
Balance as of January 1, 2013 | 6,109 | $ | 11.77 | ||||||||||||||||||||||
Granted | — | $ | — | ||||||||||||||||||||||
Exercised | (1,440 | ) | $ | 6.2 | |||||||||||||||||||||
Forfeited | (359 | ) | $ | 17.26 | |||||||||||||||||||||
Expired | — | $ | — | ||||||||||||||||||||||
Balance as of January 1, 2014 | 4,310 | $ | 13.17 | ||||||||||||||||||||||
Granted | — | $ | — | ||||||||||||||||||||||
Exercised | (921 | ) | $ | 8.1 | |||||||||||||||||||||
Forfeited | (885 | ) | $ | 19.32 | |||||||||||||||||||||
Expired | — | $ | — | ||||||||||||||||||||||
Balance as of December 31, 2014 | 2,504 | $ | 12.86 | ||||||||||||||||||||||
Exercisable as of December 31, 2014 | 2,501 | $ | 12.86 | ||||||||||||||||||||||
Information about Stock Options Outstanding | The following table summarizes information about stock options outstanding as of December 31, 2014: | ||||||||||||||||||||||||
Outstanding | Exercisable | ||||||||||||||||||||||||
Exercise price range | Shares in | Average | Average | Shares in | Average | Average | |||||||||||||||||||
thousands | life (1) | exercise | thousands | life (1) | exercise | ||||||||||||||||||||
price | price | ||||||||||||||||||||||||
$2.00 - $2.46 (2) | 394 | 4.07 | $ | 2.44 | 394 | 4.07 | $ | 2.44 | |||||||||||||||||
$7.36 - $7.80 | 547 | 2.42 | $ | 7.8 | 547 | 2.42 | $ | 7.8 | |||||||||||||||||
$9.10 - $14.18 | 1,228 | 4.87 | $ | 14.15 | 1,225 | 4.86 | $ | 14.15 | |||||||||||||||||
$14.92 - $22.80 | 123 | 3.26 | $ | 21.96 | 123 | 3.26 | $ | 21.96 | |||||||||||||||||
$30.52 - $34.13 | 212 | 1.4 | $ | 32.56 | 212 | 1.4 | $ | 32.55 | |||||||||||||||||
2,504 | $ | 12.86 | 2,501 | $ | 12.86 | ||||||||||||||||||||
(1) | Average contractual life remaining in years. | ||||||||||||||||||||||||
(2) | These shares have an aggregate intrinsic value of $2 million each for total options outstanding and exercisable options. | ||||||||||||||||||||||||
Status of Our Other Equity-Based Awards | The following table summarizes the status of our other equity-based awards as of December 31, 2014 and 2013: | ||||||||||||||||||||||||
RSUs | DSUs | SARs | |||||||||||||||||||||||
(Awards in thousands) | Number of | Weighted- | Number of | Weighted- | Number of | Weighted- | |||||||||||||||||||
awards | average grant | awards | average | awards | average grant | ||||||||||||||||||||
date fair value | fair value | date fair value | |||||||||||||||||||||||
Balance as of January 1, 2013 | 2,280 | $ | 12.97 | 690 | $ | 8.74 | 10,359 | $ | 4.44 | ||||||||||||||||
Granted | 2,018 | $ | 9.27 | 98 | $ | 12.17 | 4,604 | $ | 3.4 | ||||||||||||||||
Exercised | (985 | ) | $ | 14.75 | (209 | ) | $ | 4.73 | (1,618 | ) | $ | 5.97 | |||||||||||||
Terminated | (426 | ) | $ | 10.01 | — | $ | — | (980 | ) | $ | 2.91 | ||||||||||||||
Balance as of January 1, 2014 | 2,887 | $ | 10.21 | 579 | $ | 9.43 | 12,365 | $ | 4 | ||||||||||||||||
Granted | 1,226 | $ | 15 | 113 | $ | 12.98 | 2,960 | $ | 3.05 | ||||||||||||||||
Exercised | (938 | ) | $ | 10.06 | (58 | ) | $ | 6.65 | (1,353 | ) | $ | 3.88 | |||||||||||||
Terminated | (262 | ) | $ | 12.16 | — | $ | — | (1,905 | ) | $ | 5.23 | ||||||||||||||
Balance as of December 31, 2014 | 2,913 | $ | 12.09 | 634 | $ | 9.96 | 12,067 | $ | 3.62 | ||||||||||||||||
Genworth Canada | |||||||||||||||||||||||||
Status of Our Other Equity-Based Awards | The following table summarizes the status of Genworth Canada’s stock option activity and other equity-based awards as of December 31, 2014 and 2013: | ||||||||||||||||||||||||
Stock options | RSUs & PSUs | DSUs | Executive deferred | ||||||||||||||||||||||
stock units (“EDSUs”) | |||||||||||||||||||||||||
(Shares and Awards in thousands) | Shares subject | Number of | Number of | Number of | |||||||||||||||||||||
to option | awards | awards | awards | ||||||||||||||||||||||
Balance as of January 1, 2013 | 1,027 | 143 | 34 | — | |||||||||||||||||||||
Granted | 100 | 106 | 11 | 20 | |||||||||||||||||||||
Exercised | (91 | ) | (66 | ) | — | — | |||||||||||||||||||
Terminated | (49 | ) | (6 | ) | — | — | |||||||||||||||||||
Balance as of January 1, 2014 | 987 | 177 | 45 | 20 | |||||||||||||||||||||
Granted | 114 | 93 | 9 | 1 | |||||||||||||||||||||
Exercised | (93 | ) | (67 | ) | — | — | |||||||||||||||||||
Terminated | (6 | ) | — | — | — | ||||||||||||||||||||
Balance as of December 31, 2014 | 1,002 | 203 | 54 | 21 | |||||||||||||||||||||
Fair_Value_of_Financial_Instru1
Fair Value of Financial Instruments (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||||||||||||||||||
Fair Value Financial Instruments Not Required to be Carried at Fair Value | The following represents our estimated fair value of financial assets and liabilities that are not required to be carried at fair value as of December 31: | ||||||||||||||||||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||||||||||||||||||
Notional | Carrying | Fair value | |||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | amount | amount | Total | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage loans | $ | (1) | $ | 6,100 | $ | 6,573 | $ | — | $ | — | $ | 6,573 | |||||||||||||||||||||||||||||||||
Restricted commercial mortgage loans (2) | (1) | 201 | 228 | — | — | 228 | |||||||||||||||||||||||||||||||||||||||
Other invested assets | (1) | 374 | 385 | — | 300 | 85 | |||||||||||||||||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Long-term borrowings (3) | (1) | 4,639 | 4,300 | — | 4,181 | 119 | |||||||||||||||||||||||||||||||||||||||
Non-recourse funding obligations (3) | (1) | 1,996 | 1,438 | — | — | 1,438 | |||||||||||||||||||||||||||||||||||||||
Borrowings related to securitization entities (2) | (1) | 134 | 146 | — | 146 | — | |||||||||||||||||||||||||||||||||||||||
Investment contracts | (1) | 17,497 | 18,023 | — | 7 | 18,016 | |||||||||||||||||||||||||||||||||||||||
Other firm commitments: | |||||||||||||||||||||||||||||||||||||||||||||
Commitments to fund limited partnerships | 53 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Ordinary course of business lending commitments | 155 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||||||||||
Notional | Carrying | Fair value | |||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | amount | amount | Total | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage loans | $ | (1) | $ | 5,899 | $ | 6,137 | $ | — | $ | — | $ | 6,137 | |||||||||||||||||||||||||||||||||
Restricted commercial mortgage loans (2) | (1) | 233 | 258 | — | — | 258 | |||||||||||||||||||||||||||||||||||||||
Other invested assets | (1) | 307 | 311 | — | 221 | 90 | |||||||||||||||||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Long-term borrowings (3) | (1) | 5,161 | 5,590 | — | 5,460 | 130 | |||||||||||||||||||||||||||||||||||||||
Non-recourse funding obligations (3) | (1) | 2,038 | 1,459 | — | — | 1,459 | |||||||||||||||||||||||||||||||||||||||
Borrowings related to securitization entities (2) | (1) | 167 | 182 | — | 182 | — | |||||||||||||||||||||||||||||||||||||||
Investment contracts | (1) | 17,330 | 17,827 | — | 86 | 17,741 | |||||||||||||||||||||||||||||||||||||||
Other firm commitments: | |||||||||||||||||||||||||||||||||||||||||||||
Commitments to fund limited partnerships | 65 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Ordinary course of business lending commitments | 138 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
(1) | These financial instruments do not have notional amounts. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(3) | See note 13 for additional information related to borrowings. | ||||||||||||||||||||||||||||||||||||||||||||
Assets and Liabilities that are Measured at Fair Value on Recurring Basis | The following tables set forth our assets and liabilities by class of instrument that are measured at fair value on a recurring basis as of December 31: | ||||||||||||||||||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Total | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||||||||||||||
Investments: | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 6,000 | $ | — | $ | 5,996 | $ | 4 | |||||||||||||||||||||||||||||||||||||
Tax-exempt | 362 | — | 362 | — | |||||||||||||||||||||||||||||||||||||||||
Government—non-U.S. | 2,106 | — | 2,099 | 7 | |||||||||||||||||||||||||||||||||||||||||
U.S. corporate | 27,200 | — | 24,752 | 2,448 | |||||||||||||||||||||||||||||||||||||||||
Corporate—non-U.S. | 15,132 | — | 13,327 | 1,805 | |||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 5,240 | — | 5,165 | 75 | |||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 2,702 | — | 2,697 | 5 | |||||||||||||||||||||||||||||||||||||||||
Other asset-backed | 3,705 | — | 2,285 | 1,420 | |||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities | 62,447 | — | 56,683 | 5,764 | |||||||||||||||||||||||||||||||||||||||||
Equity securities | 282 | 244 | 4 | 34 | |||||||||||||||||||||||||||||||||||||||||
Other invested assets: | |||||||||||||||||||||||||||||||||||||||||||||
Trading securities | 241 | — | 241 | — | |||||||||||||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 1,091 | — | 1,091 | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency swaps | 6 | — | 6 | — | |||||||||||||||||||||||||||||||||||||||||
Credit default swaps | 4 | — | 1 | 3 | |||||||||||||||||||||||||||||||||||||||||
Equity index options | 17 | — | — | 17 | |||||||||||||||||||||||||||||||||||||||||
Other foreign currency contracts | 14 | — | 14 | — | |||||||||||||||||||||||||||||||||||||||||
Total derivative assets | 1,132 | — | 1,112 | 20 | |||||||||||||||||||||||||||||||||||||||||
Securities lending collateral | 289 | — | 289 | — | |||||||||||||||||||||||||||||||||||||||||
Total other invested assets | 1,662 | — | 1,642 | 20 | |||||||||||||||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (1) | 411 | — | 181 | 230 | |||||||||||||||||||||||||||||||||||||||||
Reinsurance recoverable (2) | 13 | — | — | 13 | |||||||||||||||||||||||||||||||||||||||||
Separate account assets | 9,208 | 9,208 | — | — | |||||||||||||||||||||||||||||||||||||||||
Total assets | $ | 74,023 | $ | 9,452 | $ | 58,510 | $ | 6,061 | |||||||||||||||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (3) | $ | 291 | $ | — | $ | — | $ | 291 | |||||||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives | 276 | — | — | 276 | |||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives | 7 | — | — | 7 | |||||||||||||||||||||||||||||||||||||||||
Total policyholder account balances | 574 | — | — | 574 | |||||||||||||||||||||||||||||||||||||||||
Derivative liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 204 | — | 204 | — | |||||||||||||||||||||||||||||||||||||||||
Interest rate swaps related to securitization entities (1) | 26 | — | 26 | — | |||||||||||||||||||||||||||||||||||||||||
Inflation indexed swaps | 42 | — | 42 | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency swaps | 7 | — | 7 | — | |||||||||||||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities (1) | 17 | — | — | 17 | |||||||||||||||||||||||||||||||||||||||||
Equity return swaps | 1 | — | 1 | — | |||||||||||||||||||||||||||||||||||||||||
Other foreign currency contracts | 13 | — | 13 | — | |||||||||||||||||||||||||||||||||||||||||
Total derivative liabilities | 310 | — | 293 | 17 | |||||||||||||||||||||||||||||||||||||||||
Borrowings related to securitization entities (1) | 85 | — | — | 85 | |||||||||||||||||||||||||||||||||||||||||
Total liabilities | $ | 969 | $ | — | $ | 293 | $ | 676 | |||||||||||||||||||||||||||||||||||||
-1 | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
-2 | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||||||||||||||||||||||
-3 | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||||||||||||||||||||||
2013 | |||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Total | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||||||||||||||
Investments: | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 4,810 | $ | — | $ | 4,805 | $ | 5 | |||||||||||||||||||||||||||||||||||||
Tax-exempt | 295 | — | 295 | — | |||||||||||||||||||||||||||||||||||||||||
Government—non-U.S. | 2,146 | — | 2,123 | 23 | |||||||||||||||||||||||||||||||||||||||||
U.S. corporate | 25,035 | — | 22,635 | 2,400 | |||||||||||||||||||||||||||||||||||||||||
Corporate—non-U.S. | 15,071 | — | 13,252 | 1,819 | |||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 5,225 | — | 5,120 | 105 | |||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 2,898 | — | 2,892 | 6 | |||||||||||||||||||||||||||||||||||||||||
Other asset-backed | 3,149 | — | 1,983 | 1,166 | |||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities | 58,629 | — | 53,105 | 5,524 | |||||||||||||||||||||||||||||||||||||||||
Equity securities | 341 | 256 | 7 | 78 | |||||||||||||||||||||||||||||||||||||||||
Other invested assets: | |||||||||||||||||||||||||||||||||||||||||||||
Trading securities | 239 | — | 205 | 34 | |||||||||||||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 436 | — | 436 | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency swaps | 4 | — | 4 | — | |||||||||||||||||||||||||||||||||||||||||
Credit default swaps | 11 | — | 1 | 10 | |||||||||||||||||||||||||||||||||||||||||
Equity index options | 12 | — | — | 12 | |||||||||||||||||||||||||||||||||||||||||
Other foreign currency contracts | 8 | — | 5 | 3 | |||||||||||||||||||||||||||||||||||||||||
Total derivative assets | 471 | — | 446 | 25 | |||||||||||||||||||||||||||||||||||||||||
Securities lending collateral | 187 | — | 187 | — | |||||||||||||||||||||||||||||||||||||||||
Derivatives counterparty collateral | 70 | — | 70 | — | |||||||||||||||||||||||||||||||||||||||||
Total other invested assets | 967 | — | 908 | 59 | |||||||||||||||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (1) | 391 | — | 180 | 211 | |||||||||||||||||||||||||||||||||||||||||
Reinsurance recoverable (2) | (1 | ) | — | — | (1 | ) | |||||||||||||||||||||||||||||||||||||||
Separate account assets | 10,138 | 10,138 | — | — | |||||||||||||||||||||||||||||||||||||||||
Total assets | $ | 70,465 | $ | 10,394 | $ | 54,200 | $ | 5,871 | |||||||||||||||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (3) | $ | 96 | $ | — | $ | — | $ | 96 | |||||||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives | 143 | — | — | 143 | |||||||||||||||||||||||||||||||||||||||||
Total policyholder account balances | 239 | — | — | 239 | |||||||||||||||||||||||||||||||||||||||||
Derivative liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 575 | — | 575 | — | |||||||||||||||||||||||||||||||||||||||||
Interest rate swaps related to securitization entities (1) | 16 | — | 16 | — | |||||||||||||||||||||||||||||||||||||||||
Inflation indexed swaps | 60 | — | 60 | — | |||||||||||||||||||||||||||||||||||||||||
Foreign currency swaps | 2 | — | 2 | — | |||||||||||||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities (1) | 32 | — | — | 32 | |||||||||||||||||||||||||||||||||||||||||
Equity return swaps | 1 | — | 1 | — | |||||||||||||||||||||||||||||||||||||||||
Forward bond purchase commitments | 13 | — | 13 | — | |||||||||||||||||||||||||||||||||||||||||
Other foreign currency contracts | 4 | — | 3 | 1 | |||||||||||||||||||||||||||||||||||||||||
Total derivative liabilities | 703 | — | 670 | 33 | |||||||||||||||||||||||||||||||||||||||||
Borrowings related to securitization entities (1) | 75 | — | — | 75 | |||||||||||||||||||||||||||||||||||||||||
Total liabilities | $ | 1,017 | $ | — | $ | 670 | $ | 347 | |||||||||||||||||||||||||||||||||||||
(1) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||||||||||||||||||||||
(3) | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||||||||||||||||||||||
Assets Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value | The following tables present additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of or for the dates indicated: | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Total realized and | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total gains | |||||||||||||||||||||||||||||||||||
balance | unrealized gains | into | out of | balance | (losses) | ||||||||||||||||||||||||||||||||||||||||
as of | (losses) | Level 3 | Level 3 | as of | included in | ||||||||||||||||||||||||||||||||||||||||
January 1, | December 31, | net income | |||||||||||||||||||||||||||||||||||||||||||
2014 | 2014 | (loss) | |||||||||||||||||||||||||||||||||||||||||||
attributable | |||||||||||||||||||||||||||||||||||||||||||||
to assets | |||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
income | |||||||||||||||||||||||||||||||||||||||||||||
(loss) | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 5 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | (1 | ) | $ | — | $ | — | $ | 4 | $ | — | ||||||||||||||||||||||
Government—non-U.S. | 23 | — | — | 3 | — | — | (2 | ) | — | (17 | ) | 7 | — | ||||||||||||||||||||||||||||||||
U.S. corporate (1) | 2,400 | 27 | 57 | 211 | (60 | ) | — | (253 | ) | 272 | (206 | ) | 2,448 | 12 | |||||||||||||||||||||||||||||||
Corporate—non-U.S. | 1,819 | 4 | 9 | 282 | (123 | ) | — | (222 | ) | 97 | (61 | ) | 1,805 | 2 | |||||||||||||||||||||||||||||||
Residential mortgage-backed | 105 | — | (3 | ) | 16 | (23 | ) | — | (13 | ) | 24 | (31 | ) | 75 | — | ||||||||||||||||||||||||||||||
Commercial mortgage-backed | 6 | — | 2 | — | — | — | (2 | ) | 7 | (8 | ) | 5 | — | ||||||||||||||||||||||||||||||||
Other asset-backed (1) | 1,166 | 5 | (3 | ) | 298 | (15 | ) | — | (181 | ) | 244 | (94 | ) | 1,420 | 1 | ||||||||||||||||||||||||||||||
Total fixed maturity securities | 5,524 | 36 | 62 | 810 | (221 | ) | — | (674 | ) | 644 | (417 | ) | 5,764 | 15 | |||||||||||||||||||||||||||||||
Equity securities | 78 | — | — | 1 | (38 | ) | — | — | — | (7 | ) | 34 | — | ||||||||||||||||||||||||||||||||
Other invested assets: | |||||||||||||||||||||||||||||||||||||||||||||
Trading securities | 34 | — | — | — | — | — | (3 | ) | — | (31 | ) | — | — | ||||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps | 10 | — | — | — | — | — | (7 | ) | — | — | 3 | — | |||||||||||||||||||||||||||||||||
Equity index options | 12 | (31 | ) | — | 36 | — | — | — | — | — | 17 | (28 | ) | ||||||||||||||||||||||||||||||||
Other foreign currency contracts | 3 | (2 | ) | — | — | (1 | ) | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Total derivative assets | 25 | (33 | ) | — | 36 | (1 | ) | — | (7 | ) | — | — | 20 | (28 | ) | ||||||||||||||||||||||||||||||
Total other invested assets | 59 | (33 | ) | — | 36 | (1 | ) | — | (10 | ) | — | (31 | ) | 20 | (28 | ) | |||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (2) | 211 | 19 | — | — | — | — | — | — | — | 230 | 18 | ||||||||||||||||||||||||||||||||||
Reinsurance recoverable (3) | (1 | ) | 11 | — | — | — | 3 | — | — | — | 13 | 11 | |||||||||||||||||||||||||||||||||
Total Level 3 assets | $ | 5,871 | $ | 33 | $ | 62 | $ | 847 | $ | (260 | ) | $ | 3 | $ | (684 | ) | $ | 644 | $ | (455 | ) | $ | 6,061 | $ | 16 | ||||||||||||||||||||
(1) | The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(3) | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Total realized and | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total gains | |||||||||||||||||||||||||||||||||||
balance | unrealized gains | into | out of | balance | (losses) | ||||||||||||||||||||||||||||||||||||||||
as of | (losses) | Level 3 | Level 3 | as of | included in | ||||||||||||||||||||||||||||||||||||||||
January 1, | December 31, | net income | |||||||||||||||||||||||||||||||||||||||||||
2013 | 2013 | (loss) | |||||||||||||||||||||||||||||||||||||||||||
attributable | |||||||||||||||||||||||||||||||||||||||||||||
to assets | |||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
income | |||||||||||||||||||||||||||||||||||||||||||||
(loss) | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 9 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | (4 | ) | $ | — | $ | — | $ | 5 | $ | — | ||||||||||||||||||||||
Government—non-U.S. | 9 | — | 1 | — | — | — | (3 | ) | 16 | — | 23 | — | |||||||||||||||||||||||||||||||||
U.S. corporate (1) | 2,683 | 18 | (15 | ) | 178 | (151 | ) | — | (349 | ) | 195 | (159 | ) | 2,400 | 13 | ||||||||||||||||||||||||||||||
Corporate—non-U.S. (1) | 1,983 | 4 | (24 | ) | 120 | (33 | ) | — | (220 | ) | 76 | (87 | ) | 1,819 | 2 | ||||||||||||||||||||||||||||||
Residential mortgage-backed | 157 | (9 | ) | 7 | — | (8 | ) | — | (29 | ) | 14 | (27 | ) | 105 | — | ||||||||||||||||||||||||||||||
Commercial mortgage-backed | 35 | (5 | ) | (1 | ) | — | — | — | (32 | ) | 11 | (2 | ) | 6 | (4 | ) | |||||||||||||||||||||||||||||
Other asset-backed (1) | 864 | 4 | 10 | 200 | (49 | ) | — | (89 | ) | 246 | (20 | ) | 1,166 | 4 | |||||||||||||||||||||||||||||||
Total fixed maturity securities | 5,740 | 12 | (22 | ) | 498 | (241 | ) | — | (726 | ) | 558 | (295 | ) | 5,524 | 15 | ||||||||||||||||||||||||||||||
Equity securities | 99 | 2 | — | 1 | (24 | ) | — | — | — | — | 78 | — | |||||||||||||||||||||||||||||||||
Other invested assets: | |||||||||||||||||||||||||||||||||||||||||||||
Trading securities | 76 | 7 | — | — | (40 | ) | — | (9 | ) | — | — | 34 | 2 | ||||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 2 | (1 | ) | — | — | — | — | (1 | ) | — | — | — | (1 | ) | |||||||||||||||||||||||||||||||
Credit default swaps | 7 | 12 | — | — | — | — | (9 | ) | — | — | 10 | 6 | |||||||||||||||||||||||||||||||||
Equity index options | 25 | (43 | ) | — | 39 | — | — | (9 | ) | — | — | 12 | (40 | ) | |||||||||||||||||||||||||||||||
Other foreign currency contracts | — | (1 | ) | — | 4 | — | — | — | — | — | 3 | (1 | ) | ||||||||||||||||||||||||||||||||
Total derivative assets | 34 | (33 | ) | — | 43 | — | — | (19 | ) | — | — | 25 | (36 | ) | |||||||||||||||||||||||||||||||
Total other invested assets | 110 | (26 | ) | — | 43 | (40 | ) | — | (28 | ) | — | — | 59 | (34 | ) | ||||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (2) | 194 | (1 | ) | — | 19 | — | — | (20 | ) | 19 | — | 211 | (1 | ) | |||||||||||||||||||||||||||||||
Other assets (3) | 9 | — | — | — | — | — | (9 | ) | — | — | — | — | |||||||||||||||||||||||||||||||||
Reinsurance recoverable (4) | 10 | (14 | ) | — | — | — | 3 | — | — | — | (1 | ) | (14 | ) | |||||||||||||||||||||||||||||||
Total Level 3 assets | $ | 6,162 | $ | (27 | ) | $ | (22 | ) | $ | 561 | $ | (305 | ) | $ | 3 | $ | (783 | ) | $ | 577 | $ | (295 | ) | $ | 5,871 | $ | (34 | ) | |||||||||||||||||
(1) | The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(3) | Represents contingent receivables associated with recent business dispositions. | ||||||||||||||||||||||||||||||||||||||||||||
(4) | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Total realized and | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total gains | |||||||||||||||||||||||||||||||||||
balance | unrealized gains | into | out of | balance | (losses) | ||||||||||||||||||||||||||||||||||||||||
as of | (losses) | Level 3 | Level 3 | as of | included in | ||||||||||||||||||||||||||||||||||||||||
January 1, | December 31, | net income | |||||||||||||||||||||||||||||||||||||||||||
2012 | 2012 | (loss) | |||||||||||||||||||||||||||||||||||||||||||
attributable | |||||||||||||||||||||||||||||||||||||||||||||
to assets | |||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
income | |||||||||||||||||||||||||||||||||||||||||||||
(loss) | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises | $ | 13 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 9 | $ | (13 | ) | $ | 9 | $ | — | ||||||||||||||||||||||
Government—non-U.S. | 10 | — | — | — | — | — | (1 | ) | — | — | 9 | — | |||||||||||||||||||||||||||||||||
U.S. corporate (1) | 2,511 | 12 | 118 | 147 | (122 | ) | — | (214 | ) | 726 | (495 | ) | 2,683 | 14 | |||||||||||||||||||||||||||||||
Corporate—non-U.S. (1) | 1,284 | 3 | 92 | 269 | (29 | ) | — | (186 | ) | 711 | (161 | ) | 1,983 | 2 | |||||||||||||||||||||||||||||||
Residential mortgage-backed (1) | 95 | (7 | ) | 14 | 20 | (17 | ) | — | (31 | ) | 86 | (3 | ) | 157 | (7 | ) | |||||||||||||||||||||||||||||
Commercial mortgage-backed | 39 | (2 | ) | 5 | — | (1 | ) | — | (2 | ) | 3 | (7 | ) | 35 | (1 | ) | |||||||||||||||||||||||||||||
Other asset-backed (1) | 271 | (2 | ) | 45 | 350 | (46 | ) | — | (94 | ) | 369 | (29 | ) | 864 | 2 | ||||||||||||||||||||||||||||||
Total fixed maturity securities | 4,223 | 4 | 274 | 786 | (215 | ) | — | (528 | ) | 1,904 | (708 | ) | 5,740 | 10 | |||||||||||||||||||||||||||||||
Equity securities | 98 | 1 | (2 | ) | 10 | (8 | ) | — | — | — | — | 99 | — | ||||||||||||||||||||||||||||||||
Other invested assets: | |||||||||||||||||||||||||||||||||||||||||||||
Trading securities | 264 | 13 | — | 24 | (72 | ) | — | (125 | ) | 4 | (32 | ) | 76 | 15 | |||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Interest rate swaps | 5 | — | — | — | — | — | (3 | ) | — | — | 2 | — | |||||||||||||||||||||||||||||||||
Credit default swaps | — | 12 | — | — | — | — | (5 | ) | — | — | 7 | 12 | |||||||||||||||||||||||||||||||||
Equity index options | 39 | (59 | ) | — | 55 | — | — | (10 | ) | — | — | 25 | (42 | ) | |||||||||||||||||||||||||||||||
Other foreign currency contracts | 9 | (11 | ) | — | 3 | — | — | (1 | ) | — | — | — | (11 | ) | |||||||||||||||||||||||||||||||
Total derivative assets | 53 | (58 | ) | — | 58 | — | — | (19 | ) | — | — | 34 | (41 | ) | |||||||||||||||||||||||||||||||
Total other invested assets | 317 | (45 | ) | — | 82 | (72 | ) | — | (144 | ) | 4 | (32 | ) | 110 | (26 | ) | |||||||||||||||||||||||||||||
Restricted other invested assets related to securitization entities (2) | 176 | 18 | — | 100 | (100 | ) | — | — | — | — | 194 | 13 | |||||||||||||||||||||||||||||||||
Other assets (3) | — | (7 | ) | — | — | — | 16 | — | — | — | 9 | (7 | ) | ||||||||||||||||||||||||||||||||
Reinsurance recoverable (4) | 16 | (9 | ) | — | — | — | 3 | — | — | — | 10 | (9 | ) | ||||||||||||||||||||||||||||||||
Total Level 3 assets | $ | 4,830 | $ | (38 | ) | $ | 272 | $ | 978 | $ | (395 | ) | $ | 19 | $ | (672 | ) | $ | 1,908 | $ | (740 | ) | $ | 6,162 | $ | (19 | ) | ||||||||||||||||||
(1) | The transfers into and out of Level 3 were primarily related to private fixed rate U.S. corporate and private fixed rate corporate—non-U.S. securities and resulted from a change in the observability of the additional premium to the public bond spread to adjust for the liquidity and other features of our private placements and resulted in unobservable inputs having a significant impact on certain valuations for transfers in or no longer having significant impact on certain valuations for transfers out. During the second quarter of 2012, we began classifying private securities without an external rating as Level 3, which resulted in a significant number of securities being transferred into Level 3. The transfers into Level 3 for structured securities primarily related to securities that were recently purchased and initially classified as Level 2 based on market data that existed at the time of purchase and subsequent valuation included significant unobservable inputs. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(3) | Represents contingent receivables associated with recent business dispositions. | ||||||||||||||||||||||||||||||||||||||||||||
(4) | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | ||||||||||||||||||||||||||||||||||||||||||||
Gains and Losses Included in Net Income (Loss) from Assets and Liabilities Recorded at Fair Value | The following table presents the gains and losses included in net income (loss) from assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||||||||||
Total realized and unrealized gains (losses) included in net income (loss): | |||||||||||||||||||||||||||||||||||||||||||||
Net investment income | $ | 43 | $ | 35 | $ | 32 | |||||||||||||||||||||||||||||||||||||||
Net investment gains (losses) | (10 | ) | (62 | ) | (70 | ) | |||||||||||||||||||||||||||||||||||||||
Total | $ | 33 | $ | (27 | ) | $ | (38 | ) | |||||||||||||||||||||||||||||||||||||
Total gains (losses) included in net income (loss) attributable to assets still held: | |||||||||||||||||||||||||||||||||||||||||||||
Net investment income | $ | 19 | $ | 33 | $ | 25 | |||||||||||||||||||||||||||||||||||||||
Net investment gains (losses) | (3 | ) | (67 | ) | (44 | ) | |||||||||||||||||||||||||||||||||||||||
Total | $ | 16 | $ | (34 | ) | $ | (19 | ) | |||||||||||||||||||||||||||||||||||||
The following table presents the gains and losses included in net (income) loss from liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: | |||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||||||||||||||||||
Total realized and unrealized (gains) losses included in net (income) loss: | |||||||||||||||||||||||||||||||||||||||||||||
Net investment income | $ | — | $ | — | $ | — | |||||||||||||||||||||||||||||||||||||||
Net investment (gains) losses | 177 | (339 | ) | (283 | ) | ||||||||||||||||||||||||||||||||||||||||
Total | $ | 177 | $ | (339 | ) | $ | (283 | ) | |||||||||||||||||||||||||||||||||||||
Total (gains) losses included in net (income) loss attributable to liabilities still held: | |||||||||||||||||||||||||||||||||||||||||||||
Net investment income | $ | — | $ | — | $ | — | |||||||||||||||||||||||||||||||||||||||
Net investment (gains) losses | 178 | (337 | ) | (276 | ) | ||||||||||||||||||||||||||||||||||||||||
Total | $ | 178 | $ | (337 | ) | $ | (276 | ) | |||||||||||||||||||||||||||||||||||||
Liabilities Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value | The following tables present additional information about liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of or for the dates indicated: | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Total realized and | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total (gains) | |||||||||||||||||||||||||||||||||||
balance | unrealized (gains) | into | out of | balance | losses | ||||||||||||||||||||||||||||||||||||||||
as of | losses | Level 3 | Level 3 | as of | included in | ||||||||||||||||||||||||||||||||||||||||
January 1, | December 31, | net (income) | |||||||||||||||||||||||||||||||||||||||||||
2014 | 2014 | loss | |||||||||||||||||||||||||||||||||||||||||||
attributable | |||||||||||||||||||||||||||||||||||||||||||||
to liabilities | |||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
(income) | |||||||||||||||||||||||||||||||||||||||||||||
loss | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) | $ | 96 | $ | 158 | $ | — | $ | — | $ | — | $ | 37 | $ | — | $ | — | $ | — | $ | 291 | $ | 160 | |||||||||||||||||||||||
Fixed index annuity embedded derivatives | 143 | 27 | — | — | — | 108 | (2 | ) | — | — | 276 | 27 | |||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives | — | 1 | — | — | — | 6 | — | — | — | 7 | 1 | ||||||||||||||||||||||||||||||||||
Total policyholder account balances | 239 | 186 | — | — | — | 151 | (2 | ) | — | — | 574 | 188 | |||||||||||||||||||||||||||||||||
Derivative liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities (2) | 32 | (19 | ) | — | 4 | — | — | — | — | — | 17 | (19 | ) | ||||||||||||||||||||||||||||||||
Other foreign currency contracts | 1 | 1 | — | — | (2 | ) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Total derivative liabilities | 33 | (18 | ) | — | 4 | (2 | ) | — | — | — | — | 17 | (19 | ) | |||||||||||||||||||||||||||||||
Borrowings related to securitization entities (2) | 75 | 9 | — | — | — | 1 | — | — | — | 85 | 9 | ||||||||||||||||||||||||||||||||||
Total Level 3 liabilities | $ | 347 | $ | 177 | $ | — | $ | 4 | $ | (2 | ) | $ | 152 | $ | (2 | ) | $ | — | $ | — | $ | 676 | $ | 178 | |||||||||||||||||||||
(1) | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total | ||||||||||||||||||||||||||||||||||||
balance | Total realized and | into | out of | balance | (gains) | ||||||||||||||||||||||||||||||||||||||||
as of | unrealized (gains) | Level 3 | Level 3 | as of | losses | ||||||||||||||||||||||||||||||||||||||||
January 1, | losses | December 31, | included in | ||||||||||||||||||||||||||||||||||||||||||
2013 | 2013 | net | |||||||||||||||||||||||||||||||||||||||||||
(income) | |||||||||||||||||||||||||||||||||||||||||||||
loss | |||||||||||||||||||||||||||||||||||||||||||||
attributable | |||||||||||||||||||||||||||||||||||||||||||||
to liabilities | |||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
(income) | |||||||||||||||||||||||||||||||||||||||||||||
loss | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) | $ | 350 | $ | (291 | ) | $ | — | $ | — | $ | — | $ | 37 | $ | — | $ | — | $ | — | $ | 96 | $ | (289 | ) | |||||||||||||||||||||
Fixed index annuity embedded derivatives | 27 | 18 | — | — | — | 98 | — | — | — | 143 | 18 | ||||||||||||||||||||||||||||||||||
Total policyholder account balances | 377 | (273 | ) | — | — | — | 135 | — | — | — | 239 | (271 | ) | ||||||||||||||||||||||||||||||||
Derivative liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps | 1 | (1 | ) | — | — | — | — | — | — | — | — | (1 | ) | ||||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities (2) | 104 | (77 | ) | — | 5 | — | — | — | — | — | 32 | (77 | ) | ||||||||||||||||||||||||||||||||
Equity index options | — | 1 | — | — | — | — | (1 | ) | — | — | — | 1 | |||||||||||||||||||||||||||||||||
Other foreign currency contracts | — | (2 | ) | — | 3 | — | — | — | — | — | 1 | (2 | ) | ||||||||||||||||||||||||||||||||
Total derivative liabilities | 105 | (79 | ) | — | 8 | — | — | (1 | ) | — | — | 33 | (79 | ) | |||||||||||||||||||||||||||||||
Borrowings related to securitization entities (2) | 62 | 13 | — | — | — | — | — | — | — | 75 | 13 | ||||||||||||||||||||||||||||||||||
Total Level 3 liabilities | $ | 544 | $ | (339 | ) | $ | — | $ | 8 | $ | — | $ | 135 | $ | (1 | ) | $ | — | $ | — | $ | 347 | $ | (337 | ) | ||||||||||||||||||||
(1) | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Beginning | Purchases | Sales | Issuances | Settlements | Transfer | Transfer | Ending | Total | ||||||||||||||||||||||||||||||||||||
balance | into | out of | balance as of | (gains) | |||||||||||||||||||||||||||||||||||||||||
as of | Level 3 | Level 3 | December 31, | losses | |||||||||||||||||||||||||||||||||||||||||
January 1, | 2012 | included in | |||||||||||||||||||||||||||||||||||||||||||
2012 | net | ||||||||||||||||||||||||||||||||||||||||||||
(income) | |||||||||||||||||||||||||||||||||||||||||||||
Total realized | loss | ||||||||||||||||||||||||||||||||||||||||||||
and unrealized | attributable | ||||||||||||||||||||||||||||||||||||||||||||
(gains) losses | to liabilities | ||||||||||||||||||||||||||||||||||||||||||||
Included | Included | still held | |||||||||||||||||||||||||||||||||||||||||||
in net | in OCI | ||||||||||||||||||||||||||||||||||||||||||||
(income) | |||||||||||||||||||||||||||||||||||||||||||||
loss | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) | $ | 492 | $ | (179 | ) | $ | — | $ | — | $ | — | $ | 37 | $ | — | $ | — | $ | — | $ | 350 | $ | (175 | ) | |||||||||||||||||||||
Fixed index annuity embedded derivatives | 4 | 1 | — | — | — | 22 | — | — | — | 27 | 1 | ||||||||||||||||||||||||||||||||||
Total policyholder account balances | 496 | (178 | ) | — | — | — | 59 | — | — | — | 377 | (174 | ) | ||||||||||||||||||||||||||||||||
Derivative liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps | 57 | (43 | ) | — | 2 | — | — | (15 | ) | — | — | 1 | (40 | ) | |||||||||||||||||||||||||||||||
Credit default swaps related to securitization entities (2) | 177 | (76 | ) | — | 3 | — | — | — | — | — | 104 | (76 | ) | ||||||||||||||||||||||||||||||||
Total derivative liabilities | 234 | (119 | ) | — | 5 | — | — | (15 | ) | — | — | 105 | (116 | ) | |||||||||||||||||||||||||||||||
Borrowings related to securitization entities (2) | 48 | 14 | — | — | — | — | — | — | — | 62 | 14 | ||||||||||||||||||||||||||||||||||
Total Level 3 liabilities | $ | 778 | $ | (283 | ) | $ | — | $ | 5 | $ | — | $ | 59 | $ | (15 | ) | $ | — | $ | — | $ | 544 | $ | (276 | ) | ||||||||||||||||||||
(1) | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | See note 18 for additional information related to consolidated securitization entities. | ||||||||||||||||||||||||||||||||||||||||||||
Fair Value Inputs, Assets and Liabilities, Quantitative Information | The following table presents a summary of the significant unobservable inputs used for certain fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2014: | ||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) | Valuation technique | Fair value | Unobservable input | Range | |||||||||||||||||||||||||||||||||||||||||
(weighted-average) | |||||||||||||||||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||
U.S. corporate | Internal models | $ | 2,234 | Credit spreads | 76bps -463bps (197bps) | ||||||||||||||||||||||||||||||||||||||||
Corporate—non-U.S. | Internal models | 1,588 | Credit spreads | 81bps - 808bps (178bps) | |||||||||||||||||||||||||||||||||||||||||
Derivative assets: | |||||||||||||||||||||||||||||||||||||||||||||
Credit default swaps (1) | Discounted cash flows | 3 | Credit spreads | —bps - 25bps (7bps) | |||||||||||||||||||||||||||||||||||||||||
Equity index options | Discounted cash flows | 17 | Equity index volatility | 14% - 23% (20%) | |||||||||||||||||||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||||||||||||||
Policyholder account balances: | |||||||||||||||||||||||||||||||||||||||||||||
Withdrawal utilization rate | — % - 98% | ||||||||||||||||||||||||||||||||||||||||||||
Lapse rate | — % - 15% | ||||||||||||||||||||||||||||||||||||||||||||
Non-performance risk (credit spreads) | 40bps - 85bps (70bps) | ||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (2) | Stochastic cash flow model | 291 | Equity index volatility | 17% - 24% (21%) | |||||||||||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives | Option budget method | 276 | Expected future | — % - 3% (2%) | |||||||||||||||||||||||||||||||||||||||||
interest credited | |||||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives | Option budget method | 7 | Expected future | 3% - 9% (6%) | |||||||||||||||||||||||||||||||||||||||||
interest credited | |||||||||||||||||||||||||||||||||||||||||||||
(1) | Unobservable input valuation based on the current market credit default swap premium. | ||||||||||||||||||||||||||||||||||||||||||||
(2) | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Variable_Interest_and_Securiti1
Variable Interest and Securitization Entities (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||
Schedule of Securitized Assets | The following table summarizes the total securitized assets as of December 31: | ||||||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||||||
Receivables secured by: | |||||||||||||||||
Other assets | $ | 142 | $ | 147 | |||||||||||||
Total securitized assets not required to be consolidated | 142 | 147 | |||||||||||||||
Total securitized assets required to be consolidated | 300 | 314 | |||||||||||||||
Total securitized assets | $ | 442 | $ | 461 | |||||||||||||
Schedule of Variable Interest Entities | The following table shows the assets and liabilities that were recorded for the consolidated securitization entities as of December 31: | ||||||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||||||
Assets | |||||||||||||||||
Investments: | |||||||||||||||||
Restricted commercial mortgage loans | $ | 201 | $ | 233 | |||||||||||||
Restricted other invested assets: | |||||||||||||||||
Trading securities | 411 | 391 | |||||||||||||||
Total restricted other invested assets | 411 | 391 | |||||||||||||||
Total investments | 612 | 624 | |||||||||||||||
Cash and cash equivalents | 1 | 1 | |||||||||||||||
Accrued investment income | 1 | 1 | |||||||||||||||
Total assets | $ | 614 | $ | 626 | |||||||||||||
Liabilities | |||||||||||||||||
Other liabilities: | |||||||||||||||||
Derivative liabilities | $ | 43 | $ | 48 | |||||||||||||
Other liabilities | 2 | 2 | |||||||||||||||
Total other liabilities | 45 | 50 | |||||||||||||||
Borrowings related to securitization entities | 219 | 242 | |||||||||||||||
Total liabilities | $ | 264 | $ | 292 | |||||||||||||
Schedule of Income Statement Activity Related to Variable Interest Entities | The following table shows the activity presented in our consolidated statement of income related to the consolidated securitization entities for the years ended December 31: | ||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||
Revenues: | |||||||||||||||||
Net investment income: | |||||||||||||||||
Restricted commercial mortgage loans | $ | 14 | $ | 23 | $ | 29 | |||||||||||
Restricted other invested assets | 5 | 4 | 4 | ||||||||||||||
Total net investment income | 19 | 27 | 33 | ||||||||||||||
Net investment gains (losses): | |||||||||||||||||
Trading securities | 15 | (4 | ) | 23 | |||||||||||||
Derivatives | 10 | 86 | 72 | ||||||||||||||
Borrowings related to securitization entities recorded at fair value | (9 | ) | (13 | ) | (14 | ) | |||||||||||
Total net investment gains (losses) | 16 | 69 | 81 | ||||||||||||||
Other income | — | — | 1 | ||||||||||||||
Total revenues | 35 | 96 | 115 | ||||||||||||||
Expenses: | |||||||||||||||||
Interest expense | 10 | 16 | 21 | ||||||||||||||
Acquisition and operating expenses | — | — | 1 | ||||||||||||||
Total expenses | 10 | 16 | 22 | ||||||||||||||
Income before income taxes | 25 | 80 | 93 | ||||||||||||||
Provision for income taxes | 9 | 27 | 33 | ||||||||||||||
Net income | $ | 16 | $ | 53 | $ | 60 | |||||||||||
Borrowings Related to Consolidated Securitization Entities | Borrowings related to securitization entities were as follows as of December 31: | ||||||||||||||||
2014 | 2013 | ||||||||||||||||
(Amounts in millions) | Principal | Carrying | Principal | Carrying | |||||||||||||
amount | value | amount | value | ||||||||||||||
GFCM LLC, due 2035, 5.2541% | $ | 21 | $ | 21 | $ | 54 | $ | 54 | |||||||||
GFCM LLC, due 2035, 5.7426% | 113 | 113 | 113 | 113 | |||||||||||||
Marvel Finance 2007-4 LLC, due 2017 (1), (2) | 12 | 12 | 12 | 12 | |||||||||||||
Genworth Special Purpose Five, LLC, due 2040 (1), (2) | NA | (3) | 73 | NA | (3) | 63 | |||||||||||
Total | $ | 146 | $ | 219 | $ | 179 | $ | 242 | |||||||||
(1) | Accrual of interest based on three-month LIBOR that resets every three months plus a fixed margin. | ||||||||||||||||
(2) | Carrying value represents fair value as a result of electing fair value option for these liabilities. | ||||||||||||||||
(3) | Principal amount not applicable. Notional balance was $115 million as of December 31, 2014 and 2013. |
Insurance_Subsidiary_Financial1
Insurance Subsidiary Financial Information and Regulatory Matters (Tables) | 12 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Schedule of Combined Statutory Net Income (Loss) | The tables below include the combined statutory net income (loss) and statutory capital and surplus for our U.S. domiciled insurance subsidiaries: | ||||||||||||
Years ended December 31, | |||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||
Combined statutory net income (loss): | |||||||||||||
Life insurance subsidiaries, excluding captive life reinsurance subsidiaries | $ | (179 | ) | $ | 359 | $ | 378 | ||||||
Mortgage insurance subsidiaries | 198 | 85 | (137 | ) | |||||||||
Combined statutory net income (loss), excluding captive reinsurance subsidiaries | 19 | 444 | 241 | ||||||||||
Captive life insurance subsidiaries | (281 | ) | (102 | ) | (478 | ) | |||||||
Combined statutory net income (loss) | $ | (262 | ) | $ | 342 | $ | (237 | ) | |||||
Schedule of Combined Statutory Capital and Surplus | As of December 31, | ||||||||||||
(Amounts in millions) | 2014 | 2013 | |||||||||||
Combined statutory capital and surplus: | |||||||||||||
Life insurance subsidiaries, excluding captive life reinsurance subsidiaries | $ | 2,560 | $ | 2,777 | |||||||||
Mortgage insurance subsidiaries | 1,792 | 1,226 | |||||||||||
Combined statutory capital and surplus | $ | 4,352 | $ | 4,003 | |||||||||
Segment_Information_Tables
Segment Information (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||||||||||
Summary of Segments and Corporate and Other Activities | The following is a summary of our segments and Corporate and Other activities as of or for the years ended December 31: | ||||||||||||||||||||||||||||
2014 | U.S. Life | International | U.S. | International | Runoff | Corporate | Total | ||||||||||||||||||||||
Insurance | Mortgage | Mortgage | Protection | and Other | |||||||||||||||||||||||||
Insurance | Insurance | ||||||||||||||||||||||||||||
(Amounts in millions) | |||||||||||||||||||||||||||||
Premiums | $ | 3,169 | $ | 950 | $ | 578 | $ | 731 | $ | 3 | $ | — | $ | 5,431 | |||||||||||||||
Net investment income | 2,665 | 303 | 59 | 101 | 129 | (15 | ) | 3,242 | |||||||||||||||||||||
Net investment gains (losses) | 41 | 1 | — | — | (66 | ) | 4 | (20 | ) | ||||||||||||||||||||
Insurance and investment product fees and other | 712 | (14 | ) | 2 | 5 | 209 | (2 | ) | 912 | ||||||||||||||||||||
Total revenues | 6,587 | 1,240 | 639 | 837 | 275 | (13 | ) | 9,565 | |||||||||||||||||||||
Benefits and other changes in policy reserves | 5,820 | 204 | 357 | 202 | 37 | — | 6,620 | ||||||||||||||||||||||
Interest credited | 618 | — | — | — | 119 | — | 737 | ||||||||||||||||||||||
Acquisition and operating expenses, net of deferrals | 658 | 223 | 140 | 462 | 84 | 18 | 1,585 | ||||||||||||||||||||||
Amortization of deferred acquisition costs and intangibles | 345 | 59 | 7 | 118 | 39 | 3 | 571 | ||||||||||||||||||||||
Goodwill impairment | 849 | — | — | — | — | — | 849 | ||||||||||||||||||||||
Interest expense | 87 | 31 | — | 46 | 1 | 314 | 479 | ||||||||||||||||||||||
Total benefits and expenses | 8,377 | 517 | 504 | 828 | 280 | 335 | 10,841 | ||||||||||||||||||||||
Income (loss) from continuing operations before income taxes | (1,790 | ) | 723 | 135 | 9 | (5 | ) | (348 | ) | (1,276 | ) | ||||||||||||||||||
Provision (benefit) for income taxes | (385 | ) | 358 | 44 | (107 | ) | (19 | ) | (119 | ) | (228 | ) | |||||||||||||||||
Income (loss) from continuing operations | (1,405 | ) | 365 | 91 | 116 | 14 | (229 | ) | (1,048 | ) | |||||||||||||||||||
Income (loss) from discontinued operations, net of taxes | — | — | — | — | — | — | — | ||||||||||||||||||||||
Net income (loss) | (1,405 | ) | 365 | 91 | 116 | 14 | (229 | ) | (1,048 | ) | |||||||||||||||||||
Less: net income attributable to noncontrolling interests | — | 196 | — | — | — | — | 196 | ||||||||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (1,405 | ) | $ | 169 | $ | 91 | $ | 116 | $ | 14 | $ | (229 | ) | $ | (1,244 | ) | ||||||||||||
Total assets | $ | 82,906 | $ | 8,815 | $ | 2,324 | $ | 1,833 | $ | 12,971 | $ | 2,509 | $ | 111,358 | |||||||||||||||
International | U.S. | ||||||||||||||||||||||||||||
2013 | U.S. Life | Mortgage | Mortgage | International | Runoff | Corporate | Total | ||||||||||||||||||||||
Insurance | Insurance | Insurance | Protection | and Other | |||||||||||||||||||||||||
(Amounts in millions) | |||||||||||||||||||||||||||||
Premiums | $ | 2,957 | $ | 996 | $ | 554 | $ | 636 | $ | 5 | $ | — | $ | 5,148 | |||||||||||||||
Net investment income | 2,621 | 333 | 60 | 119 | 139 | (1 | ) | 3,271 | |||||||||||||||||||||
Net investment gains (losses) | (3 | ) | 32 | — | 27 | (58 | ) | (35 | ) | (37 | ) | ||||||||||||||||||
Insurance and investment product fees and other | 755 | — | 2 | 4 | 216 | 44 | 1,021 | ||||||||||||||||||||||
Total revenues | 6,330 | 1,361 | 616 | 786 | 302 | 8 | 9,403 | ||||||||||||||||||||||
Benefits and other changes in policy reserves | 3,975 | 317 | 412 | 159 | 32 | — | 4,895 | ||||||||||||||||||||||
Interest credited | 619 | — | — | — | 119 | — | 738 | ||||||||||||||||||||||
Acquisition and operating expenses, net of deferrals | 658 | 241 | 144 | 433 | 81 | 102 | 1,659 | ||||||||||||||||||||||
Amortization of deferred acquisition costs and intangibles | 384 | 60 | 6 | 106 | 6 | 7 | 569 | ||||||||||||||||||||||
Interest expense | 97 | 33 | — | 42 | 2 | 318 | 492 | ||||||||||||||||||||||
Total benefits and expenses | 5,733 | 651 | 562 | 740 | 240 | 427 | 8,353 | ||||||||||||||||||||||
Income (loss) from continuing operations before income taxes | 597 | 710 | 54 | 46 | 62 | (419 | ) | 1,050 | |||||||||||||||||||||
Provision (benefit) for income taxes | 213 | 184 | 17 | 7 | 13 | (110 | ) | 324 | |||||||||||||||||||||
Income (loss) from continuing operations | 384 | 526 | 37 | 39 | 49 | (309 | ) | 726 | |||||||||||||||||||||
Loss from discontinued operations, net of taxes | — | — | — | — | — | (12 | ) | (12 | ) | ||||||||||||||||||||
Net income (loss) | 384 | 526 | 37 | 39 | 49 | (321 | ) | 714 | |||||||||||||||||||||
Less: net income attributable to noncontrolling interests | — | 154 | — | — | — | — | 154 | ||||||||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | 384 | $ | 372 | $ | 37 | $ | 39 | $ | 49 | $ | (321 | ) | $ | 560 | ||||||||||||||
Total assets | $ | 77,261 | $ | 9,194 | $ | 2,361 | $ | 2,061 | $ | 14,062 | $ | 3,106 | $ | 108,045 | |||||||||||||||
International | U.S. | ||||||||||||||||||||||||||||
2012 | U.S. Life | Mortgage | Mortgage | International | Runoff | Corporate | Total | ||||||||||||||||||||||
Insurance | Insurance | Insurance | Protection | and Other | |||||||||||||||||||||||||
(Amounts in millions) | |||||||||||||||||||||||||||||
Premiums | $ | 2,789 | $ | 1,016 | $ | 549 | $ | 682 | $ | 5 | $ | — | $ | 5,041 | |||||||||||||||
Net investment income | 2,594 | 375 | 68 | 131 | 145 | 30 | 3,343 | ||||||||||||||||||||||
Net investment gains (losses) | (8 | ) | 16 | 36 | 6 | 24 | (47 | ) | 27 | ||||||||||||||||||||
Insurance and investment product fees and other | 875 | 1 | 23 | 3 | 207 | 120 | 1,229 | ||||||||||||||||||||||
Total revenues | 6,250 | 1,408 | 676 | 822 | 381 | 103 | 9,640 | ||||||||||||||||||||||
Benefits and other changes in policy reserves | 3,950 | 516 | 725 | 150 | 37 | — | 5,378 | ||||||||||||||||||||||
Interest credited | 643 | — | — | — | 132 | — | 775 | ||||||||||||||||||||||
Acquisition and operating expenses, net of deferrals | 677 | 55 | 143 | 483 | 79 | 157 | 1,594 | ||||||||||||||||||||||
Amortization of deferred acquisition costs and intangibles | 477 | 64 | 5 | 113 | 51 | 12 | 722 | ||||||||||||||||||||||
Goodwill impairment | — | — | — | 89 | — | — | 89 | ||||||||||||||||||||||
Interest expense | 86 | 36 | — | 45 | 1 | 308 | 476 | ||||||||||||||||||||||
Total benefits and expenses | 5,833 | 671 | 873 | 880 | 300 | 477 | 9,034 | ||||||||||||||||||||||
Income (loss) from continuing operations before income taxes | 417 | 737 | (197 | ) | (58 | ) | 81 | (374 | ) | 606 | |||||||||||||||||||
Provision (benefit) for income taxes | 143 | 188 | (83 | ) | 1 | 23 | (134 | ) | 138 | ||||||||||||||||||||
Income (loss) from continuing operations | 274 | 549 | (114 | ) | (59 | ) | 58 | (240 | ) | 468 | |||||||||||||||||||
Income from discontinued operations, net of taxes | — | — | — | — | — | 57 | 57 | ||||||||||||||||||||||
Net income (loss) | 274 | 549 | (114 | ) | (59 | ) | 58 | (183 | ) | 525 | |||||||||||||||||||
Less: net income attributable to noncontrolling interests | — | 200 | — | — | — | — | 200 | ||||||||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | 274 | $ | 349 | $ | (114 | ) | $ | (59 | ) | $ | 58 | $ | (183 | ) | $ | 325 | ||||||||||||
Summary of Revenues of Major Product Groups for Segments and Corporate and Other Activities | The following is a summary of revenues of major product groups for our segments and Corporate and Other activities for the years ended December 31: | ||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||||||
U.S. Life Insurance segment: | |||||||||||||||||||||||||||||
Long-term care insurance | $ | 3,523 | $ | 3,316 | $ | 3,207 | |||||||||||||||||||||||
Life insurance | 1,981 | 1,982 | 1,926 | ||||||||||||||||||||||||||
Fixed annuities | 1,083 | 1,032 | 1,117 | ||||||||||||||||||||||||||
U.S. Life Insurance segment’s revenues | 6,587 | 6,330 | 6,250 | ||||||||||||||||||||||||||
International Mortgage Insurance segment: | |||||||||||||||||||||||||||||
Canada | 669 | 760 | 786 | ||||||||||||||||||||||||||
Australia | 537 | 555 | 567 | ||||||||||||||||||||||||||
Other Countries | 34 | 46 | 55 | ||||||||||||||||||||||||||
International Mortgage Insurance segment’s revenues | 1,240 | 1,361 | 1,408 | ||||||||||||||||||||||||||
U.S. Mortgage Insurance segment’s revenues | 639 | 616 | 676 | ||||||||||||||||||||||||||
International Protection segment’s revenues | 837 | 786 | 822 | ||||||||||||||||||||||||||
Runoff segment’s revenues | 275 | 302 | 381 | ||||||||||||||||||||||||||
Corporate and Other’s revenues | (13 | ) | 8 | 103 | |||||||||||||||||||||||||
Total revenues | $ | 9,565 | $ | 9,403 | $ | 9,640 | |||||||||||||||||||||||
Summary of Net Operating Income (Loss) Available to Company's Common Stockholders for Segments and Corporate and Other Activities | The following is a summary of net operating income (loss) for our segments and Corporate and Other activities for the years ended December 31: | ||||||||||||||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||||||||||||||
U.S. Life Insurance segment: | |||||||||||||||||||||||||||||
Long-term care insurance | $ | (815 | ) | $ | 129 | $ | 101 | ||||||||||||||||||||||
Life insurance | 74 | 173 | 151 | ||||||||||||||||||||||||||
Fixed annuities | 100 | 92 | 82 | ||||||||||||||||||||||||||
U.S. Life Insurance segment’s net operating income (loss) | (641 | ) | 394 | 334 | |||||||||||||||||||||||||
International Mortgage Insurance segment: | |||||||||||||||||||||||||||||
Canada | 170 | 170 | 234 | ||||||||||||||||||||||||||
Australia | 200 | 228 | 142 | ||||||||||||||||||||||||||
Other Countries | (25 | ) | (37 | ) | (34 | ) | |||||||||||||||||||||||
International Mortgage Insurance segment’s net operating income | 345 | 361 | 342 | ||||||||||||||||||||||||||
U.S. Mortgage Insurance segment’s net operating income (loss) | 91 | 37 | (138 | ) | |||||||||||||||||||||||||
International Protection segment’s net operating income | 8 | 24 | 24 | ||||||||||||||||||||||||||
Runoff segment’s net operating income | 48 | 66 | 46 | ||||||||||||||||||||||||||
Corporate and Other’s net operating loss | (232 | ) | (266 | ) | (205 | ) | |||||||||||||||||||||||
Net operating income (loss) | (381 | ) | 616 | 403 | |||||||||||||||||||||||||
Net investment gains (losses), net | (4 | ) | (11 | ) | (1 | ) | |||||||||||||||||||||||
Goodwill impairment, net | (791 | ) | — | (86 | ) | ||||||||||||||||||||||||
Gains (losses) on early extinguishment of debt, net | (2 | ) | (20 | ) | (1 | ) | |||||||||||||||||||||||
Gains (losses) from life block transactions, net | — | — | (47 | ) | |||||||||||||||||||||||||
Tax impact from potential business portfolio changes | (66 | ) | — | — | |||||||||||||||||||||||||
Expenses related to restructuring, net | — | (13 | ) | — | |||||||||||||||||||||||||
Income (loss) from discontinued operations, net of taxes | — | (12 | ) | 57 | |||||||||||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | (1,244 | ) | 560 | 325 | |||||||||||||||||||||||||
Add: net income attributable to noncontrolling interests | 196 | 154 | 200 | ||||||||||||||||||||||||||
Net income (loss) | $ | (1,048 | ) | $ | 714 | $ | 525 | ||||||||||||||||||||||
Schedule of Revenue, Net Income and Assets by Geographic Location | The following is a summary of geographic region activity as of or for the years ended December 31: | ||||||||||||||||||||||||||||
2014 | |||||||||||||||||||||||||||||
(Amounts in millions) | United States | Canada | Australia | Other | Total | ||||||||||||||||||||||||
Countries | |||||||||||||||||||||||||||||
Total revenues | $ | 7,488 | $ | 669 | $ | 537 | $ | 871 | $ | 9,565 | |||||||||||||||||||
Income (loss) from continuing operations | $ | (1,529 | ) | $ | 307 | $ | 83 | $ | 91 | $ | (1,048 | ) | |||||||||||||||||
Net income (loss) | $ | (1,529 | ) | $ | 307 | $ | 83 | $ | 91 | $ | (1,048 | ) | |||||||||||||||||
Total assets | $ | 100,710 | $ | 4,922 | $ | 3,495 | $ | 2,231 | $ | 111,358 | |||||||||||||||||||
2013 | |||||||||||||||||||||||||||||
(Amounts in millions) | United States | Canada | Australia | Other | Total | ||||||||||||||||||||||||
Countries | |||||||||||||||||||||||||||||
Total revenues | $ | 7,256 | $ | 760 | $ | 555 | $ | 832 | $ | 9,403 | |||||||||||||||||||
Income from continuing operations | $ | 161 | $ | 336 | $ | 227 | $ | 2 | $ | 726 | |||||||||||||||||||
Net income | $ | 149 | $ | 336 | $ | 227 | $ | 2 | $ | 714 | |||||||||||||||||||
Total assets | $ | 96,790 | $ | 5,313 | $ | 3,419 | $ | 2,523 | $ | 108,045 | |||||||||||||||||||
2012 | |||||||||||||||||||||||||||||
(Amounts in millions) | United States | Canada | Australia | Other | Total | ||||||||||||||||||||||||
Countries | |||||||||||||||||||||||||||||
Total revenues | $ | 7,410 | $ | 786 | $ | 567 | $ | 877 | $ | 9,640 | |||||||||||||||||||
Income (loss) from continuing operations | $ | (22 | ) | $ | 439 | $ | 140 | $ | (89 | ) | $ | 468 | |||||||||||||||||
Net income (loss) | $ | 35 | $ | 439 | $ | 140 | $ | (89 | ) | $ | 525 | ||||||||||||||||||
Quarterly_Results_of_Operation1
Quarterly Results of Operations (unaudited) (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||
Quarterly Results of Operations | Our unaudited quarterly results of operations for the year ended December 31, 2014 are summarized in the table below. | ||||||||||||||||
Three months ended | |||||||||||||||||
(Amounts in millions, except per share amounts) | March 31, | June 30, | September 30, | December 31, | |||||||||||||
2014 | 2014 | 2014 | 2014 | ||||||||||||||
Total revenues | $ | 2,322 | $ | 2,415 | $ | 2,404 | $ | 2,424 | |||||||||
Total benefits and expenses (1) | $ | 2,016 | $ | 2,102 | $ | 3,376 | $ | 3,347 | |||||||||
Income (loss) from continuing operations (2) | $ | 219 | $ | 228 | $ | (787 | ) | $ | (708 | ) | |||||||
Net income (loss) (2) | $ | 219 | $ | 228 | $ | (787 | ) | $ | (708 | ) | |||||||
Net income attributable to noncontrolling interests | $ | 35 | $ | 52 | $ | 57 | $ | 52 | |||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders (2) | $ | 184 | $ | 176 | $ | (844 | ) | $ | (760 | ) | |||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per common share: | |||||||||||||||||
Basic | $ | 0.37 | $ | 0.35 | $ | (1.70 | ) | $ | (1.53 | ) | |||||||
Diluted | $ | 0.37 | $ | 0.35 | $ | (1.70 | ) | $ | (1.53 | ) | |||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders per common share: | |||||||||||||||||
Basic | $ | 0.37 | $ | 0.35 | $ | (1.70 | ) | $ | (1.53 | ) | |||||||
Diluted | $ | 0.37 | $ | 0.35 | $ | (1.70 | ) | $ | (1.53 | ) | |||||||
Weighted-average common shares outstanding: | |||||||||||||||||
Basic | 495.8 | 496.6 | 496.6 | 496.7 | |||||||||||||
Diluted (3) | 502.7 | 503.6 | 496.6 | 496.7 | |||||||||||||
(1) | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates. | ||||||||||||||||
(2) | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. | ||||||||||||||||
(3) | Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2014 and December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2014 and December 31, 2014, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.4 million and 3.2 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2014 and December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million and 499.9 million, respectively. | ||||||||||||||||
Our unaudited quarterly results of operations for the year ended December 31, 2013 are summarized in the table below. | |||||||||||||||||
Three months ended | |||||||||||||||||
(Amounts in millions, except per share amounts) | March 31, | June 30, | September 30, | December 31, | |||||||||||||
2013 | 2013 | 2013 | 2013 | ||||||||||||||
Total revenues | $ | 2,303 | $ | 2,371 | $ | 2,317 | $ | 2,412 | |||||||||
Total benefits and expenses | $ | 2,066 | $ | 2,124 | $ | 2,066 | $ | 2,097 | |||||||||
Income from continuing operations | $ | 161 | $ | 174 | $ | 146 | $ | 245 | |||||||||
Income (loss) from discontinued operations, net of taxes | $ | (20 | ) | $ | 6 | $ | 2 | $ | — | ||||||||
Net income | $ | 141 | $ | 180 | $ | 148 | $ | 245 | |||||||||
Net income attributable to noncontrolling interests | $ | 38 | $ | 39 | $ | 40 | $ | 37 | |||||||||
Net income available to Genworth Financial, Inc.’s common stockholders | $ | 103 | $ | 141 | $ | 108 | $ | 208 | |||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per common share: | |||||||||||||||||
Basic | $ | 0.25 | $ | 0.27 | $ | 0.21 | $ | 0.42 | |||||||||
Diluted | $ | 0.25 | $ | 0.27 | $ | 0.21 | $ | 0.42 | |||||||||
Net income available to Genworth Financial, Inc.’s common stockholders per common share: | |||||||||||||||||
Basic | $ | 0.21 | $ | 0.29 | $ | 0.22 | $ | 0.42 | |||||||||
Diluted | $ | 0.21 | $ | 0.28 | $ | 0.22 | $ | 0.41 | |||||||||
Weighted-average common shares outstanding: | |||||||||||||||||
Basic | 492.5 | 493.4 | 494 | 494.7 | |||||||||||||
Diluted | 496.8 | 497.5 | 499.3 | 501.2 |
Changes_In_Accumulated_Other_C1
Changes In Accumulated Other Comprehensive Income (Loss) (Tables) | 12 Months Ended | ||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||
Component of Changes in Accumulated Other Comprehensive Income (Loss), Net of Taxes | The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated: | ||||||||||||||||
(Amounts in millions) | Net | Derivatives | Foreign | Total | |||||||||||||
unrealized | qualifying as | currency | |||||||||||||||
investment | hedges (2) | translation | |||||||||||||||
gains | and other | ||||||||||||||||
(losses) (1) | adjustments | ||||||||||||||||
Balances as of January 1, 2014 | $ | 926 | $ | 1,319 | $ | 297 | $ | 2,542 | |||||||||
OCI before reclassifications | 1,595 | 788 | (537 | ) | 1,846 | ||||||||||||
Amounts reclassified from (to) OCI | (12 | ) | (37 | ) | — | (49 | ) | ||||||||||
Current period OCI | 1,583 | 751 | (537 | ) | 1,797 | ||||||||||||
Balances as of December 31, 2014 before noncontrolling interests | 2,509 | 2,070 | (240 | ) | 4,339 | ||||||||||||
Less: change in OCI attributable to noncontrolling interests | 56 | — | (163 | ) | (107 | ) | |||||||||||
Balances as of December 31, 2014 | $ | 2,453 | $ | 2,070 | $ | (77 | ) | $ | 4,446 | ||||||||
(1) | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. | ||||||||||||||||
(2) | See note 5 for additional information. | ||||||||||||||||
(Amounts in millions) | Net | Derivatives | Foreign | Total | |||||||||||||
unrealized | qualifying as | currency | |||||||||||||||
investment | hedges (2) | translation | |||||||||||||||
gains | and other | ||||||||||||||||
(losses) (1) | adjustments | ||||||||||||||||
Balances as of January 1, 2013 | $ | 2,638 | $ | 1,909 | $ | 655 | $ | 5,202 | |||||||||
OCI before reclassifications | (1,772 | ) | (561 | ) | (442 | ) | (2,775 | ) | |||||||||
Amounts reclassified from (to) OCI | 21 | (29 | ) | — | (8 | ) | |||||||||||
Current period OCI | (1,751 | ) | (590 | ) | (442 | ) | (2,783 | ) | |||||||||
Balances as of December 31, 2013 before noncontrolling interests | 887 | 1,319 | 213 | 2,419 | |||||||||||||
Less: change in OCI attributable to noncontrolling interests | (39 | ) | — | (84 | ) | (123 | ) | ||||||||||
Balances as of December 31, 2013 | $ | 926 | $ | 1,319 | $ | 297 | $ | 2,542 | |||||||||
(1) | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. | ||||||||||||||||
(2) | See note 5 for additional information. | ||||||||||||||||
(Amounts in millions) | Net | Derivatives | Foreign | Total | |||||||||||||
unrealized | qualifying as | currency | |||||||||||||||
investment | hedges (2) | translation | |||||||||||||||
gains | and other | ||||||||||||||||
(losses) (1) | adjustments | ||||||||||||||||
Balances as of January 1, 2012 | $ | 1,485 | $ | 2,009 | $ | 553 | $ | 4,047 | |||||||||
OCI before reclassifications | 1,106 | (77 | ) | 126 | 1,155 | ||||||||||||
Amounts reclassified from (to) OCI | 50 | (23 | ) | — | 27 | ||||||||||||
Current period OCI | 1,156 | (100 | ) | 126 | 1,182 | ||||||||||||
Balances as of December 31, 2012 before noncontrolling interests | 2,641 | 1,909 | 679 | 5,229 | |||||||||||||
Less: change in OCI attributable to noncontrolling interests | 3 | — | 24 | 27 | |||||||||||||
Balances as of December 31, 2012 | $ | 2,638 | $ | 1,909 | $ | 655 | $ | 5,202 | |||||||||
(1) | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. | ||||||||||||||||
(2) | See note 5 for additional information. | ||||||||||||||||
Reclassifications out of Accumulated Other Comprehensive Income (Loss) net of Taxes | The following table shows reclassifications out of accumulated other comprehensive income (loss), net of taxes, for the periods presented: | ||||||||||||||||
Amount reclassified from accumulated | Affected line item in the | ||||||||||||||||
other comprehensive income (loss) | consolidated statements | ||||||||||||||||
Years ended December 31, | of income | ||||||||||||||||
(Amounts in millions) | 2014 | 2013 | 2012 | ||||||||||||||
Net unrealized investment (gains) losses: | |||||||||||||||||
Unrealized (gains) losses on investments (1) | $ | (19 | ) | $ | 33 | $ | 77 | Net investment (gains) losses | |||||||||
Provision for income taxes | 7 | (12 | ) | (27 | ) | Provision for income taxes | |||||||||||
Total | $ | (12 | ) | $ | 21 | $ | 50 | ||||||||||
Derivatives qualifying as hedges: | |||||||||||||||||
Interest rate swaps hedging assets | $ | (63 | ) | $ | (47 | ) | $ | (40 | ) | Net investment income | |||||||
Interest rate swaps hedging assets | (2 | ) | (1 | ) | (2 | ) | Net investment (gains) losses | ||||||||||
Interest rate swaps hedging liabilities | (1 | ) | (2 | ) | (2 | ) | Interest expense | ||||||||||
Inflation indexed swaps | 9 | 5 | 9 | Net investment income | |||||||||||||
Provision for income taxes | 20 | 16 | 12 | Provision for income taxes | |||||||||||||
Total | $ | (37 | ) | $ | (29 | ) | $ | (23 | ) | ||||||||
(1) | Amounts exclude adjustments to DAC, PVFP, sales inducements and benefit reserves. |
Noncontrolling_Interests_Table
Noncontrolling Interests (Tables) | 12 Months Ended | ||||
Dec. 31, 2014 | |||||
Changes in Ownership Interests and the Effect on Stockholders' Equity | A summary of the changes in ownership interests and the effect on stockholders’ equity as a result of the initial public offering of Genworth Australia was as follows for the year ended December 31: | ||||
(Amounts in millions) | 2014 | ||||
Net loss available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | ||
Transfers to the noncontrolling interests: | |||||
Decrease in Genworth Financial, Inc.’s additional paid-in capital for initial sale of Genworth Australia shares to noncontrolling interests | (145 | ) | |||
Net transfers to noncontrolling interests | (145 | ) | |||
Change from net loss available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests | $ | (1,389 | ) | ||
Discontinued_Operations_Tables
Discontinued Operations (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Summary of Operating Results of Discontinued Operations | Summary operating results of discontinued operations were as follows for the years ended December 31: | ||||||||
(Amounts in millions) | 2013 | 2012 | |||||||
Revenues | $ | 211 | $ | 387 | |||||
Income (loss) before income taxes | $ | (5 | ) | $ | 110 | ||||
Provision for income taxes | 7 | 53 | |||||||
Income (loss) from discontinued operations, net of taxes | $ | (12 | ) | $ | 57 | ||||
Condensed_Consolidating_Financ1
Condensed Consolidating Financial Information (Tables) | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2014 | |||||||||||||||||||||
Condensed Consolidating Balance Sheet | The following table presents the condensed consolidating balance sheet information as of December 31, 2014: | ||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Assets | |||||||||||||||||||||
Investments: | |||||||||||||||||||||
Fixed maturity securities available-for-sale, at fair value | $ | — | $ | 150 | $ | 62,497 | $ | (200 | ) | $ | 62,447 | ||||||||||
Equity securities available-for-sale, at fair value | — | — | 282 | — | 282 | ||||||||||||||||
Commercial mortgage loans | — | — | 6,100 | — | 6,100 | ||||||||||||||||
Restricted commercial mortgage loans related to securitization entities | — | — | 201 | — | 201 | ||||||||||||||||
Policy loans | — | — | 1,501 | — | 1,501 | ||||||||||||||||
Other invested assets | — | 14 | 2,287 | (5 | ) | 2,296 | |||||||||||||||
Restricted other invested assets related to securitization entities, at fair value | — | — | 411 | — | 411 | ||||||||||||||||
Investments in subsidiaries | 14,895 | 15,003 | — | (29,898 | ) | — | |||||||||||||||
Total investments | 14,895 | 15,167 | 73,279 | (30,103 | ) | 73,238 | |||||||||||||||
Cash and cash equivalents | — | 953 | 3,965 | — | 4,918 | ||||||||||||||||
Accrued investment income | — | — | 689 | (4 | ) | 685 | |||||||||||||||
Deferred acquisition costs | — | — | 5,042 | — | 5,042 | ||||||||||||||||
Intangible assets | — | — | 272 | — | 272 | ||||||||||||||||
Goodwill | — | — | 16 | — | 16 | ||||||||||||||||
Reinsurance recoverable | — | — | 17,346 | — | 17,346 | ||||||||||||||||
Other assets | 2 | 207 | 425 | (1 | ) | 633 | |||||||||||||||
Intercompany notes receivable | 9 | 267 | 395 | (671 | ) | — | |||||||||||||||
Separate account assets | — | — | 9,208 | — | 9,208 | ||||||||||||||||
Total assets | $ | 14,906 | $ | 16,594 | $ | 110,637 | $ | (30,779 | ) | $ | 111,358 | ||||||||||
Liabilities and stockholders’ equity | |||||||||||||||||||||
Liabilities: | |||||||||||||||||||||
Future policy benefits | $ | — | $ | — | $ | 35,915 | $ | — | $ | 35,915 | |||||||||||
Policyholder account balances | — | — | 26,043 | — | 26,043 | ||||||||||||||||
Liability for policy and contract claims | — | — | 8,043 | — | 8,043 | ||||||||||||||||
Unearned premiums | — | — | 3,986 | — | 3,986 | ||||||||||||||||
Other liabilities | 3 | 251 | 3,361 | (11 | ) | 3,604 | |||||||||||||||
Intercompany notes payable | — | 604 | 267 | (871 | ) | — | |||||||||||||||
Borrowings related to securitization entities | — | — | 219 | — | 219 | ||||||||||||||||
Non-recourse funding obligations | — | — | 1,996 | — | 1,996 | ||||||||||||||||
Long-term borrowings | — | 4,151 | 488 | — | 4,639 | ||||||||||||||||
Deferred tax liability | (20 | ) | (970 | ) | 1,898 | — | 908 | ||||||||||||||
Separate account liabilities | — | — | 9,208 | — | 9,208 | ||||||||||||||||
Total liabilities | (17 | ) | 4,036 | 91,424 | (882 | ) | 94,561 | ||||||||||||||
Stockholders’ equity: | |||||||||||||||||||||
Common stock | 1 | — | — | — | 1 | ||||||||||||||||
Additional paid-in capital | 11,997 | 9,162 | 17,080 | (26,242 | ) | 11,997 | |||||||||||||||
Accumulated other comprehensive income (loss) | 4,446 | 4,449 | 4,459 | (8,908 | ) | 4,446 | |||||||||||||||
Retained earnings | 1,179 | (1,053 | ) | (4,205 | ) | 5,258 | 1,179 | ||||||||||||||
Treasury stock, at cost | (2,700 | ) | — | — | — | (2,700 | ) | ||||||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity | 14,923 | 12,558 | 17,334 | (29,892 | ) | 14,923 | |||||||||||||||
Noncontrolling interests | — | — | 1,879 | (5 | ) | 1,874 | |||||||||||||||
Total stockholders’ equity | 14,923 | 12,558 | 19,213 | (29,897 | ) | 16,797 | |||||||||||||||
Total liabilities and stockholders’ equity | $ | 14,906 | $ | 16,594 | $ | 110,637 | $ | (30,779 | ) | $ | 111,358 | ||||||||||
The following table presents the condensed consolidating balance sheet information as of December 31, 2013: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Assets | |||||||||||||||||||||
Investments: | |||||||||||||||||||||
Fixed maturity securities available-for-sale, at fair value | $ | — | $ | 150 | $ | 58,679 | $ | (200 | ) | $ | 58,629 | ||||||||||
Equity securities available-for-sale, at fair value | — | — | 341 | — | 341 | ||||||||||||||||
Commercial mortgage loans | — | — | 5,899 | — | 5,899 | ||||||||||||||||
Restricted commercial mortgage loans related to securitization entities | — | — | 233 | — | 233 | ||||||||||||||||
Policy loans | — | — | 1,434 | — | 1,434 | ||||||||||||||||
Other invested assets | — | 91 | 1,595 | — | 1,686 | ||||||||||||||||
Restricted other invested assets related to securitization entities, at fair value | — | — | 391 | — | 391 | ||||||||||||||||
Investments in subsidiaries | 14,358 | 14,929 | — | (29,287 | ) | — | |||||||||||||||
Total investments | 14,358 | 15,170 | 68,572 | (29,487 | ) | 68,613 | |||||||||||||||
Cash and cash equivalents | — | 1,219 | 2,995 | — | 4,214 | ||||||||||||||||
Accrued investment income | — | — | 682 | (4 | ) | 678 | |||||||||||||||
Deferred acquisition costs | — | — | 5,278 | — | 5,278 | ||||||||||||||||
Intangible assets | — | — | 399 | — | 399 | ||||||||||||||||
Goodwill | — | — | 867 | — | 867 | ||||||||||||||||
Reinsurance recoverable | — | — | 17,219 | — | 17,219 | ||||||||||||||||
Other assets | (2 | ) | 276 | 367 | (2 | ) | 639 | ||||||||||||||
Intercompany notes receivable | 8 | 248 | 393 | (649 | ) | — | |||||||||||||||
Separate account assets | — | — | 10,138 | — | 10,138 | ||||||||||||||||
Total assets | $ | 14,364 | $ | 16,913 | $ | 106,910 | $ | (30,142 | ) | $ | 108,045 | ||||||||||
Liabilities and stockholders’ equity | |||||||||||||||||||||
Liabilities: | |||||||||||||||||||||
Future policy benefits | $ | — | $ | — | $ | 33,705 | $ | — | $ | 33,705 | |||||||||||
Policyholder account balances | — | — | 25,528 | — | 25,528 | ||||||||||||||||
Liability for policy and contract claims | — | — | 7,204 | — | 7,204 | ||||||||||||||||
Unearned premiums | — | — | 4,107 | — | 4,107 | ||||||||||||||||
Other liabilities | (3 | ) | 365 | 3,739 | (5 | ) | 4,096 | ||||||||||||||
Intercompany notes payable | — | 601 | 248 | (849 | ) | — | |||||||||||||||
Borrowings related to securitization entities | — | — | 242 | — | 242 | ||||||||||||||||
Non-recourse funding obligations | — | — | 2,038 | — | 2,038 | ||||||||||||||||
Long-term borrowings | — | 4,636 | 525 | — | 5,161 | ||||||||||||||||
Deferred tax liability | (26 | ) | (796 | ) | 1,028 | — | 206 | ||||||||||||||
Separate account liabilities | — | — | 10,138 | — | 10,138 | ||||||||||||||||
Total liabilities | (29 | ) | 4,806 | 88,502 | (854 | ) | 92,425 | ||||||||||||||
Stockholders’ equity: | |||||||||||||||||||||
Common stock | 1 | — | — | — | 1 | ||||||||||||||||
Additional paid-in capital | 12,127 | 9,297 | 17,215 | (26,512 | ) | 12,127 | |||||||||||||||
Accumulated other comprehensive income (loss) | 2,542 | 2,507 | 2,512 | (5,019 | ) | 2,542 | |||||||||||||||
Retained earnings | 2,423 | 303 | (2,551 | ) | 2,248 | 2,423 | |||||||||||||||
Treasury stock, at cost | (2,700 | ) | — | — | — | (2,700 | ) | ||||||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity | 14,393 | 12,107 | 17,176 | (29,283 | ) | 14,393 | |||||||||||||||
Noncontrolling interests | — | — | 1,232 | (5 | ) | 1,227 | |||||||||||||||
Total stockholders’ equity | 14,393 | 12,107 | 18,408 | (29,288 | ) | 15,620 | |||||||||||||||
Total liabilities and stockholders’ equity | $ | 14,364 | $ | 16,913 | $ | 106,910 | $ | (30,142 | ) | $ | 108,045 | ||||||||||
Condensed Consolidating Income Statement | The following table presents the condensed consolidating income statement information for the year ended December 31, 2014: | ||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||
Premiums | $ | — | $ | — | $ | 5,431 | $ | — | $ | 5,431 | |||||||||||
Net investment income | (2 | ) | — | 3,259 | (15 | ) | 3,242 | ||||||||||||||
Net investment gains (losses) | — | 4 | (24 | ) | — | (20 | ) | ||||||||||||||
Insurance and investment product fees and other | — | (4 | ) | 917 | (1 | ) | 912 | ||||||||||||||
Total revenues | (2 | ) | — | 9,583 | (16 | ) | 9,565 | ||||||||||||||
Benefits and expenses: | |||||||||||||||||||||
Benefits and other changes in policy reserves | — | — | 6,620 | — | 6,620 | ||||||||||||||||
Interest credited | — | — | 737 | — | 737 | ||||||||||||||||
Acquisition and operating expenses, net of deferrals | 21 | — | 1,564 | — | 1,585 | ||||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 571 | — | 571 | ||||||||||||||||
Goodwill impairment | — | — | 849 | — | 849 | ||||||||||||||||
Interest expense | — | 321 | 174 | (16 | ) | 479 | |||||||||||||||
Total benefits and expenses | 21 | 321 | 10,515 | (16 | ) | 10,841 | |||||||||||||||
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries | (23 | ) | (321 | ) | (932 | ) | — | (1,276 | ) | ||||||||||||
Provision (benefit) for income taxes | (8 | ) | (112 | ) | (104 | ) | (4 | ) | (228 | ) | |||||||||||
Equity in income (loss) of subsidiaries | (1,229 | ) | (1,147 | ) | — | 2,376 | — | ||||||||||||||
Income (loss) from continuing operations | (1,244 | ) | (1,356 | ) | (828 | ) | 2,380 | (1,048 | ) | ||||||||||||
Income from discontinued operations, net of taxes | — | — | — | — | — | ||||||||||||||||
Net income (loss) | (1,244 | ) | (1,356 | ) | (828 | ) | 2,380 | (1,048 | ) | ||||||||||||
Less: net income attributable to noncontrolling interests | — | — | 196 | — | 196 | ||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (1,244 | ) | $ | (1,356 | ) | $ | (1,024 | ) | $ | 2,380 | $ | (1,244 | ) | |||||||
The following table presents the condensed consolidating income statement information for the year ended December 31, 2013: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||
Premiums | $ | — | $ | — | $ | 5,148 | $ | — | $ | 5,148 | |||||||||||
Net investment income | (1 | ) | 1 | 3,286 | (15 | ) | 3,271 | ||||||||||||||
Net investment gains (losses) | — | 6 | (43 | ) | — | (37 | ) | ||||||||||||||
Insurance and investment product fees and other | — | — | 1,025 | (4 | ) | 1,021 | |||||||||||||||
Total revenues | (1 | ) | 7 | 9,416 | (19 | ) | 9,403 | ||||||||||||||
Benefits and expenses: | |||||||||||||||||||||
Benefits and other changes in policy reserves | — | — | 4,895 | — | 4,895 | ||||||||||||||||
Interest credited | — | — | 738 | — | 738 | ||||||||||||||||
Acquisition and operating expenses, net of deferrals | 33 | 32 | 1,594 | — | 1,659 | ||||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 569 | — | 569 | ||||||||||||||||
Interest expense | — | 322 | 189 | (19 | ) | 492 | |||||||||||||||
Total benefits and expenses | 33 | 354 | 7,985 | (19 | ) | 8,353 | |||||||||||||||
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries | (34 | ) | (347 | ) | 1,431 | — | 1,050 | ||||||||||||||
Provision (benefit) for income taxes | 13 | (120 | ) | 431 | — | 324 | |||||||||||||||
Equity in income of subsidiaries | 607 | 796 | — | (1,403 | ) | — | |||||||||||||||
Income from continuing operations | 560 | 569 | 1,000 | (1,403 | ) | 726 | |||||||||||||||
Income (loss) from discontinued operations, net of taxes | — | (29 | ) | 17 | — | (12 | ) | ||||||||||||||
Net income | 560 | 540 | 1,017 | (1,403 | ) | 714 | |||||||||||||||
Less: net income attributable to noncontrolling interests | — | — | 154 | — | 154 | ||||||||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders | $ | 560 | $ | 540 | $ | 863 | $ | (1,403 | ) | $ | 560 | ||||||||||
The following table presents the condensed consolidating income statement information for the year ended December 31, 2012: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||
Premiums | $ | — | $ | — | $ | 5,041 | $ | — | $ | 5,041 | |||||||||||
Net investment income | — | 1 | 3,357 | (15 | ) | 3,343 | |||||||||||||||
Net investment gains (losses) | — | (29 | ) | 56 | — | 27 | |||||||||||||||
Insurance and investment product fees and other | — | (1 | ) | 1,234 | (4 | ) | 1,229 | ||||||||||||||
Total revenues | — | (29 | ) | 9,688 | (19 | ) | 9,640 | ||||||||||||||
Benefits and expenses: | |||||||||||||||||||||
Benefits and other changes in policy reserves | — | — | 5,378 | — | 5,378 | ||||||||||||||||
Interest credited | — | — | 775 | — | 775 | ||||||||||||||||
Acquisition and operating expenses, net of deferrals | 7 | 8 | 1,579 | — | 1,594 | ||||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 722 | — | 722 | ||||||||||||||||
Goodwill impairment | — | — | 89 | — | 89 | ||||||||||||||||
Interest expense | — | 315 | 179 | (18 | ) | 476 | |||||||||||||||
Total benefits and expenses | 7 | 323 | 8,722 | (18 | ) | 9,034 | |||||||||||||||
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries | (7 | ) | (352 | ) | 966 | (1 | ) | 606 | |||||||||||||
Provision (benefit) for income taxes | (3 | ) | (110 | ) | 251 | — | 138 | ||||||||||||||
Equity in income (loss) of subsidiaries | 329 | 636 | (38 | ) | (927 | ) | — | ||||||||||||||
Income from continuing operations | 325 | 394 | 677 | (928 | ) | 468 | |||||||||||||||
Income from discontinued operations, net of taxes | — | — | 57 | — | 57 | ||||||||||||||||
Net income | 325 | 394 | 734 | (928 | ) | 525 | |||||||||||||||
Less: net income attributable to noncontrolling interests | — | — | 200 | — | 200 | ||||||||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders | $ | 325 | $ | 394 | $ | 534 | $ | (928 | ) | $ | 325 | ||||||||||
Condensed Consolidating Statement of Comprehensive Income | The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2014: | ||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Net income (loss) | $ | (1,244 | ) | $ | (1,356 | ) | $ | (828 | ) | $ | 2,380 | $ | (1,048 | ) | |||||||
Other comprehensive income (loss), net of taxes: | |||||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,539 | 1,510 | 1,573 | (3,049 | ) | 1,573 | |||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 10 | 11 | 10 | (21 | ) | 10 | |||||||||||||||
Derivatives qualifying as hedges | 751 | 751 | 794 | (1,545 | ) | 751 | |||||||||||||||
Foreign currency translation and other adjustments | (339 | ) | (273 | ) | (537 | ) | 612 | (537 | ) | ||||||||||||
Total other comprehensive income (loss) | 1,961 | 1,999 | 1,840 | (4,003 | ) | 1,797 | |||||||||||||||
Total comprehensive income (loss) | 717 | 643 | 1,012 | (1,623 | ) | 749 | |||||||||||||||
Less: comprehensive income attributable to noncontrolling interests | — | — | 32 | — | 32 | ||||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | 717 | $ | 643 | $ | 980 | $ | (1,623 | ) | $ | 717 | ||||||||||
The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2013: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Net income | $ | 560 | $ | 540 | $ | 1,017 | $ | (1,403 | ) | $ | 714 | ||||||||||
Other comprehensive income (loss), net of taxes: | |||||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | (1,778 | ) | (1,733 | ) | (1,817 | ) | 3,511 | (1,817 | ) | ||||||||||||
Net unrealized gains (losses) on other-than- temporarily impaired securities | 66 | 65 | 66 | (131 | ) | 66 | |||||||||||||||
Derivatives qualifying as hedges | (590 | ) | (590 | ) | (615 | ) | 1,205 | (590 | ) | ||||||||||||
Foreign currency translation and other adjustments | (358 | ) | (335 | ) | (442 | ) | 693 | (442 | ) | ||||||||||||
Total other comprehensive income (loss) | (2,660 | ) | (2,593 | ) | (2,808 | ) | 5,278 | (2,783 | ) | ||||||||||||
Total comprehensive income (loss) | (2,100 | ) | (2,053 | ) | (1,791 | ) | 3,875 | (2,069 | ) | ||||||||||||
Less: comprehensive income attributable to noncontrolling interests | — | — | 31 | — | 31 | ||||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (2,100 | ) | $ | (2,053 | ) | $ | (1,822 | ) | $ | 3,875 | $ | (2,100 | ) | |||||||
The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2012: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Net income | $ | 325 | $ | 394 | $ | 734 | $ | (928 | ) | $ | 525 | ||||||||||
Other comprehensive income (loss), net of taxes: | |||||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,075 | 1,046 | 1,078 | (2,121 | ) | 1,078 | |||||||||||||||
Net unrealized gains (losses) on other-than- temporarily impaired securities | 78 | 78 | 78 | (156 | ) | 78 | |||||||||||||||
Derivatives qualifying as hedges | (100 | ) | (100 | ) | (98 | ) | 198 | (100 | ) | ||||||||||||
Foreign currency translation and other adjustments | 102 | 81 | 126 | (183 | ) | 126 | |||||||||||||||
Total other comprehensive income (loss) | 1,155 | 1,105 | 1,184 | (2,262 | ) | 1,182 | |||||||||||||||
Total comprehensive income (loss) | 1,480 | 1,499 | 1,918 | (3,190 | ) | 1,707 | |||||||||||||||
Less: comprehensive income attributable to noncontrolling interests | — | — | 227 | — | 227 | ||||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | 1,480 | $ | 1,499 | $ | 1,691 | $ | (3,190 | ) | $ | 1,480 | ||||||||||
Condensed Consolidating Statement of Cash Flows | The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2014: | ||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||
Net income (loss) | $ | (1,244 | ) | $ | (1,356 | ) | $ | (828 | ) | $ | 2,380 | $ | (1,048 | ) | |||||||
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||||||||||||||||||||
Equity in (income) loss from subsidiaries | 1,229 | 1,147 | — | (2,376 | ) | — | |||||||||||||||
Dividends from subsidiaries | — | 630 | (630 | ) | — | — | |||||||||||||||
Amortization of fixed maturity discounts and premiums and limited partnerships | — | — | (97 | ) | — | (97 | ) | ||||||||||||||
Net investment losses (gains) | — | (4 | ) | 24 | — | 20 | |||||||||||||||
Charges assessed to policyholders | — | — | (777 | ) | — | (777 | ) | ||||||||||||||
Acquisition costs deferred | — | — | (473 | ) | — | (473 | ) | ||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 571 | — | 571 | ||||||||||||||||
Goodwill impairment | — | — | 849 | — | 849 | ||||||||||||||||
Deferred income taxes | 4 | (146 | ) | (341 | ) | (4 | ) | (487 | ) | ||||||||||||
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | — | 1 | 205 | — | 206 | ||||||||||||||||
Stock-based compensation expense | 21 | — | 9 | — | 30 | ||||||||||||||||
Change in certain assets and liabilities: | |||||||||||||||||||||
Accrued investment income and other assets | (4 | ) | (9 | ) | (117 | ) | 1 | (129 | ) | ||||||||||||
Insurance reserves | — | — | 3,212 | — | 3,212 | ||||||||||||||||
Current tax liabilities | (2 | ) | (77 | ) | (101 | ) | — | (180 | ) | ||||||||||||
Other liabilities, policy and contract claims and other policy-related balances | 11 | 91 | 645 | (6 | ) | 741 | |||||||||||||||
Net cash from operating activities | 15 | 277 | 2,151 | (5 | ) | 2,438 | |||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||
Proceeds from maturities and repayments of investments: | |||||||||||||||||||||
Fixed maturity securities | — | 150 | 5,214 | — | 5,364 | ||||||||||||||||
Commercial mortgage loans | — | — | 765 | — | 765 | ||||||||||||||||
Restricted commercial mortgage loans related to securitization entities | — | — | 32 | — | 32 | ||||||||||||||||
Proceeds from sales of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | — | 2,490 | — | 2,490 | ||||||||||||||||
Purchases and originations of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | (150 | ) | (9,342 | ) | — | (9,492 | ) | |||||||||||||
Commercial mortgage loans | — | — | (967 | ) | — | (967 | ) | ||||||||||||||
Other invested assets, net | — | — | (45 | ) | 5 | (40 | ) | ||||||||||||||
Policy loans, net | — | — | 12 | — | 12 | ||||||||||||||||
Intercompany notes receivable | (1 | ) | (19 | ) | (2 | ) | 22 | — | |||||||||||||
Capital contributions to subsidiaries | (12 | ) | — | 12 | — | — | |||||||||||||||
Net cash from investing activities | (13 | ) | (19 | ) | (1,831 | ) | 27 | (1,836 | ) | ||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||
Deposits to universal life and investment contracts | — | — | 2,993 | — | 2,993 | ||||||||||||||||
Withdrawals from universal life and investment contracts | — | — | (2,588 | ) | — | (2,588 | ) | ||||||||||||||
Redemption and repurchase of non-recourse funding obligations | — | — | (42 | ) | — | (42 | ) | ||||||||||||||
Proceeds from the issuance of long-term debt | — | — | 144 | — | 144 | ||||||||||||||||
Repayment and repurchase of long-term debt | — | (485 | ) | (136 | ) | — | (621 | ) | |||||||||||||
Repayment of borrowings related to securitization entities | — | — | (32 | ) | — | (32 | ) | ||||||||||||||
Proceeds from intercompany notes payable | — | 3 | 19 | (22 | ) | — | |||||||||||||||
Repurchase of subsidiary shares | — | — | (28 | ) | — | (28 | ) | ||||||||||||||
Dividends paid to noncontrolling interests | — | — | (75 | ) | — | (75 | ) | ||||||||||||||
Dividends paid to parent | — | — | — | — | — | ||||||||||||||||
Proceeds from the sale of subsidiary shares to noncontrolling interests | — | — | 517 | — | 517 | ||||||||||||||||
Other, net | (2 | ) | (42 | ) | (19 | ) | — | (63 | ) | ||||||||||||
Net cash from financing activities | (2 | ) | (524 | ) | 753 | (22 | ) | 205 | |||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | (103 | ) | — | (103 | ) | ||||||||||||||
Net change in cash and cash equivalents | — | (266 | ) | 970 | — | 704 | |||||||||||||||
Cash and cash equivalents at beginning of period | — | 1,219 | 2,995 | — | 4,214 | ||||||||||||||||
Cash and cash equivalents at end of period | $ | — | $ | 953 | $ | 3,965 | $ | — | $ | 4,918 | |||||||||||
The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2013: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||
Net income | $ | 560 | $ | 540 | $ | 1,017 | $ | (1,403 | ) | $ | 714 | ||||||||||
Less (income) loss from discontinued operations, net of taxes | — | 29 | (17 | ) | — | 12 | |||||||||||||||
Adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||
Equity in earnings from subsidiaries | (607 | ) | (796 | ) | — | 1,403 | — | ||||||||||||||
Dividends from subsidiaries | 535 | 376 | (497 | ) | (414 | ) | — | ||||||||||||||
Amortization of fixed maturity discounts and premiums and limited partnerships | — | — | (97 | ) | — | (97 | ) | ||||||||||||||
Net investment losses (gains) | — | (6 | ) | 43 | — | 37 | |||||||||||||||
Charges assessed to policyholders | — | — | (812 | ) | — | (812 | ) | ||||||||||||||
Acquisition costs deferred | — | — | (457 | ) | — | (457 | ) | ||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 569 | — | 569 | ||||||||||||||||
Deferred income taxes | 24 | (138 | ) | 35 | — | (79 | ) | ||||||||||||||
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | — | 1 | (60 | ) | — | (59 | ) | ||||||||||||||
Stock-based compensation expense | 26 | — | 15 | — | 41 | ||||||||||||||||
Change in certain assets and liabilities: | |||||||||||||||||||||
Accrued investment income and other assets | 2 | 67 | (112 | ) | — | (43 | ) | ||||||||||||||
Insurance reserves | — | — | 2,256 | — | 2,256 | ||||||||||||||||
Current tax liabilities | 3 | 45 | 240 | — | 288 | ||||||||||||||||
Other liabilities, policy and contract claims and other policy-related balances | (4 | ) | (11 | ) | (1,024 | ) | — | (1,039 | ) | ||||||||||||
Cash from operating activities—discontinued operations | — | — | 68 | — | 68 | ||||||||||||||||
Net cash from operating activities | 539 | 107 | 1,167 | (414 | ) | 1,399 | |||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||
Proceeds from maturities and repayments of investments: | |||||||||||||||||||||
Fixed maturity securities | — | — | 5,040 | — | 5,040 | ||||||||||||||||
Commercial mortgage loans | — | — | 896 | — | 896 | ||||||||||||||||
Restricted commercial mortgage loans related to securitization entities | — | — | 60 | — | 60 | ||||||||||||||||
Proceeds from sales of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | 150 | 4,286 | — | 4,436 | ||||||||||||||||
Purchases and originations of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | (150 | ) | (10,655 | ) | — | (10,805 | ) | |||||||||||||
Commercial mortgage loans | — | — | (873 | ) | — | (873 | ) | ||||||||||||||
Other invested assets, net | — | — | 89 | — | 89 | ||||||||||||||||
Policy loans, net | — | — | 242 | — | 242 | ||||||||||||||||
Intercompany notes receivable | (8 | ) | (3 | ) | 95 | (84 | ) | — | |||||||||||||
Capital contributions to subsidiaries | (531 | ) | (1 | ) | 532 | — | — | ||||||||||||||
Proceeds from sale of a subsidiary, net of cash transferred | — | 425 | (60 | ) | — | 365 | |||||||||||||||
Cash from investing activities—discontinued operations | — | (30 | ) | — | — | (30 | ) | ||||||||||||||
Net cash from investing activities | (539 | ) | 391 | (348 | ) | (84 | ) | (580 | ) | ||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||
Deposits to universal life and investment contracts | — | — | 2,999 | — | 2,999 | ||||||||||||||||
Withdrawals from universal life and investment contracts | — | — | (3,269 | ) | — | (3,269 | ) | ||||||||||||||
Redemption and repurchase of non-recourse funding obligations | — | — | (28 | ) | — | (28 | ) | ||||||||||||||
Proceeds from the issuance of long-term debt | — | 793 | — | — | 793 | ||||||||||||||||
Repayment and repurchase of long-term debt | — | (365 | ) | — | — | (365 | ) | ||||||||||||||
Repayment of borrowings related to securitization entities | — | — | (108 | ) | — | (108 | ) | ||||||||||||||
Proceeds from intercompany notes payable | — | (87 | ) | 3 | 84 | — | |||||||||||||||
Repurchase of subsidiary shares | — | — | (43 | ) | — | (43 | ) | ||||||||||||||
Dividends paid to noncontrolling interests | — | — | (52 | ) | — | (52 | ) | ||||||||||||||
Dividends paid to parent | — | (414 | ) | — | 414 | — | |||||||||||||||
Other, net | — | (49 | ) | (24 | ) | — | (73 | ) | |||||||||||||
Cash from financing activities—discontinued operations | — | — | (3 | ) | — | (3 | ) | ||||||||||||||
Net cash from financing activities | — | (122 | ) | (525 | ) | 498 | (149 | ) | |||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | (109 | ) | — | (109 | ) | ||||||||||||||
Net change in cash and cash equivalents | — | 376 | 185 | — | 561 | ||||||||||||||||
Cash and cash equivalents at beginning of period | — | 843 | 2,810 | — | 3,653 | ||||||||||||||||
Cash and cash equivalents at end of period | — | 1,219 | 2,995 | — | 4,214 | ||||||||||||||||
Less cash and cash equivalents of discontinued operations at end of period | — | — | — | — | — | ||||||||||||||||
Cash and cash equivalents of continuing operations at end of period | $ | — | $ | 1,219 | $ | 2,995 | $ | — | $ | 4,214 | |||||||||||
The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2012: | |||||||||||||||||||||
(Amounts in millions) | Parent | Issuer | All Other | Eliminations | Consolidated | ||||||||||||||||
Guarantor | Subsidiaries | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||
Net income | $ | 325 | $ | 394 | $ | 734 | $ | (928 | ) | $ | 525 | ||||||||||
Less income from discontinued operations, net of taxes | — | — | (57 | ) | — | (57 | ) | ||||||||||||||
Adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||
Equity in (income) loss from subsidiaries | (329 | ) | (636 | ) | 38 | 927 | — | ||||||||||||||
Dividends from subsidiaries | — | 545 | (545 | ) | — | — | |||||||||||||||
Amortization of fixed maturity discounts and premiums and limited partnerships | — | — | (88 | ) | — | (88 | ) | ||||||||||||||
Net investment losses (gains) | — | 29 | (56 | ) | — | (27 | ) | ||||||||||||||
Charges assessed to policyholders | — | — | (801 | ) | — | (801 | ) | ||||||||||||||
Acquisition costs deferred | — | — | (611 | ) | — | (611 | ) | ||||||||||||||
Amortization of deferred acquisition costs and intangibles | — | — | 722 | — | 722 | ||||||||||||||||
Goodwill impairment | — | — | 89 | — | 89 | ||||||||||||||||
Deferred income taxes | (3 | ) | (274 | ) | 359 | — | 82 | ||||||||||||||
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | — | (27 | ) | 218 | — | 191 | |||||||||||||||
Stock-based compensation expense | 7 | 16 | 3 | — | 26 | ||||||||||||||||
Change in certain assets and liabilities: | |||||||||||||||||||||
Accrued investment income and other assets | — | 53 | (122 | ) | 1 | (68 | ) | ||||||||||||||
Insurance reserves | — | — | 2,330 | — | 2,330 | ||||||||||||||||
Current tax liabilities | — | (43 | ) | (191 | ) | — | (234 | ) | |||||||||||||
Other liabilities, policy and contract claims and other policy-related balances | — | 10 | (1,181 | ) | 5 | (1,166 | ) | ||||||||||||||
Cash from operating activities—discontinued operations | — | — | 49 | — | 49 | ||||||||||||||||
Net cash from operating activities | — | 67 | 890 | 5 | 962 | ||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||
Proceeds from maturities and repayments of investments: | |||||||||||||||||||||
Fixed maturity securities | — | — | 5,176 | — | 5,176 | ||||||||||||||||
Commercial mortgage loans | — | — | 891 | — | 891 | ||||||||||||||||
Restricted commercial mortgage loans related to securitization entities | — | — | 67 | — | 67 | ||||||||||||||||
Proceeds from sales of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | 10 | 5,725 | — | 5,735 | ||||||||||||||||
Purchases and originations of investments: | |||||||||||||||||||||
Fixed maturity and equity securities | — | (150 | ) | (12,172 | ) | — | (12,322 | ) | |||||||||||||
Commercial mortgage loans | — | — | (692 | ) | — | (692 | ) | ||||||||||||||
Other invested assets, net | — | 30 | 391 | (5 | ) | 416 | |||||||||||||||
Policy loans, net | — | — | (29 | ) | — | (29 | ) | ||||||||||||||
Intercompany notes receivable | — | (31 | ) | (58 | ) | 89 | — | ||||||||||||||
Capital contributions to subsidiaries | — | (20 | ) | 20 | — | — | |||||||||||||||
Proceeds from sale of a subsidiary, net of cash transferred | — | — | 77 | — | 77 | ||||||||||||||||
Cash from investing activities—discontinued operations | — | (18 | ) | (23 | ) | — | (41 | ) | |||||||||||||
Net cash from investing activities | — | (179 | ) | (627 | ) | 84 | (722 | ) | |||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||
Deposits to universal life and investment contracts | — | — | 2,810 | — | 2,810 | ||||||||||||||||
Withdrawals from universal life and investment contracts | — | — | (2,781 | ) | — | (2,781 | ) | ||||||||||||||
Redemption and repurchase of non-recourse funding obligations | — | — | (1,056 | ) | — | (1,056 | ) | ||||||||||||||
Proceeds from the issuance of long-term debt | — | 361 | — | — | 361 | ||||||||||||||||
Repayment and repurchase of long-term debt | — | (322 | ) | — | — | (322 | ) | ||||||||||||||
Repayment of borrowings related to securitization entities | — | — | (72 | ) | — | (72 | ) | ||||||||||||||
Proceeds from intercompany notes payable | — | 58 | 31 | (89 | ) | — | |||||||||||||||
Dividends paid to noncontrolling interests | — | — | (50 | ) | — | (50 | ) | ||||||||||||||
Other, net | — | (49 | ) | 103 | — | 54 | |||||||||||||||
Cash from financing activities—discontinued operations | — | — | (45 | ) | — | (45 | ) | ||||||||||||||
Net cash from financing activities | — | 48 | (1,060 | ) | (89 | ) | (1,101 | ) | |||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | — | 26 | — | 26 | ||||||||||||||||
Net change in cash and cash equivalents | — | (64 | ) | (771 | ) | — | (835 | ) | |||||||||||||
Cash and cash equivalents at beginning of period | — | 907 | 3,581 | — | 4,488 | ||||||||||||||||
Cash and cash equivalents at end of period | — | 843 | 2,810 | — | 3,653 | ||||||||||||||||
Less cash and cash equivalents of discontinued operations at end of period | — | — | 21 | — | 21 | ||||||||||||||||
Cash and cash equivalents of continuing operations at end of period | $ | — | $ | 843 | $ | 2,789 | $ | — | $ | 3,632 | |||||||||||
Formation_of_Genworth_and_Basi
Formation of Genworth and Basis of Presentation - Additional Information (Detail) (Genworth Holdings) | Apr. 02, 2013 |
Genworth Holdings | |
Percentage of subsidiary equity ownership | 100.00% |
Summary_of_Significant_Account2
Summary of Significant Accounting Policies - Additional Information (Detail) (USD $) | 12 Months Ended | ||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||
Accounting Policies [Abstract] | |||||
Equity securities, impairment charge recognition within number of months | 18 months | ||||
Non-accrual status of loans after number of days past due | 90 days | ||||
Repurchase agreements, fair value of securities pledged | $592 | $890 | |||
Repurchase agreements, fair value of repurchase obligation | 553 | 919 | |||
Cash equivalents determination for original maturities of investments, maximum number of days | 90 days | ||||
Short-term investments determination for original maturities of investments, minimum number of days | 90 days | ||||
Unearned premiums, increase in earned premiums due to updated premium recognition factors for international mortgage insurance business | 6 | 12 | 36 | ||
Subject to enforceable master netting arrangement | |||||
Accounting Policies [Abstract] | |||||
Fair value of non-cash collateral received | 884 | 199 | |||
Derivative assets | Non-cash | |||||
Accounting Policies [Abstract] | |||||
Fair value of non-cash collateral received | 287 | 70 | |||
Derivative assets | Subject to enforceable master netting arrangement | |||||
Accounting Policies [Abstract] | |||||
Fair value of non-cash collateral received | 884 | [1] | 199 | [1] | |
Derivative liabilities | Subject to enforceable master netting arrangement | |||||
Accounting Policies [Abstract] | |||||
Fair value of non-cash collateral pledged | 49 | [2] | 394 | [2] | |
United States | |||||
Accounting Policies [Abstract] | |||||
Cash and government securities collateral, minimum amount of the fair value of the applicable securities loaned | 102.00% | ||||
Securities lending activity, fair value of securities loaned | 288 | 191 | |||
Securities lending activity, fair value of collateral held | 289 | 187 | |||
Securities lending activity, obligation to return collateral | 299 | 199 | |||
Canada | |||||
Accounting Policies [Abstract] | |||||
Cash and government securities collateral, minimum amount of the fair value of the applicable securities loaned | 105.00% | ||||
Securities lending activity, fair value of securities loaned | $371 | $229 | |||
[1] | Included $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2014 and 2013. | ||||
[2] | Included $6 million and $7 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2014 and 2013, respectively. |
Earnings_Loss_Per_Share_Detail
Earnings (Loss) Per Share (Detail) (USD $) | 3 Months Ended | 12 Months Ended | ||||||||||||||||
In Millions, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||||||
Earnings (Loss) Per Share [Abstract] | ||||||||||||||||||
Weighted-average common shares used in basic earnings (loss) per common share calculations | 496.7 | 496.6 | 496.6 | 495.8 | 494.7 | 494 | 493.4 | 492.5 | 496.4 | 493.6 | 491.6 | |||||||
Stock options, restricted stock units and stock appreciation rights | 0 | 5.1 | 2.8 | |||||||||||||||
Weighted-average common shares used in diluted earnings (loss) per common share calculations | 496.7 | [1] | 496.6 | [1] | 503.6 | [1] | 502.7 | [1] | 501.2 | 499.3 | 497.5 | 496.8 | 496.4 | [2] | 498.7 | [2] | 494.4 | [2] |
Income (loss) from continuing operations: | ||||||||||||||||||
Income (loss) from continuing operations | ($708) | [3] | ($787) | [3] | $228 | [3] | $219 | [3] | $245 | $146 | $174 | $161 | ($1,048) | $726 | $468 | |||
Less: income from continuing operations attributable to noncontrolling interests | 196 | 154 | 200 | |||||||||||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders | -1,244 | 572 | 268 | |||||||||||||||
Basic per common share | ($1.53) | ($1.70) | $0.35 | $0.37 | $0.42 | $0.21 | $0.27 | $0.25 | ($2.51) | $1.16 | $0.55 | |||||||
Diluted per common share | ($1.53) | ($1.70) | $0.35 | $0.37 | $0.42 | $0.21 | $0.27 | $0.25 | ($2.51) | $1.15 | $0.54 | |||||||
Income (loss) from discontinued operations: | ||||||||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | 2 | 6 | -20 | 0 | -12 | 57 | |||||||||||
Less: income from discontinued operations, net of taxes, attributable to noncontrolling interests | 0 | 0 | 0 | |||||||||||||||
Income (loss) from discontinued operations, net of taxes, available to Genworth Financial, Inc.'s common stockholders | 0 | -12 | 57 | |||||||||||||||
Basic per common share | $0 | ($0.02) | $0.12 | |||||||||||||||
Diluted per common share | $0 | ($0.02) | $0.12 | |||||||||||||||
Net income (loss): | ||||||||||||||||||
Income (loss) from continuing operations | -708 | [3] | -787 | [3] | 228 | [3] | 219 | [3] | 245 | 146 | 174 | 161 | -1,048 | 726 | 468 | |||
Income (loss) from discontinued operations, net of taxes | 0 | 2 | 6 | -20 | 0 | -12 | 57 | |||||||||||
Net income (loss) | -708 | [3] | -787 | [3] | 228 | [3] | 219 | [3] | 245 | 148 | 180 | 141 | -1,048 | 714 | 525 | |||
Less: net income attributable to noncontrolling interests | 52 | 57 | 52 | 35 | 37 | 40 | 39 | 38 | 196 | 154 | 200 | |||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | ($760) | [3] | ($844) | [3] | $176 | [3] | $184 | [3] | $208 | $108 | $141 | $103 | ($1,244) | $560 | $325 | |||
Basic per common share | ($1.53) | ($1.70) | $0.35 | $0.37 | $0.42 | $0.22 | $0.29 | $0.21 | ($2.51) | $1.13 | $0.66 | |||||||
Diluted per common share | ($1.53) | ($1.70) | $0.35 | $0.37 | $0.41 | $0.22 | $0.28 | $0.21 | ($2.51) | $1.12 | $0.66 | |||||||
[1] | Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2014 and December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2014 and December 31, 2014, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.4 million and 3.2 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2014 and December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million and 499.9 million, respectively. | |||||||||||||||||
[2] | Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the year ended December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the year ended December 31, 2014, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.6 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the year ended December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million. | |||||||||||||||||
[3] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. |
Earnings_Loss_Per_Share_Parent
Earnings (Loss) Per Share (Parenthetical) (Detail) | 3 Months Ended | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Dec. 31, 2014 |
Earnings Per Share Disclosure [Line Items] | |||
Weighted-average diluted common shares outstanding, antidilutive securities (stock options, RSUs and SARs) | 3.2 | 5.4 | 5.6 |
Weighted-average number of diluted shares if not in a loss position | 499.9 | 502 | 502 |
Net_Investment_Income_Detail
Net Investment Income (Detail) (USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | $3,336 | $3,364 | $3,433 | |||
Expenses and fees | -94 | -93 | -90 | |||
Net investment income | 3,242 | 3,271 | 3,343 | |||
Fixed maturity securities - taxable | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | 2,631 | 2,642 | 2,666 | |||
Fixed maturity securities - non-taxable | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | 12 | 9 | 11 | |||
Commercial mortgage loans | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | 333 | 335 | 340 | |||
Restricted commercial mortgage loans related to securitization entities | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | 14 | [1] | 23 | [1] | 32 | [1] |
Equity Securities | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | 14 | 17 | 19 | |||
Other invested assets | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | 174 | [2] | 185 | [2] | 206 | [2] |
Restricted other invested assets related to securitization entities | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | 5 | [1] | 4 | [1] | 1 | [1] |
Policy Loans | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | 129 | 129 | 123 | |||
Cash, cash equivalents and short-term investments | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | $24 | $20 | $35 | |||
[1] | See note 18 for additional information related to consolidated securitization entities. | |||||
[2] | Included in other invested assets was $8 million, $13 million and $21 million of net investment income related to trading securities for the years ended December 31, 2014, 2013 and 2012, respectively. |
Net_Investment_Income_Parenthe
Net Investment Income (Parenthetical) (Detail) (USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | $3,336 | $3,364 | $3,433 | |||
Other invested assets | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | 174 | [1] | 185 | [1] | 206 | [1] |
Other invested assets | Trading Securities | ||||||
Net Investment Income [Line Items] | ||||||
Gross investment income before expenses and fees | $8 | $13 | $21 | |||
[1] | Included in other invested assets was $8 million, $13 million and $21 million of net investment income related to trading securities for the years ended December 31, 2014, 2013 and 2012, respectively. |
Net_Investment_Gains_Losses_De
Net Investment Gains (Losses) (Detail) (USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Investments [Abstract] | ||||||
Realized gains | $74 | $176 | $172 | |||
Realized losses | -46 | -184 | -143 | |||
Net realized gains (losses) on available-for-sale securities | 28 | -8 | 29 | |||
Total other-than-temporary impairments | -9 | -16 | -62 | |||
Portion of other-than-temporary impairments included in other comprehensive income (loss) | 0 | -9 | -44 | |||
Net other-than-temporary impairments | -9 | -25 | -106 | |||
Trading securities | 39 | -23 | 21 | |||
Commercial mortgage loans | 11 | 4 | 4 | |||
Net gains (losses) related to securitization entities | 16 | [1] | 69 | [1] | 81 | [1] |
Derivative instruments | -103 | [2] | -49 | [2] | 4 | [2] |
Contingent consideration adjustment | -2 | 0 | -6 | |||
Other | 0 | -5 | 0 | |||
Net investment gains (losses) | ($20) | ($37) | $27 | |||
[1] | See note 18 for additional information related to consolidated securitization entities. | |||||
[2] | See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). |
Investments_Additional_Informa
Investments - Additional Information (Detail) (USD $) | 12 Months Ended | ||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||
Loan | Loan | ||||
Schedule of Investments [Line Items] | |||||
Aggregate fair value of securities sold | $873 | $1,794 | $1,491 | ||
Aggregate fair value of securities sold, percentage of book value | 95.00% | 91.00% | 92.00% | ||
12 months or more, Gross unrealized losses | 173 | [1] | 365 | [2] | |
Investments subject to call provisions | 6,713 | ||||
Percentage of investment portfolio by which no other industry group exceeded | 10.00% | ||||
Percentage of stockholders' equity by which no single issuer of fixed maturity securities exceeded | 10 | ||||
Securities on deposit with various state or foreign government insurance departments | 49 | 50 | |||
Commercial mortgage loans outstanding more than 90 days, interest accruing | 0 | 0 | |||
Commercial mortgage loans on nonaccrual status, past due less than 90 days | 0 | 0 | |||
Commercial mortgage loans modified or extended, number of loans | 28 | 33 | |||
Commercial mortgage loans modified or extended, carrying value | 254 | 165 | |||
Commercial mortgage loans, recorded investment | 6,123 | 5,932 | |||
Floating rate commercial mortgage loans | |||||
Schedule of Investments [Line Items] | |||||
Commercial mortgage loans, recorded investment | 9 | 109 | |||
Investment grade | |||||
Schedule of Investments [Line Items] | |||||
12 months or more, Gross unrealized losses | 146 | [1] | 315 | [2] | |
Retail | |||||
Schedule of Investments [Line Items] | |||||
Individually impaired commercial mortgage loans | 2 | ||||
Impaired loans, unpaid principal balance | 3 | ||||
Individually impaired loans, charge-offs | 1 | ||||
Individually impaired loans, average recorded investment | 2 | ||||
Commercial mortgage loans, recorded investment | 2,150 | 2,073 | |||
Industrial | |||||
Schedule of Investments [Line Items] | |||||
Individually impaired commercial mortgage loans | 15 | ||||
Impaired loans, unpaid principal balance | 16 | ||||
Individually impaired loans, charge-offs | 1 | ||||
Individually impaired loans, average recorded investment | 15 | ||||
Commercial mortgage loans, recorded investment | 1,597 | 1,581 | |||
Less Than Twelve Months | |||||
Schedule of Investments [Line Items] | |||||
Average fair value percentage below cost for securities in a continuous loss position | 2.00% | ||||
Less Than Twelve Months | Less Than 20 Percent Below Cost | Investment grade | |||||
Schedule of Investments [Line Items] | |||||
Stated percentage below cost of securities in unrealized loss position | 20.00% | ||||
Fixed maturity securities | |||||
Schedule of Investments [Line Items] | |||||
12 months or more, Gross unrealized losses | 169 | [1] | 365 | [2] | |
Fixed maturity securities | Utilities and energy | |||||
Schedule of Investments [Line Items] | |||||
Percent of investment portfolio, greater than 10% | 24.00% | ||||
Fixed maturity securities | Finance and insurance | |||||
Schedule of Investments [Line Items] | |||||
Percent of investment portfolio, greater than 10% | 19.00% | ||||
Fixed maturity securities | Consumer-non-cyclical | |||||
Schedule of Investments [Line Items] | |||||
Percent of investment portfolio, greater than 10% | 12.00% | ||||
Fixed maturity securities | Less Than 20 Percent Below Cost | |||||
Schedule of Investments [Line Items] | |||||
12 months or more, Gross unrealized losses | 115 | [1] | 163 | [2] | |
Fixed maturity securities | Less Than 20 Percent Below Cost | Investment grade | |||||
Schedule of Investments [Line Items] | |||||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 86.00% | ||||
Fixed maturity securities | 12 Months Or More | Less Than 20 Percent Below Cost | |||||
Schedule of Investments [Line Items] | |||||
Stated percentage below cost of securities in unrealized loss position | 20.00% | ||||
Average fair value percentage below cost for securities in a continuous loss position | 4.00% | ||||
Fixed maturity securities | 12 Months Or More | More Than 20% Below Cost | |||||
Schedule of Investments [Line Items] | |||||
Stated percentage below cost of securities in unrealized loss position | 20.00% | ||||
Structured Securities | More Than 20% Below Cost | |||||
Schedule of Investments [Line Items] | |||||
12 months or more, Gross unrealized losses | 37 | ||||
Structured Securities | 12 Months Or More | More Than 20% Below Cost | |||||
Schedule of Investments [Line Items] | |||||
Stated percentage below cost of securities in unrealized loss position | 20.00% | ||||
Unrealized losses on other than temporarily impaired securities, portion recognized in OCI, securities in a loss position | $1 | ||||
[1] | Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities. | ||||
[2] | Amounts included $7 million of unrealized losses on other-than-temporarily impaired securities. |
Credit_Losses_Recognized_in_Ne
Credit Losses Recognized in Net Income (Loss) on Debt Securities (Detail) (Debt Securities, USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Debt Securities | |||
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Line Items] | |||
Cumulative credit losses, beginning balance | $101 | $387 | $646 |
Other-than-temporary impairments not previously recognized | 1 | 4 | 16 |
Increases related to other-than-temporary impairments previously recognized | 1 | 11 | 55 |
Securities sold, paid down or disposed | -20 | -301 | -330 |
Cumulative credit losses, ending balance | $83 | $101 | $387 |
Net_Unrealized_Gains_and_Losse
Net Unrealized Gains and Losses on Available-for-Sale Investment Securities Reflected as Separate Component of Accumulated Other Comprehensive Income (Loss) (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | ||||
In Millions, unless otherwise specified | ||||||||
Components of Net Unrealized Investment Gains Losses Included in Accumulated Other Comprehensive Income Loss [Line Items] | ||||||||
Adjustments to DAC, PVFP, sales inducements and benefit reserves | ($1,656) | ($869) | ($1,925) | |||||
Income taxes, net | -1,372 | -517 | -1,457 | |||||
Net unrealized investment gains (losses) including noncontrolling interests | 2,562 | 979 | 2,730 | |||||
Less: net unrealized investment gains (losses) attributable to noncontrolling interests | 109 | 53 | 92 | |||||
Net unrealized investment gains (losses) | 2,453 | [1] | 926 | [1] | 2,638 | [1] | 1,485 | [1] |
Net Unrealized Gains (Losses) On Investment Securities | ||||||||
Components of Net Unrealized Investment Gains Losses Included in Accumulated Other Comprehensive Income Loss [Line Items] | ||||||||
Fixed maturity securities | 5,560 | 2,346 | 6,086 | |||||
Equity securities | 32 | 23 | 34 | |||||
Other invested assets | -2 | -4 | -8 | |||||
Subtotal | $5,590 | $2,365 | $6,112 | |||||
[1] | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. |
Change_in_Net_Unrealized_Gains
Change in Net Unrealized Gains (Losses) on Available-for-Sale Securities Reported in Accumulated Other Comprehensive Income (Loss) (Detail) (USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Investments [Abstract] | ||||||
Net unrealized investment gains (losses), beginning of period | $926 | [1] | $2,638 | [1] | $1,485 | [1] |
Unrealized gains (losses) on investment securities | 3,244 | -3,780 | 2,318 | |||
Adjustment to DAC | -172 | 248 | -159 | |||
Adjustment to PVFP | -66 | 95 | -6 | |||
Adjustment to sales inducements | -15 | 40 | -33 | |||
Adjustment to benefit reserves | -534 | 673 | -424 | |||
Provision for income taxes | -862 | 952 | -590 | |||
Change in unrealized gains (losses) on investment securities | 1,595 | [1] | -1,772 | [1] | 1,106 | [1] |
Reclassification adjustments to net investment (gains) losses, net of taxes | -12 | [1] | 21 | [1] | 50 | [1] |
Change in net unrealized investment gains (losses) | 1,583 | [1] | -1,751 | [1] | 1,156 | [1] |
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests | 56 | [1] | -39 | [1] | 3 | [1] |
Net unrealized investment gains (losses), end of period | $2,453 | [1] | $926 | [1] | $2,638 | [1] |
[1] | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. |
Change_in_Net_Unrealized_Gains1
Change in Net Unrealized Gains (Losses) on Available-for-Sale Securities Reported in Accumulated Other Comprehensive Income (Loss) (Parenthetical) (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Components of Net Unrealized Investment Gains Losses Included in Accumulated Other Comprehensive Income Loss [Line Items] | |||
Reclassification adjustments to net investment (gains) losses, taxes | $7 | ($12) | ($27) |
Amortized_Cost_or_Cost_Gross_U
Amortized Cost or Cost, Gross Unrealized Gains (Losses) and Fair Value of Fixed Maturity and Equity Securities Classified as Available-for-Sale (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Schedule of Investments [Line Items] | ||
Amortized cost or cost, fixed maturity securities | $56,950 | $56,309 |
Fair value, fixed maturity securities | 62,447 | 58,629 |
Amortized cost or cost, equity securities | 253 | 318 |
Fair value, equity securities | 282 | 341 |
Amortized cost or cost, total | 57,203 | 56,627 |
Fair value, total | 62,729 | 58,970 |
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises | ||
Schedule of Investments [Line Items] | ||
Amortized cost or cost, fixed maturity securities | 5,006 | 4,710 |
Fair value, fixed maturity securities | 6,000 | 4,810 |
Fixed maturity securities | Tax-exempt | ||
Schedule of Investments [Line Items] | ||
Amortized cost or cost, fixed maturity securities | 347 | 324 |
Fair value, fixed maturity securities | 362 | 295 |
Fixed maturity securities | Government - non-U.S. | ||
Schedule of Investments [Line Items] | ||
Amortized cost or cost, fixed maturity securities | 1,952 | 2,057 |
Fair value, fixed maturity securities | 2,106 | 2,146 |
Fixed maturity securities | U.S. corporate | ||
Schedule of Investments [Line Items] | ||
Amortized cost or cost, fixed maturity securities | 24,251 | 23,614 |
Fair value, fixed maturity securities | 27,200 | 25,035 |
Fixed maturity securities | Corporate - non-U.S. | ||
Schedule of Investments [Line Items] | ||
Amortized cost or cost, fixed maturity securities | 14,214 | 14,489 |
Fair value, fixed maturity securities | 15,132 | 15,071 |
Fixed maturity securities | Residential mortgage-backed | ||
Schedule of Investments [Line Items] | ||
Amortized cost or cost, fixed maturity securities | 4,881 | 5,058 |
Fair value, fixed maturity securities | 5,240 | 5,225 |
Fixed maturity securities | Commercial mortgage-backed | ||
Schedule of Investments [Line Items] | ||
Amortized cost or cost, fixed maturity securities | 2,564 | 2,886 |
Fair value, fixed maturity securities | 2,702 | 2,898 |
Fixed maturity securities | Other asset-backed | ||
Schedule of Investments [Line Items] | ||
Amortized cost or cost, fixed maturity securities | 3,735 | 3,171 |
Fair value, fixed maturity securities | 3,705 | 3,149 |
Not other-than-temporary impairments | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 5,740 | 3,283 |
Gross unrealized losses, fixed maturity securities | -282 | -986 |
Gross unrealized gains, equity securities | 36 | 36 |
Gross unrealized losses, equity securities | -7 | -13 |
Gross unrealized gains | 5,776 | 3,319 |
Gross unrealized losses | -289 | -999 |
Not other-than-temporary impairments | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 995 | 331 |
Gross unrealized losses, fixed maturity securities | -1 | -231 |
Not other-than-temporary impairments | Fixed maturity securities | Tax-exempt | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 29 | 7 |
Gross unrealized losses, fixed maturity securities | -14 | -36 |
Not other-than-temporary impairments | Fixed maturity securities | Government - non-U.S. | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 156 | 104 |
Gross unrealized losses, fixed maturity securities | -2 | -15 |
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 3,017 | 1,761 |
Gross unrealized losses, fixed maturity securities | -88 | -359 |
Not other-than-temporary impairments | Fixed maturity securities | Corporate - non-U.S. | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 1,015 | 738 |
Gross unrealized losses, fixed maturity securities | -97 | -156 |
Not other-than-temporary impairments | Fixed maturity securities | Residential mortgage-backed | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 362 | 232 |
Gross unrealized losses, fixed maturity securities | -17 | -70 |
Not other-than-temporary impairments | Fixed maturity securities | Commercial mortgage-backed | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 143 | 75 |
Gross unrealized losses, fixed maturity securities | -9 | -62 |
Not other-than-temporary impairments | Fixed maturity securities | Other asset-backed | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 23 | 35 |
Gross unrealized losses, fixed maturity securities | -54 | -57 |
Other-than-temporary impairments | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 40 | 30 |
Gross unrealized losses, fixed maturity securities | -1 | -7 |
Gross unrealized gains, equity securities | 0 | 0 |
Gross unrealized losses, equity securities | 0 | 0 |
Gross unrealized gains | 40 | 30 |
Gross unrealized losses | -1 | -7 |
Other-than-temporary impairments | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 0 | 0 |
Gross unrealized losses, fixed maturity securities | 0 | 0 |
Other-than-temporary impairments | Fixed maturity securities | Tax-exempt | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 0 | 0 |
Gross unrealized losses, fixed maturity securities | 0 | 0 |
Other-than-temporary impairments | Fixed maturity securities | Government - non-U.S. | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 0 | 0 |
Gross unrealized losses, fixed maturity securities | 0 | 0 |
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 20 | 19 |
Gross unrealized losses, fixed maturity securities | 0 | 0 |
Other-than-temporary impairments | Fixed maturity securities | Corporate - non-U.S. | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 0 | 0 |
Gross unrealized losses, fixed maturity securities | 0 | 0 |
Other-than-temporary impairments | Fixed maturity securities | Residential mortgage-backed | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 15 | 9 |
Gross unrealized losses, fixed maturity securities | -1 | -4 |
Other-than-temporary impairments | Fixed maturity securities | Commercial mortgage-backed | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 4 | 2 |
Gross unrealized losses, fixed maturity securities | 0 | -3 |
Other-than-temporary impairments | Fixed maturity securities | Other asset-backed | ||
Schedule of Investments [Line Items] | ||
Gross unrealized gains, fixed maturity securities | 1 | 0 |
Gross unrealized losses, fixed maturity securities | $0 | $0 |
Gross_Unrealized_Losses_and_Fa
Gross Unrealized Losses and Fair Value of Investment Securities (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | Securities | Securities | ||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | $5,215 | $12,339 | ||
Less than 12 months, Gross unrealized losses | -117 | -641 | ||
Less than 12 months, Number of securities in a continuous loss position | 803 | 1,624 | ||
12 months or more, Fair value | 3,233 | 2,054 | ||
12 months or more, Gross unrealized losses | -173 | [1] | -365 | [2] |
12 months or more, Number of securities in a continuous loss position | 504 | 309 | ||
Fair value | 8,448 | 14,393 | ||
Gross unrealized losses | -290 | [1] | -1,006 | [2] |
Number of securities in a continuous loss position | 1,307 | 1,933 | ||
Below investment grade | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 592 | [3] | 443 | [4] |
Less than 12 months, Gross unrealized losses | -42 | [3] | -25 | [4] |
Less than 12 months, Number of securities in a continuous loss position | 128 | [3] | 109 | [4] |
12 months or more, Fair value | 297 | [3] | 423 | [4] |
12 months or more, Gross unrealized losses | -27 | [1],[3] | -50 | [2],[4] |
12 months or more, Number of securities in a continuous loss position | 73 | [3] | 101 | [4] |
Fair value | 889 | [3] | 866 | [4] |
Gross unrealized losses | -69 | [1],[3] | -75 | [2],[4] |
Number of securities in a continuous loss position | 201 | [3] | 210 | [4] |
Investment grade | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 4,623 | 11,896 | ||
Less than 12 months, Gross unrealized losses | -75 | -616 | ||
Less than 12 months, Number of securities in a continuous loss position | 675 | 1,515 | ||
12 months or more, Fair value | 2,936 | 1,631 | ||
12 months or more, Gross unrealized losses | -146 | [1] | -315 | [2] |
12 months or more, Number of securities in a continuous loss position | 431 | 208 | ||
Fair value | 7,559 | 13,527 | ||
Gross unrealized losses | -221 | [1] | -931 | [2] |
Number of securities in a continuous loss position | 1,106 | 1,723 | ||
Fixed maturity securities | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 5,185 | 12,244 | ||
Less than 12 months, Gross unrealized losses | -114 | -628 | ||
Less than 12 months, Number of securities in a continuous loss position | 757 | 1,583 | ||
12 months or more, Fair value | 3,185 | 2,054 | ||
12 months or more, Gross unrealized losses | -169 | [1] | -365 | [2] |
12 months or more, Number of securities in a continuous loss position | 498 | 309 | ||
Fair value | 8,370 | 14,298 | ||
Gross unrealized losses | -283 | [1] | -993 | [2] |
Number of securities in a continuous loss position | 1,255 | 1,892 | ||
Fixed maturity securities | Less Than 20 Percent Below Cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 5,148 | 12,009 | ||
Less than 12 months, Gross unrealized losses | -103 | -547 | ||
Less than 12 months, Number of securities in a continuous loss position | 753 | 1,571 | ||
12 months or more, Fair value | 3,054 | 1,575 | ||
12 months or more, Gross unrealized losses | -115 | [1] | -163 | [2] |
12 months or more, Number of securities in a continuous loss position | 477 | 238 | ||
Fair value | 8,202 | 13,584 | ||
Gross unrealized losses | -218 | [1] | -710 | [2] |
Number of securities in a continuous loss position | 1,230 | 1,809 | ||
Fixed maturity securities | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 37 | 235 | ||
Less than 12 months, Gross unrealized losses | -11 | -81 | ||
Less than 12 months, Number of securities in a continuous loss position | 4 | 12 | ||
12 months or more, Fair value | 131 | 466 | ||
12 months or more, Gross unrealized losses | -53 | [1] | -187 | [2] |
12 months or more, Number of securities in a continuous loss position | 15 | 51 | ||
Fair value | 168 | 701 | ||
Gross unrealized losses | -64 | [1] | -268 | [2] |
Number of securities in a continuous loss position | 19 | 63 | ||
Fixed maturity securities | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 0 | 0 | ||
Less than 12 months, Gross unrealized losses | 0 | 0 | ||
Less than 12 months, Number of securities in a continuous loss position | 0 | 0 | ||
12 months or more, Fair value | 0 | 13 | ||
12 months or more, Gross unrealized losses | -1 | [1] | -15 | [2] |
12 months or more, Number of securities in a continuous loss position | 6 | 20 | ||
Fair value | 0 | 13 | ||
Gross unrealized losses | -1 | [1] | -15 | [2] |
Number of securities in a continuous loss position | 6 | 20 | ||
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 0 | 796 | ||
Less than 12 months, Gross unrealized losses | 0 | -109 | ||
Less than 12 months, Number of securities in a continuous loss position | 0 | 32 | ||
12 months or more, Fair value | 75 | 335 | ||
12 months or more, Gross unrealized losses | -1 | [1] | -122 | [2] |
12 months or more, Number of securities in a continuous loss position | 10 | 13 | ||
Fair value | 75 | 1,131 | ||
Gross unrealized losses | -1 | [1] | -231 | [2] |
Number of securities in a continuous loss position | 10 | 45 | ||
Fixed maturity securities | Tax-exempt | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 0 | 82 | ||
Less than 12 months, Gross unrealized losses | 0 | -3 | ||
Less than 12 months, Number of securities in a continuous loss position | 0 | 26 | ||
12 months or more, Fair value | 111 | 97 | ||
12 months or more, Gross unrealized losses | -14 | [1] | -33 | [2] |
12 months or more, Number of securities in a continuous loss position | 10 | 9 | ||
Fair value | 111 | 179 | ||
Gross unrealized losses | -14 | [1] | -36 | [2] |
Number of securities in a continuous loss position | 10 | 35 | ||
Fixed maturity securities | Government - non-U.S. | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 67 | 479 | ||
Less than 12 months, Gross unrealized losses | -1 | -15 | ||
Less than 12 months, Number of securities in a continuous loss position | 18 | 60 | ||
12 months or more, Fair value | 22 | 0 | ||
12 months or more, Gross unrealized losses | -1 | [1] | 0 | [2] |
12 months or more, Number of securities in a continuous loss position | 4 | 0 | ||
Fair value | 89 | 479 | ||
Gross unrealized losses | -2 | [1] | -15 | [2] |
Number of securities in a continuous loss position | 22 | 60 | ||
Fixed maturity securities | U.S. corporate | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 1,656 | 4,774 | ||
Less than 12 months, Gross unrealized losses | -31 | -260 | ||
Less than 12 months, Number of securities in a continuous loss position | 240 | 707 | ||
12 months or more, Fair value | 1,359 | 663 | ||
12 months or more, Gross unrealized losses | -57 | [1] | -99 | [2] |
12 months or more, Number of securities in a continuous loss position | 210 | 82 | ||
Fair value | 3,015 | 5,437 | ||
Gross unrealized losses | -88 | [1] | -359 | [2] |
Number of securities in a continuous loss position | 450 | 789 | ||
Fixed maturity securities | Corporate - non-U.S. | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 1,568 | 3,005 | ||
Less than 12 months, Gross unrealized losses | -69 | -127 | ||
Less than 12 months, Number of securities in a continuous loss position | 239 | 379 | ||
12 months or more, Fair value | 515 | 287 | ||
12 months or more, Gross unrealized losses | -28 | [1] | -29 | [2] |
12 months or more, Number of securities in a continuous loss position | 70 | 34 | ||
Fair value | 2,083 | 3,292 | ||
Gross unrealized losses | -97 | [1] | -156 | [2] |
Number of securities in a continuous loss position | 309 | 413 | ||
Fixed maturity securities | Residential mortgage-backed | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 180 | 1,052 | ||
Less than 12 months, Gross unrealized losses | -1 | -55 | ||
Less than 12 months, Number of securities in a continuous loss position | 24 | 139 | ||
12 months or more, Fair value | 254 | 157 | ||
12 months or more, Gross unrealized losses | -17 | [1] | -19 | [2] |
12 months or more, Number of securities in a continuous loss position | 90 | 92 | ||
Fair value | 434 | 1,209 | ||
Gross unrealized losses | -18 | [1] | -74 | [2] |
Number of securities in a continuous loss position | 114 | 231 | ||
Fixed maturity securities | Commercial mortgage-backed | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 163 | 967 | ||
Less than 12 months, Gross unrealized losses | 0 | -42 | ||
Less than 12 months, Number of securities in a continuous loss position | 21 | 107 | ||
12 months or more, Fair value | 362 | 370 | ||
12 months or more, Gross unrealized losses | -9 | [1] | -23 | [2] |
12 months or more, Number of securities in a continuous loss position | 49 | 62 | ||
Fair value | 525 | 1,337 | ||
Gross unrealized losses | -9 | [1] | -65 | [2] |
Number of securities in a continuous loss position | 70 | 169 | ||
Fixed maturity securities | Other asset-backed | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 1,551 | 1,089 | ||
Less than 12 months, Gross unrealized losses | -12 | -17 | ||
Less than 12 months, Number of securities in a continuous loss position | 215 | 133 | ||
12 months or more, Fair value | 487 | 145 | ||
12 months or more, Gross unrealized losses | -42 | [1] | -40 | [2] |
12 months or more, Number of securities in a continuous loss position | 55 | 17 | ||
Fair value | 2,038 | 1,234 | ||
Gross unrealized losses | -54 | [1] | -57 | [2] |
Number of securities in a continuous loss position | 270 | 150 | ||
Fixed maturity securities | Below investment grade | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 20 | |||
12 months or more, Gross unrealized losses | -10 | |||
12 months or more, Number of securities in a continuous loss position | 6 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 4.00% | |||
Fixed maturity securities | Below investment grade | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | -1 | |||
12 months or more, Number of securities in a continuous loss position | 6 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Fixed maturity securities | Below investment grade | U.S. corporate | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 8 | |||
12 months or more, Gross unrealized losses | -2 | |||
12 months or more, Number of securities in a continuous loss position | 1 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 1.00% | |||
Fixed maturity securities | Below investment grade | U.S. corporate | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | 0 | |||
12 months or more, Number of securities in a continuous loss position | 0 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Fixed maturity securities | Below investment grade | Corporate - non-U.S. | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 3 | |||
12 months or more, Gross unrealized losses | -2 | |||
12 months or more, Number of securities in a continuous loss position | 1 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 1.00% | |||
Fixed maturity securities | Below investment grade | Corporate - non-U.S. | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | 0 | |||
12 months or more, Number of securities in a continuous loss position | 0 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Fixed maturity securities | Investment grade | Less Than 20 Percent Below Cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 86.00% | |||
Fixed maturity securities | Investment grade | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 111 | |||
12 months or more, Gross unrealized losses | -43 | |||
12 months or more, Number of securities in a continuous loss position | 9 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 14.00% | |||
Fixed maturity securities | Investment grade | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | 0 | |||
12 months or more, Number of securities in a continuous loss position | 0 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Fixed maturity securities | Investment grade | Tax-exempt | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 10 | |||
12 months or more, Gross unrealized losses | -3 | |||
12 months or more, Number of securities in a continuous loss position | 1 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 1.00% | |||
Fixed maturity securities | Investment grade | Tax-exempt | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | 0 | |||
12 months or more, Number of securities in a continuous loss position | 0 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Fixed maturity securities | Investment grade | U.S. corporate | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 25 | |||
12 months or more, Gross unrealized losses | -10 | |||
12 months or more, Number of securities in a continuous loss position | 1 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 3.00% | |||
Fixed maturity securities | Investment grade | U.S. corporate | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | 0 | |||
12 months or more, Number of securities in a continuous loss position | 0 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Equity Securities | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 30 | 95 | ||
Less than 12 months, Gross unrealized losses | -3 | -13 | ||
Less than 12 months, Number of securities in a continuous loss position | 46 | 41 | ||
12 months or more, Fair value | 48 | 0 | ||
12 months or more, Gross unrealized losses | -4 | [1] | 0 | [2] |
12 months or more, Number of securities in a continuous loss position | 6 | 0 | ||
Fair value | 78 | 95 | ||
Gross unrealized losses | -7 | [1] | -13 | [2] |
Number of securities in a continuous loss position | 52 | 41 | ||
Equity Securities | Less Than 20 Percent Below Cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 26 | 87 | ||
Less than 12 months, Gross unrealized losses | -2 | -11 | ||
Less than 12 months, Number of securities in a continuous loss position | 40 | 40 | ||
12 months or more, Fair value | 48 | 0 | ||
12 months or more, Gross unrealized losses | -4 | [1] | 0 | [2] |
12 months or more, Number of securities in a continuous loss position | 6 | 0 | ||
Fair value | 74 | 87 | ||
Gross unrealized losses | -6 | [1] | -11 | [2] |
Number of securities in a continuous loss position | 46 | 40 | ||
Equity Securities | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
Less than 12 months, Fair value | 4 | 8 | ||
Less than 12 months, Gross unrealized losses | -1 | -2 | ||
Less than 12 months, Number of securities in a continuous loss position | 6 | 1 | ||
12 months or more, Fair value | 0 | 0 | ||
12 months or more, Gross unrealized losses | 0 | [1] | 0 | [2] |
12 months or more, Number of securities in a continuous loss position | 0 | 0 | ||
Fair value | 4 | 8 | ||
Gross unrealized losses | -1 | [1] | -2 | [2] |
Number of securities in a continuous loss position | 6 | 1 | ||
Structured Securities | Below investment grade | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 9 | |||
12 months or more, Gross unrealized losses | -6 | |||
12 months or more, Number of securities in a continuous loss position | 4 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 2.00% | |||
Structured Securities | Below investment grade | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | -1 | |||
12 months or more, Number of securities in a continuous loss position | 6 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Structured Securities | Below investment grade | Residential mortgage-backed | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | 0 | |||
12 months or more, Number of securities in a continuous loss position | 0 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Structured Securities | Below investment grade | Residential mortgage-backed | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | -1 | |||
12 months or more, Number of securities in a continuous loss position | 6 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Structured Securities | Below investment grade | Other asset-backed | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 9 | |||
12 months or more, Gross unrealized losses | -6 | |||
12 months or more, Number of securities in a continuous loss position | 4 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 2.00% | |||
Structured Securities | Below investment grade | Other asset-backed | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | 0 | |||
12 months or more, Number of securities in a continuous loss position | 0 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Structured Securities | Investment grade | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 76 | |||
12 months or more, Gross unrealized losses | -30 | |||
12 months or more, Number of securities in a continuous loss position | 7 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 10.00% | |||
Structured Securities | Investment grade | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | 0 | |||
12 months or more, Number of securities in a continuous loss position | 0 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Structured Securities | Investment grade | Residential mortgage-backed | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 5 | |||
12 months or more, Gross unrealized losses | -4 | |||
12 months or more, Number of securities in a continuous loss position | 3 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 1.00% | |||
Structured Securities | Investment grade | Residential mortgage-backed | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | 0 | |||
12 months or more, Number of securities in a continuous loss position | 0 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
Structured Securities | Investment grade | Other asset-backed | 20 To 50 percent below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 71 | |||
12 months or more, Gross unrealized losses | -26 | |||
12 months or more, Number of securities in a continuous loss position | 4 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 9.00% | |||
Structured Securities | Investment grade | Other asset-backed | Greater than 50% below cost | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Fair value | 0 | |||
12 months or more, Gross unrealized losses | $0 | |||
12 months or more, Number of securities in a continuous loss position | 0 | |||
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position | 0.00% | |||
[1] | Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities. | |||
[2] | Amounts included $7 million of unrealized losses on other-than-temporarily impaired securities. | |||
[3] | Amounts that have been in a continuous unrealized loss position for 12 months or more included $1 million of unrealized losses on other-than-temporarily impaired securities. | |||
[4] | Amounts that have been in a continuous unrealized loss position for 12 months or more included $7 million of unrealized losses on other-than-temporarily impaired securities. |
Gross_Unrealized_Losses_and_Fa1
Gross Unrealized Losses and Fair Value of Investment Securities (Parenthetical) (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Gross unrealized losses | $173 | [1] | $365 | [2] |
Gross unrealized losses | 290 | [1] | 1,006 | [2] |
Other-than-temporary impairments | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Gross unrealized losses | 1 | 7 | ||
Gross unrealized losses | 1 | 7 | ||
Below investment grade | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Gross unrealized losses | 27 | [1],[3] | 50 | [2],[4] |
Gross unrealized losses | 69 | [1],[3] | 75 | [2],[4] |
Below investment grade | Other-than-temporary impairments | ||||
Available for Sale Securities Continuous Unrealized Loss Position [Line Items] | ||||
12 months or more, Gross unrealized losses | $1 | $7 | ||
[1] | Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities. | |||
[2] | Amounts included $7 million of unrealized losses on other-than-temporarily impaired securities. | |||
[3] | Amounts that have been in a continuous unrealized loss position for 12 months or more included $1 million of unrealized losses on other-than-temporarily impaired securities. | |||
[4] | Amounts that have been in a continuous unrealized loss position for 12 months or more included $7 million of unrealized losses on other-than-temporarily impaired securities. |
Scheduled_Maturity_Distributio
Scheduled Maturity Distribution of Fixed Maturity Securities (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Amortized cost or cost | ||
Due one year or less | $2,307 | |
Due after one year through five years | 10,858 | |
Due after five years through ten years | 11,888 | |
Due after ten years | 20,717 | |
Subtotal | 45,770 | |
Amortized cost or cost, fixed maturity securities | 56,950 | 56,309 |
Fair value | ||
Due one year or less | 2,326 | |
Due after one year through five years | 11,410 | |
Due after five years through ten years | 12,496 | |
Due after ten years | 24,568 | |
Subtotal | 50,800 | |
Fair value, fixed maturity securities | 62,447 | 58,629 |
Residential mortgage-backed | ||
Amortized cost or cost | ||
Fixed maturity securities | 4,881 | |
Fair value | ||
Fixed maturity securities | 5,240 | |
Commercial mortgage-backed | ||
Amortized cost or cost | ||
Fixed maturity securities | 2,564 | |
Fair value | ||
Fixed maturity securities | 2,702 | |
Other asset-backed | ||
Amortized cost or cost | ||
Fixed maturity securities | 3,735 | |
Fair value | ||
Fixed maturity securities | $3,705 |
Distribution_Across_Property_T
Distribution Across Property Type and Geographic Region for Commercial Mortgage Loans (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | $6,123 | $5,932 |
Unamortized balance of loan origination fees and costs | -1 | 0 |
% of total | 100.00% | 100.00% |
Allowance for losses | -22 | -33 |
Total | 6,100 | 5,899 |
Commercial Mortgage Loan | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 6,123 | 5,932 |
Unamortized balance of loan origination fees and costs | -1 | 0 |
% of total | 100.00% | 100.00% |
Allowance for losses | -22 | -33 |
Total | 6,100 | 5,899 |
South Atlantic | Commercial Mortgage Loan | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,673 | 1,535 |
% of total | 27.00% | 26.00% |
Pacific | Commercial Mortgage Loan | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,636 | 1,590 |
% of total | 27.00% | 27.00% |
Middle Atlantic | Commercial Mortgage Loan | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 826 | 828 |
% of total | 14.00% | 14.00% |
Mountain | Commercial Mortgage Loan | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 536 | 478 |
% of total | 9.00% | 8.00% |
East North Central | Commercial Mortgage Loan | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 397 | 404 |
% of total | 7.00% | 7.00% |
West North Central | Commercial Mortgage Loan | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 382 | 377 |
% of total | 6.00% | 6.00% |
West South Central | Commercial Mortgage Loan | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 268 | 241 |
% of total | 4.00% | 4.00% |
New England | Commercial Mortgage Loan | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 264 | 337 |
% of total | 4.00% | 6.00% |
East South Central | Commercial Mortgage Loan | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 141 | 142 |
% of total | 2.00% | 2.00% |
Retail | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 2,150 | 2,073 |
% of total | 35.00% | 35.00% |
Office | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,643 | 1,558 |
% of total | 27.00% | 26.00% |
Industrial | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,597 | 1,581 |
% of total | 26.00% | 27.00% |
Apartments | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 494 | 491 |
% of total | 8.00% | 8.00% |
Mixed use/other | ||
Distribution of Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | $239 | $229 |
% of total | 4.00% | 4.00% |
Aging_of_Past_Due_Commercial_M
Aging of Past Due Commercial Mortgage Loans by Property Type (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | $6,123 | $5,932 |
% of total | 100.00% | 100.00% |
Retail | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 2,150 | 2,073 |
% of total | 35.00% | 35.00% |
Office | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,643 | 1,558 |
% of total | 27.00% | 26.00% |
Industrial | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,597 | 1,581 |
% of total | 26.00% | 27.00% |
Apartments | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 494 | 491 |
% of total | 8.00% | 8.00% |
Mixed use/other | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 239 | 229 |
% of total | 4.00% | 4.00% |
31-60 days past due | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 3 |
% of total | 0.00% | 0.00% |
31-60 days past due | Retail | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 0 |
31-60 days past due | Office | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 0 |
31-60 days past due | Industrial | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 2 |
31-60 days past due | Apartments | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 0 |
31-60 days past due | Mixed use/other | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 1 |
61-90 days past due | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 2 |
% of total | 0.00% | 0.00% |
61-90 days past due | Retail | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 0 |
61-90 days past due | Office | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 0 |
61-90 days past due | Industrial | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 2 |
61-90 days past due | Apartments | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 0 |
61-90 days past due | Mixed use/other | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 0 |
Greater than 90 days past due | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 8 | 32 |
% of total | 0.00% | 1.00% |
Greater than 90 days past due | Retail | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 10 |
Greater than 90 days past due | Office | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 6 | 6 |
Greater than 90 days past due | Industrial | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 2 | 16 |
Greater than 90 days past due | Apartments | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 0 |
Greater than 90 days past due | Mixed use/other | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 0 |
Total past due | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 8 | 37 |
% of total | 0.00% | 1.00% |
Total past due | Retail | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 10 |
Total past due | Office | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 6 | 6 |
Total past due | Industrial | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 2 | 20 |
Total past due | Apartments | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 0 |
Total past due | Mixed use/other | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 0 | 1 |
Current | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 6,115 | 5,895 |
% of total | 100.00% | 99.00% |
Current | Retail | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 2,150 | 2,063 |
Current | Office | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,637 | 1,552 |
Current | Industrial | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,595 | 1,561 |
Current | Apartments | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | 494 | 491 |
Current | Mixed use/other | ||
Aging of Past Due Commercial Mortgage Loans [Line Items] | ||
Commercial mortgage loans, recorded investment | $239 | $228 |
Allowance_for_Credit_Losses_an
Allowance for Credit Losses and Recorded Investment in Commercial Mortgage Loans (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Financing Receivable, Allowance for Credit Losses [Line Items] | |||
Ending balance | $22 | $33 | |
Ending balance | 6,123 | 5,932 | |
Allowance for Credit Losses | |||
Financing Receivable, Allowance for Credit Losses [Line Items] | |||
Beginning balance | 33 | 42 | 51 |
Charge-offs | -1 | -2 | -2 |
Recoveries | 0 | 0 | 0 |
Provision | -10 | -7 | -7 |
Ending balance | 22 | 33 | 42 |
Ending allowance for individually impaired loans | 0 | 0 | 0 |
Ending allowance for loans not individually impaired that were evaluated collectively for impairment | 22 | 33 | 42 |
Commercial Mortgage Loans Recorded Investment | |||
Financing Receivable, Allowance for Credit Losses [Line Items] | |||
Ending balance | 6,123 | 5,932 | 5,912 |
Ending balance of individually impaired loans | 15 | 2 | 0 |
Ending balance of loans not individually impaired that were evaluated collectively for impairment | $6,108 | $5,930 | $5,912 |
LoantoValue_of_Commercial_Mort
Loan-to-Value of Commercial Mortgage Loans by Property Type (Detail) (USD $) | 12 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | $6,123 | $5,932 | ||
% of total | 100.00% | 100.00% | ||
Weighted-average debt service coverage ratio | 1.78 | 1.75 | ||
Retail | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 2,150 | 2,073 | ||
% of total | 35.00% | 35.00% | ||
Office | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 1,643 | 1,558 | ||
% of total | 27.00% | 26.00% | ||
Industrial | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 1,597 | 1,581 | ||
% of total | 26.00% | 27.00% | ||
Apartments | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 494 | 491 | ||
% of total | 8.00% | 8.00% | ||
Mixed use/other | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 239 | 229 | ||
% of total | 4.00% | 4.00% | ||
Greater than 100% | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 77 | [1] | 106 | [2] |
% of total | 1.00% | [1] | 2.00% | [2] |
Weighted-average debt service coverage ratio | 0.72 | [1] | 0.63 | [2] |
Greater than 100% | Retail | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 18 | [1] | 22 | [2] |
Greater than 100% | Office | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 36 | [1] | 63 | [2] |
Greater than 100% | Industrial | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 23 | [1] | 20 | [2] |
Greater than 100% | Apartments | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 0 | [1] | 1 | [2] |
Greater than 100% | Mixed use/other | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 0 | [1] | 0 | [2] |
0% - 50% | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 1,761 | 1,695 | ||
% of total | 29.00% | 28.00% | ||
Weighted-average debt service coverage ratio | 2.27 | 2.14 | ||
0% - 50% | Retail | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 671 | 596 | ||
0% - 50% | Office | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 383 | 397 | ||
0% - 50% | Industrial | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 451 | 430 | ||
0% - 50% | Apartments | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 211 | 201 | ||
0% - 50% | Mixed use/other | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 45 | 71 | ||
51% - 60% | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 1,101 | 886 | ||
% of total | 18.00% | 15.00% | ||
Weighted-average debt service coverage ratio | 1.75 | 1.79 | ||
51% - 60% | Retail | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 419 | 336 | ||
51% - 60% | Office | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 278 | 191 | ||
51% - 60% | Industrial | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 285 | 237 | ||
51% - 60% | Apartments | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 76 | 86 | ||
51% - 60% | Mixed use/other | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 43 | 36 | ||
61% - 75% | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 2,871 | 2,774 | ||
% of total | 47.00% | 47.00% | ||
Weighted-average debt service coverage ratio | 1.61 | 1.66 | ||
61% - 75% | Retail | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 967 | 1,024 | ||
61% - 75% | Office | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 782 | 716 | ||
61% - 75% | Industrial | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 778 | 748 | ||
61% - 75% | Apartments | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 199 | 176 | ||
61% - 75% | Mixed use/other | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 145 | 110 | ||
76% - 100% | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 313 | 471 | ||
% of total | 5.00% | 8.00% | ||
Weighted-average debt service coverage ratio | 1.02 | 1.03 | ||
76% - 100% | Retail | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 75 | 95 | ||
76% - 100% | Office | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 164 | 191 | ||
76% - 100% | Industrial | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 60 | 146 | ||
76% - 100% | Apartments | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 8 | 27 | ||
76% - 100% | Mixed use/other | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | $6 | $12 | ||
[1] | Included $15 million of impaired loans, $6 million of loans past due and not individually impaired and $56 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 120%. | |||
[2] | Included $2 million of impaired loans, $5 million of loans past due and not individually impaired and $99 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 119%. |
LoantoValue_of_Commercial_Mort1
Loan-to-Value of Commercial Mortgage Loans by Property Type (Parenthetical) (Detail) (USD $) | 12 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 6,123 | 5,932 | ||
Greater than 100% | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 77 | [1] | 106 | [2] |
Greater than 100% | Weighted Average Loan-To-Value | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Weighted-average loan-to-value | 120.00% | 119.00% | ||
Greater than 100% | Impaired Loans | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 15 | 2 | ||
Greater than 100% | Loans Past Due and Not Individually Impaired | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 6 | 5 | ||
Greater than 100% | Loans in Good Standing | ||||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||||
Commercial mortgage loans, recorded investment | 56 | 99 | ||
[1] | Included $15 million of impaired loans, $6 million of loans past due and not individually impaired and $56 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 120%. | |||
[2] | Included $2 million of impaired loans, $5 million of loans past due and not individually impaired and $99 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 119%. |
Debt_Service_Coverage_Ratio_fo
Debt Service Coverage Ratio for Fixed Rate Commercial Mortgage Loans by Property Type (Detail) (USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | $6,123 | $5,932 |
% of total | 100.00% | 100.00% |
Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 6,114 | 5,823 |
% of total | 100.00% | 100.00% |
Weighted-average loan-to-value | 59.00% | 59.00% |
Retail | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 2,150 | 2,073 |
% of total | 35.00% | 35.00% |
Retail | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 2,150 | 1,972 |
Office | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,643 | 1,558 |
% of total | 27.00% | 26.00% |
Office | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,636 | 1,550 |
Industrial | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,597 | 1,581 |
% of total | 26.00% | 27.00% |
Industrial | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,595 | 1,581 |
Apartments | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 494 | 491 |
% of total | 8.00% | 8.00% |
Apartments | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 494 | 491 |
Mixed use/other | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 239 | 229 |
% of total | 4.00% | 4.00% |
Mixed use/other | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 239 | 229 |
Less than 1.00 | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 364 | 451 |
% of total | 6.00% | 8.00% |
Weighted-average loan-to-value | 77.00% | 80.00% |
Less than 1.00 | Retail | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 80 | 106 |
Less than 1.00 | Office | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 119 | 131 |
Less than 1.00 | Industrial | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 158 | 195 |
Less than 1.00 | Apartments | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 1 | 3 |
Less than 1.00 | Mixed use/other | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 6 | 16 |
1.00 - 1.25 | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 545 | 635 |
% of total | 9.00% | 11.00% |
Weighted-average loan-to-value | 64.00% | 68.00% |
1.00 - 1.25 | Retail | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 253 | 314 |
1.00 - 1.25 | Office | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 101 | 181 |
1.00 - 1.25 | Industrial | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 142 | 100 |
1.00 - 1.25 | Apartments | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 48 | 31 |
1.00 - 1.25 | Mixed use/other | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 1 | 9 |
1.26 - 1.50 | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,166 | 1,008 |
% of total | 19.00% | 17.00% |
Weighted-average loan-to-value | 64.00% | 63.00% |
1.26 - 1.50 | Retail | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 524 | 374 |
1.26 - 1.50 | Office | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 247 | 225 |
1.26 - 1.50 | Industrial | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 246 | 270 |
1.26 - 1.50 | Apartments | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 88 | 107 |
1.26 - 1.50 | Mixed use/other | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 61 | 32 |
1.51 - 2.00 | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 2,677 | 2,430 |
% of total | 44.00% | 42.00% |
Weighted-average loan-to-value | 59.00% | 60.00% |
1.51 - 2.00 | Retail | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 870 | 779 |
1.51 - 2.00 | Office | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 780 | 637 |
1.51 - 2.00 | Industrial | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 706 | 721 |
1.51 - 2.00 | Apartments | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 186 | 187 |
1.51 - 2.00 | Mixed use/other | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 135 | 106 |
Greater than 2.00 | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 1,362 | 1,299 |
% of total | 22.00% | 22.00% |
Weighted-average loan-to-value | 45.00% | 43.00% |
Greater than 2.00 | Retail | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 423 | 399 |
Greater than 2.00 | Office | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 389 | 376 |
Greater than 2.00 | Industrial | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 343 | 295 |
Greater than 2.00 | Apartments | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | 171 | 163 |
Greater than 2.00 | Mixed use/other | Fixed Rate Commercial Mortgage Loans | ||
Commercial Mortgage Loans by Credit Quality Indicator [Line Items] | ||
Commercial mortgage loans, recorded investment | $36 | $66 |
Schedule_of_Positions_in_Deriv
Schedule of Positions in Derivative Instruments (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | $1,145 | $470 | ||
Derivative liabilities, fair value | 884 | 942 | ||
Designated As Hedging Instrument | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 645 | 126 | ||
Derivative liabilities, fair value | 69 | 644 | ||
Designated As Hedging Instrument | Cash Flow Hedges | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 645 | 125 | ||
Derivative liabilities, fair value | 69 | 644 | ||
Designated As Hedging Instrument | Cash Flow Hedges | Interest rate swaps | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 27 | 569 | ||
Designated As Hedging Instrument | Cash Flow Hedges | Interest rate swaps | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 639 | 121 | ||
Designated As Hedging Instrument | Cash Flow Hedges | Inflation indexed swaps | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 42 | 60 | ||
Designated As Hedging Instrument | Cash Flow Hedges | Inflation indexed swaps | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 0 | 0 | ||
Designated As Hedging Instrument | Cash Flow Hedges | Foreign currency swaps | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 0 | 2 | ||
Designated As Hedging Instrument | Cash Flow Hedges | Foreign currency swaps | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 6 | 4 | ||
Designated As Hedging Instrument | Cash Flow Hedges | Forward bond purchase commitments | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 0 | 13 | ||
Designated As Hedging Instrument | Cash Flow Hedges | Forward bond purchase commitments | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 0 | 0 | ||
Designated As Hedging Instrument | Fair value hedges | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 0 | 1 | ||
Derivative liabilities, fair value | 0 | 0 | ||
Designated As Hedging Instrument | Fair value hedges | Interest rate swaps | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 0 | 0 | ||
Designated As Hedging Instrument | Fair value hedges | Interest rate swaps | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 0 | 1 | ||
Derivatives not designated as hedges | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 500 | 344 | ||
Derivative liabilities, fair value | 815 | 298 | ||
Derivatives not designated as hedges | Interest rate swaps | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 177 | 6 | ||
Derivatives not designated as hedges | Interest rate swaps | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 452 | 314 | ||
Derivatives not designated as hedges | Foreign currency swaps | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 7 | 0 | ||
Derivatives not designated as hedges | Foreign currency swaps | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 0 | 0 | ||
Derivatives not designated as hedges | Interest rate swaps related to securitization entities | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 26 | [1] | 16 | [1] |
Derivatives not designated as hedges | Interest rate swaps related to securitization entities | Restricted other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 0 | [1] | 0 | [1] |
Derivatives not designated as hedges | Credit default swaps | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 0 | 0 | ||
Derivatives not designated as hedges | Credit default swaps | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 4 | 11 | ||
Derivatives not designated as hedges | Credit default swaps related to securitization entities | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 17 | [1] | 32 | [1] |
Derivatives not designated as hedges | Credit default swaps related to securitization entities | Restricted other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 0 | [1] | 0 | [1] |
Derivatives not designated as hedges | Equity index options | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 0 | 0 | ||
Derivatives not designated as hedges | Equity index options | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 17 | 12 | ||
Derivatives not designated as hedges | Financial futures | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 0 | 0 | ||
Derivatives not designated as hedges | Financial futures | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 0 | 0 | ||
Derivatives not designated as hedges | Equity return swaps | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 1 | 1 | ||
Derivatives not designated as hedges | Equity return swaps | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 0 | 0 | ||
Derivatives not designated as hedges | Other foreign currency contracts | Other liabilities | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 13 | 4 | ||
Derivatives not designated as hedges | Other foreign currency contracts | Other invested assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 14 | 8 | ||
Derivatives not designated as hedges | GMWB embedded derivatives | Policyholder account balances | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 291 | [2] | 96 | [2] |
Derivatives not designated as hedges | GMWB embedded derivatives | Reinsurance recoverable | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 13 | [3] | -1 | [3] |
Derivatives not designated as hedges | Fixed index annuity embedded derivatives | Policyholder account balances | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 276 | [4] | 143 | [4] |
Derivatives not designated as hedges | Fixed index annuity embedded derivatives | Other assets | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | 0 | 0 | ||
Derivatives not designated as hedges | Indexed universal life embedded derivatives | Policyholder account balances | ||||
Derivative [Line Items] | ||||
Derivative liabilities, fair value | 7 | [5] | 0 | [5] |
Derivatives not designated as hedges | Indexed universal life embedded derivatives | Reinsurance recoverable | ||||
Derivative [Line Items] | ||||
Derivative assets, fair value | $0 | $0 | ||
[1] | See note 18 for additional information related to consolidated securitization entities. | |||
[2] | Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | |||
[3] | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | |||
[4] | Represents the embedded derivatives associated with our fixed index annuity liabilities. | |||
[5] | Represents the embedded derivatives associated with our indexed universal life liabilities. |
Activity_Associated_with_Deriv
Activity Associated with Derivative Instruments (Detail) (USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | |
Derivative [Line Items] | ||
Notional amount, beginning balance | $23,263 | |
Additions | 8,650 | |
Maturities/ terminations | -10,527 | |
Notional amount, ending balance | 21,386 | |
Derivatives Designated As Hedges | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 14,765 | |
Additions | 15 | |
Maturities/ terminations | -2,213 | |
Notional amount, ending balance | 12,567 | |
Derivatives Designated As Hedges | Cash Flow Hedges | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 14,759 | |
Additions | 15 | |
Maturities/ terminations | -2,207 | |
Notional amount, ending balance | 12,567 | |
Derivatives Designated As Hedges | Cash Flow Hedges | Interest rate swaps | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 13,926 | |
Additions | 0 | |
Maturities/ terminations | -1,965 | |
Notional amount, ending balance | 11,961 | |
Derivatives Designated As Hedges | Cash Flow Hedges | Inflation indexed swaps | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 561 | |
Additions | 15 | |
Maturities/ terminations | -5 | |
Notional amount, ending balance | 571 | |
Derivatives Designated As Hedges | Cash Flow Hedges | Foreign currency swaps | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 35 | |
Additions | 0 | |
Maturities/ terminations | 0 | |
Notional amount, ending balance | 35 | |
Derivatives Designated As Hedges | Cash Flow Hedges | Forward bond purchase commitments | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 237 | |
Additions | 0 | |
Maturities/ terminations | -237 | |
Notional amount, ending balance | 0 | |
Derivatives Designated As Hedges | Fair value hedges | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 6 | |
Additions | 0 | |
Maturities/ terminations | -6 | |
Notional amount, ending balance | 0 | |
Derivatives Designated As Hedges | Fair value hedges | Interest rate swaps | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 6 | |
Additions | 0 | |
Maturities/ terminations | -6 | |
Notional amount, ending balance | 0 | |
Derivatives not designated as hedges | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 8,498 | |
Additions | 8,635 | |
Maturities/ terminations | -8,314 | |
Notional amount, ending balance | 8,819 | |
Derivatives not designated as hedges | GMWB embedded derivatives | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 42,045 | |
Additions | 0 | |
Maturities/ terminations | -3,030 | |
Notional amount, ending balance | 39,015 | |
Derivatives not designated as hedges | Fixed index annuity embedded derivatives | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 7,705 | |
Additions | 6,436 | |
Maturities/ terminations | -240 | |
Notional amount, ending balance | 13,901 | |
Derivatives not designated as hedges | Indexed universal life embedded derivatives | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 29 | |
Additions | 394 | |
Maturities/ terminations | -2 | |
Notional amount, ending balance | 421 | |
Derivatives not designated as hedges | Interest rate swaps | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 4,822 | |
Additions | 508 | |
Maturities/ terminations | -256 | |
Notional amount, ending balance | 5,074 | |
Derivatives not designated as hedges | Foreign currency swaps | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 0 | |
Additions | 104 | |
Maturities/ terminations | 0 | |
Notional amount, ending balance | 104 | |
Derivatives not designated as hedges | Interest rate swaps related to securitization entities | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 91 | [1] |
Additions | 0 | [1] |
Maturities/ terminations | -14 | [1] |
Notional amount, ending balance | 77 | [1] |
Derivatives not designated as hedges | Credit default swaps | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 639 | |
Additions | 5 | |
Maturities/ terminations | -250 | |
Notional amount, ending balance | 394 | |
Derivatives not designated as hedges | Credit default swaps related to securitization entities | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 312 | [1] |
Additions | 0 | [1] |
Maturities/ terminations | 0 | [1] |
Notional amount, ending balance | 312 | [1] |
Derivatives not designated as hedges | Equity index options | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 777 | |
Additions | 1,276 | |
Maturities/ terminations | -1,059 | |
Notional amount, ending balance | 994 | |
Derivatives not designated as hedges | Financial futures | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 1,260 | |
Additions | 5,723 | |
Maturities/ terminations | -5,652 | |
Notional amount, ending balance | 1,331 | |
Derivatives not designated as hedges | Equity return swaps | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 110 | |
Additions | 231 | |
Maturities/ terminations | -233 | |
Notional amount, ending balance | 108 | |
Derivatives not designated as hedges | Other foreign currency contracts | ||
Derivative [Line Items] | ||
Notional amount, beginning balance | 487 | |
Additions | 788 | |
Maturities/ terminations | -850 | |
Notional amount, ending balance | $425 | |
[1] | See note 18 for additional information related to consolidated securitization entities. |
Schedule_of_PreTax_Income_Loss
Schedule of Pre-Tax Income (Loss) Effects of Cash Flow Hedges (Detail) (Cash Flow Hedges, USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in OCI | $1,215 | ($866) | ($115) | |||
Gain (loss) reclassified into net income (loss) from OCI | 57 | 45 | 35 | |||
Gain (loss) recognized in net income (loss) | 15 | [1] | -14 | [1] | -12 | [1] |
Interest Rate Swaps Hedging Assets | Net Investment Income | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in OCI | 1,229 | -892 | -74 | |||
Gain (loss) reclassified into net income (loss) from OCI | 63 | 47 | 40 | |||
Interest Rate Swaps Hedging Assets | Net Investment Gains (Losses) | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in OCI | 0 | 0 | 0 | |||
Gain (loss) reclassified into net income (loss) from OCI | 2 | 1 | 2 | |||
Gain (loss) recognized in net income (loss) | 15 | [1] | -14 | [1] | -12 | [1] |
Interest Rate Swaps Hedging Liabilities | Net Investment Gains (Losses) | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in net income (loss) | 0 | [1] | 0 | [1] | 0 | [1] |
Interest Rate Swaps Hedging Liabilities | Interest Expense | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in OCI | -69 | 42 | 0 | |||
Gain (loss) reclassified into net income (loss) from OCI | 1 | 2 | 2 | |||
Forward bond purchase commitments | Net Investment Income | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in OCI | 34 | -60 | 14 | |||
Gain (loss) reclassified into net income (loss) from OCI | 0 | 0 | 0 | |||
Forward bond purchase commitments | Net Investment Gains (Losses) | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in net income (loss) | 0 | [1] | 0 | [1] | 0 | [1] |
Inflation indexed swaps | Net Investment Income | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in OCI | 17 | 45 | -58 | |||
Gain (loss) reclassified into net income (loss) from OCI | -9 | -5 | -9 | |||
Inflation indexed swaps | Net Investment Gains (Losses) | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in net income (loss) | 0 | [1] | 0 | [1] | 0 | [1] |
Foreign currency swaps | Net Investment Gains (Losses) | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in net income (loss) | 0 | [1] | 0 | [1] | 0 | [1] |
Foreign currency swaps | Interest Expense | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in OCI | 4 | -1 | 3 | |||
Gain (loss) reclassified into net income (loss) from OCI | 0 | 0 | 0 | |||
Gain Or Loss Recognized In Net Income | Interest Rate Swaps Hedging Assets | Net Investment Gains (Losses) | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Gain (loss) recognized in net income (loss) | $0 | [1] | $0 | [1] | $0 | [1] |
[1] | Represents ineffective portion of cash flow hedges as there were no amounts excluded from the measurement of effectiveness. |
Reconciliation_of_Current_Peri
Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedges (Detail) (USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Derivative Instruments [Abstract] | ||||||
Derivatives qualifying as effective accounting hedges, beginning of period | $1,319 | [1] | $1,909 | [1] | $2,009 | [1] |
Current period increases (decreases) in fair value, net of deferred taxes | 788 | [1] | -561 | [1] | -77 | [1] |
Reclassification to net (income) loss, net of deferred taxes | -37 | [1] | -29 | [1] | -23 | [1] |
Derivatives qualifying as effective accounting hedges, end of period | $2,070 | [1] | $1,319 | [1] | $1,909 | [1] |
[1] | See note 5 for additional information. |
Reconciliation_of_Current_Peri1
Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedges (Parenthetical) (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Current period increases (decreases) in fair value, deferred taxes | ($427) | $305 | $38 |
Reclassification to net (income) loss, deferred taxes | $20 | $16 | $12 |
Derivative_Instruments_Additio
Derivative Instruments - Additional Information (Detail) (USD $) | 12 Months Ended | |||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | ||||
Derivative [Line Items] | ||||||||
Derivatives designated as cash flow hedges gain (loss), amount expected to be reclassified to future net income (loss), net of tax | $2,070 | [1] | $1,319 | [1] | $1,909 | [1] | $2,009 | [1] |
Year by which all forecasted transactions associated with qualifying cash flow hedges are expected to occur | 2047 | |||||||
Derivatives designated as cash flow hedges gain (loss), amount expected to be reclassified to net income (loss) in the next 12 months, net of tax | 57 | |||||||
Derivative assets | Subject to enforceable master netting arrangement | ||||||||
Derivative [Line Items] | ||||||||
Amount to claim from counterparties if the downgrade provisions had been triggered | 47 | [2] | 27 | [2] | ||||
Derivative liabilities | Subject to enforceable master netting arrangement | ||||||||
Derivative [Line Items] | ||||||||
Amount required for disbursement to counterparties if the downgrade provisions had been triggered | $2 | [3] | $5 | [3] | ||||
[1] | See note 5 for additional information. | |||||||
[2] | Included $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2014 and 2013. | |||||||
[3] | Included $6 million and $7 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2014 and 2013, respectively. |
Schedule_of_PreTax_Income_Loss1
Schedule of Pre-Tax Income (Loss) Effects of Fair Value Hedges and Related Hedged Items (Detail) (Fair value hedges, USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Derivative [Line Items] | ||
Gain (loss) recognized in net income (loss) | ($42) | ($30) |
Hedged item, gain (loss) recognized in net income (loss) | 42 | 29 |
Other impacts to net income (loss) | 13 | 36 |
Interest Rate Swaps Hedging Assets | Net Investment Gains (Losses) | ||
Derivative [Line Items] | ||
Gain (loss) recognized in net income (loss) | 1 | |
Hedged item, gain (loss) recognized in net income (loss) | -1 | |
Interest Rate Swaps Hedging Assets | Net Investment Income | ||
Derivative [Line Items] | ||
Other impacts to net income (loss) | -4 | |
Interest Rate Swaps Hedging Liabilities | Interest credited | ||
Derivative [Line Items] | ||
Other impacts to net income (loss) | 13 | 38 |
Interest Rate Swaps Hedging Liabilities | Net Investment Gains (Losses) | ||
Derivative [Line Items] | ||
Gain (loss) recognized in net income (loss) | -11 | -30 |
Hedged item, gain (loss) recognized in net income (loss) | 11 | 30 |
Foreign currency swaps | Interest credited | ||
Derivative [Line Items] | ||
Other impacts to net income (loss) | 0 | 2 |
Foreign currency swaps | Net Investment Gains (Losses) | ||
Derivative [Line Items] | ||
Gain (loss) recognized in net income (loss) | -31 | -1 |
Hedged item, gain (loss) recognized in net income (loss) | $31 | $0 |
Schedule_of_PreTax_Gain_Loss_R
Schedule of Pre-Tax Gain (Loss) Recognized in Net Income (Loss) for Effects of Derivatives not Designated as Hedges (Detail) (Derivatives not designated as hedges, USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | ($110) | $50 | $87 | |||
Interest rate swaps | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | 1 | -7 | 21 | |||
Interest rate swaps related to securitization entities | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | -9 | [1] | 9 | [1] | -4 | [1] |
Credit default swaps | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | 1 | 14 | 57 | |||
Credit default swaps related to securitization entities | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | 19 | [1] | 77 | [1] | 76 | [1] |
Equity index options | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | -31 | -43 | -58 | |||
Financial futures | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | 90 | -232 | -121 | |||
Equity return swaps | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | 5 | -33 | -37 | |||
Other foreign currency contracts | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | -4 | 6 | -19 | |||
Foreign currency swaps | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | -7 | 0 | 0 | |||
Reinsurance embedded derivatives | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | 0 | 0 | 3 | |||
GMWB embedded derivatives | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | -147 | 277 | 170 | |||
Fixed index annuity embedded derivatives | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | -27 | -18 | -1 | |||
Indexed universal life embedded derivatives | Net Investment Gains (Losses) | ||||||
Derivative [Line Items] | ||||||
Pre-tax gain (loss) recognized in net income (loss) | ($1) | $0 | $0 | |||
[1] | See note 18 for additional information related to consolidated securitization entities. |
Additional_Information_about_D
Additional Information about Derivative Assets and Liabilities Subject to Enforceable Master Netting Arrangement (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Derivative [Line Items] | ||||
Gross amounts recognized, derivatives assets | $1,145 | $470 | ||
Gross amounts recognized, derivatives liabilities | 884 | 942 | ||
Subject to enforceable master netting arrangement | ||||
Derivative [Line Items] | ||||
Collateral received | -884 | -199 | ||
Over collateralization, derivatives assets | -4 | -7 | ||
Gross amounts recognized, net derivatives | 884 | -166 | ||
Gross amounts offset in the balance sheet, net derivatives | 0 | 0 | ||
Net amounts presented in the balance sheet, net derivatives | 884 | -166 | ||
Gross amounts not offset in the balance sheet, financial instruments, net derivatives | 0 | [1] | 0 | [1] |
Collateral pledged | 49 | 394 | ||
Net amount | 45 | 22 | ||
Derivative assets | Subject to enforceable master netting arrangement | ||||
Derivative [Line Items] | ||||
Gross amounts recognized, derivatives assets | 1,157 | [2] | 496 | [2] |
Gross amounts offset in the balance sheet, derivatives assets | 0 | [2] | 0 | [2] |
Net amounts presented in the balance sheet, derivatives assets | 1,157 | [2] | 496 | [2] |
Gross amounts not offset in the balance sheet, financial instruments, derivatives assets | -227 | [1],[2] | -286 | [1],[2] |
Collateral received | -884 | [2] | -199 | [2] |
Over collateralization, derivatives assets | 1 | [2] | 16 | [2] |
Net amount, derivatives assets | 47 | [2] | 27 | [2] |
Derivative liabilities | Subject to enforceable master netting arrangement | ||||
Derivative [Line Items] | ||||
Gross amounts recognized, derivatives liabilities | 273 | [3] | 662 | [3] |
Gross amounts offset in the balance sheet, derivatives liabilities | 0 | [3] | 0 | [3] |
Net amounts presented in the balance sheet, derivatives liabilities | 273 | [3] | 662 | [3] |
Gross amounts not offset in the balance sheet, financial instruments, derivative liabilities | -227 | [1],[3] | -286 | [1],[3] |
Collateral pledged | -49 | [3] | -394 | [3] |
Over collateralization, derivatives liabilities | 5 | [3] | 23 | [3] |
Net amount, derivatives liabilities | $2 | [3] | $5 | [3] |
[1] | Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. | |||
[2] | Included $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2014 and 2013. | |||
[3] | Included $6 million and $7 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2014 and 2013, respectively. |
Additional_Information_about_D1
Additional Information about Derivative Assets and Liabilities Subject to Enforceable Master Netting Arrangement (Parenthetical) (Detail) (Subject to enforceable master netting arrangement, USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Derivative assets | ||||
Derivative [Line Items] | ||||
Net amounts presented in the balance sheet, accruals on derivative assets | $1,157 | [1] | $496 | [1] |
Derivative assets | Other assets | ||||
Derivative [Line Items] | ||||
Net amounts presented in the balance sheet, accruals on derivative assets | 25 | 25 | ||
Derivative liabilities | ||||
Derivative [Line Items] | ||||
Net amounts presented in the balance sheet, accruals on derivative liabilities | 273 | [2] | 662 | [2] |
Derivative liabilities | Other liabilities | ||||
Derivative [Line Items] | ||||
Net amounts presented in the balance sheet, accruals on derivative liabilities | $6 | $7 | ||
[1] | Included $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2014 and 2013. | |||
[2] | Included $6 million and $7 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2014 and 2013, respectively. |
Derivative_Instruments_Schedul
Derivative Instruments Schedule of Credit Default Swaps where we Sell Protection on Single Name Reference Entities and Fair Values (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Derivative [Line Items] | ||
Notional value | $21,386 | $23,263 |
Credit default swaps | Single Name Reference Entities | ||
Derivative [Line Items] | ||
Notional value | 39 | 39 |
Assets | 1 | 1 |
Liabilities | 0 | 0 |
Credit default swaps | Single Name Reference Entities | Investment grade | Matures Less Than One Year | ||
Derivative [Line Items] | ||
Notional value | 0 | 0 |
Assets | 0 | 0 |
Liabilities | 0 | 0 |
Credit default swaps | Single Name Reference Entities | Investment grade | Matures After One Year Through Five Years | ||
Derivative [Line Items] | ||
Notional value | 39 | 39 |
Assets | 1 | 1 |
Liabilities | $0 | $0 |
Schedule_of_Credit_Default_Swa
Schedule of Credit Default Swaps where we Sell Protection on Credit Default Swap Index Tranches and Fair Values (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Derivative [Line Items] | ||||
Notional value | $21,386 | $23,263 | ||
Credit default swaps | Original Index Tranche Attachment/Detachment Point And Maturity | Index Tranches | ||||
Derivative [Line Items] | ||||
Notional value | 350 | 600 | ||
Assets | 3 | 10 | ||
Liabilities | 0 | 0 | ||
Credit default swaps | Original Index Tranche Attachment/Detachment Point And Maturity | Index Tranches | Matures Less Than One Year | 9% - 12% | ||||
Derivative [Line Items] | ||||
Notional value | 250 | [1] | 0 | [1] |
Assets | 2 | [1] | 0 | [1] |
Liabilities | 0 | [1] | 0 | [1] |
Credit default swaps | Original Index Tranche Attachment/Detachment Point And Maturity | Index Tranches | Matures Less Than One Year | 10% - 15% | ||||
Derivative [Line Items] | ||||
Notional value | 0 | [2] | 250 | [2] |
Assets | 0 | [2] | 2 | [2] |
Liabilities | 0 | [2] | 0 | [2] |
Credit default swaps | Original Index Tranche Attachment/Detachment Point And Maturity | Index Tranches | Matures After One Year Through Five Years | 7% - 15% | ||||
Derivative [Line Items] | ||||
Notional value | 100 | [3] | 100 | [3] |
Assets | 1 | [3] | 3 | [3] |
Liabilities | 0 | [3] | 0 | [3] |
Credit default swaps | Original Index Tranche Attachment/Detachment Point And Maturity | Index Tranches | Matures After One Year Through Five Years | 9% - 12% | ||||
Derivative [Line Items] | ||||
Notional value | 0 | [1] | 250 | [1] |
Assets | 0 | [1] | 5 | [1] |
Liabilities | 0 | [1] | 0 | [1] |
Credit default swaps | Securitization Entities | Index Tranches | ||||
Derivative [Line Items] | ||||
Notional value | 312 | 312 | ||
Assets | 0 | 0 | ||
Liabilities | 17 | 32 | ||
Credit default swaps | Securitization Entities | Index Tranches | Portion Backing Third-Party Borrowings Maturing 2017 | ||||
Derivative [Line Items] | ||||
Notional value | 12 | [4] | 12 | [4] |
Assets | 0 | [4] | 0 | [4] |
Liabilities | 0 | [4] | 1 | [4] |
Credit default swaps | Securitization Entities | Index Tranches | Portion Backing Interest Maturing 2017 | ||||
Derivative [Line Items] | ||||
Notional value | 300 | [5] | 300 | [5] |
Assets | 0 | [5] | 0 | [5] |
Liabilities | 17 | [5] | 31 | [5] |
Total Credit Default Swaps on Index Tranches | ||||
Derivative [Line Items] | ||||
Notional value | 662 | 912 | ||
Assets | 3 | 10 | ||
Liabilities | $17 | $32 | ||
[1] | The current attachment/detachment as of December 31, 2014 and 2013 was 9% - 12%. | |||
[2] | The current attachment/detachment as of December 31, 2014 and 2013 was 10% - 15%. | |||
[3] | The current attachment/detachment as of December 31, 2014 and 2013 was 7% - 15%. | |||
[4] | Original notional value was $39 million. | |||
[5] | Original notional value was $300 million. |
Schedule_of_Credit_Default_Swa1
Schedule of Credit Default Swaps where we Sell Protection on Credit Default Swap Index Tranches and Fair Values (Parenthetical) (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Derivative [Line Items] | ||||
Notional value | $21,386 | $23,263 | ||
Index Tranches | Original Index Tranche Attachment/Detachment Point And Maturity | Credit default swaps | ||||
Derivative [Line Items] | ||||
Notional value | 350 | 600 | ||
Index Tranches | Securitization Entities | Credit default swaps | ||||
Derivative [Line Items] | ||||
Notional value | 312 | 312 | ||
Index Tranches | Securitization Entities | Portion Backing Third-Party Borrowings Maturing 2017 | Credit default swaps | ||||
Derivative [Line Items] | ||||
Notional value | 12 | [1] | 12 | [1] |
Index Tranches | Securitization Entities | Portion Backing Interest Maturing 2017 | Credit default swaps | ||||
Derivative [Line Items] | ||||
Notional value | 300 | [2] | 300 | [2] |
7% - 15% | Index Tranches | Original Index Tranche Attachment/Detachment Point And Maturity | Matures After One Year Through Five Years | Credit default swaps | ||||
Derivative [Line Items] | ||||
Current attachment percentage | 7.00% | 7.00% | ||
Current detachment percentage | 15.00% | 15.00% | ||
Notional value | 100 | [3] | 100 | [3] |
9% - 12% | Index Tranches | Original Index Tranche Attachment/Detachment Point And Maturity | Matures Less Than One Year | Credit default swaps | ||||
Derivative [Line Items] | ||||
Current attachment percentage | 9.00% | 9.00% | ||
Current detachment percentage | 12.00% | 12.00% | ||
Notional value | 250 | [4] | 0 | [4] |
9% - 12% | Index Tranches | Original Index Tranche Attachment/Detachment Point And Maturity | Matures After One Year Through Five Years | Credit default swaps | ||||
Derivative [Line Items] | ||||
Current attachment percentage | 9.00% | 9.00% | ||
Current detachment percentage | 12.00% | 12.00% | ||
Notional value | 0 | [4] | 250 | [4] |
10% - 15% | Index Tranches | Original Index Tranche Attachment/Detachment Point And Maturity | Matures Less Than One Year | Credit default swaps | ||||
Derivative [Line Items] | ||||
Current attachment percentage | 10.00% | 10.00% | ||
Current detachment percentage | 15.00% | 15.00% | ||
Notional value | 0 | [5] | 250 | [5] |
Original Amount | Securitization Entities | Portion Backing Third-Party Borrowings Maturing 2017 | ||||
Derivative [Line Items] | ||||
Notional value | 39 | |||
Original Amount | Securitization Entities | Portion Backing Interest Maturing 2017 | ||||
Derivative [Line Items] | ||||
Notional value | $300 | |||
[1] | Original notional value was $39 million. | |||
[2] | Original notional value was $300 million. | |||
[3] | The current attachment/detachment as of December 31, 2014 and 2013 was 7% - 15%. | |||
[4] | The current attachment/detachment as of December 31, 2014 and 2013 was 9% - 12%. | |||
[5] | The current attachment/detachment as of December 31, 2014 and 2013 was 10% - 15%. |
Activity_Impacting_Deferred_Ac
Activity Impacting Deferred Acquisition Costs (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Unamortized balance as of January 1 | $5,454 | $5,460 | $5,458 |
Impact of foreign currency translation | -44 | -12 | 9 |
Costs deferred | 473 | 457 | 611 |
Amortization, net of interest accretion | -493 | -451 | -618 |
Unamortized balance as of December 31 | 5,390 | 5,454 | 5,460 |
Accumulated effect of net unrealized investment (gains) losses | -348 | -176 | -424 |
Balance as of December 31 | $5,042 | $5,278 | $5,036 |
Deferred_Acquisition_Costs_Add
Deferred Acquisition Costs - Additional Information (Detail) (USD $) | 12 Months Ended | 3 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Mar. 31, 2012 |
Deferred Policy Acquisition Costs [Line Items] | |||||
DAC Amortization expense | $493 | $451 | $618 | ||
Life Block Transaction | Loss Recognition Testing | |||||
Deferred Policy Acquisition Costs [Line Items] | |||||
DAC Amortization expense | 39 | ||||
Life Block Transaction | Term Life Reinsurance Write-Off | |||||
Deferred Policy Acquisition Costs [Line Items] | |||||
DAC Amortization expense | $142 |
Intangible_Assets_Detail
Intangible Assets (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross carrying amount | $2,995 | $3,014 |
Accumulated amortization | -2,723 | -2,615 |
Present Value Of Future Profits | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross carrying amount | 1,995 | 2,061 |
Accumulated amortization | -1,917 | -1,900 |
Capitalized Software | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross carrying amount | 736 | 704 |
Accumulated amortization | -604 | -545 |
Deferred Sales Inducements To Contractholders | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross carrying amount | 209 | 195 |
Accumulated amortization | -153 | -123 |
Other Intangible Assets | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross carrying amount | 55 | 54 |
Accumulated amortization | ($49) | ($47) |
Intangible_Assets_Additional_I
Intangible Assets - Additional Information (Detail) (USD $) | 12 Months Ended | 3 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2014 |
Finite-Lived Intangible Assets [Line Items] | ||||
Amortization expense related to PVFP, capitalized software and other intangible assets | $78 | $118 | $104 | |
Amortization expense related to deferred sales inducements | 30 | 24 | 29 | |
PVFP amortization expense | 31 | 66 | 60 | |
Long-term Care Insurance | Loss Recognition Testing | Acquired Block | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
PVFP amortization expense | $6 |
Activity_in_Present_Value_of_F
Activity in Present Value of Future Profits (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Finite-Lived Intangible Assets [Line Items] | |||
Unamortized balance as of January 1 | $246 | $297 | $339 |
Interest accreted at 5.89%, 5.52% and 5.66% | 14 | 15 | 18 |
Amortization | -31 | -66 | -60 |
Unamortized balance as of December 31 | 229 | 246 | 297 |
Accumulated effect of net unrealized investment (gains) losses | -151 | -85 | -180 |
Balance as of December 31 | $78 | $161 | $117 |
Activity_in_Present_Value_of_F1
Activity in Present Value of Future Profits (Parenthetical) (Detail) | 12 Months Ended | ||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |
Finite-Lived Intangible Assets [Line Items] | |||
Interest accreted percentage | 5.89% | 5.52% | 5.66% |
Percentage_of_PVFP_Balance_Net
Percentage of PVFP Balance Net of Interest Accretion, before Effect of Unrealized Investment Gains or Losses, Estimated to be Amortized Over Next Five years (Detail) | 12 Months Ended |
Dec. 31, 2014 | |
Finite-Lived Intangible Assets [Line Items] | |
2015 | 9.10% |
2016 | 11.10% |
2017 | 9.50% |
2018 | 7.70% |
2019 | 6.20% |
Summary_of_Goodwill_Balance_by
Summary of Goodwill Balance by Segment and Corporate and Other Activities (Detail) (USD $) | 12 Months Ended | 3 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2014 | Sep. 30, 2012 |
Goodwill [Line Items] | |||||
Impairment losses | ($849) | $0 | ($89) | ||
Foreign exchange translation | -2 | -1 | |||
Gross goodwill | 1,231 | 1,233 | 1,263 | 1,231 | |
Accumulated impairment losses | -1,215 | -366 | -395 | -1,215 | |
Goodwill | 16 | 867 | 868 | 16 | |
U.S. Life Insurance | |||||
Goodwill [Line Items] | |||||
Impairment losses | -849 | -299 | |||
Foreign exchange translation | 0 | 0 | |||
Gross goodwill | 1,034 | 1,034 | 1,034 | 1,034 | |
Accumulated impairment losses | -1,034 | -185 | -185 | -1,034 | |
Goodwill | 0 | 849 | 849 | 0 | |
International Mortgage Insurance | |||||
Goodwill [Line Items] | |||||
Impairment losses | 0 | ||||
Foreign exchange translation | -2 | -1 | |||
Gross goodwill | 16 | 18 | 19 | 16 | |
Accumulated impairment losses | 0 | 0 | 0 | 0 | |
Goodwill | 16 | 18 | 19 | 16 | |
U.S. Mortgage Insurance | |||||
Goodwill [Line Items] | |||||
Impairment losses | 0 | ||||
Foreign exchange translation | 0 | 0 | |||
Gross goodwill | 22 | 22 | 22 | 22 | |
Accumulated impairment losses | -22 | -22 | -22 | -22 | |
Goodwill | 0 | 0 | 0 | 0 | |
International Protection | |||||
Goodwill [Line Items] | |||||
Impairment losses | 0 | -89 | |||
Foreign exchange translation | 0 | 0 | |||
Gross goodwill | 89 | 89 | 89 | 89 | |
Accumulated impairment losses | -89 | -89 | -89 | -89 | |
Goodwill | 0 | 0 | 0 | 0 | |
Runoff | |||||
Goodwill [Line Items] | |||||
Impairment losses | 0 | ||||
Foreign exchange translation | 0 | 0 | |||
Gross goodwill | 70 | 70 | 70 | 70 | |
Accumulated impairment losses | -70 | -70 | -70 | -70 | |
Goodwill | 0 | 0 | 0 | 0 | |
Corporate and Other | |||||
Goodwill [Line Items] | |||||
Impairment losses | 0 | ||||
Foreign exchange translation | 0 | 0 | |||
Gross goodwill | 0 | 0 | 29 | 0 | |
Accumulated impairment losses | 0 | 0 | -29 | 0 | |
Goodwill | $0 | $0 | $0 | $0 |
Goodwill_and_Dispositions_Addi
Goodwill and Dispositions - Addition Information (Detail) (USD $) | 12 Months Ended | 1 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Apr. 02, 2013 | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Sep. 30, 2012 |
Goodwill [Line Items] | ||||||||
Goodwill impairment | $849 | $0 | $89 | |||||
Goodwill | 16 | 867 | 868 | 16 | ||||
Reverse Mortgage Business | ||||||||
Goodwill [Line Items] | ||||||||
Proceeds from sale of business | 22 | |||||||
U.S. Life Insurance | ||||||||
Goodwill [Line Items] | ||||||||
Goodwill impairment | 849 | 299 | ||||||
Goodwill | 0 | 849 | 849 | 0 | ||||
Life Insurance | ||||||||
Goodwill [Line Items] | ||||||||
Goodwill impairment | 495 | 145 | 350 | |||||
Goodwill | 145 | |||||||
Long-term Care Insurance | ||||||||
Goodwill [Line Items] | ||||||||
Goodwill impairment | 354 | 154 | 200 | |||||
Goodwill | 154 | |||||||
Overall long-term care insurance industry sales decline | 30.00% | |||||||
International Protection | ||||||||
Goodwill [Line Items] | ||||||||
Goodwill impairment | 0 | 89 | ||||||
Goodwill | $0 | $0 | $0 | $0 |
Reinsurance_Additional_Informa
Reinsurance - Additional Information (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
Maximum amount of individual ordinary life insurance normally retained by us on any one individual life policy | $5 | ||
Reinsurance recoverable | 17,346 | 17,219 | |
Minimum amount of risk-based capital General Electric Capital Corporation agreed to maintain | 150.00% | ||
Reinsurance recoveries recognized as a reduction of benefits and other changes in reserves | 2,872 | 2,645 | 2,951 |
U.S. Life Insurance Subsidiaries | Fixed maturity securities | |||
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
Assets pledged as collateral | 8,737 | 7,823 | |
U.S. Life Insurance Subsidiaries | Commercial Mortgage Loan | |||
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
Assets pledged as collateral | 544 | 603 | |
International Mortgage Insurance Subsidiaries | Other invested assets | |||
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
Assets pledged as collateral | 33 | ||
Union Fidelity Life Insurance Company | Ceded Credit Risk | |||
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items] | |||
Reinsurance recoverable | $14,494 | $14,622 |
Net_Domestic_Life_Insurance_In
Net Domestic Life Insurance In-Force (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
In Millions, unless otherwise specified | ||||||
Reinsurance [Abstract] | ||||||
Direct life insurance in-force | $701,797 | $708,271 | $730,016 | |||
Amounts assumed from other companies | 935 | 1,070 | 1,148 | |||
Amounts ceded to other companies | -393,244 | [1] | -313,593 | [1] | -331,909 | [1] |
Net life insurance in-force | $309,488 | $395,748 | $399,255 | |||
Percentage of amount assumed to net | 0.00% | 0.00% | 0.00% | |||
[1] | Includes amounts accounted for under the deposit method. |
Effects_of_Reinsurance_on_Prem
Effects of Reinsurance on Premiums Written and Earned (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Reinsurance [Abstract] | |||
Direct, Written | $6,226 | $5,922 | $5,952 |
Assumed, Written | 635 | 431 | 455 |
Ceded, Written | -1,239 | -1,169 | -1,350 |
Net premiums, Written | 5,622 | 5,184 | 5,057 |
Direct, Earned | 6,029 | 5,852 | 5,873 |
Assumed, Earned | 630 | 455 | 489 |
Ceded, Earned | -1,228 | -1,159 | -1,321 |
Net premiums, Earned | 5,431 | 5,148 | 5,041 |
Percentage of amount assumed to net | 12.00% | 9.00% | 10.00% |
Life insurance | |||
Reinsurance [Abstract] | |||
Direct, Written | 1,241 | 1,199 | 1,284 |
Assumed, Written | 45 | 9 | 9 |
Ceded, Written | -351 | -342 | -528 |
Direct, Earned | 1,257 | 1,214 | 1,304 |
Assumed, Earned | 39 | 8 | 7 |
Ceded, Earned | -351 | -343 | -527 |
Accident and Health Insurance Product Line | |||
Reinsurance [Abstract] | |||
Direct, Written | 3,063 | 2,944 | 2,853 |
Assumed, Written | 568 | 403 | 419 |
Ceded, Written | -790 | -735 | -690 |
Direct, Earned | 3,087 | 2,945 | 2,840 |
Assumed, Earned | 559 | 414 | 440 |
Ceded, Earned | -783 | -725 | -672 |
Property, Liability and Casualty Insurance Product Line | |||
Reinsurance [Abstract] | |||
Direct, Written | 108 | 97 | 95 |
Assumed, Written | 2 | 0 | 0 |
Ceded, Written | -3 | 0 | 0 |
Direct, Earned | 97 | 85 | 84 |
Assumed, Earned | 1 | 0 | 0 |
Ceded, Earned | -3 | 0 | 0 |
Mortgage insurance | |||
Reinsurance [Abstract] | |||
Direct, Written | 1,814 | 1,682 | 1,720 |
Assumed, Written | 20 | 19 | 27 |
Ceded, Written | -95 | -92 | -132 |
Direct, Earned | 1,588 | 1,608 | 1,645 |
Assumed, Earned | 31 | 33 | 42 |
Ceded, Earned | ($91) | ($91) | ($122) |
Recorded_Liabilities_and_Major
Recorded Liabilities and Major Assumptions Underlying Future Policy Benefits (Detail) (USD $) | 12 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | ||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||||
Future policy benefits | $35,915 | $33,705 | ||
Long Term Care Insurance Contracts | ||||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||||
Liability for long-term care insurance contracts, Interest rate assumption, Low end | 3.75% | [1] | 3.75% | [1] |
Liability for long-term care insurance contracts, Interest rate assumption, High end | 7.50% | [1] | 7.50% | [1] |
Future policy benefits | 19,310 | [1] | 17,023 | [1] |
Structured Settlements with Life Contingencies | ||||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||||
Structured settlements with life contingencies, Interest rate assumption, Lower limit | 1.50% | [2] | 1.50% | [2] |
Structured settlements with life contingencies, Interest rate assumption, Upper limit | 8.00% | [2] | 8.00% | [2] |
Future policy benefits | 9,133 | [2] | 9,267 | [2] |
Annuity Contracts with Life Contingencies | ||||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||||
Liability for policyholder contract deposits, Interest rate, annuities, Low end | 1.50% | [2] | 1.50% | [2] |
Liability for policyholder contract deposits, Interest rate, annuities, High end | 8.00% | [2] | 8.00% | [2] |
Future policy benefits | 4,470 | [2] | 4,425 | [2] |
Traditional Life Insurance Contracts | ||||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||||
Traditional life insurance contracts, Interest rate assumption, Lower limit | 3.00% | [3] | 3.00% | [3] |
Traditional life insurance contracts, Interest rate assumption, Upper limit | 7.50% | [3] | 7.50% | [3] |
Future policy benefits | 2,733 | [3] | 2,736 | [3] |
Supplementary Contracts with Life Contingencies | ||||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||||
Supplementary contracts with life contingencies, Interest rate, Low end | 1.50% | [2] | 1.50% | [2] |
Supplementary contracts with life contingencies, Interest rate, High end | 8.00% | [2] | 8.00% | [2] |
Future policy benefits | 265 | [2] | 249 | [2] |
Accident and Health Insurance Contracts | ||||
Liability for Future Policy Benefit, by Product Segment [Line Items] | ||||
Accident and health insurance contracts, Interest rate, Low end | 3.50% | [4] | 3.50% | [4] |
Accident and health insurance contracts, Interest rate, High end | 7.00% | [4] | 7.00% | [4] |
Future policy benefits | $4 | [4] | $5 | [4] |
[1] | The 1983 Individual Annuitant Mortality Table or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality Table and the 1985 National Nursing Home Study and company experience. | |||
[2] | Assumptions for limited-payment contracts come from either the U.S. Population Table, 1983 Group Annuitant Mortality Table, 1983 Individual Annuitant Mortality Table or Annuity 2000 Mortality Table. | |||
[3] | Principally modifications based on company experience of the Society of Actuaries 1965-70 or 1975-80 Select and Ultimate Tables, 1941, 1958, 1980 and 2001 Commissioner's Standard Ordinary Tables, 1980 Commissioner's Extended Term table and (IA) Standard Table 1996 (modified). | |||
[4] | The 1958 and 1980 Commissioner's Standard Ordinary Tables, or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality. |
Insurance_Reserves_Additional_
Insurance Reserves - Additional Information (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Long-term Care Insurance | Loss Recognition Testing | Acquired Block | ||
Insurance Reserves [Line Items] | ||
Present value of future profits balance written off | $6 | |
Increase in reserves from loss recognition testing | 710 | |
Federal Home Loan Bank | ||
Insurance Reserves [Line Items] | ||
Federal Home Loan Bank common stock held | 33 | 70 |
Amount of funding agreements issued to the Federal Home Loan Bank | 199 | 493 |
Letters of credit related to the Federal Home Loan Bank | 583 | 583 |
Pledged assets for Federal Home Loan Bank at fair value | 854 | 1,153 |
Variable Annuity | Nontraditional Long-Duration Contracts | ||
Insurance Reserves [Line Items] | ||
Nontraditional long-duration contracts liability | 7,108 | 7,704 |
Guaranteed Minimum Death Benefit | Nontraditional Long-Duration Contracts | Annuity contracts | ||
Insurance Reserves [Line Items] | ||
Nontraditional long-duration contracts liability | 55 | 39 |
Guaranteed Minimum Withdrawal And Guaranteed Annuitization Benefit Contracts | ||
Insurance Reserves [Line Items] | ||
Guaranteed annuitization benefit contracts | $532 | $467 |
Recorded_Liabilities_for_Polic
Recorded Liabilities for Policyholder Account Balances (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Insurance Reserves [Line Items] | ||
Policyholder account balances | $26,043 | $25,528 |
Investment contracts | ||
Insurance Reserves [Line Items] | ||
Policyholder account balances | 17,497 | 17,330 |
Investment contracts | Annuity contracts | ||
Insurance Reserves [Line Items] | ||
Policyholder account balances | 14,406 | 13,730 |
Investment contracts | GICs, funding agreements and FABNs | ||
Insurance Reserves [Line Items] | ||
Policyholder account balances | 493 | 896 |
Investment contracts | Structured settlements without life contingencies | ||
Insurance Reserves [Line Items] | ||
Policyholder account balances | 1,828 | 1,956 |
Investment contracts | Supplementary contracts without life contingencies | ||
Insurance Reserves [Line Items] | ||
Policyholder account balances | 742 | 714 |
Investment contracts | Other | ||
Insurance Reserves [Line Items] | ||
Policyholder account balances | 28 | 34 |
Universal life insurance contracts | ||
Insurance Reserves [Line Items] | ||
Policyholder account balances | $8,546 | $8,198 |
Information_about_Variable_Ann
Information about Variable Annuity Products Death and Living Benefit Guarantees (Detail) (USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Guaranteed minimum standard death benefit | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Death benefits account value | $2,877 | $3,164 |
Net amount at risk | 5 | 6 |
Average attained age of contractholders | 72 years | 72 years |
Guaranteed minimum enhanced death benefit | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Death benefits account value | 3,443 | 3,853 |
Net amount at risk | 119 | 114 |
Average attained age of contractholders | 73 years | 72 years |
Guaranteed minimum living benefit | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Living benefit guarantees | 3,675 | 4,054 |
Guaranteed annuitization benefits | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Living benefit guarantees | $1,362 | $1,508 |
Account_Balances_of_Variable_A
Account Balances of Variable Annuity Contract with Death or Living Benefit Guarantees Invested in Separate Account Investment Options (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | |
In Millions, unless otherwise specified | |||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | |||
Separate account investment | $6,290 | $6,960 | [1] |
Balanced funds | |||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | |||
Separate account investment | 3,848 | 4,187 | [1] |
Equity funds | |||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | |||
Separate account investment | 1,639 | 1,778 | [1] |
Bond funds | |||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | |||
Separate account investment | 707 | 897 | [1] |
Money market funds | |||
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items] | |||
Separate account investment | $96 | $98 | [1] |
[1] | The balances as of December 31, 2013 have been represented as a result of classification changes and to exclude fixed account assets from bond funds. |
Liability_for_Policy_and_Contr2
Liability for Policy and Contract Claims (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Millions, unless otherwise specified | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total liability for policy and contract claims | $8,043 | $7,204 | ||
Long-term Care Insurance | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total liability for policy and contract claims | 6,216 | 4,999 | 4,655 | 4,130 |
U.S. Mortgage Insurance | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total liability for policy and contract claims | 1,180 | 1,482 | 2,009 | 2,488 |
International Mortgage Insurance | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total liability for policy and contract claims | 308 | 378 | ||
Life Insurance | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total liability for policy and contract claims | 197 | 188 | ||
Lifestyle Protection Insurance | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total liability for policy and contract claims | 106 | 108 | ||
Fixed Annuities | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total liability for policy and contract claims | 21 | 29 | ||
Runoff | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Total liability for policy and contract claims | $15 | $20 |
Changes_in_Liability_for_Polic
Changes in Liability for Policy and Contract Claims (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] | |||
Ending balance as of December 31 | $8,043 | $7,204 | |
Long-term Care Insurance | |||
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] | |||
Beginning balance | 4,999 | 4,655 | 4,130 |
Less reinsurance recoverables | -1,707 | -1,574 | -1,387 |
Net balance as of January 1 | 3,292 | 3,081 | 2,743 |
Current year | 1,474 | 1,323 | 1,271 |
Prior years | 726 | 3 | 93 |
Total incurred | 2,200 | 1,326 | 1,364 |
Current year | -134 | -131 | -111 |
Prior years | -1,263 | -1,160 | -1,068 |
Total paid | -1,397 | -1,291 | -1,179 |
Interest on liability for policy and contract claims | 195 | 176 | 153 |
Net balance as of December 31 | 4,290 | 3,292 | 3,081 |
Add reinsurance recoverables | 1,926 | 1,707 | 1,574 |
Ending balance as of December 31 | 6,216 | 4,999 | 4,655 |
U.S. Mortgage Insurance | |||
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] | |||
Beginning balance | 1,482 | 2,009 | 2,488 |
Less reinsurance recoverables | -44 | -80 | -178 |
Net balance as of January 1 | 1,438 | 1,929 | 2,310 |
Current year | 328 | 476 | 717 |
Prior years | 29 | -63 | 7 |
Total incurred | 357 | 413 | 724 |
Current year | -21 | -45 | -92 |
Prior years | -618 | -859 | -1,013 |
Total paid | -639 | -904 | -1,105 |
Net balance as of December 31 | 1,156 | 1,438 | 1,929 |
Add reinsurance recoverables | 24 | 44 | 80 |
Ending balance as of December 31 | $1,180 | $1,482 | $2,009 |
Liability_for_Policy_and_Contr3
Liability for Policy and Contract Claims - Additional Information (Detail) (Long-term Care Insurance, USD $) | 3 Months Ended | 12 Months Ended | 3 Months Ended | |||
In Millions, unless otherwise specified | Sep. 30, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||
Increase in reinsurance recoverable | $1,926 | $1,926 | $1,707 | $1,574 | $1,387 | |
Reserve Correction | ||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||
Increase (Decrease) in claim reserves | 61 | 604 | ||||
Changes in assumptions and methodologies | ||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||
Increase in reinsurance recoverable | 73 | 73 | ||||
Correction to Claims Reserve | ||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||
Increase (Decrease) in claim reserves | 81 | |||||
Revised Interest Rate Assumption | ||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||
Increase (Decrease) in claim reserves | 21 | |||||
Refinement of Claim Termination Rate Assumptions | ||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||||
Increase (Decrease) in claim reserves | -49 | |||||
Increase in reinsurance recoverable | $17 | $17 |
Employee_Benefit_Plans_Additio
Employee Benefit Plans - Additional Information (Detail) (USD $) | 12 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2009 |
Savings Plan | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Costs associated with plan | $16 | $17 | $20 | |
Maximum contribution to employees savings plans, revised plan | 6.00% | |||
Defined contribution plan required years of service to vest for employees hired on or after January 1, 2011 | 2 years | |||
Deposits recorded by our life insurance subsidiaries | 1 | 1 | ||
Defined Contribution Pension Plan | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Percentage funding of plan by Genworth | 100.00% | |||
Defined contribution pension plan required years of service to vest | 3 years | |||
Liability related to benefit plan | -13 | -13 | ||
Defined Benefit Pension Plans | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Liability related to benefit plan | -71 | -38 | ||
Change in other comprehensive income, increase (reduction) | -34 | 23 | ||
Defined Benefit Pension Plans | United Kingdom | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Curtailment gain | 4 | |||
Retiree Health and Life Insurance Benefit Plans | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Liability related to benefit plan | -90 | -79 | ||
Change in other comprehensive income, increase (reduction) | -10 | 11 | ||
Curtailment gain | 1 | |||
Age for retirees receiving policy coverage | 65 years | |||
Number of years before retirement eligibility at which retiree medical benefits are available to employees | 10 years | |||
Pension and Retiree Health and Life Insurance Benefit Plans | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Costs associated with plan | $21 | $22 | $28 |
Borrowings_and_Other_Financing2
Borrowings and Other Financings - Additional Information (Detail) | 12 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 3 Months Ended | 1 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2014 | Dec. 31, 2013 | 31-May-14 | Dec. 31, 2013 | Apr. 02, 2013 | Dec. 31, 2013 | Jan. 31, 2012 | Sep. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2014 | Dec. 31, 2013 | Mar. 26, 2012 | Dec. 31, 2014 | Dec. 31, 2012 | Jan. 31, 2012 | Dec. 31, 2012 | Sep. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2012 | Sep. 30, 2012 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2012 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Aug. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Aug. 31, 2013 | Jun. 30, 2013 | Mar. 31, 2012 | Mar. 31, 2011 | Dec. 31, 2012 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Apr. 30, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Jun. 30, 2014 | Jun. 30, 2011 | Dec. 31, 2014 | Dec. 31, 2013 | Jun. 30, 2013 | Feb. 28, 2009 | Dec. 31, 2014 | Sep. 30, 2013 | Sep. 30, 2013 | |||
USD ($) | USD ($) | USD ($) | Debt Covenant | Genworth Holdings | Genworth Mortgage Insurance Corporation (GEMICO) | Genworth Mortgage Insurance Corporation (GEMICO) | Genworth Mortgage Insurance Corporation (GEMICO) | U.S. Mortgage Insurance | Life Block Transaction | Life Block Transaction | Life Block Transaction | River Lake Insurance Company II (a), Due 2035 | River Lake Insurance Company II (a), Due 2035 | River Lake IV | River Lake IV | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Non-Recourse Funding Obligations | Fixed Rate Senior Notes | Fixed Rate Senior Notes | Fixed Rate Senior Notes | 5.75% Senior Notes, Due 2014 | 5.75% Senior Notes, Due 2014 | 5.75% Senior Notes, Due 2014 | 5.75% Senior Notes, Due 2014 | 4.80% Senior Notes, Due 2024 | 4.80% Senior Notes, Due 2024 | 4.80% Senior Notes, Due 2024 | 4.90% Senior Notes, Due 2023 | 4.90% Senior Notes, Due 2023 | 4.90% Senior Notes, Due 2023 | 4.95% Senior Notes, Due 2015 | 4.95% Senior Notes, Due 2015 | 7.625% Senior Notes, Due September 2021 | 7.625% Senior Notes, Due September 2021 | 5.65% Senior Notes, Due 2012 | Junior Notes due Two Thousand and Sixty Six | 5.68% Senior Notes, Due 2020 | 5.68% Senior Notes, Due 2020 | 4.24% Senior Notes, Due 2024 | 4.24% Senior Notes, Due 2024 | 4.24% Senior Notes, Due 2024 | 4.59% senior notes due December 2015 | Floating Rate Junior Notes, Due 2021 | Floating Rate Junior Notes, Due 2021 | Floating Rate Junior Notes, Due 2021 | Short-term borrowings | Short-term borrowings | Short-term borrowings | Short-term borrowings | Letter of Credit | |||
Extension | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Class B Floating Rate Subordinated Notes Due 2028 | Class B Floating Rate Subordinated Notes Due 2028 | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Floating Rate Subordinated Notes Due in 2035 | Floating Rate Subordinated Notes Due 2033 | Floating Rate Subordinated Notes Due 2033 | River Lake Insurance Company II (a), Due 2035 | River Lake IV | River Lake IV | Genworth Holdings | Minimum | Maximum | Genworth Holdings | Genworth Holdings | Genworth Holdings | Maximum | Genworth Holdings | Genworth Holdings | Genworth Holdings | Genworth Holdings | Genworth Holdings | Genworth Holdings | Genworth Holdings | Genworth Holdings | Genworth Holdings | Genworth Holdings | Genworth Holdings | Genworth Holdings | Genworth MI Canada Inc. | Genworth MI Canada Inc. | Genworth MI Canada Inc. | Genworth MI Canada Inc. | Genworth MI Canada Inc. | Genworth MI Canada Inc. | Genworth Financial Mortgage Insurance Pty Limited | Genworth Financial Mortgage Insurance Pty Limited | Genworth Financial Mortgage Insurance Pty Limited | Commercial Paper | Commercial Paper | Revolving Credit Facility Maturing September 2016 | Revolving Credit Facility Maturing September 2016 | Revolving Credit Facility Maturing September 2016 | |||||||
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Genworth Holdings | Genworth Holdings | USD ($) | USD ($) | USD ($) | Genworth Holdings | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | CAD | CAD | AUD | USD ($) | USD ($) | USD ($) | USD ($) | ||||||||||||||||||||||||||||||||||||
USD ($) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commercial paper program, terminated | $1,000,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commercial paper program, amount outstanding | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Facility, maximum borrowing capacity | 300,000,000 | 100,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Line of credit facility, expiration date | 30-Sep-16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount outstanding, credit facility | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Extend maturity date | 1 year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of extensions | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Request to extend maturity date, commitments consent | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Priority Indebtness | 7.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial covenants, maximum capitalization ratio | 0.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial covenants, consolidated net worth | 8,900,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial covenants, consolidated net income | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit facility covenant for regulatory proceedings | 30 days | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Customary events of default, cross-defaults with other material indebtedness, minimum | 100,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest rate | 4.80% | 8.63% | 5.75% | 5.75% | 4.80% | 4.80% | 4.80% | 4.90% | 4.90% | 4.90% | 4.95% | 7.63% | 7.63% | 5.65% | 6.15% | 5.68% | 5.68% | 4.24% | 4.24% | 4.24% | 4.59% | |||||||||||||||||||||||||||||||||||||||||||
Senior notes redemption option | 100.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt instrument, redemption description | We have the option to redeem all or a portion of each series of senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repayment of debt | 485,000,000 | 222,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity month and year | 2014-06 | 2012-06 | 2066-11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued notes, aggregate principal amount | 400,000,000 | 400,000,000 | 400,000,000 | 400,000,000 | 400,000,000 | 598,000,000 | 160,000,000 | 140,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt instrument, maturity year | 2035 | [1] | 2035 | [1] | 2035 | 2033 | 2033 | 2014 | 2014 | 2024 | 2024 | 2024 | 2023 | 2023 | 2023 | 2015 | 2020 | 2020 | 2024 | 2024 | 2024 | 2021 | 2021 | 2021 | ||||||||||||||||||||||||||||||||||||||||
Issued senior notes, net proceeds | 397,000,000 | 396,000,000 | 358,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capital contributions | 300,000,000 | 100,000,000 | 100,000,000 | 300,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Early redemption of senior notes | 346,000,000 | 150,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pre-tax make-whole expense on redemption of senior notes | 30,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate principal amount of notes repurchased | 100,000,000 | 15,000,000 | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt tender offer | 100,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pre-tax gain (loss) on repurchase of senior notes | 4,000,000 | -6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, increase, additional borrowing | 350,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Public offering price | 103.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Issued senior notes, effective interest rates | 7.18% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarterly interest rate after November 15, 2016 | Three-month London Interbank Offered Rate ("LIBOR") plus 2.0025% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scheduled redemption date | 15-Nov-36 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Redemption date, subject to terms | 15-Nov-16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Right to defer the payment of interest on the 2066 Notes during period, years | 10 years | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Early redemption fee | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest paid | 437,000,000 | 453,000,000 | 465,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subordinated floating rate notes, margin | 4.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repayment of secured debt | 3,000,000 | 16,000,000 | 26,000,000 | 28,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase of secured debt | 475,000,000 | 20,000,000 | 176,000,000 | 20,000,000 | 235,000,000 | 270,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secured Debt | 1,996,000,000 | 2,038,000,000 | 192,000,000 | [1] | 192,000,000 | [1] | 8,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Maturity date | 25-May-28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. GAAP after-tax gain on repurchase transaction | 52,000,000 | 21,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Increase in amortization of DAC, due to loss recognition testing | 25,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net U.S. GAAP after-tax loss | 41,000,000 | 6,000,000 | 41,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. GAAP after-tax loss on reinsurance transaction | $93,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Non-recourse funding obligations weighted-average interest rate | 1.51% | 1.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[1] | Accrual of interest based on one-month LIBOR that resets every 28 days plus a fixed margin. |
Schedule_of_Long_Term_Borrowin
Schedule of Long Term Borrowings (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | $4,639 | $5,161 |
Genworth Holdings | 5.75% Senior Notes, Due 2014 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 0 | 485 |
Genworth Holdings | 8.625% Senior Notes, Due 2016 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 300 | 300 |
Genworth Holdings | 6.52% Senior Notes, Due 2018 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 600 | 600 |
Genworth Holdings | 7.70% Senior Notes, Due 2020 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 400 | 400 |
Genworth Holdings | 7.20% Senior Notes, Due 2021 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 399 | 399 |
Genworth Holdings | 7.625% Senior Notes, Due 2021 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 758 | 759 |
Genworth Holdings | 4.90% Senior Notes, Due 2023 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 399 | 399 |
Genworth Holdings | 4.80% Senior Notes, Due 2024 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 400 | 400 |
Genworth Holdings | 6.50% Senior Notes, Due 2034 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 297 | 297 |
Genworth Holdings | 6.15% Fixed-to-Floating Rate Junior Subordinated Notes, Due 2066 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 598 | 598 |
Genworth MI Canada Inc. | 4.59% Senior Notes, Due 2015 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 0 | 141 |
Genworth MI Canada Inc. | 5.68% Senior Notes, Due 2020 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 236 | 258 |
Genworth MI Canada Inc. | 4.24% Senior Notes, Due 2024 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | 138 | 0 |
Genworth Financial Mortgage Insurance Pty Limited | Floating Rate Junior Notes, Due 2021 | ||
Debt Instrument [Line Items] | ||
Long-term borrowings | $114 | $125 |
Schedule_of_Long_Term_Borrowin1
Schedule of Long Term Borrowings (Parenthetical) (Detail) | 12 Months Ended | 1 Months Ended | ||||
Dec. 31, 2014 | Dec. 31, 2013 | Aug. 31, 2013 | Dec. 31, 2013 | Apr. 30, 2014 | Jun. 30, 2011 | |
5.75% Senior Notes, Due 2014 | Genworth Holdings | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 5.75% | 5.75% | 5.75% | |||
Debt instrument, maturity year | 2014 | 2014 | ||||
8.625% Senior Notes, Due 2016 | Genworth Holdings | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 8.63% | 8.63% | 8.63% | |||
Debt instrument, maturity year | 2016 | 2016 | ||||
6.52% Senior Notes, Due 2018 | Genworth Holdings | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 6.52% | 6.52% | 6.52% | |||
Debt instrument, maturity year | 2018 | 2018 | ||||
7.70% Senior Notes, Due 2020 | Genworth Holdings | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 7.70% | 7.70% | 7.70% | |||
Debt instrument, maturity year | 2020 | 2020 | ||||
7.20% Senior Notes, Due 2021 | Genworth Holdings | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 7.20% | 7.20% | 7.20% | |||
Debt instrument, maturity year | 2021 | 2021 | ||||
7.625% Senior Notes, Due 2021 | Genworth Holdings | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 7.63% | 7.63% | 7.63% | |||
Debt instrument, maturity year | 2021 | 2021 | ||||
4.90% Senior Notes, Due 2023 | Genworth Holdings | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 4.90% | 4.90% | 4.90% | 4.90% | ||
Debt instrument, maturity year | 2023 | 2023 | 2023 | |||
4.80% Senior Notes, Due 2024 | Genworth Holdings | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 4.80% | 4.80% | 4.80% | |||
Debt instrument, maturity year | 2024 | 2024 | 2024 | |||
6.50% Senior Notes, Due 2034 | Genworth Holdings | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 6.50% | 6.50% | 6.50% | |||
Debt instrument, maturity year | 2034 | 2034 | ||||
6.15% Fixed-to-Floating Rate Junior Subordinated Notes, Due 2066 | Genworth Holdings | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 6.15% | 6.15% | 6.15% | |||
Debt instrument, maturity year | 2066 | 2066 | ||||
4.59% Senior Notes, Due 2015 | Genworth MI Canada Inc. | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 4.59% | 4.59% | 4.59% | |||
Debt instrument, maturity year | 2015 | 2015 | ||||
5.68% Senior Notes, Due 2020 | Genworth MI Canada Inc. | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 5.68% | 5.68% | 5.68% | |||
Debt instrument, maturity year | 2020 | 2020 | ||||
4.24% Senior Notes, Due 2024 | Genworth MI Canada Inc. | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate | 4.24% | 4.24% | 4.24% | 4.24% | ||
Debt instrument, maturity year | 2024 | 2024 | 2024 | |||
Floating Rate Junior Notes, Due 2021 | Genworth Financial Mortgage Insurance Pty Limited | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity year | 2021 | 2021 | 2021 |
Schedule_of_Nonrecourse_Fundin
Schedule of Non-recourse Funding Obligations of Special Purpose Consolidated Captive Insurance Subsidiaries (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Non-recourse funding obligations | $1,996 | $2,038 | ||
River Lake Insurance Company (a), Due 2033 | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Non-recourse funding obligations | 570 | [1] | 570 | [1] |
River Lake Insurance Company (b), Due 2033 | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Non-recourse funding obligations | 435 | [2] | 461 | [2] |
River Lake Insurance Company II (a), Due 2035 | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Non-recourse funding obligations | 192 | [1] | 192 | [1] |
River Lake Insurance Company II (b), Due 2035 | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Non-recourse funding obligations | 484 | [2] | 500 | [2] |
Rivermont Life Insurance Company I (a), due 2050 | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Non-recourse funding obligations | $315 | [1] | $315 | [1] |
[1] | Accrual of interest based on one-month LIBOR that resets every 28 days plus a fixed margin. | |||
[2] | Accrual of interest based on one-month LIBOR that resets on a specified date each month plus a contractual margin. |
Schedule_of_Nonrecourse_Fundin1
Schedule of Non-recourse Funding Obligations of Special Purpose Consolidated Captive Insurance Subsidiaries (Parenthetical) (Detail) | 12 Months Ended | |||
Dec. 31, 2014 | Dec. 31, 2013 | |||
Nonrecourse Funding Obligations [Line Items] | ||||
Interest rate reset period, number of days | 28 days | 28 days | ||
River Lake Insurance Company (a), Due 2033 | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Debt instrument, maturity year | 2033 | [1] | 2033 | [1] |
River Lake Insurance Company (b), Due 2033 | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Debt instrument, maturity year | 2033 | [2] | 2033 | [2] |
River Lake Insurance Company II (a), Due 2035 | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Debt instrument, maturity year | 2035 | [1] | 2035 | [1] |
River Lake Insurance Company II (b), Due 2035 | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Debt instrument, maturity year | 2035 | [2] | 2035 | [2] |
Rivermont Life Insurance Company I (a), due 2050 | ||||
Nonrecourse Funding Obligations [Line Items] | ||||
Debt instrument, maturity year | 2050 | [1] | 2050 | [1] |
[1] | Accrual of interest based on one-month LIBOR that resets every 28 days plus a fixed margin. | |||
[2] | Accrual of interest based on one-month LIBOR that resets on a specified date each month plus a contractual margin. |
Principal_Amounts_of_Long_Term
Principal Amounts of Long Term Debt Including Senior Notes and Non-recourse Funding by Maturity (Detail) (Long-term borrowings, USD $) | Dec. 31, 2014 | |
In Millions, unless otherwise specified | ||
Long-term borrowings | ||
Principal Amounts Of Long Term Debt Including Senior Notes And Non Recourse Funding By Maturity [Line Items] | ||
2015 | $0 | |
2016 | 300 | |
2017 | 0 | |
2018 | 600 | |
2019 and thereafter | 5,735 | [1] |
Total | $6,635 | |
[1] | Repayment of $2.0 billion of our non-recourse funding obligations requires regulatory approval. |
Principal_Amounts_of_Long_Term1
Principal Amounts of Long Term Debt Including Senior Notes and Non-recourse Funding by Maturity (Parenthetical) (Detail) (Repayments Requiring Regulatory Approval, USD $) | 12 Months Ended |
In Billions, unless otherwise specified | Dec. 31, 2014 |
Repayments Requiring Regulatory Approval | |
Principal Amounts Of Long Term Debt Including Senior Notes And Non Recourse Funding By Maturity [Line Items] | |
Repayment of secured debt | $2 |
Components_of_Income_Loss_befo
Components of Income (Loss) before Income Taxes (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Income Taxes [Abstract] | |||
Domestic | ($2,008) | $294 | ($73) |
Foreign | 732 | 756 | 679 |
Income (loss) from continuing operations before income taxes | ($1,276) | $1,050 | $606 |
Components_of_Income_Tax_Benef
Components of Income Tax (Benefit) Expense (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Income Taxes [Abstract] | |||
Current federal income taxes | ($3) | ($18) | ($68) |
Deferred federal income taxes | -443 | 160 | 36 |
Total federal income taxes | -446 | 142 | -32 |
Current state income taxes | 4 | -1 | -16 |
Deferred state income taxes | -4 | -9 | -9 |
Total state income taxes | 0 | -10 | -25 |
Current foreign income taxes | 258 | 422 | 138 |
Deferred foreign income taxes | -40 | -230 | 57 |
Total foreign income taxes | 218 | 192 | 195 |
Total provision (benefit) for income taxes | ($228) | $324 | $138 |
Income_Taxes_Additional_Inform
Income Taxes - Additional Information (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Income Tax Examination [Line Items] | |||||
Current income tax receivable | $30 | $30 | |||
Current income tax payable | 132 | ||||
Tax impact from potential business portfolio changes | 66 | 66 | 0 | 0 | |
Stock based compensation | 4 | 25 | 0 | ||
Valuation allowances | 301 | 301 | 312 | ||
NOL carryforwards | 5,191 | 5,191 | |||
NOL carryforwards benefit recorded in APIC when realized | 24 | 24 | |||
Foreign tax credit carryforwards | 666 | 666 | 432 | ||
Net operating loss carryforwards, expiration date/(year) | 2021 | ||||
Foreign tax credit carryforwards, expiration year | 2015 | ||||
Unremitted foreign income that is considered permanently reinvested on which U.S. deferred income tax are not provided | 1,642 | 1,642 | |||
International businesses cash and short-term investments related to the unremitted earnings of foreign operations | 124 | 124 | |||
Unrecognized tax benefits | 49 | 49 | 41 | 55 | 226 |
Unrecognized tax benefits, amount that if recognized would affect the effective rate on continuing operations | 44 | 44 | |||
Unrecognized tax benefits, interest and penalties (expense) | 3 | 1 | 5 | ||
Unrecognized tax benefits, accrued interest and penalties | 0 | 0 | 3 | ||
Unrecognized tax benefits, amount that is reasonably possible that it will be recognized in 2015 | 14 | 14 | |||
Section 338 Election | |||||
Income Tax Examination [Line Items] | |||||
Remaining deferred tax assets related to Section 338 election deduction | 599 | 599 | 599 | ||
Tax matters agreement obligation related to Section 338 election, period of repayment, years | 9 years | ||||
Maximum deferred tax assets related to Section 338 election deduction | 640 | 640 | |||
Percentage of tax savings associated with Section 338 deductions | 80.00% | ||||
Additional paid-in capital | |||||
Income Tax Examination [Line Items] | |||||
Adjustment to deferred tax liability for unsupported balance | 6 | 17 | -36 | ||
Australia Mortgage Insurance | |||||
Income Tax Examination [Line Items] | |||||
Tax impact from potential business portfolio changes | 174 | ||||
Lifestyle Protection Insurance | |||||
Income Tax Examination [Line Items] | |||||
Tax impact from potential business portfolio changes | -108 | ||||
Tax Matters Agreement | |||||
Income Tax Examination [Line Items] | |||||
Interest expense related to tax matters agreement | 13 | 15 | 17 | ||
Accretion rate for tax matters agreement | 5.72% | 5.72% | 5.72% | ||
Liability for estimated present value of tax payments to former parent | 216 | 216 | 245 | ||
Correction of prior years | |||||
Income Tax Examination [Line Items] | |||||
Stock based compensation | $13 |
Reconciliation_of_Federal_Stat
Reconciliation of Federal Statutory Tax Rate to Effective Income Tax Rate (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Income Tax Examination [Line Items] | |||
Pre-tax income (loss) | ($1,276) | $1,050 | $606 |
Statutory U.S. federal income tax rate | -447 | 368 | 212 |
State income tax, net of federal income tax effect | 0 | -2 | -16 |
Benefit on tax favored investments | -18 | -18 | -9 |
Effect of foreign operations | -69 | -75 | -66 |
Change in indefinite reinvestment assertion | 66 | 0 | 0 |
Interest on uncertain tax positions | -2 | -1 | -3 |
Non-deductible expenses | 4 | 2 | 3 |
Non-deductible goodwill | 245 | 0 | 19 |
Valuation allowance | -6 | 16 | 0 |
Stock-based compensation | 4 | 25 | 0 |
Other, net | -5 | 9 | -2 |
Total provision (benefit) for income taxes | ($228) | $324 | $138 |
Statutory U.S. federal income tax rate | 35.00% | 35.00% | 35.00% |
State income tax, net of federal income tax effect | 0.00% | -0.20% | -2.70% |
Benefit on tax favored investments | 1.40% | -1.70% | -1.40% |
Effect of foreign operations | 5.40% | -7.10% | -10.90% |
Change in indefinite reinvestment assertion | -5.20% | 0.00% | 0.00% |
Interest on uncertain tax positions | 0.10% | -0.10% | -0.60% |
Non-deductible expenses | -0.30% | 0.20% | 0.50% |
Non-deductible goodwill | -19.20% | 0.00% | 3.10% |
Valuation allowance | 0.50% | 1.50% | 0.00% |
Stock-based compensation | -0.30% | 2.40% | 0.00% |
Other, net | 0.50% | 0.90% | -0.20% |
Effective rate | 17.90% | 30.90% | 22.80% |
Components_of_Net_Deferred_Inc
Components of Net Deferred Income Tax Liability (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Income Taxes [Abstract] | ||
Foreign tax credit carryforwards | $666 | $432 |
Accrued commission and general expenses | 219 | 339 |
State income taxes | 275 | 278 |
Net operating loss carryforwards | 1,803 | 1,762 |
Net unrealized losses on derivatives | 0 | 160 |
Other | 37 | 41 |
Gross deferred income tax assets | 3,000 | 3,012 |
Valuation allowance | -301 | -312 |
Total deferred income tax assets | 2,699 | 2,700 |
Investments | 100 | 140 |
Net unrealized gains on investment securities | 1,283 | 454 |
Net unrealized gains on derivatives | 222 | 0 |
Insurance reserves | 544 | 1,034 |
DAC | 1,095 | 1,130 |
PVFP and other intangibles | 5 | 53 |
Investment in foreign subsidiaries | 310 | 13 |
Other | 48 | 82 |
Total deferred income tax liabilities | 3,607 | 2,906 |
Net deferred income tax liability | $908 | $206 |
Reconciliation_of_Unrecognized
Reconciliation of Unrecognized Tax Benefits (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Income Taxes [Abstract] | |||
Balance as of January 1 | $41 | $55 | $226 |
Gross additions, current period | 7 | 3 | 14 |
Gross reductions, current period | -3 | 0 | 0 |
Gross additions, prior years | 17 | 4 | 0 |
Gross reductions, prior years | -13 | -21 | -131 |
Settlements | 0 | 0 | -54 |
Balance as of December 31 | $49 | $41 | $55 |
Supplemental_Cash_Flow_Informa1
Supplemental Cash Flow Information - Additional Information (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Supplemental Cash Flow Information [Abstract] | |||
Net cash paid for taxes | $439 | $146 | $287 |
Cash paid for interest | $437 | $453 | $465 |
StockBased_Compensation_Additi
Stock-Based Compensation - Additional Information (Detail) (USD $) | 12 Months Ended | |||
In Millions, except Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Share Based Employee Compensation [Line Items] | ||||
Stock-based compensation expense | $30 | $41 | $26 | |
Stock options granted | 0 | 0 | 0 | |
Unrecognized stock-based compensation expense | 35 | 30 | ||
Unrecognized stock-based compensation expense, expected weighted-average period of recognition (years) | 2 years | 2 years | ||
Amounts received from option exercises | 20 | 19 | ||
Tax benefit realized from the exercise of share based awards | 11 | 10 | ||
Genworth Canada | ||||
Share Based Employee Compensation [Line Items] | ||||
Stock-based compensation expense | 6 | 11 | 3 | |
Unrecognized stock-based compensation expense | 3 | 3 | 1 | |
Genworth Australia | ||||
Share Based Employee Compensation [Line Items] | ||||
Stock-based compensation expense | 2 | |||
Unrecognized stock-based compensation expense | 5 | |||
Outstanding restricted share rights, outstanding | 2,803,025 | |||
Vested restricted share rights | 99,250 | |||
Unvested restricted share rights | 2,703,775 | |||
Restricted share rights, exercised | 4,901 | |||
Stock Appreciation Rights | ||||
Share Based Employee Compensation [Line Items] | ||||
Granted stock options, exercise price range, lower limit | $14.30 | $7.90 | ||
Granted stock options, exercise price range, upper limit | $17.89 | $9.06 | ||
Granted, number of awards | 2,960,000 | 4,604,000 | ||
Granted stock options, fair value | $3.05 | $3.40 | ||
Terminated, number of awards | 1,905,000 | 980,000 | ||
Vested restricted share rights | 1,353,000 | 1,618,000 | ||
Unvested restricted share rights | 12,067,000 | 12,365,000 | 10,359,000 | |
Stock Appreciation Rights Cap Price | ||||
Share Based Employee Compensation [Line Items] | ||||
Maximum share value at exercise of SARs | $75 | |||
Employee Stock Option and Stock Appreciation Rights | ||||
Share Based Employee Compensation [Line Items] | ||||
Granted stock options, exercise term (years) | 10 years | 10 years | ||
Stock Appreciation Rights (SARs) | ||||
Share Based Employee Compensation [Line Items] | ||||
Average vesting period | 4 years | 4 years | 4 years | |
Restricted Stock Units | ||||
Share Based Employee Compensation [Line Items] | ||||
Granted stock options, exercise price range, lower limit | $9.19 | $7.90 | ||
Granted stock options, exercise price range, upper limit | $17.89 | $15.40 | ||
Average vesting period | 4 years | 4 years | ||
Granted, number of awards | 1,226,000 | 2,018,000 | ||
Granted stock options, fair value | $15 | $9.27 | ||
Terminated, number of awards | 262,000 | 426,000 | ||
Vested restricted share rights | 938,000 | 985,000 | ||
Unvested restricted share rights | 2,913,000 | 2,887,000 | 2,280,000 | |
Performance Stock Units ("PSUs") | ||||
Share Based Employee Compensation [Line Items] | ||||
Average vesting period | 3 years | |||
Granted, number of awards | 343,000 | |||
Terminated, number of awards | 39,000 | |||
Performance Stock Units ("PSUs") | Minimum | ||||
Share Based Employee Compensation [Line Items] | ||||
Granted stock options, fair value | $15.23 | |||
Performance Stock Units ("PSUs") | Maximum | ||||
Share Based Employee Compensation [Line Items] | ||||
Granted stock options, fair value | $17.89 | |||
Omnibus Incentive Plan | ||||
Share Based Employee Compensation [Line Items] | ||||
Equity awards, amount of shares authorized to grant | 16,000,000 | 25,000,000 | ||
Stock-based compensation expense | $22 | $30 | $23 |
Stock_Option_and_SAR_WeightedA
Stock Option and SAR Weighted-Average Grant-Date Fair Value Information and Related Valuation Assumptions (Detail) (USD $) | 12 Months Ended | |||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock options and SARs, granted | 0 | 0 | 0 | |
Black-Scholes Model | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Expected term (years) | 6 years | 5 years 10 months 24 days | 6 years | |
Expected volatility | 100.20% | 100.70% | 100.70% | |
Expected dividend yield | 0.50% | 0.50% | 0.50% | |
Risk-free interest rate | 1.90% | 1.10% | 1.10% | |
Black-Scholes Model | Stock Compensation Plan | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock options and SARs, granted | 2,960 | 3,404 | 5,085 | |
Fair value per options and SARs | 3.05 | 2.53 | 2.34 | |
Black-Scholes Model | Stock Appreciation Rights (SARs) | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Maximum share value at exercise of SARs | 75 | 75 | 75 | |
Monte-Carlo Simulation | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Expected volatility | 102.50% | [1] | ||
Expected dividend yield | 0.50% | [1] | ||
Risk-free interest rate | 1.10% | [1] | ||
Monte-Carlo Simulation | Stock Compensation Plan | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock options and SARs, granted | 1,200 | [1] | ||
Fair value per options and SARs | 5.88 | [1] | ||
Monte-Carlo Simulation | Stock Appreciation Rights (SARs) | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Maximum share value at exercise of SARs | 75 | [1] | ||
[1] | For purposes of determining the fair value of 1.2 million shares of performance-accelerated SARs that were issued in January 2013, we used a Monte-Carlo Simulation technique. Monte-Carlo Simulation is a method used to simulate future stock price movements in order to determine the fair value due to unique vesting and exercising provisions. The performance-accelerated SARs have a derived service period of one year on average and have a grant price of $7.90. The performance-accelerated SARs vest on the third anniversary of the grant date but are subject to earlier vesting on or after the one year anniversary of the grant date based on the closing price of our Class A Common Stock exceeding certain specified amounts ($12.00, $16.00 and $20.00, respectively) for 45 consecutive trading days. Based on the closing price of our Class A Common Stock, the first tranche at $12.00 vested in January 2014 and the second tranche at $16.00 vested in June 2014. |
Stock_Option_and_SAR_WeightedA1
Stock Option and SAR Weighted-Average Grant-Date Fair Value Information and Related Valuation Assumptions (Parenthetical) (Detail) (USD $) | 1 Months Ended | 12 Months Ended | 1 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Jan. 31, 2014 | Dec. 31, 2014 | Jun. 30, 2014 | Jan. 31, 2013 |
Share Price One | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Performance-accelerated SARs subject to earlier vesting on or after one year anniversary of the grant date based on the closing price of our Class A Common Stock | $12 | |||
Vesting based on closing stock price | $12 | |||
Share Price Two | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Performance-accelerated SARs subject to earlier vesting on or after one year anniversary of the grant date based on the closing price of our Class A Common Stock | $16 | |||
Vesting based on closing stock price | $16 | |||
Share Price Three | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Performance-accelerated SARs subject to earlier vesting on or after one year anniversary of the grant date based on the closing price of our Class A Common Stock | $20 | |||
Early Vesting in One Third Increments | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of consecutive trading days exceeding certain specified amounts | 45 days | |||
Performance Accelerated Stock Appreciation Rights | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Omnibus Incentive Plan, shares issued | 1.2 | |||
Options grant-date fair value | $7.90 |
Rollforward_of_ShareBased_Comp
Rollforward of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding (Detail) (USD $) | 12 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Stock-Based Compensation [Abstract] | |||
Beginning balance, shares subject to option | 4,310 | 6,109 | |
Granted, shares subject to option | 0 | 0 | 0 |
Exercised, shares subject to option | -921 | -1,440 | |
Forfeited, shares subject to option | -885 | -359 | |
Expired, shares subject to option | 0 | 0 | |
Ending balance, shares subject to option | 2,504 | 4,310 | 6,109 |
Beginning balance, weighted-average exercise price | $13.17 | $11.77 | |
Exercisable as of December 31, shares subject to option | 2,501 | ||
Granted, weighted-average exercise price | $0 | $0 | |
Exercised, weighted-average exercise price | $8.10 | $6.20 | |
Forfeited, weighted-average exercise price | $19.32 | $17.26 | |
Expired, weighted-average exercise price | $0 | $0 | |
Ending balance, weighted-average exercise price | $12.86 | $13.17 | $11.77 |
Exercisable as of December 31, weighted-average exercise price | $12.86 |
Information_about_Stock_Option
Information about Stock Options Outstanding (Detail) (USD $) | 12 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2014 | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | ||
Outstanding, shares | 2,504 | |
Outstanding, average exercise price | $12.86 | |
Exercisable, shares | 2,501 | |
Exercisable, average exercise price | $12.86 | |
Exercise Price Range, $ 2.00 - $ 2.46 | ||
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | ||
Exercise price range, lower limit | $2 | |
Exercise price range, upper limit | $2.46 | |
Outstanding, shares | 394 | [1] |
Outstanding, average life (years) | 4 years 26 days | [1],[2] |
Outstanding, average exercise price | $2.44 | [1] |
Exercisable, shares | 394 | [1] |
Exercisable, average life (years) | 4 years 26 days | [1],[2] |
Exercisable, average exercise price | $2.44 | [1] |
Exercise Price Range, $ 7.36 - $ 7.80 | ||
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | ||
Exercise price range, lower limit | $7.36 | |
Exercise price range, upper limit | $7.80 | |
Outstanding, shares | 547 | |
Outstanding, average life (years) | 2 years 5 months 1 day | [2] |
Outstanding, average exercise price | $7.80 | |
Exercisable, shares | 547 | |
Exercisable, average life (years) | 2 years 5 months 1 day | [2] |
Exercisable, average exercise price | $7.80 | |
Exercise Price Range, $ 9.10 - $ 14.18 | ||
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | ||
Exercise price range, lower limit | $9.10 | |
Exercise price range, upper limit | $14.18 | |
Outstanding, shares | 1,228 | |
Outstanding, average life (years) | 4 years 10 months 13 days | [2] |
Outstanding, average exercise price | $14.15 | |
Exercisable, shares | 1,225 | |
Exercisable, average life (years) | 4 years 10 months 10 days | [2] |
Exercisable, average exercise price | $14.15 | |
Exercise Price Range, $14.92 - $22.80 | ||
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | ||
Exercise price range, lower limit | $14.92 | |
Exercise price range, upper limit | $22.80 | |
Outstanding, shares | 123 | |
Outstanding, average life (years) | 3 years 3 months 4 days | [2] |
Outstanding, average exercise price | $21.96 | |
Exercisable, shares | 123 | |
Exercisable, average life (years) | 3 years 3 months 4 days | [2] |
Exercisable, average exercise price | $21.96 | |
Exercise Price Range, $30.52 - $34.13 | ||
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | ||
Exercise price range, lower limit | $30.52 | |
Exercise price range, upper limit | $34.13 | |
Outstanding, shares | 212 | |
Outstanding, average life (years) | 1 year 4 months 24 days | [2] |
Outstanding, average exercise price | $32.56 | |
Exercisable, shares | 212 | |
Exercisable, average life (years) | 1 year 4 months 24 days | [2] |
Exercisable, average exercise price | $32.55 | |
[1] | These shares have an aggregate intrinsic value of $2 million each for total options outstanding and exercisable options. | |
[2] | Average contractual life remaining in years. |
Information_about_Stock_Option1
Information about Stock Options Outstanding (Parenthetical) (Detail) (Exercise Price Range, $ 2.00 - $ 2.46, USD $) | Dec. 31, 2014 |
In Millions, unless otherwise specified | |
Exercise Price Range, $ 2.00 - $ 2.46 | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Aggregate intrinsic value, total options outstanding | $2 |
Aggregate intrinsic value, exercisable options | $2 |
Stock_Option_Activity_and_Othe
Stock Option Activity and Other Equity-Based Awards (Detail) (USD $) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Beginning balance, shares subject to option | 4,310,000 | 6,109,000 |
Exercised, shares subject to option | -921,000 | -1,440,000 |
Ending balance, shares subject to option | 2,504,000 | 4,310,000 |
Deferred Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Balance as of January 1, number of awards | 579,000 | 690,000 |
Granted, number of awards | 113,000 | 98,000 |
Exercised, number of awards | -58,000 | -209,000 |
Terminated, number of awards | 0 | 0 |
Balance as of December 31, number of awards | 634,000 | 579,000 |
Balance as of January 1, weighted-average grant date fair value | 9.43 | 8.74 |
Granted, weighted-average grant date fair value | 12.98 | 12.17 |
Exercised, weighted-average grant date fair value | 6.65 | 4.73 |
Terminated, weighted-average grant date fair value | 0 | 0 |
Balance as of December 31, weighted-average grant date fair value | 9.96 | 9.43 |
Restricted Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Balance as of January 1, number of awards | 2,887,000 | 2,280,000 |
Granted, number of awards | 1,226,000 | 2,018,000 |
Exercised, number of awards | -938,000 | -985,000 |
Terminated, number of awards | -262,000 | -426,000 |
Balance as of December 31, number of awards | 2,913,000 | 2,887,000 |
Balance as of January 1, weighted-average grant date fair value | 10.21 | 12.97 |
Granted, weighted-average grant date fair value | 15 | 9.27 |
Exercised, weighted-average grant date fair value | 10.06 | 14.75 |
Terminated, weighted-average grant date fair value | 12.16 | 10.01 |
Balance as of December 31, weighted-average grant date fair value | 12.09 | 10.21 |
Stock Appreciation Rights | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Balance as of January 1, number of awards | 12,365,000 | 10,359,000 |
Granted, number of awards | 2,960,000 | 4,604,000 |
Exercised, number of awards | -1,353,000 | -1,618,000 |
Terminated, number of awards | -1,905,000 | -980,000 |
Balance as of December 31, number of awards | 12,067,000 | 12,365,000 |
Balance as of January 1, weighted-average grant date fair value | 4 | 4.44 |
Granted, weighted-average grant date fair value | 3.05 | 3.4 |
Exercised, weighted-average grant date fair value | 3.88 | 5.97 |
Terminated, weighted-average grant date fair value | 5.23 | 2.91 |
Balance as of December 31, weighted-average grant date fair value | 3.62 | 4 |
Genworth Canada | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Beginning balance, shares subject to option | 987,000 | 1,027,000 |
Granted, shares subject to option | 114,000 | 100,000 |
Exercised, shares subject to option | -93,000 | -91,000 |
Terminated, shares subject to option | -6,000 | -49,000 |
Ending balance, shares subject to option | 1,002,000 | 987,000 |
Genworth Canada | Restricted Stock Units and Performance Stock Unit Awards | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Balance as of January 1, number of awards | 177,000 | 143,000 |
Granted, number of awards | 93,000 | 106,000 |
Exercised, number of awards | -67,000 | -66,000 |
Terminated, number of awards | 0 | -6,000 |
Balance as of December 31, number of awards | 203,000 | 177,000 |
Genworth Canada | Deferred Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Balance as of January 1, number of awards | 45,000 | 34,000 |
Granted, number of awards | 9,000 | 11,000 |
Exercised, number of awards | 0 | 0 |
Terminated, number of awards | 0 | 0 |
Balance as of December 31, number of awards | 54,000 | 45,000 |
Genworth Canada | Executive Deferred Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Balance as of January 1, number of awards | 20,000 | 0 |
Granted, number of awards | 1,000 | 20,000 |
Exercised, number of awards | 0 | 0 |
Terminated, number of awards | 0 | 0 |
Balance as of December 31, number of awards | 21,000 | 20,000 |
Fair_Value_Financial_Instrumen
Fair Value Financial Instruments Not Required to Be Carried at Fair Value (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Commercial mortgage loans | $6,100 | $5,899 | ||
Restricted commercial mortgage loans | 201 | 233 | ||
Other invested assets | 2,296 | 1,686 | ||
Long-term borrowings | 4,639 | 5,161 | ||
Non-recourse funding obligations | 1,996 | 2,038 | ||
Notional amount | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Commercial mortgage loans | 0 | [1] | 0 | [1] |
Restricted commercial mortgage loans | 0 | [1],[2] | 0 | [1],[2] |
Other invested assets | 0 | [1] | 0 | [1] |
Long-term borrowings | 0 | [1],[3] | 0 | [1],[3] |
Non-recourse funding obligations | 0 | [1],[3] | 0 | [1],[3] |
Borrowings related to securitization entities | 0 | [1],[2] | 0 | [1],[2] |
Investment contracts | 0 | [1] | 0 | [1] |
Commitments to fund limited partnerships | 53 | 65 | ||
Ordinary course of business lending commitments | 155 | 138 | ||
Carrying value | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Commercial mortgage loans | 6,100 | 5,899 | ||
Restricted commercial mortgage loans | 201 | [2] | 233 | [2] |
Other invested assets | 374 | 307 | ||
Long-term borrowings | 4,639 | [3] | 5,161 | [3] |
Non-recourse funding obligations | 1,996 | [3] | 2,038 | [3] |
Borrowings related to securitization entities | 134 | [2] | 167 | [2] |
Investment contracts | 17,497 | 17,330 | ||
Commitments to fund limited partnerships | 0 | 0 | ||
Ordinary course of business lending commitments | 0 | 0 | ||
Fair value | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Commercial mortgage loans | 6,573 | 6,137 | ||
Restricted commercial mortgage loans | 228 | [2] | 258 | [2] |
Other invested assets | 385 | 311 | ||
Long-term borrowings | 4,300 | [3] | 5,590 | [3] |
Non-recourse funding obligations | 1,438 | [3] | 1,459 | [3] |
Borrowings related to securitization entities | 146 | [2] | 182 | [2] |
Investment contracts | 18,023 | 17,827 | ||
Commitments to fund limited partnerships | 0 | 0 | ||
Ordinary course of business lending commitments | 0 | 0 | ||
Level 1 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Commercial mortgage loans | 0 | 0 | ||
Restricted commercial mortgage loans | 0 | [2] | 0 | [2] |
Other invested assets | 0 | 0 | ||
Long-term borrowings | 0 | [3] | 0 | [3] |
Non-recourse funding obligations | 0 | [3] | 0 | [3] |
Borrowings related to securitization entities | 0 | [2] | 0 | [2] |
Investment contracts | 0 | 0 | ||
Commitments to fund limited partnerships | 0 | 0 | ||
Ordinary course of business lending commitments | 0 | 0 | ||
Level 2 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Commercial mortgage loans | 0 | 0 | ||
Restricted commercial mortgage loans | 0 | [2] | 0 | [2] |
Other invested assets | 300 | 221 | ||
Long-term borrowings | 4,181 | [3] | 5,460 | [3] |
Non-recourse funding obligations | 0 | [3] | 0 | [3] |
Borrowings related to securitization entities | 146 | [2] | 182 | [2] |
Investment contracts | 7 | 86 | ||
Commitments to fund limited partnerships | 0 | 0 | ||
Ordinary course of business lending commitments | 0 | 0 | ||
Level 3 | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Commercial mortgage loans | 6,573 | 6,137 | ||
Restricted commercial mortgage loans | 228 | [2] | 258 | [2] |
Other invested assets | 85 | 90 | ||
Long-term borrowings | 119 | [3] | 130 | [3] |
Non-recourse funding obligations | 1,438 | [3] | 1,459 | [3] |
Borrowings related to securitization entities | 0 | [2] | 0 | [2] |
Investment contracts | 18,016 | 17,741 | ||
Commitments to fund limited partnerships | 0 | 0 | ||
Ordinary course of business lending commitments | $0 | $0 | ||
[1] | These financial instruments do not have notional amounts. | |||
[2] | See note 18 for additional information related to consolidated securitization entities. | |||
[3] | See note 13 for additional information related to borrowings. |
Fair_Value_of_Financial_Instru2
Fair Value of Financial Instruments - Additional Information (Detail) (USD $) | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Fair Value of Financial Instruments [Line Items] | ||
Period end valuation | 0 | |
GMWB non-performance risk impact | $74 | $46 |
Minimum | ||
Fair Value of Financial Instruments [Line Items] | ||
Percentage of changes in fair value of fixed maturity, equity and trading securities each month | 10.00% |
Assets_and_Liabilities_that_ar
Assets and Liabilities that are Measured at Fair Value on Recurring Basis (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | $62,447 | $58,629 | ||
Available-for-sale equity securities | 282 | 341 | ||
Securities lending collateral | 289 | 187 | ||
Derivatives counterparty collateral | 70 | |||
Total other invested assets | 1,662 | 967 | ||
Restricted other invested assets related to securitization entities | 411 | [1] | 391 | [1] |
Reinsurance recoverable | 13 | [2] | -1 | [2] |
Separate account assets | 9,208 | 10,138 | ||
Total assets | 74,023 | 70,465 | ||
Policyholder account balances | 26,043 | 25,528 | ||
Borrowings related to securitization entities | 85 | [1] | 75 | [1] |
Total liabilities | 969 | 1,017 | ||
Trading Securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Trading securities | 241 | 239 | ||
Fixed maturity securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 62,447 | 58,629 | ||
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 6,000 | 4,810 | ||
Fixed maturity securities | Tax-exempt | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 362 | 295 | ||
Fixed maturity securities | Government - non-U.S. | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 2,106 | 2,146 | ||
Fixed maturity securities | U.S. corporate | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 27,200 | 25,035 | ||
Fixed maturity securities | Corporate - non-U.S. | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 15,132 | 15,071 | ||
Fixed maturity securities | Residential mortgage-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 5,240 | 5,225 | ||
Fixed maturity securities | Commercial mortgage-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 2,702 | 2,898 | ||
Fixed maturity securities | Other asset-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 3,705 | 3,149 | ||
Equity Securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale equity securities | 282 | 341 | ||
Derivative assets | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 1,132 | 471 | ||
Derivative assets | Interest rate swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 1,091 | 436 | ||
Derivative assets | Foreign currency swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 6 | 4 | ||
Derivative assets | Credit default swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 4 | 11 | ||
Derivative assets | Equity index options | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 17 | 12 | ||
Derivative assets | Other foreign currency contracts | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 14 | 8 | ||
Fair value | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 574 | 239 | ||
Fair value | GMWB embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 291 | [3] | 96 | [3] |
Fair value | Fixed index annuity embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 276 | 143 | ||
Fair value | Indexed universal life embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 7 | |||
Derivative liabilities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 310 | 703 | ||
Derivative liabilities | Interest rate swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 204 | 575 | ||
Derivative liabilities | Foreign currency swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 7 | 2 | ||
Derivative liabilities | Forward bond purchase commitments | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 13 | |||
Derivative liabilities | Other foreign currency contracts | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 13 | 4 | ||
Derivative liabilities | Interest rate swaps related to securitization entities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 26 | [1] | 16 | [1] |
Derivative liabilities | Inflation indexed swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 42 | 60 | ||
Derivative liabilities | Credit default swaps related to securitization entities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 17 | [1] | 32 | [1] |
Derivative liabilities | Equity return swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 1 | 1 | ||
Level 1 | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Securities lending collateral | 0 | 0 | ||
Derivatives counterparty collateral | 0 | |||
Total other invested assets | 0 | 0 | ||
Restricted other invested assets related to securitization entities | 0 | [1] | 0 | [1] |
Reinsurance recoverable | 0 | [2] | 0 | [2] |
Separate account assets | 9,208 | 10,138 | ||
Total assets | 9,452 | 10,394 | ||
Borrowings related to securitization entities | 0 | [1] | 0 | [1] |
Total liabilities | 0 | 0 | ||
Level 1 | Trading Securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Trading securities | 0 | 0 | ||
Level 1 | Fixed maturity securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 0 | 0 | ||
Level 1 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 0 | 0 | ||
Level 1 | Fixed maturity securities | Tax-exempt | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 0 | 0 | ||
Level 1 | Fixed maturity securities | Government - non-U.S. | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 0 | 0 | ||
Level 1 | Fixed maturity securities | U.S. corporate | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 0 | 0 | ||
Level 1 | Fixed maturity securities | Corporate - non-U.S. | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 0 | 0 | ||
Level 1 | Fixed maturity securities | Residential mortgage-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 0 | 0 | ||
Level 1 | Fixed maturity securities | Commercial mortgage-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 0 | 0 | ||
Level 1 | Fixed maturity securities | Other asset-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 0 | 0 | ||
Level 1 | Equity Securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale equity securities | 244 | 256 | ||
Level 1 | Derivative assets | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 0 | 0 | ||
Level 1 | Derivative assets | Interest rate swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 0 | 0 | ||
Level 1 | Derivative assets | Foreign currency swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 0 | 0 | ||
Level 1 | Derivative assets | Credit default swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 0 | 0 | ||
Level 1 | Derivative assets | Equity index options | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 0 | 0 | ||
Level 1 | Derivative assets | Other foreign currency contracts | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 0 | 0 | ||
Level 1 | Fair value | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 0 | 0 | ||
Level 1 | Fair value | GMWB embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 0 | [3] | 0 | [3] |
Level 1 | Fair value | Fixed index annuity embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 0 | 0 | ||
Level 1 | Fair value | Indexed universal life embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 0 | |||
Level 1 | Derivative liabilities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | 0 | ||
Level 1 | Derivative liabilities | Interest rate swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | 0 | ||
Level 1 | Derivative liabilities | Foreign currency swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | 0 | ||
Level 1 | Derivative liabilities | Forward bond purchase commitments | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | |||
Level 1 | Derivative liabilities | Other foreign currency contracts | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | 0 | ||
Level 1 | Derivative liabilities | Interest rate swaps related to securitization entities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | [1] | 0 | [1] |
Level 1 | Derivative liabilities | Inflation indexed swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | 0 | ||
Level 1 | Derivative liabilities | Credit default swaps related to securitization entities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | [1] | 0 | [1] |
Level 1 | Derivative liabilities | Equity return swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | 0 | ||
Level 2 | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Securities lending collateral | 289 | 187 | ||
Derivatives counterparty collateral | 70 | |||
Total other invested assets | 1,642 | 908 | ||
Restricted other invested assets related to securitization entities | 181 | [1] | 180 | [1] |
Reinsurance recoverable | 0 | [2] | 0 | [2] |
Separate account assets | 0 | 0 | ||
Total assets | 58,510 | 54,200 | ||
Borrowings related to securitization entities | 0 | [1] | 0 | [1] |
Total liabilities | 293 | 670 | ||
Level 2 | Trading Securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Trading securities | 241 | 205 | ||
Level 2 | Fixed maturity securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 56,683 | 53,105 | ||
Level 2 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 5,996 | 4,805 | ||
Level 2 | Fixed maturity securities | Tax-exempt | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 362 | 295 | ||
Level 2 | Fixed maturity securities | Government - non-U.S. | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 2,099 | 2,123 | ||
Level 2 | Fixed maturity securities | U.S. corporate | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 24,752 | 22,635 | ||
Level 2 | Fixed maturity securities | Corporate - non-U.S. | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 13,327 | 13,252 | ||
Level 2 | Fixed maturity securities | Residential mortgage-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 5,165 | 5,120 | ||
Level 2 | Fixed maturity securities | Commercial mortgage-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 2,697 | 2,892 | ||
Level 2 | Fixed maturity securities | Other asset-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 2,285 | 1,983 | ||
Level 2 | Equity Securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale equity securities | 4 | 7 | ||
Level 2 | Derivative assets | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 1,112 | 446 | ||
Level 2 | Derivative assets | Interest rate swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 1,091 | 436 | ||
Level 2 | Derivative assets | Foreign currency swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 6 | 4 | ||
Level 2 | Derivative assets | Credit default swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 1 | 1 | ||
Level 2 | Derivative assets | Equity index options | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 0 | 0 | ||
Level 2 | Derivative assets | Other foreign currency contracts | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 14 | 5 | ||
Level 2 | Fair value | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 0 | 0 | ||
Level 2 | Fair value | GMWB embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 0 | [3] | 0 | [3] |
Level 2 | Fair value | Fixed index annuity embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 0 | 0 | ||
Level 2 | Fair value | Indexed universal life embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 0 | |||
Level 2 | Derivative liabilities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 293 | 670 | ||
Level 2 | Derivative liabilities | Interest rate swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 204 | 575 | ||
Level 2 | Derivative liabilities | Foreign currency swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 7 | 2 | ||
Level 2 | Derivative liabilities | Forward bond purchase commitments | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 13 | |||
Level 2 | Derivative liabilities | Other foreign currency contracts | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 13 | 3 | ||
Level 2 | Derivative liabilities | Interest rate swaps related to securitization entities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 26 | [1] | 16 | [1] |
Level 2 | Derivative liabilities | Inflation indexed swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 42 | 60 | ||
Level 2 | Derivative liabilities | Credit default swaps related to securitization entities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | [1] | 0 | [1] |
Level 2 | Derivative liabilities | Equity return swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 1 | 1 | ||
Level 3 | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Securities lending collateral | 0 | 0 | ||
Derivatives counterparty collateral | 0 | |||
Total other invested assets | 20 | 59 | ||
Restricted other invested assets related to securitization entities | 230 | [1] | 211 | [1] |
Reinsurance recoverable | 13 | [2] | -1 | [2] |
Separate account assets | 0 | 0 | ||
Total assets | 6,061 | 5,871 | ||
Borrowings related to securitization entities | 85 | [1] | 75 | [1] |
Total liabilities | 676 | 347 | ||
Level 3 | Trading Securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Trading securities | 0 | 34 | ||
Level 3 | Fixed maturity securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 5,764 | 5,524 | ||
Level 3 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 4 | 5 | ||
Level 3 | Fixed maturity securities | Tax-exempt | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 0 | 0 | ||
Level 3 | Fixed maturity securities | Government - non-U.S. | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 7 | 23 | ||
Level 3 | Fixed maturity securities | U.S. corporate | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 2,448 | 2,400 | ||
Level 3 | Fixed maturity securities | Corporate - non-U.S. | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 1,805 | 1,819 | ||
Level 3 | Fixed maturity securities | Residential mortgage-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 75 | 105 | ||
Level 3 | Fixed maturity securities | Commercial mortgage-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 5 | 6 | ||
Level 3 | Fixed maturity securities | Other asset-backed | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale debt securities | 1,420 | 1,166 | ||
Level 3 | Equity Securities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Available-for-sale equity securities | 34 | 78 | ||
Level 3 | Derivative assets | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 20 | 25 | ||
Level 3 | Derivative assets | Interest rate swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 0 | 0 | ||
Level 3 | Derivative assets | Foreign currency swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 0 | 0 | ||
Level 3 | Derivative assets | Credit default swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 3 | 10 | ||
Level 3 | Derivative assets | Equity index options | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 17 | 12 | ||
Level 3 | Derivative assets | Other foreign currency contracts | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Assets | 0 | 3 | ||
Level 3 | Fair value | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 574 | 239 | ||
Level 3 | Fair value | GMWB embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 291 | [3] | 96 | [3] |
Level 3 | Fair value | Fixed index annuity embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 276 | 143 | ||
Level 3 | Fair value | Indexed universal life embedded derivatives | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Policyholder account balances | 7 | |||
Level 3 | Derivative liabilities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 17 | 33 | ||
Level 3 | Derivative liabilities | Interest rate swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | 0 | ||
Level 3 | Derivative liabilities | Foreign currency swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | 0 | ||
Level 3 | Derivative liabilities | Forward bond purchase commitments | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | |||
Level 3 | Derivative liabilities | Other foreign currency contracts | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | 1 | ||
Level 3 | Derivative liabilities | Interest rate swaps related to securitization entities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | [1] | 0 | [1] |
Level 3 | Derivative liabilities | Inflation indexed swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 0 | 0 | ||
Level 3 | Derivative liabilities | Credit default swaps related to securitization entities | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | 17 | [1] | 32 | [1] |
Level 3 | Derivative liabilities | Equity return swaps | ||||
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] | ||||
Derivative Liabilities | $0 | $0 | ||
[1] | See note 18 for additional information related to consolidated securitization entities. | |||
[2] | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | |||
[3] | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Assets_Measured_at_Fair_Value_
Assets Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value (Detail) (USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | $5,871 | $6,162 | $4,830 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | 33 | -27 | -38 | |||
Total realized and unrealized gains (losses), Included in OCI | 62 | -22 | 272 | |||
Purchases | 847 | 561 | 978 | |||
Sales | -260 | -305 | -395 | |||
Issuances | 3 | 3 | 19 | |||
Settlements | -684 | -783 | -672 | |||
Transfer into Level 3 | 644 | 577 | 1,908 | |||
Transfer out of Level 3 | -455 | -295 | -740 | |||
Ending balance | 6,061 | 5,871 | 6,162 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | 16 | -34 | -19 | |||
Restricted other invested assets related to securitization entities | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 211 | [1] | 194 | [1] | 176 | [1] |
Total realized and unrealized gains (losses), Included in net income (loss) | 19 | [1] | -1 | [1] | 18 | [1] |
Total realized and unrealized gains (losses), Included in OCI | 0 | [1] | 0 | [1] | 0 | [1] |
Purchases | 0 | [1] | 19 | [1] | 100 | [1] |
Sales | 0 | [1] | 0 | [1] | -100 | [1] |
Issuances | 0 | [1] | 0 | [1] | 0 | [1] |
Settlements | 0 | [1] | -20 | [1] | 0 | [1] |
Transfer into Level 3 | 0 | [1] | 19 | [1] | 0 | [1] |
Transfer out of Level 3 | 0 | [1] | 0 | [1] | 0 | [1] |
Ending balance | 230 | [1] | 211 | [1] | 194 | [1] |
Total gains (losses) included in net income (loss) attributable to assets still held | 18 | [1] | -1 | [1] | 13 | [1] |
Reinsurance recoverable | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | -1 | [2] | 10 | [2] | 16 | [2] |
Total realized and unrealized gains (losses), Included in net income (loss) | 11 | [2] | -14 | [2] | -9 | [2] |
Total realized and unrealized gains (losses), Included in OCI | 0 | [2] | 0 | [2] | 0 | [2] |
Purchases | 0 | [2] | 0 | [2] | 0 | [2] |
Sales | 0 | [2] | 0 | [2] | 0 | [2] |
Issuances | 3 | [2] | 3 | [2] | 3 | [2] |
Settlements | 0 | [2] | 0 | [2] | 0 | [2] |
Transfer into Level 3 | 0 | [2] | 0 | [2] | 0 | [2] |
Transfer out of Level 3 | 0 | [2] | 0 | [2] | 0 | [2] |
Ending balance | 13 | [2] | -1 | [2] | 10 | [2] |
Total gains (losses) included in net income (loss) attributable to assets still held | 11 | [2] | -14 | [2] | -9 | [2] |
Other assets | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 9 | [3] | 0 | [3] | ||
Total realized and unrealized gains (losses), Included in net income (loss) | 0 | [3] | -7 | [3] | ||
Total realized and unrealized gains (losses), Included in OCI | 0 | [3] | 0 | [3] | ||
Purchases | 0 | [3] | 0 | [3] | ||
Sales | 0 | [3] | 0 | [3] | ||
Issuances | 0 | [3] | 16 | [3] | ||
Settlements | -9 | [3] | 0 | [3] | ||
Transfer into Level 3 | 0 | [3] | 0 | [3] | ||
Transfer out of Level 3 | 0 | [3] | 0 | [3] | ||
Ending balance | 0 | [3] | 9 | [3] | ||
Total gains (losses) included in net income (loss) attributable to assets still held | 0 | [3] | -7 | [3] | ||
Fixed maturity securities | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 5,524 | 5,740 | 4,223 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | 36 | 12 | 4 | |||
Total realized and unrealized gains (losses), Included in OCI | 62 | -22 | 274 | |||
Purchases | 810 | 498 | 786 | |||
Sales | -221 | -241 | -215 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | -674 | -726 | -528 | |||
Transfer into Level 3 | 644 | 558 | 1,904 | |||
Transfer out of Level 3 | -417 | -295 | -708 | |||
Ending balance | 5,764 | 5,524 | 5,740 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | 15 | 15 | 10 | |||
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 5 | 9 | 13 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | 0 | 0 | 0 | |||
Total realized and unrealized gains (losses), Included in OCI | 0 | 0 | 0 | |||
Purchases | 0 | 0 | 0 | |||
Sales | 0 | 0 | 0 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | -1 | -4 | 0 | |||
Transfer into Level 3 | 0 | 0 | 9 | |||
Transfer out of Level 3 | 0 | 0 | -13 | |||
Ending balance | 4 | 5 | 9 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | 0 | 0 | 0 | |||
Fixed maturity securities | Government - non-U.S. | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 23 | 9 | 10 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | 0 | 0 | 0 | |||
Total realized and unrealized gains (losses), Included in OCI | 0 | 1 | 0 | |||
Purchases | 3 | 0 | 0 | |||
Sales | 0 | 0 | 0 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | -2 | -3 | -1 | |||
Transfer into Level 3 | 0 | 16 | 0 | |||
Transfer out of Level 3 | -17 | 0 | 0 | |||
Ending balance | 7 | 23 | 9 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | 0 | 0 | 0 | |||
Fixed maturity securities | U.S. corporate | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 2,400 | [4] | 2,683 | [4],[5] | 2,511 | [5] |
Total realized and unrealized gains (losses), Included in net income (loss) | 27 | [4] | 18 | [4] | 12 | [5] |
Total realized and unrealized gains (losses), Included in OCI | 57 | [4] | -15 | [4] | 118 | [5] |
Purchases | 211 | [4] | 178 | [4] | 147 | [5] |
Sales | -60 | [4] | -151 | [4] | -122 | [5] |
Issuances | 0 | [4] | 0 | [4] | 0 | [5] |
Settlements | -253 | [4] | -349 | [4] | -214 | [5] |
Transfer into Level 3 | 272 | [4] | 195 | [4] | 726 | [5] |
Transfer out of Level 3 | -206 | [4] | -159 | [4] | -495 | [5] |
Ending balance | 2,448 | [4] | 2,400 | [4] | 2,683 | [4],[5] |
Total gains (losses) included in net income (loss) attributable to assets still held | 12 | [4] | 13 | [4] | 14 | [5] |
Fixed maturity securities | Corporate - non-U.S. | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 1,819 | [4] | 1,983 | [4],[5] | 1,284 | [5] |
Total realized and unrealized gains (losses), Included in net income (loss) | 4 | 4 | [4] | 3 | [5] | |
Total realized and unrealized gains (losses), Included in OCI | 9 | -24 | [4] | 92 | [5] | |
Purchases | 282 | 120 | [4] | 269 | [5] | |
Sales | -123 | -33 | [4] | -29 | [5] | |
Issuances | 0 | 0 | [4] | 0 | [5] | |
Settlements | -222 | -220 | [4] | -186 | [5] | |
Transfer into Level 3 | 97 | 76 | [4] | 711 | [5] | |
Transfer out of Level 3 | -61 | -87 | [4] | -161 | [5] | |
Ending balance | 1,805 | 1,819 | [4] | 1,983 | [4],[5] | |
Total gains (losses) included in net income (loss) attributable to assets still held | 2 | 2 | [4] | 2 | [5] | |
Fixed maturity securities | Residential mortgage-backed | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 105 | 157 | [5] | 95 | [5] | |
Total realized and unrealized gains (losses), Included in net income (loss) | 0 | -9 | -7 | [5] | ||
Total realized and unrealized gains (losses), Included in OCI | -3 | 7 | 14 | [5] | ||
Purchases | 16 | 0 | 20 | [5] | ||
Sales | -23 | -8 | -17 | [5] | ||
Issuances | 0 | 0 | 0 | [5] | ||
Settlements | -13 | -29 | -31 | [5] | ||
Transfer into Level 3 | 24 | 14 | 86 | [5] | ||
Transfer out of Level 3 | -31 | -27 | -3 | [5] | ||
Ending balance | 75 | 105 | 157 | [5] | ||
Total gains (losses) included in net income (loss) attributable to assets still held | 0 | 0 | -7 | [5] | ||
Fixed maturity securities | Commercial mortgage-backed | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 6 | 35 | 39 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | 0 | -5 | -2 | |||
Total realized and unrealized gains (losses), Included in OCI | 2 | -1 | 5 | |||
Purchases | 0 | 0 | 0 | |||
Sales | 0 | 0 | -1 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | -2 | -32 | -2 | |||
Transfer into Level 3 | 7 | 11 | 3 | |||
Transfer out of Level 3 | -8 | -2 | -7 | |||
Ending balance | 5 | 6 | 35 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | 0 | -4 | -1 | |||
Fixed maturity securities | Other asset-backed | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 1,166 | [4] | 864 | [4],[5] | 271 | [5] |
Total realized and unrealized gains (losses), Included in net income (loss) | 5 | [4] | 4 | [4] | -2 | [5] |
Total realized and unrealized gains (losses), Included in OCI | -3 | [4] | 10 | [4] | 45 | [5] |
Purchases | 298 | [4] | 200 | [4] | 350 | [5] |
Sales | -15 | [4] | -49 | [4] | -46 | [5] |
Issuances | 0 | [4] | 0 | [4] | 0 | [5] |
Settlements | -181 | [4] | -89 | [4] | -94 | [5] |
Transfer into Level 3 | 244 | [4] | 246 | [4] | 369 | [5] |
Transfer out of Level 3 | -94 | [4] | -20 | [4] | -29 | [5] |
Ending balance | 1,420 | [4] | 1,166 | [4] | 864 | [4],[5] |
Total gains (losses) included in net income (loss) attributable to assets still held | 1 | [4] | 4 | [4] | 2 | [5] |
Equity Securities | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 78 | 99 | 98 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | 0 | 2 | 1 | |||
Total realized and unrealized gains (losses), Included in OCI | 0 | 0 | -2 | |||
Purchases | 1 | 1 | 10 | |||
Sales | -38 | -24 | -8 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | 0 | 0 | 0 | |||
Transfer into Level 3 | 0 | 0 | 0 | |||
Transfer out of Level 3 | -7 | 0 | 0 | |||
Ending balance | 34 | 78 | 99 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | 0 | 0 | 0 | |||
Other invested assets | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 59 | 110 | 317 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | -33 | -26 | -45 | |||
Total realized and unrealized gains (losses), Included in OCI | 0 | 0 | 0 | |||
Purchases | 36 | 43 | 82 | |||
Sales | -1 | -40 | -72 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | -10 | -28 | -144 | |||
Transfer into Level 3 | 0 | 0 | 4 | |||
Transfer out of Level 3 | -31 | 0 | -32 | |||
Ending balance | 20 | 59 | 110 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | -28 | -34 | -26 | |||
Other invested assets | Derivative assets | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 25 | 34 | 53 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | -33 | -33 | -58 | |||
Total realized and unrealized gains (losses), Included in OCI | 0 | 0 | 0 | |||
Purchases | 36 | 43 | 58 | |||
Sales | -1 | 0 | 0 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | -7 | -19 | -19 | |||
Transfer into Level 3 | 0 | 0 | 0 | |||
Transfer out of Level 3 | 0 | 0 | 0 | |||
Ending balance | 20 | 25 | 34 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | -28 | -36 | -41 | |||
Other invested assets | Trading Securities | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 34 | 76 | 264 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | 0 | 7 | 13 | |||
Total realized and unrealized gains (losses), Included in OCI | 0 | 0 | 0 | |||
Purchases | 0 | 0 | 24 | |||
Sales | 0 | -40 | -72 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | -3 | -9 | -125 | |||
Transfer into Level 3 | 0 | 0 | 4 | |||
Transfer out of Level 3 | -31 | 0 | -32 | |||
Ending balance | 0 | 34 | 76 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | 0 | 2 | 15 | |||
Other invested assets | Credit default swaps | Derivative assets | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 10 | 7 | 0 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | 0 | 12 | 12 | |||
Total realized and unrealized gains (losses), Included in OCI | 0 | 0 | 0 | |||
Purchases | 0 | 0 | 0 | |||
Sales | 0 | 0 | 0 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | -7 | -9 | -5 | |||
Transfer into Level 3 | 0 | 0 | 0 | |||
Transfer out of Level 3 | 0 | 0 | 0 | |||
Ending balance | 3 | 10 | 7 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | 0 | 6 | 12 | |||
Other invested assets | Equity index options | Derivative assets | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 12 | 25 | 39 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | -31 | -43 | -59 | |||
Total realized and unrealized gains (losses), Included in OCI | 0 | 0 | 0 | |||
Purchases | 36 | 39 | 55 | |||
Sales | 0 | 0 | 0 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | 0 | -9 | -10 | |||
Transfer into Level 3 | 0 | 0 | 0 | |||
Transfer out of Level 3 | 0 | 0 | 0 | |||
Ending balance | 17 | 12 | 25 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | -28 | -40 | -42 | |||
Other invested assets | Other foreign currency contracts | Derivative assets | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 3 | 0 | 9 | |||
Total realized and unrealized gains (losses), Included in net income (loss) | -2 | -1 | -11 | |||
Total realized and unrealized gains (losses), Included in OCI | 0 | 0 | 0 | |||
Purchases | 0 | 4 | 3 | |||
Sales | -1 | 0 | 0 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | 0 | 0 | -1 | |||
Transfer into Level 3 | 0 | 0 | 0 | |||
Transfer out of Level 3 | 0 | 0 | 0 | |||
Ending balance | 0 | 3 | 0 | |||
Total gains (losses) included in net income (loss) attributable to assets still held | 0 | -1 | -11 | |||
Other invested assets | Interest rate swaps | Derivative assets | ||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 2 | 5 | ||||
Total realized and unrealized gains (losses), Included in net income (loss) | -1 | 0 | ||||
Total realized and unrealized gains (losses), Included in OCI | 0 | 0 | ||||
Purchases | 0 | 0 | ||||
Sales | 0 | 0 | ||||
Issuances | 0 | 0 | ||||
Settlements | -1 | -3 | ||||
Transfer into Level 3 | 0 | 0 | ||||
Transfer out of Level 3 | 0 | 0 | ||||
Ending balance | 0 | 2 | ||||
Total gains (losses) included in net income (loss) attributable to assets still held | ($1) | $0 | ||||
[1] | See note 18 for additional information related to consolidated securitization entities. | |||||
[2] | Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. | |||||
[3] | Represents contingent receivables associated with recent business dispositions. | |||||
[4] | The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads. | |||||
[5] | The transfers into and out of Level 3 were primarily related to private fixed rate U.S. corporate and private fixed rate corporate-non-U.S. securities and resulted from a change in the observability of the additional premium to the public bond spread to adjust for the liquidity and other features of our private placements and resulted in unobservable inputs having a significant impact on certain valuations for transfers in or no longer having significant impact on certain valuations for transfers out. During the second quarter of 2012, we began classifying private securities without an external rating as Level 3, which resulted in a significant number of securities being transferred into Level 3. The transfers into Level 3 for structured securities primarily related to securities that were recently purchased and initially classified as Level 2 based on market data that existed at the time of purchase and subsequent valuation included significant unobservable inputs. |
Gains_and_Losses_Included_in_N
Gains and Losses Included in Net Income (Loss) from Assets and Liabilities Recorded at Fair Value (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Fair value of financial instruments [Abstract] | |||
Total realized and unrealized gains (losses) included in net income (loss), assets | $33 | ($27) | ($38) |
Total gains (losses) included in net income (loss) attributable to assets still held, assets | 16 | -34 | -19 |
Total realized and unrealized (gains) losses included in net (income) loss, liabilities | 177 | -339 | -283 |
Total (gains) losses included in net (income) loss attributable to liabilities still held, liabilities | 178 | -337 | -276 |
Net Investment Income | |||
Fair value of financial instruments [Abstract] | |||
Total realized and unrealized gains (losses) included in net income (loss), assets | 43 | 35 | 32 |
Total gains (losses) included in net income (loss) attributable to assets still held, assets | 19 | 33 | 25 |
Total realized and unrealized (gains) losses included in net (income) loss, liabilities | 0 | 0 | 0 |
Total (gains) losses included in net (income) loss attributable to liabilities still held, liabilities | 0 | 0 | 0 |
Net Investment Gains (Losses) | |||
Fair value of financial instruments [Abstract] | |||
Total realized and unrealized gains (losses) included in net income (loss), assets | -10 | -62 | -70 |
Total gains (losses) included in net income (loss) attributable to assets still held, assets | -3 | -67 | -44 |
Total realized and unrealized (gains) losses included in net (income) loss, liabilities | 177 | -339 | -283 |
Total (gains) losses included in net (income) loss attributable to liabilities still held, liabilities | $178 | ($337) | ($276) |
Liabilities_Measured_at_Fair_V
Liabilities Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value (Detail) (USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | $347 | $544 | $778 | |||
Total realized and unrealized (gains) losses included in net (income) loss | 177 | -339 | -283 | |||
Total realized and unrealized (gains) losses included in OCI | 0 | 0 | 0 | |||
Purchases | 4 | 8 | 5 | |||
Sales | -2 | 0 | 0 | |||
Issuances | 152 | 135 | 59 | |||
Settlements | -2 | -1 | -15 | |||
Transfer into Level 3 | 0 | 0 | 0 | |||
Transfer out of Level 3 | 0 | 0 | 0 | |||
Ending balance | 676 | 347 | 544 | |||
Total (gains) losses included in net (income) loss attributable to liabilities still held | 178 | -337 | -276 | |||
Derivative liabilities | ||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 33 | 105 | 234 | |||
Total realized and unrealized (gains) losses included in net (income) loss | -18 | -79 | -119 | |||
Total realized and unrealized (gains) losses included in OCI | 0 | 0 | 0 | |||
Purchases | 4 | 8 | 5 | |||
Sales | -2 | 0 | 0 | |||
Issuances | 0 | 0 | 0 | |||
Settlements | 0 | -1 | -15 | |||
Transfer into Level 3 | 0 | 0 | 0 | |||
Transfer out of Level 3 | 0 | 0 | 0 | |||
Ending balance | 17 | 33 | 105 | |||
Total (gains) losses included in net (income) loss attributable to liabilities still held | -19 | -79 | -116 | |||
Policyholder account balances | ||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 239 | 377 | 496 | |||
Total realized and unrealized (gains) losses included in net (income) loss | 186 | -273 | -178 | |||
Total realized and unrealized (gains) losses included in OCI | 0 | 0 | 0 | |||
Purchases | 0 | 0 | 0 | |||
Sales | 0 | 0 | 0 | |||
Issuances | 151 | 135 | 59 | |||
Settlements | -2 | 0 | 0 | |||
Transfer into Level 3 | 0 | 0 | 0 | |||
Transfer out of Level 3 | 0 | 0 | 0 | |||
Ending balance | 574 | 239 | 377 | |||
Total (gains) losses included in net (income) loss attributable to liabilities still held | 188 | -271 | -174 | |||
Policyholder account balances | GMWB embedded derivatives | ||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 96 | [1] | 350 | [1] | 492 | [1] |
Total realized and unrealized (gains) losses included in net (income) loss | 158 | [1] | -291 | [1] | -179 | [1] |
Total realized and unrealized (gains) losses included in OCI | 0 | [1] | 0 | [1] | 0 | [1] |
Purchases | 0 | [1] | 0 | [1] | 0 | [1] |
Sales | 0 | [1] | 0 | [1] | 0 | [1] |
Issuances | 37 | [1] | 37 | [1] | 37 | [1] |
Settlements | 0 | [1] | 0 | [1] | 0 | [1] |
Transfer into Level 3 | 0 | [1] | 0 | [1] | 0 | [1] |
Transfer out of Level 3 | 0 | [1] | 0 | [1] | 0 | [1] |
Ending balance | 291 | [1] | 96 | [1] | 350 | [1] |
Total (gains) losses included in net (income) loss attributable to liabilities still held | 160 | [1] | -289 | [1] | -175 | [1] |
Policyholder account balances | Fixed index annuity embedded derivatives | ||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 143 | 27 | 4 | |||
Total realized and unrealized (gains) losses included in net (income) loss | 27 | 18 | 1 | |||
Total realized and unrealized (gains) losses included in OCI | 0 | 0 | 0 | |||
Purchases | 0 | 0 | 0 | |||
Sales | 0 | 0 | 0 | |||
Issuances | 108 | 98 | 22 | |||
Settlements | -2 | 0 | 0 | |||
Transfer into Level 3 | 0 | 0 | 0 | |||
Transfer out of Level 3 | 0 | 0 | 0 | |||
Ending balance | 276 | 143 | 27 | |||
Total (gains) losses included in net (income) loss attributable to liabilities still held | 27 | 18 | 1 | |||
Policyholder account balances | Indexed universal life embedded derivatives | ||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 0 | |||||
Total realized and unrealized (gains) losses included in net (income) loss | 1 | |||||
Total realized and unrealized (gains) losses included in OCI | 0 | |||||
Purchases | 0 | |||||
Sales | 0 | |||||
Issuances | 6 | |||||
Settlements | 0 | |||||
Transfer into Level 3 | 0 | |||||
Transfer out of Level 3 | 0 | |||||
Ending balance | 7 | |||||
Total (gains) losses included in net (income) loss attributable to liabilities still held | 1 | |||||
Credit default swaps related to securitization entities | Derivative liabilities | ||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 32 | [2] | 104 | [2] | 177 | [2] |
Total realized and unrealized (gains) losses included in net (income) loss | -19 | [2] | -77 | [2] | -76 | [2] |
Total realized and unrealized (gains) losses included in OCI | 0 | [2] | 0 | [2] | 0 | [2] |
Purchases | 4 | [2] | 5 | [2] | 3 | [2] |
Sales | 0 | [2] | 0 | [2] | 0 | [2] |
Issuances | 0 | [2] | 0 | [2] | 0 | [2] |
Settlements | 0 | [2] | 0 | [2] | 0 | [2] |
Transfer into Level 3 | 0 | [2] | 0 | [2] | 0 | [2] |
Transfer out of Level 3 | 0 | [2] | 0 | [2] | 0 | [2] |
Ending balance | 17 | [2] | 32 | [2] | 104 | [2] |
Total (gains) losses included in net (income) loss attributable to liabilities still held | -19 | [2] | -77 | [2] | -76 | [2] |
Other foreign currency contracts | Derivative liabilities | ||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 1 | 0 | ||||
Total realized and unrealized (gains) losses included in net (income) loss | 1 | -2 | ||||
Total realized and unrealized (gains) losses included in OCI | 0 | 0 | ||||
Purchases | 0 | 3 | ||||
Sales | -2 | 0 | ||||
Issuances | 0 | 0 | ||||
Settlements | 0 | 0 | ||||
Transfer into Level 3 | 0 | 0 | ||||
Transfer out of Level 3 | 0 | 0 | ||||
Ending balance | 0 | 1 | ||||
Total (gains) losses included in net (income) loss attributable to liabilities still held | 0 | -2 | ||||
Borrowings related to securitization entities | ||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 75 | [2] | 62 | [2] | 48 | [2] |
Total realized and unrealized (gains) losses included in net (income) loss | 9 | [2] | 13 | [2] | 14 | [2] |
Total realized and unrealized (gains) losses included in OCI | 0 | [2] | 0 | [2] | 0 | [2] |
Purchases | 0 | [2] | 0 | [2] | 0 | [2] |
Sales | 0 | [2] | 0 | [2] | 0 | [2] |
Issuances | 1 | [2] | 0 | [2] | 0 | [2] |
Settlements | 0 | [2] | 0 | [2] | 0 | [2] |
Transfer into Level 3 | 0 | [2] | 0 | [2] | 0 | [2] |
Transfer out of Level 3 | 0 | [2] | 0 | [2] | 0 | [2] |
Ending balance | 85 | [2] | 75 | [2] | 62 | [2] |
Total (gains) losses included in net (income) loss attributable to liabilities still held | 9 | [2] | 13 | [2] | 14 | [2] |
Equity index options | Derivative liabilities | ||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 0 | |||||
Total realized and unrealized (gains) losses included in net (income) loss | 1 | |||||
Total realized and unrealized (gains) losses included in OCI | 0 | |||||
Purchases | 0 | |||||
Sales | 0 | |||||
Issuances | 0 | |||||
Settlements | -1 | |||||
Transfer into Level 3 | 0 | |||||
Transfer out of Level 3 | 0 | |||||
Ending balance | 0 | |||||
Total (gains) losses included in net (income) loss attributable to liabilities still held | 1 | |||||
Credit default swaps | Derivative liabilities | ||||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||
Beginning balance | 1 | 57 | ||||
Total realized and unrealized (gains) losses included in net (income) loss | -1 | -43 | ||||
Total realized and unrealized (gains) losses included in OCI | 0 | 0 | ||||
Purchases | 0 | 2 | ||||
Sales | 0 | 0 | ||||
Issuances | 0 | 0 | ||||
Settlements | 0 | -15 | ||||
Transfer into Level 3 | 0 | 0 | ||||
Transfer out of Level 3 | 0 | 0 | ||||
Ending balance | 0 | 1 | ||||
Total (gains) losses included in net (income) loss attributable to liabilities still held | ($1) | ($40) | ||||
[1] | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | |||||
[2] | See note 18 for additional information related to consolidated securitization entities. |
Summary_of_Significant_Unobser
Summary of Significant Unobservable Inputs Used for Fair Value Measurements Classified As Level 3 (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | |
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Fixed maturity securities available-for-sale, at fair value | $62,447 | $58,629 | |
Policyholder account balances | 26,043 | 25,528 | |
Level 3 | GMWB embedded derivatives | Policyholder account balances | |||
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Fair value, withdrawal utilization rate, lower limit | 0.00% | ||
Valuation technique | Stochastic cash flow model | [1] | |
Fair value, withdrawal utilization rate, upper limit | 98.00% | ||
Policyholder account balances | 291 | [1] | |
Fair value, lapse rate, lower limit | 0.00% | ||
Fair value, lapse rate, upper limit | 15.00% | ||
Fair value input, credit spreads, lower limit | 0.40% | ||
Fair value input, credit spreads, upper limit | 0.85% | ||
Fair value input, credit spreads, weighted-average | 0.70% | ||
Fair value input, equity index volatility, lower limit | 17.00% | [1] | |
Fair value input, equity index volatility, upper limit | 24.00% | [1] | |
Fair value input, equity index volatility, weighted-average | 21.00% | [1] | |
Level 3 | Fixed index annuity embedded derivatives | Policyholder account balances | |||
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Valuation technique | Option budget method | ||
Policyholder account balances | 276 | ||
Fair value, expected future interest credited, lower limit | 0.00% | ||
Fair value, expected future interest credited, upper limit | 3.00% | ||
Fair value, expected future interest credited, weighted-average | 2.00% | ||
Level 3 | Indexed universal life embedded derivatives | Policyholder account balances | |||
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Valuation technique | Option budget method | ||
Policyholder account balances | 7 | ||
Fair value, expected future interest credited, lower limit | 3.00% | ||
Fair value, expected future interest credited, upper limit | 9.00% | ||
Fair value, expected future interest credited, weighted-average | 6.00% | ||
Derivative assets | Level 3 | Credit default swaps | |||
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Valuation technique | Discounted cash flows | [2] | |
Derivative assets, fair value | 3 | [2] | |
Fair value input, credit spreads, lower limit | 0.00% | [2] | |
Fair value input, credit spreads, upper limit | 0.25% | [2] | |
Fair value input, credit spreads, weighted-average | 0.07% | [2] | |
Derivative assets | Level 3 | Equity index options | |||
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Valuation technique | Discounted cash flows | ||
Derivative assets, fair value | 17 | ||
Fair value input, equity index volatility, lower limit | 14.00% | ||
Fair value input, equity index volatility, upper limit | 23.00% | ||
Fair value input, equity index volatility, weighted-average | 20.00% | ||
Internal Models | Level 3 | U.S. corporate | |||
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Valuation technique | Internal models | ||
Fixed maturity securities available-for-sale, at fair value | 2,234 | ||
Fair value input, credit spreads, lower limit | 0.76% | ||
Fair value input, credit spreads, upper limit | 4.63% | ||
Fair value input, credit spreads, weighted-average | 1.97% | ||
Internal Models | Level 3 | Corporate - non-U.S. | |||
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Valuation technique | Internal models | ||
Fixed maturity securities available-for-sale, at fair value | $1,588 | ||
Fair value input, credit spreads, lower limit | 0.81% | ||
Fair value input, credit spreads, upper limit | 8.08% | ||
Fair value input, credit spreads, weighted-average | 1.78% | ||
[1] | Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. | ||
[2] | Unobservable input valuation based on the current market credit default swap premium. |
Schedule_of_Securitized_Assets
Schedule of Securitized Assets (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Variable Interest Entity [Line Items] | ||
Total assets | $111,358 | $108,045 |
Securitized assets not required to be consolidated | ||
Variable Interest Entity [Line Items] | ||
Total assets | 142 | 147 |
Securitized assets required to be consolidated | ||
Variable Interest Entity [Line Items] | ||
Total assets | 300 | 314 |
Total securitized assets | ||
Variable Interest Entity [Line Items] | ||
Total assets | 442 | 461 |
Other assets | Securitized assets not required to be consolidated | ||
Variable Interest Entity [Line Items] | ||
Total assets | $142 | $147 |
Assets_and_Liabilities_Recorde
Assets and Liabilities Recorded for Consolidated Securitization Entities (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
In Millions, unless otherwise specified | |||
Variable Interest Entity [Line Items] | |||
Restricted commercial mortgage loans | $201 | $233 | |
Total restricted other invested assets | 411 | 391 | |
Total investments | 73,238 | 68,613 | |
Cash and cash equivalents | 4,918 | 4,214 | 3,632 |
Accrued investment income | 685 | 678 | |
Borrowings related to securitization entities | 219 | 242 | |
Securitization entities | |||
Variable Interest Entity [Line Items] | |||
Restricted commercial mortgage loans | 201 | 233 | |
Trading securities | 411 | 391 | |
Total restricted other invested assets | 411 | 391 | |
Total investments | 612 | 624 | |
Cash and cash equivalents | 1 | 1 | |
Accrued investment income | 1 | 1 | |
Total assets | 614 | 626 | |
Derivative liabilities | 43 | 48 | |
Other liabilities | 2 | 2 | |
Total other liabilities | 45 | 50 | |
Borrowings related to securitization entities | 219 | 242 | |
Total liabilities | $264 | $292 |
Activity_Presented_in_Consolid
Activity Presented in Consolidated Statement of Income Related to Consolidated Securitization Entities (Detail) (USD $) | 3 Months Ended | 12 Months Ended | ||||||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||||||
Variable Interest Entity [Line Items] | ||||||||||||||||||
Net investment income | $3,242 | $3,271 | $3,343 | |||||||||||||||
Derivatives | -103 | [1] | -49 | [1] | 4 | [1] | ||||||||||||
Total net investment gains (losses) | 16 | [2] | 69 | [2] | 81 | [2] | ||||||||||||
Total revenues | 2,424 | 2,404 | 2,415 | 2,322 | 2,412 | 2,317 | 2,371 | 2,303 | 9,565 | 9,403 | 9,640 | |||||||
Interest expense | 479 | 492 | 476 | |||||||||||||||
Acquisition and operating expenses | 1,585 | 1,659 | 1,594 | |||||||||||||||
Income before income taxes | -1,276 | 1,050 | 606 | |||||||||||||||
Provision for income taxes | -228 | 324 | 138 | |||||||||||||||
Net income | -708 | [3] | -787 | [3] | 228 | [3] | 219 | [3] | 245 | 148 | 180 | 141 | -1,048 | 714 | 525 | |||
Securitization entities | ||||||||||||||||||
Variable Interest Entity [Line Items] | ||||||||||||||||||
Restricted commercial mortgage loans | 14 | 23 | 29 | |||||||||||||||
Restricted other invested assets | 5 | 4 | 4 | |||||||||||||||
Net investment income | 19 | 27 | 33 | |||||||||||||||
Trading securities | 15 | -4 | 23 | |||||||||||||||
Derivatives | 10 | 86 | 72 | |||||||||||||||
Borrowings related to securitization entities recorded at fair value | -9 | -13 | -14 | |||||||||||||||
Total net investment gains (losses) | 16 | 69 | 81 | |||||||||||||||
Other income | 0 | 0 | 1 | |||||||||||||||
Total revenues | 35 | 96 | 115 | |||||||||||||||
Interest expense | 10 | 16 | 21 | |||||||||||||||
Acquisition and operating expenses | 0 | 0 | 1 | |||||||||||||||
Total expenses | 10 | 16 | 22 | |||||||||||||||
Income before income taxes | 25 | 80 | 93 | |||||||||||||||
Provision for income taxes | 9 | 27 | 33 | |||||||||||||||
Net income | $16 | $53 | $60 | |||||||||||||||
[1] | See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). | |||||||||||||||||
[2] | See note 18 for additional information related to consolidated securitization entities. | |||||||||||||||||
[3] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. |
Borrowings_Related_to_Securiti
Borrowings Related to Securitization Entities (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Variable Interest Entity [Line Items] | ||||
Principal amount | $146 | $179 | ||
Borrowings related to securitization entities | 219 | 242 | ||
GFCM LLC, due 2035, 5.2541% | ||||
Variable Interest Entity [Line Items] | ||||
Principal amount | 21 | 54 | ||
Borrowings related to securitization entities | 21 | 54 | ||
GFCM LLC, due 2035, 5.7426% | ||||
Variable Interest Entity [Line Items] | ||||
Principal amount | 113 | 113 | ||
Borrowings related to securitization entities | 113 | 113 | ||
Marvel Finance 2007-4 LLC, due 2017 | ||||
Variable Interest Entity [Line Items] | ||||
Principal amount | 12 | [1],[2] | 12 | [1],[2] |
Borrowings related to securitization entities | 12 | [1],[2] | 12 | [1],[2] |
Genworth Special Purpose Five, LLC, due 2040 | ||||
Variable Interest Entity [Line Items] | ||||
Principal amount | [1],[2],[3] | [1],[2],[3] | ||
Borrowings related to securitization entities | $73 | [1],[2] | $63 | [1],[2] |
[1] | Accrual of interest based on three-month LIBOR that resets every three months plus a fixed margin. | |||
[2] | Carrying value represents fair value as a result of electing fair value option for these liabilities. | |||
[3] | Principal amount not applicable. Notional balance was $115 million as of December 31, 2014 and 2013. |
Borrowings_Related_to_Securiti1
Borrowings Related to Securitization Entities (Parenthetical) (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Variable Interest Entity [Line Items] | ||
Notional balance | $115 | $115 |
Insurance_Subsidiary_Financial2
Insurance Subsidiary Financial Information and Regulatory Matters - Additional Information (Detail) (USD $) | 12 Months Ended | 1 Months Ended | |||||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | 31-May-14 | Dec. 31, 2013 | Apr. 02, 2013 | Jan. 31, 2013 | |
Statutory Accounting Practices [Line Items] | |||||||
Amount of dividend our subsidiaries could pay in 2015 without obtaining regulatory approval | $500,000,000 | ||||||
Dividends received from insurance subsidiaries | 0 | 0 | 0 | ||||
Additional statutory reserves | 70,000,000 | 80,000,000 | 80,000,000 | ||||
Statutory contingency reserve, annual additions, percentage of earned premiums, minimum | 50.00% | ||||||
Minimum loss ratio requirement to hold statutory contingency reserve | 35.00% | ||||||
Period of time when statutory contingency reserve has to be held, in years | 10 years | ||||||
Statutory contingency reserve | 193,000,000 | 59,000,000 | 59,000,000 | ||||
Genworth Financial's Subsidiaries | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Restricted net assets | 14,400,000,000 | ||||||
Genworth Holdings' Subsidiaries | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Restricted net assets | 14,500,000,000 | ||||||
Genworth Mortgage Insurance Corporation (GEMICO) | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Capital contribution | 300,000,000 | 100,000,000 | 100,000,000 | ||||
Genworth Mortgage Holdings, LLC | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Capital contribution | 300,000,000 | ||||||
Genworth Holdings | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Issued notes, aggregate principal amount | 400,000,000 | 400,000,000 | |||||
Rivermont Insurance Company I | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Maximum potential amount of future obligation | 95,000,000 | ||||||
Limited Guarantee Provided to a subsidiary accounted for as a derivative | 5,000,000 | 0 | 0 | ||||
U.S. Mortgage Insurance subsidiaries | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Maximum risk-to-capital ratio | 25 | ||||||
Number of states with risk-to-capital requirements | 15 | ||||||
Private mortgage insurance eligibility requirements guidelines, transition period, years | 2 years | ||||||
Amount of subsidiary common shares distributed as a capital contribution | 230,000,000 | ||||||
U.S. Mortgage Insurance subsidiaries | Genworth Mortgage Insurance Corporation (GEMICO) | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Risk-to-capital ratio | 14.3 | 19.3 | 19.3 | ||||
Long-term Care Insurance | Brookfield Life and Annuity Insurance Company Limited ("BLAIC") | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Percent of in-force long-term care insurance business, reinsured | 50.00% | ||||||
Australian Mortgage Insurance Subsidiaries | Brookfield Life and Annuity Insurance Company Limited ("BLAIC") | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Ownership percentage | 66.20% | ||||||
Canadian Mortgage Insurance Subsidiaries | Brookfield Life and Annuity Insurance Company Limited ("BLAIC") | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Ownership percentage | 40.60% | ||||||
Lifestyle Protection Insurance | Brookfield Life and Annuity Insurance Company Limited ("BLAIC") | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Ownership percentage | 100.00% | ||||||
Domestic insurance subsidiaries | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Dividends received from insurance subsidiaries | 108,000,000 | 418,000,000 | 374,000,000 | ||||
Domestic insurance subsidiaries | Extraordinary Dividend | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Dividends received from insurance subsidiaries | 0 | 0 | 175,000,000 | ||||
International insurance subsidiaries | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Dividends received from insurance subsidiaries | 630,000,000 | 317,000,000 | 240,000,000 | ||||
Combined statutory capital and surplus | 6,968,000,000 | 8,248,000,000 | 8,248,000,000 | ||||
Capital contribution | 21,000,000 | ||||||
Combined statutory net income (loss) | -65,000,000 | 605,000,000 | 1,190,000,000 | ||||
Statutory capital and surplus required | 2,506,000,000 | 3,435,000,000 | 3,435,000,000 | ||||
Increase (decrease) in statutory capital | 205,000,000 | 359,000,000 | |||||
U.S. domiciled life insurance subsidiaries | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Impact of permitted practices on combined statutory capital and surplus | 365,000,000 | 450,000,000 | |||||
Consolidated RBC ratio | 435.00% | 485.00% | 485.00% | ||||
Domestic subsidiaries | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Combined statutory capital and surplus | 4,352,000,000 | 4,003,000,000 | 4,003,000,000 | ||||
Combined statutory net income (loss) | -262,000,000 | 342,000,000 | -237,000,000 | ||||
Domestic subsidiaries | Captive life reinsurance subsidiaries | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Combined statutory capital and surplus | 1,057,000,000 | 1,101,000,000 | 1,101,000,000 | ||||
Combined statutory net income (loss) | -281,000,000 | -102,000,000 | -478,000,000 | ||||
Insurance Subsidiary | NEW YORK | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Additional statutory reserves | 39,000,000 | ||||||
Insurance Subsidiary | NEW YORK | To be recoreded over the next four years | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Additional statutory reserves | 156,000,000 | ||||||
Guarantees provided to third parties | |||||||
Statutory Accounting Practices [Line Items] | |||||||
Maximum potential amount of future obligation | $28,000,000 | $30,000,000 | $30,000,000 |
Schedule_of_Statutory_Accounti
Schedule of Statutory Accounting Practices (Detail) (Domestic subsidiaries, USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Statutory Accounting Practices [Line Items] | |||
Combined statutory net income (loss) | ($262) | $342 | ($237) |
Combined statutory capital and surplus | 4,352 | 4,003 | |
Life insurance subsidiaries, excluding captive life reinsurance subsidiaries | |||
Statutory Accounting Practices [Line Items] | |||
Combined statutory net income (loss) | -179 | 359 | 378 |
Combined statutory capital and surplus | 2,560 | 2,777 | |
Mortgage insurance subsidiaries | |||
Statutory Accounting Practices [Line Items] | |||
Combined statutory net income (loss) | 198 | 85 | -137 |
Combined statutory capital and surplus | 1,792 | 1,226 | |
Combined statutory net income (loss), excluding captive reinsurance subsidiaries | |||
Statutory Accounting Practices [Line Items] | |||
Combined statutory net income (loss) | 19 | 444 | 241 |
Captive life reinsurance subsidiaries | |||
Statutory Accounting Practices [Line Items] | |||
Combined statutory net income (loss) | -281 | -102 | -478 |
Combined statutory capital and surplus | $1,057 | $1,101 |
Segment_Information_Additional
Segment Information - Additional Information (Detail) (USD $) | 3 Months Ended | 12 Months Ended | 3 Months Ended | 1 Months Ended | 3 Months Ended | |||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Jun. 30, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2014 | Sep. 30, 2012 | Jan. 31, 2012 | Mar. 31, 2012 | Dec. 31, 2012 | Jun. 30, 2014 | Sep. 30, 2013 |
Segment | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Number of operating segments | 5 | |||||||||||
Goodwill impairment, net | $791 | $0 | $86 | |||||||||
Gains (losses) on early extinguishment of debt, net | -2 | -20 | -1 | |||||||||
Tax impact from potential business portfolio changes | 66 | 66 | 0 | 0 | ||||||||
Expenses related to reorganization, net | 13 | 0 | 13 | 0 | ||||||||
Assumed tax rate on adjustments to net operating income | 35.00% | |||||||||||
Long-term Care Insurance | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Goodwill impairment, net | 129 | 167 | ||||||||||
Life Insurance | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Goodwill impairment, net | 145 | 350 | ||||||||||
Lifestyle Protection Insurance | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Goodwill impairment, net | 86 | |||||||||||
Tax impact from potential business portfolio changes | -108 | |||||||||||
Australia Mortgage Insurance | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Tax impact from potential business portfolio changes | 174 | |||||||||||
Life Block Transaction | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Net U.S. GAAP after-tax loss | 6 | 41 | 41 | |||||||||
Non-Recourse Funding Obligations | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Gains (losses) on early extinguishment of debt, net | 3 | |||||||||||
Repurchase of secured debt | 475 | 176 | 20 | |||||||||
Genworth Canada | 4.59% senior notes due December 2015 | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Gains (losses) on early extinguishment of debt, net | -2 | |||||||||||
Genworth Holdings | 4.95% Senior Notes, Due 2015 | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Gains (losses) on early extinguishment of debt, net | -20 | |||||||||||
Repurchase of senior notes | 4 | |||||||||||
Genworth Holdings | 5.75% Senior Notes, Due 2014 | ||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||
Gains (losses) on early extinguishment of debt, net | -4 | |||||||||||
Repurchase of senior notes | $15 | $100 | $100 |
Summary_of_Segments_and_Corpor
Summary of Segments and Corporate and Other Activities (Detail) (USD $) | 3 Months Ended | 12 Months Ended | 3 Months Ended | |||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | ||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Premiums | $5,431 | $5,148 | $5,041 | |||||||||||||
Net investment income | 3,242 | 3,271 | 3,343 | |||||||||||||
Net investment gains (losses) | -20 | -37 | 27 | |||||||||||||
Insurance and investment product fees and other | 912 | 1,021 | 1,229 | |||||||||||||
Total revenues | 2,424 | 2,404 | 2,415 | 2,322 | 2,412 | 2,317 | 2,371 | 2,303 | 9,565 | 9,403 | 9,640 | |||||
Benefits and other changes in policy reserves | 6,620 | 4,895 | 5,378 | |||||||||||||
Interest credited | 737 | 738 | 775 | |||||||||||||
Acquisition and operating expenses, net of deferrals | 1,585 | 1,659 | 1,594 | |||||||||||||
Amortization of deferred acquisition costs and intangibles | 571 | 569 | 722 | |||||||||||||
Goodwill impairment | 849 | 0 | 89 | |||||||||||||
Interest expense | 479 | 492 | 476 | |||||||||||||
Total benefits and expenses | 3,347 | [1] | 3,376 | [1] | 2,102 | [1] | 2,016 | [1] | 2,097 | 2,066 | 2,124 | 2,066 | 10,841 | 8,353 | 9,034 | |
Income (loss) from continuing operations before income taxes | -1,276 | 1,050 | 606 | |||||||||||||
Provision (benefit) for income taxes | -228 | 324 | 138 | |||||||||||||
Income (loss) from continuing operations | -708 | [2] | -787 | [2] | 228 | [2] | 219 | [2] | 245 | 146 | 174 | 161 | -1,048 | 726 | 468 | |
Income (loss) from discontinued operations, net of taxes | 0 | 2 | 6 | -20 | 0 | -12 | 57 | |||||||||
Net income (loss) | -708 | [2] | -787 | [2] | 228 | [2] | 219 | [2] | 245 | 148 | 180 | 141 | -1,048 | 714 | 525 | |
Less: net income attributable to noncontrolling interests | 52 | 57 | 52 | 35 | 37 | 40 | 39 | 38 | 196 | 154 | 200 | |||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -760 | [2] | -844 | [2] | 176 | [2] | 184 | [2] | 208 | 108 | 141 | 103 | -1,244 | 560 | 325 | |
Total assets | 111,358 | 108,045 | 111,358 | 108,045 | ||||||||||||
U.S. Life Insurance | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Total revenues | 6,587 | 6,330 | 6,250 | |||||||||||||
Goodwill impairment | 299 | 849 | ||||||||||||||
U.S. Life Insurance | Segment, Continuing Operations | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Premiums | 3,169 | 2,957 | 2,789 | |||||||||||||
Net investment income | 2,665 | 2,621 | 2,594 | |||||||||||||
Net investment gains (losses) | 41 | -3 | -8 | |||||||||||||
Insurance and investment product fees and other | 712 | 755 | 875 | |||||||||||||
Total revenues | 6,587 | 6,330 | 6,250 | |||||||||||||
Benefits and other changes in policy reserves | 5,820 | 3,975 | 3,950 | |||||||||||||
Interest credited | 618 | 619 | 643 | |||||||||||||
Acquisition and operating expenses, net of deferrals | 658 | 658 | 677 | |||||||||||||
Amortization of deferred acquisition costs and intangibles | 345 | 384 | 477 | |||||||||||||
Goodwill impairment | 849 | 0 | ||||||||||||||
Interest expense | 87 | 97 | 86 | |||||||||||||
Total benefits and expenses | 8,377 | 5,733 | 5,833 | |||||||||||||
Income (loss) from continuing operations before income taxes | -1,790 | 597 | 417 | |||||||||||||
Provision (benefit) for income taxes | -385 | 213 | 143 | |||||||||||||
Income (loss) from continuing operations | -1,405 | 384 | 274 | |||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | 0 | 0 | |||||||||||||
Net income (loss) | -1,405 | 384 | 274 | |||||||||||||
Less: net income attributable to noncontrolling interests | 0 | 0 | 0 | |||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -1,405 | 384 | 274 | |||||||||||||
Total assets | 82,906 | 77,261 | 82,906 | 77,261 | ||||||||||||
International Mortgage Insurance | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Total revenues | 1,240 | 1,361 | 1,408 | |||||||||||||
Goodwill impairment | 0 | |||||||||||||||
International Mortgage Insurance | Segment, Continuing Operations | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Premiums | 950 | 996 | 1,016 | |||||||||||||
Net investment income | 303 | 333 | 375 | |||||||||||||
Net investment gains (losses) | 1 | 32 | 16 | |||||||||||||
Insurance and investment product fees and other | -14 | 0 | 1 | |||||||||||||
Total revenues | 1,240 | 1,361 | 1,408 | |||||||||||||
Benefits and other changes in policy reserves | 204 | 317 | 516 | |||||||||||||
Interest credited | 0 | 0 | 0 | |||||||||||||
Acquisition and operating expenses, net of deferrals | 223 | 241 | 55 | |||||||||||||
Amortization of deferred acquisition costs and intangibles | 59 | 60 | 64 | |||||||||||||
Goodwill impairment | 0 | 0 | ||||||||||||||
Interest expense | 31 | 33 | 36 | |||||||||||||
Total benefits and expenses | 517 | 651 | 671 | |||||||||||||
Income (loss) from continuing operations before income taxes | 723 | 710 | 737 | |||||||||||||
Provision (benefit) for income taxes | 358 | 184 | 188 | |||||||||||||
Income (loss) from continuing operations | 365 | 526 | 549 | |||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | 0 | 0 | |||||||||||||
Net income (loss) | 365 | 526 | 549 | |||||||||||||
Less: net income attributable to noncontrolling interests | 196 | 154 | 200 | |||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | 169 | 372 | 349 | |||||||||||||
Total assets | 8,815 | 9,194 | 8,815 | 9,194 | ||||||||||||
U.S. Mortgage Insurance | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Total revenues | 639 | 616 | 676 | |||||||||||||
Goodwill impairment | 0 | |||||||||||||||
U.S. Mortgage Insurance | Segment, Continuing Operations | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Premiums | 578 | 554 | 549 | |||||||||||||
Net investment income | 59 | 60 | 68 | |||||||||||||
Net investment gains (losses) | 0 | 0 | 36 | |||||||||||||
Insurance and investment product fees and other | 2 | 2 | 23 | |||||||||||||
Total revenues | 639 | 616 | 676 | |||||||||||||
Benefits and other changes in policy reserves | 357 | 412 | 725 | |||||||||||||
Interest credited | 0 | 0 | 0 | |||||||||||||
Acquisition and operating expenses, net of deferrals | 140 | 144 | 143 | |||||||||||||
Amortization of deferred acquisition costs and intangibles | 7 | 6 | 5 | |||||||||||||
Goodwill impairment | 0 | 0 | ||||||||||||||
Interest expense | 0 | 0 | 0 | |||||||||||||
Total benefits and expenses | 504 | 562 | 873 | |||||||||||||
Income (loss) from continuing operations before income taxes | 135 | 54 | -197 | |||||||||||||
Provision (benefit) for income taxes | 44 | 17 | -83 | |||||||||||||
Income (loss) from continuing operations | 91 | 37 | -114 | |||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | 0 | 0 | |||||||||||||
Net income (loss) | 91 | 37 | -114 | |||||||||||||
Less: net income attributable to noncontrolling interests | 0 | 0 | 0 | |||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | 91 | 37 | -114 | |||||||||||||
Total assets | 2,324 | 2,361 | 2,324 | 2,361 | ||||||||||||
International Protection | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Total revenues | 837 | 786 | 822 | |||||||||||||
Goodwill impairment | 0 | 89 | ||||||||||||||
International Protection | Segment, Continuing Operations | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Premiums | 731 | 636 | 682 | |||||||||||||
Net investment income | 101 | 119 | 131 | |||||||||||||
Net investment gains (losses) | 0 | 27 | 6 | |||||||||||||
Insurance and investment product fees and other | 5 | 4 | 3 | |||||||||||||
Total revenues | 837 | 786 | 822 | |||||||||||||
Benefits and other changes in policy reserves | 202 | 159 | 150 | |||||||||||||
Interest credited | 0 | 0 | 0 | |||||||||||||
Acquisition and operating expenses, net of deferrals | 462 | 433 | 483 | |||||||||||||
Amortization of deferred acquisition costs and intangibles | 118 | 106 | 113 | |||||||||||||
Goodwill impairment | 0 | 89 | ||||||||||||||
Interest expense | 46 | 42 | 45 | |||||||||||||
Total benefits and expenses | 828 | 740 | 880 | |||||||||||||
Income (loss) from continuing operations before income taxes | 9 | 46 | -58 | |||||||||||||
Provision (benefit) for income taxes | -107 | 7 | 1 | |||||||||||||
Income (loss) from continuing operations | 116 | 39 | -59 | |||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | 0 | 0 | |||||||||||||
Net income (loss) | 116 | 39 | -59 | |||||||||||||
Less: net income attributable to noncontrolling interests | 0 | 0 | 0 | |||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | 116 | 39 | -59 | |||||||||||||
Total assets | 1,833 | 2,061 | 1,833 | 2,061 | ||||||||||||
Runoff | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Total revenues | 275 | 302 | 381 | |||||||||||||
Goodwill impairment | 0 | |||||||||||||||
Runoff | Segment, Continuing Operations | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Premiums | 3 | 5 | 5 | |||||||||||||
Net investment income | 129 | 139 | 145 | |||||||||||||
Net investment gains (losses) | -66 | -58 | 24 | |||||||||||||
Insurance and investment product fees and other | 209 | 216 | 207 | |||||||||||||
Total revenues | 275 | 302 | 381 | |||||||||||||
Benefits and other changes in policy reserves | 37 | 32 | 37 | |||||||||||||
Interest credited | 119 | 119 | 132 | |||||||||||||
Acquisition and operating expenses, net of deferrals | 84 | 81 | 79 | |||||||||||||
Amortization of deferred acquisition costs and intangibles | 39 | 6 | 51 | |||||||||||||
Goodwill impairment | 0 | 0 | ||||||||||||||
Interest expense | 1 | 2 | 1 | |||||||||||||
Total benefits and expenses | 280 | 240 | 300 | |||||||||||||
Income (loss) from continuing operations before income taxes | -5 | 62 | 81 | |||||||||||||
Provision (benefit) for income taxes | -19 | 13 | 23 | |||||||||||||
Income (loss) from continuing operations | 14 | 49 | 58 | |||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | 0 | 0 | |||||||||||||
Net income (loss) | 14 | 49 | 58 | |||||||||||||
Less: net income attributable to noncontrolling interests | 0 | 0 | 0 | |||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | 14 | 49 | 58 | |||||||||||||
Total assets | 12,971 | 14,062 | 12,971 | 14,062 | ||||||||||||
Corporate and Other | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Total revenues | -13 | 8 | 103 | |||||||||||||
Goodwill impairment | 0 | |||||||||||||||
Corporate and Other | Segment, Continuing Operations | ||||||||||||||||
Segment Reporting Information [Line Items] | ||||||||||||||||
Premiums | 0 | 0 | 0 | |||||||||||||
Net investment income | -15 | -1 | 30 | |||||||||||||
Net investment gains (losses) | 4 | -35 | -47 | |||||||||||||
Insurance and investment product fees and other | -2 | 44 | 120 | |||||||||||||
Total revenues | -13 | 8 | 103 | |||||||||||||
Benefits and other changes in policy reserves | 0 | 0 | 0 | |||||||||||||
Interest credited | 0 | 0 | 0 | |||||||||||||
Acquisition and operating expenses, net of deferrals | 18 | 102 | 157 | |||||||||||||
Amortization of deferred acquisition costs and intangibles | 3 | 7 | 12 | |||||||||||||
Goodwill impairment | 0 | 0 | ||||||||||||||
Interest expense | 314 | 318 | 308 | |||||||||||||
Total benefits and expenses | 335 | 427 | 477 | |||||||||||||
Income (loss) from continuing operations before income taxes | -348 | -419 | -374 | |||||||||||||
Provision (benefit) for income taxes | -119 | -110 | -134 | |||||||||||||
Income (loss) from continuing operations | -229 | -309 | -240 | |||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | -12 | 57 | |||||||||||||
Net income (loss) | -229 | -321 | -183 | |||||||||||||
Less: net income attributable to noncontrolling interests | 0 | 0 | 0 | |||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -229 | -321 | -183 | |||||||||||||
Total assets | $2,509 | $3,106 | $2,509 | $3,106 | ||||||||||||
[1] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates. | |||||||||||||||
[2] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. |
Summary_of_Revenues_for_Segmen
Summary of Revenues for Segments and Corporate and Other Activities (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Segment Reporting Information [Line Items] | |||||||||||
Revenues | $2,424 | $2,404 | $2,415 | $2,322 | $2,412 | $2,317 | $2,371 | $2,303 | $9,565 | $9,403 | $9,640 |
Long-term Care Insurance | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 3,523 | 3,316 | 3,207 | ||||||||
Life Insurance | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 1,981 | 1,982 | 1,926 | ||||||||
Fixed Annuities | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 1,083 | 1,032 | 1,117 | ||||||||
U.S. Life Insurance | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 6,587 | 6,330 | 6,250 | ||||||||
Canada Mortgage Insurance | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 669 | 760 | 786 | ||||||||
Australia Mortgage Insurance | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 537 | 555 | 567 | ||||||||
Other Countries Mortgage Insurance | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 34 | 46 | 55 | ||||||||
International Mortgage Insurance | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 1,240 | 1,361 | 1,408 | ||||||||
U.S. Mortgage Insurance | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 639 | 616 | 676 | ||||||||
International Protection | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 837 | 786 | 822 | ||||||||
Runoff | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | 275 | 302 | 381 | ||||||||
Corporate and Other | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Revenues | ($13) | $8 | $103 |
Summary_of_Net_Operating_Incom
Summary of Net Operating Income (Loss) for Segments and Corporate and Other Activities (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | ($381) | $616 | $403 | ||||||||||||
Net investment gains (losses), net | -4 | -11 | -1 | ||||||||||||
Goodwill impairment, net | -791 | 0 | -86 | ||||||||||||
Gains (losses) on early extinguishment of debt, net | -2 | -20 | -1 | ||||||||||||
Gains (losses) from life block transactions, net | 0 | 0 | -47 | ||||||||||||
Tax Impact From Potential Business Portfolio Changes | -66 | -66 | 0 | 0 | |||||||||||
Expenses related to restructuring, net | -13 | 0 | -13 | 0 | |||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | 2 | 6 | -20 | 0 | -12 | 57 | ||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -760 | [1] | -844 | [1] | 176 | [1] | 184 | [1] | 208 | 108 | 141 | 103 | -1,244 | 560 | 325 |
Add: net income attributable to noncontrolling interests | 52 | 57 | 52 | 35 | 37 | 40 | 39 | 38 | 196 | 154 | 200 | ||||
Net income (loss) | -708 | [1] | -787 | [1] | 228 | [1] | 219 | [1] | 245 | 148 | 180 | 141 | -1,048 | 714 | 525 |
Long-term Care Insurance | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | -815 | 129 | 101 | ||||||||||||
Goodwill impairment, net | -129 | -167 | |||||||||||||
Life Insurance | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | 74 | 173 | 151 | ||||||||||||
Goodwill impairment, net | -145 | -350 | |||||||||||||
Fixed Annuities | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | 100 | 92 | 82 | ||||||||||||
U.S. Life Insurance | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | -641 | 394 | 334 | ||||||||||||
Goodwill impairment, net | -274 | ||||||||||||||
Canada Mortgage Insurance | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | 170 | 170 | 234 | ||||||||||||
Australia Mortgage Insurance | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | 200 | 228 | 142 | ||||||||||||
Tax Impact From Potential Business Portfolio Changes | -174 | ||||||||||||||
Other Countries Mortgage Insurance | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | -25 | -37 | -34 | ||||||||||||
International Mortgage Insurance | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | 345 | 361 | 342 | ||||||||||||
U.S. Mortgage Insurance | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | 91 | 37 | -138 | ||||||||||||
International Protection | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | 8 | 24 | 24 | ||||||||||||
Runoff | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | 48 | 66 | 46 | ||||||||||||
Corporate and Other | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Net operating income (loss) | ($232) | ($266) | ($205) | ||||||||||||
[1] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. |
Schedule_of_Revenue_Net_Income
Schedule of Revenue, Net Income and Assets by Geographic Location (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||
Segment Reporting Information [Line Items] | |||||||||||||||
Total revenues | $2,424 | $2,404 | $2,415 | $2,322 | $2,412 | $2,317 | $2,371 | $2,303 | $9,565 | $9,403 | $9,640 | ||||
Income (loss) from continuing operations | -708 | [1] | -787 | [1] | 228 | [1] | 219 | [1] | 245 | 146 | 174 | 161 | -1,048 | 726 | 468 |
Net income (loss) | -708 | [1] | -787 | [1] | 228 | [1] | 219 | [1] | 245 | 148 | 180 | 141 | -1,048 | 714 | 525 |
Total assets | 111,358 | 108,045 | 111,358 | 108,045 | |||||||||||
United States | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Total revenues | 7,488 | 7,256 | 7,410 | ||||||||||||
Income (loss) from continuing operations | -1,529 | 161 | -22 | ||||||||||||
Net income (loss) | -1,529 | 149 | 35 | ||||||||||||
Total assets | 100,710 | 96,790 | 100,710 | 96,790 | |||||||||||
Canada | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Total revenues | 669 | 760 | 786 | ||||||||||||
Income (loss) from continuing operations | 307 | 336 | 439 | ||||||||||||
Net income (loss) | 307 | 336 | 439 | ||||||||||||
Total assets | 4,922 | 5,313 | 4,922 | 5,313 | |||||||||||
Australia | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Total revenues | 537 | 555 | 567 | ||||||||||||
Income (loss) from continuing operations | 83 | 227 | 140 | ||||||||||||
Net income (loss) | 83 | 227 | 140 | ||||||||||||
Total assets | 3,495 | 3,419 | 3,495 | 3,419 | |||||||||||
Other Countries | |||||||||||||||
Segment Reporting Information [Line Items] | |||||||||||||||
Total revenues | 871 | 832 | 877 | ||||||||||||
Income (loss) from continuing operations | 91 | 2 | -89 | ||||||||||||
Net income (loss) | 91 | 2 | -89 | ||||||||||||
Total assets | $2,231 | $2,523 | $2,231 | $2,523 | |||||||||||
[1] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. |
Quarterly_Results_of_Operation2
Quarterly Results of Operations (Detail) (USD $) | 3 Months Ended | 12 Months Ended | ||||||||||||||||
In Millions, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||||||
Quarterly Results Of Operations [Abstract] | ||||||||||||||||||
Total revenues | $2,424 | $2,404 | $2,415 | $2,322 | $2,412 | $2,317 | $2,371 | $2,303 | $9,565 | $9,403 | $9,640 | |||||||
Total benefits and expenses | 3,347 | [1] | 3,376 | [1] | 2,102 | [1] | 2,016 | [1] | 2,097 | 2,066 | 2,124 | 2,066 | 10,841 | 8,353 | 9,034 | |||
Income (loss) from continuing operations | -708 | [2] | -787 | [2] | 228 | [2] | 219 | [2] | 245 | 146 | 174 | 161 | -1,048 | 726 | 468 | |||
Net income | -708 | [2] | -787 | [2] | 228 | [2] | 219 | [2] | 245 | 148 | 180 | 141 | -1,048 | 714 | 525 | |||
Net income attributable to noncontrolling interests | 52 | 57 | 52 | 35 | 37 | 40 | 39 | 38 | 196 | 154 | 200 | |||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -760 | [2] | -844 | [2] | 176 | [2] | 184 | [2] | 208 | 108 | 141 | 103 | -1,244 | 560 | 325 | |||
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per common share: | ||||||||||||||||||
Basic | ($1.53) | ($1.70) | $0.35 | $0.37 | $0.42 | $0.21 | $0.27 | $0.25 | ($2.51) | $1.16 | $0.55 | |||||||
Diluted | ($1.53) | ($1.70) | $0.35 | $0.37 | $0.42 | $0.21 | $0.27 | $0.25 | ($2.51) | $1.15 | $0.54 | |||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders per common share: | ||||||||||||||||||
Basic | ($1.53) | ($1.70) | $0.35 | $0.37 | $0.42 | $0.22 | $0.29 | $0.21 | ($2.51) | $1.13 | $0.66 | |||||||
Diluted | ($1.53) | ($1.70) | $0.35 | $0.37 | $0.41 | $0.22 | $0.28 | $0.21 | ($2.51) | $1.12 | $0.66 | |||||||
Weighted-average common shares outstanding: | ||||||||||||||||||
Basic | 496.7 | 496.6 | 496.6 | 495.8 | 494.7 | 494 | 493.4 | 492.5 | 496.4 | 493.6 | 491.6 | |||||||
Diluted | 496.7 | [3] | 496.6 | [3] | 503.6 | [3] | 502.7 | [3] | 501.2 | 499.3 | 497.5 | 496.8 | 496.4 | [4] | 498.7 | [4] | 494.4 | [4] |
Income (loss) from discontinued operations, net of taxes | $0 | $2 | $6 | ($20) | $0 | ($12) | $57 | |||||||||||
[1] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates. | |||||||||||||||||
[2] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. | |||||||||||||||||
[3] | Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2014 and December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2014 and December 31, 2014, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.4 million and 3.2 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2014 and December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million and 499.9 million, respectively. | |||||||||||||||||
[4] | Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the year ended December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the year ended December 31, 2014, as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.6 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the year ended December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million. |
Quarterly_Results_of_Operation3
Quarterly Results of Operations (Parenthetical) (Detail) (USD $) | 3 Months Ended | 12 Months Ended | 3 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 |
Quarterly Financial Information [Line Items] | ||||||
Goodwill impairment | $849 | $0 | $89 | |||
Goodwill impairment, net | 791 | 0 | 86 | |||
Tax impact from business portfolio changes | 66 | 66 | 0 | 0 | ||
Weighted-average diluted common shares outstanding, antidilutive securities (stock options, RSUs and SARs) | 3.2 | 5.4 | 5.6 | |||
Weighted-average number of diluted shares if not in a loss position | 499.9 | 502 | 502 | |||
Long-term Care Insurance | ||||||
Quarterly Financial Information [Line Items] | ||||||
Additional expenses | 735 | |||||
Goodwill impairment | 154 | 200 | 354 | |||
Additional expenses, net of taxes | 478 | |||||
Goodwill impairment, net | 129 | 167 | ||||
U.S. Life Insurance | ||||||
Quarterly Financial Information [Line Items] | ||||||
Goodwill impairment | 299 | 849 | ||||
Goodwill impairment, net | 274 | |||||
Life Insurance | ||||||
Quarterly Financial Information [Line Items] | ||||||
Goodwill impairment | 145 | 350 | 495 | |||
Goodwill impairment, net | 145 | 350 | ||||
Australia Mortgage Insurance | ||||||
Quarterly Financial Information [Line Items] | ||||||
Tax impact from business portfolio changes | 174 | |||||
Lifestyle Protection Insurance | ||||||
Quarterly Financial Information [Line Items] | ||||||
Goodwill impairment, net | 86 | |||||
Tax impact from business portfolio changes | -108 | |||||
Reserve Correction | Life Insurance | ||||||
Quarterly Financial Information [Line Items] | ||||||
Correction to reserves on a reinsurance transaction | 49 | |||||
Correction to reserves on a reinsurance transaction, net of taxes | 32 | |||||
Claim Reserve Correction | Long-term Care Insurance | ||||||
Quarterly Financial Information [Line Items] | ||||||
Adjustment made to the claim reserves, net of reinsurance | 67 | |||||
Adjustment made to the claim reserves, net of reinsurance and taxes | 44 | |||||
Claim Reserve Refinement | Long-term Care Insurance | ||||||
Quarterly Financial Information [Line Items] | ||||||
Adjustment made to the claim reserves, net of reinsurance | 43 | |||||
Adjustment made to the claim reserves, net of reinsurance and taxes | $28 |
Commitments_and_Contingencies_
Commitments and Contingencies - Additional Information (Detail) (USD $) | Dec. 31, 2014 |
In Millions, unless otherwise specified | |
Commitments and Contingencies Disclosure [Line Items] | |
Commitment to fund limited partnership investments | $53 |
Commitment to fund U.S. commercial mortgage loan investments | 128 |
Commitment to fund private placement investments | 27 |
Rivermont Insurance Company I | |
Commitments and Contingencies Disclosure [Line Items] | |
One time commitment fee | 2 |
Maximum potential amount of future obligation | 95 |
U.S. Mortgage Insurance | |
Commitments and Contingencies Disclosure [Line Items] | |
Arbitration settlement | $53 |
Component_of_Changes_In_Accumu
Component of Changes In Accumulated Other Comprehensive Income (Loss), Net of Taxes (Detail) (USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items] | ||||||
Net unrealized investment gains (losses), beginning of period | $926 | [1] | $2,638 | [1] | $1,485 | [1] |
Net unrealized investment gains (losses), OCI before reclassifications | 1,595 | [1] | -1,772 | [1] | 1,106 | [1] |
Net unrealized investment gains (losses), amounts reclassified from (to) OCI | -12 | [1] | 21 | [1] | 50 | [1] |
Net unrealized investment gains (losses), current period OCI | 1,583 | [1] | -1,751 | [1] | 1,156 | [1] |
Net unrealized investment gains (losses), before noncontrolling interest | 2,509 | [1] | 887 | [1] | 2,641 | [1] |
Less: Net unrealized investment gains (losses), change in OCI attributable to noncontrolling interests | 56 | [1] | -39 | [1] | 3 | [1] |
Net unrealized investment gains (losses), end of period | 2,453 | [1] | 926 | [1] | 2,638 | [1] |
Derivatives qualifying as effective accounting hedges, beginning of period | 1,319 | [2] | 1,909 | [2] | 2,009 | [2] |
Derivatives qualifying as hedges, OCI before reclassifications | 788 | [2] | -561 | [2] | -77 | [2] |
Derivatives qualifying as hedges, amounts reclassified from (to) OCI | -37 | [2] | -29 | [2] | -23 | [2] |
Derivatives qualifying as hedges, current period OCI | 751 | [2] | -590 | [2] | -100 | [2] |
Derivatives qualifying as hedges, before noncontrolling interests | 2,070 | [2] | 1,319 | [2] | 1,909 | [2] |
Less: Derivatives qualifying as hedges, change in OCI attributable to noncontrolling interests | 0 | [2] | 0 | [2] | 0 | [2] |
Derivatives qualifying as effective accounting hedges, end of period | 2,070 | [2] | 1,319 | [2] | 1,909 | [2] |
Foreign currency translation and other adjustments, beginning balances | 297 | 655 | 553 | |||
Foreign currency translation and other adjustments, OCI before reclassifications | -537 | -442 | 126 | |||
Foreign currency translation and other adjustments, amounts reclassified from (to) OCI | 0 | 0 | 0 | |||
Foreign currency translation and other adjustments, current period OCI | -537 | -442 | 126 | |||
Foreign currency translation and other adjustments, before noncontrolling interests | -240 | 213 | 679 | |||
Less: Foreign currency translation and other adjustments, change in OCI attributable to noncontrolling interests | -163 | -84 | 24 | |||
Foreign currency translation and other adjustments, ending balances | -77 | 297 | 655 | |||
Accumulated other comprehensive income (loss), beginning balances | 2,542 | 5,202 | 4,047 | |||
OCI before reclassifications | 1,846 | -2,775 | 1,155 | |||
Amounts reclassified from (to) OCI | -49 | -8 | 27 | |||
Total other comprehensive income (loss) | 1,797 | -2,783 | 1,182 | |||
Accumulated other comprehensive income (loss), before noncontrolling interests | 4,339 | 2,419 | 5,229 | |||
Less: change in OCI attributable to noncontrolling interests | -107 | -123 | 27 | |||
Accumulated other comprehensive income (loss), ending balances | $4,446 | $2,542 | $5,202 | |||
[1] | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. | |||||
[2] | See note 5 for additional information. |
Changes_In_Accumulated_Other_C2
Changes In Accumulated Other Comprehensive Income (Loss) - Additional Information (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items] | |||
Unrecognized postretirement benefit obligation, current period OCI | $37 | $6 | $26 |
Unrecognized postretirement benefit obligation, current period OCI, tax | 14 | 1 | 15 |
Foreign currency translation and other adjustments, current period OCI, tax | ($10) | $39 | $58 |
Reclassifications_Out_of_Accum
Reclassifications Out of Accumulated Other Comprehensive Income (Loss) Net of Taxes (Detail) (USD $) | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items] | ||||||
Net unrealized investment gains (losses), amounts reclassified from (to) OCI, provision for income taxes | $7 | ($12) | ($27) | |||
Net unrealized investment gains (losses), amounts reclassified from (to) OCI | -12 | [1] | 21 | [1] | 50 | [1] |
Derivatives qualifying as hedges, amounts reclassified from (to) OCI | -37 | [2] | -29 | [2] | -23 | [2] |
Unrealized gains (losses) on investment | Net Investment Gains (Losses) | ||||||
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items] | ||||||
Net unrealized investment gains (losses), amounts reclassified from (to) OCI, before tax | -19 | [3] | 33 | [3] | 77 | [3] |
Provision for income taxes | ||||||
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items] | ||||||
Net unrealized investment gains (losses), amounts reclassified from (to) OCI, provision for income taxes | 7 | -12 | -27 | |||
Derivatives qualifying as hedges, amounts reclassified from (to) OCI | 20 | 16 | 12 | |||
Interest Rate Swaps Hedging Assets | Net Investment Gains (Losses) | ||||||
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items] | ||||||
Derivatives qualifying as hedges, amounts reclassified from (to) OCI | -2 | -1 | -2 | |||
Interest Rate Swaps Hedging Assets | Net Investment Income | ||||||
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items] | ||||||
Derivatives qualifying as hedges, amounts reclassified from (to) OCI | -63 | -47 | -40 | |||
Interest Rate Swaps Hedging Liabilities | Interest Expense | ||||||
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items] | ||||||
Derivatives qualifying as hedges, amounts reclassified from (to) OCI | -1 | -2 | -2 | |||
Inflation indexed swaps | Net Investment Income | ||||||
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items] | ||||||
Derivatives qualifying as hedges, amounts reclassified from (to) OCI | $9 | $5 | $9 | |||
[1] | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. | |||||
[2] | See note 5 for additional information. | |||||
[3] | Amounts exclude adjustments to DAC, PVFP, sales inducements and benefit reserves. |
Noncontrolling_Interests_Addit
Noncontrolling Interests - Additional Information (Detail) | 12 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||
In Millions, except Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | 15-May-14 | Dec. 31, 2014 | Dec. 31, 2013 | 21-May-14 | 15-May-14 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Jul. 31, 2009 |
USD ($) | USD ($) | USD ($) | Genworth Australia | Genworth Australia | Genworth Australia | Genworth Australia | Genworth Australia | Genworth Canada | Genworth Canada | Genworth Canada | Genworth Canada | Genworth Canada | Genworth Canada IPO | |
USD ($) | USD ($) | AUD | USD ($) | CAD | USD ($) | CAD | USD ($) | |||||||
Noncontrolling Interest [Line Items] | ||||||||||||||
Beneficial ownership percentage of ordinary shares | 66.20% | 66.20% | 57.30% | 57.30% | 57.50% | |||||||||
Repurchase of subsidiary shares through issuer bid, number of shares | 1,900,000 | 1,900,000 | 3,900,000 | 3,900,000 | ||||||||||
Common shares repurchased, value | 75 | 105 | ||||||||||||
Shares authorized to be repurchased | 4,700,000 | 4,700,000 | 4,900,000 | 4,900,000 | ||||||||||
Amount received as a result of participation in Issuer Bid | 38 | 58 | ||||||||||||
Dividend paid to noncontrolling interests | 75 | 52 | 50 | 6 | 69 | 52 | 50 | |||||||
Common shares of Genworth Australia sold in initial public offering | 220,000,000 | |||||||||||||
Offering price per ordinary share | 2.65 | |||||||||||||
Gross proceeds of the Offer | 541 | |||||||||||||
Fees and expenses in connection with the Offer | $27 | $3 |
Changes_in_Ownership_Interests
Changes in Ownership Interests and Effect on Stockholders' Equity (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] | |||||||||||||||
Net loss available to Genworth Financial, Inc.'s common stockholders | ($760) | [1] | ($844) | [1] | $176 | [1] | $184 | [1] | $208 | $108 | $141 | $103 | ($1,244) | $560 | $325 |
Transfers to the noncontrolling interests: | |||||||||||||||
Decrease in Genworth Financial, Inc.'s additional paid-in capital for initial sale of Genworth Australia shares to noncontrolling interests | -145 | ||||||||||||||
Net transfers to noncontrolling interests | -145 | ||||||||||||||
Change from net loss available to Genworth Financial, Inc.'s common stockholders and transfers to noncontrolling interests | ($1,389) | ||||||||||||||
[1] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. |
Summary_Operating_Results_of_D
Summary Operating Results of Discontinued Operations (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||
In Millions, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||
Revenues | $211 | $387 | |||||
Income (loss) before income taxes | -5 | 110 | |||||
Provision for income taxes | 7 | 53 | |||||
Income (loss) from discontinued operations, net of taxes | $0 | $2 | $6 | ($20) | $0 | ($12) | $57 |
Discontinued_Operations_Additi
Discontinued Operations - Additional Information (Detail) (USD $) | 12 Months Ended | 0 Months Ended | 3 Months Ended | 0 Months Ended | |||
In Millions, unless otherwise specified | Dec. 31, 2012 | Dec. 31, 2010 | Aug. 29, 2008 | Aug. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2013 | Apr. 02, 2012 |
Altegris Capital Llc | |||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||
Acquisition of businesses, approximate amount paid | $40 | ||||||
Additional performance-based payments, maximum | 88 | ||||||
Contingent consideration | 18 | ||||||
Quantuvis Consulting Inc | |||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||
Acquisition of businesses, approximate amount paid | 3 | ||||||
Additional performance-based payments, maximum | 3 | ||||||
Wealth Management Business | |||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||
Proceeds from sale of business | 412 | ||||||
Net proceeds from sale of business | 360 | ||||||
Wealth Management Business | Contingent Consideration Liability | |||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||
Loss on sale of discontinued operations, net of taxes | -5 | ||||||
Business acquisition contingent consideration liability | 40 | ||||||
Wealth Management Business | Fair Value Less Costs to Sell Adjustment | |||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||
Loss on sale of discontinued operations, net of taxes | -9 | ||||||
Wealth Management Business | Closing | |||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||
Loss on sale of discontinued operations, net of taxes | -2 | ||||||
Wealth Management Business | Goodwill Impairment Loss | |||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||
Loss on sale of discontinued operations, net of taxes | -13 | ||||||
Genworth Financial Investment Services | |||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||
Proceeds from sale of business | 79 | ||||||
Contingent consideration to be received | 25 | ||||||
Gain on sale of discontinued operations | $13 |
Condensed_Consolidating_Balanc
Condensed Consolidating Balance Sheet (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Millions, unless otherwise specified | ||||
Assets | ||||
Fixed maturity securities available-for-sale, at fair value | $62,447 | $58,629 | ||
Equity securities available-for-sale, at fair value | 282 | 341 | ||
Commercial mortgage loans | 6,100 | 5,899 | ||
Restricted commercial mortgage loans related to securitization entities | 201 | 233 | ||
Policy loans | 1,501 | 1,434 | ||
Other invested assets | 2,296 | 1,686 | ||
Restricted other invested assets related to securitization entities, at fair value | 411 | 391 | ||
Investments in subsidiaries | 0 | 0 | ||
Total investments | 73,238 | 68,613 | ||
Cash and cash equivalents | 4,918 | 4,214 | 3,632 | |
Accrued investment income | 685 | 678 | ||
Deferred acquisition costs | 5,042 | 5,278 | 5,036 | |
Intangible assets | 272 | 399 | ||
Goodwill | 16 | 867 | 868 | |
Reinsurance recoverable | 17,346 | 17,219 | ||
Other assets | 633 | 639 | ||
Intercompany notes receivable | 0 | 0 | ||
Separate account assets | 9,208 | 10,138 | ||
Total assets | 111,358 | 108,045 | ||
Liabilities and stockholders' equity | ||||
Future policy benefits | 35,915 | 33,705 | ||
Policyholder account balances | 26,043 | 25,528 | ||
Liability for policy and contract claims | 8,043 | 7,204 | ||
Unearned premiums | 3,986 | 4,107 | ||
Other liabilities | 3,604 | 4,096 | ||
Intercompany notes payable | 0 | 0 | ||
Borrowings related to securitization entities | 219 | 242 | ||
Non-recourse funding obligations | 1,996 | 2,038 | ||
Long-term borrowings | 4,639 | 5,161 | ||
Deferred tax liability | 908 | 206 | ||
Separate account liabilities | 9,208 | 10,138 | ||
Total liabilities | 94,561 | 92,425 | ||
Stockholders' equity: | ||||
Common stock | 1 | 1 | ||
Additional paid-in capital | 11,997 | 12,127 | ||
Accumulated other comprehensive income (loss) | 4,446 | 2,542 | 5,202 | 4,047 |
Retained earnings | 1,179 | 2,423 | ||
Treasury stock, at cost | -2,700 | -2,700 | ||
Total Genworth Financial, Inc.'s stockholders' equity | 14,923 | 14,393 | ||
Noncontrolling interests | 1,874 | 1,227 | ||
Total stockholders' equity | 16,797 | 15,620 | 17,781 | 16,132 |
Total liabilities and stockholders' equity | 111,358 | 108,045 | ||
Parent Guarantor | ||||
Assets | ||||
Fixed maturity securities available-for-sale, at fair value | 0 | 0 | ||
Equity securities available-for-sale, at fair value | 0 | 0 | ||
Commercial mortgage loans | 0 | 0 | ||
Restricted commercial mortgage loans related to securitization entities | 0 | 0 | ||
Policy loans | 0 | 0 | ||
Other invested assets | 0 | 0 | ||
Restricted other invested assets related to securitization entities, at fair value | 0 | 0 | ||
Investments in subsidiaries | 14,895 | 14,358 | ||
Total investments | 14,895 | 14,358 | ||
Cash and cash equivalents | 0 | 0 | 0 | |
Accrued investment income | 0 | 0 | ||
Deferred acquisition costs | 0 | 0 | ||
Intangible assets | 0 | 0 | ||
Goodwill | 0 | 0 | ||
Reinsurance recoverable | 0 | 0 | ||
Other assets | 2 | -2 | ||
Intercompany notes receivable | 9 | 8 | ||
Separate account assets | 0 | 0 | ||
Total assets | 14,906 | 14,364 | ||
Liabilities and stockholders' equity | ||||
Future policy benefits | 0 | 0 | ||
Policyholder account balances | 0 | 0 | ||
Liability for policy and contract claims | 0 | 0 | ||
Unearned premiums | 0 | 0 | ||
Other liabilities | 3 | -3 | ||
Intercompany notes payable | 0 | 0 | ||
Borrowings related to securitization entities | 0 | 0 | ||
Non-recourse funding obligations | 0 | 0 | ||
Long-term borrowings | 0 | 0 | ||
Deferred tax liability | -20 | -26 | ||
Separate account liabilities | 0 | 0 | ||
Total liabilities | -17 | -29 | ||
Stockholders' equity: | ||||
Common stock | 1 | 1 | ||
Additional paid-in capital | 11,997 | 12,127 | ||
Accumulated other comprehensive income (loss) | 4,446 | 2,542 | ||
Retained earnings | 1,179 | 2,423 | ||
Treasury stock, at cost | -2,700 | -2,700 | ||
Total Genworth Financial, Inc.'s stockholders' equity | 14,923 | 14,393 | ||
Noncontrolling interests | 0 | 0 | ||
Total stockholders' equity | 14,923 | 14,393 | ||
Total liabilities and stockholders' equity | 14,906 | 14,364 | ||
Issuer | ||||
Assets | ||||
Fixed maturity securities available-for-sale, at fair value | 150 | 150 | ||
Equity securities available-for-sale, at fair value | 0 | 0 | ||
Commercial mortgage loans | 0 | 0 | ||
Restricted commercial mortgage loans related to securitization entities | 0 | 0 | ||
Policy loans | 0 | 0 | ||
Other invested assets | 14 | 91 | ||
Restricted other invested assets related to securitization entities, at fair value | 0 | 0 | ||
Investments in subsidiaries | 15,003 | 14,929 | ||
Total investments | 15,167 | 15,170 | ||
Cash and cash equivalents | 953 | 1,219 | 843 | |
Accrued investment income | 0 | 0 | ||
Deferred acquisition costs | 0 | 0 | ||
Intangible assets | 0 | 0 | ||
Goodwill | 0 | 0 | ||
Reinsurance recoverable | 0 | 0 | ||
Other assets | 207 | 276 | ||
Intercompany notes receivable | 267 | 248 | ||
Separate account assets | 0 | 0 | ||
Total assets | 16,594 | 16,913 | ||
Liabilities and stockholders' equity | ||||
Future policy benefits | 0 | 0 | ||
Policyholder account balances | 0 | 0 | ||
Liability for policy and contract claims | 0 | 0 | ||
Unearned premiums | 0 | 0 | ||
Other liabilities | 251 | 365 | ||
Intercompany notes payable | 604 | 601 | ||
Borrowings related to securitization entities | 0 | 0 | ||
Non-recourse funding obligations | 0 | 0 | ||
Long-term borrowings | 4,151 | 4,636 | ||
Deferred tax liability | -970 | -796 | ||
Separate account liabilities | 0 | 0 | ||
Total liabilities | 4,036 | 4,806 | ||
Stockholders' equity: | ||||
Common stock | 0 | 0 | ||
Additional paid-in capital | 9,162 | 9,297 | ||
Accumulated other comprehensive income (loss) | 4,449 | 2,507 | ||
Retained earnings | -1,053 | 303 | ||
Treasury stock, at cost | 0 | 0 | ||
Total Genworth Financial, Inc.'s stockholders' equity | 12,558 | 12,107 | ||
Noncontrolling interests | 0 | 0 | ||
Total stockholders' equity | 12,558 | 12,107 | ||
Total liabilities and stockholders' equity | 16,594 | 16,913 | ||
All Other Subsidiaries | ||||
Assets | ||||
Fixed maturity securities available-for-sale, at fair value | 62,497 | 58,679 | ||
Equity securities available-for-sale, at fair value | 282 | 341 | ||
Commercial mortgage loans | 6,100 | 5,899 | ||
Restricted commercial mortgage loans related to securitization entities | 201 | 233 | ||
Policy loans | 1,501 | 1,434 | ||
Other invested assets | 2,287 | 1,595 | ||
Restricted other invested assets related to securitization entities, at fair value | 411 | 391 | ||
Investments in subsidiaries | 0 | 0 | ||
Total investments | 73,279 | 68,572 | ||
Cash and cash equivalents | 3,965 | 2,995 | 2,789 | |
Accrued investment income | 689 | 682 | ||
Deferred acquisition costs | 5,042 | 5,278 | ||
Intangible assets | 272 | 399 | ||
Goodwill | 16 | 867 | ||
Reinsurance recoverable | 17,346 | 17,219 | ||
Other assets | 425 | 367 | ||
Intercompany notes receivable | 395 | 393 | ||
Separate account assets | 9,208 | 10,138 | ||
Total assets | 110,637 | 106,910 | ||
Liabilities and stockholders' equity | ||||
Future policy benefits | 35,915 | 33,705 | ||
Policyholder account balances | 26,043 | 25,528 | ||
Liability for policy and contract claims | 8,043 | 7,204 | ||
Unearned premiums | 3,986 | 4,107 | ||
Other liabilities | 3,361 | 3,739 | ||
Intercompany notes payable | 267 | 248 | ||
Borrowings related to securitization entities | 219 | 242 | ||
Non-recourse funding obligations | 1,996 | 2,038 | ||
Long-term borrowings | 488 | 525 | ||
Deferred tax liability | 1,898 | 1,028 | ||
Separate account liabilities | 9,208 | 10,138 | ||
Total liabilities | 91,424 | 88,502 | ||
Stockholders' equity: | ||||
Common stock | 0 | 0 | ||
Additional paid-in capital | 17,080 | 17,215 | ||
Accumulated other comprehensive income (loss) | 4,459 | 2,512 | ||
Retained earnings | -4,205 | -2,551 | ||
Treasury stock, at cost | 0 | 0 | ||
Total Genworth Financial, Inc.'s stockholders' equity | 17,334 | 17,176 | ||
Noncontrolling interests | 1,879 | 1,232 | ||
Total stockholders' equity | 19,213 | 18,408 | ||
Total liabilities and stockholders' equity | 110,637 | 106,910 | ||
Eliminations | ||||
Assets | ||||
Fixed maturity securities available-for-sale, at fair value | -200 | -200 | ||
Equity securities available-for-sale, at fair value | 0 | 0 | ||
Commercial mortgage loans | 0 | 0 | ||
Restricted commercial mortgage loans related to securitization entities | 0 | 0 | ||
Policy loans | 0 | 0 | ||
Other invested assets | -5 | 0 | ||
Restricted other invested assets related to securitization entities, at fair value | 0 | 0 | ||
Investments in subsidiaries | -29,898 | -29,287 | ||
Total investments | -30,103 | -29,487 | ||
Cash and cash equivalents | 0 | 0 | 0 | |
Accrued investment income | -4 | -4 | ||
Deferred acquisition costs | 0 | 0 | ||
Intangible assets | 0 | 0 | ||
Goodwill | 0 | 0 | ||
Reinsurance recoverable | 0 | 0 | ||
Other assets | -1 | -2 | ||
Intercompany notes receivable | -671 | -649 | ||
Separate account assets | 0 | 0 | ||
Total assets | -30,779 | -30,142 | ||
Liabilities and stockholders' equity | ||||
Future policy benefits | 0 | 0 | ||
Policyholder account balances | 0 | 0 | ||
Liability for policy and contract claims | 0 | 0 | ||
Unearned premiums | 0 | 0 | ||
Other liabilities | -11 | -5 | ||
Intercompany notes payable | -871 | -849 | ||
Borrowings related to securitization entities | 0 | 0 | ||
Non-recourse funding obligations | 0 | 0 | ||
Long-term borrowings | 0 | 0 | ||
Deferred tax liability | 0 | 0 | ||
Separate account liabilities | 0 | 0 | ||
Total liabilities | -882 | -854 | ||
Stockholders' equity: | ||||
Common stock | 0 | 0 | ||
Additional paid-in capital | -26,242 | -26,512 | ||
Accumulated other comprehensive income (loss) | -8,908 | -5,019 | ||
Retained earnings | 5,258 | 2,248 | ||
Treasury stock, at cost | 0 | 0 | ||
Total Genworth Financial, Inc.'s stockholders' equity | -29,892 | -29,283 | ||
Noncontrolling interests | -5 | -5 | ||
Total stockholders' equity | -29,897 | -29,288 | ||
Total liabilities and stockholders' equity | ($30,779) | ($30,142) |
Condensed_Consolidating_Income
Condensed Consolidating Income Statement (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||
Revenues: | |||||||||||||||
Premiums | $5,431 | $5,148 | $5,041 | ||||||||||||
Net investment income | 3,242 | 3,271 | 3,343 | ||||||||||||
Net investment gains (losses) | -20 | -37 | 27 | ||||||||||||
Insurance and investment product fees and other | 912 | 1,021 | 1,229 | ||||||||||||
Total revenues | 2,424 | 2,404 | 2,415 | 2,322 | 2,412 | 2,317 | 2,371 | 2,303 | 9,565 | 9,403 | 9,640 | ||||
Benefits and expenses: | |||||||||||||||
Benefits and other changes in policy reserves | 6,620 | 4,895 | 5,378 | ||||||||||||
Interest credited | 737 | 738 | 775 | ||||||||||||
Acquisition and operating expenses, net of deferrals | 1,585 | 1,659 | 1,594 | ||||||||||||
Amortization of deferred acquisition costs and intangibles | 571 | 569 | 722 | ||||||||||||
Goodwill impairment | 849 | 0 | 89 | ||||||||||||
Interest expense | 479 | 492 | 476 | ||||||||||||
Total benefits and expenses | 3,347 | [1] | 3,376 | [1] | 2,102 | [1] | 2,016 | [1] | 2,097 | 2,066 | 2,124 | 2,066 | 10,841 | 8,353 | 9,034 |
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries | -1,276 | 1,050 | 606 | ||||||||||||
Provision (benefit) for income taxes | -228 | 324 | 138 | ||||||||||||
Equity in income (loss) of subsidiaries | 0 | 0 | 0 | ||||||||||||
Income (loss) from continuing operations | -708 | [2] | -787 | [2] | 228 | [2] | 219 | [2] | 245 | 146 | 174 | 161 | -1,048 | 726 | 468 |
Income (loss) from discontinued operations, net of taxes | 0 | 2 | 6 | -20 | 0 | -12 | 57 | ||||||||
Net income (loss) | -708 | [2] | -787 | [2] | 228 | [2] | 219 | [2] | 245 | 148 | 180 | 141 | -1,048 | 714 | 525 |
Less: net income attributable to noncontrolling interests | 52 | 57 | 52 | 35 | 37 | 40 | 39 | 38 | 196 | 154 | 200 | ||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -760 | [2] | -844 | [2] | 176 | [2] | 184 | [2] | 208 | 108 | 141 | 103 | -1,244 | 560 | 325 |
Parent Guarantor | |||||||||||||||
Revenues: | |||||||||||||||
Premiums | 0 | 0 | 0 | ||||||||||||
Net investment income | -2 | -1 | 0 | ||||||||||||
Net investment gains (losses) | 0 | 0 | 0 | ||||||||||||
Insurance and investment product fees and other | 0 | 0 | 0 | ||||||||||||
Total revenues | -2 | -1 | 0 | ||||||||||||
Benefits and expenses: | |||||||||||||||
Benefits and other changes in policy reserves | 0 | 0 | 0 | ||||||||||||
Interest credited | 0 | 0 | 0 | ||||||||||||
Acquisition and operating expenses, net of deferrals | 21 | 33 | 7 | ||||||||||||
Amortization of deferred acquisition costs and intangibles | 0 | 0 | 0 | ||||||||||||
Goodwill impairment | 0 | 0 | |||||||||||||
Interest expense | 0 | 0 | 0 | ||||||||||||
Total benefits and expenses | 21 | 33 | 7 | ||||||||||||
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries | -23 | -34 | -7 | ||||||||||||
Provision (benefit) for income taxes | -8 | 13 | -3 | ||||||||||||
Equity in income (loss) of subsidiaries | -1,229 | 607 | 329 | ||||||||||||
Income (loss) from continuing operations | -1,244 | 560 | 325 | ||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | 0 | 0 | ||||||||||||
Net income (loss) | -1,244 | 560 | 325 | ||||||||||||
Less: net income attributable to noncontrolling interests | 0 | 0 | 0 | ||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -1,244 | 560 | 325 | ||||||||||||
Issuer | |||||||||||||||
Revenues: | |||||||||||||||
Premiums | 0 | 0 | 0 | ||||||||||||
Net investment income | 0 | 1 | 1 | ||||||||||||
Net investment gains (losses) | 4 | 6 | -29 | ||||||||||||
Insurance and investment product fees and other | -4 | 0 | -1 | ||||||||||||
Total revenues | 0 | 7 | -29 | ||||||||||||
Benefits and expenses: | |||||||||||||||
Benefits and other changes in policy reserves | 0 | 0 | 0 | ||||||||||||
Interest credited | 0 | 0 | 0 | ||||||||||||
Acquisition and operating expenses, net of deferrals | 0 | 32 | 8 | ||||||||||||
Amortization of deferred acquisition costs and intangibles | 0 | 0 | 0 | ||||||||||||
Goodwill impairment | 0 | 0 | |||||||||||||
Interest expense | 321 | 322 | 315 | ||||||||||||
Total benefits and expenses | 321 | 354 | 323 | ||||||||||||
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries | -321 | -347 | -352 | ||||||||||||
Provision (benefit) for income taxes | -112 | -120 | -110 | ||||||||||||
Equity in income (loss) of subsidiaries | -1,147 | 796 | 636 | ||||||||||||
Income (loss) from continuing operations | -1,356 | 569 | 394 | ||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | -29 | 0 | ||||||||||||
Net income (loss) | -1,356 | 540 | 394 | ||||||||||||
Less: net income attributable to noncontrolling interests | 0 | 0 | 0 | ||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -1,356 | 540 | 394 | ||||||||||||
All Other Subsidiaries | |||||||||||||||
Revenues: | |||||||||||||||
Premiums | 5,431 | 5,148 | 5,041 | ||||||||||||
Net investment income | 3,259 | 3,286 | 3,357 | ||||||||||||
Net investment gains (losses) | -24 | -43 | 56 | ||||||||||||
Insurance and investment product fees and other | 917 | 1,025 | 1,234 | ||||||||||||
Total revenues | 9,583 | 9,416 | 9,688 | ||||||||||||
Benefits and expenses: | |||||||||||||||
Benefits and other changes in policy reserves | 6,620 | 4,895 | 5,378 | ||||||||||||
Interest credited | 737 | 738 | 775 | ||||||||||||
Acquisition and operating expenses, net of deferrals | 1,564 | 1,594 | 1,579 | ||||||||||||
Amortization of deferred acquisition costs and intangibles | 571 | 569 | 722 | ||||||||||||
Goodwill impairment | 849 | 89 | |||||||||||||
Interest expense | 174 | 189 | 179 | ||||||||||||
Total benefits and expenses | 10,515 | 7,985 | 8,722 | ||||||||||||
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries | -932 | 1,431 | 966 | ||||||||||||
Provision (benefit) for income taxes | -104 | 431 | 251 | ||||||||||||
Equity in income (loss) of subsidiaries | 0 | 0 | -38 | ||||||||||||
Income (loss) from continuing operations | -828 | 1,000 | 677 | ||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | 17 | 57 | ||||||||||||
Net income (loss) | -828 | 1,017 | 734 | ||||||||||||
Less: net income attributable to noncontrolling interests | 196 | 154 | 200 | ||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -1,024 | 863 | 534 | ||||||||||||
Eliminations | |||||||||||||||
Revenues: | |||||||||||||||
Premiums | 0 | 0 | 0 | ||||||||||||
Net investment income | -15 | -15 | -15 | ||||||||||||
Net investment gains (losses) | 0 | 0 | 0 | ||||||||||||
Insurance and investment product fees and other | -1 | -4 | -4 | ||||||||||||
Total revenues | -16 | -19 | -19 | ||||||||||||
Benefits and expenses: | |||||||||||||||
Benefits and other changes in policy reserves | 0 | 0 | 0 | ||||||||||||
Interest credited | 0 | 0 | 0 | ||||||||||||
Acquisition and operating expenses, net of deferrals | 0 | 0 | 0 | ||||||||||||
Amortization of deferred acquisition costs and intangibles | 0 | 0 | 0 | ||||||||||||
Goodwill impairment | 0 | 0 | |||||||||||||
Interest expense | -16 | -19 | -18 | ||||||||||||
Total benefits and expenses | -16 | -19 | -18 | ||||||||||||
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries | 0 | 0 | -1 | ||||||||||||
Provision (benefit) for income taxes | -4 | 0 | 0 | ||||||||||||
Equity in income (loss) of subsidiaries | 2,376 | -1,403 | -927 | ||||||||||||
Income (loss) from continuing operations | 2,380 | -1,403 | -928 | ||||||||||||
Income (loss) from discontinued operations, net of taxes | 0 | 0 | 0 | ||||||||||||
Net income (loss) | 2,380 | -1,403 | -928 | ||||||||||||
Less: net income attributable to noncontrolling interests | 0 | 0 | 0 | ||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | $2,380 | ($1,403) | ($928) | ||||||||||||
[1] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates. | ||||||||||||||
[2] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. |
Condensed_Consolidating_Statem
Condensed Consolidating Statement of Comprehensive Income (Detail) (USD $) | 3 Months Ended | 12 Months Ended | ||||||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||
Net income (loss) | ($708) | [1] | ($787) | [1] | $228 | [1] | $219 | [1] | $245 | $148 | $180 | $141 | ($1,048) | $714 | $525 | |||
Other comprehensive income (loss), net of taxes: | ||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,573 | -1,817 | 1,078 | |||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 10 | 66 | 78 | |||||||||||||||
Derivatives qualifying as hedges | 751 | [2] | -590 | [2] | -100 | [2] | ||||||||||||
Foreign currency translation and other adjustments | -537 | -442 | 126 | |||||||||||||||
Total other comprehensive income (loss) | 1,797 | -2,783 | 1,182 | |||||||||||||||
Total comprehensive income (loss) | 749 | -2,069 | 1,707 | |||||||||||||||
Less: comprehensive income attributable to noncontrolling interests | 32 | 31 | 227 | |||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders | 717 | -2,100 | 1,480 | |||||||||||||||
Parent Guarantor | ||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||
Net income (loss) | -1,244 | 560 | 325 | |||||||||||||||
Other comprehensive income (loss), net of taxes: | ||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,539 | -1,778 | 1,075 | |||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 10 | 66 | 78 | |||||||||||||||
Derivatives qualifying as hedges | 751 | -590 | -100 | |||||||||||||||
Foreign currency translation and other adjustments | -339 | -358 | 102 | |||||||||||||||
Total other comprehensive income (loss) | 1,961 | -2,660 | 1,155 | |||||||||||||||
Total comprehensive income (loss) | 717 | -2,100 | 1,480 | |||||||||||||||
Less: comprehensive income attributable to noncontrolling interests | 0 | 0 | 0 | |||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders | 717 | -2,100 | 1,480 | |||||||||||||||
Issuer | ||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||
Net income (loss) | -1,356 | 540 | 394 | |||||||||||||||
Other comprehensive income (loss), net of taxes: | ||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,510 | -1,733 | 1,046 | |||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 11 | 65 | 78 | |||||||||||||||
Derivatives qualifying as hedges | 751 | -590 | -100 | |||||||||||||||
Foreign currency translation and other adjustments | -273 | -335 | 81 | |||||||||||||||
Total other comprehensive income (loss) | 1,999 | -2,593 | 1,105 | |||||||||||||||
Total comprehensive income (loss) | 643 | -2,053 | 1,499 | |||||||||||||||
Less: comprehensive income attributable to noncontrolling interests | 0 | 0 | 0 | |||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders | 643 | -2,053 | 1,499 | |||||||||||||||
All Other Subsidiaries | ||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||
Net income (loss) | -828 | 1,017 | 734 | |||||||||||||||
Other comprehensive income (loss), net of taxes: | ||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,573 | -1,817 | 1,078 | |||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 10 | 66 | 78 | |||||||||||||||
Derivatives qualifying as hedges | 794 | -615 | -98 | |||||||||||||||
Foreign currency translation and other adjustments | -537 | -442 | 126 | |||||||||||||||
Total other comprehensive income (loss) | 1,840 | -2,808 | 1,184 | |||||||||||||||
Total comprehensive income (loss) | 1,012 | -1,791 | 1,918 | |||||||||||||||
Less: comprehensive income attributable to noncontrolling interests | 32 | 31 | 227 | |||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders | 980 | -1,822 | 1,691 | |||||||||||||||
Eliminations | ||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||
Net income (loss) | 2,380 | -1,403 | -928 | |||||||||||||||
Other comprehensive income (loss), net of taxes: | ||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | -3,049 | 3,511 | -2,121 | |||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | -21 | -131 | -156 | |||||||||||||||
Derivatives qualifying as hedges | -1,545 | 1,205 | 198 | |||||||||||||||
Foreign currency translation and other adjustments | 612 | 693 | -183 | |||||||||||||||
Total other comprehensive income (loss) | -4,003 | 5,278 | -2,262 | |||||||||||||||
Total comprehensive income (loss) | -1,623 | 3,875 | -3,190 | |||||||||||||||
Less: comprehensive income attributable to noncontrolling interests | 0 | 0 | 0 | |||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders | ($1,623) | $3,875 | ($3,190) | |||||||||||||||
[1] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. | |||||||||||||||||
[2] | See note 5 for additional information. |
Condensed_Consolidating_Statem1
Condensed Consolidating Statement of Cash Flows (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Cash flows from operating activities: | |||
Net income | ($1,048) | $714 | $525 |
Less (income) loss from discontinued operations, net of taxes | 0 | 12 | -57 |
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||
Equity in (income) loss from subsidiaries | 0 | 0 | 0 |
Dividends from subsidiaries | 0 | 0 | 0 |
Amortization of fixed maturity discounts and premiums and limited partnerships | -97 | -97 | -88 |
Net investment losses (gains) | 20 | 37 | -27 |
Charges assessed to policyholders | -777 | -812 | -801 |
Acquisition costs deferred | -473 | -457 | -611 |
Amortization of deferred acquisition costs and intangibles | 571 | 569 | 722 |
Goodwill impairment | 849 | 0 | 89 |
Deferred income taxes | -487 | -79 | 82 |
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | 206 | -59 | 191 |
Stock-based compensation expense | 30 | 41 | 26 |
Change in certain assets and liabilities: | |||
Accrued investment income and other assets | -129 | -43 | -68 |
Insurance reserves | 3,212 | 2,256 | 2,330 |
Current tax liabilities | -180 | 288 | -234 |
Other liabilities, policy and contract claims and other policy-related balances | 741 | -1,039 | -1,166 |
Cash from operating activities-discontinued operations | 0 | 68 | 49 |
Net cash from operating activities | 2,438 | 1,399 | 962 |
Cash flows from investing activities: | |||
Fixed maturity securities | 5,364 | 5,040 | 5,176 |
Commercial mortgage loans | 765 | 896 | 891 |
Restricted commercial mortgage loans related to securitization entities | 32 | 60 | 67 |
Proceeds from sales of investments: | |||
Fixed maturity and equity securities | 2,490 | 4,436 | 5,735 |
Purchases and originations of investments: | |||
Fixed maturity and equity securities | -9,492 | -10,805 | -12,322 |
Commercial mortgage loans | -967 | -873 | -692 |
Other invested assets, net | -40 | 89 | 416 |
Policy loans, net | 12 | 242 | -29 |
Intercompany notes receivable | 0 | 0 | 0 |
Capital contributions to subsidiaries | 0 | 0 | 0 |
Proceeds from sale of a subsidiary, net of cash transferred | 0 | 365 | 77 |
Cash from investing activities-discontinued operations | 0 | -30 | -41 |
Net cash from investing activities | -1,836 | -580 | -722 |
Cash flows from financing activities: | |||
Deposits to universal life and investment contracts | 2,993 | 2,999 | 2,810 |
Withdrawals from universal life and investment contracts | -2,588 | -3,269 | -2,781 |
Redemption and repurchase of non-recourse funding obligations | -42 | -28 | -1,056 |
Proceeds from the issuance of long-term debt | 144 | 793 | 361 |
Repayment and repurchase of long-term debt | -621 | -365 | -322 |
Repayment of borrowings related to securitization entities | -32 | -108 | -72 |
Proceeds from intercompany notes payable | 0 | 0 | 0 |
Repurchase of subsidiary shares | -28 | -43 | 0 |
Dividends paid to noncontrolling interests | -75 | -52 | -50 |
Dividends paid to parent | 0 | 0 | |
Proceeds from the sale of subsidiary shares to noncontrolling interests | 517 | 0 | 0 |
Other, net | -63 | -73 | 54 |
Cash from financing activities-discontinued operations | 0 | -3 | -45 |
Net cash from financing activities | 205 | -149 | -1,101 |
Effect of exchange rate changes on cash and cash equivalents | -103 | -109 | 26 |
Net change in cash and cash equivalents | 704 | 561 | -835 |
Cash and cash equivalents at beginning of period | 4,214 | 3,653 | 4,488 |
Cash and cash equivalents at end of period | 4,918 | 4,214 | 3,653 |
Less cash and cash equivalents of discontinued operations at end of period | 0 | 0 | 21 |
Cash and cash equivalents at end of year | 4,918 | 4,214 | 3,632 |
Parent Guarantor | |||
Cash flows from operating activities: | |||
Net income | -1,244 | 560 | 325 |
Less (income) loss from discontinued operations, net of taxes | 0 | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||
Equity in (income) loss from subsidiaries | 1,229 | -607 | -329 |
Dividends from subsidiaries | 0 | 535 | 0 |
Amortization of fixed maturity discounts and premiums and limited partnerships | 0 | 0 | 0 |
Net investment losses (gains) | 0 | 0 | 0 |
Charges assessed to policyholders | 0 | 0 | 0 |
Acquisition costs deferred | 0 | 0 | 0 |
Amortization of deferred acquisition costs and intangibles | 0 | 0 | 0 |
Goodwill impairment | 0 | 0 | |
Deferred income taxes | 4 | 24 | -3 |
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | 0 | 0 | 0 |
Stock-based compensation expense | 21 | 26 | 7 |
Change in certain assets and liabilities: | |||
Accrued investment income and other assets | -4 | 2 | 0 |
Insurance reserves | 0 | 0 | 0 |
Current tax liabilities | -2 | 3 | 0 |
Other liabilities, policy and contract claims and other policy-related balances | 11 | -4 | 0 |
Cash from operating activities-discontinued operations | 0 | 0 | |
Net cash from operating activities | 15 | 539 | 0 |
Cash flows from investing activities: | |||
Fixed maturity securities | 0 | 0 | 0 |
Commercial mortgage loans | 0 | 0 | 0 |
Restricted commercial mortgage loans related to securitization entities | 0 | 0 | 0 |
Proceeds from sales of investments: | |||
Fixed maturity and equity securities | 0 | 0 | 0 |
Purchases and originations of investments: | |||
Fixed maturity and equity securities | 0 | 0 | 0 |
Commercial mortgage loans | 0 | 0 | 0 |
Other invested assets, net | 0 | 0 | 0 |
Policy loans, net | 0 | 0 | 0 |
Intercompany notes receivable | -1 | -8 | 0 |
Capital contributions to subsidiaries | -12 | -531 | 0 |
Proceeds from sale of a subsidiary, net of cash transferred | 0 | 0 | |
Cash from investing activities-discontinued operations | 0 | 0 | |
Net cash from investing activities | -13 | -539 | 0 |
Cash flows from financing activities: | |||
Deposits to universal life and investment contracts | 0 | 0 | 0 |
Withdrawals from universal life and investment contracts | 0 | 0 | 0 |
Redemption and repurchase of non-recourse funding obligations | 0 | 0 | 0 |
Proceeds from the issuance of long-term debt | 0 | 0 | 0 |
Repayment and repurchase of long-term debt | 0 | 0 | 0 |
Repayment of borrowings related to securitization entities | 0 | 0 | 0 |
Proceeds from intercompany notes payable | 0 | 0 | 0 |
Repurchase of subsidiary shares | 0 | 0 | |
Dividends paid to noncontrolling interests | 0 | 0 | 0 |
Dividends paid to parent | 0 | 0 | |
Proceeds from the sale of subsidiary shares to noncontrolling interests | 0 | ||
Other, net | -2 | 0 | 0 |
Cash from financing activities-discontinued operations | 0 | 0 | |
Net cash from financing activities | -2 | 0 | 0 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0 |
Net change in cash and cash equivalents | 0 | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 | 0 |
Cash and cash equivalents at end of period | 0 | 0 | 0 |
Less cash and cash equivalents of discontinued operations at end of period | 0 | 0 | |
Cash and cash equivalents at end of year | 0 | 0 | 0 |
Issuer | |||
Cash flows from operating activities: | |||
Net income | -1,356 | 540 | 394 |
Less (income) loss from discontinued operations, net of taxes | 0 | 29 | 0 |
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||
Equity in (income) loss from subsidiaries | 1,147 | -796 | -636 |
Dividends from subsidiaries | 630 | 376 | 545 |
Amortization of fixed maturity discounts and premiums and limited partnerships | 0 | 0 | 0 |
Net investment losses (gains) | -4 | -6 | 29 |
Charges assessed to policyholders | 0 | 0 | 0 |
Acquisition costs deferred | 0 | 0 | 0 |
Amortization of deferred acquisition costs and intangibles | 0 | 0 | 0 |
Goodwill impairment | 0 | 0 | |
Deferred income taxes | -146 | -138 | -274 |
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | 1 | 1 | -27 |
Stock-based compensation expense | 0 | 0 | 16 |
Change in certain assets and liabilities: | |||
Accrued investment income and other assets | -9 | 67 | 53 |
Insurance reserves | 0 | 0 | 0 |
Current tax liabilities | -77 | 45 | -43 |
Other liabilities, policy and contract claims and other policy-related balances | 91 | -11 | 10 |
Cash from operating activities-discontinued operations | 0 | 0 | |
Net cash from operating activities | 277 | 107 | 67 |
Cash flows from investing activities: | |||
Fixed maturity securities | 150 | 0 | 0 |
Commercial mortgage loans | 0 | 0 | 0 |
Restricted commercial mortgage loans related to securitization entities | 0 | 0 | 0 |
Proceeds from sales of investments: | |||
Fixed maturity and equity securities | 0 | 150 | 10 |
Purchases and originations of investments: | |||
Fixed maturity and equity securities | -150 | -150 | -150 |
Commercial mortgage loans | 0 | 0 | 0 |
Other invested assets, net | 0 | 0 | 30 |
Policy loans, net | 0 | 0 | 0 |
Intercompany notes receivable | -19 | -3 | -31 |
Capital contributions to subsidiaries | 0 | -1 | -20 |
Proceeds from sale of a subsidiary, net of cash transferred | 425 | 0 | |
Cash from investing activities-discontinued operations | -30 | -18 | |
Net cash from investing activities | -19 | 391 | -179 |
Cash flows from financing activities: | |||
Deposits to universal life and investment contracts | 0 | 0 | 0 |
Withdrawals from universal life and investment contracts | 0 | 0 | 0 |
Redemption and repurchase of non-recourse funding obligations | 0 | 0 | 0 |
Proceeds from the issuance of long-term debt | 0 | 793 | 361 |
Repayment and repurchase of long-term debt | -485 | -365 | -322 |
Repayment of borrowings related to securitization entities | 0 | 0 | 0 |
Proceeds from intercompany notes payable | 3 | -87 | 58 |
Repurchase of subsidiary shares | 0 | 0 | |
Dividends paid to noncontrolling interests | 0 | 0 | 0 |
Dividends paid to parent | 0 | -414 | |
Proceeds from the sale of subsidiary shares to noncontrolling interests | 0 | ||
Other, net | -42 | -49 | -49 |
Cash from financing activities-discontinued operations | 0 | 0 | |
Net cash from financing activities | -524 | -122 | 48 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0 |
Net change in cash and cash equivalents | -266 | 376 | -64 |
Cash and cash equivalents at beginning of period | 1,219 | 843 | 907 |
Cash and cash equivalents at end of period | 953 | 1,219 | 843 |
Less cash and cash equivalents of discontinued operations at end of period | 0 | 0 | |
Cash and cash equivalents at end of year | 953 | 1,219 | 843 |
All Other Subsidiaries | |||
Cash flows from operating activities: | |||
Net income | -828 | 1,017 | 734 |
Less (income) loss from discontinued operations, net of taxes | 0 | -17 | -57 |
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||
Equity in (income) loss from subsidiaries | 0 | 0 | 38 |
Dividends from subsidiaries | -630 | -497 | -545 |
Amortization of fixed maturity discounts and premiums and limited partnerships | -97 | -97 | -88 |
Net investment losses (gains) | 24 | 43 | -56 |
Charges assessed to policyholders | -777 | -812 | -801 |
Acquisition costs deferred | -473 | -457 | -611 |
Amortization of deferred acquisition costs and intangibles | 571 | 569 | 722 |
Goodwill impairment | 849 | 89 | |
Deferred income taxes | -341 | 35 | 359 |
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | 205 | -60 | 218 |
Stock-based compensation expense | 9 | 15 | 3 |
Change in certain assets and liabilities: | |||
Accrued investment income and other assets | -117 | -112 | -122 |
Insurance reserves | 3,212 | 2,256 | 2,330 |
Current tax liabilities | -101 | 240 | -191 |
Other liabilities, policy and contract claims and other policy-related balances | 645 | -1,024 | -1,181 |
Cash from operating activities-discontinued operations | 68 | 49 | |
Net cash from operating activities | 2,151 | 1,167 | 890 |
Cash flows from investing activities: | |||
Fixed maturity securities | 5,214 | 5,040 | 5,176 |
Commercial mortgage loans | 765 | 896 | 891 |
Restricted commercial mortgage loans related to securitization entities | 32 | 60 | 67 |
Proceeds from sales of investments: | |||
Fixed maturity and equity securities | 2,490 | 4,286 | 5,725 |
Purchases and originations of investments: | |||
Fixed maturity and equity securities | -9,342 | -10,655 | -12,172 |
Commercial mortgage loans | -967 | -873 | -692 |
Other invested assets, net | -45 | 89 | 391 |
Policy loans, net | 12 | 242 | -29 |
Intercompany notes receivable | -2 | 95 | -58 |
Capital contributions to subsidiaries | 12 | 532 | 20 |
Proceeds from sale of a subsidiary, net of cash transferred | -60 | 77 | |
Cash from investing activities-discontinued operations | 0 | -23 | |
Net cash from investing activities | -1,831 | -348 | -627 |
Cash flows from financing activities: | |||
Deposits to universal life and investment contracts | 2,993 | 2,999 | 2,810 |
Withdrawals from universal life and investment contracts | -2,588 | -3,269 | -2,781 |
Redemption and repurchase of non-recourse funding obligations | -42 | -28 | -1,056 |
Proceeds from the issuance of long-term debt | 144 | 0 | 0 |
Repayment and repurchase of long-term debt | -136 | 0 | 0 |
Repayment of borrowings related to securitization entities | -32 | -108 | -72 |
Proceeds from intercompany notes payable | 19 | 3 | 31 |
Repurchase of subsidiary shares | -28 | -43 | |
Dividends paid to noncontrolling interests | -75 | -52 | -50 |
Dividends paid to parent | 0 | 0 | |
Proceeds from the sale of subsidiary shares to noncontrolling interests | 517 | ||
Other, net | -19 | -24 | 103 |
Cash from financing activities-discontinued operations | -3 | -45 | |
Net cash from financing activities | 753 | -525 | -1,060 |
Effect of exchange rate changes on cash and cash equivalents | -103 | -109 | 26 |
Net change in cash and cash equivalents | 970 | 185 | -771 |
Cash and cash equivalents at beginning of period | 2,995 | 2,810 | 3,581 |
Cash and cash equivalents at end of period | 3,965 | 2,995 | 2,810 |
Less cash and cash equivalents of discontinued operations at end of period | 0 | 21 | |
Cash and cash equivalents at end of year | 3,965 | 2,995 | 2,789 |
Eliminations | |||
Cash flows from operating activities: | |||
Net income | 2,380 | -1,403 | -928 |
Less (income) loss from discontinued operations, net of taxes | 0 | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||
Equity in (income) loss from subsidiaries | -2,376 | 1,403 | 927 |
Dividends from subsidiaries | 0 | -414 | 0 |
Amortization of fixed maturity discounts and premiums and limited partnerships | 0 | 0 | 0 |
Net investment losses (gains) | 0 | 0 | 0 |
Charges assessed to policyholders | 0 | 0 | 0 |
Acquisition costs deferred | 0 | 0 | 0 |
Amortization of deferred acquisition costs and intangibles | 0 | 0 | 0 |
Goodwill impairment | 0 | 0 | |
Deferred income taxes | -4 | 0 | 0 |
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 |
Change in certain assets and liabilities: | |||
Accrued investment income and other assets | 1 | 0 | 1 |
Insurance reserves | 0 | 0 | 0 |
Current tax liabilities | 0 | 0 | 0 |
Other liabilities, policy and contract claims and other policy-related balances | -6 | 0 | 5 |
Cash from operating activities-discontinued operations | 0 | 0 | |
Net cash from operating activities | -5 | -414 | 5 |
Cash flows from investing activities: | |||
Fixed maturity securities | 0 | 0 | 0 |
Commercial mortgage loans | 0 | 0 | 0 |
Restricted commercial mortgage loans related to securitization entities | 0 | 0 | 0 |
Proceeds from sales of investments: | |||
Fixed maturity and equity securities | 0 | 0 | 0 |
Purchases and originations of investments: | |||
Fixed maturity and equity securities | 0 | 0 | 0 |
Commercial mortgage loans | 0 | 0 | 0 |
Other invested assets, net | 5 | 0 | -5 |
Policy loans, net | 0 | 0 | 0 |
Intercompany notes receivable | 22 | -84 | 89 |
Capital contributions to subsidiaries | 0 | 0 | 0 |
Proceeds from sale of a subsidiary, net of cash transferred | 0 | 0 | |
Cash from investing activities-discontinued operations | 0 | 0 | |
Net cash from investing activities | 27 | -84 | 84 |
Cash flows from financing activities: | |||
Deposits to universal life and investment contracts | 0 | 0 | 0 |
Withdrawals from universal life and investment contracts | 0 | 0 | 0 |
Redemption and repurchase of non-recourse funding obligations | 0 | 0 | 0 |
Proceeds from the issuance of long-term debt | 0 | 0 | 0 |
Repayment and repurchase of long-term debt | 0 | 0 | 0 |
Repayment of borrowings related to securitization entities | 0 | 0 | 0 |
Proceeds from intercompany notes payable | -22 | 84 | -89 |
Repurchase of subsidiary shares | 0 | 0 | |
Dividends paid to noncontrolling interests | 0 | 0 | 0 |
Dividends paid to parent | 0 | 414 | |
Proceeds from the sale of subsidiary shares to noncontrolling interests | 0 | ||
Other, net | 0 | 0 | 0 |
Cash from financing activities-discontinued operations | 0 | 0 | |
Net cash from financing activities | -22 | 498 | -89 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0 |
Net change in cash and cash equivalents | 0 | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 | 0 |
Cash and cash equivalents at end of period | 0 | 0 | 0 |
Less cash and cash equivalents of discontinued operations at end of period | 0 | 0 | |
Cash and cash equivalents at end of year | $0 | $0 | $0 |
Schedule_I_Genworth_Financial_1
Schedule I Genworth Financial, Inc. Summary of Investments-Other than Investments in Related Parties (Detail) (USD $) | Dec. 31, 2014 | |
In Millions, unless otherwise specified | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | $66,548 | |
Fair value | 0 | |
Carrying value | 73,238 | |
Commercial mortgage loans | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 6,100 | |
Fair value | 0 | |
Carrying value | 6,100 | |
Restricted commercial mortgage loans related to securitization entities | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 201 | |
Fair value | 0 | |
Carrying value | 201 | |
Policy Loans | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 1,501 | |
Fair value | 0 | |
Carrying value | 1,501 | |
Other invested assets | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 1,132 | [1] |
Fair value | 0 | [1] |
Carrying value | 2,296 | [1] |
Restricted other invested assets related to securitization entities | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 411 | |
Fair value | 0 | |
Carrying value | 411 | |
Fixed maturity securities | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 56,950 | |
Fair value | 62,447 | |
Carrying value | 62,447 | |
Fixed maturity securities | Bonds | U.S. government, agencies and authorities | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 5,006 | |
Fair value | 6,000 | |
Carrying value | 6,000 | |
Fixed maturity securities | Bonds | Tax-exempt | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 347 | |
Fair value | 362 | |
Carrying value | 362 | |
Fixed maturity securities | Bonds | Government - non-U.S. | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 1,952 | |
Fair value | 2,106 | |
Carrying value | 2,106 | |
Fixed maturity securities | Bonds | Public Utilities | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 3,551 | |
Fair value | 4,167 | |
Carrying value | 4,167 | |
Fixed maturity securities | Bonds | All Other Corporate Bonds | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 46,094 | |
Fair value | 49,812 | |
Carrying value | 49,812 | |
Equity Securities | ||
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items] | ||
Amortized cost or cost | 253 | |
Fair value | 282 | |
Carrying value | $282 | |
[1] | The amount shown in the consolidated balance sheet for other invested assets differs from amortized cost or cost presented, as other invested assets include certain assets with a carrying amount that differs from amortized cost or cost. |
Schedule_II_Genworth_Financial1
Schedule II Genworth Financial, Inc. (Parent Company Only) (Balance Sheets) (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | ||||
In Millions, unless otherwise specified | ||||||||
Assets | ||||||||
Investments in subsidiaries | $0 | $0 | ||||||
Deferred tax asset | 2,699 | 2,700 | ||||||
Other assets | 633 | 639 | ||||||
Intercompany notes receivable | 0 | 0 | ||||||
Total assets | 111,358 | 108,045 | ||||||
Liabilities: | ||||||||
Other liabilities | 3,604 | 4,096 | ||||||
Total liabilities | 94,561 | 92,425 | ||||||
Commitments and contingencies | ||||||||
Stockholders' equity: | ||||||||
Common stock | 1 | 1 | ||||||
Additional paid-in capital | 11,997 | 12,127 | ||||||
Net unrealized investment gains (losses): | ||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 2,431 | 914 | ||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 22 | 12 | ||||||
Net unrealized investment gains (losses) | 2,453 | [1] | 926 | [1] | 2,638 | [1] | 1,485 | [1] |
Derivatives qualifying as hedges | 2,070 | [2] | 1,319 | [2] | 1,909 | [2] | 2,009 | [2] |
Foreign currency translation and other adjustments | -77 | 297 | 655 | 553 | ||||
Total accumulated other comprehensive income (loss) | 4,446 | 2,542 | 5,202 | 4,047 | ||||
Retained earnings | 1,179 | 2,423 | ||||||
Treasury stock, at cost | -2,700 | -2,700 | ||||||
Total Genworth Financial, Inc.'s stockholders' equity | 14,923 | 14,393 | ||||||
Total liabilities and stockholders' equity | 111,358 | 108,045 | ||||||
Parent Company | ||||||||
Assets | ||||||||
Investments in subsidiaries | 14,895 | 14,358 | ||||||
Deferred tax asset | 20 | 26 | ||||||
Other assets | 2 | 7 | ||||||
Intercompany notes receivable | 9 | 8 | ||||||
Total assets | 14,926 | 14,399 | ||||||
Liabilities: | ||||||||
Other liabilities | 3 | 6 | ||||||
Total liabilities | 3 | 6 | ||||||
Commitments and contingencies | ||||||||
Stockholders' equity: | ||||||||
Common stock | 1 | 1 | ||||||
Additional paid-in capital | 11,997 | 12,127 | ||||||
Net unrealized investment gains (losses): | ||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 2,431 | 914 | ||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 22 | 12 | ||||||
Net unrealized investment gains (losses) | 2,453 | 926 | ||||||
Derivatives qualifying as hedges | 2,070 | 1,319 | ||||||
Foreign currency translation and other adjustments | -77 | 297 | ||||||
Total accumulated other comprehensive income (loss) | 4,446 | 2,542 | ||||||
Retained earnings | 1,179 | 2,423 | ||||||
Treasury stock, at cost | -2,700 | -2,700 | ||||||
Total Genworth Financial, Inc.'s stockholders' equity | 14,923 | 14,393 | ||||||
Total liabilities and stockholders' equity | $14,926 | $14,399 | ||||||
[1] | Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. | |||||||
[2] | See note 5 for additional information. |
Schedule_II_Genworth_Financial2
Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Income) (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | ||||
Revenues: | |||||||||||||||
Net investment income | $3,242 | $3,271 | $3,343 | ||||||||||||
Total revenues | 2,424 | 2,404 | 2,415 | 2,322 | 2,412 | 2,317 | 2,371 | 2,303 | 9,565 | 9,403 | 9,640 | ||||
Benefits and expenses: | |||||||||||||||
Acquisition and operating expenses, net of deferrals | 1,585 | 1,659 | 1,594 | ||||||||||||
Total benefits and expenses | 3,347 | [1] | 3,376 | [1] | 2,102 | [1] | 2,016 | [1] | 2,097 | 2,066 | 2,124 | 2,066 | 10,841 | 8,353 | 9,034 |
Loss before income taxes and equity in income (loss) of subsidiaries | -1,276 | 1,050 | 606 | ||||||||||||
Provision (benefit) from income taxes | -228 | 324 | 138 | ||||||||||||
Equity in income (loss) of subsidiaries | 0 | 0 | 0 | ||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -760 | [2] | -844 | [2] | 176 | [2] | 184 | [2] | 208 | 108 | 141 | 103 | -1,244 | 560 | 325 |
Parent Company | |||||||||||||||
Revenues: | |||||||||||||||
Net investment income | -2 | -1 | 0 | ||||||||||||
Total revenues | -2 | -1 | 0 | ||||||||||||
Benefits and expenses: | |||||||||||||||
Acquisition and operating expenses, net of deferrals | 21 | 33 | 7 | ||||||||||||
Total benefits and expenses | 21 | 33 | 7 | ||||||||||||
Loss before income taxes and equity in income (loss) of subsidiaries | -23 | -34 | -7 | ||||||||||||
Provision (benefit) from income taxes | -8 | 13 | -3 | ||||||||||||
Equity in income (loss) of subsidiaries | -1,229 | 607 | 329 | ||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | ($1,244) | $560 | $325 | ||||||||||||
[1] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates. | ||||||||||||||
[2] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. |
Schedule_II_Genworth_Financial3
Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Comprehensive Income) (Detail) (USD $) | 3 Months Ended | 12 Months Ended | ||||||||||||||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | |||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | ($708) | [1] | ($787) | [1] | $228 | [1] | $219 | [1] | $245 | $148 | $180 | $141 | ($1,048) | $714 | $525 | |||
Other comprehensive income (loss), net of taxes: | ||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,573 | -1,817 | 1,078 | |||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 10 | 66 | 78 | |||||||||||||||
Derivatives qualifying as hedges | 751 | [2] | -590 | [2] | -100 | [2] | ||||||||||||
Foreign currency translation and other adjustments | -537 | -442 | 126 | |||||||||||||||
Total other comprehensive income (loss) | 1,797 | -2,783 | 1,182 | |||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders | 717 | -2,100 | 1,480 | |||||||||||||||
Parent Company | ||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ||||||||||||||||||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -1,244 | 560 | 325 | |||||||||||||||
Other comprehensive income (loss), net of taxes: | ||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired | 1,539 | -1,778 | 1,075 | |||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities | 10 | 66 | 78 | |||||||||||||||
Derivatives qualifying as hedges | 751 | -590 | -100 | |||||||||||||||
Foreign currency translation and other adjustments | -339 | -358 | 102 | |||||||||||||||
Total other comprehensive income (loss) | 1,961 | -2,660 | 1,155 | |||||||||||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders | $717 | ($2,100) | $1,480 | |||||||||||||||
[1] | During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was a $66 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. As we consider potential business portfolio changes, we recognized a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in the fourth quarter of 2014, we recognized a net $108 million of tax benefits in our lifestyle protection insurance business primarily from an internal debt restructuring related to the planned sale of that business. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. | |||||||||||||||||
[2] | See note 5 for additional information. |
Schedule_II_Genworth_Financial4
Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Cash Flows) (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Cash flows from operating activities: | |||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | ($1,048) | $714 | $525 |
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||
Equity in (income) loss from subsidiaries | 0 | 0 | 0 |
Dividends from subsidiaries | 0 | 0 | 0 |
Deferred income taxes | -487 | -79 | 82 |
Stock-based compensation expense | 30 | 41 | 26 |
Change in certain assets and liabilities: | |||
Accrued investment income and other assets | -129 | -43 | -68 |
Current tax liabilities | -180 | 288 | -234 |
Other liabilities and other policy-related balances | 741 | -1,039 | -1,166 |
Net cash from operating activities | 2,438 | 1,399 | 962 |
Cash flows from investing activities: | |||
Intercompany notes receivable | 0 | 0 | 0 |
Capital contribution paid to subsidiaries | 0 | 0 | 0 |
Net cash from investing activities | -1,836 | -580 | -722 |
Cash flows from financing activities: | |||
Other, net | -63 | -73 | 54 |
Net cash from financing activities | 205 | -149 | -1,101 |
Effect of exchange rate changes on cash and cash equivalents | -103 | -109 | 26 |
Cash and cash equivalents at beginning of year | 4,214 | 3,632 | |
Cash and cash equivalents at end of year | 4,918 | 4,214 | 3,632 |
Parent Company | |||
Cash flows from operating activities: | |||
Net income (loss) available to Genworth Financial, Inc.'s common stockholders | -1,244 | 560 | 325 |
Adjustments to reconcile net income (loss) to net cash from operating activities: | |||
Equity in (income) loss from subsidiaries | 1,229 | -607 | -329 |
Dividends from subsidiaries | 0 | 535 | 0 |
Deferred income taxes | 4 | 24 | -3 |
Stock-based compensation expense | 21 | 26 | 7 |
Change in certain assets and liabilities: | |||
Accrued investment income and other assets | -4 | 2 | 0 |
Current tax liabilities | -2 | 3 | 0 |
Other liabilities and other policy-related balances | 11 | -4 | 0 |
Net cash from operating activities | 15 | 539 | 0 |
Cash flows from investing activities: | |||
Intercompany notes receivable | -1 | -8 | 0 |
Capital contribution paid to subsidiaries | -12 | -531 | 0 |
Net cash from investing activities | -13 | -539 | 0 |
Cash flows from financing activities: | |||
Other, net | -2 | 0 | 0 |
Net cash from financing activities | -2 | 0 | 0 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 | 0 |
Cash and cash equivalents at beginning of year | 0 | 0 | 0 |
Cash and cash equivalents at end of year | $0 | $0 | $0 |
Schedule_II_Genworth_Financial5
Schedule II Genworth Financial, Inc. (Parent Company Only) - Additional Information (Detail) (USD $) | 1 Months Ended | 12 Months Ended | |||
In Millions, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Apr. 02, 2013 | 31-May-14 | Dec. 31, 2014 | Dec. 31, 2013 |
Condensed Financial Statements, Captions [Line Items] | |||||
Class A Common Stock, par value | $0.00 | $0.00 | $0.00 | ||
Current income tax receivable | $30 | ||||
Current income tax payable | 132 | 132 | |||
Genworth Holdings | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Class A Common Stock, par value | 0.001 | ||||
Percentage of subsidiary equity ownership | 100.00% | ||||
Genworth Financial | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Class A Common Stock, par value | 0.001 | ||||
Genworth Mortgage Holdings, LLC | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Percentage of subsidiary common shares distributed as a dividend | 84.60% | ||||
Percentage of subsidiary equity ownership | 15.40% | ||||
Capital contributions | 300 | ||||
Genworth Mortgage Holdings, Inc. | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Percentage of subsidiary common shares distributed as a dividend | 100.00% | ||||
Genworth Holdings/U.S. Mortgage Insurance Business | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Percentage of subsidiary equity ownership | 100.00% | ||||
Genworth Mortgage Insurance Corporation (GEMICO) | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Capital contributions | 100 | 100 | 300 | ||
Parent Company | |||||
Condensed Financial Statements, Captions [Line Items] | |||||
Deferred tax assets related to tax elections | 20 | 26 | |||
Current income tax receivable | 3 | ||||
Current income tax payable | 6 | 6 | |||
Net cash received for taxes | $23 | $5 |
Schedule_III_Genworth_Financia1
Schedule III Genworth Financial, Inc. Supplemental Insurance Information (Schedule of Supplemental Insurance Information) (Detail) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 |
Supplementary Insurance Information, by Segment [Line Items] | |||
Deferred Acquisition Costs | $5,042 | $5,278 | |
Future Policy Benefits | 35,915 | 33,705 | |
Policyholder Account Balances | 26,043 | 25,528 | |
Liability for Policy and Contract Claims | 8,043 | 7,204 | |
Unearned Premiums | 3,986 | 4,107 | |
Premium Revenue | 5,431 | 5,148 | 5,041 |
Net Investment Income | 3,242 | 3,271 | 3,343 |
Interest Credited and Benefits and Other Changes in Policy Reserves | 7,357 | 5,633 | 6,153 |
Amortization of Deferred Acquisition Costs | 493 | 451 | 618 |
Other Operating Expenses | 2,991 | 2,269 | 2,263 |
Premiums Written | 5,622 | 5,184 | 5,057 |
U.S. Life Insurance | |||
Supplementary Insurance Information, by Segment [Line Items] | |||
Deferred Acquisition Costs | 4,390 | 4,537 | |
Future Policy Benefits | 35,911 | 33,700 | |
Policyholder Account Balances | 22,874 | 22,210 | |
Liability for Policy and Contract Claims | 6,434 | 5,216 | |
Unearned Premiums | 639 | 632 | |
Premium Revenue | 3,169 | 2,957 | 2,789 |
Net Investment Income | 2,665 | 2,621 | 2,594 |
Interest Credited and Benefits and Other Changes in Policy Reserves | 6,438 | 4,594 | 4,593 |
Amortization of Deferred Acquisition Costs | 291 | 298 | 410 |
Other Operating Expenses | 1,648 | 841 | 830 |
Premiums Written | 3,172 | 2,963 | 2,818 |
International Mortgage Insurance | |||
Supplementary Insurance Information, by Segment [Line Items] | |||
Deferred Acquisition Costs | 150 | 152 | |
Future Policy Benefits | 0 | 0 | |
Policyholder Account Balances | 0 | 0 | |
Liability for Policy and Contract Claims | 308 | 378 | |
Unearned Premiums | 2,723 | 2,815 | |
Premium Revenue | 950 | 996 | 1,016 |
Net Investment Income | 303 | 333 | 375 |
Interest Credited and Benefits and Other Changes in Policy Reserves | 204 | 317 | 516 |
Amortization of Deferred Acquisition Costs | 50 | 48 | 52 |
Other Operating Expenses | 263 | 286 | 103 |
Premiums Written | 1,111 | 1,042 | 1,061 |
U.S. Mortgage Insurance | |||
Supplementary Insurance Information, by Segment [Line Items] | |||
Deferred Acquisition Costs | 16 | 12 | |
Future Policy Benefits | 0 | 0 | |
Policyholder Account Balances | 0 | 0 | |
Liability for Policy and Contract Claims | 1,180 | 1,482 | |
Unearned Premiums | 178 | 129 | |
Premium Revenue | 578 | 554 | 549 |
Net Investment Income | 59 | 60 | 68 |
Interest Credited and Benefits and Other Changes in Policy Reserves | 357 | 412 | 725 |
Amortization of Deferred Acquisition Costs | 5 | 4 | 3 |
Other Operating Expenses | 142 | 146 | 145 |
Premiums Written | 628 | 567 | 554 |
International Protection | |||
Supplementary Insurance Information, by Segment [Line Items] | |||
Deferred Acquisition Costs | 193 | 243 | |
Future Policy Benefits | 0 | 0 | |
Policyholder Account Balances | 11 | 16 | |
Liability for Policy and Contract Claims | 106 | 108 | |
Unearned Premiums | 439 | 522 | |
Premium Revenue | 731 | 636 | 682 |
Net Investment Income | 101 | 119 | 131 |
Interest Credited and Benefits and Other Changes in Policy Reserves | 202 | 159 | 150 |
Amortization of Deferred Acquisition Costs | 110 | 97 | 106 |
Other Operating Expenses | 516 | 484 | 624 |
Premiums Written | 709 | 608 | 619 |
Runoff | |||
Supplementary Insurance Information, by Segment [Line Items] | |||
Deferred Acquisition Costs | 293 | 334 | |
Future Policy Benefits | 4 | 5 | |
Policyholder Account Balances | 3,158 | 3,302 | |
Liability for Policy and Contract Claims | 15 | 20 | |
Unearned Premiums | 7 | 9 | |
Premium Revenue | 3 | 5 | 5 |
Net Investment Income | 129 | 139 | 145 |
Interest Credited and Benefits and Other Changes in Policy Reserves | 156 | 151 | 169 |
Amortization of Deferred Acquisition Costs | 37 | 4 | 47 |
Other Operating Expenses | 87 | 85 | 84 |
Premiums Written | 2 | 4 | 5 |
Corporate and Other | |||
Supplementary Insurance Information, by Segment [Line Items] | |||
Deferred Acquisition Costs | 0 | 0 | |
Future Policy Benefits | 0 | 0 | |
Policyholder Account Balances | 0 | 0 | |
Liability for Policy and Contract Claims | 0 | 0 | |
Unearned Premiums | 0 | 0 | |
Premium Revenue | 0 | 0 | 0 |
Net Investment Income | -15 | -1 | 30 |
Interest Credited and Benefits and Other Changes in Policy Reserves | 0 | 0 | 0 |
Amortization of Deferred Acquisition Costs | 0 | 0 | 0 |
Other Operating Expenses | 335 | 427 | 477 |
Premiums Written | $0 | $0 | $0 |